#if (!require("BiocManager", quietly = TRUE))
# install.packages("BiocManager")
#BiocManager::install("multiMiR")
#browseVignettes("multiMiR")
#install.packages("rentrez")Search of mRNA targets with multiMiR
multiMiR
Installation
Documentation
library("multiMiR")Welcome to multiMiR.
multiMiR database URL has been set to the
default value: http://multimir.org/
Database Version: 2.4.0 Updated: 2024-08-28library("kableExtra")
library("dplyr")
Adjuntando el paquete: 'dplyr'The following object is masked from 'package:kableExtra':
group_rowsThe following object is masked from 'package:multiMiR':
selectThe following objects are masked from 'package:stats':
filter, lagThe following objects are masked from 'package:base':
intersect, setdiff, setequal, unionlibrary("ggplot2") # Para visualización (opcional)
library("clusterProfiler") # Para análisis funcional (opcional)clusterProfiler v4.12.6 Learn more at https://yulab-smu.top/contribution-knowledge-mining/
Please cite:
S Xu, E Hu, Y Cai, Z Xie, X Luo, L Zhan, W Tang, Q Wang, B Liu, R Wang,
W Xie, T Wu, L Xie, G Yu. Using clusterProfiler to characterize
multiomics data. Nature Protocols. 2024, doi:10.1038/s41596-024-01020-z
Adjuntando el paquete: 'clusterProfiler'The following object is masked from 'package:multiMiR':
selectThe following object is masked from 'package:stats':
filterlibrary("org.Hs.eg.db") # Base de datos de genes humanosCargando paquete requerido: AnnotationDbiCargando paquete requerido: stats4Cargando paquete requerido: BiocGenerics
Adjuntando el paquete: 'BiocGenerics'The following objects are masked from 'package:dplyr':
combine, intersect, setdiff, unionThe following objects are masked from 'package:stats':
IQR, mad, sd, var, xtabsThe following objects are masked from 'package:base':
anyDuplicated, aperm, append, as.data.frame, basename, cbind,
colnames, dirname, do.call, duplicated, eval, evalq, Filter, Find,
get, grep, grepl, intersect, is.unsorted, lapply, Map, mapply,
match, mget, order, paste, pmax, pmax.int, pmin, pmin.int,
Position, rank, rbind, Reduce, rownames, sapply, setdiff, table,
tapply, union, unique, unsplit, which.max, which.minCargando paquete requerido: BiobaseWelcome to Bioconductor
Vignettes contain introductory material; view with
'browseVignettes()'. To cite Bioconductor, see
'citation("Biobase")', and for packages 'citation("pkgname")'.Cargando paquete requerido: IRangesCargando paquete requerido: S4Vectors
Adjuntando el paquete: 'S4Vectors'The following object is masked from 'package:clusterProfiler':
renameThe following objects are masked from 'package:dplyr':
first, renameThe following object is masked from 'package:utils':
findMatchesThe following objects are masked from 'package:base':
expand.grid, I, unname
Adjuntando el paquete: 'IRanges'The following object is masked from 'package:clusterProfiler':
sliceThe following objects are masked from 'package:dplyr':
collapse, desc, slice
Adjuntando el paquete: 'AnnotationDbi'The following object is masked from 'package:clusterProfiler':
selectThe following object is masked from 'package:dplyr':
selectlibrary("rentrez")Library
The multiMiR database is now versioned. By default multiMiR will use the most recent version each time multiMiR is loaded. However it is now possible to switch between database versions and get information about the multiMiR database versions. multimir_dbInfoVersions() returns a dataframe with the available versions.
db.ver = multimir_dbInfoVersions()
db.ver VERSION UPDATED RDA DBNAME
1 2.4.0 2024-08-28 multimir_cutoffs_2.4.rda multimir2_4
2 2.3.0 2020-04-15 multimir_cutoffs_2.3.rda multimir2_3
3 2.2.0 2017-08-08 multimir_cutoffs_2.2.rda multimir2_2
4 2.1.0 2016-12-22 multimir_cutoffs_2.1.rda multimir2_1
5 2.0.0 2015-05-01 multimir_cutoffs.rda multimir
SCHEMA PUBLIC TABLES
1 multiMiR_DB_schema.sql 1 multiMiR_dbTables.txt
2 multiMiR_DB_schema.sql 1 multiMiR_dbTables.txt
3 multiMiR_DB_schema.sql 1 multiMiR_dbTables.txt
4 multiMiR_DB_schema.sql 1 multiMiR_dbTables.txt
5 multiMiR_DB_schema.sql 1 multiMiR_dbTables.txtTo switch between versions we can use multimir_switchDBVersion().
multimir_switchDBVersion(db_version = "2.4.0")Now using database version: 2.4.0# curr_vers <- vers_table[1, "VERSION"] # current version
# multimir_switchDBVersion(db_version = curr_vers)The remaining functions will query the selected version until the package is reloaded or until we switch to another version.
Information from each external database is stored in a table in the multiMiR database. To see a list of the tables, we can use the multimir_dbTables() function.
db.tables = multimir_dbTables()
db.tables [1] "diana_microt" "elmmo" "map_counts" "map_metadata" "microcosm"
[6] "mir2disease" "miranda" "mirdb" "mirecords" "mirna"
[11] "mirtarbase" "pharmaco_mir" "phenomir" "pictar" "pita"
[16] "tarbase" "target" "targetscan" The function multimir_dbInfo() will display information about the external miRNA and miRNA-target databases in multiMiR, including version, release date, link to download the data, and the corresponding table in multiMiR.
db.info = multimir_dbInfo()
db.info <- as.data.frame(db.info)
db.info |>
kable(format = "html") |>
kable_styling("striped")| map_name | source_name | source_version | source_date | source_url |
|---|---|---|---|---|
| diana_microt | DIANA-microT | 5 | Sept, 2013 | http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=microT_CDS/index |
| elmmo | EIMMo | 5 | Jan, 2011 | http://www.mirz.unibas.ch/miRNAtargetPredictionBulk.php |
| microcosm | MicroCosm | 5 | Sept, 2009 | http://www.ebi.ac.uk/enright-srv/microcosm/cgi-bin/targets/v5/download.pl |
| mir2disease | miR2Disease | Mar 14, 2011 | http://www.mir2disease.org | |
| miranda | miRanda | Aug, 2010 | http://www.microrna.org/microrna/getDownloads.do | |
| mirdb | miRDB | 6 | June, 2019 | http://mirdb.org |
| mirecords | miRecords | 4 | Apr 27, 2013 | http://mirecords.biolead.org/download.php |
| mirtarbase | miRTarBase | 9 | Sept 2021 | http://mirtarbase.mbc.nctu.edu.tw/php/download.php |
| pharmaco_mir | Pharmaco-miR (Verified Sets) | http://www.pharmaco-mir.org/home/download_VERSE_db | ||
| phenomir | PhenomiR | 2 | Feb 15, 2011 | http://mips.helmholtz-muenchen.de/phenomir/ |
| pictar | PicTar | 2 | Dec 21, 2012 | http://dorina.mdc-berlin.de |
| pita | PITA | 6 | Aug 31, 2008 | http://genie.weizmann.ac.il/pubs/mir07/mir07_data.html |
| tarbase | TarBase | 9 | 2023 | https://dianalab.e-ce.uth.gr/tarbasev9 |
| targetscan | TargetScan | 8 | Sept 2021 | https://www.targetscan.org/cgi-bin/targetscan/data_download.vert80.cgi |
Predicted tables
predicted_tables()[1] "diana_microt" "elmmo" "microcosm" "miranda" "mirdb"
[6] "pictar" "pita" "targetscan" Validated Tables
validated_tables()[1] "mirecords" "mirtarbase" "tarbase" Diseasedrug Tables
diseasedrug_tables()[1] "mir2disease" "pharmaco_mir" "phenomir" To see how many records are in these 14 external databases we refer to the multimir_dbCount function.
db.count = multimir_dbCount()
db.count map_name human_count mouse_count rat_count total_count
1 diana_microt 7664602 3747171 0 11411773
2 elmmo 3959112 1449133 547191 5955436
3 microcosm 762987 534735 353378 1651100
4 mir2disease 2875 0 0 2875
5 miranda 5429955 2379881 247368 8057204
6 mirdb 1990425 1091263 199250 3280938
7 mirecords 2425 449 171 3045
8 mirtarbase 957034 116689 1384 1075107
9 pharmaco_mir 308 5 0 313
10 phenomir 15138 491 0 15629
11 pictar 404066 302236 0 706302
12 pita 7710936 5163153 0 12874089
13 tarbase 1290272 473266 1031 1764713
14 targetscan 13964425 10387912 0 24352337db.count |>
kable(format = "html") |>
kable_styling("striped")| map_name | human_count | mouse_count | rat_count | total_count |
|---|---|---|---|---|
| diana_microt | 7664602 | 3747171 | 0 | 11411773 |
| elmmo | 3959112 | 1449133 | 547191 | 5955436 |
| microcosm | 762987 | 534735 | 353378 | 1651100 |
| mir2disease | 2875 | 0 | 0 | 2875 |
| miranda | 5429955 | 2379881 | 247368 | 8057204 |
| mirdb | 1990425 | 1091263 | 199250 | 3280938 |
| mirecords | 2425 | 449 | 171 | 3045 |
| mirtarbase | 957034 | 116689 | 1384 | 1075107 |
| pharmaco_mir | 308 | 5 | 0 | 313 |
| phenomir | 15138 | 491 | 0 | 15629 |
| pictar | 404066 | 302236 | 0 | 706302 |
| pita | 7710936 | 5163153 | 0 | 12874089 |
| tarbase | 1290272 | 473266 | 1031 | 1764713 |
| targetscan | 13964425 | 10387912 | 0 | 24352337 |
Objective
1.Bioinformatic prediction of miR-520-5p and miR-655-3p mRNA targets
Publically available databases will be used to search for mir-520d-5p and mir-655-3p predicted mRNA targets. Most relevant mRNA search will be selected according to the highest score prediction from several algorithms. We intend to construct a list (35-40 mRNA targets) that will be further categorized according to their putative role on metabolism (by bibliographic analysis) to finally summarize 10-15 miRNA-mRNA targets with potential interest in metabolism. Gene ontology /annotation and enrichment analysis of mRNA targets will be performed using public data base (genecodis)
Methodology
To create the validated and predicted table, it was necessary to examine specific parameters available in the tables to ensure reliable results. These parameters were analyzed for each scenario (Validated and Predicted) since they vary depending on whether the goal is to validate or predict targets.
Parameters
Validated
In this case, there is no need to specify a cutoff, as this table will contain only validated targets. Therefore, you should filter based on the columns of the table that you will be obtaining:
Table Information
The columns represent various features or metadata associated with the interactions between microRNAs (miRNAs) and their potential targets.
database: Indicates the source database of the information (e.g., mirtarbase, targetscan, miRDB). This is useful if you want to focus on specific sources or compare results across databases.
mature_mirna_acc: The accession identifier for the mature version of the miRNA in the database (e.g., MIMAT0003331). This unique identifier is useful for unambiguous miRNA identification.
mature_mirna_id: The name of the mature miRNA in standard format (e.g., hsa-miR-655-3p). You can use this to filter specific miRNA interactions.
target_symbol: The gene symbol of the miRNA target (e.g., TGFBR2). Useful for focusing on results for a particular gene.
target_entrez: The unique gene identifier in the Entrez Gene database (e.g., 7048). This is important for bioinformatic analyses requiring unique gene identifiers.
target_ensembl: The unique gene identifier in the Ensembl database (e.g., ENSG00000163513). Similar to the previous field, this is helpful for integration with tools and analyses using Ensembl.
experiment: Describes the experimental methods used to validate the interaction (e.g., Luciferase reporter assay/Western blot/qRT-PCR). This field is crucial if you want to prioritize results with strong experimental evidence.
support_type: Indicates the level of support for the interaction, such as “Functional MTI” (functional miRNA-target interaction). If you are only interested in functional or strongly supported interactions, this field is essential for filtering.
pubmed_id: The identifier of the article in PubMed where the interaction was reported (e.g., 23690952). Useful for exploring the original studies to obtain more details.
DB.link: A link to the entry in the original database where the interaction can be verified. This is helpful for directly consulting the source.
type: Specifies whether the interaction is “validated” or “predicted.” Validated interactions are usually more reliable as they are backed by experimental evidence. This is one of the most important fields for filtering reliable interactions.
Which Columns Are Useful for Filtering More Accurate Results?
To obtain more specific and reliable results, the following columns can be particularly useful:
- type: Filter by “validated” if you are only interested in experimentally confirmed interactions.
- experiment: Prioritize interactions with high-confidence experimental methods, such as Luciferase reporter assay or Western blot.
- support_type: Use “Functional MTI” to focus on functional interactions supported by experimental evidence.
- pubmed_id: Examine the references to validate the reliability of the reported data.
- database: Select databases that are most relevant or recognized for your research.
Predicted
In the function get_multimir you need to adjust the following paramaters: #### 1. predicted.cutoff.type = ““ ##### predicted.cutoff.type = "p" - Default Value (predicted.cutoff = NULL):
- Automatically selects the top 20% of predictions if percentage-based cutoff is used (predicted.cutoff.type = "p"). This behavior is generally suitable for human studies because:
- It provides a balanced set of high-quality predictions.
- The filter is designed to reduce noise (i.e., less reliable interactions).
- The resulting set remains manageable, even in large-scale analyses.
- Recommended if you prioritize quality over quantity and do not have a specific criterion to customize the cutoff.
- Customizing the Percentage (
predicted.cutoff = X):- If you want a more restricted (stricter) set, you can reduce this percentage (e.g., selecting the top 10%,
predicted.cutoff = 10).
- If you want a more restricted (stricter) set, you can reduce this percentage (e.g., selecting the top 10%,
predicted.cutoff.type = "n"
Absolute cutoff is useful if you have a fixed dataset size in mind or if you want to maximize the scope of the analysis without focusing on relative proportions.
- Default Value (
predicted.cutoff = NULL):- Selects the top 300,000 predictions or all available records if there are fewer than 300,000.
- This approach can be helpful for comprehensive studies but is less precise if you aim to prioritize high-quality predictions.
- Selects the top 300,000 predictions or all available records if there are fewer than 300,000.
- Customizing the Number (
predicted.cutoff = X):- For example, setting
predicted.cutoff = 50,000will select the top 50,000 predictions, providing a balance between result size and relevance.
- This is useful if you have computational limitations or know the exact number of records you need to process.
- For example, setting
predicted.site = “conserved”
For humans, the default settings are reasonable in most cases because:
Conserved Predictions: Conserved target sites (
predicted.site = "conserved") are generally more reliable for humans, as they are supported by evolutionary criteria and are more likely to be functional.
Top 20% as Default: Provides high-quality predictions by filtering interactions with the highest scores.
Biological Significance: Conserved sites are often associated with critical functions in organisms. In the case of miRNAs, these sites are more likely to represent real and functional interactions between the miRNA and the target gene. For example, if a binding site for a miRNA in a human gene is also present in mice and rats, it is likely to have an essential biological role.
Higher Likelihood of Experimental Validation: Since conserved sites hold greater biological relevance, they are more likely to have been experimentally validated, increasing confidence in the prediction.
Reduction of Noise in Predictions: Prediction databases such as TargetScan, miRanda, and PITA generate numerous potential interactions, but not all are biologically significant.
Filtering for conserved sites removes less reliable predictions (based solely on sequence matches) and prioritizes those more likely to be functional.
Reliability of the Database Using
predicted.site = "conserved"
- Focus on More Robust Predictions:
- By setting
predicted.site = "conserved", you obtain results that meet conservation criteria in at least one of the three databases (TargetScan, miRanda, or PITA). This means the selected target sites have additional support in terms of evolutionary relevance.
- By setting
- Limitations:
- Lower Coverage: Some miRNAs or genes may not have conserved target sites in these databases, potentially reducing the number of predictions.
- Context Dependency: Not all functional interactions are conserved. Species- or tissue-specific interactions might be excluded.
- Lower Coverage: Some miRNAs or genes may not have conserved target sites in these databases, potentially reducing the number of predictions.
- When to Use Conserved Sites
- Recommended:
- If you are looking for miRNA-gene interactions with a high likelihood of being functional and relevant.
- For comparative studies across species or general approaches in evolutionary biology.
- Avoid It:
- If you are working with species-specific miRNAs or genes with emerging, less-studied roles.
- If you want to maximize the coverage of predictions and are willing to analyze additional results (potentially with more noise).
Search
miRNA targets
hsa-miR-520d-5p
1. Validated Datasets
# The default is to search validated interactions in human
val_hsa_miR_520d_5p <- get_multimir(org = "hsa",
mirna = 'hsa-miR-520d-5p',
table = "validated",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE)Searching mirecords ...Warning: `as_data_frame()` was deprecated in tibble 2.0.0.
ℹ Please use `as_tibble()` (with slightly different semantics) to convert to a
tibble, or `as.data.frame()` to convert to a data frame.
ℹ The deprecated feature was likely used in the multiMiR package.
Please report the issue at <https://github.com/KechrisLab/multiMiR/issues>.Searching mirtarbase ...
Searching tarbase ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.# Check which types of associations were returned
table(val_hsa_miR_520d_5p@data$type)
validated
471 dim(val_hsa_miR_520d_5p@data)[1] 471 11# Detailed information of the validated miRNA-target interaction
head(val_hsa_miR_520d_5p@data)# A tibble: 6 × 11
database mature_mirna_acc mature_mirna_id target_symbol target_entrez
<chr> <chr> <chr> <chr> <chr>
1 mirtarbase MIMAT0002855 hsa-miR-520d-5p NCOA3 8202
2 mirtarbase MIMAT0002855 hsa-miR-520d-5p NCOA3 8202
3 mirtarbase MIMAT0002855 hsa-miR-520d-5p NCOA3 8202
4 mirtarbase MIMAT0002855 hsa-miR-520d-5p NCOA3 8202
5 mirtarbase MIMAT0002855 hsa-miR-520d-5p CD164 8763
6 mirtarbase MIMAT0002855 hsa-miR-520d-5p CD164 8763
# ℹ 6 more variables: target_ensembl <chr>, experiment <chr>,
# support_type <chr>, pubmed_id <chr>, DB.link <chr>, type <chr># Filter with the updated databases, experiment, support_type y type
filter_val_hsa_miR_520d_5p <-val_hsa_miR_520d_5p@data[
val_hsa_miR_520d_5p@data[["database"]] %in% c("mirtarbase", "tarbase") & # Filtrar por bases de datos específicas
grepl("Luciferase|Western blot|qRT-PCR", val_hsa_miR_520d_5p@data[["experiment"]], ignore.case = TRUE) & # Filtro por experimentos específicos
val_hsa_miR_520d_5p@data[["support_type"]] %in% c("Functional MTI", "Functional MTI (Weak)") & # Filtro por soporte funcional
val_hsa_miR_520d_5p@data[["type"]] == "validated", # Filtro por tipo validado
]
# Table with kable
filter_val_hsa_miR_520d_5p |>
kable(format = "html") |>
kable_styling("striped")| database | mature_mirna_acc | mature_mirna_id | target_symbol | target_entrez | target_ensembl | experiment | support_type | pubmed_id | DB.link | type |
|---|---|---|---|---|---|---|---|---|---|---|
| mirtarbase | MIMAT0002855 | hsa-miR-520d-5p | PPIB | 5479 | ENSG00000166794 | ChIP-seq//Immunoprecipitaion//In situ hybridization//Luciferase reporter assay//Western blot | Functional MTI | 28011625 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-520d-5p&targets=PPIB&opt=adv | validated |
2. Predicted
# Conserved Sites
# The default is to search validated interactions in human
pre_hsa_miR_520d_5p <- get_multimir(org = "hsa",
mirna = 'hsa-miR-520d-5p',
table = "predicted",
predicted.cutoff = 10,
predicted.cutoff.type = "p",
predicted.site = "conserved",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE)Searching diana_microt ...
Searching elmmo ...
Searching microcosm ...
Searching miranda ...
Searching mirdb ...
Searching pictar ...
Searching pita ...
Searching targetscan ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.# Check which types of associations were returned
table(pre_hsa_miR_520d_5p@data$type)
predicted
7954 dim(pre_hsa_miR_520d_5p@data)[1] 7954 9# Detailed information of the validated miRNA-target interaction
head(pre_hsa_miR_520d_5p@data)# A tibble: 6 × 9
database mature_mirna_acc mature_mirna_id target_symbol target_entrez
<chr> <chr> <chr> <chr> <chr>
1 diana_microt MIMAT0002855 hsa-miR-520d-5p TEAD1 7003
2 diana_microt MIMAT0002855 hsa-miR-520d-5p ELAVL2 1993
3 diana_microt MIMAT0002855 hsa-miR-520d-5p ELAVL2 1993
4 diana_microt MIMAT0002855 hsa-miR-520d-5p CPEB3 22849
5 diana_microt MIMAT0002855 hsa-miR-520d-5p CPEB3 22849
6 diana_microt MIMAT0002855 hsa-miR-520d-5p ATAD2B 54454
# ℹ 4 more variables: target_ensembl <chr>, score <chr>, DB.link <chr>,
# type <chr># Filter with the updated databases (targetscan)
filter_pre_hsa_miR_520d_5p <- pre_hsa_miR_520d_5p@data[pre_hsa_miR_520d_5p@data[["database"]] %in% c("targetscan", "mirdb") ,]
#as.data.frame(pre_hsa_miR_520d_5p@data)
dim(filter_pre_hsa_miR_520d_5p)[1] 575 9# Table with kable
filter_pre_hsa_miR_520d_5p |>
kable(format = "html") |>
kable_styling("striped")| database | mature_mirna_acc | mature_mirna_id | target_symbol | target_entrez | target_ensembl | score | DB.link | type |
|---|---|---|---|---|---|---|---|---|
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PELI2 | 57161 | ENSG00000139946 | 99.980235779241 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PELI2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PUM2 | 23369 | ENSG00000055917 | 99.9729204636042 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PUM2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ELAVL2 | 1993 | ENSG00000107105 | 99.9578485356912 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ELAVL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MTM1 | 4534 | ENSG00000171100 | 99.9552565287217 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MTM1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | STRBP | 55342 | ENSG00000165209 | 99.8694020722623 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=STRBP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPRE | 5791 | ENSG00000132334 | 99.8529927966043 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPRE | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ELAVL2 | 1993 | ENSG00000107105 | 99.7920379734711 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ELAVL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CPEB2 | 132864 | ENSG00000137449 | 99.7641634401973 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CPEB2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAPK1 | 5594 | ENSG00000100030 | 99.7612014950742 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAPK1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARPP19 | 10776 | ENSG00000128989 | 99.7539055634471 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARPP19 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TEAD1 | 7003 | ENSG00000187079 | 99.7348195681701 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TEAD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAP2C | 57826 | ENSG00000123728 | 99.7237760710509 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAP2C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HOOK3 | 84376 | ENSG00000168172 | 99.6954211033544 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HOOK3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SGIP1 | 84251 | ENSG00000118473 | 99.6914694751931 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SGIP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADAMTS5 | 11096 | ENSG00000154736 | 99.6358396371309 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADAMTS5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SBF2 | 81846 | ENSG00000133812 | 99.5976691143591 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SBF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EBF2 | 64641 | ENSG00000221818 | 99.5708106166337 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EBF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | STRBP | 55342 | ENSG00000165209 | 99.529655022945 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=STRBP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAB11A | 8766 | ENSG00000103769 | 99.4826501595753 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAB11A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC22A10 | 387775 | ENSG00000184999 | 99.44892323481 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC22A10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PUM2 | 23369 | ENSG00000055917 | 99.4394160317056 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PUM2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM39 | 9584 | ENSG00000131051 | 99.413050251026 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM39 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRSF10 | 10772 | ENSG00000188529 | 99.4048255805591 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRSF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SP8 | 221833 | ENSG00000164651 | 99.4002077963732 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SP8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAB33B | 83452 | ENSG00000172007 | 99.3611338881331 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAB33B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TMED7 | 51014 | ENSG00000134970 | 99.3538494822258 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TMED7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NBEA | 26960 | ENSG00000172915 | 99.3237618648754 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NBEA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPN13 | 5783 | ENSG00000163629 | 99.28742120645 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPN13 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VAV3 | 10451 | ENSG00000134215 | 99.2629693587275 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VAV3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DCAF7 | 10238 | ENSG00000136485 | 99.23771021284 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DCAF7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAB2 | 23118 | ENSG00000055208 | 99.2339062859548 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAB2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ANKRD44 | 91526 | ENSG00000065413 | 99.2242095904206 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ANKRD44 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KDM5A | 5927 | ENSG00000073614 | 99.1624362523074 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KDM5A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNOT2 | 4848 | ENSG00000111596 | 99.1508005130787 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNOT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | OGA | 10724 | ENSG00000198408 | 99.146948473802 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=OGA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEH1L | 81929 | ENSG00000085415 | 99.146767673113 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEH1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DNAJC6 | 9829 | ENSG00000116675 | 99.1461486728123 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DNAJC6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RRAS2 | 22800 | ENSG00000133818 | 99.1158104653 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RRAS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPN13 | 5783 | ENSG00000163629 | 99.08065166145 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPN13 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | THSD7A | 221981 | ENSG00000005108 | 99.0751702191554 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=THSD7A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DLG5 | 9231 | ENSG00000151208 | 99.0462309870105 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DLG5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DLG5 | 9231 | ENSG00000274429 | 99.0462309870105 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DLG5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FBXO3 | 26273 | ENSG00000110429 | 99.0040935167127 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FBXO3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | C11orf58 | 10944 | ENSG00000110696 | 98.9957122545536 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=C11orf58 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDK6 | 1021 | ENSG00000105810 | 98.9827966669743 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDK6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LRRTM3 | 347731 | ENSG00000198739 | 98.9686448989064 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LRRTM3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LTN1 | 26046 | ENSG00000198862 | 98.96737921048 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LTN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IGSF3 | 3321 | ENSG00000143061 | 98.9334842148346 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IGSF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MTSS1 | 9788 | ENSG00000170873 | 98.91911934669 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MTSS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC35D1 | 23169 | ENSG00000116704 | 98.9065532653315 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC35D1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NFYB | 4801 | ENSG00000120837 | 98.8796871032645 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NFYB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | INO80D | 54891 | ENSG00000114933 | 98.8762828885989 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=INO80D | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | INO80D | 54891 | ENSG00000283510 | 98.8762828885989 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=INO80D | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SP8 | 221833 | ENSG00000164651 | 98.8710801483011 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SP8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SGMS1 | 259230 | ENSG00000198964 | 98.8544552706709 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SGMS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FBXO30 | 84085 | ENSG00000118496 | 98.7856358928 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FBXO30 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC16A4 | 9122 | ENSG00000168679 | 98.7764814884056 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC16A4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC16A4 | 9122 | ENSG00000168679 | 98.77234439899 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC16A4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GRIN3A | 116443 | ENSG00000198785 | 98.7719038681153 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GRIN3A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NRK | 203447 | ENSG00000123572 | 98.770020011591 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NRK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CSMD3 | 114788 | ENSG00000164796 | 98.752963592066 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CSMD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPRE | 5791 | ENSG00000132334 | 98.7473519034998 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPRE | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CREBRF | 153222 | ENSG00000164463 | 98.7209383306982 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CREBRF | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CPEB2 | 132864 | ENSG00000137449 | 98.7096036443638 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CPEB2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARPP19 | 10776 | ENSG00000128989 | 98.6006497745475 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARPP19 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PDE10A | 10846 | ENSG00000112541 | 98.5890713903771 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PDE10A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAOK1 | 57551 | ENSG00000160551 | 98.5453625985667 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAOK1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FOXD3 | 27022 | ENSG00000187140 | 98.5262462395106 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FOXD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HCFC2 | 29915 | ENSG00000111727 | 98.4803817689046 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HCFC2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZMIZ1 | 57178 | ENSG00000108175 | 98.4544552316208 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZMIZ1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAF4 | 6874 | ENSG00000130699 | 98.4541456455365 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAF4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAF4 | 6874 | ENSG00000280529 | 98.4541456455365 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAF4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM26 | 64062 | ENSG00000139746 | 98.4521022686476 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM26 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SYT4 | 6860 | ENSG00000132872 | 98.368188318322 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SYT4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SOCS6 | 9306 | ENSG00000170677 | 98.3250644615392 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SOCS6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | INTS6 | 26512 | ENSG00000102786 | 98.3241498429012 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=INTS6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | APPBP2 | 10513 | ENSG00000062725 | 98.3211141215772 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=APPBP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | WASHC4 | 23325 | ENSG00000136051 | 98.3170284781958 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=WASHC4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AKIRIN1 | 79647 | ENSG00000174574 | 98.3112547762265 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AKIRIN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA7 | 2045 | ENSG00000135333 | 98.2818166069472 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DCAF10 | 79269 | ENSG00000122741 | 98.2816556912012 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DCAF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GALNT7 | 51809 | ENSG00000109586 | 98.2534802067199 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GALNT7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMC3 | 9126 | ENSG00000108055 | 98.21573448925 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMC3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HIRA | 7290 | ENSG00000100084 | 98.19999 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HIRA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VIRMA | 25962 | ENSG00000164944 | 98.1732009206137 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VIRMA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SGIP1 | 84251 | ENSG00000118473 | 98.1534237572532 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SGIP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DLX1 | 1745 | ENSG00000144355 | 98.1403597126 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DLX1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CHN2 | 1124 | ENSG00000106069 | 98.13227252012 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CHN2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RPRD1A | 55197 | ENSG00000141425 | 98.1222539264259 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RPRD1A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PLEKHF2 | 79666 | ENSG00000175895 | 98.0941973977 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PLEKHF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC30A6 | 55676 | ENSG00000152683 | 98.0798450646213 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC30A6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLITRK4 | 139065 | ENSG00000179542 | 98.0739668539641 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLITRK4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CEBPD | 1052 | ENSG00000221869 | 98.0592423176296 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CEBPD | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LTN1 | 26046 | ENSG00000198862 | 98.030353868 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LTN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAB12 | 201475 | ENSG00000206418 | 97.9542880478369 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAB12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TFRC | 7037 | ENSG00000072274 | 97.9427463284835 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TFRC | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMNDC1 | 10285 | ENSG00000119953 | 97.9412177947846 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMNDC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PSPC1 | 55269 | ENSG00000121390 | 97.92398662613 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PSPC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KPNA1 | 3836 | ENSG00000114030 | 97.8491587775036 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KPNA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM39 | 9584 | ENSG00000131051 | 97.82188355914 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM39 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ASH1L | 55870 | ENSG00000116539 | 97.81426817095 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ASH1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNOT6L | 246175 | ENSG00000138767 | 97.7980802204241 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNOT6L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CCNT2 | 905 | ENSG00000082258 | 97.7167643091764 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CCNT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CEP120 | 153241 | ENSG00000168944 | 97.7147587710757 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CEP120 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PDIK1L | 149420 | ENSG00000175087 | 97.6890766300613 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PDIK1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF704 | 619279 | ENSG00000164684 | 97.6758431033522 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF704 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAB11A | 8766 | ENSG00000103769 | 97.6740716241233 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAB11A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMURF2 | 64750 | ENSG00000108854 | 97.6462640094 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMURF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | YBX1 | 4904 | ENSG00000065978 | 97.5999041240619 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=YBX1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPP3CA | 5530 | ENSG00000138814 | 97.4392442130339 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPP3CA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EED | 8726 | ENSG00000074266 | 97.4189467285 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EED | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZMAT3 | 64393 | ENSG00000172667 | 97.2947272177482 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZMAT3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATAD2B | 54454 | ENSG00000119778 | 97.2757532437194 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATAD2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SCN2A | 6326 | ENSG00000136531 | 97.2697552125 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SCN2A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MEOX2 | 4223 | ENSG00000106511 | 97.2627462203158 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MEOX2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PNOC | 5368 | ENSG00000168081 | 97.2523736757 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PNOC | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC6A6 | 6533 | ENSG00000131389 | 97.1829646020826 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC6A6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | WASHC4 | 23325 | ENSG00000136051 | 97.1554265742646 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=WASHC4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAP4K3 | 8491 | ENSG00000011566 | 97.14987086267 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAP4K3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SHISA3 | 152573 | ENSG00000178343 | 97.14858937066 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SHISA3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | JARID2 | 3720 | ENSG00000008083 | 97.1464728092 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=JARID2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NR4A2 | 4929 | ENSG00000153234 | 97.1350013549127 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NR4A2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AGRN | 375790 | ENSG00000188157 | 97.05871 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AGRN | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAP2C | 57826 | ENSG00000123728 | 97.0555894321592 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAP2C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | E2F8 | 79733 | ENSG00000129173 | 97.0429885891 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=E2F8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | USF3 | 205717 | ENSG00000176542 | 97.0165983429737 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=USF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRSF10 | 10772 | ENSG00000188529 | 97.0117440882891 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRSF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DCAF10 | 79269 | ENSG00000122741 | 97.0013564751862 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DCAF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LYPD6 | 130574 | ENSG00000187123 | 96.9904137084418 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LYPD6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SP3 | 6670 | ENSG00000172845 | 96.9199950608268 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SP3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DOCK10 | 55619 | ENSG00000135905 | 96.91846754985 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DOCK10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATP2B1 | 490 | ENSG00000070961 | 96.901931517418 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATP2B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KAT6A | 7994 | ENSG00000083168 | 96.8988306462472 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KAT6A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SS18 | 6760 | ENSG00000141380 | 96.8808269555438 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SS18 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FZD3 | 7976 | ENSG00000104290 | 96.8771938971039 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FZD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RSBN1 | 54665 | ENSG00000081019 | 96.8543011825 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RSBN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PHIP | 55023 | ENSG00000146247 | 96.8293627005297 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PHIP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PCDH9 | 5101 | ENSG00000184226 | 96.8290130066 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PCDH9 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MEF2C | 4208 | ENSG00000081189 | 96.825211963981 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MEF2C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GLUD1 | 2746 | ENSG00000148672 | 96.81969788728 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GLUD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZBTB34 | 403341 | ENSG00000177125 | 96.8065602477241 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZBTB34 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATP2B1 | 490 | ENSG00000070961 | 96.7583490037814 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATP2B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARL13B | 200894 | ENSG00000169379 | 96.7580337035244 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARL13B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RIN2 | 54453 | ENSG00000132669 | 96.7324740916972 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RIN2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KCNN4 | 3783 | ENSG00000104783 | 96.71794 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KCNN4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA7 | 2045 | ENSG00000135333 | 96.6884086494545 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC6A6 | 6533 | ENSG00000131389 | 96.6742523169886 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC6A6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLHL28 | 54813 | ENSG00000179454 | 96.6685777634971 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLHL28 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM76B | 143684 | ENSG00000077458 | 96.655553285342 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM76B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IPMK | 253430 | ENSG00000151151 | 96.6393144213068 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IPMK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MBNL1 | 4154 | ENSG00000152601 | 96.635728193 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MBNL1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAP1B | 5908 | ENSG00000127314 | 96.563274001169 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAP1B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ANKRD46 | 157567 | ENSG00000186106 | 96.5603431823267 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ANKRD46 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRKRA | 8575 | ENSG00000180228 | 96.523340249 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRKRA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CEP350 | 9857 | ENSG00000135837 | 96.49348051634 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CEP350 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IGSF3 | 3321 | ENSG00000143061 | 96.4923260624342 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IGSF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAFA1 | 407738 | ENSG00000183662 | 96.474690197 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAFA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM126A | 84668 | ENSG00000122591 | 96.4486617038817 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM126A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PNISR | 25957 | ENSG00000132424 | 96.4321705606567 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PNISR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PNISR | 25957 | ENSG00000132424 | 96.4169808588181 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PNISR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NKRF | 55922 | ENSG00000186416 | 96.4108453445 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NKRF | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDK6 | 1021 | ENSG00000105810 | 96.3982020613525 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDK6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | JMY | 133746 | ENSG00000152409 | 96.3923971331477 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=JMY | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM221A | 340277 | ENSG00000188732 | 96.37799579164 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM221A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PARP8 | 79668 | ENSG00000151883 | 96.3694749765039 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PARP8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VAV3 | 10451 | ENSG00000134215 | 96.3492509332969 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VAV3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLHL28 | 54813 | ENSG00000179454 | 96.3471864319276 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLHL28 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RNF138 | 51444 | ENSG00000134758 | 96.3459469543736 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RNF138 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MBTPS1 | 8720 | ENSG00000140943 | 96.3416401816 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MBTPS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAOK1 | 57551 | ENSG00000160551 | 96.303315703559 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAOK1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAP4K5 | 11183 | ENSG00000012983 | 96.2933906208 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAP4K5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZFR | 51663 | ENSG00000056097 | 96.2348567867 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZFR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | L3MBTL3 | 84456 | ENSG00000198945 | 96.22942846583 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=L3MBTL3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBE2Q2 | 92912 | ENSG00000140367 | 96.2283312247826 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBE2Q2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SPCS3 | 60559 | ENSG00000129128 | 96.2193427455392 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SPCS3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNR1 | 1268 | ENSG00000118432 | 96.1608185696827 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDC42BPB | 9578 | ENSG00000198752 | 96.1466905201962 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDC42BPB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CAMTA1 | 23261 | ENSG00000171735 | 96.1374282237347 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CAMTA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAFA2 | 338811 | ENSG00000198673 | 96.1267323244264 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAFA2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | APPL2 | 55198 | ENSG00000136044 | 96.10724 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=APPL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLF6 | 1316 | ENSG00000067082 | 96.0778163188019 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLF6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SIX4 | 51804 | ENSG00000100625 | 96.07193235595 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SIX4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | WWC2 | 80014 | ENSG00000151718 | 96.0064503842795 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=WWC2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EGFL6 | 25975 | ENSG00000198759 | 96.0000778888 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EGFL6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SUZ12 | 23512 | ENSG00000178691 | 95.996302048 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SUZ12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRKCB | 5579 | ENSG00000166501 | 95.9744343032972 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRKCB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GDF10 | 2662 | ENSG00000266524 | 95.96981 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GDF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RPRD1A | 55197 | ENSG00000141425 | 95.9679657695789 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RPRD1A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF367 | 195828 | ENSG00000165244 | 95.9636311195476 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF367 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ANGPTL7 | 10218 | ENSG00000171819 | 95.9426153824 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ANGPTL7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM3C | 10447 | ENSG00000196937 | 95.9257270204 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM3C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NEGR1 | 257194 | ENSG00000172260 | 95.9095117862723 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NEGR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRKD3 | 23683 | ENSG00000115825 | 95.8932801888743 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRKD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC1A2 | 6506 | ENSG00000110436 | 95.856515298118 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC1A2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | STK26 | 51765 | ENSG00000134602 | 95.8342380368539 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=STK26 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6B | 55889 | ENSG00000215186 | 95.8332734304 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZMYM1 | 79830 | ENSG00000197056 | 95.78845 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZMYM1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RNF138 | 51444 | ENSG00000134758 | 95.7544887581899 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RNF138 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | JUN | 3725 | ENSG00000177606 | 95.7470851401177 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=JUN | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZEB2 | 9839 | ENSG00000169554 | 95.7295414892482 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZEB2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TSNAX | 7257 | ENSG00000116918 | 95.7026540234112 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TSNAX | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CCSER1 | 401145 | ENSG00000184305 | 95.6882678444157 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CCSER1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATMIN | 23300 | ENSG00000166454 | 95.6747850235844 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATMIN | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPP1R1B | 84152 | ENSG00000131771 | 95.65546 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPP1R1B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ETS2 | 2114 | ENSG00000157557 | 95.6463425301539 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ETS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZBTB43 | 23099 | ENSG00000169155 | 95.6214050483869 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZBTB43 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FBN1 | 2200 | ENSG00000166147 | 95.620669509405 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FBN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IRX2 | 153572 | ENSG00000170561 | 95.5736023734 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IRX2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SESTD1 | 91404 | ENSG00000187231 | 95.5260041424791 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SESTD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GTF2A1 | 2957 | ENSG00000165417 | 95.5221040191355 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GTF2A1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA5 | 2044 | ENSG00000145242 | 95.4999845732955 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EGLN1 | 54583 | ENSG00000135766 | 95.49259240566 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EGLN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADCYAP1 | 116 | ENSG00000141433 | 95.4365350303 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADCYAP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CREM | 1390 | ENSG00000095794 | 95.4123482197138 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CREM | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SCYL2 | 55681 | ENSG00000136021 | 95.3969180414681 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SCYL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PDIK1L | 149420 | ENSG00000175087 | 95.3478343812677 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PDIK1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPM1L | 151742 | ENSG00000163590 | 95.3215120881492 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPM1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MECOM | 2122 | ENSG00000085276 | 95.2863329589988 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MECOM | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NSG1 | 27065 | ENSG00000168824 | 95.28088 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NSG1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | USP53 | 54532 | ENSG00000145390 | 95.276165118231 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=USP53 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NWD2 | 57495 | ENSG00000174145 | 95.2478007832 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NWD2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CLVS2 | 134829 | ENSG00000146352 | 95.1932083901349 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CLVS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FBXO32 | 114907 | ENSG00000156804 | 95.167334365 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FBXO32 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GATAD2B | 57459 | ENSG00000261992 | 95.1373292283146 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GATAD2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GATAD2B | 57459 | ENSG00000143614 | 95.1373292283146 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GATAD2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CREM | 1390 | ENSG00000095794 | 95.1111417595265 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CREM | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRD5A1 | 6715 | ENSG00000145545 | 95.0641452874 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRD5A1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AHCTF1 | 25909 | ENSG00000153207 | 95.01533869376 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AHCTF1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | WIPF3 | 644150 | ENSG00000122574 | 95.01247224994 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=WIPF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CTHRC1 | 115908 | ENSG00000164932 | 94.99182962698 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CTHRC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TMEM181 | 57583 | ENSG00000146433 | 94.9851272018718 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TMEM181 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBN2 | 254048 | ENSG00000157741 | 94.938379530314 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBN2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLITRK4 | 139065 | ENSG00000179542 | 94.9307383853984 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLITRK4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TMEM161B | 153396 | ENSG00000164180 | 94.930181505456 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TMEM161B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SECISBP2L | 9728 | ENSG00000138593 | 94.8700718830783 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SECISBP2L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AMFR | 267 | ENSG00000159461 | 94.86686 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AMFR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF106 | 64397 | ENSG00000103994 | 94.8521800078199 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF106 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KCNK2 | 3776 | ENSG00000082482 | 94.831185272 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KCNK2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PDE10A | 10846 | ENSG00000112541 | 94.8217410252762 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PDE10A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TES | 26136 | ENSG00000135269 | 94.818028704949 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TES | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NCOA1 | 8648 | ENSG00000084676 | 94.7976103189 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NCOA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | INTS10 | 55174 | ENSG00000104613 | 94.7921202730579 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=INTS10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HIP1 | 3092 | ENSG00000127946 | 94.78812345325 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HIP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TSHZ1 | 10194 | ENSG00000179981 | 94.78602 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TSHZ1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KIAA1324 | 57535 | ENSG00000116299 | 94.7661622682185 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KIAA1324 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBE2D3 | 7323 | ENSG00000109332 | 94.7353109869969 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBE2D3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | L3MBTL3 | 84456 | ENSG00000198945 | 94.73112727187 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=L3MBTL3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SCYL2 | 55681 | ENSG00000136021 | 94.7304608520739 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SCYL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC40A1 | 30061 | ENSG00000138449 | 94.70282837427 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC40A1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HEY2 | 23493 | ENSG00000135547 | 94.69909264 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HEY2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SELENOI | 85465 | ENSG00000138018 | 94.6911098630401 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SELENOI | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM12 | 10137 | ENSG00000244462 | 94.6871113476334 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SAFB | 6294 | ENSG00000160633 | 94.68149 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SAFB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BCOR | 54880 | ENSG00000183337 | 94.650969781 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BCOR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAPK1IP1L | 93487 | ENSG00000168175 | 94.6205359353834 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAPK1IP1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RORA | 6095 | ENSG00000069667 | 94.5713428667958 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RORA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CLK4 | 57396 | ENSG00000113240 | 94.56125 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CLK4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CSMD3 | 114788 | ENSG00000164796 | 94.5537460863026 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CSMD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTHLH | 5744 | ENSG00000087494 | 94.5063316497871 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTHLH | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATP2B2 | 491 | ENSG00000157087 | 94.4887564092356 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATP2B2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZBTB44 | 29068 | ENSG00000196323 | 94.4848641703019 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZBTB44 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | USP54 | 159195 | ENSG00000166348 | 94.4607100753 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=USP54 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAST4 | 375449 | ENSG00000069020 | 94.4581635077383 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAST4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GLUD1 | 2746 | ENSG00000148672 | 94.4554766984 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GLUD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NXPH2 | 11249 | ENSG00000144227 | 94.4366824567 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NXPH2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DIP2C | 22982 | ENSG00000151240 | 94.41218499112 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DIP2C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATP8A1 | 10396 | ENSG00000124406 | 94.4023374079443 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATP8A1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NCOA1 | 8648 | ENSG00000084676 | 94.38621526105 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NCOA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RSPH4A | 345895 | ENSG00000111834 | 94.3823532859619 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RSPH4A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA1 | 2041 | ENSG00000146904 | 94.37266 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA1 | 2041 | ENSG00000284816 | 94.37266 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNTN1 | 1272 | ENSG00000018236 | 94.3272020143 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNTN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MTMR12 | 54545 | ENSG00000150712 | 94.2541997424 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MTMR12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CCNT2 | 905 | ENSG00000082258 | 94.2415087505623 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CCNT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HMGA2 | 8091 | ENSG00000149948 | 94.2393958031059 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HMGA2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | C1orf35 | 79169 | ENSG00000143793 | 94.23088 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=C1orf35 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMAD3 | 4088 | ENSG00000166949 | 94.22777 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMAD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM76A | 199870 | ENSG00000009780 | 94.2042015937 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM76A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPP6C | 5537 | ENSG00000119414 | 94.199178246899 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPP6C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PREX2 | 80243 | ENSG00000046889 | 94.1910997004152 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PREX2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA3 | 2042 | ENSG00000044524 | 94.1868958658 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PNISR | 25957 | ENSG00000132424 | 94.161706204186 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PNISR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZCRB1 | 85437 | ENSG00000139168 | 94.1095044807627 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZCRB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SYF2 | 25949 | ENSG00000117614 | 94.0775384491 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SYF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | JAG1 | 182 | ENSG00000101384 | 94.0739259298002 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=JAG1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MIS18BP1 | 55320 | ENSG00000129534 | 94.0642882411 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MIS18BP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TTBK2 | 146057 | ENSG00000128881 | 94.0585537244688 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TTBK2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SH3KBP1 | 30011 | ENSG00000147010 | 94.0512747570537 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SH3KBP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MEAF6 | 64769 | ENSG00000163875 | 94.0508498464024 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MEAF6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RUFY2 | 55680 | ENSG00000204130 | 94.04038 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RUFY2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CYP7B1 | 9420 | ENSG00000172817 | 94.02064 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CYP7B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LYPD6 | 130574 | ENSG00000187123 | 93.9971822786555 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LYPD6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PDCD10 | 11235 | ENSG00000114209 | 93.98456 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PDCD10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DENND5B | 160518 | ENSG00000170456 | 93.981805179393 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DENND5B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CPEB3 | 22849 | ENSG00000107864 | 93.9607084808627 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CPEB3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM169A | 26049 | ENSG00000198780 | 93.9336551408901 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM169A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6A | 342096 | ENSG00000159289 | 93.9249295444 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBA3 | 9039 | ENSG00000144744 | 93.9113965406 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBA3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | B4GALT1 | 2683 | ENSG00000086062 | 93.89526303574 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=B4GALT1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GPM6A | 2823 | ENSG00000150625 | 93.8613364086293 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GPM6A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | POC5 | 134359 | ENSG00000152359 | 93.85851 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=POC5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PUS7 | 54517 | ENSG00000091127 | 93.847 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PUS7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RSPH4A | 345895 | ENSG00000111834 | 93.8167660786199 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RSPH4A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | REST | 5978 | ENSG00000084093 | 93.7916543955048 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=REST | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNTN5 | 53942 | ENSG00000149972 | 93.7880934744615 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNTN5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | API5 | 8539 | ENSG00000166181 | 93.7624183848193 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=API5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DRAM1 | 55332 | ENSG00000136048 | 93.7621825402517 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DRAM1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CREB1 | 1385 | ENSG00000118260 | 93.7270110951005 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CREB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ANKRD46 | 157567 | ENSG00000186106 | 93.7238982908594 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ANKRD46 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BTAF1 | 9044 | ENSG00000095564 | 93.6993636554 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BTAF1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TCF7L2 | 6934 | ENSG00000148737 | 93.6820215605 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TCF7L2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NFIA | 4774 | ENSG00000162599 | 93.663245058196 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NFIA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ELF1 | 1997 | ENSG00000120690 | 93.6569199036 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ELF1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FGFR2 | 2263 | ENSG00000066468 | 93.6481321216 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FGFR2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAI14 | 26064 | ENSG00000039560 | 93.64412 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAI14 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEC24B | 10427 | ENSG00000138802 | 93.6313540009 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEC24B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | JARID2 | 3720 | ENSG00000008083 | 93.630187122 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=JARID2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAP3K8 | 1326 | ENSG00000107968 | 93.6042151023145 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAP3K8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EED | 8726 | ENSG00000074266 | 93.6028379155 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EED | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MTSS1 | 9788 | ENSG00000170873 | 93.582503072 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MTSS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NFIA | 4774 | ENSG00000162599 | 93.5818533508314 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NFIA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DOCK1 | 1793 | ENSG00000150760 | 93.5608 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DOCK1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | USP25 | 29761 | ENSG00000155313 | 93.5573365219957 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=USP25 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CSMD1 | 64478 | ENSG00000183117 | 93.5436915218 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CSMD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MSRB3 | 253827 | ENSG00000174099 | 93.5389603963696 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MSRB3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GPBP1 | 65056 | ENSG00000062194 | 93.53639 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GPBP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZBTB43 | 23099 | ENSG00000169155 | 93.5350133341011 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZBTB43 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FBLN2 | 2199 | ENSG00000163520 | 93.52903 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FBLN2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPFIA1 | 8500 | ENSG00000131626 | 93.52667141982 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPFIA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | YWHAQ | 10971 | ENSG00000134308 | 93.5124153088 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=YWHAQ | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MLLT6 | 4302 | ENSG00000275851 | 93.4707963344 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MLLT6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MLLT6 | 4302 | ENSG00000275023 | 93.4707963344 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MLLT6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DOCK4 | 9732 | ENSG00000128512 | 93.4633546144 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DOCK4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDH4 | 1002 | ENSG00000179242 | 93.410433159 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDH4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDH4 | 1002 | ENSG00000280641 | 93.410433159 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDH4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6D | 653643 | ENSG00000140478 | 93.3967222066 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6D | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IQGAP2 | 10788 | ENSG00000145703 | 93.3836642728 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IQGAP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | OXSR1 | 9943 | ENSG00000172939 | 93.3486158775 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=OXSR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SPRED1 | 161742 | ENSG00000166068 | 93.2824151806357 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SPRED1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PIP5K1A | 8394 | ENSG00000143398 | 93.24938 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PIP5K1A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TMEM170B | 100113407 | ENSG00000205269 | 93.249208343303 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TMEM170B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPP3R1 | 5534 | ENSG00000221823 | 93.2299854468202 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPP3R1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLIT2 | 9353 | ENSG00000145147 | 93.2140527692375 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLIT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZMAT3 | 64393 | ENSG00000172667 | 93.1981422069849 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZMAT3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMPX | 23676 | ENSG00000091482 | 93.19426 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMPX | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARHGAP33 | 115703 | ENSG00000004777 | 93.18625 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARHGAP33 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SUZ12 | 23512 | ENSG00000178691 | 93.174923588 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SUZ12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ITPR1 | 3708 | ENSG00000150995 | 93.1714795682 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ITPR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBE2Q2 | 92912 | ENSG00000140367 | 93.1692266580888 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBE2Q2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GPT2 | 84706 | ENSG00000166123 | 93.14939 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GPT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GSPT1 | 2935 | ENSG00000103342 | 93.1359680713932 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GSPT1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLF6 | 1316 | ENSG00000067082 | 93.1189305755287 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLF6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC10A4 | 201780 | ENSG00000145248 | 93.04061 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC10A4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LRRC3B | 116135 | ENSG00000179796 | 93.02061 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LRRC3B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ACTR3B | 57180 | ENSG00000133627 | 92.9706604576 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ACTR3B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SIRT1 | 23411 | ENSG00000096717 | 92.96487 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SIRT1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADIPOR1 | 51094 | ENSG00000159346 | 92.96416 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADIPOR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CAV2 | 858 | ENSG00000105971 | 92.95874 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CAV2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NPAT | 4863 | ENSG00000149308 | 92.9416397617 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NPAT | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HNRNPK | 3190 | ENSG00000165119 | 92.90225728284 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HNRNPK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RYR2 | 6262 | ENSG00000198626 | 92.90128 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RYR2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAF12 | 6883 | ENSG00000120656 | 92.8869538556 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAF12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CHN2 | 1124 | ENSG00000106069 | 92.8653 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CHN2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | 1124 | ENSG00000285162 | 92.8653 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox= | predicted | |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NR2F1 | 7025 | ENSG00000175745 | 92.8634476011 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NR2F1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CD46 | 4179 | ENSG00000117335 | 92.8447658508262 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CD46 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CD46 | 4179 | ENSG00000117335 | 92.833139758687 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CD46 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPC1 | 80314 | ENSG00000120616 | 92.8034761622 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BCOR | 54880 | ENSG00000183337 | 92.7702752926 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BCOR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATAD2B | 54454 | ENSG00000119778 | 92.7686512257555 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATAD2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRSF10 | 10772 | ENSG00000188529 | 92.7348958916319 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRSF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ATF2 | 1386 | ENSG00000115966 | 92.6953439848 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ATF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MBD2 | 8932 | ENSG00000134046 | 92.6682301899814 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MBD2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CALB1 | 793 | ENSG00000104327 | 92.6634285037 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CALB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6L10 | 647042 | ENSG00000278662 | 92.6587501428 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6L10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6L10 | 101927601 | ENSG00000278662 | 92.6587501428 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6L10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PROX1 | 5629 | ENSG00000117707 | 92.6367021251411 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PROX1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PLAGL2 | 5326 | ENSG00000126003 | 92.6070452103299 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PLAGL2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TNKS2 | 80351 | ENSG00000107854 | 92.6025174974156 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TNKS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KIF2A | 3796 | ENSG00000068796 | 92.58091 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KIF2A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NSG1 | 27065 | ENSG00000168824 | 92.57799 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NSG1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GTF2A1 | 2957 | ENSG00000165417 | 92.5549248796676 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GTF2A1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADAM23 | 8745 | ENSG00000114948 | 92.5391667520527 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADAM23 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CD46 | 4179 | ENSG00000117335 | 92.5258238409437 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CD46 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBBP5 | 5929 | ENSG00000117222 | 92.51971 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBBP5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MEGF9 | 1955 | ENSG00000106780 | 92.5085926433848 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MEGF9 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AMFR | 267 | ENSG00000159461 | 92.49968 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AMFR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EBF3 | 253738 | ENSG00000108001 | 92.4977220508 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EBF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TM4SF4 | 7104 | ENSG00000169903 | 92.43572 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TM4SF4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VCAN | 1462 | ENSG00000038427 | 92.42903 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VCAN | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AKIRIN1 | 79647 | ENSG00000174574 | 92.4176288820115 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AKIRIN1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC17A6 | 57084 | ENSG00000091664 | 92.40492 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC17A6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEC14L2 | 23541 | ENSG00000100003 | 92.39091 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEC14L2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8M | 653720 | ENSG00000188626 | 92.3877019383949 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8M | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8M | 653720 | ENSG00000278186 | 92.3877019383949 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8M | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PEX5 | 5830 | ENSG00000139197 | 92.38343 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PEX5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GPR180 | 160897 | ENSG00000152749 | 92.3492937386486 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GPR180 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CADM2 | 253559 | ENSG00000175161 | 92.3424054802331 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CADM2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RANBP9 | 10048 | ENSG00000010017 | 92.33567 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RANBP9 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CAV2 | 858 | ENSG00000105971 | 92.33389 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CAV2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CHAMP1 | 283489 | ENSG00000198824 | 92.33223 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CHAMP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PUM1 | 9698 | ENSG00000134644 | 92.2567418032 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PUM1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BDNF | 627 | ENSG00000176697 | 92.2428 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BDNF | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SERPINB1 | 1992 | ENSG00000021355 | 92.22902 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SERPINB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPHA5 | 2044 | ENSG00000145242 | 92.221948552872 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPHA5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GIPC2 | 54810 | ENSG00000137960 | 92.2186078066111 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GIPC2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF106 | 64397 | ENSG00000103994 | 92.2007236090235 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF106 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CRHBP | 1393 | ENSG00000145708 | 92.1423244604143 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CRHBP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SCAMP5 | 192683 | ENSG00000198794 | 92.1387399912 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SCAMP5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TAL1 | 6886 | ENSG00000162367 | 92.0756574274139 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TAL1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | APPBP2 | 10513 | ENSG00000062725 | 92.0736606706468 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=APPBP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TCF4 | 6925 | ENSG00000196628 | 92.0688956156948 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TCF4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAP3K8 | 1326 | ENSG00000107968 | 91.9916081524588 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAP3K8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SOX8 | 30812 | ENSG00000005513 | 91.9662673984 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SOX8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TRIO | 7204 | ENSG00000038382 | 91.95777 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TRIO | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | C11orf54 | 28970 | ENSG00000182919 | 91.9496615101 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=C11orf54 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBFOX1 | 54715 | ENSG00000078328 | 91.9242855631 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBFOX1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CACNA1D | 776 | ENSG00000157388 | 91.915254586 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CACNA1D | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EFEMP1 | 2202 | ENSG00000115380 | 91.88585434 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EFEMP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BZW1 | 9689 | ENSG00000082153 | 91.86251 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BZW1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VAMP4 | 8674 | ENSG00000117533 | 91.8555266440369 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VAMP4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TFDP2 | 7029 | ENSG00000114126 | 91.852689778109 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TFDP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNKSR2 | 22866 | ENSG00000149970 | 91.8340728170369 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNKSR2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARHGAP33 | 115703 | ENSG00000004777 | 91.82542 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARHGAP33 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRBD1 | 55133 | ENSG00000068784 | 91.7448103288 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRBD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GPC6 | 10082 | ENSG00000183098 | 91.7401608784 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GPC6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HNRNPK | 3190 | ENSG00000165119 | 91.7327155474 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HNRNPK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF638 | 27332 | ENSG00000075292 | 91.72902 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF638 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SFSWAP | 6433 | ENSG00000061936 | 91.7182443794 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SFSWAP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RNF130 | 55819 | ENSG00000113269 | 91.68084 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RNF130 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLF4 | 9314 | ENSG00000136826 | 91.65776 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLF4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SH3KBP1 | 30011 | ENSG00000147010 | 91.6512887381646 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SH3KBP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SPTY2D1 | 144108 | ENSG00000179119 | 91.6403145205381 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SPTY2D1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRSF2 | 6427 | ENSG00000161547 | 91.6392132313 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRSF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HNRNPK | 3190 | ENSG00000165119 | 91.6381625526 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HNRNPK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FRMD6 | 122786 | ENSG00000139926 | 91.63238 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FRMD6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SGK3 | 23678 | ENSG00000104205 | 91.5960813861502 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SGK3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SGK3 | 100533105 | ENSG00000104205 | 91.5960813861502 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SGK3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SERINC5 | 256987 | ENSG00000164300 | 91.5630491500939 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SERINC5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SULF1 | 23213 | ENSG00000137573 | 91.5618820278215 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SULF1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | APC | 324 | ENSG00000134982 | 91.5281929725 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=APC | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IL1A | 3552 | ENSG00000115008 | 91.52802 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IL1A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HS3ST3B1 | 9953 | ENSG00000125430 | 91.5250778152 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HS3ST3B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RAI14 | 26064 | ENSG00000039560 | 91.46157 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RAI14 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ANKRA2 | 57763 | ENSG00000164331 | 91.42036 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ANKRA2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RGCC | 28984 | ENSG00000102760 | 91.38796 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RGCC | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CETN3 | 1070 | ENSG00000153140 | 91.3577564341 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CETN3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADAMTSL3 | 57188 | ENSG00000156218 | 91.35679279638 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADAMTSL3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6C | 653641 | ENSG00000167195 | 91.2969750184 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MED4 | 29079 | ENSG00000136146 | 91.2881947583 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MED4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PAFAH1B1 | 5048 | ENSG00000007168 | 91.2851911435 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PAFAH1B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RHOT1 | 55288 | ENSG00000126858 | 91.2757067575 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RHOT1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SIPA1L1 | 26037 | ENSG00000197555 | 91.2548667106 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SIPA1L1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | OGA | 10724 | ENSG00000198408 | 91.2065389209832 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=OGA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DDX17 | 10521 | ENSG00000100201 | 91.1788327934 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DDX17 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BSDC1 | 55108 | ENSG00000160058 | 91.14989 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BSDC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GART | 2618 | ENSG00000159131 | 91.13978 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GART | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TUBB2B | 347733 | ENSG00000137285 | 91.11478 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TUBB2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FAM184A | 79632 | ENSG00000111879 | 91.08693 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FAM184A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DNTTIP1 | 116092 | ENSG00000101457 | 91.05428 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DNTTIP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZFC3H1 | 196441 | ENSG00000133858 | 91.00228863 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZFC3H1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | STXBP5 | 134957 | ENSG00000164506 | 90.9962039866435 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=STXBP5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | VGLL3 | 389136 | ENSG00000206538 | 90.9897282176031 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=VGLL3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SP3 | 6670 | ENSG00000172845 | 90.9520712316119 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SP3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SRSF10 | 10772 | ENSG00000188529 | 90.9518814836724 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SRSF10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CCDC6 | 8030 | ENSG00000108091 | 90.9499526335644 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CCDC6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PEX3 | 8504 | ENSG00000034693 | 90.92895 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PEX3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARFGEF3 | 57221 | ENSG00000112379 | 90.9054476675504 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARFGEF3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBR1 | 197131 | ENSG00000159459 | 90.9044254253 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBR1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IRAK3 | 11213 | ENSG00000090376 | 90.897942140532 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IRAK3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HDAC2 | 3066 | ENSG00000196591 | 90.8962022360737 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HDAC2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NBEA | 26960 | ENSG00000172915 | 90.8853861802662 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NBEA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SOS1 | 6654 | ENSG00000115904 | 90.8842313020438 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SOS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | YY1 | 7528 | ENSG00000100811 | 90.8614904128 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=YY1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBE2D3 | 7323 | ENSG00000109332 | 90.855309065467 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBE2D3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CLNS1A | 1207 | ENSG00000074201 | 90.8503064379 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CLNS1A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | BRD3 | 8019 | ENSG00000169925 | 90.8445404175 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=BRD3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | OPA1 | 4976 | ENSG00000198836 | 90.8409309747055 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=OPA1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLHL23 | 151230 | ENSG00000213160 | 90.7924058168454 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLHL23 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KLHL23 | 100526832 | ENSG00000213160 | 90.7924058168454 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KLHL23 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM26 | 64062 | ENSG00000139746 | 90.7806495081398 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM26 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RALGPS2 | 55103 | ENSG00000116191 | 90.78016 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RALGPS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ELK4 | 2005 | ENSG00000158711 | 90.7718870624333 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ELK4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | WDFY3 | 23001 | ENSG00000163625 | 90.7499251759964 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=WDFY3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DLX1 | 1745 | ENSG00000144355 | 90.7436145942 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DLX1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SPTSSA | 171546 | ENSG00000165389 | 90.71725 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SPTSSA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8A | 23015 | ENSG00000175265 | 90.7123411 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8B | 440270 | ENSG00000215252 | 90.7042371964 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPN12 | 5782 | ENSG00000127947 | 90.6456105388 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPN12 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ICK | 22858 | ENSG00000112144 | 90.62979 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ICK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | API5 | 8539 | ENSG00000166181 | 90.577909980374 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=API5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NXT2 | 55916 | ENSG00000101888 | 90.5759052230309 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NXT2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ARIH1 | 25820 | ENSG00000166233 | 90.54894 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ARIH1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ADK | 132 | ENSG00000156110 | 90.51075 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ADK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | API5 | 8539 | ENSG00000166181 | 90.4812949979071 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=API5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IRAK2 | 3656 | ENSG00000134070 | 90.4771261372565 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IRAK2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAP3K5 | 4217 | ENSG00000197442 | 90.457747904 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAP3K5 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | KAT2B | 8850 | ENSG00000114166 | 90.4506203928901 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=KAT2B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNRIP1 | 25927 | ENSG00000119865 | 90.43747 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNRIP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAPK8 | 5599 | ENSG00000107643 | 90.4290180943777 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAPK8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEC24B | 10427 | ENSG00000138802 | 90.4277769891 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEC24B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AJAP1 | 55966 | ENSG00000196581 | 90.42161 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AJAP1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RSBN1L | 222194 | ENSG00000187257 | 90.4096627958 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RSBN1L | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SMARCAD1 | 56916 | ENSG00000163104 | 90.4086395248956 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SMARCAD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RIF1 | 55183 | ENSG00000080345 | 90.4014027137506 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RIF1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EPCAM | 4072 | ENSG00000119888 | 90.37746 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EPCAM | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEC24A | 10802 | ENSG00000113615 | 90.3678327251934 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEC24A | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UBE2E3 | 10477 | ENSG00000170035 | 90.3616721293242 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UBE2E3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRELID3B | 51012 | ENSG00000101166 | 90.333656677084 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRELID3B | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MPP6 | 51678 | ENSG00000105926 | 90.3059338530407 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MPP6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDH19 | 28513 | ENSG00000071991 | 90.2716305322291 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDH19 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | IRF2 | 3660 | ENSG00000168310 | 90.26021 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=IRF2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | COX18 | 285521 | ENSG00000163626 | 90.2480922794808 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=COX18 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TANK | 10010 | ENSG00000136560 | 90.2408320956 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TANK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TANK | 10010 | ENSG00000136560 | 90.2327278591 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TANK | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PTPRG | 5793 | ENSG00000144724 | 90.2152552564246 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PTPRG | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PCDH9 | 5101 | ENSG00000184226 | 90.2020656765 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PCDH9 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PLPPR4 | 9890 | ENSG00000117600 | 90.157497909 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PLPPR4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TFEC | 22797 | ENSG00000105967 | 90.1398450548984 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TFEC | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | INTS6 | 26512 | ENSG00000102786 | 90.0926935293387 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=INTS6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AR | 367 | ENSG00000169083 | 90.090432150149 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AR | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDC25C | 995 | ENSG00000158402 | 90.08049 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDC25C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRIM2 | 5558 | ENSG00000146143 | 90.07563 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRIM2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZNF711 | 7552 | ENSG00000147180 | 90.05155 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZNF711 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ENPP4 | 22875 | ENSG00000001561 | 90.04788 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ENPP4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ST18 | 9705 | ENSG00000147488 | 90.0327487801667 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ST18 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TET2 | 54790 | ENSG00000168769 | 90.0312290334 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TET2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRKCB | 5579 | ENSG00000166501 | 90.016822641 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRKCB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PNRC1 | 10957 | ENSG00000146278 | 89.9972135232 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PNRC1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TRPS1 | 7227 | ENSG00000104447 | 89.9767854137044 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TRPS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MAMLD1 | 10046 | ENSG00000013619 | 89.9665322802 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MAMLD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | FOXJ3 | 22887 | ENSG00000198815 | 89.9496 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=FOXJ3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CERS6 | 253782 | ENSG00000172292 | 89.9375331297936 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CERS6 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | COX16 | 51241 | ENSG00000133983 | 89.9374 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=COX16 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SYNJ2BP-COX16 | 100529257 | ENSG00000258644 | 89.9374 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SYNJ2BP-COX16 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NDUFS1 | 4719 | ENSG00000023228 | 89.9234 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NDUFS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NDUFS1 | 4719 | ENSG00000283447 | 89.9234 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NDUFS1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | DDHD1 | 80821 | ENSG00000100523 | 89.9050416715 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=DDHD1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TTC28 | 23331 | ENSG00000100154 | 89.9025268694 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TTC28 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MITF | 4286 | ENSG00000187098 | 89.8955304739171 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MITF | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | NOP58 | 51602 | ENSG00000055044 | 89.8846 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=NOP58 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CNTNAP3 | 79937 | ENSG00000106714 | 89.8816633100632 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CNTNAP3 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RRAS2 | 22800 | ENSG00000133818 | 89.8696636852 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RRAS2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GORASP2 | 26003 | ENSG00000115806 | 89.857629202 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GORASP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SLC34A2 | 10568 | ENSG00000157765 | 89.8545116123773 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SLC34A2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | OSTM1 | 28962 | ENSG00000081087 | 89.8537330501 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=OSTM1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | MYOF | 26509 | ENSG00000138119 | 89.8478 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=MYOF | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HEY1 | 23462 | ENSG00000164683 | 89.8118 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HEY1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | STK10 | 6793 | ENSG00000072786 | 89.7982 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=STK10 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | RBM23 | 55147 | ENSG00000100461 | 89.7805599232 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=RBM23 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HADHB | 3032 | ENSG00000138029 | 89.7745 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HADHB | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8R | 101059918 | ENSG00000186399 | 89.772503415 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8R | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | LRRC58 | 116064 | ENSG00000163428 | 89.7564692893561 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=LRRC58 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8K | 653125 | ENSG00000249931 | 89.7548946904 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8K | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8T | 653075 | ENSG00000284076 | 89.7548946904 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8T | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8T | 653125 | ENSG00000284076 | 89.7548946904 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8T | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CDH19 | 28513 | ENSG00000071991 | 89.7546512288689 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CDH19 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PLCB1 | 23236 | ENSG00000182621 | 89.719321039 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PLCB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8N | 643699 | ENSG00000232653 | 89.702859378 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8N | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA8N | 643699 | ENSG00000283589 | 89.702859378 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA8N | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TMEM33 | 55161 | ENSG00000109133 | 89.6994915391 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TMEM33 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ITM2C | 81618 | ENSG00000135916 | 89.6985 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ITM2C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PARP8 | 79668 | ENSG00000151883 | 89.6924726622477 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PARP8 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | ZEB2 | 9839 | ENSG00000169554 | 89.6739362049341 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=ZEB2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | GOLGA6L4 | 643707 | ENSG00000184206 | 89.663218129 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=GOLGA6L4 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | TSC22D2 | 9819 | ENSG00000196428 | 89.6366 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=TSC22D2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | HOXB7 | 3217 | ENSG00000260027 | 89.6363409796 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=HOXB7 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | UNC13C | 440279 | ENSG00000137766 | 89.6243816700917 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=UNC13C | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | SEPSECS | 51091 | ENSG00000109618 | 89.6225750089257 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=SEPSECS | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRNP | 5621 | ENSG00000171867 | 89.613575615 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRNP | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PRKAB1 | 5564 | ENSG00000111725 | 89.5887643672 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PRKAB1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | AP2B1 | 163 | ENSG00000006125 | 89.5772703917987 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=AP2B1 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | PPP3CA | 5530 | ENSG00000138814 | 89.5656108215795 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=PPP3CA | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | CTTNBP2 | 83992 | ENSG00000077063 | 89.544 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=CTTNBP2 | predicted |
| mirdb | MIMAT0002855 | hsa-miR-520d-5p | EDIL3 | 10085 | ENSG00000164176 | 89.5375530643325 | http://mirdb.org/cgi-bin/search.cgi?species=Human&searchType=gene&geneChoice=symbol&searchBox=EDIL3 | predicted |
3. Filter and Combine
combined_targets_miR_520d_5p <- filter_val_hsa_miR_520d_5p %>%
mutate(type = "validated") %>%
bind_rows(
filter_pre_hsa_miR_520d_5p %>% mutate(type = "predicted") # Agregar etiquetas de origen
) %>%
distinct()4. Resumir targets por miRNA
summary_targets_miR_520d_5p <- combined_targets_miR_520d_5p %>%
group_by(mature_mirna_id, type) %>%
summarise(
num_targets = n(),
top_targets = paste0(unique(target_symbol)[1:20], collapse = ", ")
)`summarise()` has grouped output by 'mature_mirna_id'. You can override using
the `.groups` argument.summary_targets_miR_520d_5p |>
kable(format = "html") |>
kable_styling("striped")| mature_mirna_id | type | num_targets | top_targets |
|---|---|---|---|
| hsa-miR-520d-5p | predicted | 575 | PELI2, PUM2, ELAVL2, MTM1, STRBP, PTPRE, CPEB2, MAPK1, ARPP19, TEAD1, RAP2C, HOOK3, SGIP1, ADAMTS5, SBF2, EBF2, RAB11A, SLC22A10, RBM39, SRSF10 |
| hsa-miR-520d-5p | validated | 1 | PPIB, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA |
5: Análisis funcional
Validated
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_520d_5p_validated <- filter_val_hsa_miR_520d_5p$target_symbol %>% unique()
go_results_miR_520d_5p_validated <- enrichGO(
gene = gene_symbols_miR_520d_5p_validated,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # BP Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
go_results_miR_520d_5p_validated@result |>
kable(format = "html") |>
kable_styling("striped")| ID | Description | GeneRatio | BgRatio | RichFactor | FoldEnrichment | zScore | pvalue | p.adjust | qvalue | geneID | Count | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO:0044794 | GO:0044794 | positive regulation by host of viral process | 1/1 | 20/18888 | 0.0500000 | 944.40000 | 30.714817 | 0.0010589 | 0.0131300 | NA | PPIB | 1 |
| GO:0000413 | GO:0000413 | protein peptidyl-prolyl isomerization | 1/1 | 25/18888 | 0.0400000 | 755.52000 | 27.468527 | 0.0013236 | 0.0131300 | NA | PPIB | 1 |
| GO:0044827 | GO:0044827 | modulation by host of viral genome replication | 1/1 | 26/18888 | 0.0384615 | 726.46154 | 26.934393 | 0.0013765 | 0.0131300 | NA | PPIB | 1 |
| GO:0040018 | GO:0040018 | positive regulation of multicellular organism growth | 1/1 | 31/18888 | 0.0322581 | 609.29032 | 24.663542 | 0.0016413 | 0.0131300 | NA | PPIB | 1 |
| GO:0018208 | GO:0018208 | peptidyl-proline modification | 1/1 | 39/18888 | 0.0256410 | 484.30769 | 21.984260 | 0.0020648 | 0.0132147 | NA | PPIB | 1 |
| GO:0044788 | GO:0044788 | modulation by host of viral process | 1/1 | 49/18888 | 0.0204082 | 385.46939 | 19.607891 | 0.0025942 | 0.0138359 | NA | PPIB | 1 |
| GO:0040014 | GO:0040014 | regulation of multicellular organism growth | 1/1 | 64/18888 | 0.0156250 | 295.12500 | 17.150073 | 0.0033884 | 0.0154898 | NA | PPIB | 1 |
| GO:0061077 | GO:0061077 | chaperone-mediated protein folding | 1/1 | 75/18888 | 0.0133333 | 251.84000 | 15.837929 | 0.0039708 | 0.0156108 | NA | PPIB | 1 |
| GO:0051851 | GO:0051851 | modulation by host of symbiont process | 1/1 | 86/18888 | 0.0116279 | 219.62791 | 14.786071 | 0.0045532 | 0.0156108 | NA | PPIB | 1 |
| GO:0030593 | GO:0030593 | neutrophil chemotaxis | 1/1 | 107/18888 | 0.0093458 | 176.52336 | 13.248523 | 0.0056650 | 0.0156108 | NA | PPIB | 1 |
| GO:0051702 | GO:0051702 | biological process involved in interaction with symbiont | 1/1 | 119/18888 | 0.0084034 | 158.72269 | 12.558769 | 0.0063003 | 0.0156108 | NA | PPIB | 1 |
| GO:0071621 | GO:0071621 | granulocyte chemotaxis | 1/1 | 128/18888 | 0.0078125 | 147.56250 | 12.106300 | 0.0067768 | 0.0156108 | NA | PPIB | 1 |
| GO:0019079 | GO:0019079 | viral genome replication | 1/1 | 129/18888 | 0.0077519 | 146.41860 | 12.058964 | 0.0068297 | 0.0156108 | NA | PPIB | 1 |
| GO:1990266 | GO:1990266 | neutrophil migration | 1/1 | 129/18888 | 0.0077519 | 146.41860 | 12.058964 | 0.0068297 | 0.0156108 | NA | PPIB | 1 |
| GO:0035264 | GO:0035264 | multicellular organism growth | 1/1 | 147/18888 | 0.0068027 | 128.48980 | 11.291138 | 0.0077827 | 0.0163066 | NA | PPIB | 1 |
| GO:0097530 | GO:0097530 | granulocyte migration | 1/1 | 154/18888 | 0.0064935 | 122.64935 | 11.029476 | 0.0081533 | 0.0163066 | NA | PPIB | 1 |
| GO:0048639 | GO:0048639 | positive regulation of developmental growth | 1/1 | 169/18888 | 0.0059172 | 111.76331 | 10.524415 | 0.0089475 | 0.0168423 | NA | PPIB | 1 |
| GO:0060348 | GO:0060348 | bone development | 1/1 | 215/18888 | 0.0046512 | 87.85116 | 9.319397 | 0.0113829 | 0.0184051 | NA | PPIB | 1 |
| GO:0050821 | GO:0050821 | protein stabilization | 1/1 | 218/18888 | 0.0045872 | 86.64220 | 9.254307 | 0.0115417 | 0.0184051 | NA | PPIB | 1 |
| GO:0006457 | GO:0006457 | protein folding | 1/1 | 225/18888 | 0.0044444 | 83.94667 | 9.107506 | 0.0119123 | 0.0184051 | NA | PPIB | 1 |
| GO:0030595 | GO:0030595 | leukocyte chemotaxis | 1/1 | 237/18888 | 0.0042194 | 79.69620 | 8.871088 | 0.0125476 | 0.0184051 | NA | PPIB | 1 |
| GO:0097529 | GO:0097529 | myeloid leukocyte migration | 1/1 | 239/18888 | 0.0041841 | 79.02929 | 8.833419 | 0.0126535 | 0.0184051 | NA | PPIB | 1 |
| GO:0045927 | GO:0045927 | positive regulation of growth | 1/1 | 258/18888 | 0.0038760 | 73.20930 | 8.497606 | 0.0136595 | 0.0190045 | NA | PPIB | 1 |
| GO:0044403 | GO:0044403 | biological process involved in symbiotic interaction | 1/1 | 311/18888 | 0.0032154 | 60.73312 | 7.728720 | 0.0164655 | 0.0199673 | NA | PPIB | 1 |
| GO:0019058 | GO:0019058 | viral life cycle | 1/1 | 319/18888 | 0.0031348 | 59.21003 | 7.629550 | 0.0168890 | 0.0199673 | NA | PPIB | 1 |
| GO:0060326 | GO:0060326 | cell chemotaxis | 1/1 | 322/18888 | 0.0031056 | 58.65839 | 7.593312 | 0.0170479 | 0.0199673 | NA | PPIB | 1 |
| GO:0031647 | GO:0031647 | regulation of protein stability | 1/1 | 326/18888 | 0.0030675 | 57.93865 | 7.545770 | 0.0172596 | 0.0199673 | NA | PPIB | 1 |
| GO:0048638 | GO:0048638 | regulation of developmental growth | 1/1 | 330/18888 | 0.0030303 | 57.23636 | 7.499091 | 0.0174714 | 0.0199673 | NA | PPIB | 1 |
| GO:0050900 | GO:0050900 | leukocyte migration | 1/1 | 396/18888 | 0.0025253 | 47.69697 | 6.833518 | 0.0209657 | 0.0231346 | NA | PPIB | 1 |
| GO:0016032 | GO:0016032 | viral process | 1/1 | 428/18888 | 0.0023364 | 44.13084 | 6.567407 | 0.0226599 | 0.0241705 | NA | PPIB | 1 |
| GO:0006935 | GO:0006935 | chemotaxis | 1/1 | 466/18888 | 0.0021459 | 40.53219 | 6.287463 | 0.0246717 | 0.0247776 | NA | PPIB | 1 |
| GO:0042330 | GO:0042330 | taxis | 1/1 | 468/18888 | 0.0021368 | 40.35897 | 6.273673 | 0.0247776 | 0.0247776 | NA | PPIB | 1 |
# Visualización del análisis funcional
barplot(go_results_miR_520d_5p_validated, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
Predicted
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_520d_5p_predicted <- filter_pre_hsa_miR_520d_5p$target_symbol %>% unique()
go_results_miR_520d_5p_predicted <- enrichGO(
gene = gene_symbols_miR_520d_5p_predicted,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
go_results_miR_520d_5p_predicted@result |>
kable(format = "html") |>
kable_styling("striped")| ID | Description | GeneRatio | BgRatio | RichFactor | FoldEnrichment | zScore | pvalue | p.adjust | qvalue | geneID | Count | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO:0007030 | GO:0007030 | Golgi organization | 17/439 | 156/18888 | 0.1089744 | 4.6886280 | 7.1361245 | 0.0000001 | 0.0005639 | 0.0004946 | MAPK1/RAB33B/TMED7/GOLGA6B/PDCD10/GOLGA6A/GOLGA6D/GOLGA8M/VAMP4/GOLGA6C/GOLGA8A/GOLGA8B/GORASP2/GOLGA8R/GOLGA8K/GOLGA8T/GOLGA8N | 17 |
| GO:0043484 | GO:0043484 | regulation of RNA splicing | 16/439 | 186/18888 | 0.0860215 | 3.7010802 | 5.7105410 | 0.0000075 | 0.0061788 | 0.0054194 | RBM39/SRSF10/MBNL1/RBM12/CLK4/REST/HNRNPK/TAF12/RBFOX1/ZNF638/SFSWAP/SRSF2/DDX17/CLNS1A/KAT2B/RBM23 | 16 |
| GO:0007613 | GO:0007613 | memory | 13/439 | 126/18888 | 0.1031746 | 4.4390932 | 5.9747121 | 0.0000076 | 0.0061788 | 0.0054194 | SYT4/SCN2A/CNR1/TAFA2/KCNK2/CPEB3/CREB1/CSMD1/CALB1/BDNF/KAT2B/PLCB1/PRNP | 13 |
| GO:0001837 | GO:0001837 | epithelial to mesenchymal transition | 16/439 | 187/18888 | 0.0855615 | 3.6812883 | 5.6840676 | 0.0000081 | 0.0061788 | 0.0054194 | DLG5/USF3/HEY2/HMGA2/SMAD3/EPHA3/JAG1/TCF7L2/FGFR2/SPRED1/PPP3R1/ADIPOR1/RGCC/DDX17/HDAC2/HEY1 | 16 |
| GO:0007611 | GO:0007611 | learning or memory | 20/439 | 278/18888 | 0.0719424 | 3.0953278 | 5.4291086 | 0.0000087 | 0.0061788 | 0.0054194 | MAPK1/SYT4/SCN2A/MEF2C/CNR1/TAFA2/PPP1R1B/AMFR/KCNK2/ATP8A1/CPEB3/CREB1/CSMD1/CALB1/BDNF/CRHBP/PAFAH1B1/KAT2B/PLCB1/PRNP | 20 |
| GO:0072073 | GO:0072073 | kidney epithelium development | 14/439 | 152/18888 | 0.0921053 | 3.9628342 | 5.6574150 | 0.0000128 | 0.0061788 | 0.0054194 | MTSS1/EPHA7/MEF2C/SIX4/IRX2/SMAD3/JAG1/FGFR2/SLIT2/CALB1/SOX8/HS3ST3B1/EPCAM/HOXB7 | 14 |
| GO:0060562 | GO:0060562 | epithelial tube morphogenesis | 22/439 | 335/18888 | 0.0656716 | 2.8255261 | 5.2003278 | 0.0000132 | 0.0061788 | 0.0054194 | DLG5/MTSS1/EPHA7/FZD3/MEF2C/ARL13B/SIX4/IRX2/CTHRC1/SMAD3/FGFR2/SEC24B/CSMD1/PPP3R1/SLIT2/RYR2/PROX1/SOX8/HS3ST3B1/OPA1/AR/HOXB7 | 22 |
| GO:0071375 | GO:0071375 | cellular response to peptide hormone stimulus | 21/439 | 311/18888 | 0.0675241 | 2.9052289 | 5.2259699 | 0.0000136 | 0.0061788 | 0.0054194 | PTPRE/CPEB2/MAPK1/PPP3CA/NR4A2/ATP2B1/PHIP/APPL2/PRKCB/FBN1/SRD5A1/ZNF106/NCOA1/SIRT1/ADIPOR1/CAV2/CRHBP/APC/SOS1/KAT2B/PLCB1 | 21 |
| GO:0060485 | GO:0060485 | mesenchyme development | 22/439 | 336/18888 | 0.0654762 | 2.8171168 | 5.1842323 | 0.0000138 | 0.0061788 | 0.0054194 | MAPK1/ADAMTS5/DLG5/USF3/MEF2C/SIX4/HEY2/HMGA2/SMAD3/EPHA3/JAG1/TCF7L2/FGFR2/SPRED1/PPP3R1/ADIPOR1/SOX8/APC/RGCC/DDX17/HDAC2/HEY1 | 22 |
| GO:0048762 | GO:0048762 | mesenchymal cell differentiation | 19/439 | 269/18888 | 0.0706320 | 3.0389445 | 5.1955402 | 0.0000188 | 0.0075454 | 0.0066181 | MAPK1/DLG5/USF3/MEF2C/HEY2/HMGA2/SMAD3/EPHA3/JAG1/TCF7L2/FGFR2/SPRED1/PPP3R1/ADIPOR1/SOX8/RGCC/DDX17/HDAC2/HEY1 | 19 |
| GO:0050803 | GO:0050803 | regulation of synapse structure or activity | 18/439 | 249/18888 | 0.0722892 | 3.1102451 | 5.1706912 | 0.0000228 | 0.0077670 | 0.0068125 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/SIX4/NEGR1/EGLN1/GPM6A/ARHGAP33/SLC17A6/BDNF/PAFAH1B1/SIPA1L1/PRNP/CTTNBP2 | 18 |
| GO:0048568 | GO:0048568 | embryonic organ development | 26/439 | 455/18888 | 0.0571429 | 2.4585747 | 4.8580692 | 0.0000256 | 0.0077670 | 0.0068125 | MAPK1/TEAD1/E2F8/SP3/FZD3/MEF2C/ARL13B/PRKRA/SIX4/FBN1/EGLN1/CTHRC1/NCOA1/TSHZ1/HEY2/SMAD3/SYF2/FGFR2/SEC24B/RYR2/PROX1/TAL1/EFEMP1/TUBB2B/HEY1/HOXB7 | 26 |
| GO:1901653 | GO:1901653 | cellular response to peptide | 23/439 | 376/18888 | 0.0611702 | 2.6318519 | 4.9303225 | 0.0000262 | 0.0077670 | 0.0068125 | PTPRE/CPEB2/MAPK1/PPP3CA/NR4A2/ATP2B1/PHIP/APPL2/PRKCB/FBN1/SRD5A1/ZNF106/NCOA1/SIRT1/ADIPOR1/CAV2/CRHBP/KLF4/APC/SOS1/KAT2B/PLCB1/PRNP | 23 |
| GO:0032869 | GO:0032869 | cellular response to insulin stimulus | 16/439 | 206/18888 | 0.0776699 | 3.3417520 | 5.2130292 | 0.0000270 | 0.0077670 | 0.0068125 | PTPRE/CPEB2/MAPK1/ATP2B1/PHIP/APPL2/PRKCB/SRD5A1/ZNF106/NCOA1/SIRT1/ADIPOR1/CAV2/APC/SOS1/KAT2B | 16 |
| GO:0072001 | GO:0072001 | renal system development | 21/439 | 329/18888 | 0.0638298 | 2.7462802 | 4.9290354 | 0.0000315 | 0.0082808 | 0.0072632 | DLG5/MTSS1/EPHA7/PPP3CA/MEF2C/SIX4/FBN1/IRX2/SMAD3/JAG1/NFIA/FGFR2/SLIT2/CALB1/PROX1/SOX8/SULF1/HS3ST3B1/EPCAM/HOXB7/AP2B1 | 21 |
| GO:0048638 | GO:0048638 | regulation of developmental growth | 21/439 | 330/18888 | 0.0636364 | 2.7379582 | 4.9131275 | 0.0000329 | 0.0082808 | 0.0072632 | PUM2/MTM1/SYT4/EPHA7/JARID2/AGRN/MEF2C/SIX4/WWC2/KCNK2/HEY2/CREB1/FGFR2/CDH4/PROX1/PEX5/BDNF/PAFAH1B1/YY1/AR/PLCB1 | 21 |
| GO:0021543 | GO:0021543 | pallium development | 15/439 | 191/18888 | 0.0785340 | 3.3789312 | 5.0972969 | 0.0000422 | 0.0094406 | 0.0082804 | CDK6/ZMIZ1/DLX1/CEP120/SCN2A/EPHA5/SRD5A1/NCOA1/SLIT2/PROX1/PEX5/PAFAH1B1/GART/TUBB2B/PLCB1 | 15 |
| GO:0048639 | GO:0048639 | positive regulation of developmental growth | 14/439 | 169/18888 | 0.0828402 | 3.5642059 | 5.1651419 | 0.0000422 | 0.0094406 | 0.0082804 | PUM2/MTM1/SYT4/AGRN/MEF2C/HEY2/CREB1/FGFR2/CDH4/PROX1/PEX5/BDNF/PAFAH1B1/PLCB1 | 14 |
| GO:0050807 | GO:0050807 | regulation of synapse organization | 17/439 | 243/18888 | 0.0699588 | 3.0099834 | 4.8645397 | 0.0000577 | 0.0118481 | 0.0103921 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/SIX4/NEGR1/EGLN1/GPM6A/ARHGAP33/BDNF/PAFAH1B1/SIPA1L1/PRNP/CTTNBP2 | 17 |
| GO:0003184 | GO:0003184 | pulmonary valve morphogenesis | 5/439 | 19/18888 | 0.2631579 | 11.3223834 | 6.9439995 | 0.0000589 | 0.0118481 | 0.0103921 | ADAMTS5/HEY2/JAG1/SLIT2/HEY1 | 5 |
| GO:0001822 | GO:0001822 | kidney development | 20/439 | 319/18888 | 0.0626959 | 2.6974957 | 4.7166876 | 0.0000621 | 0.0119054 | 0.0104423 | DLG5/MTSS1/EPHA7/PPP3CA/MEF2C/SIX4/FBN1/IRX2/SMAD3/JAG1/FGFR2/SLIT2/CALB1/PROX1/SOX8/SULF1/HS3ST3B1/EPCAM/HOXB7/AP2B1 | 20 |
| GO:0043583 | GO:0043583 | ear development | 16/439 | 223/18888 | 0.0717489 | 3.0869996 | 4.8360205 | 0.0000703 | 0.0123696 | 0.0108494 | MAPK1/CEBPD/FZD3/PRKRA/SIX4/CTHRC1/KCNK2/TSHZ1/HEY2/JAG1/FGFR2/SEC24B/CALB1/PROX1/PAFAH1B1/PLPPR4 | 16 |
| GO:0050890 | GO:0050890 | cognition | 20/439 | 322/18888 | 0.0621118 | 2.6723638 | 4.6690320 | 0.0000707 | 0.0123696 | 0.0108494 | MAPK1/SYT4/SCN2A/MEF2C/CNR1/TAFA2/PPP1R1B/AMFR/KCNK2/ATP8A1/CPEB3/CREB1/CSMD1/CALB1/BDNF/CRHBP/PAFAH1B1/KAT2B/PLCB1/PRNP | 20 |
| GO:2001014 | GO:2001014 | regulation of skeletal muscle cell differentiation | 5/439 | 20/18888 | 0.2500000 | 10.7562642 | 6.7338425 | 0.0000770 | 0.0129143 | 0.0113272 | AKIRIN1/MEF2C/SIX4/RBFOX1/DDX17 | 5 |
| GO:0030900 | GO:0030900 | forebrain development | 23/439 | 408/18888 | 0.0563725 | 2.4254321 | 4.4900686 | 0.0000914 | 0.0147102 | 0.0129024 | HOOK3/CDK6/ZMIZ1/DLX1/CEP120/SCN2A/NR4A2/PCDH9/ARL13B/SLC1A2/EPHA5/SCYL2/SRD5A1/NCOA1/CREB1/FGFR2/SLIT2/PROX1/PEX5/PAFAH1B1/GART/TUBB2B/PLCB1 | 23 |
| GO:0050804 | GO:0050804 | modulation of chemical synaptic transmission | 26/439 | 493/18888 | 0.0527383 | 2.2690699 | 4.4043970 | 0.0000968 | 0.0149023 | 0.0130709 | MAPK1/GRIN3A/SYT4/EPHA7/PPP3CA/SLC6A6/MEF2C/RAP1B/CNR1/PRKCB/NSG1/HIP1/CPEB3/PPP3R1/CALB1/BDNF/TRIO/PAFAH1B1/SIPA1L1/TUBB2B/STXBP5/PLPPR4/MYOF/PLCB1/UNC13C/PRNP | 26 |
| GO:0099177 | GO:0099177 | regulation of trans-synaptic signaling | 26/439 | 494/18888 | 0.0526316 | 2.2644767 | 4.3930237 | 0.0001000 | 0.0149023 | 0.0130709 | MAPK1/GRIN3A/SYT4/EPHA7/PPP3CA/SLC6A6/MEF2C/RAP1B/CNR1/PRKCB/NSG1/HIP1/CPEB3/PPP3R1/CALB1/BDNF/TRIO/PAFAH1B1/SIPA1L1/TUBB2B/STXBP5/PLPPR4/MYOF/PLCB1/UNC13C/PRNP | 26 |
| GO:1990830 | GO:1990830 | cellular response to leukemia inhibitory factor | 10/439 | 104/18888 | 0.0961538 | 4.1370247 | 4.9484354 | 0.0001546 | 0.0211694 | 0.0185678 | NFYB/TFRC/JARID2/RNF138/PDCD10/CREB1/SIRT1/ADAM23/KLF4/RIF1 | 10 |
| GO:0045165 | GO:0045165 | cell fate commitment | 18/439 | 289/18888 | 0.0622837 | 2.6797613 | 4.4389376 | 0.0001557 | 0.0211694 | 0.0185678 | EBF2/DLX1/MEF2C/ETS2/GATAD2B/HEY2/JAG1/TCF7L2/NFIA/FGFR2/PROX1/TAL1/SOX8/KLF4/APC/HDAC2/AR/MITF | 18 |
| GO:0003177 | GO:0003177 | pulmonary valve development | 5/439 | 23/18888 | 0.2173913 | 9.3532732 | 6.1832889 | 0.0001578 | 0.0211694 | 0.0185678 | ADAMTS5/HEY2/JAG1/SLIT2/HEY1 | 5 |
| GO:0031507 | GO:0031507 | heterochromatin formation | 10/439 | 105/18888 | 0.0952381 | 4.0976245 | 4.9098505 | 0.0001674 | 0.0215699 | 0.0189191 | KDM5A/JARID2/L3MBTL3/SUZ12/HMGA2/SIRT1/MBD2/SPTY2D1/HDAC2/RIF1 | 10 |
| GO:1990823 | GO:1990823 | response to leukemia inhibitory factor | 10/439 | 106/18888 | 0.0943396 | 4.0589676 | 4.8717414 | 0.0001811 | 0.0215699 | 0.0189191 | NFYB/TFRC/JARID2/RNF138/PDCD10/CREB1/SIRT1/ADAM23/KLF4/RIF1 | 10 |
| GO:0043010 | GO:0043010 | camera-type eye development | 20/439 | 346/18888 | 0.0578035 | 2.4869975 | 4.3062311 | 0.0001866 | 0.0215699 | 0.0189191 | DLX1/SP3/ANGPTL7/FBN1/ATP2B2/SMAD3/JAG1/GPM6A/NFIA/SPRED1/CALB1/PROX1/SLC17A6/SOX8/EFEMP1/KLF4/HDAC2/SOS1/YY1/MITF | 20 |
| GO:0003231 | GO:0003231 | cardiac ventricle development | 11/439 | 127/18888 | 0.0866142 | 3.7265797 | 4.7557543 | 0.0001870 | 0.0215699 | 0.0189191 | MEF2C/EGLN1/KCNK2/HEY2/JAG1/FGFR2/SLIT2/RYR2/PROX1/HEY1/AP2B1 | 11 |
| GO:0001701 | GO:0001701 | in utero embryonic development | 22/439 | 401/18888 | 0.0548628 | 2.3604769 | 4.2477357 | 0.0001901 | 0.0215699 | 0.0189191 | MAPK1/CNOT2/FOXD3/ZMIZ1/YBX1/E2F8/SP3/MBNL1/EGLN1/NCOA1/HEY2/BCOR/SMAD3/SYF2/FGFR2/NPAT/ATF2/SOX8/KLF4/AR/SLC34A2/HEY1 | 22 |
| GO:0097150 | GO:0097150 | neuronal stem cell population maintenance | 5/439 | 24/18888 | 0.2083333 | 8.9635535 | 6.0217534 | 0.0001956 | 0.0215699 | 0.0189191 | HOOK3/SS18/JAG1/REST/PROX1 | 5 |
| GO:0003007 | GO:0003007 | heart morphogenesis | 17/439 | 269/18888 | 0.0631970 | 2.7190556 | 4.3804148 | 0.0001983 | 0.0215699 | 0.0189191 | ADAMTS5/ZMIZ1/MEF2C/ARL13B/EGLN1/HEY2/SMAD3/JAG1/FGFR2/SEC24B/SLIT2/RYR2/ATF2/PROX1/APC/SOS1/HEY1 | 17 |
| GO:0050808 | GO:0050808 | synapse organization | 25/439 | 493/18888 | 0.0507099 | 2.1817980 | 4.1015136 | 0.0002397 | 0.0241913 | 0.0212183 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/DOCK10/MEF2C/RAP1B/SIX4/NEGR1/EGLN1/GPM6A/REST/CNTN5/NFIA/PPFIA1/ARHGAP33/BDNF/CNKSR2/PAFAH1B1/SIPA1L1/UNC13C/PRNP/CTTNBP2 | 25 |
| GO:0045444 | GO:0045444 | fat cell differentiation | 16/439 | 248/18888 | 0.0645161 | 2.7758101 | 4.3423692 | 0.0002405 | 0.0241913 | 0.0212183 | EBF2/CEBPD/NR4A2/GDF10/RORA/HMGA2/SMAD3/JAG1/CREB1/TCF7L2/SIRT1/ATF2/SOX8/TRIO/KLF4/PLCB1 | 16 |
| GO:0048863 | GO:0048863 | stem cell differentiation | 16/439 | 248/18888 | 0.0645161 | 2.7758101 | 4.3423692 | 0.0002405 | 0.0241913 | 0.0212183 | MAPK1/CDK6/JARID2/MEF2C/GATAD2B/HMGA2/JAG1/GPM6A/PUS7/REST/FGFR2/PUM1/TAL1/SOX8/HDAC2/EPCAM | 16 |
| GO:0021537 | GO:0021537 | telencephalon development | 17/439 | 275/18888 | 0.0618182 | 2.6597308 | 4.2768414 | 0.0002572 | 0.0246904 | 0.0216561 | CDK6/ZMIZ1/DLX1/CEP120/SCN2A/ARL13B/SLC1A2/EPHA5/SRD5A1/NCOA1/SLIT2/PROX1/PEX5/PAFAH1B1/GART/TUBB2B/PLCB1 | 17 |
| GO:0043434 | GO:0043434 | response to peptide hormone | 23/439 | 438/18888 | 0.0525114 | 2.2593066 | 4.1133693 | 0.0002577 | 0.0246904 | 0.0216561 | PTPRE/CPEB2/MAPK1/PPP3CA/NR4A2/ATP2B1/PHIP/APPL2/PRKCB/FBN1/SRD5A1/ZNF106/NCOA1/SMAD3/CREB1/SIRT1/ADIPOR1/CAV2/CRHBP/APC/SOS1/KAT2B/PLCB1 | 23 |
| GO:0045445 | GO:0045445 | myoblast differentiation | 10/439 | 111/18888 | 0.0900901 | 3.8761313 | 4.6879657 | 0.0002644 | 0.0247440 | 0.0217031 | AKIRIN1/MEF2C/MBNL1/JAG1/REST/TCF7L2/SOX8/DDX17/MAP3K5/PLCB1 | 10 |
| GO:0048024 | GO:0048024 | regulation of mRNA splicing, via spliceosome | 10/439 | 112/18888 | 0.0892857 | 3.8415229 | 4.6524956 | 0.0002844 | 0.0260126 | 0.0228158 | RBM39/SRSF10/REST/HNRNPK/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 10 |
| GO:0090596 | GO:0090596 | sensory organ morphogenesis | 17/439 | 278/18888 | 0.0611511 | 2.6310287 | 4.2260841 | 0.0002919 | 0.0261026 | 0.0228948 | MAPK1/SP3/FZD3/PRKRA/SIX4/FBN1/CTHRC1/TSHZ1/JAG1/FGFR2/SEC24B/CALB1/PROX1/SOX8/EFEMP1/HDAC2/YY1 | 17 |
| GO:0050684 | GO:0050684 | regulation of mRNA processing | 11/439 | 134/18888 | 0.0820896 | 3.5319077 | 4.5371239 | 0.0002990 | 0.0261591 | 0.0229443 | RBM39/SRSF10/SAFB/REST/HNRNPK/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 11 |
| GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 11/439 | 135/18888 | 0.0814815 | 3.5057454 | 4.5070853 | 0.0003189 | 0.0273037 | 0.0239482 | KDM5A/JARID2/L3MBTL3/SUZ12/HMGA2/SIRT1/EPC1/MBD2/SPTY2D1/HDAC2/RIF1 | 11 |
| GO:0051963 | GO:0051963 | regulation of synapse assembly | 10/439 | 115/18888 | 0.0869565 | 3.7413093 | 4.5484922 | 0.0003523 | 0.0295305 | 0.0259013 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/SIX4/NEGR1/BDNF | 10 |
| GO:0060996 | GO:0060996 | dendritic spine development | 9/439 | 96/18888 | 0.0937500 | 4.0335991 | 4.5965780 | 0.0003963 | 0.0325428 | 0.0285434 | DLG5/GRIN3A/DOCK10/MEF2C/CPEB3/ARHGAP33/PAFAH1B1/SIPA1L1/HDAC2 | 9 |
| GO:0051480 | GO:0051480 | regulation of cytosolic calcium ion concentration | 7/439 | 59/18888 | 0.1186441 | 5.1046678 | 4.8709955 | 0.0004201 | 0.0338057 | 0.0296512 | ATP2B1/CNR1/ATP2B2/ITPR1/CAV2/RYR2/CALB1 | 7 |
| GO:0060412 | GO:0060412 | ventricular septum morphogenesis | 6/439 | 43/18888 | 0.1395349 | 6.0034963 | 5.0668387 | 0.0004482 | 0.0353635 | 0.0310175 | EGLN1/HEY2/FGFR2/SLIT2/PROX1/HEY1 | 6 |
| GO:0070828 | GO:0070828 | heterochromatin organization | 11/439 | 141/18888 | 0.0780142 | 3.3565647 | 4.3326177 | 0.0004629 | 0.0358250 | 0.0314223 | KDM5A/JARID2/L3MBTL3/SUZ12/MECOM/HMGA2/SIRT1/MBD2/SPTY2D1/HDAC2/RIF1 | 11 |
| GO:0001657 | GO:0001657 | ureteric bud development | 9/439 | 99/18888 | 0.0909091 | 3.9113688 | 4.4801270 | 0.0004977 | 0.0377904 | 0.0331462 | SIX4/SMAD3/FGFR2/SLIT2/CALB1/SOX8/HS3ST3B1/EPCAM/HOXB7 | 9 |
| GO:0072080 | GO:0072080 | nephron tubule development | 9/439 | 100/18888 | 0.0900000 | 3.8722551 | 4.4423224 | 0.0005360 | 0.0385119 | 0.0337790 | MTSS1/MEF2C/SIX4/IRX2/JAG1/CALB1/SOX8/HS3ST3B1/HOXB7 | 9 |
| GO:0072163 | GO:0072163 | mesonephric epithelium development | 9/439 | 100/18888 | 0.0900000 | 3.8722551 | 4.4423224 | 0.0005360 | 0.0385119 | 0.0337790 | SIX4/SMAD3/FGFR2/SLIT2/CALB1/SOX8/HS3ST3B1/EPCAM/HOXB7 | 9 |
| GO:0072164 | GO:0072164 | mesonephric tubule development | 9/439 | 100/18888 | 0.0900000 | 3.8722551 | 4.4423224 | 0.0005360 | 0.0385119 | 0.0337790 | SIX4/SMAD3/FGFR2/SLIT2/CALB1/SOX8/HS3ST3B1/EPCAM/HOXB7 | 9 |
| GO:0003205 | GO:0003205 | cardiac chamber development | 12/439 | 168/18888 | 0.0714286 | 3.0732184 | 4.1636489 | 0.0005769 | 0.0407303 | 0.0357248 | MEF2C/EGLN1/KCNK2/HEY2/JAG1/FGFR2/SLIT2/RYR2/PROX1/SOS1/HEY1/AP2B1 | 12 |
| GO:0032868 | GO:0032868 | response to insulin | 16/439 | 269/18888 | 0.0594796 | 2.5591112 | 3.9728520 | 0.0005902 | 0.0409480 | 0.0359157 | PTPRE/CPEB2/MAPK1/ATP2B1/PHIP/APPL2/PRKCB/SRD5A1/ZNF106/NCOA1/SIRT1/ADIPOR1/CAV2/APC/SOS1/KAT2B | 16 |
| GO:0048562 | GO:0048562 | embryonic organ morphogenesis | 17/439 | 297/18888 | 0.0572391 | 2.4627137 | 3.9193452 | 0.0006215 | 0.0423870 | 0.0371779 | MAPK1/SP3/FZD3/MEF2C/ARL13B/PRKRA/SIX4/FBN1/CTHRC1/TSHZ1/SMAD3/FGFR2/SEC24B/RYR2/PROX1/EFEMP1/HOXB7 | 17 |
| GO:0060537 | GO:0060537 | muscle tissue development | 22/439 | 438/18888 | 0.0502283 | 2.1610759 | 3.7925108 | 0.0006345 | 0.0425571 | 0.0373271 | MTM1/AKIRIN1/CCNT2/PPP3CA/MEOX2/JARID2/MEF2C/SIX4/EGLN1/KCNK2/HEY2/SMAD3/CREB1/FGFR2/CAV2/RYR2/PROX1/SOX8/RBFOX1/DDX17/YY1/HEY1 | 22 |
| GO:0051960 | GO:0051960 | regulation of nervous system development | 23/439 | 468/18888 | 0.0491453 | 2.1144793 | 3.7659752 | 0.0006489 | 0.0428061 | 0.0375455 | HOOK3/PTPN13/DLG5/LRRTM3/SYT4/EPHA7/DLX1/SLITRK4/PPP3CA/AGRN/FZD3/APPL2/HEY2/REST/CDH4/SLIT2/PROX1/VCAN/BDNF/SOX8/PAFAH1B1/HDAC2/HEY1 | 23 |
| GO:0040029 | GO:0040029 | epigenetic regulation of gene expression | 14/439 | 220/18888 | 0.0636364 | 2.7379582 | 3.9997155 | 0.0006635 | 0.0430658 | 0.0377733 | KDM5A/JARID2/L3MBTL3/SUZ12/HMGA2/SIRT1/EPC1/ATF2/MBD2/RBBP5/SPTY2D1/HDAC2/KAT2B/RIF1 | 14 |
| GO:0048839 | GO:0048839 | inner ear development | 13/439 | 196/18888 | 0.0663265 | 2.8537028 | 4.0240890 | 0.0006970 | 0.0438465 | 0.0384580 | CEBPD/FZD3/SIX4/CTHRC1/KCNK2/HEY2/JAG1/FGFR2/SEC24B/CALB1/PROX1/PAFAH1B1/PLPPR4 | 13 |
| GO:0001823 | GO:0001823 | mesonephros development | 9/439 | 104/18888 | 0.0865385 | 3.7233222 | 4.2958489 | 0.0007137 | 0.0438465 | 0.0384580 | SIX4/SMAD3/FGFR2/SLIT2/CALB1/SOX8/HS3ST3B1/EPCAM/HOXB7 | 9 |
| GO:0061326 | GO:0061326 | renal tubule development | 9/439 | 104/18888 | 0.0865385 | 3.7233222 | 4.2958489 | 0.0007137 | 0.0438465 | 0.0384580 | MTSS1/MEF2C/SIX4/IRX2/JAG1/CALB1/SOX8/HS3ST3B1/HOXB7 | 9 |
| GO:0008286 | GO:0008286 | insulin receptor signaling pathway | 10/439 | 126/18888 | 0.0793651 | 3.4146871 | 4.1950187 | 0.0007266 | 0.0438465 | 0.0384580 | PTPRE/MAPK1/PHIP/PRKCB/ZNF106/SIRT1/ADIPOR1/CAV2/APC/SOS1 | 10 |
| GO:0060711 | GO:0060711 | labyrinthine layer development | 6/439 | 47/18888 | 0.1276596 | 5.4925605 | 4.7568364 | 0.0007300 | 0.0438465 | 0.0384580 | MAPK1/EGLN1/NCOA1/HEY2/FGFR2/HEY1 | 6 |
| GO:0014855 | GO:0014855 | striated muscle cell proliferation | 8/439 | 84/18888 | 0.0952381 | 4.0976245 | 4.3890510 | 0.0007445 | 0.0440542 | 0.0386402 | AKIRIN1/KPNA1/JARID2/MEF2C/KCNK2/HEY2/FGFR2/CAV2 | 8 |
| GO:0003206 | GO:0003206 | cardiac chamber morphogenesis | 10/439 | 127/18888 | 0.0787402 | 3.3877998 | 4.1648475 | 0.0007728 | 0.0444226 | 0.0389633 | MEF2C/EGLN1/HEY2/JAG1/FGFR2/SLIT2/RYR2/PROX1/SOS1/HEY1 | 10 |
| GO:0021987 | GO:0021987 | cerebral cortex development | 10/439 | 127/18888 | 0.0787402 | 3.3877998 | 4.1648475 | 0.0007728 | 0.0444226 | 0.0389633 | ZMIZ1/CEP120/SRD5A1/NCOA1/SLIT2/PEX5/PAFAH1B1/GART/TUBB2B/PLCB1 | 10 |
| GO:0007517 | GO:0007517 | muscle organ development | 19/439 | 359/18888 | 0.0529248 | 2.2770922 | 3.7685198 | 0.0007902 | 0.0447870 | 0.0392830 | MTM1/AKIRIN1/CCNT2/PPP3CA/MEOX2/MEF2C/SIX4/EGLN1/HEY2/SMAD3/CREB1/FGFR2/SIRT1/CAV2/RYR2/PROX1/SOX8/RBFOX1/DDX17 | 19 |
| GO:0140718 | GO:0140718 | facultative heterochromatin formation | 6/439 | 48/18888 | 0.1250000 | 5.3781321 | 4.6848573 | 0.0008182 | 0.0457291 | 0.0401092 | KDM5A/JARID2/L3MBTL3/SUZ12/SIRT1/MBD2 | 6 |
| GO:0001654 | GO:0001654 | eye development | 20/439 | 393/18888 | 0.0508906 | 2.1895703 | 3.6760936 | 0.0009417 | 0.0519121 | 0.0455324 | DLX1/SP3/ANGPTL7/FBN1/ATP2B2/SMAD3/JAG1/GPM6A/NFIA/SPRED1/CALB1/PROX1/SLC17A6/SOX8/EFEMP1/KLF4/HDAC2/SOS1/YY1/MITF | 20 |
| GO:0021953 | GO:0021953 | central nervous system neuron differentiation | 12/439 | 178/18888 | 0.0674157 | 2.9005656 | 3.9299164 | 0.0009606 | 0.0522338 | 0.0458145 | TAOK1/ZMIZ1/DLX1/NR4A2/SCYL2/RORA/FGFR2/SLIT2/PROX1/PEX5/TAL1/PAFAH1B1 | 12 |
| GO:0001892 | GO:0001892 | embryonic placenta development | 8/439 | 88/18888 | 0.0909091 | 3.9113688 | 4.2226683 | 0.0010128 | 0.0543420 | 0.0476637 | MAPK1/E2F8/SP3/EGLN1/NCOA1/HEY2/FGFR2/HEY1 | 8 |
| GO:0001649 | GO:0001649 | osteoblast differentiation | 15/439 | 257/18888 | 0.0583658 | 2.5111901 | 3.7626594 | 0.0010493 | 0.0547976 | 0.0480633 | RRAS2/CDK6/HIRA/CEBPD/PPP3CA/MEF2C/GDF10/CTHRC1/PTHLH/SMAD3/JAG1/REST/FGFR2/VCAN/SOX8 | 15 |
| GO:0150063 | GO:0150063 | visual system development | 20/439 | 397/18888 | 0.0503778 | 2.1675092 | 3.6266253 | 0.0010649 | 0.0547976 | 0.0480633 | DLX1/SP3/ANGPTL7/FBN1/ATP2B2/SMAD3/JAG1/GPM6A/NFIA/SPRED1/CALB1/PROX1/SLC17A6/SOX8/EFEMP1/KLF4/HDAC2/SOS1/YY1/MITF | 20 |
| GO:2000027 | GO:2000027 | regulation of animal organ morphogenesis | 8/439 | 89/18888 | 0.0898876 | 3.8674208 | 4.1826007 | 0.0010907 | 0.0547976 | 0.0480633 | SIX4/PRKCB/SEC24B/SOX8/SULF1/AJAP1/AR/HOXB7 | 8 |
| GO:0045927 | GO:0045927 | positive regulation of growth | 15/439 | 258/18888 | 0.0581395 | 2.5014568 | 3.7457915 | 0.0010910 | 0.0547976 | 0.0480633 | PUM2/MTM1/TEAD1/SYT4/AGRN/MEF2C/HEY2/CREB1/FGFR2/CDH4/PROX1/PEX5/BDNF/PAFAH1B1/PLCB1 | 15 |
| GO:0006979 | GO:0006979 | response to oxidative stress | 20/439 | 398/18888 | 0.0502513 | 2.1620632 | 3.6143495 | 0.0010977 | 0.0547976 | 0.0480633 | CPEB2/MAPK1/NR4A2/PRKRA/ANGPTL7/STK26/JUN/PDCD10/MSRB3/OXSR1/SIRT1/ATF2/PEX5/KLF4/IL1A/HDAC2/MAP3K5/KAT2B/MAPK8/PRNP | 20 |
| GO:0001763 | GO:0001763 | morphogenesis of a branching structure | 13/439 | 206/18888 | 0.0631068 | 2.7151735 | 3.8181881 | 0.0011030 | 0.0547976 | 0.0480633 | DLG5/EPHA7/SIX4/FGFR2/CSMD1/PPP3R1/SLIT2/PROX1/SOX8/SULF1/HS3ST3B1/AR/HOXB7 | 13 |
| GO:0048013 | GO:0048013 | ephrin receptor signaling pathway | 6/439 | 51/18888 | 0.1176471 | 5.0617714 | 4.4804541 | 0.0011326 | 0.0552050 | 0.0484207 | EPHA7/SS18/EPHA5/EPHA1/EPHA3/SIPA1L1 | 6 |
| GO:0090398 | GO:0090398 | cellular senescence | 9/439 | 111/18888 | 0.0810811 | 3.4885181 | 4.0561736 | 0.0011387 | 0.0552050 | 0.0484207 | CDK6/ZMIZ1/YBX1/KAT6A/HMGA2/SIRT1/OPA1/MAP3K5/MAPK8 | 9 |
| GO:0019827 | GO:0019827 | stem cell population maintenance | 12/439 | 182/18888 | 0.0659341 | 2.8368169 | 3.8409481 | 0.0011644 | 0.0557790 | 0.0489241 | HOOK3/CNOT2/SMC3/SS18/HMGA2/JAG1/REST/PROX1/TAL1/KLF4/HDAC2/RIF1 | 12 |
| GO:0072006 | GO:0072006 | nephron development | 11/439 | 158/18888 | 0.0696203 | 2.9954154 | 3.8852619 | 0.0011922 | 0.0564405 | 0.0495043 | MTSS1/PPP3CA/MEF2C/SIX4/IRX2/JAG1/CALB1/SOX8/SULF1/HS3ST3B1/HOXB7 | 11 |
| GO:0007213 | GO:0007213 | G protein-coupled acetylcholine receptor signaling pathway | 4/439 | 21/18888 | 0.1904762 | 8.1952489 | 5.0889875 | 0.0012586 | 0.0585884 | 0.0513882 | AGRN/PRKCB/ITPR1/PLCB1 | 4 |
| GO:0048880 | GO:0048880 | sensory system development | 20/439 | 403/18888 | 0.0496278 | 2.1352386 | 3.5535077 | 0.0012754 | 0.0585884 | 0.0513882 | DLX1/SP3/ANGPTL7/FBN1/ATP2B2/SMAD3/JAG1/GPM6A/NFIA/SPRED1/CALB1/PROX1/SLC17A6/SOX8/EFEMP1/KLF4/HDAC2/SOS1/YY1/MITF | 20 |
| GO:0003208 | GO:0003208 | cardiac ventricle morphogenesis | 7/439 | 71/18888 | 0.0985915 | 4.2419070 | 4.2216466 | 0.0012903 | 0.0585884 | 0.0513882 | MEF2C/HEY2/JAG1/FGFR2/RYR2/PROX1/HEY1 | 7 |
| GO:0071314 | GO:0071314 | cellular response to cocaine | 3/439 | 10/18888 | 0.3000000 | 12.9075171 | 5.8099254 | 0.0013249 | 0.0585884 | 0.0513882 | SLC1A2/PPP1R1B/CRHBP | 3 |
| GO:0098917 | GO:0098917 | retrograde trans-synaptic signaling | 3/439 | 10/18888 | 0.3000000 | 12.9075171 | 5.8099254 | 0.0013249 | 0.0585884 | 0.0513882 | SYT4/CNR1/PLCB1 | 3 |
| GO:0099566 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration | 3/439 | 10/18888 | 0.3000000 | 12.9075171 | 5.8099254 | 0.0013249 | 0.0585884 | 0.0513882 | ATP2B2/ITPR1/CALB1 | 3 |
| GO:0060688 | GO:0060688 | regulation of morphogenesis of a branching structure | 6/439 | 53/18888 | 0.1132075 | 4.8707612 | 4.3529014 | 0.0013886 | 0.0594205 | 0.0521180 | SIX4/FGFR2/SOX8/SULF1/AR/HOXB7 | 6 |
| GO:0060411 | GO:0060411 | cardiac septum morphogenesis | 7/439 | 72/18888 | 0.0972222 | 4.1829916 | 4.1741248 | 0.0014013 | 0.0594205 | 0.0521180 | EGLN1/HEY2/JAG1/FGFR2/SLIT2/PROX1/HEY1 | 7 |
| GO:1900076 | GO:1900076 | regulation of cellular response to insulin stimulus | 7/439 | 72/18888 | 0.0972222 | 4.1829916 | 4.1741248 | 0.0014013 | 0.0594205 | 0.0521180 | PTPRE/ATP2B1/APPL2/PRKCB/NCOA1/SIRT1/ADIPOR1 | 7 |
| GO:0098727 | GO:0098727 | maintenance of cell number | 12/439 | 186/18888 | 0.0645161 | 2.7758101 | 3.7543634 | 0.0014028 | 0.0594205 | 0.0521180 | HOOK3/CNOT2/SMC3/SS18/HMGA2/JAG1/REST/PROX1/TAL1/KLF4/HDAC2/RIF1 | 12 |
| GO:0022037 | GO:0022037 | metencephalon development | 9/439 | 115/18888 | 0.0782609 | 3.3671784 | 3.9277189 | 0.0014612 | 0.0612503 | 0.0537230 | GDF10/NCOA1/RORA/CNTN1/TTBK2/SEC24B/ATF2/PROX1/GART | 9 |
| GO:0003170 | GO:0003170 | heart valve development | 7/439 | 73/18888 | 0.0958904 | 4.1256904 | 4.1274575 | 0.0015195 | 0.0623925 | 0.0547248 | ADAMTS5/MEF2C/HEY2/JAG1/SLIT2/APC/HEY1 | 7 |
| GO:0060420 | GO:0060420 | regulation of heart growth | 7/439 | 73/18888 | 0.0958904 | 4.1256904 | 4.1274575 | 0.0015195 | 0.0623925 | 0.0547248 | JARID2/MEF2C/KCNK2/HEY2/FGFR2/PROX1/YY1 | 7 |
| GO:0021766 | GO:0021766 | hippocampus development | 8/439 | 94/18888 | 0.0851064 | 3.6617070 | 3.9906339 | 0.0015550 | 0.0625975 | 0.0549046 | CDK6/DLX1/SCN2A/EPHA5/SRD5A1/NCOA1/PROX1/PAFAH1B1 | 8 |
| GO:0060070 | GO:0060070 | canonical Wnt signaling pathway | 17/439 | 323/18888 | 0.0526316 | 2.2644767 | 3.5358346 | 0.0015556 | 0.0625975 | 0.0549046 | KPNA1/SMURF2/SHISA3/NR4A2/LYPD6/FZD3/ZEB2/SCYL2/CTHRC1/AMFR/SMAD3/TCF7L2/FGFR2/TMEM170B/TNKS2/KLF4/APC | 17 |
| GO:0030336 | GO:0030336 | negative regulation of cell migration | 19/439 | 381/18888 | 0.0498688 | 2.1456065 | 3.4846349 | 0.0015812 | 0.0629972 | 0.0552552 | RAP2C/DLG5/MEOX2/MEF2C/STK26/ZEB2/EPHA1/JAG1/PDCD10/SPRED1/SLIT2/ADIPOR1/KLF4/SULF1/RGCC/HDAC2/PTPRG/MITF/PLCB1 | 19 |
| GO:0061138 | GO:0061138 | morphogenesis of a branching epithelium | 12/439 | 189/18888 | 0.0634921 | 2.7317496 | 3.6909159 | 0.0016070 | 0.0633606 | 0.0555739 | DLG5/SIX4/FGFR2/CSMD1/PPP3R1/SLIT2/PROX1/SOX8/SULF1/HS3ST3B1/AR/HOXB7 | 12 |
| GO:1901888 | GO:1901888 | regulation of cell junction assembly | 13/439 | 215/18888 | 0.0604651 | 2.6015151 | 3.6430954 | 0.0016218 | 0.0633606 | 0.0555739 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/RAP1B/SIX4/NEGR1/SMAD3/EPHA3/BDNF | 13 |
| GO:0003281 | GO:0003281 | ventricular septum development | 7/439 | 74/18888 | 0.0945946 | 4.0699378 | 4.0816166 | 0.0016454 | 0.0636629 | 0.0558391 | EGLN1/HEY2/FGFR2/SLIT2/PROX1/HEY1/AP2B1 | 7 |
| GO:0070482 | GO:0070482 | response to oxygen levels | 18/439 | 354/18888 | 0.0508475 | 2.1877148 | 3.4798181 | 0.0016811 | 0.0637607 | 0.0559248 | CPEB2/TFRC/SCN2A/NR4A2/ZEB2/EGLN1/KCNK2/RORA/SMAD3/REST/FGFR2/ITPR1/SIRT1/RYR2/ATF2/IL1A/RGCC/HDAC2 | 18 |
| GO:0010633 | GO:0010633 | negative regulation of epithelial cell migration | 9/439 | 118/18888 | 0.0762712 | 3.2815721 | 3.8350445 | 0.0017484 | 0.0637607 | 0.0559248 | MEOX2/MEF2C/PDCD10/SPRED1/SLIT2/ADIPOR1/KLF4/RGCC/PTPRG | 9 |
| GO:0003180 | GO:0003180 | aortic valve morphogenesis | 5/439 | 38/18888 | 0.1315789 | 5.6611917 | 4.4367036 | 0.0017685 | 0.0637607 | 0.0559248 | ADAMTS5/HEY2/JAG1/SLIT2/HEY1 | 5 |
| GO:0035909 | GO:0035909 | aorta morphogenesis | 5/439 | 38/18888 | 0.1315789 | 5.6611917 | 4.4367036 | 0.0017685 | 0.0637607 | 0.0559248 | HEY2/JAG1/SEC24B/PROX1/HEY1 | 5 |
| GO:0036293 | GO:0036293 | response to decreased oxygen levels | 17/439 | 327/18888 | 0.0519878 | 2.2367767 | 3.4801007 | 0.0017724 | 0.0637607 | 0.0559248 | CPEB2/TFRC/SCN2A/NR4A2/ZEB2/EGLN1/KCNK2/RORA/SMAD3/REST/FGFR2/ITPR1/SIRT1/RYR2/ATF2/IL1A/RGCC | 17 |
| GO:1902893 | GO:1902893 | regulation of miRNA transcription | 7/439 | 75/18888 | 0.0933333 | 4.0156720 | 4.0365751 | 0.0017792 | 0.0637607 | 0.0559248 | TEAD1/JUN/SMAD3/REST/KLF4/YY1/AR | 7 |
| GO:0008063 | GO:0008063 | Toll signaling pathway | 3/439 | 11/18888 | 0.2727273 | 11.7341064 | 5.4931706 | 0.0017905 | 0.0637607 | 0.0559248 | PELI2/IRAK3/IRAK2 | 3 |
| GO:0021860 | GO:0021860 | pyramidal neuron development | 3/439 | 11/18888 | 0.2727273 | 11.7341064 | 5.4931706 | 0.0017905 | 0.0637607 | 0.0559248 | ZMIZ1/SCYL2/FGFR2 | 3 |
| GO:0060601 | GO:0060601 | lateral sprouting from an epithelium | 3/439 | 11/18888 | 0.2727273 | 11.7341064 | 5.4931706 | 0.0017905 | 0.0637607 | 0.0559248 | FGFR2/SULF1/AR | 3 |
| GO:0061351 | GO:0061351 | neural precursor cell proliferation | 11/439 | 167/18888 | 0.0658683 | 2.8339858 | 3.6721213 | 0.0018586 | 0.0656044 | 0.0575420 | HOOK3/CEP120/FZD3/TAFA1/APPL2/RORA/NFIA/FGFR2/PROX1/VCAN/PAFAH1B1 | 11 |
| GO:0061614 | GO:0061614 | miRNA transcription | 7/439 | 76/18888 | 0.0921053 | 3.9628342 | 3.9923076 | 0.0019213 | 0.0672292 | 0.0589671 | TEAD1/JUN/SMAD3/REST/KLF4/YY1/AR | 7 |
| GO:0010717 | GO:0010717 | regulation of epithelial to mesenchymal transition | 9/439 | 120/18888 | 0.0750000 | 3.2268793 | 3.7749016 | 0.0019637 | 0.0681184 | 0.0597470 | USF3/SMAD3/EPHA3/JAG1/TCF7L2/SPRED1/ADIPOR1/RGCC/HDAC2 | 9 |
| GO:0072698 | GO:0072698 | protein localization to microtubule cytoskeleton | 6/439 | 57/18888 | 0.1052632 | 4.5289534 | 4.1159870 | 0.0020306 | 0.0698384 | 0.0612556 | HOOK3/RAB11A/CEP350/TTBK2/CHAMP1/APC | 6 |
| GO:0034599 | GO:0034599 | cellular response to oxidative stress | 14/439 | 248/18888 | 0.0564516 | 2.4288339 | 3.4939119 | 0.0020784 | 0.0703004 | 0.0616608 | CPEB2/MAPK1/NR4A2/PRKRA/JUN/PDCD10/SIRT1/ATF2/PEX5/KLF4/HDAC2/MAP3K5/KAT2B/MAPK8 | 14 |
| GO:0072009 | GO:0072009 | nephron epithelium development | 9/439 | 121/18888 | 0.0743802 | 3.2002108 | 3.7453024 | 0.0020790 | 0.0703004 | 0.0616608 | MTSS1/MEF2C/SIX4/IRX2/JAG1/CALB1/SOX8/HS3ST3B1/HOXB7 | 9 |
| GO:0007519 | GO:0007519 | skeletal muscle tissue development | 11/439 | 170/18888 | 0.0647059 | 2.7839743 | 3.6042148 | 0.0021386 | 0.0717132 | 0.0629000 | MTM1/AKIRIN1/CCNT2/PPP3CA/MEOX2/MEF2C/SIX4/CAV2/SOX8/RBFOX1/DDX17 | 11 |
| GO:0009755 | GO:0009755 | hormone-mediated signaling pathway | 12/439 | 196/18888 | 0.0612245 | 2.6341872 | 3.5475562 | 0.0021798 | 0.0724907 | 0.0635820 | MAPK1/CNOT2/ZMIZ1/APPL2/NCOA1/SAFB/CYP7B1/SIRT1/ADIPOR1/CRHBP/DDX17/AR | 12 |
| GO:0060998 | GO:0060998 | regulation of dendritic spine development | 6/439 | 58/18888 | 0.1034483 | 4.4508680 | 4.0601728 | 0.0022213 | 0.0732552 | 0.0642525 | DLG5/GRIN3A/MEF2C/CPEB3/PAFAH1B1/HDAC2 | 6 |
| GO:0007254 | GO:0007254 | JNK cascade | 11/439 | 171/18888 | 0.0643275 | 2.7676937 | 3.5819069 | 0.0022392 | 0.0732552 | 0.0642525 | NRK/TAOK1/MAP4K3/MECOM/SMAD3/ATF2/IL1A/PAFAH1B1/MAP3K5/MAPK8/PLCB1 | 11 |
| GO:0008380 | GO:0008380 | RNA splicing | 22/439 | 484/18888 | 0.0454545 | 1.9556844 | 3.2855524 | 0.0022651 | 0.0735076 | 0.0644739 | RBM39/SRSF10/VIRMA/SMNDC1/YBX1/MBNL1/RBM12/CLK4/ZCRB1/SYF2/PUS7/REST/HNRNPK/TAF12/RBFOX1/ZNF638/SFSWAP/SRSF2/DDX17/CLNS1A/KAT2B/RBM23 | 22 |
| GO:0060788 | GO:0060788 | ectodermal placode formation | 3/439 | 12/18888 | 0.2500000 | 10.7562642 | 5.2149065 | 0.0023464 | 0.0743448 | 0.0652083 | SIX4/PROX1/HDAC2 | 3 |
| GO:0071394 | GO:0071394 | cellular response to testosterone stimulus | 3/439 | 12/18888 | 0.2500000 | 10.7562642 | 5.2149065 | 0.0023464 | 0.0743448 | 0.0652083 | SRD5A1/SIRT1/AR | 3 |
| GO:0071697 | GO:0071697 | ectodermal placode morphogenesis | 3/439 | 12/18888 | 0.2500000 | 10.7562642 | 5.2149065 | 0.0023464 | 0.0743448 | 0.0652083 | SIX4/PROX1/HDAC2 | 3 |
| GO:0031098 | GO:0031098 | stress-activated protein kinase signaling cascade | 6/439 | 59/18888 | 0.1016949 | 4.3754295 | 4.0056109 | 0.0024252 | 0.0755942 | 0.0663041 | MAPK1/TAOK1/STK26/PDCD10/MAP3K5/MAPK8 | 6 |
| GO:0060612 | GO:0060612 | adipose tissue development | 6/439 | 59/18888 | 0.1016949 | 4.3754295 | 4.0056109 | 0.0024252 | 0.0755942 | 0.0663041 | PUM2/EBF2/NCOA1/SIRT1/ATF2/SOX8 | 6 |
| GO:2000146 | GO:2000146 | negative regulation of cell motility | 19/439 | 396/18888 | 0.0479798 | 2.0643335 | 3.3018758 | 0.0024422 | 0.0755942 | 0.0663041 | RAP2C/DLG5/MEOX2/MEF2C/STK26/ZEB2/EPHA1/JAG1/PDCD10/SPRED1/SLIT2/ADIPOR1/KLF4/SULF1/RGCC/HDAC2/PTPRG/MITF/PLCB1 | 19 |
| GO:0021761 | GO:0021761 | limbic system development | 9/439 | 125/18888 | 0.0720000 | 3.0978041 | 3.6299123 | 0.0025953 | 0.0795663 | 0.0697880 | CDK6/DLX1/SCN2A/EPHA5/SRD5A1/NCOA1/FGFR2/PROX1/PAFAH1B1 | 9 |
| GO:0046620 | GO:0046620 | regulation of organ growth | 8/439 | 102/18888 | 0.0784314 | 3.3745143 | 3.7092409 | 0.0026100 | 0.0795663 | 0.0697880 | JARID2/MEF2C/WWC2/KCNK2/HEY2/FGFR2/PROX1/YY1 | 8 |
| GO:0062197 | GO:0062197 | cellular response to chemical stress | 16/439 | 311/18888 | 0.0514469 | 2.2135078 | 3.3286053 | 0.0026517 | 0.0796258 | 0.0698403 | CPEB2/MAPK1/SCN2A/NR4A2/PRKRA/JUN/PDCD10/OXSR1/SIRT1/ATF2/PEX5/KLF4/HDAC2/MAP3K5/KAT2B/MAPK8 | 16 |
| GO:0010975 | GO:0010975 | regulation of neuron projection development | 21/439 | 460/18888 | 0.0456522 | 1.9641874 | 3.2294502 | 0.0026840 | 0.0796258 | 0.0698403 | PUM2/CSMD3/EPHA7/PPP3CA/CNR1/NEGR1/CNTN1/EPHA3/CDH4/SLIT2/ARHGAP33/NR2F1/BDNF/KLF4/PAFAH1B1/SIPA1L1/TUBB2B/HDAC2/KAT2B/PTPRG/ITM2C | 21 |
| GO:0016331 | GO:0016331 | morphogenesis of embryonic epithelium | 10/439 | 150/18888 | 0.0666667 | 2.8683371 | 3.5437787 | 0.0027021 | 0.0796258 | 0.0698403 | FZD3/SIX4/IRX2/CTHRC1/FGFR2/SEC24B/SOX8/SULF1/OPA1/AR | 10 |
| GO:0050810 | GO:0050810 | regulation of steroid biosynthetic process | 7/439 | 81/18888 | 0.0864198 | 3.7182148 | 3.7817590 | 0.0027685 | 0.0796258 | 0.0698403 | MBTPS1/REST/CREB1/SIRT1/PROX1/SEC14L2/IL1A | 7 |
| GO:0061333 | GO:0061333 | renal tubule morphogenesis | 7/439 | 81/18888 | 0.0864198 | 3.7182148 | 3.7817590 | 0.0027685 | 0.0796258 | 0.0698403 | MTSS1/MEF2C/SIX4/IRX2/SOX8/HS3ST3B1/HOXB7 | 7 |
| GO:0001709 | GO:0001709 | cell fate determination | 5/439 | 42/18888 | 0.1190476 | 5.1220306 | 4.1252816 | 0.0027781 | 0.0796258 | 0.0698403 | EBF2/MEF2C/JAG1/PROX1/KLF4 | 5 |
| GO:0001666 | GO:0001666 | response to hypoxia | 16/439 | 313/18888 | 0.0511182 | 2.1993639 | 3.3005482 | 0.0028248 | 0.0796258 | 0.0698403 | CPEB2/TFRC/SCN2A/NR4A2/EGLN1/KCNK2/RORA/SMAD3/REST/FGFR2/ITPR1/SIRT1/RYR2/ATF2/IL1A/RGCC | 16 |
| GO:0060343 | GO:0060343 | trabecula formation | 4/439 | 26/18888 | 0.1538462 | 6.6192395 | 4.4228039 | 0.0028685 | 0.0796258 | 0.0698403 | EGLN1/SLC40A1/HEY2/HEY1 | 4 |
| GO:0060740 | GO:0060740 | prostate gland epithelium morphogenesis | 4/439 | 26/18888 | 0.1538462 | 6.6192395 | 4.4228039 | 0.0028685 | 0.0796258 | 0.0698403 | CYP7B1/FGFR2/SULF1/AR | 4 |
| GO:2000773 | GO:2000773 | negative regulation of cellular senescence | 4/439 | 26/18888 | 0.1538462 | 6.6192395 | 4.4228039 | 0.0028685 | 0.0796258 | 0.0698403 | CDK6/YBX1/HMGA2/SIRT1 | 4 |
| GO:0001738 | GO:0001738 | morphogenesis of a polarized epithelium | 6/439 | 61/18888 | 0.0983607 | 4.2319728 | 3.9000430 | 0.0028749 | 0.0796258 | 0.0698403 | DLG5/FZD3/CTHRC1/SEC24B/PAFAH1B1/AJAP1 | 6 |
| GO:0003179 | GO:0003179 | heart valve morphogenesis | 6/439 | 61/18888 | 0.0983607 | 4.2319728 | 3.9000430 | 0.0028749 | 0.0796258 | 0.0698403 | ADAMTS5/MEF2C/HEY2/JAG1/SLIT2/HEY1 | 6 |
| GO:0044380 | GO:0044380 | protein localization to cytoskeleton | 6/439 | 61/18888 | 0.0983607 | 4.2319728 | 3.9000430 | 0.0028749 | 0.0796258 | 0.0698403 | HOOK3/RAB11A/CEP350/TTBK2/CHAMP1/APC | 6 |
| GO:0042471 | GO:0042471 | ear morphogenesis | 9/439 | 127/18888 | 0.0708661 | 3.0490198 | 3.5739408 | 0.0028890 | 0.0796258 | 0.0698403 | MAPK1/FZD3/PRKRA/SIX4/CTHRC1/TSHZ1/FGFR2/SEC24B/PROX1 | 9 |
| GO:0019218 | GO:0019218 | regulation of steroid metabolic process | 8/439 | 104/18888 | 0.0769231 | 3.3096198 | 3.6432624 | 0.0029455 | 0.0806298 | 0.0707209 | MBTPS1/RORA/REST/CREB1/SIRT1/PROX1/SEC14L2/IL1A | 8 |
| GO:2000142 | GO:2000142 | regulation of DNA-templated transcription initiation | 7/439 | 82/18888 | 0.0853659 | 3.6728707 | 3.7416572 | 0.0029678 | 0.0806912 | 0.0707747 | TAF4/JUN/GTF2A1/HEY2/TAF12/MED4/MITF | 7 |
| GO:0021781 | GO:0021781 | glial cell fate commitment | 3/439 | 13/18888 | 0.2307692 | 9.9288593 | 4.9676560 | 0.0029980 | 0.0809664 | 0.0710161 | NFIA/TAL1/SOX8 | 3 |
| GO:0003176 | GO:0003176 | aortic valve development | 5/439 | 43/18888 | 0.1162791 | 5.0029136 | 4.0535890 | 0.0030847 | 0.0827524 | 0.0725826 | ADAMTS5/HEY2/JAG1/SLIT2/HEY1 | 5 |
| GO:0099170 | GO:0099170 | postsynaptic modulation of chemical synaptic transmission | 4/439 | 27/18888 | 0.1481481 | 6.3740825 | 4.3105351 | 0.0033064 | 0.0881123 | 0.0772838 | PPP3CA/PPP3R1/TRIO/PLCB1 | 4 |
| GO:0021879 | GO:0021879 | forebrain neuron differentiation | 5/439 | 44/18888 | 0.1136364 | 4.8892110 | 3.9840853 | 0.0034149 | 0.0904060 | 0.0792956 | ZMIZ1/DLX1/SCYL2/FGFR2/PROX1 | 5 |
| GO:0071692 | GO:0071692 | protein localization to extracellular region | 18/439 | 379/18888 | 0.0474934 | 2.0434064 | 3.1652569 | 0.0034940 | 0.0914630 | 0.0802227 | SYT4/RAB12/PPP3CA/GLUD1/KCNN4/CNR1/PRKCB/FBN1/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/IL1A/PAFAH1B1/STXBP5/SEC24A/PLCB1 | 18 |
| GO:0007416 | GO:0007416 | synapse assembly | 12/439 | 208/18888 | 0.0576923 | 2.4822148 | 3.3157495 | 0.0035435 | 0.0914630 | 0.0802227 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/SIX4/NEGR1/GPM6A/CNTN5/BDNF | 12 |
| GO:0045667 | GO:0045667 | regulation of osteoblast differentiation | 10/439 | 156/18888 | 0.0641026 | 2.7580165 | 3.4011086 | 0.0035828 | 0.0914630 | 0.0802227 | CDK6/CEBPD/PPP3CA/MEF2C/GDF10/CTHRC1/SMAD3/JAG1/REST/FGFR2 | 10 |
| GO:0060538 | GO:0060538 | skeletal muscle organ development | 11/439 | 182/18888 | 0.0604396 | 2.6004155 | 3.3466117 | 0.0036206 | 0.0914630 | 0.0802227 | MTM1/AKIRIN1/CCNT2/PPP3CA/MEOX2/MEF2C/SIX4/CAV2/SOX8/RBFOX1/DDX17 | 11 |
| GO:0051090 | GO:0051090 | regulation of DNA-binding transcription factor activity | 18/439 | 381/18888 | 0.0472441 | 2.0326799 | 3.1411416 | 0.0036911 | 0.0914630 | 0.0802227 | KDM5A/TFRC/JMY/EPHA5/EGLN1/SMAD3/TCF7L2/SIRT1/ATF2/PROX1/KLF4/SGK3/RGCC/IRAK3/HDAC2/IRAK2/AR/PRNP | 18 |
| GO:0003279 | GO:0003279 | cardiac septum development | 8/439 | 108/18888 | 0.0740741 | 3.1870413 | 3.5159962 | 0.0037164 | 0.0914630 | 0.0802227 | EGLN1/HEY2/JAG1/FGFR2/SLIT2/PROX1/HEY1/AP2B1 | 8 |
| GO:0010586 | GO:0010586 | miRNA metabolic process | 8/439 | 108/18888 | 0.0740741 | 3.1870413 | 3.5159962 | 0.0037164 | 0.0914630 | 0.0802227 | TEAD1/JUN/SMAD3/REST/KLF4/DDX17/YY1/AR | 8 |
| GO:0048754 | GO:0048754 | branching morphogenesis of an epithelial tube | 10/439 | 157/18888 | 0.0636943 | 2.7404495 | 3.3779880 | 0.0037495 | 0.0914630 | 0.0802227 | DLG5/SIX4/FGFR2/CSMD1/PPP3R1/SLIT2/SOX8/HS3ST3B1/AR/HOXB7 | 10 |
| GO:0043922 | GO:0043922 | negative regulation by host of viral transcription | 3/439 | 14/18888 | 0.2142857 | 9.2196551 | 4.7458387 | 0.0037503 | 0.0914630 | 0.0802227 | JUN/HMGA2/REST | 3 |
| GO:0055012 | GO:0055012 | ventricular cardiac muscle cell differentiation | 3/439 | 14/18888 | 0.2142857 | 9.2196551 | 4.7458387 | 0.0037503 | 0.0914630 | 0.0802227 | MEF2C/HEY2/PROX1 | 3 |
| GO:0060837 | GO:0060837 | blood vessel endothelial cell differentiation | 3/439 | 14/18888 | 0.2142857 | 9.2196551 | 4.7458387 | 0.0037503 | 0.0914630 | 0.0802227 | HEY2/PROX1/HEY1 | 3 |
| GO:0071696 | GO:0071696 | ectodermal placode development | 3/439 | 14/18888 | 0.2142857 | 9.2196551 | 4.7458387 | 0.0037503 | 0.0914630 | 0.0802227 | SIX4/PROX1/HDAC2 | 3 |
| GO:1905664 | GO:1905664 | regulation of calcium ion import across plasma membrane | 3/439 | 14/18888 | 0.2142857 | 9.2196551 | 4.7458387 | 0.0037503 | 0.0914630 | 0.0802227 | PPP3CA/PPP3R1/PRNP | 3 |
| GO:0060512 | GO:0060512 | prostate gland morphogenesis | 4/439 | 28/18888 | 0.1428571 | 6.1464367 | 4.2038009 | 0.0037876 | 0.0918163 | 0.0805326 | CYP7B1/FGFR2/SULF1/AR | 4 |
| GO:0006470 | GO:0006470 | protein dephosphorylation | 12/439 | 210/18888 | 0.0571429 | 2.4585747 | 3.2786908 | 0.0038264 | 0.0921991 | 0.0808683 | MTM1/PTPRE/ARPP19/PTPN13/PPP3CA/CAMTA1/PPP1R1B/PPM1L/PPP6C/PPP3R1/PTPN12/PTPRG | 12 |
| GO:0021954 | GO:0021954 | central nervous system neuron development | 7/439 | 86/18888 | 0.0813953 | 3.5020395 | 3.5873083 | 0.0038765 | 0.0928507 | 0.0814399 | TAOK1/ZMIZ1/NR4A2/SCYL2/FGFR2/SLIT2/PAFAH1B1 | 7 |
| GO:0030902 | GO:0030902 | hindbrain development | 10/439 | 158/18888 | 0.0632911 | 2.7231049 | 3.3550477 | 0.0039223 | 0.0933932 | 0.0819157 | ARL13B/GDF10/NCOA1/RORA/CNTN1/TTBK2/SEC24B/ATF2/PROX1/GART | 10 |
| GO:0035904 | GO:0035904 | aorta development | 6/439 | 65/18888 | 0.0923077 | 3.9715437 | 3.7018747 | 0.0039577 | 0.0936820 | 0.0821690 | HEY2/JAG1/SEC24B/PROX1/HEY1/AP2B1 | 6 |
| GO:0042789 | GO:0042789 | mRNA transcription by RNA polymerase II | 5/439 | 46/18888 | 0.1086957 | 4.6766366 | 3.8511768 | 0.0041504 | 0.0970992 | 0.0851663 | TAF4/NCOA1/CREB1/TAF12/ATF2 | 5 |
| GO:0061383 | GO:0061383 | trabecula morphogenesis | 5/439 | 46/18888 | 0.1086957 | 4.6766366 | 3.8511768 | 0.0041504 | 0.0970992 | 0.0851663 | EGLN1/SLC40A1/HEY2/SOS1/HEY1 | 5 |
| GO:0060828 | GO:0060828 | regulation of canonical Wnt signaling pathway | 14/439 | 268/18888 | 0.0522388 | 2.2475776 | 3.1730175 | 0.0041785 | 0.0971931 | 0.0852486 | KPNA1/SMURF2/SHISA3/LYPD6/ZEB2/SCYL2/CTHRC1/AMFR/SMAD3/TCF7L2/FGFR2/TMEM170B/TNKS2/APC | 14 |
| GO:0099563 | GO:0099563 | modification of synaptic structure | 4/439 | 29/18888 | 0.1379310 | 5.9344906 | 4.1021292 | 0.0043142 | 0.0983536 | 0.0862665 | RAP1B/EGLN1/REST/CTTNBP2 | 4 |
| GO:0031668 | GO:0031668 | cellular response to extracellular stimulus | 14/439 | 269/18888 | 0.0520446 | 2.2392223 | 3.1577265 | 0.0043174 | 0.0983536 | 0.0862665 | MAPK1/SEH1L/NR4A2/JMY/SLC1A2/STK26/SRD5A1/NCOA1/SIRT1/ATF2/MAP3K5/KAT2B/MAPK8/PRKAB1 | 14 |
| GO:0050708 | GO:0050708 | regulation of protein secretion | 14/439 | 269/18888 | 0.0520446 | 2.2392223 | 3.1577265 | 0.0043174 | 0.0983536 | 0.0862665 | SYT4/PPP3CA/GLUD1/KCNN4/CNR1/PRKCB/EPHA5/REST/TCF7L2/ITPR1/IL1A/STXBP5/SEC24A/PLCB1 | 14 |
| GO:0072175 | GO:0072175 | epithelial tube formation | 9/439 | 135/18888 | 0.0666667 | 2.8683371 | 3.3605788 | 0.0043358 | 0.0983536 | 0.0862665 | FZD3/SIX4/IRX2/CTHRC1/FGFR2/SEC24B/PROX1/SOX8/OPA1 | 9 |
| GO:0043087 | GO:0043087 | regulation of GTPase activity | 15/439 | 298/18888 | 0.0503356 | 2.1656908 | 3.1288096 | 0.0043506 | 0.0983536 | 0.0862665 | CPEB2/VAV3/CHN2/AGRN/DOCK10/EPHA5/ADCYAP1/EPHA1/PREX2/EPHA3/PIP5K1A/CAV2/SIPA1L1/SOS1/RALGPS2 | 15 |
| GO:0099072 | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 7/439 | 88/18888 | 0.0795455 | 3.4224477 | 3.5135340 | 0.0044031 | 0.0989847 | 0.0868200 | RAB11A/NSG1/HIP1/PPFIA1/PPP3R1/GPC6/AP2B1 | 7 |
| GO:1905314 | GO:1905314 | semi-lunar valve development | 5/439 | 47/18888 | 0.1063830 | 4.5771337 | 3.7875595 | 0.0045575 | 0.1002257 | 0.0879085 | ADAMTS5/HEY2/JAG1/SLIT2/HEY1 | 5 |
| GO:0055021 | GO:0055021 | regulation of cardiac muscle tissue growth | 6/439 | 67/18888 | 0.0895522 | 3.8529902 | 3.6086409 | 0.0046002 | 0.1002257 | 0.0879085 | JARID2/MEF2C/KCNK2/HEY2/FGFR2/YY1 | 6 |
| GO:0021859 | GO:0021859 | pyramidal neuron differentiation | 3/439 | 15/18888 | 0.2000000 | 8.6050114 | 4.5451934 | 0.0046078 | 0.1002257 | 0.0879085 | ZMIZ1/SCYL2/FGFR2 | 3 |
| GO:0042249 | GO:0042249 | establishment of planar polarity of embryonic epithelium | 3/439 | 15/18888 | 0.2000000 | 8.6050114 | 4.5451934 | 0.0046078 | 0.1002257 | 0.0879085 | CTHRC1/SEC24B/PAFAH1B1 | 3 |
| GO:0060347 | GO:0060347 | heart trabecula formation | 3/439 | 15/18888 | 0.2000000 | 8.6050114 | 4.5451934 | 0.0046078 | 0.1002257 | 0.0879085 | EGLN1/HEY2/HEY1 | 3 |
| GO:0060572 | GO:0060572 | morphogenesis of an epithelial bud | 3/439 | 15/18888 | 0.2000000 | 8.6050114 | 4.5451934 | 0.0046078 | 0.1002257 | 0.0879085 | FGFR2/SULF1/AR | 3 |
| GO:0031346 | GO:0031346 | positive regulation of cell projection organization | 17/439 | 360/18888 | 0.0472222 | 2.0317388 | 3.0488361 | 0.0047289 | 0.1023070 | 0.0897341 | PUM2/AKIRIN1/CEP120/AGRN/CNR1/NEGR1/ATMIN/CNTN1/EPHA3/GPM6A/CDH4/SLIT2/BDNF/APC/PAFAH1B1/TUBB2B/KAT2B | 17 |
| GO:0071560 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 15/439 | 302/18888 | 0.0496689 | 2.1370061 | 3.0725620 | 0.0049128 | 0.1057168 | 0.0927248 | ZMIZ1/DLX1/SMURF2/MEF2C/APPL2/GDF10/JUN/ZEB2/FBN1/SMAD3/FGFR2/SPRED1/SIRT1/CAV2/HDAC2 | 15 |
| GO:2000144 | GO:2000144 | positive regulation of DNA-templated transcription initiation | 6/439 | 68/18888 | 0.0882353 | 3.7963286 | 3.5633639 | 0.0049488 | 0.1057327 | 0.0927388 | TAF4/JUN/GTF2A1/TAF12/MED4/MITF | 6 |
| GO:2000628 | GO:2000628 | regulation of miRNA metabolic process | 7/439 | 90/18888 | 0.0777778 | 3.3463933 | 3.4418630 | 0.0049822 | 0.1057327 | 0.0927388 | TEAD1/JUN/SMAD3/REST/KLF4/YY1/AR | 7 |
| GO:0060043 | GO:0060043 | regulation of cardiac muscle cell proliferation | 5/439 | 48/18888 | 0.1041667 | 4.4817768 | 3.7257047 | 0.0049923 | 0.1057327 | 0.0927388 | JARID2/MEF2C/KCNK2/HEY2/FGFR2 | 5 |
| GO:0050767 | GO:0050767 | regulation of neurogenesis | 18/439 | 393/18888 | 0.0458015 | 1.9706133 | 2.9994573 | 0.0050769 | 0.1069595 | 0.0938148 | HOOK3/SYT4/EPHA7/DLX1/PPP3CA/FZD3/APPL2/HEY2/REST/CDH4/SLIT2/PROX1/VCAN/BDNF/SOX8/PAFAH1B1/HDAC2/HEY1 | 18 |
| GO:0030901 | GO:0030901 | midbrain development | 7/439 | 91/18888 | 0.0769231 | 3.3096198 | 3.4067812 | 0.0052923 | 0.1109169 | 0.0972858 | DLG5/NR4A2/FZD3/GLUD1/FGFR2/YWHAQ/SOS1 | 7 |
| GO:0098926 | GO:0098926 | postsynaptic signal transduction | 5/439 | 49/18888 | 0.1020408 | 4.3903119 | 3.6655244 | 0.0054558 | 0.1137511 | 0.0997717 | KPNA1/AGRN/PRKCB/ITPR1/PLCB1 | 5 |
| GO:0033688 | GO:0033688 | regulation of osteoblast proliferation | 4/439 | 31/18888 | 0.1290323 | 5.5516203 | 3.9123518 | 0.0055108 | 0.1138628 | 0.0998697 | CTHRC1/SMAD3/FGFR2/SOX8 | 4 |
| GO:0031667 | GO:0031667 | response to nutrient levels | 21/439 | 490/18888 | 0.0428571 | 1.8439310 | 2.9197591 | 0.0055223 | 0.1138628 | 0.0998697 | MAPK1/SGIP1/SEH1L/TFRC/JMY/CNR1/APPL2/PRKCB/STK26/ZEB2/SRD5A1/NCOA1/SIRT1/ATF2/PROX1/SRSF2/IL1A/MAP3K5/KAT2B/MAPK8/PRKAB1 | 21 |
| GO:1903358 | GO:1903358 | regulation of Golgi organization | 3/439 | 16/18888 | 0.1875000 | 8.0671982 | 4.3624015 | 0.0055743 | 0.1138628 | 0.0998697 | MAPK1/RAB33B/PDCD10 | 3 |
| GO:2001212 | GO:2001212 | regulation of vasculogenesis | 3/439 | 16/18888 | 0.1875000 | 8.0671982 | 4.3624015 | 0.0055743 | 0.1138628 | 0.0998697 | RIN2/HEY2/HEY1 | 3 |
| GO:0048608 | GO:0048608 | reproductive structure development | 15/439 | 307/18888 | 0.0488599 | 2.1022015 | 3.0034677 | 0.0056970 | 0.1151591 | 0.1010067 | TAF4/ASH1L/SIX4/SRD5A1/NCOA1/CYP7B1/FGFR2/CSMD1/SLIT2/SIRT1/SOX8/SULF1/IL1A/AR/MAMLD1 | 15 |
| GO:0002062 | GO:0002062 | chondrocyte differentiation | 8/439 | 116/18888 | 0.0689655 | 2.9672453 | 3.2783821 | 0.0057184 | 0.1151591 | 0.1010067 | MEF2C/PTHLH/HMGA2/SMAD3/ATF2/EFEMP1/SULF1/TRPS1 | 8 |
| GO:0099003 | GO:0099003 | vesicle-mediated transport in synapse | 12/439 | 221/18888 | 0.0542986 | 2.3362022 | 3.0821828 | 0.0057236 | 0.1151591 | 0.1010067 | DNAJC6/SYT4/RAP1B/PRKCB/NSG1/HIP1/PPP3R1/SLC17A6/VAMP4/STXBP5/UNC13C/AP2B1 | 12 |
| GO:0009299 | GO:0009299 | mRNA transcription | 5/439 | 50/18888 | 0.1000000 | 4.3025057 | 3.6069367 | 0.0059487 | 0.1171746 | 0.1027746 | TAF4/NCOA1/CREB1/TAF12/ATF2 | 5 |
| GO:0030521 | GO:0030521 | androgen receptor signaling pathway | 5/439 | 50/18888 | 0.1000000 | 4.3025057 | 3.6069367 | 0.0059487 | 0.1171746 | 0.1027746 | MAPK1/ZMIZ1/SIRT1/DDX17/AR | 5 |
| GO:0051403 | GO:0051403 | stress-activated MAPK cascade | 5/439 | 50/18888 | 0.1000000 | 4.3025057 | 3.6069367 | 0.0059487 | 0.1171746 | 0.1027746 | MAPK1/TAOK1/PDCD10/MAP3K5/MAPK8 | 5 |
| GO:0090102 | GO:0090102 | cochlea development | 5/439 | 50/18888 | 0.1000000 | 4.3025057 | 3.6069367 | 0.0059487 | 0.1171746 | 0.1027746 | CTHRC1/KCNK2/HEY2/CALB1/PAFAH1B1 | 5 |
| GO:0030522 | GO:0030522 | intracellular receptor signaling pathway | 17/439 | 369/18888 | 0.0460705 | 1.9821842 | 2.9391699 | 0.0060167 | 0.1171746 | 0.1027746 | PUM2/MAPK1/CNOT2/HCFC2/ZMIZ1/NR4A2/NCOA1/SAFB/RORA/PPP6C/CYP7B1/SIRT1/NR2F1/PUM1/DDX17/MAPK8/AR | 17 |
| GO:0016311 | GO:0016311 | dephosphorylation | 15/439 | 309/18888 | 0.0485437 | 2.0885950 | 2.9761975 | 0.0060376 | 0.1171746 | 0.1027746 | MTM1/PTPRE/ARPP19/PTPN13/DNAJC6/PPP3CA/MEF2C/CAMTA1/PPP1R1B/PPM1L/MTMR12/PPP6C/PPP3R1/PTPN12/PTPRG | 15 |
| GO:0071559 | GO:0071559 | response to transforming growth factor beta | 15/439 | 309/18888 | 0.0485437 | 2.0885950 | 2.9761975 | 0.0060376 | 0.1171746 | 0.1027746 | ZMIZ1/DLX1/SMURF2/MEF2C/APPL2/GDF10/JUN/ZEB2/FBN1/SMAD3/FGFR2/SPRED1/SIRT1/CAV2/HDAC2 | 15 |
| GO:0040013 | GO:0040013 | negative regulation of locomotion | 19/439 | 431/18888 | 0.0440835 | 1.8966962 | 2.9048972 | 0.0060567 | 0.1171746 | 0.1027746 | RAP2C/DLG5/MEOX2/MEF2C/STK26/ZEB2/EPHA1/JAG1/PDCD10/SPRED1/SLIT2/ADIPOR1/KLF4/SULF1/RGCC/HDAC2/PTPRG/MITF/PLCB1 | 19 |
| GO:0009306 | GO:0009306 | protein secretion | 17/439 | 370/18888 | 0.0459459 | 1.9768269 | 2.9271757 | 0.0061758 | 0.1179444 | 0.1034497 | SYT4/RAB12/PPP3CA/GLUD1/KCNN4/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/IL1A/PAFAH1B1/STXBP5/SEC24A/PLCB1 | 17 |
| GO:0061384 | GO:0061384 | heart trabecula morphogenesis | 4/439 | 32/18888 | 0.1250000 | 5.3781321 | 3.8235467 | 0.0061845 | 0.1179444 | 0.1034497 | EGLN1/HEY2/SOS1/HEY1 | 4 |
| GO:0070498 | GO:0070498 | interleukin-1-mediated signaling pathway | 4/439 | 32/18888 | 0.1250000 | 5.3781321 | 3.8235467 | 0.0061845 | 0.1179444 | 0.1034497 | IRAK3/IRAK2/ST18/PLCB1 | 4 |
| GO:0045664 | GO:0045664 | regulation of neuron differentiation | 11/439 | 196/18888 | 0.0561224 | 2.4146716 | 3.0710233 | 0.0062843 | 0.1189055 | 0.1042927 | DLX1/MEF2C/NCOA1/HEY2/JAG1/REST/PROX1/BDNF/TCF4/SOX8/HEY1 | 11 |
| GO:0003158 | GO:0003158 | endothelium development | 9/439 | 143/18888 | 0.0629371 | 2.7078707 | 3.1623332 | 0.0062940 | 0.1189055 | 0.1042927 | RAP2C/RAP1B/SLC40A1/HEY2/JAG1/PDCD10/PROX1/HEY1/PLCB1 | 9 |
| GO:0035592 | GO:0035592 | establishment of protein localization to extracellular region | 17/439 | 371/18888 | 0.0458221 | 1.9714986 | 2.9152187 | 0.0063384 | 0.1191853 | 0.1045381 | SYT4/RAB12/PPP3CA/GLUD1/KCNN4/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/IL1A/PAFAH1B1/STXBP5/SEC24A/PLCB1 | 17 |
| GO:0061458 | GO:0061458 | reproductive system development | 15/439 | 311/18888 | 0.0482315 | 2.0751635 | 2.9491323 | 0.0063946 | 0.1196824 | 0.1049742 | TAF4/ASH1L/SIX4/SRD5A1/NCOA1/CYP7B1/FGFR2/CSMD1/SLIT2/SIRT1/SOX8/SULF1/IL1A/AR/MAMLD1 | 15 |
| GO:0034198 | GO:0034198 | cellular response to amino acid starvation | 5/439 | 51/18888 | 0.0980392 | 4.2181428 | 3.5498653 | 0.0064722 | 0.1200195 | 0.1052698 | MAPK1/SEH1L/ATF2/MAP3K5/MAPK8 | 5 |
| GO:0042220 | GO:0042220 | response to cocaine | 5/439 | 51/18888 | 0.0980392 | 4.2181428 | 3.5498653 | 0.0064722 | 0.1200195 | 0.1052698 | CNR1/SLC1A2/PPP1R1B/CRHBP/HDAC2 | 5 |
| GO:0090276 | GO:0090276 | regulation of peptide hormone secretion | 11/439 | 197/18888 | 0.0558376 | 2.4024143 | 3.0522530 | 0.0065215 | 0.1203411 | 0.1055518 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0016055 | GO:0016055 | Wnt signaling pathway | 20/439 | 466/18888 | 0.0429185 | 1.8465690 | 2.8543962 | 0.0065782 | 0.1203411 | 0.1055518 | KPNA1/SMURF2/SHISA3/NR4A2/LYPD6/FZD3/RNF138/ZEB2/SCYL2/CTHRC1/AMFR/SMAD3/TCF7L2/FGFR2/TMEM170B/TNKS2/KLF4/SULF1/APC/MITF | 20 |
| GO:0051047 | GO:0051047 | positive regulation of secretion | 15/439 | 312/18888 | 0.0480769 | 2.0685124 | 2.9356757 | 0.0065793 | 0.1203411 | 0.1055518 | SYT4/PPP3CA/GLUD1/KCNN4/PRKCB/ADCYAP1/CREB1/TCF7L2/ITPR1/SCAMP5/IL1A/RGCC/STXBP5/SEC24A/PLCB1 | 15 |
| GO:0198738 | GO:0198738 | cell-cell signaling by wnt | 20/439 | 468/18888 | 0.0427350 | 1.8386776 | 2.8340044 | 0.0068833 | 0.1241449 | 0.1088882 | KPNA1/SMURF2/SHISA3/NR4A2/LYPD6/FZD3/RNF138/ZEB2/SCYL2/CTHRC1/AMFR/SMAD3/TCF7L2/FGFR2/TMEM170B/TNKS2/KLF4/SULF1/APC/MITF | 20 |
| GO:0007264 | GO:0007264 | small GTPase-mediated signal transduction | 21/439 | 500/18888 | 0.0420000 | 1.8070524 | 2.8212841 | 0.0068953 | 0.1241449 | 0.1088882 | RAP2C/RAB33B/VAV3/RRAS2/CHN2/RAB12/DOCK10/RIN2/RAP1B/PREX2/DOCK1/YWHAQ/DOCK4/SLIT2/ARHGAP33/TRIO/RHOT1/SIPA1L1/ARFGEF3/SOS1/RALGPS2 | 21 |
| GO:0001975 | GO:0001975 | response to amphetamine | 4/439 | 33/18888 | 0.1212121 | 5.2151584 | 3.7383929 | 0.0069106 | 0.1241449 | 0.1088882 | PPP3CA/NR4A2/PPP1R1B/HDAC2 | 4 |
| GO:0051647 | GO:0051647 | nucleus localization | 4/439 | 33/18888 | 0.1212121 | 5.2151584 | 3.7383929 | 0.0069106 | 0.1241449 | 0.1088882 | HOOK3/CEP120/SIRT1/PAFAH1B1 | 4 |
| GO:2000036 | GO:2000036 | regulation of stem cell population maintenance | 6/439 | 73/18888 | 0.0821918 | 3.5363061 | 3.3491786 | 0.0069886 | 0.1249880 | 0.1096277 | CNOT2/SS18/HMGA2/REST/TAL1/HDAC2 | 6 |
| GO:0003197 | GO:0003197 | endocardial cushion development | 5/439 | 52/18888 | 0.0961538 | 4.1370247 | 3.4942390 | 0.0070272 | 0.1251212 | 0.1097446 | ADAMTS5/HEY2/JAG1/APC/HEY1 | 5 |
| GO:0002791 | GO:0002791 | regulation of peptide secretion | 11/439 | 200/18888 | 0.0550000 | 2.3663781 | 2.9966210 | 0.0072754 | 0.1289693 | 0.1131197 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0042063 | GO:0042063 | gliogenesis | 16/439 | 346/18888 | 0.0462428 | 1.9895980 | 2.8658002 | 0.0073196 | 0.1291850 | 0.1133089 | MAPK1/RRAS2/CDK6/ZMIZ1/DLX1/SUZ12/ZEB2/CNTN1/NFIA/PPP3R1/VCAN/TAL1/SOX8/PAFAH1B1/HDAC2/SOS1 | 16 |
| GO:0050680 | GO:0050680 | negative regulation of epithelial cell proliferation | 10/439 | 173/18888 | 0.0578035 | 2.4869975 | 3.0308589 | 0.0073522 | 0.1291933 | 0.1133162 | CDK6/MTSS1/MEF2C/PDCD10/B4GALT1/FGFR2/CAV2/SULF1/RGCC/AR | 10 |
| GO:0140747 | GO:0140747 | regulation of ncRNA transcription | 7/439 | 97/18888 | 0.0721649 | 3.1049010 | 3.2060474 | 0.0074662 | 0.1306260 | 0.1145728 | TEAD1/JUN/SMAD3/REST/KLF4/YY1/AR | 7 |
| GO:0048009 | GO:0048009 | insulin-like growth factor receptor signaling pathway | 5/439 | 53/18888 | 0.0943396 | 4.0589676 | 3.4399913 | 0.0076145 | 0.1326447 | 0.1163434 | MAPK1/PHIP/SOS1/AR/PLCB1 | 5 |
| GO:0090183 | GO:0090183 | regulation of kidney development | 4/439 | 34/18888 | 0.1176471 | 5.0617714 | 3.6566258 | 0.0076910 | 0.1326635 | 0.1163599 | PPP3CA/SIX4/SOX8/HOXB7 | 4 |
| GO:0110110 | GO:0110110 | positive regulation of animal organ morphogenesis | 4/439 | 34/18888 | 0.1176471 | 5.0617714 | 3.6566258 | 0.0076910 | 0.1326635 | 0.1163599 | SIX4/PRKCB/SOX8/AR | 4 |
| GO:0061448 | GO:0061448 | connective tissue development | 14/439 | 288/18888 | 0.0486111 | 2.0914958 | 2.8793150 | 0.0077475 | 0.1326635 | 0.1163599 | PUM2/EBF2/MEF2C/NCOA1/PTHLH/HMGA2/SMAD3/NFIA/SIRT1/ATF2/SOX8/EFEMP1/SULF1/TRPS1 | 14 |
| GO:1903532 | GO:1903532 | positive regulation of secretion by cell | 14/439 | 288/18888 | 0.0486111 | 2.0914958 | 2.8793150 | 0.0077475 | 0.1326635 | 0.1163599 | SYT4/GLUD1/KCNN4/PRKCB/ADCYAP1/CREB1/TCF7L2/ITPR1/SCAMP5/IL1A/RGCC/STXBP5/SEC24A/PLCB1 | 14 |
| GO:0090087 | GO:0090087 | regulation of peptide transport | 11/439 | 202/18888 | 0.0544554 | 2.3429486 | 2.9600855 | 0.0078146 | 0.1332451 | 0.1168700 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0090190 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 3/439 | 18/18888 | 0.1666667 | 7.1708428 | 4.0403792 | 0.0078480 | 0.1332509 | 0.1168752 | SIX4/SOX8/HOXB7 | 3 |
| GO:0060993 | GO:0060993 | kidney morphogenesis | 7/439 | 98/18888 | 0.0714286 | 3.0732184 | 3.1741104 | 0.0078844 | 0.1333067 | 0.1169241 | PPP3CA/SIX4/IRX2/CALB1/SOX8/HS3ST3B1/HOXB7 | 7 |
| GO:0030518 | GO:0030518 | intracellular steroid hormone receptor signaling pathway | 8/439 | 123/18888 | 0.0650407 | 2.7983777 | 3.0866438 | 0.0080657 | 0.1351727 | 0.1185608 | MAPK1/CNOT2/ZMIZ1/SAFB/CYP7B1/SIRT1/DDX17/AR | 8 |
| GO:0010001 | GO:0010001 | glial cell differentiation | 13/439 | 260/18888 | 0.0500000 | 2.1512528 | 2.8833782 | 0.0080728 | 0.1351727 | 0.1185608 | MAPK1/CDK6/DLX1/SUZ12/ZEB2/CNTN1/NFIA/PPP3R1/VCAN/TAL1/SOX8/HDAC2/SOS1 | 13 |
| GO:0000302 | GO:0000302 | response to reactive oxygen species | 11/439 | 203/18888 | 0.0541872 | 2.3314070 | 2.9419795 | 0.0080956 | 0.1351727 | 0.1185608 | MAPK1/STK26/JUN/PDCD10/SIRT1/PEX5/KLF4/IL1A/HDAC2/MAP3K5/MAPK8 | 11 |
| GO:0035148 | GO:0035148 | tube formation | 9/439 | 149/18888 | 0.0604027 | 2.5988289 | 3.0223814 | 0.0081625 | 0.1352591 | 0.1186365 | FZD3/SIX4/IRX2/CTHRC1/FGFR2/SEC24B/PROX1/SOX8/OPA1 | 9 |
| GO:0021872 | GO:0021872 | forebrain generation of neurons | 5/439 | 54/18888 | 0.0925926 | 3.9838016 | 3.3870598 | 0.0082352 | 0.1352591 | 0.1186365 | ZMIZ1/DLX1/SCYL2/FGFR2/PROX1 | 5 |
| GO:0030520 | GO:0030520 | intracellular estrogen receptor signaling pathway | 5/439 | 54/18888 | 0.0925926 | 3.9838016 | 3.3870598 | 0.0082352 | 0.1352591 | 0.1186365 | CNOT2/SAFB/CYP7B1/DDX17/AR | 5 |
| GO:1990928 | GO:1990928 | response to amino acid starvation | 5/439 | 54/18888 | 0.0925926 | 3.9838016 | 3.3870598 | 0.0082352 | 0.1352591 | 0.1186365 | MAPK1/SEH1L/ATF2/MAP3K5/MAPK8 | 5 |
| GO:0060419 | GO:0060419 | heart growth | 7/439 | 99/18888 | 0.0707071 | 3.0421757 | 3.1425791 | 0.0083197 | 0.1360916 | 0.1193667 | JARID2/MEF2C/KCNK2/HEY2/FGFR2/PROX1/YY1 | 7 |
| GO:0010811 | GO:0010811 | positive regulation of cell-substrate adhesion | 8/439 | 124/18888 | 0.0645161 | 2.7758101 | 3.0603563 | 0.0084525 | 0.1372534 | 0.1203857 | CDK6/RIN2/EGFL6/EPHA1/SMAD3/DOCK1/FBLN2/EDIL3 | 8 |
| GO:0001890 | GO:0001890 | placenta development | 9/439 | 150/18888 | 0.0600000 | 2.5815034 | 2.9997253 | 0.0085111 | 0.1372534 | 0.1203857 | MAPK1/ASH1L/E2F8/SP3/EGLN1/NCOA1/HEY2/FGFR2/HEY1 | 9 |
| GO:0048048 | GO:0048048 | embryonic eye morphogenesis | 4/439 | 35/18888 | 0.1142857 | 4.9171494 | 3.5780076 | 0.0085272 | 0.1372534 | 0.1203857 | SP3/FBN1/PROX1/EFEMP1 | 4 |
| GO:0048333 | GO:0048333 | mesodermal cell differentiation | 4/439 | 35/18888 | 0.1142857 | 4.9171494 | 3.5780076 | 0.0085272 | 0.1372534 | 0.1203857 | HMGA2/FGFR2/TAL1/KLF4 | 4 |
| GO:0001503 | GO:0001503 | ossification | 19/439 | 446/18888 | 0.0426009 | 1.8329060 | 2.7459129 | 0.0085828 | 0.1375981 | 0.1206881 | MAPK1/RRAS2/CDK6/HIRA/CEBPD/PPP3CA/SP3/ATP2B1/MEF2C/GDF10/CTHRC1/BCOR/PTHLH/SMAD3/JAG1/REST/FGFR2/VCAN/SOX8 | 19 |
| GO:0008593 | GO:0008593 | regulation of Notch signaling pathway | 7/439 | 100/18888 | 0.0700000 | 3.0117540 | 3.1114436 | 0.0087724 | 0.1398839 | 0.1226930 | ZMIZ1/DLX1/HEY2/JAG1/PDCD10/CD46/HEY1 | 7 |
| GO:0007411 | GO:0007411 | axon guidance | 12/439 | 234/18888 | 0.0512821 | 2.2064132 | 2.8644771 | 0.0088549 | 0.1398839 | 0.1226930 | EPHA7/FZD3/EPHA5/CNTN1/EPHA3/CNTN5/CDH4/SLIT2/BDNF/TRIO/TUBB2B/SOS1 | 12 |
| GO:0097485 | GO:0097485 | neuron projection guidance | 12/439 | 234/18888 | 0.0512821 | 2.2064132 | 2.8644771 | 0.0088549 | 0.1398839 | 0.1226930 | EPHA7/FZD3/EPHA5/CNTN1/EPHA3/CNTN5/CDH4/SLIT2/BDNF/TRIO/TUBB2B/SOS1 | 12 |
| GO:0034614 | GO:0034614 | cellular response to reactive oxygen species | 9/439 | 151/18888 | 0.0596026 | 2.5644074 | 2.9772523 | 0.0088708 | 0.1398839 | 0.1226930 | MAPK1/JUN/PDCD10/SIRT1/PEX5/KLF4/HDAC2/MAP3K5/MAPK8 | 9 |
| GO:0032970 | GO:0032970 | regulation of actin filament-based process | 17/439 | 385/18888 | 0.0441558 | 1.8998077 | 2.7516066 | 0.0090015 | 0.1398839 | 0.1226930 | MTSS1/TAOK1/WASHC4/ZEB2/EPHA5/EPHA1/SMAD3/EPHA3/PPFIA1/IQGAP2/SLIT2/RYR2/PROX1/MEGF9/FRMD6/IL1A/RGCC | 17 |
| GO:0035914 | GO:0035914 | skeletal muscle cell differentiation | 6/439 | 77/18888 | 0.0779221 | 3.3526018 | 3.1909147 | 0.0090120 | 0.1398839 | 0.1226930 | AKIRIN1/MEF2C/SIX4/SOX8/RBFOX1/DDX17 | 6 |
| GO:0045669 | GO:0045669 | positive regulation of osteoblast differentiation | 6/439 | 77/18888 | 0.0779221 | 3.3526018 | 3.1909147 | 0.0090120 | 0.1398839 | 0.1226930 | CEBPD/PPP3CA/MEF2C/GDF10/CTHRC1/JAG1 | 6 |
| GO:0007178 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 18/439 | 417/18888 | 0.0431655 | 1.8571967 | 2.7304275 | 0.0091297 | 0.1398839 | 0.1226930 | ZMIZ1/DLX1/SMURF2/APPL2/GDF10/JUN/ZEB2/FBN1/PPM1L/UBE2D3/SMAD3/NFIA/SPRED1/SIRT1/CAV2/ATF2/SULF1/HDAC2 | 18 |
| GO:0016358 | GO:0016358 | dendrite development | 12/439 | 235/18888 | 0.0510638 | 2.1970242 | 2.8483270 | 0.0091422 | 0.1398839 | 0.1226930 | DLG5/GRIN3A/CSMD3/PPP3CA/DOCK10/MEF2C/PREX2/CPEB3/ARHGAP33/PAFAH1B1/SIPA1L1/HDAC2 | 12 |
| GO:0048268 | GO:0048268 | clathrin coat assembly | 3/439 | 19/18888 | 0.1578947 | 6.7934300 | 3.8973146 | 0.0091610 | 0.1398839 | 0.1226930 | DNAJC6/NSG1/HIP1 | 3 |
| GO:0060977 | GO:0060977 | coronary vasculature morphogenesis | 3/439 | 19/18888 | 0.1578947 | 6.7934300 | 3.8973146 | 0.0091610 | 0.1398839 | 0.1226930 | HEY2/SEC24B/SPRED1 | 3 |
| GO:0061158 | GO:0061158 | 3'-UTR-mediated mRNA destabilization | 3/439 | 19/18888 | 0.1578947 | 6.7934300 | 3.8973146 | 0.0091610 | 0.1398839 | 0.1226930 | PUM2/CPEB3/PUM1 | 3 |
| GO:0003300 | GO:0003300 | cardiac muscle hypertrophy | 7/439 | 101/18888 | 0.0693069 | 2.9819346 | 3.0806945 | 0.0092429 | 0.1398839 | 0.1226930 | PPP3CA/JARID2/HEY2/SMAD3/RYR2/HDAC2/YY1 | 7 |
| GO:0010596 | GO:0010596 | negative regulation of endothelial cell migration | 7/439 | 101/18888 | 0.0693069 | 2.9819346 | 3.0806945 | 0.0092429 | 0.1398839 | 0.1226930 | MEOX2/MEF2C/PDCD10/SPRED1/SLIT2/KLF4/RGCC | 7 |
| GO:0050673 | GO:0050673 | epithelial cell proliferation | 20/439 | 482/18888 | 0.0414938 | 1.7852721 | 2.6939610 | 0.0093570 | 0.1398839 | 0.1226930 | MAPK1/CDK6/MTSS1/MEF2C/SIX4/ZEB2/SMAD3/JAG1/CYP7B1/PDCD10/B4GALT1/TCF7L2/FGFR2/SIRT1/CAV2/PROX1/SERPINB1/SULF1/RGCC/AR | 20 |
| GO:0007617 | GO:0007617 | mating behavior | 4/439 | 36/18888 | 0.1111111 | 4.7805619 | 3.5023232 | 0.0094206 | 0.1398839 | 0.1226930 | CNR1/PPP1R1B/NCOA1/HDAC2 | 4 |
| GO:0033687 | GO:0033687 | osteoblast proliferation | 4/439 | 36/18888 | 0.1111111 | 4.7805619 | 3.5023232 | 0.0094206 | 0.1398839 | 0.1226930 | CTHRC1/SMAD3/FGFR2/SOX8 | 4 |
| GO:0045920 | GO:0045920 | negative regulation of exocytosis | 4/439 | 36/18888 | 0.1111111 | 4.7805619 | 3.5023232 | 0.0094206 | 0.1398839 | 0.1226930 | RAB33B/SYT4/RAP1B/REST | 4 |
| GO:0071539 | GO:0071539 | protein localization to centrosome | 4/439 | 36/18888 | 0.1111111 | 4.7805619 | 3.5023232 | 0.0094206 | 0.1398839 | 0.1226930 | HOOK3/RAB11A/CEP350/APC | 4 |
| GO:1905332 | GO:1905332 | positive regulation of morphogenesis of an epithelium | 4/439 | 36/18888 | 0.1111111 | 4.7805619 | 3.5023232 | 0.0094206 | 0.1398839 | 0.1226930 | SIX4/SOX8/AR/HOXB7 | 4 |
| GO:1902895 | GO:1902895 | positive regulation of miRNA transcription | 5/439 | 56/18888 | 0.0892857 | 3.8415229 | 3.2849162 | 0.0095800 | 0.1413282 | 0.1239598 | TEAD1/JUN/SMAD3/KLF4/AR | 5 |
| GO:0035265 | GO:0035265 | organ growth | 10/439 | 180/18888 | 0.0555556 | 2.3902809 | 2.8910292 | 0.0095881 | 0.1413282 | 0.1239598 | JARID2/MEF2C/WWC2/KCNK2/HEY2/FGFR2/ATF2/PROX1/YY1/AR | 10 |
| GO:0141091 | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 17/439 | 388/18888 | 0.0438144 | 1.8851185 | 2.7174323 | 0.0096746 | 0.1420823 | 0.1246212 | ZMIZ1/DLX1/SMURF2/APPL2/GDF10/JUN/ZEB2/FBN1/UBE2D3/SMAD3/NFIA/SPRED1/SIRT1/CAV2/ATF2/SULF1/HDAC2 | 17 |
| GO:0048511 | GO:0048511 | rhythmic process | 14/439 | 297/18888 | 0.0471380 | 2.0281172 | 2.7548426 | 0.0099933 | 0.1455974 | 0.1277044 | KDM5A/GRIN3A/PSPC1/GDF10/CREM/NCOA1/RORA/CREB1/SLIT2/SIRT1/PROX1/HDAC2/KAT2B/MAPK8 | 14 |
| GO:0071456 | GO:0071456 | cellular response to hypoxia | 9/439 | 154/18888 | 0.0584416 | 2.5144514 | 2.9109033 | 0.0100193 | 0.1455974 | 0.1277044 | CPEB2/SCN2A/EGLN1/KCNK2/RORA/FGFR2/SIRT1/ATF2/RGCC | 9 |
| GO:0034329 | GO:0034329 | cell junction assembly | 19/439 | 453/18888 | 0.0419426 | 1.8045830 | 2.6737802 | 0.0100225 | 0.1455974 | 0.1277044 | PTPN13/DLG5/LRRTM3/EPHA7/SLITRK4/AGRN/MEF2C/RAP1B/SIX4/NEGR1/SMAD3/EPHA3/GPM6A/CNTN5/CDH4/PIP5K1A/BDNF/APC/CDH19 | 19 |
| GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 14/439 | 298/18888 | 0.0469799 | 2.0213114 | 2.7412835 | 0.0102715 | 0.1469721 | 0.1289100 | RAB11A/MEOX2/MEF2C/RIN2/PDCD10/DOCK1/SPRED1/SLIT2/SIRT1/ADIPOR1/PROX1/KLF4/RGCC/PTPRG | 14 |
| GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 12/439 | 239/18888 | 0.0502092 | 2.1602539 | 2.7845277 | 0.0103646 | 0.1469721 | 0.1289100 | CDK6/TFRC/PPP3CA/SP3/L3MBTL3/FBN1/CREB1/SIRT1/TAL1/PAFAH1B1/MITF/OSTM1 | 12 |
| GO:0031669 | GO:0031669 | cellular response to nutrient levels | 12/439 | 239/18888 | 0.0502092 | 2.1602539 | 2.7845277 | 0.0103646 | 0.1469721 | 0.1289100 | MAPK1/SEH1L/JMY/STK26/SRD5A1/NCOA1/SIRT1/ATF2/MAP3K5/KAT2B/MAPK8/PRKAB1 | 12 |
| GO:0001736 | GO:0001736 | establishment of planar polarity | 4/439 | 37/18888 | 0.1081081 | 4.6513575 | 3.4293780 | 0.0103728 | 0.1469721 | 0.1289100 | FZD3/CTHRC1/SEC24B/PAFAH1B1 | 4 |
| GO:0007164 | GO:0007164 | establishment of tissue polarity | 4/439 | 37/18888 | 0.1081081 | 4.6513575 | 3.4293780 | 0.0103728 | 0.1469721 | 0.1289100 | FZD3/CTHRC1/SEC24B/PAFAH1B1 | 4 |
| GO:0046621 | GO:0046621 | negative regulation of organ growth | 4/439 | 37/18888 | 0.1081081 | 4.6513575 | 3.4293780 | 0.0103728 | 0.1469721 | 0.1289100 | JARID2/WWC2/KCNK2/YY1 | 4 |
| GO:1905508 | GO:1905508 | protein localization to microtubule organizing center | 4/439 | 37/18888 | 0.1081081 | 4.6513575 | 3.4293780 | 0.0103728 | 0.1469721 | 0.1289100 | HOOK3/RAB11A/CEP350/APC | 4 |
| GO:0051961 | GO:0051961 | negative regulation of nervous system development | 9/439 | 155/18888 | 0.0580645 | 2.4982291 | 2.8891344 | 0.0104260 | 0.1472079 | 0.1291169 | HOOK3/PTPN13/SYT4/EPHA7/DLX1/PPP3CA/APPL2/REST/PROX1 | 9 |
| GO:0007409 | GO:0007409 | axonogenesis | 19/439 | 455/18888 | 0.0417582 | 1.7966507 | 2.6534016 | 0.0104676 | 0.1472781 | 0.1291785 | EPHA7/SLITRK4/NR4A2/FZD3/EPHA5/CNTN1/EPHA3/CNTN5/CREB1/FGFR2/CDH4/SLIT2/BDNF/TRIO/PAFAH1B1/SIPA1L1/TUBB2B/SOS1/PLPPR4 | 19 |
| GO:0045722 | GO:0045722 | positive regulation of gluconeogenesis | 3/439 | 20/18888 | 0.1500000 | 6.4537585 | 3.7642227 | 0.0105945 | 0.1475166 | 0.1293876 | ARPP19/SIRT1/KAT2B | 3 |
| GO:0060716 | GO:0060716 | labyrinthine layer blood vessel development | 3/439 | 20/18888 | 0.1500000 | 6.4537585 | 3.7642227 | 0.0105945 | 0.1475166 | 0.1293876 | MAPK1/HEY2/HEY1 | 3 |
| GO:0072079 | GO:0072079 | nephron tubule formation | 3/439 | 20/18888 | 0.1500000 | 6.4537585 | 3.7642227 | 0.0105945 | 0.1475166 | 0.1293876 | SIX4/IRX2/SOX8 | 3 |
| GO:0007565 | GO:0007565 | female pregnancy | 10/439 | 183/18888 | 0.0546448 | 2.3510960 | 2.8330891 | 0.0106915 | 0.1483540 | 0.1301221 | ASH1L/SMURF2/PNOC/SP3/CNR1/ADCYAP1/PTHLH/CSMD1/CRHBP/AR | 10 |
| GO:0014897 | GO:0014897 | striated muscle hypertrophy | 7/439 | 104/18888 | 0.0673077 | 2.8959173 | 2.9906759 | 0.0107654 | 0.1488655 | 0.1305708 | PPP3CA/JARID2/HEY2/SMAD3/RYR2/HDAC2/YY1 | 7 |
| GO:0043433 | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 9/439 | 156/18888 | 0.0576923 | 2.4822148 | 2.8675349 | 0.0108450 | 0.1494527 | 0.1310858 | EGLN1/TCF7L2/SIRT1/PROX1/KLF4/IRAK3/HDAC2/IRAK2/PRNP | 9 |
| GO:0044706 | GO:0044706 | multi-multicellular organism process | 11/439 | 212/18888 | 0.0518868 | 2.2324322 | 2.7836612 | 0.0109922 | 0.1509641 | 0.1324114 | ASH1L/SMURF2/PNOC/SP3/CNR1/ADCYAP1/PTHLH/B4GALT1/CSMD1/CRHBP/AR | 11 |
| GO:0072132 | GO:0072132 | mesenchyme morphogenesis | 5/439 | 58/18888 | 0.0862069 | 3.7090566 | 3.1873830 | 0.0110686 | 0.1514974 | 0.1328792 | ADAMTS5/HEY2/SMAD3/APC/HEY1 | 5 |
| GO:0021549 | GO:0021549 | cerebellum development | 7/439 | 105/18888 | 0.0666667 | 2.8683371 | 2.9613842 | 0.0113111 | 0.1542495 | 0.1352932 | GDF10/NCOA1/RORA/CNTN1/TTBK2/PROX1/GART | 7 |
| GO:0071383 | GO:0071383 | cellular response to steroid hormone stimulus | 11/439 | 213/18888 | 0.0516432 | 2.2219513 | 2.7665640 | 0.0113574 | 0.1542495 | 0.1352932 | MAPK1/CNOT2/ZMIZ1/FBXO32/SRD5A1/SAFB/CYP7B1/REST/SIRT1/DDX17/AR | 11 |
| GO:0003151 | GO:0003151 | outflow tract morphogenesis | 6/439 | 81/18888 | 0.0740741 | 3.1870413 | 3.0427555 | 0.0114231 | 0.1542495 | 0.1352932 | MEF2C/HEY2/JAG1/FGFR2/SEC24B/ATF2 | 6 |
| GO:0048844 | GO:0048844 | artery morphogenesis | 6/439 | 81/18888 | 0.0740741 | 3.1870413 | 3.0427555 | 0.0114231 | 0.1542495 | 0.1352932 | ZMIZ1/HEY2/JAG1/SEC24B/PROX1/HEY1 | 6 |
| GO:0010718 | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 5/439 | 59/18888 | 0.0847458 | 3.6461913 | 3.1402263 | 0.0118690 | 0.1587454 | 0.1392365 | SMAD3/JAG1/TCF7L2/RGCC/HDAC2 | 5 |
| GO:0014896 | GO:0014896 | muscle hypertrophy | 7/439 | 106/18888 | 0.0660377 | 2.8412773 | 2.9324361 | 0.0118766 | 0.1587454 | 0.1392365 | PPP3CA/JARID2/HEY2/SMAD3/RYR2/HDAC2/YY1 | 7 |
| GO:0032526 | GO:0032526 | response to retinoic acid | 7/439 | 106/18888 | 0.0660377 | 2.8412773 | 2.9324361 | 0.0118766 | 0.1587454 | 0.1392365 | TFRC/NCOA1/EPHA3/CREB1/FGFR2/KLF4/HDAC2 | 7 |
| GO:0007405 | GO:0007405 | neuroblast proliferation | 6/439 | 82/18888 | 0.0731707 | 3.1481749 | 3.0071541 | 0.0120906 | 0.1587454 | 0.1392365 | FZD3/TAFA1/FGFR2/PROX1/VCAN/PAFAH1B1 | 6 |
| GO:0043537 | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 6/439 | 82/18888 | 0.0731707 | 3.1481749 | 3.0071541 | 0.0120906 | 0.1587454 | 0.1392365 | MEOX2/MEF2C/PDCD10/SPRED1/KLF4/RGCC | 6 |
| GO:0046928 | GO:0046928 | regulation of neurotransmitter secretion | 6/439 | 82/18888 | 0.0731707 | 3.1481749 | 3.0071541 | 0.0120906 | 0.1587454 | 0.1392365 | SYT4/MEF2C/RAP1B/PRKCB/STXBP5/MYOF | 6 |
| GO:0070886 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 3/439 | 21/18888 | 0.1428571 | 6.1464367 | 3.6399230 | 0.0121505 | 0.1587454 | 0.1392365 | PPP3CA/CAMTA1/PPP3R1 | 3 |
| GO:0071498 | GO:0071498 | cellular response to fluid shear stress | 3/439 | 21/18888 | 0.1428571 | 6.1464367 | 3.6399230 | 0.0121505 | 0.1587454 | 0.1392365 | MTSS1/MEF2C/KLF4 | 3 |
| GO:0090189 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 3/439 | 21/18888 | 0.1428571 | 6.1464367 | 3.6399230 | 0.0121505 | 0.1587454 | 0.1392365 | SIX4/SOX8/HOXB7 | 3 |
| GO:0106058 | GO:0106058 | positive regulation of calcineurin-mediated signaling | 3/439 | 21/18888 | 0.1428571 | 6.1464367 | 3.6399230 | 0.0121505 | 0.1587454 | 0.1392365 | PPP3CA/CAMTA1/PPP3R1 | 3 |
| GO:0007179 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 12/439 | 245/18888 | 0.0489796 | 2.1073497 | 2.6911461 | 0.0124310 | 0.1607304 | 0.1409775 | ZMIZ1/SMURF2/APPL2/GDF10/JUN/ZEB2/FBN1/SMAD3/SPRED1/SIRT1/CAV2/HDAC2 | 12 |
| GO:0017158 | GO:0017158 | regulation of calcium ion-dependent exocytosis | 4/439 | 39/18888 | 0.1025641 | 4.4128264 | 3.2910136 | 0.0124587 | 0.1607304 | 0.1409775 | SYT4/RAP1B/REST/SCAMP5 | 4 |
| GO:0071312 | GO:0071312 | cellular response to alkaloid | 4/439 | 39/18888 | 0.1025641 | 4.4128264 | 3.2910136 | 0.0124587 | 0.1607304 | 0.1409775 | SLC1A2/PPP1R1B/RYR2/CRHBP | 4 |
| GO:0030316 | GO:0030316 | osteoclast differentiation | 7/439 | 107/18888 | 0.0654206 | 2.8147234 | 2.9038240 | 0.0124622 | 0.1607304 | 0.1409775 | TFRC/PPP3CA/FBN1/CREB1/PAFAH1B1/MITF/OSTM1 | 7 |
| GO:0002064 | GO:0002064 | epithelial cell development | 11/439 | 216/18888 | 0.0509259 | 2.1910909 | 2.7158369 | 0.0125091 | 0.1608197 | 0.1410559 | RAP2C/CDK6/RAP1B/JAG1/B4GALT1/PROX1/SOX8/FRMD6/IL1A/AR/PLCB1 | 11 |
| GO:0002244 | GO:0002244 | hematopoietic progenitor cell differentiation | 8/439 | 133/18888 | 0.0601504 | 2.5879734 | 2.8349006 | 0.0125854 | 0.1612323 | 0.1414178 | CDK6/CEBPD/SP3/PUS7/REST/ATF2/TAL1/SOS1 | 8 |
| GO:0006473 | GO:0006473 | protein acetylation | 5/439 | 60/18888 | 0.0833333 | 3.5854214 | 3.0940848 | 0.0127077 | 0.1612323 | 0.1414178 | TAOK1/KAT6A/SIRT1/HDAC2/KAT2B | 5 |
| GO:0022029 | GO:0022029 | telencephalon cell migration | 5/439 | 60/18888 | 0.0833333 | 3.5854214 | 3.0940848 | 0.0127077 | 0.1612323 | 0.1414178 | ZMIZ1/ARL13B/SLIT2/PEX5/PAFAH1B1 | 5 |
| GO:0060038 | GO:0060038 | cardiac muscle cell proliferation | 5/439 | 60/18888 | 0.0833333 | 3.5854214 | 3.0940848 | 0.0127077 | 0.1612323 | 0.1414178 | JARID2/MEF2C/KCNK2/HEY2/FGFR2 | 5 |
| GO:0008361 | GO:0008361 | regulation of cell size | 10/439 | 188/18888 | 0.0531915 | 2.2885669 | 2.7390024 | 0.0127415 | 0.1612323 | 0.1414178 | PUM2/VAV3/EPHA7/KCNN4/CREB1/CDH4/OXSR1/BDNF/PAFAH1B1/CLNS1A | 10 |
| GO:2000736 | GO:2000736 | regulation of stem cell differentiation | 6/439 | 83/18888 | 0.0722892 | 3.1102451 | 2.9720945 | 0.0127851 | 0.1612763 | 0.1414564 | CDK6/GATAD2B/JAG1/PUS7/REST/HDAC2 | 6 |
| GO:0001667 | GO:0001667 | ameboidal-type cell migration | 20/439 | 498/18888 | 0.0401606 | 1.7279139 | 2.5394003 | 0.0130141 | 0.1636524 | 0.1435404 | RAB11A/SMURF2/MEOX2/MEF2C/RIN2/APPL2/ZEB2/PDCD10/DOCK1/SPRED1/PIP5K1A/SLIT2/SIRT1/ADIPOR1/PROX1/SOX8/KLF4/RGCC/PAFAH1B1/PTPRG | 20 |
| GO:0010976 | GO:0010976 | positive regulation of neuron projection development | 9/439 | 161/18888 | 0.0559006 | 2.4051274 | 2.7619885 | 0.0131319 | 0.1640966 | 0.1439301 | PUM2/CNR1/NEGR1/CNTN1/EPHA3/BDNF/PAFAH1B1/TUBB2B/KAT2B | 9 |
| GO:0036294 | GO:0036294 | cellular response to decreased oxygen levels | 9/439 | 161/18888 | 0.0559006 | 2.4051274 | 2.7619885 | 0.0131319 | 0.1640966 | 0.1439301 | CPEB2/SCN2A/EGLN1/KCNK2/RORA/FGFR2/SIRT1/ATF2/RGCC | 9 |
| GO:0006352 | GO:0006352 | DNA-templated transcription initiation | 10/439 | 189/18888 | 0.0529101 | 2.2764580 | 2.7205430 | 0.0131848 | 0.1640966 | 0.1439301 | TAF4/JUN/GTF2A1/HEY2/TAF12/ATF2/RBBP5/MED4/KAT2B/MITF | 10 |
| GO:0140014 | GO:0140014 | mitotic nuclear division | 13/439 | 277/18888 | 0.0469314 | 2.0192265 | 2.6360465 | 0.0132126 | 0.1640966 | 0.1439301 | RAB11A/SEH1L/SMC3/PHIP/NFIA/CAV2/KIF2A/CHAMP1/APC/IL1A/RGCC/KAT2B/CDC25C | 13 |
| GO:0045599 | GO:0045599 | negative regulation of fat cell differentiation | 5/439 | 61/18888 | 0.0819672 | 3.5266440 | 3.0489180 | 0.0135856 | 0.1669206 | 0.1464070 | RORA/SMAD3/JAG1/SIRT1/TRIO | 5 |
| GO:0055008 | GO:0055008 | cardiac muscle tissue morphogenesis | 5/439 | 61/18888 | 0.0819672 | 3.5266440 | 3.0489180 | 0.0135856 | 0.1669206 | 0.1464070 | EGLN1/HEY2/FGFR2/RYR2/PROX1 | 5 |
| GO:0070884 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 4/439 | 40/18888 | 0.1000000 | 4.3025057 | 3.2252863 | 0.0135950 | 0.1669206 | 0.1464070 | PPP3CA/CAMTA1/PPP3R1/PRNP | 4 |
| GO:0016050 | GO:0016050 | vesicle organization | 16/439 | 371/18888 | 0.0431267 | 1.8555281 | 2.5672209 | 0.0136059 | 0.1669206 | 0.1464070 | HOOK3/RAB11A/VAV3/SYT4/WASHC4/PLEKHF2/RAB12/ZEB2/PPP6C/CREB1/SEC24B/CAV2/VAMP4/PAFAH1B1/SEC24A/UNC13C | 16 |
| GO:0007530 | GO:0007530 | sex determination | 3/439 | 22/18888 | 0.1363636 | 5.8670532 | 3.5234236 | 0.0138305 | 0.1676327 | 0.1470316 | SIX4/SRD5A1/AR | 3 |
| GO:0018394 | GO:0018394 | peptidyl-lysine acetylation | 3/439 | 22/18888 | 0.1363636 | 5.8670532 | 3.5234236 | 0.0138305 | 0.1676327 | 0.1470316 | SIRT1/HDAC2/KAT2B | 3 |
| GO:0048025 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 3/439 | 22/18888 | 0.1363636 | 5.8670532 | 3.5234236 | 0.0138305 | 0.1676327 | 0.1470316 | SRSF10/HNRNPK/SFSWAP | 3 |
| GO:0099010 | GO:0099010 | modification of postsynaptic structure | 3/439 | 22/18888 | 0.1363636 | 5.8670532 | 3.5234236 | 0.0138305 | 0.1676327 | 0.1470316 | RAP1B/EGLN1/CTTNBP2 | 3 |
| GO:1903311 | GO:1903311 | regulation of mRNA metabolic process | 17/439 | 404/18888 | 0.0420792 | 1.8104603 | 2.5401057 | 0.0139713 | 0.1688303 | 0.1480821 | PUM2/RBM39/SRSF10/CNOT2/CNOT6L/YBX1/SAFB/CPEB3/REST/HNRNPK/PUM1/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 17 |
| GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 8/439 | 136/18888 | 0.0588235 | 2.5308857 | 2.7638582 | 0.0142462 | 0.1716363 | 0.1505432 | ARPP19/RAB11A/CDK6/TAOK1/MBTPS1/SYF2/CDC25C/PLCB1 | 8 |
| GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 7/439 | 110/18888 | 0.0636364 | 2.7379582 | 2.8199300 | 0.0143437 | 0.1722952 | 0.1511212 | RORA/IRAK3/YY1/IRAK2/TANK/ST18/PLCB1 | 7 |
| GO:0030111 | GO:0030111 | regulation of Wnt signaling pathway | 15/439 | 342/18888 | 0.0438596 | 1.8870639 | 2.5537017 | 0.0144267 | 0.1727769 | 0.1515436 | KPNA1/SMURF2/SHISA3/LYPD6/ZEB2/SCYL2/CTHRC1/AMFR/SMAD3/TCF7L2/FGFR2/TMEM170B/TNKS2/SULF1/APC | 15 |
| GO:0010810 | GO:0010810 | regulation of cell-substrate adhesion | 11/439 | 221/18888 | 0.0497738 | 2.1415187 | 2.6331114 | 0.0146232 | 0.1746109 | 0.1531522 | CDK6/RIN2/EGFL6/EPHA1/SMAD3/EPHA3/JAG1/DOCK1/FBLN2/AJAP1/EDIL3 | 11 |
| GO:0003203 | GO:0003203 | endocardial cushion morphogenesis | 4/439 | 41/18888 | 0.0975610 | 4.1975665 | 3.1616787 | 0.0147951 | 0.1746447 | 0.1531819 | ADAMTS5/HEY2/APC/HEY1 | 4 |
| GO:0060421 | GO:0060421 | positive regulation of heart growth | 4/439 | 41/18888 | 0.0975610 | 4.1975665 | 3.1616787 | 0.0147951 | 0.1746447 | 0.1531819 | MEF2C/HEY2/FGFR2/PROX1 | 4 |
| GO:0106056 | GO:0106056 | regulation of calcineurin-mediated signaling | 4/439 | 41/18888 | 0.0975610 | 4.1975665 | 3.1616787 | 0.0147951 | 0.1746447 | 0.1531819 | PPP3CA/CAMTA1/PPP3R1/PRNP | 4 |
| GO:0033002 | GO:0033002 | muscle cell proliferation | 12/439 | 251/18888 | 0.0478088 | 2.0569748 | 2.6004041 | 0.0147997 | 0.1746447 | 0.1531819 | AKIRIN1/KPNA1/JARID2/MEF2C/JUN/KCNK2/HEY2/TCF7L2/FGFR2/CAV2/KLF4/MAP3K5 | 12 |
| GO:0050678 | GO:0050678 | regulation of epithelial cell proliferation | 17/439 | 407/18888 | 0.0417690 | 1.7971154 | 2.5077429 | 0.0149219 | 0.1755718 | 0.1539951 | CDK6/MTSS1/MEF2C/SIX4/SMAD3/JAG1/CYP7B1/PDCD10/B4GALT1/TCF7L2/FGFR2/SIRT1/CAV2/PROX1/SULF1/RGCC/AR | 17 |
| GO:0051147 | GO:0051147 | regulation of muscle cell differentiation | 9/439 | 165/18888 | 0.0545455 | 2.3468213 | 2.6803503 | 0.0152049 | 0.1783809 | 0.1564589 | YBX1/MEF2C/HEY2/FGFR2/SIRT1/PROX1/BDNF/YY1/HEY1 | 9 |
| GO:0021885 | GO:0021885 | forebrain cell migration | 5/439 | 63/18888 | 0.0793651 | 3.4146871 | 2.9613584 | 0.0154621 | 0.1803459 | 0.1581824 | ZMIZ1/ARL13B/SLIT2/PEX5/PAFAH1B1 | 5 |
| GO:0051965 | GO:0051965 | positive regulation of synapse assembly | 5/439 | 63/18888 | 0.0793651 | 3.4146871 | 2.9613584 | 0.0154621 | 0.1803459 | 0.1581824 | DLG5/LRRTM3/SLITRK4/AGRN/BDNF | 5 |
| GO:0021542 | GO:0021542 | dentate gyrus development | 3/439 | 23/18888 | 0.1304348 | 5.6119639 | 3.4138839 | 0.0156359 | 0.1813219 | 0.1590385 | CDK6/SCN2A/PROX1 | 3 |
| GO:0071636 | GO:0071636 | positive regulation of transforming growth factor beta production | 3/439 | 23/18888 | 0.1304348 | 5.6119639 | 3.4138839 | 0.0156359 | 0.1813219 | 0.1590385 | SMAD3/CD46/ATF2 | 3 |
| GO:0009791 | GO:0009791 | post-embryonic development | 6/439 | 87/18888 | 0.0689655 | 2.9672453 | 2.8369717 | 0.0158432 | 0.1831986 | 0.1606845 | ASH1L/NR4A2/FGFR2/ITPR1/PLAGL2/KLF4 | 6 |
| GO:0095500 | GO:0095500 | acetylcholine receptor signaling pathway | 4/439 | 42/18888 | 0.0952381 | 4.0976245 | 3.1000675 | 0.0160601 | 0.1835935 | 0.1610309 | AGRN/PRKCB/ITPR1/PLCB1 | 4 |
| GO:0098703 | GO:0098703 | calcium ion import across plasma membrane | 4/439 | 42/18888 | 0.0952381 | 4.0976245 | 3.1000675 | 0.0160601 | 0.1835935 | 0.1610309 | PPP3CA/PPP3R1/CACNA1D/PRNP | 4 |
| GO:1902656 | GO:1902656 | calcium ion import into cytosol | 4/439 | 42/18888 | 0.0952381 | 4.0976245 | 3.1000675 | 0.0160601 | 0.1835935 | 0.1610309 | PPP3CA/PPP3R1/CACNA1D/PRNP | 4 |
| GO:0043401 | GO:0043401 | steroid hormone mediated signaling pathway | 8/439 | 139/18888 | 0.0575540 | 2.4762623 | 2.6946924 | 0.0160610 | 0.1835935 | 0.1610309 | MAPK1/CNOT2/ZMIZ1/SAFB/CYP7B1/SIRT1/DDX17/AR | 8 |
| GO:0046883 | GO:0046883 | regulation of hormone secretion | 12/439 | 254/18888 | 0.0472441 | 2.0326799 | 2.5559765 | 0.0161055 | 0.1835935 | 0.1610309 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/CREB1/TCF7L2/ITPR1/CRHBP/PLCB1 | 12 |
| GO:0050796 | GO:0050796 | regulation of insulin secretion | 9/439 | 167/18888 | 0.0538922 | 2.3187156 | 2.6404151 | 0.0163274 | 0.1855974 | 0.1627885 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/REST/TCF7L2/ITPR1/PLCB1 | 9 |
| GO:0060840 | GO:0060840 | artery development | 7/439 | 113/18888 | 0.0619469 | 2.6652690 | 2.7388042 | 0.0164197 | 0.1861213 | 0.1632481 | ZMIZ1/HEY2/JAG1/SEC24B/PROX1/HEY1/AP2B1 | 7 |
| GO:0019098 | GO:0019098 | reproductive behavior | 4/439 | 43/18888 | 0.0930233 | 4.0023309 | 3.0403392 | 0.0173909 | 0.1936749 | 0.1698734 | CNR1/PPP1R1B/NCOA1/HDAC2 | 4 |
| GO:0045663 | GO:0045663 | positive regulation of myoblast differentiation | 4/439 | 43/18888 | 0.0930233 | 4.0023309 | 3.0403392 | 0.0173909 | 0.1936749 | 0.1698734 | AKIRIN1/MEF2C/MAP3K5/PLCB1 | 4 |
| GO:0060113 | GO:0060113 | inner ear receptor cell differentiation | 5/439 | 65/18888 | 0.0769231 | 3.3096198 | 2.8772664 | 0.0175040 | 0.1936749 | 0.1698734 | CTHRC1/HEY2/JAG1/SEC24B/PAFAH1B1 | 5 |
| GO:1905330 | GO:1905330 | regulation of morphogenesis of an epithelium | 5/439 | 65/18888 | 0.0769231 | 3.3096198 | 2.8772664 | 0.0175040 | 0.1936749 | 0.1698734 | SIX4/SOX8/SULF1/AR/HOXB7 | 5 |
| GO:0050686 | GO:0050686 | negative regulation of mRNA processing | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | SRSF10/HNRNPK/SFSWAP | 3 |
| GO:0051315 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | SEH1L/CHAMP1/KAT2B | 3 |
| GO:0060571 | GO:0060571 | morphogenesis of an epithelial fold | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | FGFR2/SULF1/AR | 3 |
| GO:0098884 | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | HIP1/PPP3R1/AP2B1 | 3 |
| GO:0140239 | GO:0140239 | postsynaptic endocytosis | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | HIP1/PPP3R1/AP2B1 | 3 |
| GO:1901983 | GO:1901983 | regulation of protein acetylation | 3/439 | 24/18888 | 0.1250000 | 5.3781321 | 3.3105864 | 0.0175674 | 0.1936749 | 0.1698734 | TAOK1/SIRT1/HDAC2 | 3 |
| GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 19/439 | 482/18888 | 0.0394191 | 1.6960085 | 2.3877325 | 0.0181685 | 0.1993564 | 0.1748567 | AGRN/DOCK10/MEF2C/ADCYAP1/HIP1/EPHA1/SMAD3/PREX2/REST/FGFR2/PIP5K1A/SIRT1/CAV2/SIPA1L1/SOS1/RALGPS2/MAP3K5/TANK/ST18 | 19 |
| GO:0048732 | GO:0048732 | gland development | 18/439 | 449/18888 | 0.0400891 | 1.7248352 | 2.3978451 | 0.0181819 | 0.1993564 | 0.1748567 | MAPK1/IGSF3/ASH1L/JARID2/E2F8/SP3/SIX4/SRD5A1/NCOA1/SMAD3/CYP7B1/CREB1/FGFR2/CSMD1/ATF2/PROX1/SULF1/AR | 18 |
| GO:0099504 | GO:0099504 | synaptic vesicle cycle | 10/439 | 199/18888 | 0.0502513 | 2.1620632 | 2.5420880 | 0.0182773 | 0.1998580 | 0.1752966 | DNAJC6/SYT4/RAP1B/PRKCB/PPP3R1/SLC17A6/VAMP4/STXBP5/UNC13C/AP2B1 | 10 |
| GO:0001655 | GO:0001655 | urogenital system development | 5/439 | 66/18888 | 0.0757576 | 3.2594740 | 2.8364411 | 0.0185888 | 0.2021656 | 0.1773206 | SRD5A1/CYP7B1/FGFR2/SULF1/AR | 5 |
| GO:0017156 | GO:0017156 | calcium-ion regulated exocytosis | 5/439 | 66/18888 | 0.0757576 | 3.2594740 | 2.8364411 | 0.0185888 | 0.2021656 | 0.1773206 | SYT4/RAP1B/REST/SCAMP5/UNC13C | 5 |
| GO:0035329 | GO:0035329 | hippo signaling | 4/439 | 44/18888 | 0.0909091 | 3.9113688 | 2.9823894 | 0.0187885 | 0.2026938 | 0.1777839 | TEAD1/DLG5/WWC2/FRMD6 | 4 |
| GO:1905145 | GO:1905145 | cellular response to acetylcholine | 4/439 | 44/18888 | 0.0909091 | 3.9113688 | 2.9823894 | 0.0187885 | 0.2026938 | 0.1777839 | AGRN/PRKCB/ITPR1/PLCB1 | 4 |
| GO:2000300 | GO:2000300 | regulation of synaptic vesicle exocytosis | 4/439 | 44/18888 | 0.0909091 | 3.9113688 | 2.9823894 | 0.0187885 | 0.2026938 | 0.1777839 | SYT4/RAP1B/PRKCB/STXBP5 | 4 |
| GO:0030073 | GO:0030073 | insulin secretion | 10/439 | 200/18888 | 0.0500000 | 2.1512528 | 2.5248271 | 0.0188563 | 0.2028819 | 0.1779489 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/PLCB1 | 10 |
| GO:0055017 | GO:0055017 | cardiac muscle tissue growth | 6/439 | 91/18888 | 0.0659341 | 2.8368169 | 2.7093782 | 0.0193733 | 0.2045921 | 0.1794489 | JARID2/MEF2C/KCNK2/HEY2/FGFR2/YY1 | 6 |
| GO:0009267 | GO:0009267 | cellular response to starvation | 9/439 | 172/18888 | 0.0523256 | 2.2513111 | 2.5430233 | 0.0193978 | 0.2045921 | 0.1794489 | MAPK1/SEH1L/JMY/STK26/SRD5A1/SIRT1/ATF2/MAP3K5/MAPK8 | 9 |
| GO:0030534 | GO:0030534 | adult behavior | 8/439 | 144/18888 | 0.0555556 | 2.3902809 | 2.5833307 | 0.0194482 | 0.2045921 | 0.1794489 | NR4A2/SLC1A2/PPP1R1B/PREX2/PUM1/CRHBP/PAFAH1B1/HDAC2 | 8 |
| GO:0007097 | GO:0007097 | nuclear migration | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | HOOK3/CEP120/PAFAH1B1 | 3 |
| GO:0014856 | GO:0014856 | skeletal muscle cell proliferation | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | AKIRIN1/KPNA1/CAV2 | 3 |
| GO:0021884 | GO:0021884 | forebrain neuron development | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | ZMIZ1/SCYL2/FGFR2 | 3 |
| GO:0030318 | GO:0030318 | melanocyte differentiation | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | MEF2C/ZEB2/MITF | 3 |
| GO:0038095 | GO:0038095 | Fc-epsilon receptor signaling pathway | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | VAV3/SOS1/MAPK8 | 3 |
| GO:0042659 | GO:0042659 | regulation of cell fate specification | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | GATAD2B/HDAC2/AR | 3 |
| GO:0048520 | GO:0048520 | positive regulation of behavior | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | SGIP1/MEF2C/HDAC2 | 3 |
| GO:1901863 | GO:1901863 | positive regulation of muscle tissue development | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | MTM1/MEF2C/CREB1 | 3 |
| GO:1903306 | GO:1903306 | negative regulation of regulated secretory pathway | 3/439 | 25/18888 | 0.1200000 | 5.1630068 | 3.2129138 | 0.0196259 | 0.2045921 | 0.1794489 | SYT4/RAP1B/REST | 3 |
| GO:2000630 | GO:2000630 | positive regulation of miRNA metabolic process | 5/439 | 67/18888 | 0.0746269 | 3.2108251 | 2.7963903 | 0.0197169 | 0.2045921 | 0.1794489 | TEAD1/JUN/SMAD3/KLF4/AR | 5 |
| GO:0023061 | GO:0023061 | signal release | 19/439 | 487/18888 | 0.0390144 | 1.6785957 | 2.3403573 | 0.0199848 | 0.2045921 | 0.1794489 | SYT4/PPP3CA/MEF2C/GLUD1/RAP1B/CNR1/PRKCB/EPHA5/ADCYAP1/REST/CREB1/TCF7L2/ITPR1/CRHBP/IL1A/STXBP5/MYOF/PLCB1/UNC13C | 19 |
| GO:0033173 | GO:0033173 | calcineurin-NFAT signaling cascade | 4/439 | 45/18888 | 0.0888889 | 3.8244495 | 2.9261217 | 0.0202537 | 0.2045921 | 0.1794489 | PPP3CA/CAMTA1/PPP3R1/PRNP | 4 |
| GO:0035196 | GO:0035196 | miRNA processing | 4/439 | 45/18888 | 0.0888889 | 3.8244495 | 2.9261217 | 0.0202537 | 0.2045921 | 0.1794489 | PUM2/PRKRA/SMAD3/PUM1 | 4 |
| GO:0090051 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 4/439 | 45/18888 | 0.0888889 | 3.8244495 | 2.9261217 | 0.0202537 | 0.2045921 | 0.1794489 | MEOX2/PDCD10/SPRED1/KLF4 | 4 |
| GO:0045995 | GO:0045995 | regulation of embryonic development | 6/439 | 92/18888 | 0.0652174 | 2.8059820 | 2.6785635 | 0.0203331 | 0.2045921 | 0.1794489 | INO80D/JAG1/PAFAH1B1/YY1/KAT2B/PLCB1 | 6 |
| GO:0008406 | GO:0008406 | gonad development | 11/439 | 233/18888 | 0.0472103 | 2.0312259 | 2.4432138 | 0.0207871 | 0.2045921 | 0.1794489 | TAF4/SIX4/SRD5A1/NCOA1/CSMD1/SLIT2/SIRT1/SOX8/IL1A/AR/MAMLD1 | 11 |
| GO:0070918 | GO:0070918 | regulatory ncRNA processing | 5/439 | 68/18888 | 0.0735294 | 3.1636071 | 2.7570865 | 0.0208890 | 0.2045921 | 0.1794489 | PUM2/PRKRA/TSNAX/SMAD3/PUM1 | 5 |
| GO:0071300 | GO:0071300 | cellular response to retinoic acid | 5/439 | 68/18888 | 0.0735294 | 3.1636071 | 2.7570865 | 0.0208890 | 0.2045921 | 0.1794489 | EPHA3/CREB1/FGFR2/KLF4/HDAC2 | 5 |
| GO:0044703 | GO:0044703 | multi-organism reproductive process | 10/439 | 204/18888 | 0.0490196 | 2.1090714 | 2.4567842 | 0.0213078 | 0.2045921 | 0.1794489 | ASH1L/SMURF2/PNOC/SP3/CNR1/ADCYAP1/PTHLH/CSMD1/CRHBP/AR | 10 |
| GO:0001656 | GO:0001656 | metanephros development | 6/439 | 93/18888 | 0.0645161 | 2.7758101 | 2.6481597 | 0.0213246 | 0.2045921 | 0.1794489 | DLG5/SIX4/FBN1/IRX2/CALB1/SOX8 | 6 |
| GO:0001514 | GO:0001514 | selenocysteine incorporation | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SECISBP2L/SEPSECS | 2 |
| GO:0003056 | GO:0003056 | regulation of vascular associated smooth muscle contraction | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | ATP2B1/DOCK4 | 2 |
| GO:0006451 | GO:0006451 | translational readthrough | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SECISBP2L/SEPSECS | 2 |
| GO:0030953 | GO:0030953 | astral microtubule organization | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | RAB11A/CEP120 | 2 |
| GO:0032957 | GO:0032957 | inositol trisphosphate metabolic process | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | IPMK/PLCB1 | 2 |
| GO:0033210 | GO:0033210 | leptin-mediated signaling pathway | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SIRT1/ADIPOR1 | 2 |
| GO:0035907 | GO:0035907 | dorsal aorta development | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | HEY2/HEY1 | 2 |
| GO:0043587 | GO:0043587 | tongue morphogenesis | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SIX4/HDAC2 | 2 |
| GO:0046015 | GO:0046015 | regulation of transcription by glucose | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SIRT1/KAT2B | 2 |
| GO:0051124 | GO:0051124 | synaptic assembly at neuromuscular junction | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | AGRN/SIX4 | 2 |
| GO:0055015 | GO:0055015 | ventricular cardiac muscle cell development | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | HEY2/PROX1 | 2 |
| GO:0071374 | GO:0071374 | cellular response to parathyroid hormone stimulus | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | MEF2C/KAT2B | 2 |
| GO:0071600 | GO:0071600 | otic vesicle morphogenesis | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | FGFR2/PROX1 | 2 |
| GO:0072205 | GO:0072205 | metanephric collecting duct development | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | DLG5/CALB1 | 2 |
| GO:0090184 | GO:0090184 | positive regulation of kidney development | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | PPP3CA/SOX8 | 2 |
| GO:0097050 | GO:0097050 | type B pancreatic cell apoptotic process | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | TCF7L2/RYR2 | 2 |
| GO:0099159 | GO:0099159 | regulation of modification of postsynaptic structure | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | EGLN1/CTTNBP2 | 2 |
| GO:1900246 | GO:1900246 | positive regulation of RIG-I signaling pathway | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | PUM2/PUM1 | 2 |
| GO:1904179 | GO:1904179 | positive regulation of adipose tissue development | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | NCOA1/SIRT1 | 2 |
| GO:1990504 | GO:1990504 | dense core granule exocytosis | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SYT4/UNC13C | 2 |
| GO:2000048 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | RGCC/EPCAM | 2 |
| GO:2000756 | GO:2000756 | regulation of peptidyl-lysine acetylation | 2/439 | 10/18888 | 0.2000000 | 8.6050114 | 3.7106433 | 0.0214367 | 0.2045921 | 0.1794489 | SIRT1/HDAC2 | 2 |
| GO:0014706 | GO:0014706 | striated muscle tissue development | 12/439 | 265/18888 | 0.0452830 | 1.9483045 | 2.3981329 | 0.0216475 | 0.2045921 | 0.1794489 | JARID2/MEF2C/EGLN1/KCNK2/HEY2/SMAD3/CREB1/FGFR2/RYR2/PROX1/YY1/HEY1 | 12 |
| GO:0050714 | GO:0050714 | positive regulation of protein secretion | 8/439 | 147/18888 | 0.0544218 | 2.3414997 | 2.5187218 | 0.0217094 | 0.2045921 | 0.1794489 | GLUD1/KCNN4/PRKCB/TCF7L2/ITPR1/IL1A/SEC24A/PLCB1 | 8 |
| GO:0007019 | GO:0007019 | microtubule depolymerization | 4/439 | 46/18888 | 0.0869565 | 3.7413093 | 2.8714469 | 0.0217874 | 0.2045921 | 0.1794489 | TAOK1/TTBK2/KIF2A/APC | 4 |
| GO:0034314 | GO:0034314 | Arp2/3 complex-mediated actin nucleation | 4/439 | 46/18888 | 0.0869565 | 3.7413093 | 2.8714469 | 0.0217874 | 0.2045921 | 0.1794489 | WASHC4/JMY/WIPF3/IQGAP2 | 4 |
| GO:0042491 | GO:0042491 | inner ear auditory receptor cell differentiation | 4/439 | 46/18888 | 0.0869565 | 3.7413093 | 2.8714469 | 0.0217874 | 0.2045921 | 0.1794489 | HEY2/JAG1/SEC24B/PAFAH1B1 | 4 |
| GO:0140467 | GO:0140467 | integrated stress response signaling | 4/439 | 46/18888 | 0.0869565 | 3.7413093 | 2.8714469 | 0.0217874 | 0.2045921 | 0.1794489 | CEBPD/JUN/ARIH1/TMEM33 | 4 |
| GO:1905144 | GO:1905144 | response to acetylcholine | 4/439 | 46/18888 | 0.0869565 | 3.7413093 | 2.8714469 | 0.0217874 | 0.2045921 | 0.1794489 | AGRN/PRKCB/ITPR1/PLCB1 | 4 |
| GO:0021895 | GO:0021895 | cerebral cortex neuron differentiation | 3/439 | 26/18888 | 0.1153846 | 4.9644296 | 3.1203324 | 0.0218116 | 0.2045921 | 0.1794489 | DLX1/PEX5/PAFAH1B1 | 3 |
| GO:0035330 | GO:0035330 | regulation of hippo signaling | 3/439 | 26/18888 | 0.1153846 | 4.9644296 | 3.1203324 | 0.0218116 | 0.2045921 | 0.1794489 | DLG5/WWC2/FRMD6 | 3 |
| GO:0099637 | GO:0099637 | neurotransmitter receptor transport | 3/439 | 26/18888 | 0.1153846 | 4.9644296 | 3.1203324 | 0.0218116 | 0.2045921 | 0.1794489 | RAB11A/NSG1/HIP1 | 3 |
| GO:0006414 | GO:0006414 | translational elongation | 5/439 | 69/18888 | 0.0724638 | 3.1177577 | 2.7185035 | 0.0221056 | 0.2063871 | 0.1810233 | CPEB2/LTN1/SECISBP2L/CPEB3/SEPSECS | 5 |
| GO:0048645 | GO:0048645 | animal organ formation | 5/439 | 69/18888 | 0.0724638 | 3.1177577 | 2.7185035 | 0.0221056 | 0.2063871 | 0.1810233 | MAPK1/MEF2C/FGFR2/SULF1/AR | 5 |
| GO:0045666 | GO:0045666 | positive regulation of neuron differentiation | 6/439 | 94/18888 | 0.0638298 | 2.7462802 | 2.6181564 | 0.0223483 | 0.2081707 | 0.1825878 | DLX1/MEF2C/NCOA1/REST/PROX1/TCF4 | 6 |
| GO:0006836 | GO:0006836 | neurotransmitter transport | 10/439 | 206/18888 | 0.0485437 | 2.0885950 | 2.4233469 | 0.0226171 | 0.2101871 | 0.1843563 | SYT4/SLC6A6/MEF2C/RAP1B/PRKCB/SLC1A2/SLC17A6/STXBP5/MYOF/UNC13C | 10 |
| GO:0071453 | GO:0071453 | cellular response to oxygen levels | 9/439 | 177/18888 | 0.0508475 | 2.1877148 | 2.4489371 | 0.0228663 | 0.2120135 | 0.1859583 | CPEB2/SCN2A/EGLN1/KCNK2/RORA/FGFR2/SIRT1/ATF2/RGCC | 9 |
| GO:0006367 | GO:0006367 | transcription initiation at RNA polymerase II promoter | 8/439 | 149/18888 | 0.0536913 | 2.3100702 | 2.4765199 | 0.0233164 | 0.2130780 | 0.1868920 | TAF4/GTF2A1/HEY2/TAF12/ATF2/RBBP5/MED4/KAT2B | 8 |
| GO:0008584 | GO:0008584 | male gonad development | 8/439 | 149/18888 | 0.0536913 | 2.3100702 | 2.4765199 | 0.0233164 | 0.2130780 | 0.1868920 | SIX4/SRD5A1/NCOA1/CSMD1/SOX8/IL1A/AR/MAMLD1 | 8 |
| GO:0050768 | GO:0050768 | negative regulation of neurogenesis | 8/439 | 149/18888 | 0.0536913 | 2.3100702 | 2.4765199 | 0.0233164 | 0.2130780 | 0.1868920 | HOOK3/SYT4/EPHA7/DLX1/PPP3CA/APPL2/REST/PROX1 | 8 |
| GO:0042490 | GO:0042490 | mechanoreceptor differentiation | 5/439 | 70/18888 | 0.0714286 | 3.0732184 | 2.6806164 | 0.0233673 | 0.2130780 | 0.1868920 | CTHRC1/HEY2/JAG1/SEC24B/PAFAH1B1 | 5 |
| GO:0043627 | GO:0043627 | response to estrogen | 5/439 | 70/18888 | 0.0714286 | 3.0732184 | 2.6806164 | 0.0233673 | 0.2130780 | 0.1868920 | SRD5A1/RBBP5/CRHBP/AR/SLC34A2 | 5 |
| GO:0055010 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 4/439 | 47/18888 | 0.0851064 | 3.6617070 | 2.8182825 | 0.0233901 | 0.2130780 | 0.1868920 | HEY2/FGFR2/RYR2/PROX1 | 4 |
| GO:1901861 | GO:1901861 | regulation of muscle tissue development | 4/439 | 47/18888 | 0.0851064 | 3.6617070 | 2.8182825 | 0.0233901 | 0.2130780 | 0.1868920 | MTM1/MEF2C/SMAD3/CREB1 | 4 |
| GO:0043279 | GO:0043279 | response to alkaloid | 6/439 | 95/18888 | 0.0631579 | 2.7173720 | 2.5885435 | 0.0234047 | 0.2130780 | 0.1868920 | CNR1/SLC1A2/PPP1R1B/RYR2/CRHBP/HDAC2 | 6 |
| GO:0045137 | GO:0045137 | development of primary sexual characteristics | 11/439 | 238/18888 | 0.0462185 | 1.9885531 | 2.3674258 | 0.0238530 | 0.2164403 | 0.1898410 | TAF4/SIX4/SRD5A1/NCOA1/CSMD1/SLIT2/SIRT1/SOX8/IL1A/AR/MAMLD1 | 11 |
| GO:0034976 | GO:0034976 | response to endoplasmic reticulum stress | 12/439 | 269/18888 | 0.0446097 | 1.9193334 | 2.3426011 | 0.0239776 | 0.2164403 | 0.1898410 | PARP8/MBTPS1/JUN/AMFR/USP25/ITPR1/SIRT1/SCAMP5/OPA1/MAP3K5/GORASP2/TMEM33 | 12 |
| GO:0007026 | GO:0007026 | negative regulation of microtubule depolymerization | 3/439 | 27/18888 | 0.1111111 | 4.7805619 | 3.0323771 | 0.0241248 | 0.2164403 | 0.1898410 | TAOK1/TTBK2/APC | 3 |
| GO:0021846 | GO:0021846 | cell proliferation in forebrain | 3/439 | 27/18888 | 0.1111111 | 4.7805619 | 3.0323771 | 0.0241248 | 0.2164403 | 0.1898410 | HOOK3/CEP120/FGFR2 | 3 |
| GO:0033119 | GO:0033119 | negative regulation of RNA splicing | 3/439 | 27/18888 | 0.1111111 | 4.7805619 | 3.0323771 | 0.0241248 | 0.2164403 | 0.1898410 | SRSF10/HNRNPK/SFSWAP | 3 |
| GO:1902894 | GO:1902894 | negative regulation of miRNA transcription | 3/439 | 27/18888 | 0.1111111 | 4.7805619 | 3.0323771 | 0.0241248 | 0.2164403 | 0.1898410 | SMAD3/REST/YY1 | 3 |
| GO:0046546 | GO:0046546 | development of primary male sexual characteristics | 8/439 | 150/18888 | 0.0533333 | 2.2946697 | 2.4556719 | 0.0241505 | 0.2164403 | 0.1898410 | SIX4/SRD5A1/NCOA1/CSMD1/SOX8/IL1A/AR/MAMLD1 | 8 |
| GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 13/439 | 301/18888 | 0.0431894 | 1.8582251 | 2.3152992 | 0.0243556 | 0.2177935 | 0.1910279 | MAPK1/INO80D/TFRC/E2F8/MEAF6/SIRT1/EPC1/TNKS2/KLF4/RGCC/YY1/RIF1/PRIM2 | 13 |
| GO:0018107 | GO:0018107 | peptidyl-threonine phosphorylation | 6/439 | 96/18888 | 0.0625000 | 2.6890661 | 2.5593111 | 0.0244940 | 0.2185454 | 0.1916875 | MAPK1/CDC42BPB/OXSR1/SPRED1/ATF2/MAPK8 | 6 |
| GO:0032835 | GO:0032835 | glomerulus development | 5/439 | 71/18888 | 0.0704225 | 3.0299336 | 2.6434016 | 0.0246746 | 0.2185879 | 0.1917247 | MTSS1/PPP3CA/MEF2C/JAG1/SULF1 | 5 |
| GO:0001838 | GO:0001838 | embryonic epithelial tube formation | 7/439 | 123/18888 | 0.0569106 | 2.4485805 | 2.4862697 | 0.0248658 | 0.2185879 | 0.1917247 | FZD3/SIX4/IRX2/CTHRC1/SEC24B/SOX8/OPA1 | 7 |
| GO:0045446 | GO:0045446 | endothelial cell differentiation | 7/439 | 123/18888 | 0.0569106 | 2.4485805 | 2.4862697 | 0.0248658 | 0.2185879 | 0.1917247 | RAP2C/RAP1B/HEY2/JAG1/PROX1/HEY1/PLCB1 | 7 |
| GO:0021795 | GO:0021795 | cerebral cortex cell migration | 4/439 | 48/18888 | 0.0833333 | 3.5854214 | 2.7665521 | 0.0250627 | 0.2185879 | 0.1917247 | ZMIZ1/SLIT2/PEX5/PAFAH1B1 | 4 |
| GO:0044331 | GO:0044331 | cell-cell adhesion mediated by cadherin | 4/439 | 48/18888 | 0.0833333 | 3.5854214 | 2.7665521 | 0.0250627 | 0.2185879 | 0.1917247 | CDH4/RGCC/EPCAM/CDH19 | 4 |
| GO:0072583 | GO:0072583 | clathrin-dependent endocytosis | 4/439 | 48/18888 | 0.0833333 | 3.5854214 | 2.7665521 | 0.0250627 | 0.2185879 | 0.1917247 | SGIP1/DNAJC6/SCYL2/AP2B1 | 4 |
| GO:0097720 | GO:0097720 | calcineurin-mediated signaling | 4/439 | 48/18888 | 0.0833333 | 3.5854214 | 2.7665521 | 0.0250627 | 0.2185879 | 0.1917247 | PPP3CA/CAMTA1/PPP3R1/PRNP | 4 |
| GO:1903844 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 9/439 | 180/18888 | 0.0500000 | 2.1512528 | 2.3939806 | 0.0251487 | 0.2185879 | 0.1917247 | DLX1/SMURF2/ZEB2/FBN1/SMAD3/SPRED1/SIRT1/CAV2/HDAC2 | 9 |
| GO:0071496 | GO:0071496 | cellular response to external stimulus | 14/439 | 335/18888 | 0.0417910 | 1.7980621 | 2.2734183 | 0.0255479 | 0.2185879 | 0.1917247 | MAPK1/SEH1L/NR4A2/JMY/SLC1A2/STK26/SRD5A1/NCOA1/SIRT1/ATF2/MAP3K5/KAT2B/MAPK8/PRKAB1 | 14 |
| GO:0001660 | GO:0001660 | fever generation | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | CNR1/IL1A | 2 |
| GO:0021548 | GO:0021548 | pons development | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | SEC24B/ATF2 | 2 |
| GO:0035581 | GO:0035581 | sequestering of extracellular ligand from receptor | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | FBN1/CD46 | 2 |
| GO:0051081 | GO:0051081 | nuclear membrane disassembly | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | PRKCB/PAFAH1B1 | 2 |
| GO:0060736 | GO:0060736 | prostate gland growth | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | FGFR2/AR | 2 |
| GO:0060742 | GO:0060742 | epithelial cell differentiation involved in prostate gland development | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | FGFR2/AR | 2 |
| GO:0070213 | GO:0070213 | protein auto-ADP-ribosylation | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | PARP8/TNKS2 | 2 |
| GO:0071838 | GO:0071838 | cell proliferation in bone marrow | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | HMGA2/FGFR2 | 2 |
| GO:0071872 | GO:0071872 | cellular response to epinephrine stimulus | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | SRD5A1/RYR2 | 2 |
| GO:0086070 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | RYR2/CACNA1D | 2 |
| GO:0098887 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | RAB11A/NSG1 | 2 |
| GO:0099550 | GO:0099550 | trans-synaptic signaling, modulating synaptic transmission | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | SYT4/CNR1 | 2 |
| GO:0099639 | GO:0099639 | neurotransmitter receptor transport, endosome to plasma membrane | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | RAB11A/NSG1 | 2 |
| GO:1902667 | GO:1902667 | regulation of axon guidance | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | SLIT2/TUBB2B | 2 |
| GO:2000109 | GO:2000109 | regulation of macrophage apoptotic process | 2/439 | 11/18888 | 0.1818182 | 7.8227376 | 3.4915307 | 0.0258025 | 0.2185879 | 0.1917247 | MEF2C/SIRT1 | 2 |
| GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 8/439 | 152/18888 | 0.0526316 | 2.2644767 | 2.4144683 | 0.0258811 | 0.2187929 | 0.1919045 | ARPP19/RAB11A/CDK6/TAOK1/MBTPS1/SYF2/CDC25C/PLCB1 | 8 |
| GO:0051148 | GO:0051148 | negative regulation of muscle cell differentiation | 5/439 | 72/18888 | 0.0694444 | 2.9878512 | 2.6068365 | 0.0260279 | 0.2195733 | 0.1925890 | YBX1/HEY2/BDNF/YY1/HEY1 | 5 |
| GO:0030072 | GO:0030072 | peptide hormone secretion | 11/439 | 242/18888 | 0.0454545 | 1.9556844 | 2.3081109 | 0.0265335 | 0.2213220 | 0.1941228 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0055022 | GO:0055022 | negative regulation of cardiac muscle tissue growth | 3/439 | 28/18888 | 0.1071429 | 4.6098275 | 2.9486414 | 0.0265652 | 0.2213220 | 0.1941228 | JARID2/KCNK2/YY1 | 3 |
| GO:0060966 | GO:0060966 | regulation of gene silencing by regulatory ncRNA | 3/439 | 28/18888 | 0.1071429 | 4.6098275 | 2.9486414 | 0.0265652 | 0.2213220 | 0.1941228 | PUM2/PRKRA/PUM1 | 3 |
| GO:0061117 | GO:0061117 | negative regulation of heart growth | 3/439 | 28/18888 | 0.1071429 | 4.6098275 | 2.9486414 | 0.0265652 | 0.2213220 | 0.1941228 | JARID2/KCNK2/YY1 | 3 |
| GO:1903779 | GO:1903779 | regulation of cardiac conduction | 3/439 | 28/18888 | 0.1071429 | 4.6098275 | 2.9486414 | 0.0265652 | 0.2213220 | 0.1941228 | ATP2B1/ATP2B2/RYR2 | 3 |
| GO:2000629 | GO:2000629 | negative regulation of miRNA metabolic process | 3/439 | 28/18888 | 0.1071429 | 4.6098275 | 2.9486414 | 0.0265652 | 0.2213220 | 0.1941228 | SMAD3/REST/YY1 | 3 |
| GO:0014075 | GO:0014075 | response to amine | 4/439 | 49/18888 | 0.0816327 | 3.5122495 | 2.7161843 | 0.0268055 | 0.2219064 | 0.1946354 | PPP3CA/NR4A2/PPP1R1B/HDAC2 | 4 |
| GO:0030850 | GO:0030850 | prostate gland development | 4/439 | 49/18888 | 0.0816327 | 3.5122495 | 2.7161843 | 0.0268055 | 0.2219064 | 0.1946354 | CYP7B1/FGFR2/SULF1/AR | 4 |
| GO:0051150 | GO:0051150 | regulation of smooth muscle cell differentiation | 4/439 | 49/18888 | 0.0816327 | 3.5122495 | 2.7161843 | 0.0268055 | 0.2219064 | 0.1946354 | HEY2/FGFR2/SIRT1/HEY1 | 4 |
| GO:0001952 | GO:0001952 | regulation of cell-matrix adhesion | 7/439 | 125/18888 | 0.0560000 | 2.4094032 | 2.4387453 | 0.0268560 | 0.2219064 | 0.1946354 | CDK6/RIN2/EPHA1/SMAD3/EPHA3/JAG1/AJAP1 | 7 |
| GO:0000380 | GO:0000380 | alternative mRNA splicing, via spliceosome | 5/439 | 73/18888 | 0.0684932 | 2.9469217 | 2.5708997 | 0.0274279 | 0.2247859 | 0.1971610 | REST/RBFOX1/SFSWAP/SRSF2/DDX17 | 5 |
| GO:0008333 | GO:0008333 | endosome to lysosome transport | 5/439 | 73/18888 | 0.0684932 | 2.9469217 | 2.5708997 | 0.0274279 | 0.2247859 | 0.1971610 | MTM1/HOOK3/PLEKHF2/RAB12/SCYL2 | 5 |
| GO:0045661 | GO:0045661 | regulation of myoblast differentiation | 5/439 | 73/18888 | 0.0684932 | 2.9469217 | 2.5708997 | 0.0274279 | 0.2247859 | 0.1971610 | AKIRIN1/MEF2C/SOX8/MAP3K5/PLCB1 | 5 |
| GO:0045665 | GO:0045665 | negative regulation of neuron differentiation | 5/439 | 73/18888 | 0.0684932 | 2.9469217 | 2.5708997 | 0.0274279 | 0.2247859 | 0.1971610 | DLX1/JAG1/REST/SOX8/HEY1 | 5 |
| GO:0001659 | GO:0001659 | temperature homeostasis | 9/439 | 183/18888 | 0.0491803 | 2.1159864 | 2.3400920 | 0.0275883 | 0.2251834 | 0.1975097 | ADAMTS5/EBF2/CNR1/APPL2/ADCYAP1/ADIPOR1/APC/IL1A/PRKAB1 | 9 |
| GO:0007219 | GO:0007219 | Notch signaling pathway | 9/439 | 183/18888 | 0.0491803 | 2.1159864 | 2.3400920 | 0.0275883 | 0.2251834 | 0.1975097 | CDK6/ZMIZ1/DLX1/HEY2/CNTN1/JAG1/PDCD10/CD46/HEY1 | 9 |
| GO:0051588 | GO:0051588 | regulation of neurotransmitter transport | 6/439 | 99/18888 | 0.0606061 | 2.6075792 | 2.4738051 | 0.0279638 | 0.2277857 | 0.1997922 | SYT4/MEF2C/RAP1B/PRKCB/STXBP5/MYOF | 6 |
| GO:2000241 | GO:2000241 | regulation of reproductive process | 10/439 | 214/18888 | 0.0467290 | 2.0105167 | 2.2932903 | 0.0284400 | 0.2311127 | 0.2027103 | SMURF2/CNR1/JAG1/B4GALT1/SULF1/IL1A/HDAC2/AR/CDC25C/PLCB1 | 10 |
| GO:0030099 | GO:0030099 | myeloid cell differentiation | 17/439 | 439/18888 | 0.0387244 | 1.6661184 | 2.1783346 | 0.0284871 | 0.2311127 | 0.2027103 | CDK6/TFRC/PPP3CA/SP3/KAT6A/MEF2C/L3MBTL3/FBN1/JAG1/CREB1/SIRT1/TAL1/PAFAH1B1/TET2/MITF/OSTM1/HOXB7 | 17 |
| GO:0060976 | GO:0060976 | coronary vasculature development | 4/439 | 50/18888 | 0.0800000 | 3.4420046 | 2.6671130 | 0.0286191 | 0.2317170 | 0.2032403 | HEY2/SEC24B/SPRED1/AP2B1 | 4 |
| GO:0060260 | GO:0060260 | regulation of transcription initiation by RNA polymerase II | 5/439 | 74/18888 | 0.0675676 | 2.9070984 | 2.5355708 | 0.0288748 | 0.2328504 | 0.2042344 | TAF4/GTF2A1/HEY2/TAF12/MED4 | 5 |
| GO:0060415 | GO:0060415 | muscle tissue morphogenesis | 5/439 | 74/18888 | 0.0675676 | 2.9070984 | 2.5355708 | 0.0288748 | 0.2328504 | 0.2042344 | EGLN1/HEY2/FGFR2/RYR2/PROX1 | 5 |
| GO:0003209 | GO:0003209 | cardiac atrium morphogenesis | 3/439 | 29/18888 | 0.1034483 | 4.4508680 | 2.8687675 | 0.0291327 | 0.2338056 | 0.2050723 | HEY2/PROX1/SOS1 | 3 |
| GO:0021952 | GO:0021952 | central nervous system projection neuron axonogenesis | 3/439 | 29/18888 | 0.1034483 | 4.4508680 | 2.8687675 | 0.0291327 | 0.2338056 | 0.2050723 | NR4A2/SLIT2/PAFAH1B1 | 3 |
| GO:0006282 | GO:0006282 | regulation of DNA repair | 10/439 | 215/18888 | 0.0465116 | 2.0011654 | 2.2774317 | 0.0292363 | 0.2338056 | 0.2050723 | INO80D/TAF4/HMGA2/MEAF6/SIRT1/TAF12/EPC1/YY1/KAT2B/RIF1 | 10 |
| GO:0006694 | GO:0006694 | steroid biosynthetic process | 9/439 | 185/18888 | 0.0486486 | 2.0931109 | 2.3047391 | 0.0293045 | 0.2338056 | 0.2050723 | MBTPS1/SRD5A1/CYP7B1/REST/CREB1/SIRT1/PROX1/SEC14L2/IL1A | 9 |
| GO:0010631 | GO:0010631 | epithelial cell migration | 15/439 | 375/18888 | 0.0400000 | 1.7210023 | 2.1754104 | 0.0298864 | 0.2338056 | 0.2050723 | RAB11A/MEOX2/MEF2C/RIN2/ZEB2/PDCD10/DOCK1/SPRED1/SLIT2/SIRT1/ADIPOR1/PROX1/KLF4/RGCC/PTPRG | 15 |
| GO:0048706 | GO:0048706 | embryonic skeletal system development | 7/439 | 128/18888 | 0.0546875 | 2.3529328 | 2.3691477 | 0.0300402 | 0.2338056 | 0.2050723 | DLX1/SP3/SIX4/SMAD3/FGFR2/SULF1/HOXB7 | 7 |
| GO:0002790 | GO:0002790 | peptide secretion | 11/439 | 247/18888 | 0.0445344 | 1.9160957 | 2.2355379 | 0.0301823 | 0.2338056 | 0.2050723 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0010906 | GO:0010906 | regulation of glucose metabolic process | 6/439 | 101/18888 | 0.0594059 | 2.5559440 | 2.4185399 | 0.0304485 | 0.2338056 | 0.2050723 | ARPP19/RORA/TCF7L2/SIRT1/ADIPOR1/KAT2B | 6 |
| GO:0120162 | GO:0120162 | positive regulation of cold-induced thermogenesis | 6/439 | 101/18888 | 0.0594059 | 2.5559440 | 2.4185399 | 0.0304485 | 0.2338056 | 0.2050723 | EBF2/APPL2/ADCYAP1/ADIPOR1/APC/PRKAB1 | 6 |
| GO:0010944 | GO:0010944 | negative regulation of transcription by competitive promoter binding | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | CREB1/HDAC2 | 2 |
| GO:0030397 | GO:0030397 | membrane disassembly | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | PRKCB/PAFAH1B1 | 2 |
| GO:0044341 | GO:0044341 | sodium-dependent phosphate transport | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | SLC17A6/SLC34A2 | 2 |
| GO:0048755 | GO:0048755 | branching morphogenesis of a nerve | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | EPHA7/FGFR2 | 2 |
| GO:0051451 | GO:0051451 | myoblast migration | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | AKIRIN1/SIX4 | 2 |
| GO:0051657 | GO:0051657 | maintenance of organelle location | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | SIRT1/PAFAH1B1 | 2 |
| GO:0060148 | GO:0060148 | positive regulation of post-transcriptional gene silencing | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | PUM2/PUM1 | 2 |
| GO:0070857 | GO:0070857 | regulation of bile acid biosynthetic process | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | SIRT1/PROX1 | 2 |
| GO:0072017 | GO:0072017 | distal tubule development | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | JAG1/CALB1 | 2 |
| GO:0072070 | GO:0072070 | loop of Henle development | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | IRX2/JAG1 | 2 |
| GO:0090177 | GO:0090177 | establishment of planar polarity involved in neural tube closure | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | CTHRC1/SEC24B | 2 |
| GO:1900370 | GO:1900370 | positive regulation of post-transcriptional gene silencing by RNA | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | PUM2/PUM1 | 2 |
| GO:1904779 | GO:1904779 | regulation of protein localization to centrosome | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | RAB11A/APC | 2 |
| GO:1905809 | GO:1905809 | negative regulation of synapse organization | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | PTPN13/EPHA7 | 2 |
| GO:2000637 | GO:2000637 | positive regulation of miRNA-mediated gene silencing | 2/439 | 12/18888 | 0.1666667 | 7.1708428 | 3.2984314 | 0.0304937 | 0.2338056 | 0.2050723 | PUM2/PUM1 | 2 |
| GO:0051347 | GO:0051347 | positive regulation of transferase activity | 15/439 | 376/18888 | 0.0398936 | 1.7164251 | 2.1645390 | 0.0304941 | 0.2338056 | 0.2050723 | MAPK1/TAB2/ADCYAP1/EPHA1/HMGA2/PDCD10/FGFR2/SIRT1/PROX1/KLF4/SERINC5/RGCC/MAP3K5/PRIM2/PRNP | 15 |
| GO:0019083 | GO:0019083 | viral transcription | 4/439 | 51/18888 | 0.0784314 | 3.3745143 | 2.6192764 | 0.0305040 | 0.2338056 | 0.2050723 | CCNT2/JUN/HMGA2/REST | 4 |
| GO:0048738 | GO:0048738 | cardiac muscle tissue development | 11/439 | 248/18888 | 0.0443548 | 1.9083695 | 2.2212260 | 0.0309531 | 0.2367972 | 0.2076962 | JARID2/MEF2C/EGLN1/KCNK2/HEY2/CREB1/FGFR2/RYR2/PROX1/YY1/HEY1 | 11 |
| GO:0032956 | GO:0032956 | regulation of actin cytoskeleton organization | 14/439 | 344/18888 | 0.0406977 | 1.7510198 | 2.1684839 | 0.0310141 | 0.2368135 | 0.2077105 | MTSS1/TAOK1/WASHC4/EPHA5/EPHA1/SMAD3/EPHA3/PPFIA1/IQGAP2/SLIT2/PROX1/MEGF9/IL1A/RGCC | 14 |
| GO:0090132 | GO:0090132 | epithelium migration | 15/439 | 378/18888 | 0.0396825 | 1.7073435 | 2.1428926 | 0.0317368 | 0.2402813 | 0.2107521 | RAB11A/MEOX2/MEF2C/RIN2/ZEB2/PDCD10/DOCK1/SPRED1/SLIT2/SIRT1/ADIPOR1/PROX1/KLF4/RGCC/PTPRG | 15 |
| GO:1901617 | GO:1901617 | organic hydroxy compound biosynthetic process | 11/439 | 249/18888 | 0.0441767 | 1.9007053 | 2.2069802 | 0.0317378 | 0.2402813 | 0.2107521 | NR4A2/IPMK/MBTPS1/ZEB2/CYP7B1/REST/CREB1/SIRT1/PROX1/SEC14L2/SPTSSA | 11 |
| GO:0043247 | GO:0043247 | telomere maintenance in response to DNA damage | 3/439 | 30/18888 | 0.1000000 | 4.3025057 | 2.7924392 | 0.0318265 | 0.2402813 | 0.2107521 | INO80D/YY1/RIF1 | 3 |
| GO:0043392 | GO:0043392 | negative regulation of DNA binding | 3/439 | 30/18888 | 0.1000000 | 4.3025057 | 2.7924392 | 0.0318265 | 0.2402813 | 0.2107521 | JUN/HEY2/HMGA2 | 3 |
| GO:0060603 | GO:0060603 | mammary gland duct morphogenesis | 3/439 | 30/18888 | 0.1000000 | 4.3025057 | 2.7924392 | 0.0318265 | 0.2402813 | 0.2107521 | FGFR2/CSMD1/AR | 3 |
| GO:0070168 | GO:0070168 | negative regulation of biomineral tissue development | 3/439 | 30/18888 | 0.1000000 | 4.3025057 | 2.7924392 | 0.0318265 | 0.2402813 | 0.2107521 | HEY2/BCOR/HEY1 | 3 |
| GO:0001707 | GO:0001707 | mesoderm formation | 5/439 | 76/18888 | 0.0657895 | 2.8305959 | 2.4666590 | 0.0319113 | 0.2404701 | 0.2109177 | HMGA2/SMAD3/FGFR2/TAL1/KLF4 | 5 |
| GO:0006111 | GO:0006111 | regulation of gluconeogenesis | 4/439 | 52/18888 | 0.0769231 | 3.3096198 | 2.5726171 | 0.0324604 | 0.2436949 | 0.2137462 | ARPP19/TCF7L2/SIRT1/KAT2B | 4 |
| GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 4/439 | 52/18888 | 0.0769231 | 3.3096198 | 2.5726171 | 0.0324604 | 0.2436949 | 0.2137462 | SEH1L/CHAMP1/APC/KAT2B | 4 |
| GO:0070167 | GO:0070167 | regulation of biomineral tissue development | 6/439 | 103/18888 | 0.0582524 | 2.5063140 | 2.3645901 | 0.0330734 | 0.2478351 | 0.2173776 | ATP2B1/MEF2C/HEY2/BCOR/SMAD3/HEY1 | 6 |
| GO:0001704 | GO:0001704 | formation of primary germ layer | 7/439 | 131/18888 | 0.0534351 | 2.2990488 | 2.3014777 | 0.0334695 | 0.2496483 | 0.2189680 | ETS2/HMGA2/SMAD3/FGFR2/TAL1/KLF4/BRD3 | 7 |
| GO:0001937 | GO:0001937 | negative regulation of endothelial cell proliferation | 5/439 | 77/18888 | 0.0649351 | 2.7938349 | 2.4330398 | 0.0335015 | 0.2496483 | 0.2189680 | MEF2C/PDCD10/CAV2/SULF1/RGCC | 5 |
| GO:0072078 | GO:0072078 | nephron tubule morphogenesis | 5/439 | 77/18888 | 0.0649351 | 2.7938349 | 2.4330398 | 0.0335015 | 0.2496483 | 0.2189680 | SIX4/IRX2/SOX8/HS3ST3B1/HOXB7 | 5 |
| GO:0043281 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 8/439 | 160/18888 | 0.0500000 | 2.1512528 | 2.2558610 | 0.0336667 | 0.2504154 | 0.2196408 | EPHA7/HIP1/SMAD3/REST/SIRT1/KLF4/MAP3K5/ST18 | 8 |
| GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 6/439 | 104/18888 | 0.0576923 | 2.4822148 | 2.3380894 | 0.0344392 | 0.2510081 | 0.2201606 | RAB11A/CDK6/TAOK1/MBTPS1/SYF2/CDC25C | 6 |
| GO:0032330 | GO:0032330 | regulation of chondrocyte differentiation | 4/439 | 53/18888 | 0.0754717 | 3.2471741 | 2.5270811 | 0.0344886 | 0.2510081 | 0.2201606 | PTHLH/SMAD3/EFEMP1/TRPS1 | 4 |
| GO:0046622 | GO:0046622 | positive regulation of organ growth | 4/439 | 53/18888 | 0.0754717 | 3.2471741 | 2.5270811 | 0.0344886 | 0.2510081 | 0.2201606 | MEF2C/HEY2/FGFR2/PROX1 | 4 |
| GO:1902692 | GO:1902692 | regulation of neuroblast proliferation | 4/439 | 53/18888 | 0.0754717 | 3.2471741 | 2.5270811 | 0.0344886 | 0.2510081 | 0.2201606 | FZD3/TAFA1/PROX1/VCAN | 4 |
| GO:0010575 | GO:0010575 | positive regulation of vascular endothelial growth factor production | 3/439 | 31/18888 | 0.0967742 | 4.1637152 | 2.7193760 | 0.0346461 | 0.2510081 | 0.2201606 | RORA/SULF1/IL1A | 3 |
| GO:0031114 | GO:0031114 | regulation of microtubule depolymerization | 3/439 | 31/18888 | 0.0967742 | 4.1637152 | 2.7193760 | 0.0346461 | 0.2510081 | 0.2201606 | TAOK1/TTBK2/APC | 3 |
| GO:0060045 | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 3/439 | 31/18888 | 0.0967742 | 4.1637152 | 2.7193760 | 0.0346461 | 0.2510081 | 0.2201606 | MEF2C/HEY2/FGFR2 | 3 |
| GO:0099590 | GO:0099590 | neurotransmitter receptor internalization | 3/439 | 31/18888 | 0.0967742 | 4.1637152 | 2.7193760 | 0.0346461 | 0.2510081 | 0.2201606 | HIP1/PPP3R1/AP2B1 | 3 |
| GO:1990806 | GO:1990806 | ligand-gated ion channel signaling pathway | 3/439 | 31/18888 | 0.0967742 | 4.1637152 | 2.7193760 | 0.0346461 | 0.2510081 | 0.2201606 | GRIN3A/ITPR1/PLCB1 | 3 |
| GO:0090130 | GO:0090130 | tissue migration | 15/439 | 383/18888 | 0.0391645 | 1.6850544 | 2.0893311 | 0.0350053 | 0.2510081 | 0.2201606 | RAB11A/MEOX2/MEF2C/RIN2/ZEB2/PDCD10/DOCK1/SPRED1/SLIT2/SIRT1/ADIPOR1/PROX1/KLF4/RGCC/PTPRG | 15 |
| GO:0000079 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 5/439 | 78/18888 | 0.0641026 | 2.7580165 | 2.3999554 | 0.0351402 | 0.2510081 | 0.2201606 | CCNT2/PROX1/APC/RGCC/CDC25C | 5 |
| GO:0048332 | GO:0048332 | mesoderm morphogenesis | 5/439 | 78/18888 | 0.0641026 | 2.7580165 | 2.3999554 | 0.0351402 | 0.2510081 | 0.2201606 | HMGA2/SMAD3/FGFR2/TAL1/KLF4 | 5 |
| GO:0050853 | GO:0050853 | B cell receptor signaling pathway | 5/439 | 78/18888 | 0.0641026 | 2.7580165 | 2.3999554 | 0.0351402 | 0.2510081 | 0.2201606 | MAPK1/VAV3/MEF2C/PRKCB/SOS1 | 5 |
| GO:0051145 | GO:0051145 | smooth muscle cell differentiation | 5/439 | 78/18888 | 0.0641026 | 2.7580165 | 2.3999554 | 0.0351402 | 0.2510081 | 0.2201606 | MEF2C/HEY2/FGFR2/SIRT1/HEY1 | 5 |
| GO:0006167 | GO:0006167 | AMP biosynthetic process | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | GART/ADK | 2 |
| GO:0006448 | GO:0006448 | regulation of translational elongation | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | CPEB2/CPEB3 | 2 |
| GO:0021681 | GO:0021681 | cerebellar granular layer development | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | TTBK2/PROX1 | 2 |
| GO:0033604 | GO:0033604 | negative regulation of catecholamine secretion | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | SYT4/CNR1 | 2 |
| GO:0033690 | GO:0033690 | positive regulation of osteoblast proliferation | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | CTHRC1/SOX8 | 2 |
| GO:0043568 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | PHIP/AR | 2 |
| GO:0045737 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | PROX1/RGCC | 2 |
| GO:0045956 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | SYT4/SCAMP5 | 2 |
| GO:0046541 | GO:0046541 | saliva secretion | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | PPP3CA/KCNN4 | 2 |
| GO:0051481 | GO:0051481 | negative regulation of cytosolic calcium ion concentration | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | ATP2B1/SMAD3 | 2 |
| GO:0061029 | GO:0061029 | eyelid development in camera-type eye | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | HDAC2/SOS1 | 2 |
| GO:0071107 | GO:0071107 | response to parathyroid hormone | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | MEF2C/KAT2B | 2 |
| GO:1900115 | GO:1900115 | extracellular regulation of signal transduction | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | FBN1/CD46 | 2 |
| GO:1900116 | GO:1900116 | extracellular negative regulation of signal transduction | 2/439 | 13/18888 | 0.1538462 | 6.6192395 | 3.1263175 | 0.0354929 | 0.2510081 | 0.2201606 | FBN1/CD46 | 2 |
| GO:0048592 | GO:0048592 | eye morphogenesis | 8/439 | 162/18888 | 0.0493827 | 2.1246942 | 2.2176693 | 0.0358371 | 0.2529624 | 0.2218748 | SP3/FBN1/JAG1/CALB1/PROX1/SOX8/EFEMP1/YY1 | 8 |
| GO:0014902 | GO:0014902 | myotube differentiation | 7/439 | 133/18888 | 0.0526316 | 2.2644767 | 2.2573840 | 0.0358950 | 0.2529624 | 0.2218748 | ADAMTS5/PPP3CA/MEF2C/SIX4/DOCK1/CAV2/BDNF | 7 |
| GO:0035315 | GO:0035315 | hair cell differentiation | 4/439 | 54/18888 | 0.0740741 | 3.1870413 | 2.4826180 | 0.0365889 | 0.2569521 | 0.2253742 | HEY2/JAG1/SEC24B/PAFAH1B1 | 4 |
| GO:0038093 | GO:0038093 | Fc receptor signaling pathway | 4/439 | 54/18888 | 0.0740741 | 3.1870413 | 2.4826180 | 0.0365889 | 0.2569521 | 0.2253742 | VAV3/APPL2/SOS1/MAPK8 | 4 |
| GO:0042246 | GO:0042246 | tissue regeneration | 5/439 | 79/18888 | 0.0632911 | 2.7231049 | 2.3673896 | 0.0368276 | 0.2577290 | 0.2260556 | AKIRIN1/KPNA1/PPP3CA/TM4SF4/PTPN12 | 5 |
| GO:0072088 | GO:0072088 | nephron epithelium morphogenesis | 5/439 | 79/18888 | 0.0632911 | 2.7231049 | 2.3673896 | 0.0368276 | 0.2577290 | 0.2260556 | SIX4/IRX2/SOX8/HS3ST3B1/HOXB7 | 5 |
| GO:0018210 | GO:0018210 | peptidyl-threonine modification | 6/439 | 106/18888 | 0.0566038 | 2.4353806 | 2.2860010 | 0.0372788 | 0.2596159 | 0.2277106 | MAPK1/CDC42BPB/OXSR1/SPRED1/ATF2/MAPK8 | 6 |
| GO:0042472 | GO:0042472 | inner ear morphogenesis | 6/439 | 106/18888 | 0.0566038 | 2.4353806 | 2.2860010 | 0.0372788 | 0.2596159 | 0.2277106 | FZD3/SIX4/CTHRC1/FGFR2/SEC24B/PROX1 | 6 |
| GO:0000289 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 3/439 | 32/18888 | 0.0937500 | 4.0335991 | 2.6493280 | 0.0375904 | 0.2596159 | 0.2277106 | CNOT2/CNOT6L/CPEB3 | 3 |
| GO:0003299 | GO:0003299 | muscle hypertrophy in response to stress | 3/439 | 32/18888 | 0.0937500 | 4.0335991 | 2.6493280 | 0.0375904 | 0.2596159 | 0.2277106 | PPP3CA/HEY2/SMAD3 | 3 |
| GO:0014887 | GO:0014887 | cardiac muscle adaptation | 3/439 | 32/18888 | 0.0937500 | 4.0335991 | 2.6493280 | 0.0375904 | 0.2596159 | 0.2277106 | PPP3CA/HEY2/SMAD3 | 3 |
| GO:0014898 | GO:0014898 | cardiac muscle hypertrophy in response to stress | 3/439 | 32/18888 | 0.0937500 | 4.0335991 | 2.6493280 | 0.0375904 | 0.2596159 | 0.2277106 | PPP3CA/HEY2/SMAD3 | 3 |
| GO:0060674 | GO:0060674 | placenta blood vessel development | 3/439 | 32/18888 | 0.0937500 | 4.0335991 | 2.6493280 | 0.0375904 | 0.2596159 | 0.2277106 | MAPK1/HEY2/HEY1 | 3 |
| GO:0010721 | GO:0010721 | negative regulation of cell development | 12/439 | 288/18888 | 0.0416667 | 1.7927107 | 2.0911338 | 0.0376133 | 0.2596159 | 0.2277106 | HOOK3/CDK6/SYT4/EPHA7/DLX1/PPP3CA/APPL2/FBN1/PTHLH/REST/PROX1/IL1A | 12 |
| GO:0008544 | GO:0008544 | epidermis development | 15/439 | 387/18888 | 0.0387597 | 1.6676379 | 2.0470393 | 0.0377911 | 0.2603965 | 0.2283953 | PUM2/YBX1/PPP3CA/FZD3/HEY2/PTHLH/JAG1/FGFR2/SEC24B/PIP5K1A/KLF4/IL1A/PAFAH1B1/HDAC2/SOS1 | 15 |
| GO:1901655 | GO:1901655 | cellular response to ketone | 6/439 | 107/18888 | 0.0560748 | 2.4126200 | 2.2603996 | 0.0387530 | 0.2652645 | 0.2326650 | FBXO32/SRD5A1/CREB1/SIRT1/KLF4/AR | 6 |
| GO:0000381 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 4/439 | 55/18888 | 0.0727273 | 3.1290951 | 2.4391807 | 0.0387613 | 0.2652645 | 0.2326650 | REST/RBFOX1/SRSF2/DDX17 | 4 |
| GO:0060425 | GO:0060425 | lung morphogenesis | 4/439 | 55/18888 | 0.0727273 | 3.1290951 | 2.4391807 | 0.0387613 | 0.2652645 | 0.2326650 | MAPK1/DLG5/FGFR2/SEC24B | 4 |
| GO:2000772 | GO:2000772 | regulation of cellular senescence | 4/439 | 55/18888 | 0.0727273 | 3.1290951 | 2.4391807 | 0.0387613 | 0.2652645 | 0.2326650 | CDK6/YBX1/HMGA2/SIRT1 | 4 |
| GO:0030100 | GO:0030100 | regulation of endocytosis | 12/439 | 291/18888 | 0.0412371 | 1.7742292 | 2.0531558 | 0.0401834 | 0.2699215 | 0.2367498 | SGIP1/DNAJC6/SYT4/PPP3CA/APPL2/HIP1/EPHA3/RUFY2/PPP3R1/HNRNPK/SCAMP5/VAMP4 | 12 |
| GO:1901890 | GO:1901890 | positive regulation of cell junction assembly | 6/439 | 108/18888 | 0.0555556 | 2.3902809 | 2.2350847 | 0.0402639 | 0.2699215 | 0.2367498 | DLG5/LRRTM3/SLITRK4/AGRN/SMAD3/BDNF | 6 |
| GO:0048644 | GO:0048644 | muscle organ morphogenesis | 5/439 | 81/18888 | 0.0617284 | 2.6558677 | 2.3037520 | 0.0403495 | 0.2699215 | 0.2367498 | EGLN1/HEY2/FGFR2/RYR2/PROX1 | 5 |
| GO:0072028 | GO:0072028 | nephron morphogenesis | 5/439 | 81/18888 | 0.0617284 | 2.6558677 | 2.3037520 | 0.0403495 | 0.2699215 | 0.2367498 | SIX4/IRX2/SOX8/HS3ST3B1/HOXB7 | 5 |
| GO:0097061 | GO:0097061 | dendritic spine organization | 5/439 | 81/18888 | 0.0617284 | 2.6558677 | 2.3037520 | 0.0403495 | 0.2699215 | 0.2367498 | DOCK10/ARHGAP33/PAFAH1B1/SIPA1L1/PRNP | 5 |
| GO:1904029 | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 5/439 | 81/18888 | 0.0617284 | 2.6558677 | 2.3037520 | 0.0403495 | 0.2699215 | 0.2367498 | CCNT2/PROX1/APC/RGCC/CDC25C | 5 |
| GO:2000765 | GO:2000765 | regulation of cytoplasmic translation | 3/439 | 33/18888 | 0.0909091 | 3.9113688 | 2.5820715 | 0.0406583 | 0.2699215 | 0.2367498 | CPEB2/YBX1/CPEB3 | 3 |
| GO:0006177 | GO:0006177 | GMP biosynthetic process | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | GART/ADK | 2 |
| GO:0030238 | GO:0030238 | male sex determination | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | SIX4/AR | 2 |
| GO:0032486 | GO:0032486 | Rap protein signal transduction | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | RAP2C/RAP1B | 2 |
| GO:0035331 | GO:0035331 | negative regulation of hippo signaling | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | DLG5/WWC2 | 2 |
| GO:0035791 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | HIP1/PTPN12 | 2 |
| GO:0046322 | GO:0046322 | negative regulation of fatty acid oxidation | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | CNR1/APPL2 | 2 |
| GO:0051645 | GO:0051645 | Golgi localization | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | HOOK3/PDCD10 | 2 |
| GO:0061000 | GO:0061000 | negative regulation of dendritic spine development | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | GRIN3A/HDAC2 | 2 |
| GO:0070365 | GO:0070365 | hepatocyte differentiation | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | E2F8/PROX1 | 2 |
| GO:0071871 | GO:0071871 | response to epinephrine | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | SRD5A1/RYR2 | 2 |
| GO:0071888 | GO:0071888 | macrophage apoptotic process | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | MEF2C/SIRT1 | 2 |
| GO:0072160 | GO:0072160 | nephron tubule epithelial cell differentiation | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | MTSS1/MEF2C | 2 |
| GO:1905244 | GO:1905244 | regulation of modification of synaptic structure | 2/439 | 14/18888 | 0.1428571 | 6.1464367 | 2.9714335 | 0.0407834 | 0.2699215 | 0.2367498 | EGLN1/CTTNBP2 | 2 |
| GO:0001954 | GO:0001954 | positive regulation of cell-matrix adhesion | 4/439 | 56/18888 | 0.0714286 | 3.0732184 | 2.3967248 | 0.0410060 | 0.2709062 | 0.2376134 | CDK6/RIN2/EPHA1/SMAD3 | 4 |
| GO:0051402 | GO:0051402 | neuron apoptotic process | 12/439 | 292/18888 | 0.0410959 | 1.7681530 | 2.0405946 | 0.0410668 | 0.2709062 | 0.2376134 | EPHA7/DLX1/SCN2A/NR4A2/MEF2C/SIX4/USP53/SIRT1/ATF2/BDNF/MAP3K5/PRNP | 12 |
| GO:0002520 | GO:0002520 | immune system development | 9/439 | 197/18888 | 0.0456853 | 1.9656117 | 2.1015838 | 0.0411882 | 0.2712622 | 0.2379256 | MAPK1/TFRC/JARID2/SIX4/SLC40A1/SMAD3/IRAK3/YY1/RIF1 | 9 |
| GO:1904951 | GO:1904951 | positive regulation of establishment of protein localization | 13/439 | 326/18888 | 0.0398773 | 1.7157231 | 2.0107997 | 0.0421343 | 0.2769177 | 0.2428861 | CEP120/GLUD1/KCNN4/PRKCB/UBE2D3/SMAD3/PDCD10/TCF7L2/ITPR1/IL1A/SEC24A/PLCB1/PRNP | 13 |
| GO:0003407 | GO:0003407 | neural retina development | 5/439 | 82/18888 | 0.0609756 | 2.6234791 | 2.2726510 | 0.0421845 | 0.2769177 | 0.2428861 | DLX1/ATP2B2/GPM6A/CALB1/SOX8 | 5 |
| GO:0046328 | GO:0046328 | regulation of JNK cascade | 7/439 | 138/18888 | 0.0507246 | 2.1824304 | 2.1505118 | 0.0424585 | 0.2778099 | 0.2436687 | NRK/TAOK1/MECOM/IL1A/PAFAH1B1/MAP3K5/PLCB1 | 7 |
| GO:0070555 | GO:0070555 | response to interleukin-1 | 7/439 | 138/18888 | 0.0507246 | 2.1824304 | 2.1505118 | 0.0424585 | 0.2778099 | 0.2436687 | RORA/IRAK3/YY1/IRAK2/TANK/ST18/PLCB1 | 7 |
| GO:0051962 | GO:0051962 | positive regulation of nervous system development | 12/439 | 294/18888 | 0.0408163 | 1.7561248 | 2.0156172 | 0.0428742 | 0.2800743 | 0.2456548 | DLG5/LRRTM3/SLITRK4/AGRN/FZD3/CDH4/SLIT2/VCAN/BDNF/SOX8/PAFAH1B1/HDAC2 | 12 |
| GO:0042692 | GO:0042692 | muscle cell differentiation | 16/439 | 428/18888 | 0.0373832 | 1.6084133 | 1.9639576 | 0.0430497 | 0.2807650 | 0.2462606 | ADAMTS5/HIRA/YBX1/PPP3CA/MEF2C/SIX4/HEY2/RORA/FGFR2/DOCK1/SIRT1/CAV2/PROX1/BDNF/YY1/HEY1 | 16 |
| GO:0043547 | GO:0043547 | positive regulation of GTPase activity | 10/439 | 230/18888 | 0.0434783 | 1.8706546 | 2.0492957 | 0.0431391 | 0.2808931 | 0.2463729 | AGRN/DOCK10/ADCYAP1/EPHA1/PREX2/PIP5K1A/CAV2/SIPA1L1/SOS1/RALGPS2 | 10 |
| GO:0034332 | GO:0034332 | adherens junction organization | 4/439 | 57/18888 | 0.0701754 | 3.0193022 | 2.3552087 | 0.0433230 | 0.2811803 | 0.2466249 | DLG5/MTSS1/CDH4/CDH19 | 4 |
| GO:0060997 | GO:0060997 | dendritic spine morphogenesis | 4/439 | 57/18888 | 0.0701754 | 3.0193022 | 2.3552087 | 0.0433230 | 0.2811803 | 0.2466249 | DOCK10/ARHGAP33/PAFAH1B1/SIPA1L1 | 4 |
| GO:0051100 | GO:0051100 | negative regulation of binding | 6/439 | 110/18888 | 0.0545455 | 2.3468213 | 2.1852895 | 0.0433963 | 0.2812022 | 0.2466441 | JUN/HEY2/HMGA2/TTBK2/BTAF1/MAPK8 | 6 |
| GO:0001782 | GO:0001782 | B cell homeostasis | 3/439 | 34/18888 | 0.0882353 | 3.7963286 | 2.5174059 | 0.0438487 | 0.2823156 | 0.2476207 | DOCK10/MEF2C/SOS1 | 3 |
| GO:0009112 | GO:0009112 | nucleobase metabolic process | 3/439 | 34/18888 | 0.0882353 | 3.7963286 | 2.5174059 | 0.0438487 | 0.2823156 | 0.2476207 | MAPK1/GART/ADK | 3 |
| GO:0009954 | GO:0009954 | proximal/distal pattern formation | 3/439 | 34/18888 | 0.0882353 | 3.7963286 | 2.5174059 | 0.0438487 | 0.2823156 | 0.2476207 | SP8/DLX1/IRX2 | 3 |
| GO:0034405 | GO:0034405 | response to fluid shear stress | 3/439 | 34/18888 | 0.0882353 | 3.7963286 | 2.5174059 | 0.0438487 | 0.2823156 | 0.2476207 | MTSS1/MEF2C/KLF4 | 3 |
| GO:0001570 | GO:0001570 | vasculogenesis | 5/439 | 83/18888 | 0.0602410 | 2.5918709 | 2.2420101 | 0.0440691 | 0.2828295 | 0.2480714 | ZMIZ1/RIN2/HEY2/SPRED1/HEY1 | 5 |
| GO:0050871 | GO:0050871 | positive regulation of B cell activation | 5/439 | 83/18888 | 0.0602410 | 2.5918709 | 2.2420101 | 0.0440691 | 0.2828295 | 0.2480714 | VAV3/TFRC/MEF2C/SH3KBP1/RIF1 | 5 |
| GO:0006403 | GO:0006403 | RNA localization | 9/439 | 200/18888 | 0.0450000 | 1.9361276 | 2.0530331 | 0.0446029 | 0.2853452 | 0.2502779 | PUM2/SEH1L/YBX1/AHCTF1/RBFOX1/CETN3/YY1/NXT2/NOP58 | 9 |
| GO:0007369 | GO:0007369 | gastrulation | 9/439 | 200/18888 | 0.0450000 | 1.9361276 | 2.0530331 | 0.0446029 | 0.2853452 | 0.2502779 | HIRA/ETS2/HMGA2/SMAD3/SYF2/FGFR2/TAL1/KLF4/BRD3 | 9 |
| GO:0043280 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6/439 | 111/18888 | 0.0540541 | 2.3256788 | 2.1607972 | 0.0450181 | 0.2856168 | 0.2505161 | HIP1/SMAD3/REST/SIRT1/MAP3K5/ST18 | 6 |
| GO:0090263 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 6/439 | 111/18888 | 0.0540541 | 2.3256788 | 2.1607972 | 0.0450181 | 0.2856168 | 0.2505161 | SMURF2/LYPD6/ZEB2/SMAD3/FGFR2/TNKS2 | 6 |
| GO:0090277 | GO:0090277 | positive regulation of peptide hormone secretion | 6/439 | 111/18888 | 0.0540541 | 2.3256788 | 2.1607972 | 0.0450181 | 0.2856168 | 0.2505161 | GLUD1/PRKCB/ADCYAP1/TCF7L2/ITPR1/PLCB1 | 6 |
| GO:0120034 | GO:0120034 | positive regulation of plasma membrane bounded cell projection assembly | 6/439 | 111/18888 | 0.0540541 | 2.3256788 | 2.1607972 | 0.0450181 | 0.2856168 | 0.2505161 | AKIRIN1/CEP120/AGRN/ATMIN/GPM6A/APC | 6 |
| GO:0007498 | GO:0007498 | mesoderm development | 7/439 | 140/18888 | 0.0500000 | 2.1512528 | 2.1090389 | 0.0452877 | 0.2856168 | 0.2505161 | ETS2/HMGA2/SMAD3/PUS7/FGFR2/TAL1/KLF4 | 7 |
| GO:0045010 | GO:0045010 | actin nucleation | 4/439 | 58/18888 | 0.0689655 | 2.9672453 | 2.3145933 | 0.0457122 | 0.2856168 | 0.2505161 | WASHC4/JMY/WIPF3/IQGAP2 | 4 |
| GO:0031345 | GO:0031345 | negative regulation of cell projection organization | 9/439 | 201/18888 | 0.0447761 | 1.9264951 | 2.0370359 | 0.0457820 | 0.2856168 | 0.2505161 | EPHA7/PPP3CA/SLIT2/NR2F1/PAFAH1B1/HDAC2/PTPRG/ITM2C/PRNP | 9 |
| GO:0006999 | GO:0006999 | nuclear pore organization | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | SEH1L/AHCTF1 | 2 |
| GO:0007028 | GO:0007028 | cytoplasm organization | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | ZMIZ1/SOS1 | 2 |
| GO:0009048 | GO:0009048 | dosage compensation by inactivation of X chromosome | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | JARID2/SUZ12 | 2 |
| GO:0031000 | GO:0031000 | response to caffeine | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | RYR2/HDAC2 | 2 |
| GO:0033147 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | CNOT2/CYP7B1 | 2 |
| GO:0048308 | GO:0048308 | organelle inheritance | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | MAPK1/PDCD10 | 2 |
| GO:0048313 | GO:0048313 | Golgi inheritance | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | MAPK1/PDCD10 | 2 |
| GO:0060009 | GO:0060009 | Sertoli cell development | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | SOX8/IL1A | 2 |
| GO:0061307 | GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | MAPK1/JAG1 | 2 |
| GO:0061308 | GO:0061308 | cardiac neural crest cell development involved in heart development | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | MAPK1/JAG1 | 2 |
| GO:0071599 | GO:0071599 | otic vesicle development | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | FGFR2/PROX1 | 2 |
| GO:0072044 | GO:0072044 | collecting duct development | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | DLG5/CALB1 | 2 |
| GO:0072537 | GO:0072537 | fibroblast activation | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | ZEB2/RGCC | 2 |
| GO:0099509 | GO:0099509 | regulation of presynaptic cytosolic calcium ion concentration | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | CNR1/CALB1 | 2 |
| GO:1901203 | GO:1901203 | positive regulation of extracellular matrix assembly | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | SMAD3/RGCC | 2 |
| GO:1904251 | GO:1904251 | regulation of bile acid metabolic process | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | SIRT1/PROX1 | 2 |
| GO:1904507 | GO:1904507 | positive regulation of telomere maintenance in response to DNA damage | 2/439 | 15/18888 | 0.1333333 | 5.7366743 | 2.8309097 | 0.0463488 | 0.2856168 | 0.2505161 | INO80D/YY1 | 2 |
| GO:0062012 | GO:0062012 | regulation of small molecule metabolic process | 13/439 | 331/18888 | 0.0392749 | 1.6898059 | 1.9530543 | 0.0465665 | 0.2865193 | 0.2513077 | ARPP19/MBTPS1/CNR1/APPL2/RORA/REST/CREB1/TCF7L2/SIRT1/ADIPOR1/PROX1/SEC14L2/KAT2B | 13 |
| GO:0007626 | GO:0007626 | locomotory behavior | 9/439 | 202/18888 | 0.0445545 | 1.9169580 | 2.0211302 | 0.0469817 | 0.2870988 | 0.2518160 | NR4A2/NEGR1/PPP1R1B/CNTN1/PREX2/CALB1/PUM1/TAL1/PAFAH1B1 | 9 |
| GO:0006346 | GO:0006346 | DNA methylation-dependent heterochromatin formation | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | L3MBTL3/SIRT1/MBD2 | 3 |
| GO:0006884 | GO:0006884 | cell volume homeostasis | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | KCNN4/OXSR1/CLNS1A | 3 |
| GO:0010614 | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | JARID2/SMAD3/YY1 | 3 |
| GO:0032872 | GO:0032872 | regulation of stress-activated MAPK cascade | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | MAPK1/TAOK1/PDCD10 | 3 |
| GO:0033146 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | CNOT2/CYP7B1/AR | 3 |
| GO:0099171 | GO:0099171 | presynaptic modulation of chemical synaptic transmission | 3/439 | 35/18888 | 0.0857143 | 3.6878620 | 2.4551504 | 0.0471601 | 0.2870988 | 0.2518160 | GRIN3A/PRKCB/HIP1 | 3 |
| GO:0045787 | GO:0045787 | positive regulation of cell cycle | 13/439 | 332/18888 | 0.0391566 | 1.6847161 | 1.9416222 | 0.0474904 | 0.2882816 | 0.2528535 | RAB11A/CEP120/E2F8/PHIP/FGFR2/PROX1/TAL1/IL1A/RGCC/PAFAH1B1/KAT2B/CDC25C/PLCB1 | 13 |
| GO:0010594 | GO:0010594 | regulation of endothelial cell migration | 10/439 | 234/18888 | 0.0427350 | 1.8386776 | 1.9913351 | 0.0474977 | 0.2882816 | 0.2528535 | MEOX2/MEF2C/RIN2/PDCD10/SPRED1/SLIT2/SIRT1/PROX1/KLF4/RGCC | 10 |
| GO:0003229 | GO:0003229 | ventricular cardiac muscle tissue development | 4/439 | 59/18888 | 0.0677966 | 2.9169530 | 2.2748417 | 0.0481736 | 0.2909673 | 0.2552091 | HEY2/FGFR2/RYR2/PROX1 | 4 |
| GO:0031122 | GO:0031122 | cytoplasmic microtubule organization | 4/439 | 59/18888 | 0.0677966 | 2.9169530 | 2.2748417 | 0.0481736 | 0.2909673 | 0.2552091 | HOOK3/RAB11A/CEP120/PAFAH1B1 | 4 |
| GO:0060135 | GO:0060135 | maternal process involved in female pregnancy | 4/439 | 59/18888 | 0.0677966 | 2.9169530 | 2.2748417 | 0.0481736 | 0.2909673 | 0.2552091 | ASH1L/CNR1/CSMD1/AR | 4 |
| GO:0002793 | GO:0002793 | positive regulation of peptide secretion | 6/439 | 113/18888 | 0.0530973 | 2.2845163 | 2.1125948 | 0.0483740 | 0.2909673 | 0.2552091 | GLUD1/PRKCB/ADCYAP1/TCF7L2/ITPR1/PLCB1 | 6 |
| GO:0035249 | GO:0035249 | synaptic transmission, glutamatergic | 6/439 | 113/18888 | 0.0530973 | 2.2845163 | 2.1125948 | 0.0483740 | 0.2909673 | 0.2552091 | GRIN3A/MEF2C/CNR1/SLC17A6/PLPPR4/UNC13C | 6 |
| GO:0062014 | GO:0062014 | negative regulation of small molecule metabolic process | 6/439 | 113/18888 | 0.0530973 | 2.2845163 | 2.1125948 | 0.0483740 | 0.2909673 | 0.2552091 | CNR1/APPL2/REST/TCF7L2/SIRT1/PROX1 | 6 |
| GO:0046661 | GO:0046661 | male sex differentiation | 8/439 | 173/18888 | 0.0462428 | 1.9895980 | 2.0170389 | 0.0494630 | 0.2970731 | 0.2605645 | SIX4/SRD5A1/NCOA1/CSMD1/SOX8/IL1A/AR/MAMLD1 | 8 |
| GO:0001889 | GO:0001889 | liver development | 7/439 | 143/18888 | 0.0489510 | 2.1061217 | 2.0481206 | 0.0497537 | 0.2983739 | 0.2617055 | JARID2/E2F8/SP3/SRD5A1/SMAD3/ATF2/PROX1 | 7 |
| GO:0032024 | GO:0032024 | positive regulation of insulin secretion | 5/439 | 86/18888 | 0.0581395 | 2.5014568 | 2.1527192 | 0.0500216 | 0.2994969 | 0.2626904 | GLUD1/PRKCB/TCF7L2/ITPR1/PLCB1 | 5 |
| GO:0045815 | GO:0045815 | transcription initiation-coupled chromatin remodeling | 3/439 | 36/18888 | 0.0833333 | 3.5854214 | 2.3951417 | 0.0505910 | 0.2994969 | 0.2626904 | ATF2/RBBP5/KAT2B | 3 |
| GO:0050931 | GO:0050931 | pigment cell differentiation | 3/439 | 36/18888 | 0.0833333 | 3.5854214 | 2.3951417 | 0.0505910 | 0.2994969 | 0.2626904 | MEF2C/ZEB2/MITF | 3 |
| GO:0060218 | GO:0060218 | hematopoietic stem cell differentiation | 3/439 | 36/18888 | 0.0833333 | 3.5854214 | 2.3951417 | 0.0505910 | 0.2994969 | 0.2626904 | CDK6/PUS7/TAL1 | 3 |
| GO:0060317 | GO:0060317 | cardiac epithelial to mesenchymal transition | 3/439 | 36/18888 | 0.0833333 | 3.5854214 | 2.3951417 | 0.0505910 | 0.2994969 | 0.2626904 | HEY2/JAG1/HEY1 | 3 |
| GO:0070633 | GO:0070633 | transepithelial transport | 3/439 | 36/18888 | 0.0833333 | 3.5854214 | 2.3951417 | 0.0505910 | 0.2994969 | 0.2626904 | SLC1A2/ITPR1/OSTM1 | 3 |
| GO:0001658 | GO:0001658 | branching involved in ureteric bud morphogenesis | 4/439 | 60/18888 | 0.0666667 | 2.8683371 | 2.2359192 | 0.0507068 | 0.2994969 | 0.2626904 | SIX4/SOX8/HS3ST3B1/HOXB7 | 4 |
| GO:0007080 | GO:0007080 | mitotic metaphase chromosome alignment | 4/439 | 60/18888 | 0.0666667 | 2.8683371 | 2.2359192 | 0.0507068 | 0.2994969 | 0.2626904 | RAB11A/SEH1L/CHAMP1/KAT2B | 4 |
| GO:0046686 | GO:0046686 | response to cadmium ion | 4/439 | 60/18888 | 0.0666667 | 2.8683371 | 2.2359192 | 0.0507068 | 0.2994969 | 0.2626904 | MAPK1/JUN/MAPK8/PRNP | 4 |
| GO:0007269 | GO:0007269 | neurotransmitter secretion | 7/439 | 144/18888 | 0.0486111 | 2.0914958 | 2.0281474 | 0.0513022 | 0.2994969 | 0.2626904 | SYT4/MEF2C/RAP1B/PRKCB/STXBP5/MYOF/UNC13C | 7 |
| GO:0010565 | GO:0010565 | regulation of cellular ketone metabolic process | 7/439 | 144/18888 | 0.0486111 | 2.0914958 | 2.0281474 | 0.0513022 | 0.2994969 | 0.2626904 | CNR1/APPL2/REST/CREB1/SIRT1/PROX1/KAT2B | 7 |
| GO:0034763 | GO:0034763 | negative regulation of transmembrane transport | 7/439 | 144/18888 | 0.0486111 | 2.0914958 | 2.0281474 | 0.0513022 | 0.2994969 | 0.2626904 | PPP3CA/APPL2/PRKCB/SESTD1/YWHAQ/OXSR1/PPP3R1 | 7 |
| GO:0046887 | GO:0046887 | positive regulation of hormone secretion | 7/439 | 144/18888 | 0.0486111 | 2.0914958 | 2.0281474 | 0.0513022 | 0.2994969 | 0.2626904 | GLUD1/PRKCB/ADCYAP1/CREB1/TCF7L2/ITPR1/PLCB1 | 7 |
| GO:0099643 | GO:0099643 | signal release from synapse | 7/439 | 144/18888 | 0.0486111 | 2.0914958 | 2.0281474 | 0.0513022 | 0.2994969 | 0.2626904 | SYT4/MEF2C/RAP1B/PRKCB/STXBP5/MYOF/UNC13C | 7 |
| GO:2000278 | GO:2000278 | regulation of DNA biosynthetic process | 6/439 | 115/18888 | 0.0521739 | 2.2447856 | 2.0653990 | 0.0518803 | 0.2994969 | 0.2626904 | MAPK1/KCNK2/MEAF6/TNKS2/KLF4/RGCC | 6 |
| GO:0007389 | GO:0007389 | pattern specification process | 17/439 | 474/18888 | 0.0358650 | 1.5430928 | 1.8472108 | 0.0521018 | 0.2994969 | 0.2626904 | SP8/DLX1/MEOX2/MEF2C/ARL13B/ETS2/IRX2/TSHZ1/HEY2/BCOR/SMAD3/FGFR2/APC/YY1/AR/HEY1/HOXB7 | 17 |
| GO:0003188 | GO:0003188 | heart valve formation | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | HEY2/HEY1 | 2 |
| GO:0003214 | GO:0003214 | cardiac left ventricle morphogenesis | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | HEY2/RYR2 | 2 |
| GO:0014857 | GO:0014857 | regulation of skeletal muscle cell proliferation | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | AKIRIN1/CAV2 | 2 |
| GO:0030201 | GO:0030201 | heparan sulfate proteoglycan metabolic process | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | SULF1/HS3ST3B1 | 2 |
| GO:0031649 | GO:0031649 | heat generation | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | CNR1/IL1A | 2 |
| GO:0035729 | GO:0035729 | cellular response to hepatocyte growth factor stimulus | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | APPL2/CREB1 | 2 |
| GO:0043584 | GO:0043584 | nose development | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | SIX4/PROX1 | 2 |
| GO:0060044 | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | JARID2/KCNK2 | 2 |
| GO:0060046 | GO:0060046 | regulation of acrosome reaction | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | B4GALT1/PLCB1 | 2 |
| GO:0090110 | GO:0090110 | COPII-coated vesicle cargo loading | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | SEC24B/SEC24A | 2 |
| GO:0098969 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | RAB11A/NSG1 | 2 |
| GO:0099149 | GO:0099149 | regulation of postsynaptic neurotransmitter receptor internalization | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | HIP1/PPP3R1 | 2 |
| GO:1904031 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | PROX1/RGCC | 2 |
| GO:1904177 | GO:1904177 | regulation of adipose tissue development | 2/439 | 16/18888 | 0.1250000 | 5.3781321 | 2.7025095 | 0.0521738 | 0.2994969 | 0.2626904 | NCOA1/SIRT1 | 2 |
| GO:0045786 | GO:0045786 | negative regulation of cell cycle | 15/439 | 405/18888 | 0.0370370 | 1.5935206 | 1.8625350 | 0.0523189 | 0.2999019 | 0.2630457 | CDK6/TAOK1/E2F8/FZD3/MBTPS1/ADCYAP1/SYF2/SIRT1/ATF2/PROX1/KLF4/APC/RGCC/KAT2B/TSC22D2 | 15 |
| GO:0015833 | GO:0015833 | peptide transport | 11/439 | 271/18888 | 0.0405904 | 1.7464045 | 1.9091119 | 0.0527459 | 0.3015928 | 0.2645287 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0051223 | GO:0051223 | regulation of protein transport | 16/439 | 440/18888 | 0.0363636 | 1.5645475 | 1.8483301 | 0.0527637 | 0.3015928 | 0.2645287 | SYT4/PPP3CA/GLUD1/KCNN4/CNR1/PRKCB/EPHA5/SMAD3/PDCD10/REST/TCF7L2/ITPR1/IL1A/STXBP5/SEC24A/PLCB1 | 16 |
| GO:0090090 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 7/439 | 145/18888 | 0.0482759 | 2.0770717 | 2.0083361 | 0.0528807 | 0.3018325 | 0.2647391 | SHISA3/SCYL2/CTHRC1/AMFR/TCF7L2/TMEM170B/APC | 7 |
| GO:0048545 | GO:0048545 | response to steroid hormone | 13/439 | 338/18888 | 0.0384615 | 1.6548099 | 1.8738247 | 0.0533015 | 0.3028528 | 0.2656340 | MAPK1/CNOT2/ZMIZ1/FBXO32/SRD5A1/NCOA1/SAFB/CYP7B1/REST/SLIT2/SIRT1/DDX17/AR | 13 |
| GO:0032233 | GO:0032233 | positive regulation of actin filament bundle assembly | 4/439 | 61/18888 | 0.0655738 | 2.8213152 | 2.1977931 | 0.0533118 | 0.3028528 | 0.2656340 | MTSS1/EPHA1/SMAD3/RGCC | 4 |
| GO:0051785 | GO:0051785 | positive regulation of nuclear division | 4/439 | 61/18888 | 0.0655738 | 2.8213152 | 2.1977931 | 0.0533118 | 0.3028528 | 0.2656340 | PHIP/IL1A/RGCC/PLCB1 | 4 |
| GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 6/439 | 116/18888 | 0.0517241 | 2.2254340 | 2.0421657 | 0.0536902 | 0.3028528 | 0.2656340 | RAB11A/CDK6/TAOK1/MBTPS1/SYF2/CDC25C | 6 |
| GO:0003230 | GO:0003230 | cardiac atrium development | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | HEY2/PROX1/SOS1 | 3 |
| GO:0007095 | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | TAOK1/MBTPS1/SYF2 | 3 |
| GO:0010092 | GO:0010092 | specification of animal organ identity | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | MEF2C/FGFR2/AR | 3 |
| GO:0014059 | GO:0014059 | regulation of dopamine secretion | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | SYT4/CNR1/PRKCB | 3 |
| GO:0014741 | GO:0014741 | negative regulation of muscle hypertrophy | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | JARID2/SMAD3/YY1 | 3 |
| GO:0021955 | GO:0021955 | central nervous system neuron axonogenesis | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | NR4A2/SLIT2/PAFAH1B1 | 3 |
| GO:0033144 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | CNOT2/CYP7B1/SIRT1 | 3 |
| GO:0055023 | GO:0055023 | positive regulation of cardiac muscle tissue growth | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | MEF2C/HEY2/FGFR2 | 3 |
| GO:0070306 | GO:0070306 | lens fiber cell differentiation | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | SMAD3/SPRED1/PROX1 | 3 |
| GO:0071276 | GO:0071276 | cellular response to cadmium ion | 3/439 | 37/18888 | 0.0810811 | 3.4885181 | 2.3372319 | 0.0541397 | 0.3028528 | 0.2656340 | MAPK1/JUN/MAPK8 | 3 |
| GO:0048708 | GO:0048708 | astrocyte differentiation | 5/439 | 88/18888 | 0.0568182 | 2.4446055 | 2.0952653 | 0.0542397 | 0.3028528 | 0.2656340 | MAPK1/CDK6/ZEB2/TAL1/SOX8 | 5 |
| GO:0010977 | GO:0010977 | negative regulation of neuron projection development | 7/439 | 146/18888 | 0.0479452 | 2.0628452 | 1.9886841 | 0.0544894 | 0.3028528 | 0.2656340 | EPHA7/SLIT2/NR2F1/PAFAH1B1/HDAC2/PTPRG/ITM2C | 7 |
| GO:0030177 | GO:0030177 | positive regulation of Wnt signaling pathway | 7/439 | 146/18888 | 0.0479452 | 2.0628452 | 1.9886841 | 0.0544894 | 0.3028528 | 0.2656340 | SMURF2/LYPD6/ZEB2/SMAD3/FGFR2/TNKS2/SULF1 | 7 |
| GO:0061008 | GO:0061008 | hepaticobiliary system development | 7/439 | 146/18888 | 0.0479452 | 2.0628452 | 1.9886841 | 0.0544894 | 0.3028528 | 0.2656340 | JARID2/E2F8/SP3/SRD5A1/SMAD3/ATF2/PROX1 | 7 |
| GO:0098781 | GO:0098781 | ncRNA transcription | 7/439 | 146/18888 | 0.0479452 | 2.0628452 | 1.9886841 | 0.0544894 | 0.3028528 | 0.2656340 | TEAD1/JUN/SMAD3/REST/KLF4/YY1/AR | 7 |
| GO:0017015 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 8/439 | 177/18888 | 0.0451977 | 1.9446353 | 1.9477341 | 0.0551499 | 0.3061011 | 0.2684831 | SMURF2/ZEB2/FBN1/SMAD3/SPRED1/SIRT1/CAV2/HDAC2 | 8 |
| GO:0051216 | GO:0051216 | cartilage development | 9/439 | 209/18888 | 0.0430622 | 1.8527536 | 1.9122614 | 0.0559657 | 0.3098993 | 0.2718145 | MEF2C/PTHLH/HMGA2/SMAD3/NFIA/ATF2/EFEMP1/SULF1/TRPS1 | 9 |
| GO:0060261 | GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 4/439 | 62/18888 | 0.0645161 | 2.7758101 | 2.1604324 | 0.0559883 | 0.3098993 | 0.2718145 | TAF4/GTF2A1/TAF12/MED4 | 4 |
| GO:0051783 | GO:0051783 | regulation of nuclear division | 7/439 | 147/18888 | 0.0476190 | 2.0488122 | 1.9691888 | 0.0561284 | 0.3102483 | 0.2721206 | PHIP/CAV2/APC/IL1A/RGCC/CDC25C/PLCB1 | 7 |
| GO:0000375 | GO:0000375 | RNA splicing, via transesterification reactions | 13/439 | 341/18888 | 0.0381232 | 1.6402514 | 1.8404255 | 0.0563818 | 0.3108363 | 0.2726363 | RBM39/SRSF10/SMNDC1/ZCRB1/SYF2/REST/HNRNPK/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 13 |
| GO:2000243 | GO:2000243 | positive regulation of reproductive process | 5/439 | 89/18888 | 0.0561798 | 2.4171380 | 2.0671268 | 0.0564238 | 0.3108363 | 0.2726363 | SMURF2/HDAC2/AR/CDC25C/PLCB1 | 5 |
| GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 6/439 | 118/18888 | 0.0508475 | 2.1877148 | 1.9964037 | 0.0574236 | 0.3108363 | 0.2726363 | PHIP/CAV2/APC/IL1A/RGCC/CDC25C | 6 |
| GO:0006699 | GO:0006699 | bile acid biosynthetic process | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | CYP7B1/SIRT1/PROX1 | 3 |
| GO:0031281 | GO:0031281 | positive regulation of cyclase activity | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | ADCYAP1/CACNA1D/MAPK8 | 3 |
| GO:0046688 | GO:0046688 | response to copper ion | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | TFRC/IL1A/PRNP | 3 |
| GO:0048854 | GO:0048854 | brain morphogenesis | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | FZD3/PAFAH1B1/SOS1 | 3 |
| GO:0070302 | GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | MAPK1/TAOK1/PDCD10 | 3 |
| GO:0141137 | GO:0141137 | positive regulation of gene expression, epigenetic | 3/439 | 38/18888 | 0.0789474 | 3.3967150 | 2.2812866 | 0.0578043 | 0.3108363 | 0.2726363 | ATF2/RBBP5/KAT2B | 3 |
| GO:0002076 | GO:0002076 | osteoblast development | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | PTHLH/SMAD3 | 2 |
| GO:0007379 | GO:0007379 | segment specification | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | MEOX2/IRX2 | 2 |
| GO:0007549 | GO:0007549 | sex-chromosome dosage compensation | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | JARID2/SUZ12 | 2 |
| GO:0014841 | GO:0014841 | skeletal muscle satellite cell proliferation | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | AKIRIN1/KPNA1 | 2 |
| GO:0021535 | GO:0021535 | cell migration in hindbrain | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | ARL13B/TTBK2 | 2 |
| GO:0030322 | GO:0030322 | stabilization of membrane potential | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | KCNN4/KCNK2 | 2 |
| GO:0044320 | GO:0044320 | cellular response to leptin stimulus | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | SIRT1/ADIPOR1 | 2 |
| GO:0046068 | GO:0046068 | cGMP metabolic process | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | PDE10A/RORA | 2 |
| GO:0050872 | GO:0050872 | white fat cell differentiation | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | SIRT1/ATF2 | 2 |
| GO:0060382 | GO:0060382 | regulation of DNA strand elongation | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | INO80D/YY1 | 2 |
| GO:0061548 | GO:0061548 | ganglion development | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | FZD3/SIX4 | 2 |
| GO:0098877 | GO:0098877 | neurotransmitter receptor transport to plasma membrane | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | RAB11A/NSG1 | 2 |
| GO:1902036 | GO:1902036 | regulation of hematopoietic stem cell differentiation | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | CDK6/PUS7 | 2 |
| GO:1902165 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | SIRT1/HNRNPK | 2 |
| GO:1903540 | GO:1903540 | establishment of protein localization to postsynaptic membrane | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | RAB11A/NSG1 | 2 |
| GO:1904355 | GO:1904355 | positive regulation of telomere capping | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | MAPK1/TNKS2 | 2 |
| GO:2000310 | GO:2000310 | regulation of NMDA receptor activity | 2/439 | 17/18888 | 0.1176471 | 5.0617714 | 2.5844600 | 0.0582432 | 0.3108363 | 0.2726363 | MEF2C/CRHBP | 2 |
| GO:0007422 | GO:0007422 | peripheral nervous system development | 5/439 | 90/18888 | 0.0555556 | 2.3902809 | 2.0393668 | 0.0586579 | 0.3122212 | 0.2738510 | MAPK1/PPP3R1/BDNF/SOX8/SOS1 | 5 |
| GO:0032456 | GO:0032456 | endocytic recycling | 5/439 | 90/18888 | 0.0555556 | 2.3902809 | 2.0393668 | 0.0586579 | 0.3122212 | 0.2738510 | RAB11A/RAB12/NSG1/WIPF3/VAMP4 | 5 |
| GO:0043500 | GO:0043500 | muscle adaptation | 6/439 | 119/18888 | 0.0504202 | 2.1693306 | 1.9738655 | 0.0593473 | 0.3154737 | 0.2767038 | PPP3CA/JARID2/FBXO32/HEY2/SMAD3/YY1 | 6 |
| GO:0031214 | GO:0031214 | biomineral tissue development | 8/439 | 180/18888 | 0.0444444 | 1.9122248 | 1.8969320 | 0.0596782 | 0.3168142 | 0.2778795 | ATP2B1/MEF2C/HEY2/BCOR/PTHLH/SMAD3/FGFR2/HEY1 | 8 |
| GO:0042594 | GO:0042594 | response to starvation | 9/439 | 212/18888 | 0.0424528 | 1.8265354 | 1.8668732 | 0.0601347 | 0.3188169 | 0.2796362 | MAPK1/SEH1L/JMY/STK26/SRD5A1/SIRT1/ATF2/MAP3K5/MAPK8 | 9 |
| GO:0046879 | GO:0046879 | hormone secretion | 12/439 | 311/18888 | 0.0385852 | 1.6601308 | 1.8107135 | 0.0605044 | 0.3203546 | 0.2809849 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/CREB1/TCF7L2/ITPR1/CRHBP/PLCB1 | 12 |
| GO:0007616 | GO:0007616 | long-term memory | 3/439 | 39/18888 | 0.0769231 | 3.3096198 | 2.2271833 | 0.0615831 | 0.3243593 | 0.2844974 | CPEB3/CALB1/PRNP | 3 |
| GO:0031111 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 3/439 | 39/18888 | 0.0769231 | 3.3096198 | 2.2271833 | 0.0615831 | 0.3243593 | 0.2844974 | TAOK1/TTBK2/APC | 3 |
| GO:0045746 | GO:0045746 | negative regulation of Notch signaling pathway | 3/439 | 39/18888 | 0.0769231 | 3.3096198 | 2.2271833 | 0.0615831 | 0.3243593 | 0.2844974 | DLX1/HEY2/HEY1 | 3 |
| GO:0060999 | GO:0060999 | positive regulation of dendritic spine development | 3/439 | 39/18888 | 0.0769231 | 3.3096198 | 2.2271833 | 0.0615831 | 0.3243593 | 0.2844974 | DLG5/CPEB3/PAFAH1B1 | 3 |
| GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 16/439 | 451/18888 | 0.0354767 | 1.5263878 | 1.7453250 | 0.0629272 | 0.3308960 | 0.2902308 | ARPP19/RAB11A/CDK6/TAOK1/PPP3CA/MBTPS1/APPL2/PPP6C/SYF2/NFIA/GSPT1/KLF4/APC/RGCC/CDC25C/PLCB1 | 16 |
| GO:0120161 | GO:0120161 | regulation of cold-induced thermogenesis | 7/439 | 151/18888 | 0.0463576 | 1.9945391 | 1.8927255 | 0.0629887 | 0.3308960 | 0.2902308 | ADAMTS5/EBF2/APPL2/ADCYAP1/ADIPOR1/APC/PRKAB1 | 7 |
| GO:0106027 | GO:0106027 | neuron projection organization | 5/439 | 92/18888 | 0.0543478 | 2.3383183 | 1.9849426 | 0.0632757 | 0.3312746 | 0.2905629 | DOCK10/ARHGAP33/PAFAH1B1/SIPA1L1/PRNP | 5 |
| GO:0001764 | GO:0001764 | neuron migration | 8/439 | 183/18888 | 0.0437158 | 1.8808768 | 1.8470949 | 0.0644342 | 0.3312746 | 0.2905629 | ZMIZ1/NR4A2/FZD3/MEF2C/GPM6A/PEX5/PAFAH1B1/TUBB2B | 8 |
| GO:0043534 | GO:0043534 | blood vessel endothelial cell migration | 8/439 | 183/18888 | 0.0437158 | 1.8808768 | 1.8470949 | 0.0644342 | 0.3312746 | 0.2905629 | MEOX2/MEF2C/PDCD10/SPRED1/SLIT2/SIRT1/KLF4/RGCC | 8 |
| GO:0002931 | GO:0002931 | response to ischemia | 4/439 | 65/18888 | 0.0615385 | 2.6476958 | 2.0526582 | 0.0644426 | 0.3312746 | 0.2905629 | MEF2C/REST/SOS1/MAP3K5 | 4 |
| GO:0070059 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 4/439 | 65/18888 | 0.0615385 | 2.6476958 | 2.0526582 | 0.0644426 | 0.3312746 | 0.2905629 | ITPR1/SIRT1/OPA1/MAP3K5 | 4 |
| GO:0031032 | GO:0031032 | actomyosin structure organization | 9/439 | 215/18888 | 0.0418605 | 1.8010489 | 1.8222105 | 0.0644979 | 0.3312746 | 0.2905629 | CDC42BPB/SIX4/ZEB2/EPHA1/SMAD3/PPFIA1/IQGAP2/PROX1/RGCC | 9 |
| GO:0010612 | GO:0010612 | regulation of cardiac muscle adaptation | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | PPP3CA/SMAD3 | 2 |
| GO:0010759 | GO:0010759 | positive regulation of macrophage chemotaxis | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | MAPK1/AKIRIN1 | 2 |
| GO:0016082 | GO:0016082 | synaptic vesicle priming | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | STXBP5/UNC13C | 2 |
| GO:0032874 | GO:0032874 | positive regulation of stress-activated MAPK cascade | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | TAOK1/PDCD10 | 2 |
| GO:0035728 | GO:0035728 | response to hepatocyte growth factor | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | APPL2/CREB1 | 2 |
| GO:0036035 | GO:0036035 | osteoclast development | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | FBN1/PAFAH1B1 | 2 |
| GO:0045346 | GO:0045346 | regulation of MHC class II biosynthetic process | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | SIRT1/HDAC2 | 2 |
| GO:0072189 | GO:0072189 | ureter development | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | NFIA/SOX8 | 2 |
| GO:0090281 | GO:0090281 | negative regulation of calcium ion import | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | PPP3CA/PPP3R1 | 2 |
| GO:0098751 | GO:0098751 | bone cell development | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | FBN1/PAFAH1B1 | 2 |
| GO:0099638 | GO:0099638 | endosome to plasma membrane protein transport | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | RAB11A/NSG1 | 2 |
| GO:1903242 | GO:1903242 | regulation of cardiac muscle hypertrophy in response to stress | 2/439 | 18/18888 | 0.1111111 | 4.7805619 | 2.4753350 | 0.0645426 | 0.3312746 | 0.2905629 | PPP3CA/SMAD3 | 2 |
| GO:0106106 | GO:0106106 | cold-induced thermogenesis | 7/439 | 152/18888 | 0.0460526 | 1.9814171 | 1.8739772 | 0.0647801 | 0.3316475 | 0.2908900 | ADAMTS5/EBF2/APPL2/ADCYAP1/ADIPOR1/APC/PRKAB1 | 7 |
| GO:1903531 | GO:1903531 | negative regulation of secretion by cell | 7/439 | 152/18888 | 0.0460526 | 1.9814171 | 1.8739772 | 0.0647801 | 0.3316475 | 0.2908900 | RAB33B/SYT4/PPP3CA/RAP1B/CNR1/REST/CRHBP | 7 |
| GO:0030278 | GO:0030278 | regulation of ossification | 6/439 | 122/18888 | 0.0491803 | 2.1159864 | 1.9075692 | 0.0653468 | 0.3330817 | 0.2921479 | MAPK1/ATP2B1/MEF2C/GDF10/BCOR/SMAD3 | 6 |
| GO:0045471 | GO:0045471 | response to ethanol | 6/439 | 122/18888 | 0.0491803 | 2.1159864 | 1.9075692 | 0.0653468 | 0.3330817 | 0.2921479 | GRIN3A/CNR1/PRKCB/FGFR2/CRHBP/HDAC2 | 6 |
| GO:0043403 | GO:0043403 | skeletal muscle tissue regeneration | 3/439 | 40/18888 | 0.0750000 | 3.2268793 | 2.1748102 | 0.0654741 | 0.3330817 | 0.2921479 | AKIRIN1/KPNA1/PPP3CA | 3 |
| GO:0052652 | GO:0052652 | cyclic purine nucleotide metabolic process | 3/439 | 40/18888 | 0.0750000 | 3.2268793 | 2.1748102 | 0.0654741 | 0.3330817 | 0.2921479 | PDE10A/RORA/PTHLH | 3 |
| GO:1901532 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 3/439 | 40/18888 | 0.0750000 | 3.2268793 | 2.1748102 | 0.0654741 | 0.3330817 | 0.2921479 | CDK6/PUS7/SOS1 | 3 |
| GO:0048167 | GO:0048167 | regulation of synaptic plasticity | 9/439 | 216/18888 | 0.0416667 | 1.7927107 | 1.8074801 | 0.0659957 | 0.3353115 | 0.2941036 | MAPK1/SYT4/MEF2C/NSG1/CPEB3/CALB1/SIPA1L1/UNC13C/PRNP | 9 |
| GO:0015800 | GO:0015800 | acidic amino acid transport | 4/439 | 66/18888 | 0.0606061 | 2.6075792 | 2.0180820 | 0.0674009 | 0.3416990 | 0.2997062 | SYT4/SLC6A6/SLC1A2/SLC17A6 | 4 |
| GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 6/439 | 123/18888 | 0.0487805 | 2.0987833 | 1.8858956 | 0.0674227 | 0.3416990 | 0.2997062 | MAPK1/AKIRIN1/OXSR1/SLIT2/STK10/PLCB1 | 6 |
| GO:0001942 | GO:0001942 | hair follicle development | 5/439 | 94/18888 | 0.0531915 | 2.2885669 | 1.9319176 | 0.0680925 | 0.3437944 | 0.3015440 | PUM2/FZD3/FGFR2/HDAC2/SOS1 | 5 |
| GO:0043502 | GO:0043502 | regulation of muscle adaptation | 5/439 | 94/18888 | 0.0531915 | 2.2885669 | 1.9319176 | 0.0680925 | 0.3437944 | 0.3015440 | PPP3CA/JARID2/FBXO32/SMAD3/YY1 | 5 |
| GO:0050848 | GO:0050848 | regulation of calcium-mediated signaling | 5/439 | 94/18888 | 0.0531915 | 2.2885669 | 1.9319176 | 0.0680925 | 0.3437944 | 0.3015440 | PPP3CA/CAMTA1/PPP3R1/ITPR1/PRNP | 5 |
| GO:0042552 | GO:0042552 | myelination | 7/439 | 154/18888 | 0.0454545 | 1.9556844 | 1.8369060 | 0.0684547 | 0.3451903 | 0.3027684 | MAPK1/SBF2/SCN2A/CNTN1/PPP3R1/SERINC5/SOS1 | 7 |
| GO:0051222 | GO:0051222 | positive regulation of protein transport | 10/439 | 251/18888 | 0.0398406 | 1.7141457 | 1.7569646 | 0.0692868 | 0.3470608 | 0.3044091 | GLUD1/KCNN4/PRKCB/SMAD3/PDCD10/TCF7L2/ITPR1/IL1A/SEC24A/PLCB1 | 10 |
| GO:0048736 | GO:0048736 | appendage development | 8/439 | 186/18888 | 0.0430108 | 1.8505401 | 1.7981858 | 0.0694195 | 0.3470608 | 0.3044091 | SP8/MEOX2/MBNL1/NFIA/FGFR2/HDAC2/KAT2B/PRKAB1 | 8 |
| GO:0051302 | GO:0051302 | regulation of cell division | 8/439 | 186/18888 | 0.0430108 | 1.8505401 | 1.7981858 | 0.0694195 | 0.3470608 | 0.3044091 | RAB11A/YBX1/E2F8/AHCTF1/FGFR2/TAL1/IL1A/KAT2B | 8 |
| GO:0060173 | GO:0060173 | limb development | 8/439 | 186/18888 | 0.0430108 | 1.8505401 | 1.7981858 | 0.0694195 | 0.3470608 | 0.3044091 | SP8/MEOX2/MBNL1/NFIA/FGFR2/HDAC2/KAT2B/PRKAB1 | 8 |
| GO:0009187 | GO:0009187 | cyclic nucleotide metabolic process | 3/439 | 41/18888 | 0.0731707 | 3.1481749 | 2.1240649 | 0.0694750 | 0.3470608 | 0.3044091 | PDE10A/RORA/PTHLH | 3 |
| GO:0030851 | GO:0030851 | granulocyte differentiation | 3/439 | 41/18888 | 0.0731707 | 3.1481749 | 2.1240649 | 0.0694750 | 0.3470608 | 0.3044091 | SP3/L3MBTL3/TAL1 | 3 |
| GO:0071634 | GO:0071634 | regulation of transforming growth factor beta production | 3/439 | 41/18888 | 0.0731707 | 3.1481749 | 2.1240649 | 0.0694750 | 0.3470608 | 0.3044091 | SMAD3/CD46/ATF2 | 3 |
| GO:0048285 | GO:0048285 | organelle fission | 17/439 | 493/18888 | 0.0344828 | 1.4836227 | 1.6784466 | 0.0695157 | 0.3470608 | 0.3044091 | RAB11A/SEH1L/SMC3/PHIP/NFIA/CAV2/KIF2A/CHAMP1/APC/IL1A/RGCC/OPA1/KAT2B/CDC25C/FOXJ3/DDHD1/PLCB1 | 17 |
| GO:0097193 | GO:0097193 | intrinsic apoptotic signaling pathway | 12/439 | 319/18888 | 0.0376176 | 1.6184974 | 1.7185664 | 0.0702621 | 0.3473745 | 0.3046842 | SGMS1/SCN2A/PRKRA/JMY/PDCD10/ITPR1/SIRT1/HNRNPK/ATF2/PLAGL2/OPA1/MAP3K5 | 12 |
| GO:0000288 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | CNOT2/CNOT6L/YBX1/CPEB3 | 4 |
| GO:0034605 | GO:0034605 | cellular response to heat | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | SIRT1/IL1A/HDAC2/TFEC | 4 |
| GO:0048857 | GO:0048857 | neural nucleus development | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | GLUD1/SEC24B/YWHAQ/ATF2 | 4 |
| GO:0060675 | GO:0060675 | ureteric bud morphogenesis | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | SIX4/SOX8/HS3ST3B1/HOXB7 | 4 |
| GO:0061180 | GO:0061180 | mammary gland epithelium development | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | MAPK1/FGFR2/CSMD1/AR | 4 |
| GO:0070301 | GO:0070301 | cellular response to hydrogen peroxide | 4/439 | 67/18888 | 0.0597015 | 2.5686601 | 1.9841397 | 0.0704285 | 0.3473745 | 0.3046842 | SIRT1/KLF4/HDAC2/MAP3K5 | 4 |
| GO:0046330 | GO:0046330 | positive regulation of JNK cascade | 5/439 | 95/18888 | 0.0526316 | 2.2644767 | 1.9059079 | 0.0705751 | 0.3473745 | 0.3046842 | NRK/TAOK1/IL1A/MAP3K5/PLCB1 | 5 |
| GO:0001829 | GO:0001829 | trophectodermal cell differentiation | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | CNOT2/SP3 | 2 |
| GO:0006144 | GO:0006144 | purine nucleobase metabolic process | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | GART/ADK | 2 |
| GO:0009168 | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | GART/ADK | 2 |
| GO:0016202 | GO:0016202 | regulation of striated muscle tissue development | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | SMAD3/CREB1 | 2 |
| GO:0035372 | GO:0035372 | protein localization to microtubule | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | TTBK2/CHAMP1 | 2 |
| GO:0045342 | GO:0045342 | MHC class II biosynthetic process | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | SIRT1/HDAC2 | 2 |
| GO:0060039 | GO:0060039 | pericardium development | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | SMAD3/SOS1 | 2 |
| GO:0060602 | GO:0060602 | branch elongation of an epithelium | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | SIX4/FGFR2 | 2 |
| GO:1904505 | GO:1904505 | regulation of telomere maintenance in response to DNA damage | 2/439 | 19/18888 | 0.1052632 | 4.5289534 | 2.3739721 | 0.0710581 | 0.3473745 | 0.3046842 | INO80D/YY1 | 2 |
| GO:0046890 | GO:0046890 | regulation of lipid biosynthetic process | 8/439 | 187/18888 | 0.0427807 | 1.8406441 | 1.7820830 | 0.0711324 | 0.3473745 | 0.3046842 | MBTPS1/REST/CREB1/SIRT1/PROX1/SEC14L2/IL1A/KAT2B | 8 |
| GO:0043542 | GO:0043542 | endothelial cell migration | 11/439 | 286/18888 | 0.0384615 | 1.6548099 | 1.7212571 | 0.0714834 | 0.3484000 | 0.3055837 | MEOX2/MEF2C/RIN2/ZEB2/PDCD10/SPRED1/SLIT2/SIRT1/PROX1/KLF4/RGCC | 11 |
| GO:0002065 | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 6/439 | 125/18888 | 0.0480000 | 2.0652027 | 1.8431619 | 0.0716887 | 0.3484000 | 0.3055837 | DLG5/CDK6/JAG1/FGFR2/PROX1/KLF4 | 6 |
| GO:0022612 | GO:0022612 | gland morphogenesis | 6/439 | 125/18888 | 0.0480000 | 2.0652027 | 1.8431619 | 0.0716887 | 0.3484000 | 0.3055837 | CYP7B1/FGFR2/CSMD1/PROX1/SULF1/AR | 6 |
| GO:1903305 | GO:1903305 | regulation of regulated secretory pathway | 6/439 | 125/18888 | 0.0480000 | 2.0652027 | 1.8431619 | 0.0716887 | 0.3484000 | 0.3055837 | SYT4/RAP1B/PRKCB/REST/SCAMP5/STXBP5 | 6 |
| GO:0060541 | GO:0060541 | respiratory system development | 9/439 | 220/18888 | 0.0409091 | 1.7601160 | 1.7493215 | 0.0722052 | 0.3494497 | 0.3065043 | MAPK1/DLG5/SP3/SIX4/CREB1/FGFR2/SEC24B/PPP3R1/PROX1 | 9 |
| GO:0007272 | GO:0007272 | ensheathment of neurons | 7/439 | 156/18888 | 0.0448718 | 1.9306115 | 1.8003875 | 0.0722520 | 0.3494497 | 0.3065043 | MAPK1/SBF2/SCN2A/CNTN1/PPP3R1/SERINC5/SOS1 | 7 |
| GO:0008366 | GO:0008366 | axon ensheathment | 7/439 | 156/18888 | 0.0448718 | 1.9306115 | 1.8003875 | 0.0722520 | 0.3494497 | 0.3065043 | MAPK1/SBF2/SCN2A/CNTN1/PPP3R1/SERINC5/SOS1 | 7 |
| GO:0043535 | GO:0043535 | regulation of blood vessel endothelial cell migration | 7/439 | 156/18888 | 0.0448718 | 1.9306115 | 1.8003875 | 0.0722520 | 0.3494497 | 0.3065043 | MEOX2/MEF2C/PDCD10/SPRED1/SIRT1/KLF4/RGCC | 7 |
| GO:0017157 | GO:0017157 | regulation of exocytosis | 8/439 | 188/18888 | 0.0425532 | 1.8308535 | 1.7660781 | 0.0728708 | 0.3508312 | 0.3077160 | RAB33B/SYT4/RAB12/RAP1B/PRKCB/REST/SCAMP5/STXBP5 | 8 |
| GO:0016079 | GO:0016079 | synaptic vesicle exocytosis | 5/439 | 96/18888 | 0.0520833 | 2.2408884 | 1.8802222 | 0.0731071 | 0.3508312 | 0.3077160 | SYT4/RAP1B/PRKCB/STXBP5/UNC13C | 5 |
| GO:0042982 | GO:0042982 | amyloid precursor protein metabolic process | 5/439 | 96/18888 | 0.0520833 | 2.2408884 | 1.8802222 | 0.0731071 | 0.3508312 | 0.3077160 | LRRTM3/NSG1/RANBP9/ITM2C/PRNP | 5 |
| GO:0010611 | GO:0010611 | regulation of cardiac muscle hypertrophy | 4/439 | 68/18888 | 0.0588235 | 2.5308857 | 1.9508090 | 0.0735247 | 0.3508312 | 0.3077160 | PPP3CA/JARID2/SMAD3/YY1 | 4 |
| GO:0035019 | GO:0035019 | somatic stem cell population maintenance | 4/439 | 68/18888 | 0.0588235 | 2.5308857 | 1.9508090 | 0.0735247 | 0.3508312 | 0.3077160 | REST/TAL1/KLF4/RIF1 | 4 |
| GO:0050854 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 4/439 | 68/18888 | 0.0588235 | 2.5308857 | 1.9508090 | 0.0735247 | 0.3508312 | 0.3077160 | KCNN4/PRKCB/ELF1/PRNP | 4 |
| GO:0051123 | GO:0051123 | RNA polymerase II preinitiation complex assembly | 4/439 | 68/18888 | 0.0588235 | 2.5308857 | 1.9508090 | 0.0735247 | 0.3508312 | 0.3077160 | TAF4/GTF2A1/TAF12/MED4 | 4 |
| GO:0072171 | GO:0072171 | mesonephric tubule morphogenesis | 4/439 | 68/18888 | 0.0588235 | 2.5308857 | 1.9508090 | 0.0735247 | 0.3508312 | 0.3077160 | SIX4/SOX8/HS3ST3B1/HOXB7 | 4 |
| GO:0014044 | GO:0014044 | Schwann cell development | 3/439 | 42/18888 | 0.0714286 | 3.0732184 | 2.0748535 | 0.0735839 | 0.3508312 | 0.3077160 | MAPK1/PPP3R1/SOS1 | 3 |
| GO:0014046 | GO:0014046 | dopamine secretion | 3/439 | 42/18888 | 0.0714286 | 3.0732184 | 2.0748535 | 0.0735839 | 0.3508312 | 0.3077160 | SYT4/CNR1/PRKCB | 3 |
| GO:0045922 | GO:0045922 | negative regulation of fatty acid metabolic process | 3/439 | 42/18888 | 0.0714286 | 3.0732184 | 2.0748535 | 0.0735839 | 0.3508312 | 0.3077160 | CNR1/APPL2/SIRT1 | 3 |
| GO:0051154 | GO:0051154 | negative regulation of striated muscle cell differentiation | 3/439 | 42/18888 | 0.0714286 | 3.0732184 | 2.0748535 | 0.0735839 | 0.3508312 | 0.3077160 | YBX1/BDNF/YY1 | 3 |
| GO:0000956 | GO:0000956 | nuclear-transcribed mRNA catabolic process | 6/439 | 126/18888 | 0.0476190 | 2.0488122 | 1.8220940 | 0.0738786 | 0.3518194 | 0.3085828 | CNOT2/CNOT6L/YBX1/CPEB3/GSPT1/PNRC1 | 6 |
| GO:0009914 | GO:0009914 | hormone transport | 12/439 | 322/18888 | 0.0372671 | 1.6034183 | 1.6846689 | 0.0741699 | 0.3527892 | 0.3094335 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/CREB1/TCF7L2/ITPR1/CRHBP/PLCB1 | 12 |
| GO:0007548 | GO:0007548 | sex differentiation | 11/439 | 288/18888 | 0.0381944 | 1.6433181 | 1.6970432 | 0.0742664 | 0.3528309 | 0.3094701 | TAF4/SIX4/SRD5A1/NCOA1/CSMD1/SLIT2/SIRT1/SOX8/IL1A/AR/MAMLD1 | 11 |
| GO:0007032 | GO:0007032 | endosome organization | 5/439 | 97/18888 | 0.0515464 | 2.2177864 | 1.8548525 | 0.0756880 | 0.3565610 | 0.3127417 | HOOK3/RAB11A/WASHC4/PLEKHF2/VAMP4 | 5 |
| GO:0022404 | GO:0022404 | molting cycle process | 5/439 | 97/18888 | 0.0515464 | 2.2177864 | 1.8548525 | 0.0756880 | 0.3565610 | 0.3127417 | PUM2/FZD3/FGFR2/HDAC2/SOS1 | 5 |
| GO:0022405 | GO:0022405 | hair cycle process | 5/439 | 97/18888 | 0.0515464 | 2.2177864 | 1.8548525 | 0.0756880 | 0.3565610 | 0.3127417 | PUM2/FZD3/FGFR2/HDAC2/SOS1 | 5 |
| GO:0051153 | GO:0051153 | regulation of striated muscle cell differentiation | 5/439 | 97/18888 | 0.0515464 | 2.2177864 | 1.8548525 | 0.0756880 | 0.3565610 | 0.3127417 | YBX1/MEF2C/PROX1/BDNF/YY1 | 5 |
| GO:0030282 | GO:0030282 | bone mineralization | 6/439 | 127/18888 | 0.0472441 | 2.0326799 | 1.8012206 | 0.0761063 | 0.3565610 | 0.3127417 | ATP2B1/MEF2C/BCOR/PTHLH/SMAD3/FGFR2 | 6 |
| GO:0030512 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 6/439 | 127/18888 | 0.0472441 | 2.0326799 | 1.8012206 | 0.0761063 | 0.3565610 | 0.3127417 | SMURF2/FBN1/SPRED1/SIRT1/CAV2/HDAC2 | 6 |
| GO:0071902 | GO:0071902 | positive regulation of protein serine/threonine kinase activity | 6/439 | 127/18888 | 0.0472441 | 2.0326799 | 1.8012206 | 0.0761063 | 0.3565610 | 0.3127417 | HMGA2/PDCD10/SIRT1/PROX1/RGCC/MAP3K5 | 6 |
| GO:2001056 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 6/439 | 127/18888 | 0.0472441 | 2.0326799 | 1.8012206 | 0.0761063 | 0.3565610 | 0.3127417 | HIP1/SMAD3/REST/SIRT1/MAP3K5/ST18 | 6 |
| GO:2000116 | GO:2000116 | regulation of cysteine-type endopeptidase activity | 8/439 | 190/18888 | 0.0421053 | 1.8115813 | 1.7343575 | 0.0764246 | 0.3565610 | 0.3127417 | EPHA7/HIP1/SMAD3/REST/SIRT1/KLF4/MAP3K5/ST18 | 8 |
| GO:0032007 | GO:0032007 | negative regulation of TOR signaling | 4/439 | 69/18888 | 0.0579710 | 2.4942062 | 1.9180686 | 0.0766889 | 0.3565610 | 0.3127417 | MTM1/SEH1L/SIRT1/UBR1 | 4 |
| GO:0045911 | GO:0045911 | positive regulation of DNA recombination | 4/439 | 69/18888 | 0.0579710 | 2.4942062 | 1.9180686 | 0.0766889 | 0.3565610 | 0.3127417 | TFRC/MEAF6/EPC1/RIF1 | 4 |
| GO:0003002 | GO:0003002 | regionalization | 15/439 | 429/18888 | 0.0349650 | 1.5043726 | 1.6300593 | 0.0771576 | 0.3565610 | 0.3127417 | SP8/DLX1/MEOX2/MEF2C/ARL13B/ETS2/IRX2/TSHZ1/HEY2/SMAD3/FGFR2/YY1/AR/HEY1/HOXB7 | 15 |
| GO:0031589 | GO:0031589 | cell-substrate adhesion | 13/439 | 359/18888 | 0.0362117 | 1.5580104 | 1.6466105 | 0.0773962 | 0.3565610 | 0.3127417 | CDK6/RIN2/EGFL6/EPHA1/SMAD3/EPHA3/JAG1/DOCK1/FBLN2/PPFIA1/PIP5K1A/AJAP1/EDIL3 | 13 |
| GO:0002755 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | IRAK3/IRAK2 | 2 |
| GO:0003215 | GO:0003215 | cardiac right ventricle morphogenesis | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | HEY2/JAG1 | 2 |
| GO:0007413 | GO:0007413 | axonal fasciculation | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | CNR1/EPHA3 | 2 |
| GO:0021516 | GO:0021516 | dorsal spinal cord development | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | PROX1/TAL1 | 2 |
| GO:0032253 | GO:0032253 | dense core granule localization | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | SYT4/UNC13C | 2 |
| GO:0039535 | GO:0039535 | regulation of RIG-I signaling pathway | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | PUM2/PUM1 | 2 |
| GO:0048643 | GO:0048643 | positive regulation of skeletal muscle tissue development | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | MTM1/MEF2C | 2 |
| GO:0055062 | GO:0055062 | phosphate ion homeostasis | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | SLC17A6/SLC34A2 | 2 |
| GO:0060216 | GO:0060216 | definitive hemopoiesis | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | SP3/TAL1 | 2 |
| GO:0070304 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | TAOK1/PDCD10 | 2 |
| GO:0071391 | GO:0071391 | cellular response to estrogen stimulus | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | CRHBP/AR | 2 |
| GO:0072662 | GO:0072662 | protein localization to peroxisome | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | PEX5/PEX3 | 2 |
| GO:0072663 | GO:0072663 | establishment of protein localization to peroxisome | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | PEX5/PEX3 | 2 |
| GO:0106030 | GO:0106030 | neuron projection fasciculation | 2/439 | 20/18888 | 0.1000000 | 4.3025057 | 2.2794128 | 0.0777762 | 0.3565610 | 0.3127417 | CNR1/EPHA3 | 2 |
| GO:0006476 | GO:0006476 | protein deacetylation | 3/439 | 43/18888 | 0.0697674 | 3.0017482 | 2.0270895 | 0.0777983 | 0.3565610 | 0.3127417 | SPRED1/SIRT1/KAT2B | 3 |
| GO:0010453 | GO:0010453 | regulation of cell fate commitment | 3/439 | 43/18888 | 0.0697674 | 3.0017482 | 2.0270895 | 0.0777983 | 0.3565610 | 0.3127417 | GATAD2B/HDAC2/AR | 3 |
| GO:0061001 | GO:0061001 | regulation of dendritic spine morphogenesis | 3/439 | 43/18888 | 0.0697674 | 3.0017482 | 2.0270895 | 0.0777983 | 0.3565610 | 0.3127417 | ARHGAP33/PAFAH1B1/SIPA1L1 | 3 |
| GO:1900077 | GO:1900077 | negative regulation of cellular response to insulin stimulus | 3/439 | 43/18888 | 0.0697674 | 3.0017482 | 2.0270895 | 0.0777983 | 0.3565610 | 0.3127417 | PTPRE/APPL2/PRKCB | 3 |
| GO:0048284 | GO:0048284 | organelle fusion | 7/439 | 159/18888 | 0.0440252 | 1.8941849 | 1.7466100 | 0.0781778 | 0.3578924 | 0.3139095 | VAV3/SYT4/RAB12/TFRC/CAV2/VAMP4/OPA1 | 7 |
| GO:0002042 | GO:0002042 | cell migration involved in sprouting angiogenesis | 5/439 | 98/18888 | 0.0510204 | 2.1951560 | 1.8297913 | 0.0783179 | 0.3579665 | 0.3139745 | MEOX2/PDCD10/SPRED1/SLIT2/KLF4 | 5 |
| GO:0002761 | GO:0002761 | regulation of myeloid leukocyte differentiation | 6/439 | 128/18888 | 0.0468750 | 2.0167995 | 1.7805380 | 0.0783719 | 0.3579665 | 0.3139745 | CDK6/PPP3CA/FBN1/CREB1/TAL1/MITF | 6 |
| GO:0019216 | GO:0019216 | regulation of lipid metabolic process | 12/439 | 326/18888 | 0.0368098 | 1.5837444 | 1.6400100 | 0.0795937 | 0.3627838 | 0.3181997 | MBTPS1/CNR1/APPL2/RORA/REST/CREB1/SIRT1/ADIPOR1/PROX1/SEC14L2/IL1A/KAT2B | 12 |
| GO:0032922 | GO:0032922 | circadian regulation of gene expression | 4/439 | 70/18888 | 0.0571429 | 2.4585747 | 1.8858984 | 0.0799205 | 0.3627838 | 0.3181997 | KDM5A/RORA/SIRT1/HDAC2 | 4 |
| GO:0046626 | GO:0046626 | regulation of insulin receptor signaling pathway | 4/439 | 70/18888 | 0.0571429 | 2.4585747 | 1.8858984 | 0.0799205 | 0.3627838 | 0.3181997 | PTPRE/PRKCB/SIRT1/ADIPOR1 | 4 |
| GO:2000573 | GO:2000573 | positive regulation of DNA biosynthetic process | 4/439 | 70/18888 | 0.0571429 | 2.4585747 | 1.8858984 | 0.0799205 | 0.3627838 | 0.3181997 | MAPK1/TNKS2/KLF4/RGCC | 4 |
| GO:2001233 | GO:2001233 | regulation of apoptotic signaling pathway | 14/439 | 396/18888 | 0.0353535 | 1.5210879 | 1.6165679 | 0.0799463 | 0.3627838 | 0.3181997 | SGMS1/NR4A2/PHIP/PRKRA/TCF7L2/SIRT1/HNRNPK/PLAGL2/BDNF/SGK3/IL1A/OPA1/AR/ITM2C | 14 |
| GO:0007015 | GO:0007015 | actin filament organization | 16/439 | 467/18888 | 0.0342612 | 1.4740919 | 1.6002642 | 0.0799675 | 0.3627838 | 0.3181997 | MTSS1/WASHC4/JMY/ZEB2/WIPF3/HIP1/EPHA1/SMAD3/SH3KBP1/PPFIA1/IQGAP2/SLIT2/PROX1/MEGF9/RGCC/RHOT1 | 16 |
| GO:0046777 | GO:0046777 | protein autophosphorylation | 8/439 | 192/18888 | 0.0416667 | 1.7927107 | 1.7030144 | 0.0800809 | 0.3628891 | 0.3182921 | RAP2C/TAOK1/EPHA7/STK26/EPHA1/FGFR2/OXSR1/STK10 | 8 |
| GO:0060041 | GO:0060041 | retina development in camera-type eye | 7/439 | 160/18888 | 0.0437500 | 1.8823462 | 1.7289430 | 0.0802142 | 0.3630845 | 0.3184635 | DLX1/ATP2B2/GPM6A/NFIA/CALB1/PROX1/SOX8 | 7 |
| GO:0045739 | GO:0045739 | positive regulation of DNA repair | 6/439 | 129/18888 | 0.0465116 | 2.0011654 | 1.7600427 | 0.0806751 | 0.3643509 | 0.3195743 | INO80D/MEAF6/SIRT1/EPC1/YY1/RIF1 | 6 |
| GO:0098773 | GO:0098773 | skin epidermis development | 6/439 | 129/18888 | 0.0465116 | 2.0011654 | 1.7600427 | 0.0806751 | 0.3643509 | 0.3195743 | PUM2/FZD3/FGFR2/KLF4/HDAC2/SOS1 | 6 |
| GO:1901342 | GO:1901342 | regulation of vasculature development | 13/439 | 362/18888 | 0.0359116 | 1.5450987 | 1.6153475 | 0.0813303 | 0.3667429 | 0.3216723 | PRKCB/ANGPTL7/EGLN1/EPHA1/HMGA2/PDCD10/SPRED1/SIRT1/ATF2/KLF4/SULF1/IL1A/RGCC | 13 |
| GO:0030324 | GO:0030324 | lung development | 8/439 | 193/18888 | 0.0414508 | 1.7834220 | 1.6874816 | 0.0819475 | 0.3667429 | 0.3216723 | MAPK1/DLG5/SP3/CREB1/FGFR2/SEC24B/PPP3R1/PROX1 | 8 |
| GO:0010907 | GO:0010907 | positive regulation of glucose metabolic process | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | ARPP19/SIRT1/KAT2B | 3 |
| GO:0030501 | GO:0030501 | positive regulation of bone mineralization | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | ATP2B1/MEF2C/SMAD3 | 3 |
| GO:0030890 | GO:0030890 | positive regulation of B cell proliferation | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | VAV3/TFRC/MEF2C | 3 |
| GO:0045840 | GO:0045840 | positive regulation of mitotic nuclear division | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | PHIP/IL1A/RGCC | 3 |
| GO:0060443 | GO:0060443 | mammary gland morphogenesis | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | FGFR2/CSMD1/AR | 3 |
| GO:0071604 | GO:0071604 | transforming growth factor beta production | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | SMAD3/CD46/ATF2 | 3 |
| GO:0090114 | GO:0090114 | COPII-coated vesicle budding | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | PPP6C/SEC24B/SEC24A | 3 |
| GO:1903539 | GO:1903539 | protein localization to postsynaptic membrane | 3/439 | 44/18888 | 0.0681818 | 2.9335266 | 1.9806935 | 0.0821161 | 0.3667429 | 0.3216723 | RAB11A/NSG1/GPC6 | 3 |
| GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 6/439 | 130/18888 | 0.0461538 | 1.9857719 | 1.7397312 | 0.0830159 | 0.3683991 | 0.3231250 | RAB11A/TAL1/RGCC/PAFAH1B1/CDC25C/PLCB1 | 6 |
| GO:0014743 | GO:0014743 | regulation of muscle hypertrophy | 4/439 | 71/18888 | 0.0563380 | 2.4239469 | 1.8542791 | 0.0832188 | 0.3683991 | 0.3231250 | PPP3CA/JARID2/SMAD3/YY1 | 4 |
| GO:0019933 | GO:0019933 | cAMP-mediated signaling | 4/439 | 71/18888 | 0.0563380 | 2.4239469 | 1.8542791 | 0.0832188 | 0.3683991 | 0.3231250 | PDE10A/EPHA5/ADCYAP1/CREB1 | 4 |
| GO:0032206 | GO:0032206 | positive regulation of telomere maintenance | 4/439 | 71/18888 | 0.0563380 | 2.4239469 | 1.8542791 | 0.0832188 | 0.3683991 | 0.3231250 | MAPK1/INO80D/TNKS2/YY1 | 4 |
| GO:0045670 | GO:0045670 | regulation of osteoclast differentiation | 4/439 | 71/18888 | 0.0563380 | 2.4239469 | 1.8542791 | 0.0832188 | 0.3683991 | 0.3231250 | PPP3CA/FBN1/CREB1/MITF | 4 |
| GO:0045859 | GO:0045859 | regulation of protein kinase activity | 16/439 | 470/18888 | 0.0340426 | 1.4646828 | 1.5736626 | 0.0834685 | 0.3683991 | 0.3231250 | RAP2C/TAB2/CCNT2/ADCYAP1/EPHA1/HMGA2/PDCD10/SPRED1/SIRT1/PROX1/APC/RGCC/IRAK3/MAP3K5/CDC25C/PRNP | 16 |
| GO:0034766 | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 5/439 | 100/18888 | 0.0500000 | 2.1512528 | 1.7805648 | 0.0837230 | 0.3683991 | 0.3231250 | PPP3CA/SESTD1/YWHAQ/OXSR1/PPP3R1 | 5 |
| GO:0051310 | GO:0051310 | metaphase chromosome alignment | 5/439 | 100/18888 | 0.0500000 | 2.1512528 | 1.7805648 | 0.0837230 | 0.3683991 | 0.3231250 | RAB11A/SEH1L/CHAMP1/APC/KAT2B | 5 |
| GO:2001237 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 5/439 | 100/18888 | 0.0500000 | 2.1512528 | 1.7805648 | 0.0837230 | 0.3683991 | 0.3231250 | PHIP/TCF7L2/SGK3/IL1A/AR | 5 |
| GO:0000729 | GO:0000729 | DNA double-strand break processing | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | RNF138/SMARCAD1 | 2 |
| GO:0009127 | GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | GART/ADK | 2 |
| GO:0010829 | GO:0010829 | negative regulation of glucose transmembrane transport | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | APPL2/PRKCB | 2 |
| GO:0032482 | GO:0032482 | Rab protein signal transduction | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | RAB33B/RAB12 | 2 |
| GO:0033962 | GO:0033962 | P-body assembly | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | CNOT2/CNOT6L | 2 |
| GO:0042474 | GO:0042474 | middle ear morphogenesis | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | PRKRA/TSHZ1 | 2 |
| GO:0043586 | GO:0043586 | tongue development | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | SIX4/HDAC2 | 2 |
| GO:0044321 | GO:0044321 | response to leptin | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | SIRT1/ADIPOR1 | 2 |
| GO:0046128 | GO:0046128 | purine ribonucleoside metabolic process | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | ADK/ENPP4 | 2 |
| GO:0048670 | GO:0048670 | regulation of collateral sprouting | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | EPHA7/BDNF | 2 |
| GO:0048791 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | SYT4/UNC13C | 2 |
| GO:0050849 | GO:0050849 | negative regulation of calcium-mediated signaling | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | ITPR1/PRNP | 2 |
| GO:0051988 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | APC/KAT2B | 2 |
| GO:0097709 | GO:0097709 | connective tissue replacement | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | PPP3CA/IL1A | 2 |
| GO:2000047 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin | 2/439 | 21/18888 | 0.0952381 | 4.0976245 | 2.1908585 | 0.0846842 | 0.3683991 | 0.3231250 | RGCC/EPCAM | 2 |
| GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 10/439 | 262/18888 | 0.0381679 | 1.6421777 | 1.6146315 | 0.0863004 | 0.3714391 | 0.3257914 | CDK6/PPP3CA/APPL2/PPP6C/GSPT1/NPAT/KLF4/APC/RGCC/PLCB1 | 10 |
| GO:0042542 | GO:0042542 | response to hydrogen peroxide | 5/439 | 101/18888 | 0.0495050 | 2.1299533 | 1.7563853 | 0.0864977 | 0.3714391 | 0.3257914 | STK26/SIRT1/KLF4/HDAC2/MAP3K5 | 5 |
| GO:0043543 | GO:0043543 | protein acylation | 5/439 | 101/18888 | 0.0495050 | 2.1299533 | 1.7563853 | 0.0864977 | 0.3714391 | 0.3257914 | TAOK1/KAT6A/SIRT1/HDAC2/KAT2B | 5 |
| GO:0033574 | GO:0033574 | response to testosterone | 3/439 | 45/18888 | 0.0666667 | 2.8683371 | 1.9355920 | 0.0865349 | 0.3714391 | 0.3257914 | SRD5A1/SIRT1/AR | 3 |
| GO:0048701 | GO:0048701 | embryonic cranial skeleton morphogenesis | 3/439 | 45/18888 | 0.0666667 | 2.8683371 | 1.9355920 | 0.0865349 | 0.3714391 | 0.3257914 | SIX4/SMAD3/FGFR2 | 3 |
| GO:0060428 | GO:0060428 | lung epithelium development | 3/439 | 45/18888 | 0.0666667 | 2.8683371 | 1.9355920 | 0.0865349 | 0.3714391 | 0.3257914 | CREB1/FGFR2/PPP3R1 | 3 |
| GO:0062237 | GO:0062237 | protein localization to postsynapse | 3/439 | 45/18888 | 0.0666667 | 2.8683371 | 1.9355920 | 0.0865349 | 0.3714391 | 0.3257914 | RAB11A/NSG1/GPC6 | 3 |
| GO:0090278 | GO:0090278 | negative regulation of peptide hormone secretion | 3/439 | 45/18888 | 0.0666667 | 2.8683371 | 1.9355920 | 0.0865349 | 0.3714391 | 0.3257914 | PPP3CA/REST/CRHBP | 3 |
| GO:0002067 | GO:0002067 | glandular epithelial cell differentiation | 4/439 | 72/18888 | 0.0555556 | 2.3902809 | 1.8231924 | 0.0865830 | 0.3714391 | 0.3257914 | CDK6/FGFR2/PROX1/KLF4 | 4 |
| GO:0003143 | GO:0003143 | embryonic heart tube morphogenesis | 4/439 | 72/18888 | 0.0555556 | 2.3902809 | 1.8231924 | 0.0865830 | 0.3714391 | 0.3257914 | MEF2C/ARL13B/SMAD3/RYR2 | 4 |
| GO:0030514 | GO:0030514 | negative regulation of BMP signaling pathway | 4/439 | 72/18888 | 0.0555556 | 2.3902809 | 1.8231924 | 0.0865830 | 0.3714391 | 0.3257914 | DLX1/SMURF2/FBN1/UBE2D3 | 4 |
| GO:0042698 | GO:0042698 | ovulation cycle | 4/439 | 72/18888 | 0.0555556 | 2.3902809 | 1.8231924 | 0.0865830 | 0.3714391 | 0.3257914 | GDF10/NCOA1/SLIT2/SIRT1 | 4 |
| GO:0061035 | GO:0061035 | regulation of cartilage development | 4/439 | 72/18888 | 0.0555556 | 2.3902809 | 1.8231924 | 0.0865830 | 0.3714391 | 0.3257914 | PTHLH/SMAD3/EFEMP1/TRPS1 | 4 |
| GO:0099173 | GO:0099173 | postsynapse organization | 8/439 | 196/18888 | 0.0408163 | 1.7561248 | 1.6414247 | 0.0877006 | 0.3758332 | 0.3296455 | DLG5/EPHA7/DOCK10/ARHGAP33/CNKSR2/PAFAH1B1/SIPA1L1/PRNP | 8 |
| GO:0000018 | GO:0000018 | regulation of DNA recombination | 6/439 | 132/18888 | 0.0454545 | 1.9556844 | 1.6996468 | 0.0878096 | 0.3759000 | 0.3297041 | TFRC/KPNA1/MEAF6/EPC1/SMARCAD1/RIF1 | 6 |
| GO:0007584 | GO:0007584 | response to nutrient | 7/439 | 164/18888 | 0.0426829 | 1.8364354 | 1.6595194 | 0.0886649 | 0.3783536 | 0.3318561 | TFRC/CNR1/PRKCB/NCOA1/SRSF2/IL1A/KAT2B | 7 |
| GO:0046488 | GO:0046488 | phosphatidylinositol metabolic process | 7/439 | 164/18888 | 0.0426829 | 1.8364354 | 1.6595194 | 0.0886649 | 0.3783536 | 0.3318561 | MTM1/SOCS6/IPMK/MTMR12/PIP5K1A/DDHD1/PLCB1 | 7 |
| GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 7/439 | 164/18888 | 0.0426829 | 1.8364354 | 1.6595194 | 0.0886649 | 0.3783536 | 0.3318561 | MAPK1/VAV3/TFRC/PPP3CA/MEF2C/CD46/IL1A | 7 |
| GO:0051091 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 9/439 | 230/18888 | 0.0391304 | 1.6835892 | 1.6089920 | 0.0892654 | 0.3799409 | 0.3332484 | TFRC/JMY/EPHA5/SMAD3/ATF2/RGCC/IRAK3/IRAK2/AR | 9 |
| GO:0019080 | GO:0019080 | viral gene expression | 5/439 | 102/18888 | 0.0490196 | 2.1090714 | 1.7324862 | 0.0893201 | 0.3799409 | 0.3332484 | CCNT2/SPCS3/JUN/HMGA2/REST | 5 |
| GO:2000177 | GO:2000177 | regulation of neural precursor cell proliferation | 5/439 | 102/18888 | 0.0490196 | 2.1090714 | 1.7324862 | 0.0893201 | 0.3799409 | 0.3332484 | FZD3/TAFA1/APPL2/PROX1/VCAN | 5 |
| GO:0030323 | GO:0030323 | respiratory tube development | 8/439 | 197/18888 | 0.0406091 | 1.7472104 | 1.6262492 | 0.0896694 | 0.3810240 | 0.3341984 | MAPK1/DLG5/SP3/CREB1/FGFR2/SEC24B/PPP3R1/PROX1 | 8 |
| GO:0033143 | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | 4/439 | 73/18888 | 0.0547945 | 2.3575374 | 1.7926209 | 0.0900123 | 0.3810946 | 0.3342603 | CNOT2/CYP7B1/SIRT1/AR | 4 |
| GO:0021782 | GO:0021782 | glial cell development | 6/439 | 133/18888 | 0.0451128 | 1.9409800 | 1.6798675 | 0.0902623 | 0.3810946 | 0.3342603 | MAPK1/CDK6/ZEB2/CNTN1/PPP3R1/SOS1 | 6 |
| GO:0043271 | GO:0043271 | negative regulation of monoatomic ion transport | 6/439 | 133/18888 | 0.0451128 | 1.9409800 | 1.6798675 | 0.0902623 | 0.3810946 | 0.3342603 | PPP3CA/CNR1/SESTD1/YWHAQ/OXSR1/PPP3R1 | 6 |
| GO:0048593 | GO:0048593 | camera-type eye morphogenesis | 6/439 | 133/18888 | 0.0451128 | 1.9409800 | 1.6798675 | 0.0902623 | 0.3810946 | 0.3342603 | SP3/JAG1/CALB1/PROX1/SOX8/YY1 | 6 |
| GO:0035051 | GO:0035051 | cardiocyte differentiation | 7/439 | 165/18888 | 0.0424242 | 1.8253054 | 1.6424657 | 0.0908534 | 0.3810946 | 0.3342603 | MAPK1/MEF2C/HEY2/JAG1/REST/PROX1/YY1 | 7 |
| GO:0050905 | GO:0050905 | neuromuscular process | 7/439 | 165/18888 | 0.0424242 | 1.8253054 | 1.6424657 | 0.0908534 | 0.3810946 | 0.3342603 | GRIN3A/CAMTA1/CSMD1/ITPR1/PEX5/RBFOX1/PAFAH1B1 | 7 |
| GO:0002792 | GO:0002792 | negative regulation of peptide secretion | 3/439 | 46/18888 | 0.0652174 | 2.8059820 | 1.8917170 | 0.0910522 | 0.3810946 | 0.3342603 | PPP3CA/REST/CRHBP | 3 |
| GO:0050856 | GO:0050856 | regulation of T cell receptor signaling pathway | 3/439 | 46/18888 | 0.0652174 | 2.8059820 | 1.8917170 | 0.0910522 | 0.3810946 | 0.3342603 | KCNN4/ELF1/PRNP | 3 |
| GO:0070588 | GO:0070588 | calcium ion transmembrane transport | 12/439 | 334/18888 | 0.0359281 | 1.5458104 | 1.5524714 | 0.0911776 | 0.3810946 | 0.3342603 | GRIN3A/PPP3CA/ATP2B1/SESTD1/ATP2B2/GPM6A/PPP3R1/ITPR1/RYR2/CACNA1D/PLCB1/PRNP | 12 |
| GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8/439 | 198/18888 | 0.0404040 | 1.7383861 | 1.6111605 | 0.0916637 | 0.3810946 | 0.3342603 | DLX1/SMURF2/FBN1/UBE2D3/SPRED1/SIRT1/CAV2/HDAC2 | 8 |
| GO:0002433 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | VAV3/APPL2 | 2 |
| GO:0010566 | GO:0010566 | regulation of ketone biosynthetic process | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | REST/CREB1 | 2 |
| GO:0015919 | GO:0015919 | peroxisomal membrane transport | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | PEX5/PEX3 | 2 |
| GO:0023019 | GO:0023019 | signal transduction involved in regulation of gene expression | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | SMAD3/EPCAM | 2 |
| GO:0035584 | GO:0035584 | calcium-mediated signaling using intracellular calcium source | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | RYR2/PRNP | 2 |
| GO:0038096 | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | VAV3/APPL2 | 2 |
| GO:0043249 | GO:0043249 | erythrocyte maturation | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | L3MBTL3/TAL1 | 2 |
| GO:0043574 | GO:0043574 | peroxisomal transport | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | PEX5/PEX3 | 2 |
| GO:0060008 | GO:0060008 | Sertoli cell differentiation | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | SOX8/IL1A | 2 |
| GO:0060444 | GO:0060444 | branching involved in mammary gland duct morphogenesis | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | CSMD1/AR | 2 |
| GO:0060713 | GO:0060713 | labyrinthine layer morphogenesis | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | NCOA1/FGFR2 | 2 |
| GO:0072234 | GO:0072234 | metanephric nephron tubule development | 2/439 | 22/18888 | 0.0909091 | 3.9113688 | 2.1076378 | 0.0917696 | 0.3810946 | 0.3342603 | CALB1/SOX8 | 2 |
| GO:0099175 | GO:0099175 | regulation of postsynapse organization | 5/439 | 103/18888 | 0.0485437 | 2.0885950 | 1.7088608 | 0.0921898 | 0.3824453 | 0.3354450 | EPHA7/ARHGAP33/PAFAH1B1/SIPA1L1/PRNP | 5 |
| GO:0032535 | GO:0032535 | regulation of cellular component size | 13/439 | 370/18888 | 0.0351351 | 1.5116912 | 1.5333422 | 0.0924346 | 0.3830656 | 0.3359890 | PUM2/RAB11A/VAV3/EPHA7/KCNN4/CREB1/CDH4/OXSR1/SLIT2/MEGF9/BDNF/PAFAH1B1/CLNS1A | 13 |
| GO:0062207 | GO:0062207 | regulation of pattern recognition receptor signaling pathway | 7/439 | 166/18888 | 0.0421687 | 1.8143096 | 1.6255294 | 0.0930721 | 0.3853108 | 0.3379584 | PUM2/HCFC2/APPL2/PPP6C/PUM1/IRAK3/MAPK8 | 7 |
| GO:0050795 | GO:0050795 | regulation of behavior | 4/439 | 74/18888 | 0.0540541 | 2.3256788 | 1.7625479 | 0.0935058 | 0.3867085 | 0.3391843 | SGIP1/MEF2C/CNR1/HDAC2 | 4 |
| GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 10/439 | 267/18888 | 0.0374532 | 1.6114254 | 1.5521186 | 0.0948032 | 0.3908729 | 0.3428369 | MAPK1/VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 10 |
| GO:0071900 | GO:0071900 | regulation of protein serine/threonine kinase activity | 10/439 | 267/18888 | 0.0374532 | 1.6114254 | 1.5521186 | 0.0948032 | 0.3908729 | 0.3428369 | CCNT2/HMGA2/PDCD10/SIRT1/PROX1/APC/RGCC/IRAK3/MAP3K5/CDC25C | 10 |
| GO:0010469 | GO:0010469 | regulation of signaling receptor activity | 5/439 | 104/18888 | 0.0480769 | 2.0685124 | 1.6855029 | 0.0951065 | 0.3908729 | 0.3428369 | MEF2C/TAFA1/CRHBP/HDAC2/CNRIP1 | 5 |
| GO:0030879 | GO:0030879 | mammary gland development | 6/439 | 135/18888 | 0.0444444 | 1.9122248 | 1.6408191 | 0.0952783 | 0.3908729 | 0.3428369 | MAPK1/NCOA1/CREB1/FGFR2/CSMD1/AR | 6 |
| GO:0010952 | GO:0010952 | positive regulation of peptidase activity | 7/439 | 167/18888 | 0.0419162 | 1.8034455 | 1.6087089 | 0.0953209 | 0.3908729 | 0.3428369 | HIP1/SMAD3/REST/SIRT1/MAP3K5/TANK/ST18 | 7 |
| GO:0006953 | GO:0006953 | acute-phase response | 3/439 | 47/18888 | 0.0638298 | 2.7462802 | 1.8490056 | 0.0956655 | 0.3908729 | 0.3428369 | TFRC/CNR1/IL1A | 3 |
| GO:0006984 | GO:0006984 | ER-nucleus signaling pathway | 3/439 | 47/18888 | 0.0638298 | 2.7462802 | 1.8490056 | 0.0956655 | 0.3908729 | 0.3428369 | MBTPS1/AMFR/TMEM33 | 3 |
| GO:0010824 | GO:0010824 | regulation of centrosome duplication | 3/439 | 47/18888 | 0.0638298 | 2.7462802 | 1.8490056 | 0.0956655 | 0.3908729 | 0.3428369 | CEP120/SIRT1/KAT2B | 3 |
| GO:0060119 | GO:0060119 | inner ear receptor cell development | 3/439 | 47/18888 | 0.0638298 | 2.7462802 | 1.8490056 | 0.0956655 | 0.3908729 | 0.3428369 | CTHRC1/SEC24B/PAFAH1B1 | 3 |
| GO:1900271 | GO:1900271 | regulation of long-term synaptic potentiation | 3/439 | 47/18888 | 0.0638298 | 2.7462802 | 1.8490056 | 0.0956655 | 0.3908729 | 0.3428369 | NSG1/CALB1/PRNP | 3 |
| GO:0071248 | GO:0071248 | cellular response to metal ion | 8/439 | 200/18888 | 0.0400000 | 1.7210023 | 1.5812391 | 0.0957283 | 0.3908729 | 0.3428369 | MAPK1/SYT4/MEF2C/JUN/CREB1/CRHBP/MAPK8/PRNP | 8 |
| GO:0000377 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 12/439 | 337/18888 | 0.0356083 | 1.5320495 | 1.5202348 | 0.0957755 | 0.3908729 | 0.3428369 | RBM39/SRSF10/ZCRB1/SYF2/REST/HNRNPK/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 12 |
| GO:0000398 | GO:0000398 | mRNA splicing, via spliceosome | 12/439 | 337/18888 | 0.0356083 | 1.5320495 | 1.5202348 | 0.0957755 | 0.3908729 | 0.3428369 | RBM39/SRSF10/ZCRB1/SYF2/REST/HNRNPK/RBFOX1/SFSWAP/SRSF2/DDX17/CLNS1A/RBM23 | 12 |
| GO:0009410 | GO:0009410 | response to xenobiotic stimulus | 15/439 | 444/18888 | 0.0337838 | 1.4535492 | 1.4918175 | 0.0960574 | 0.3916260 | 0.3434975 | VAV3/TFRC/SS18/FZD3/MEF2C/PRKCB/SLC1A2/SRD5A1/RORA/REST/CREB1/OXSR1/CRHBP/HDAC2/PRNP | 15 |
| GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 9/439 | 234/18888 | 0.0384615 | 1.6548099 | 1.5547641 | 0.0967044 | 0.3938647 | 0.3454610 | CDK6/PPP3CA/APPL2/PPP6C/GSPT1/KLF4/APC/RGCC/PLCB1 | 9 |
| GO:0090287 | GO:0090287 | regulation of cellular response to growth factor stimulus | 13/439 | 373/18888 | 0.0348525 | 1.4995328 | 1.5030863 | 0.0968295 | 0.3939756 | 0.3455583 | DLX1/SMURF2/PRKCB/ZEB2/FBN1/UBE2D3/SMAD3/SPRED1/SLIT2/SIRT1/CAV2/SULF1/HDAC2 | 13 |
| GO:0033674 | GO:0033674 | positive regulation of kinase activity | 11/439 | 303/18888 | 0.0363036 | 1.5619658 | 1.5211682 | 0.0973131 | 0.3955435 | 0.3469335 | TAB2/ADCYAP1/EPHA1/HMGA2/PDCD10/FGFR2/SIRT1/PROX1/RGCC/MAP3K5/PRNP | 11 |
| GO:0030509 | GO:0030509 | BMP signaling pathway | 7/439 | 168/18888 | 0.0416667 | 1.7927107 | 1.5920026 | 0.0975997 | 0.3963079 | 0.3476039 | DLX1/SMURF2/FBN1/UBE2D3/NFIA/ATF2/SULF1 | 7 |
| GO:0110020 | GO:0110020 | regulation of actomyosin structure organization | 5/439 | 105/18888 | 0.0476190 | 2.0488122 | 1.6624066 | 0.0980698 | 0.3968706 | 0.3480975 | EPHA1/SMAD3/PPFIA1/PROX1/RGCC | 5 |
| GO:0000280 | GO:0000280 | nuclear division | 15/439 | 446/18888 | 0.0336323 | 1.4470311 | 1.4737657 | 0.0987781 | 0.3968706 | 0.3480975 | RAB11A/SEH1L/SMC3/PHIP/NFIA/CAV2/KIF2A/CHAMP1/APC/IL1A/RGCC/KAT2B/CDC25C/FOXJ3/PLCB1 | 15 |
| GO:0006925 | GO:0006925 | inflammatory cell apoptotic process | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | MEF2C/SIRT1 | 2 |
| GO:0010560 | GO:0010560 | positive regulation of glycoprotein biosynthetic process | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | TCF7L2/PLCB1 | 2 |
| GO:0021533 | GO:0021533 | cell differentiation in hindbrain | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | RORA/PROX1 | 2 |
| GO:0030220 | GO:0030220 | platelet formation | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | MEF2C/TAL1 | 2 |
| GO:0031290 | GO:0031290 | retinal ganglion cell axon guidance | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | EPHA7/SLIT2 | 2 |
| GO:0032252 | GO:0032252 | secretory granule localization | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | SYT4/UNC13C | 2 |
| GO:0040019 | GO:0040019 | positive regulation of embryonic development | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | PAFAH1B1/PLCB1 | 2 |
| GO:0046033 | GO:0046033 | AMP metabolic process | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | GART/ADK | 2 |
| GO:0046058 | GO:0046058 | cAMP metabolic process | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | PDE10A/PTHLH | 2 |
| GO:0046599 | GO:0046599 | regulation of centriole replication | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | CEP120/KAT2B | 2 |
| GO:0051151 | GO:0051151 | negative regulation of smooth muscle cell differentiation | 2/439 | 23/18888 | 0.0869565 | 3.7413093 | 2.0291815 | 0.0990204 | 0.3968706 | 0.3480975 | HEY2/HEY1 | 2 |
| GO:1903829 | GO:1903829 | positive regulation of protein localization | 16/439 | 483/18888 | 0.0331263 | 1.4252607 | 1.4604551 | 0.0997761 | 0.3992364 | 0.3501726 | TFRC/CEP120/GLUD1/KCNN4/PRKCB/UBE2D3/SMAD3/EPHA3/PDCD10/TCF7L2/ITPR1/APC/IL1A/SEC24A/PLCB1/PRNP | 16 |
| GO:0001935 | GO:0001935 | endothelial cell proliferation | 8/439 | 202/18888 | 0.0396040 | 1.7039627 | 1.5516525 | 0.0998942 | 0.3992364 | 0.3501726 | MEF2C/ZEB2/PDCD10/SIRT1/CAV2/PROX1/SULF1/RGCC | 8 |
| GO:1990845 | GO:1990845 | adaptive thermogenesis | 7/439 | 169/18888 | 0.0414201 | 1.7821030 | 1.5754089 | 0.0999083 | 0.3992364 | 0.3501726 | ADAMTS5/EBF2/APPL2/ADCYAP1/ADIPOR1/APC/PRKAB1 | 7 |
| GO:0035850 | GO:0035850 | epithelial cell differentiation involved in kidney development | 3/439 | 48/18888 | 0.0625000 | 2.6890661 | 1.8073994 | 0.1003723 | 0.3997761 | 0.3506459 | MTSS1/MEF2C/JAG1 | 3 |
| GO:0090279 | GO:0090279 | regulation of calcium ion import | 3/439 | 48/18888 | 0.0625000 | 2.6890661 | 1.8073994 | 0.1003723 | 0.3997761 | 0.3506459 | PPP3CA/PPP3R1/PRNP | 3 |
| GO:1902459 | GO:1902459 | positive regulation of stem cell population maintenance | 3/439 | 48/18888 | 0.0625000 | 2.6890661 | 1.8073994 | 0.1003723 | 0.3997761 | 0.3506459 | SS18/REST/HDAC2 | 3 |
| GO:0090288 | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 6/439 | 137/18888 | 0.0437956 | 1.8843091 | 1.6024315 | 0.1004408 | 0.3997761 | 0.3506459 | DLX1/SMURF2/FBN1/UBE2D3/SLIT2/SULF1 | 6 |
| GO:0002260 | GO:0002260 | lymphocyte homeostasis | 4/439 | 76/18888 | 0.0526316 | 2.2644767 | 1.7038347 | 0.1006823 | 0.3999464 | 0.3507953 | DOCK10/MEF2C/SLC40A1/SOS1 | 4 |
| GO:0030968 | GO:0030968 | endoplasmic reticulum unfolded protein response | 4/439 | 76/18888 | 0.0526316 | 2.2644767 | 1.7038347 | 0.1006823 | 0.3999464 | 0.3507953 | PARP8/MBTPS1/AMFR/TMEM33 | 4 |
| GO:0019395 | GO:0019395 | fatty acid oxidation | 5/439 | 106/18888 | 0.0471698 | 2.0294838 | 1.6395659 | 0.1010793 | 0.4003376 | 0.3511384 | CNR1/APPL2/ADIPOR1/PEX5/HADHB | 5 |
| GO:0030148 | GO:0030148 | sphingolipid biosynthetic process | 5/439 | 106/18888 | 0.0471698 | 2.0294838 | 1.6395659 | 0.1010793 | 0.4003376 | 0.3511384 | SGMS1/PRKD3/PPM1L/SPTSSA/CERS6 | 5 |
| GO:0048709 | GO:0048709 | oligodendrocyte differentiation | 5/439 | 106/18888 | 0.0471698 | 2.0294838 | 1.6395659 | 0.1010793 | 0.4003376 | 0.3511384 | DLX1/SUZ12/CNTN1/SOX8/HDAC2 | 5 |
| GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 9/439 | 237/18888 | 0.0379747 | 1.6338629 | 1.5147669 | 0.1025128 | 0.4056161 | 0.3557682 | VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 9 |
| GO:0032231 | GO:0032231 | regulation of actin filament bundle assembly | 5/439 | 107/18888 | 0.0467290 | 2.0105167 | 1.6169752 | 0.1041345 | 0.4113273 | 0.3607776 | MTSS1/EPHA1/SMAD3/PPFIA1/RGCC | 5 |
| GO:0120032 | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 8/439 | 204/18888 | 0.0392157 | 1.6872571 | 1.5223929 | 0.1041607 | 0.4113273 | 0.3607776 | RAB11A/AKIRIN1/CEP120/AGRN/ATMIN/GPM6A/SLIT2/APC | 8 |
| GO:0014037 | GO:0014037 | Schwann cell differentiation | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | MAPK1/PPP3R1/SOS1 | 3 |
| GO:0048066 | GO:0048066 | developmental pigmentation | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | MEF2C/ZEB2/MITF | 3 |
| GO:0048538 | GO:0048538 | thymus development | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | MAPK1/JARID2/SIX4 | 3 |
| GO:0061028 | GO:0061028 | establishment of endothelial barrier | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | RAP2C/RAP1B/PLCB1 | 3 |
| GO:0098927 | GO:0098927 | vesicle-mediated transport between endosomal compartments | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | MAPK1/HOOK3/RAB11A | 3 |
| GO:0099054 | GO:0099054 | presynapse assembly | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | LRRTM3/SLITRK4/CNTN5 | 3 |
| GO:1903170 | GO:1903170 | negative regulation of calcium ion transmembrane transport | 3/439 | 49/18888 | 0.0612245 | 2.6341872 | 1.7668442 | 0.1051702 | 0.4124803 | 0.3617888 | PPP3CA/SESTD1/PPP3R1 | 3 |
| GO:0007623 | GO:0007623 | circadian rhythm | 8/439 | 205/18888 | 0.0390244 | 1.6790266 | 1.5078834 | 0.1063314 | 0.4149758 | 0.3639777 | KDM5A/PSPC1/RORA/CREB1/SIRT1/PROX1/HDAC2/MAPK8 | 8 |
| GO:0010640 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2/439 | 24/18888 | 0.0833333 | 3.5854214 | 1.9550029 | 0.1064252 | 0.4149758 | 0.3639777 | HIP1/PTPN12 | 2 |
| GO:0030539 | GO:0030539 | male genitalia development | 2/439 | 24/18888 | 0.0833333 | 3.5854214 | 1.9550029 | 0.1064252 | 0.4149758 | 0.3639777 | SRD5A1/AR | 2 |
| GO:0035357 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 2/439 | 24/18888 | 0.0833333 | 3.5854214 | 1.9550029 | 0.1064252 | 0.4149758 | 0.3639777 | NCOA1/SIRT1 | 2 |
| GO:0046628 | GO:0046628 | positive regulation of insulin receptor signaling pathway | 2/439 | 24/18888 | 0.0833333 | 3.5854214 | 1.9550029 | 0.1064252 | 0.4149758 | 0.3639777 | SIRT1/ADIPOR1 | 2 |
| GO:0048634 | GO:0048634 | regulation of muscle organ development | 2/439 | 24/18888 | 0.0833333 | 3.5854214 | 1.9550029 | 0.1064252 | 0.4149758 | 0.3639777 | SMAD3/CREB1 | 2 |
| GO:0039531 | GO:0039531 | regulation of cytoplasmic pattern recognition receptor signaling pathway | 5/439 | 108/18888 | 0.0462963 | 1.9919008 | 1.5946290 | 0.1072350 | 0.4177286 | 0.3663922 | PUM2/HCFC2/PPP6C/PUM1/MAPK8 | 5 |
| GO:0010827 | GO:0010827 | regulation of glucose transmembrane transport | 4/439 | 78/18888 | 0.0512821 | 2.2064132 | 1.6469344 | 0.1081053 | 0.4198993 | 0.3682961 | ARPP19/APPL2/PRKCB/SLC1A2 | 4 |
| GO:0050772 | GO:0050772 | positive regulation of axonogenesis | 4/439 | 78/18888 | 0.0512821 | 2.2064132 | 1.6469344 | 0.1081053 | 0.4198993 | 0.3682961 | CDH4/SLIT2/BDNF/PAFAH1B1 | 4 |
| GO:0051101 | GO:0051101 | regulation of DNA binding | 4/439 | 78/18888 | 0.0512821 | 2.2064132 | 1.6469344 | 0.1081053 | 0.4198993 | 0.3682961 | JUN/HEY2/HMGA2/MAPK8 | 4 |
| GO:0048813 | GO:0048813 | dendrite morphogenesis | 6/439 | 140/18888 | 0.0428571 | 1.8439310 | 1.5460404 | 0.1084550 | 0.4203205 | 0.3686655 | PPP3CA/DOCK10/PREX2/ARHGAP33/PAFAH1B1/SIPA1L1 | 6 |
| GO:0065004 | GO:0065004 | protein-DNA complex assembly | 9/439 | 240/18888 | 0.0375000 | 1.6134396 | 1.4753283 | 0.1085164 | 0.4203205 | 0.3686655 | TAF4/HIRA/KAT6A/GTF2A1/HEY2/TAF12/TCF4/SPTY2D1/MED4 | 9 |
| GO:0060491 | GO:0060491 | regulation of cell projection assembly | 8/439 | 206/18888 | 0.0388350 | 1.6708760 | 1.4934528 | 0.1085271 | 0.4203205 | 0.3686655 | RAB11A/AKIRIN1/CEP120/AGRN/ATMIN/GPM6A/SLIT2/APC | 8 |
| GO:0051048 | GO:0051048 | negative regulation of secretion | 7/439 | 173/18888 | 0.0404624 | 1.7408983 | 1.5101290 | 0.1094389 | 0.4233910 | 0.3713587 | RAB33B/SYT4/PPP3CA/RAP1B/CNR1/REST/CRHBP | 7 |
| GO:0007215 | GO:0007215 | glutamate receptor signaling pathway | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | GRIN3A/PLCB1/PRNP | 3 |
| GO:0035094 | GO:0035094 | response to nicotine | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | MAPK1/CNR1/HDAC2 | 3 |
| GO:0043330 | GO:0043330 | response to exogenous dsRNA | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | MAPK1/HCFC2/IRAK3 | 3 |
| GO:0045747 | GO:0045747 | positive regulation of Notch signaling pathway | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | ZMIZ1/JAG1/PDCD10 | 3 |
| GO:0060071 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | SMURF2/FZD3/CTHRC1 | 3 |
| GO:0071320 | GO:0071320 | cellular response to cAMP | 3/439 | 50/18888 | 0.0600000 | 2.5815034 | 1.7272893 | 0.1100564 | 0.4233910 | 0.3713587 | RAP1B/SRD5A1/CRHBP | 3 |
| GO:0002526 | GO:0002526 | acute inflammatory response | 5/439 | 109/18888 | 0.0458716 | 1.9736265 | 1.5725220 | 0.1103804 | 0.4237105 | 0.3716390 | TFRC/ASH1L/CNR1/B4GALT1/IL1A | 5 |
| GO:0061387 | GO:0061387 | regulation of extent of cell growth | 5/439 | 109/18888 | 0.0458716 | 1.9736265 | 1.5725220 | 0.1103804 | 0.4237105 | 0.3716390 | PUM2/EPHA7/CDH4/BDNF/PAFAH1B1 | 5 |
| GO:0007160 | GO:0007160 | cell-matrix adhesion | 9/439 | 241/18888 | 0.0373444 | 1.6067449 | 1.4623034 | 0.1105607 | 0.4237105 | 0.3716390 | CDK6/RIN2/EPHA1/SMAD3/EPHA3/JAG1/PPFIA1/PIP5K1A/AJAP1 | 9 |
| GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 9/439 | 241/18888 | 0.0373444 | 1.6067449 | 1.4623034 | 0.1105607 | 0.4237105 | 0.3716390 | VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 9 |
| GO:0042886 | GO:0042886 | amide transport | 11/439 | 312/18888 | 0.0352564 | 1.5169091 | 1.4201777 | 0.1129850 | 0.4270272 | 0.3745480 | PPP3CA/GLUD1/CNR1/PRKCB/EPHA5/ADCYAP1/REST/TCF7L2/ITPR1/CRHBP/PLCB1 | 11 |
| GO:0050851 | GO:0050851 | antigen receptor-mediated signaling pathway | 8/439 | 208/18888 | 0.0384615 | 1.6548099 | 1.4648252 | 0.1129927 | 0.4270272 | 0.3745480 | MAPK1/VAV3/MEF2C/KCNN4/PRKCB/ELF1/SOS1/PRNP | 8 |
| GO:0001708 | GO:0001708 | cell fate specification | 5/439 | 110/18888 | 0.0454545 | 1.9556844 | 1.5506490 | 0.1135701 | 0.4270272 | 0.3745480 | GATAD2B/NFIA/APC/HDAC2/AR | 5 |
| GO:2001252 | GO:2001252 | positive regulation of chromosome organization | 5/439 | 110/18888 | 0.0454545 | 1.9556844 | 1.5506490 | 0.1135701 | 0.4270272 | 0.3745480 | MAPK1/INO80D/TNKS2/TAL1/YY1 | 5 |
| GO:0006887 | GO:0006887 | exocytosis | 12/439 | 348/18888 | 0.0344828 | 1.4836227 | 1.4046520 | 0.1138181 | 0.4270272 | 0.3745480 | RAB11A/RAB33B/SYT4/RAB12/RAP1B/PRKCB/WIPF3/REST/CRHBP/SCAMP5/STXBP5/UNC13C | 12 |
| GO:0032496 | GO:0032496 | response to lipopolysaccharide | 12/439 | 348/18888 | 0.0344828 | 1.4836227 | 1.4046520 | 0.1138181 | 0.4270272 | 0.3745480 | MAPK1/TAB2/FBXO3/MEF2C/CNR1/FGFR2/IL1A/IRAK3/HDAC2/IRAK2/MAPK8/HADHB | 12 |
| GO:0030859 | GO:0030859 | polarized epithelial cell differentiation | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | DLG5/AJAP1 | 2 |
| GO:0032331 | GO:0032331 | negative regulation of chondrocyte differentiation | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | PTHLH/EFEMP1 | 2 |
| GO:0033617 | GO:0033617 | mitochondrial cytochrome c oxidase assembly | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | COX18/COX16 | 2 |
| GO:0034453 | GO:0034453 | microtubule anchoring | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | HOOK3/CEP350 | 2 |
| GO:0036344 | GO:0036344 | platelet morphogenesis | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | MEF2C/TAL1 | 2 |
| GO:0043567 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | PHIP/AR | 2 |
| GO:0045540 | GO:0045540 | regulation of cholesterol biosynthetic process | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | MBTPS1/SEC14L2 | 2 |
| GO:0050860 | GO:0050860 | negative regulation of T cell receptor signaling pathway | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | ELF1/PRNP | 2 |
| GO:0060117 | GO:0060117 | auditory receptor cell development | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | SEC24B/PAFAH1B1 | 2 |
| GO:0060964 | GO:0060964 | regulation of miRNA-mediated gene silencing | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | PUM2/PUM1 | 2 |
| GO:0071676 | GO:0071676 | negative regulation of mononuclear cell migration | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | SLIT2/PLCB1 | 2 |
| GO:0072170 | GO:0072170 | metanephric tubule development | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | CALB1/SOX8 | 2 |
| GO:0072243 | GO:0072243 | metanephric nephron epithelium development | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | CALB1/SOX8 | 2 |
| GO:0090280 | GO:0090280 | positive regulation of calcium ion import | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | PPP3CA/PPP3R1 | 2 |
| GO:0106118 | GO:0106118 | regulation of sterol biosynthetic process | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | MBTPS1/SEC14L2 | 2 |
| GO:1902993 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | LRRTM3/RANBP9 | 2 |
| GO:1905523 | GO:1905523 | positive regulation of macrophage migration | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | MAPK1/AKIRIN1 | 2 |
| GO:2000178 | GO:2000178 | negative regulation of neural precursor cell proliferation | 2/439 | 25/18888 | 0.0800000 | 3.4420046 | 1.8846835 | 0.1139730 | 0.4270272 | 0.3745480 | APPL2/PROX1 | 2 |
| GO:0060560 | GO:0060560 | developmental growth involved in morphogenesis | 9/439 | 243/18888 | 0.0370370 | 1.5935206 | 1.4364321 | 0.1147134 | 0.4281909 | 0.3755688 | PUM2/SYT4/EPHA7/SIX4/FGFR2/CDH4/SLIT2/BDNF/PAFAH1B1 | 9 |
| GO:0051146 | GO:0051146 | striated muscle cell differentiation | 11/439 | 313/18888 | 0.0351438 | 1.5120627 | 1.4091533 | 0.1148109 | 0.4281909 | 0.3755688 | ADAMTS5/YBX1/PPP3CA/MEF2C/SIX4/HEY2/DOCK1/CAV2/PROX1/BDNF/YY1 | 11 |
| GO:0008206 | GO:0008206 | bile acid metabolic process | 3/439 | 51/18888 | 0.0588235 | 2.5308857 | 1.6886876 | 0.1150284 | 0.4281909 | 0.3755688 | CYP7B1/SIRT1/PROX1 | 3 |
| GO:0010719 | GO:0010719 | negative regulation of epithelial to mesenchymal transition | 3/439 | 51/18888 | 0.0588235 | 2.5308857 | 1.6886876 | 0.1150284 | 0.4281909 | 0.3755688 | USF3/SPRED1/ADIPOR1 | 3 |
| GO:0050885 | GO:0050885 | neuromuscular process controlling balance | 3/439 | 51/18888 | 0.0588235 | 2.5308857 | 1.6886876 | 0.1150284 | 0.4281909 | 0.3755688 | CAMTA1/RBFOX1/PAFAH1B1 | 3 |
| GO:0051496 | GO:0051496 | positive regulation of stress fiber assembly | 3/439 | 51/18888 | 0.0588235 | 2.5308857 | 1.6886876 | 0.1150284 | 0.4281909 | 0.3755688 | EPHA1/SMAD3/RGCC | 3 |
| GO:0071622 | GO:0071622 | regulation of granulocyte chemotaxis | 3/439 | 51/18888 | 0.0588235 | 2.5308857 | 1.6886876 | 0.1150284 | 0.4281909 | 0.3755688 | MAPK1/AKIRIN1/SLIT2 | 3 |
| GO:0042113 | GO:0042113 | B cell activation | 10/439 | 278/18888 | 0.0359712 | 1.5476639 | 1.4190271 | 0.1151933 | 0.4284085 | 0.3757596 | VAV3/TFRC/SP3/DOCK10/MEF2C/KLF6/PRKCB/SH3KBP1/YY1/RIF1 | 10 |
| GO:0021536 | GO:0021536 | diencephalon development | 4/439 | 80/18888 | 0.0500000 | 2.1512528 | 1.5917386 | 0.1157669 | 0.4301441 | 0.3772819 | NR4A2/SRD5A1/NCOA1/CREB1 | 4 |
| GO:0006997 | GO:0006997 | nucleus organization | 6/439 | 143/18888 | 0.0419580 | 1.8052471 | 1.4910144 | 0.1167879 | 0.4312759 | 0.3782746 | SEH1L/PRKCB/AHCTF1/SIRT1/EPC1/PAFAH1B1 | 6 |
| GO:0014074 | GO:0014074 | response to purine-containing compound | 6/439 | 143/18888 | 0.0419580 | 1.8052471 | 1.4910144 | 0.1167879 | 0.4312759 | 0.3782746 | RAP1B/SRD5A1/CREB1/RYR2/CRHBP/HDAC2 | 6 |
| GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 6/439 | 143/18888 | 0.0419580 | 1.8052471 | 1.4910144 | 0.1167879 | 0.4312759 | 0.3782746 | VAV3/TFRC/PPP3CA/MEF2C/CD46/IL1A | 6 |
| GO:0014812 | GO:0014812 | muscle cell migration | 5/439 | 111/18888 | 0.0450450 | 1.9380656 | 1.5290051 | 0.1168037 | 0.4312759 | 0.3782746 | AKIRIN1/MEF2C/SIX4/DOCK4/SLIT2 | 5 |
| GO:0030038 | GO:0030038 | contractile actin filament bundle assembly | 5/439 | 111/18888 | 0.0450450 | 1.9380656 | 1.5290051 | 0.1168037 | 0.4312759 | 0.3782746 | ZEB2/EPHA1/SMAD3/PPFIA1/RGCC | 5 |
| GO:0043149 | GO:0043149 | stress fiber assembly | 5/439 | 111/18888 | 0.0450450 | 1.9380656 | 1.5290051 | 0.1168037 | 0.4312759 | 0.3782746 | ZEB2/EPHA1/SMAD3/PPFIA1/RGCC | 5 |
| GO:2001234 | GO:2001234 | negative regulation of apoptotic signaling pathway | 9/439 | 244/18888 | 0.0368852 | 1.5869898 | 1.4235845 | 0.1168218 | 0.4312759 | 0.3782746 | NR4A2/PHIP/TCF7L2/SIRT1/BDNF/SGK3/IL1A/OPA1/AR | 9 |
| GO:0003012 | GO:0003012 | muscle system process | 15/439 | 459/18888 | 0.0326797 | 1.4060476 | 1.3585003 | 0.1176165 | 0.4338117 | 0.3804988 | PPP3CA/SCN2A/JARID2/ATP2B1/FBXO32/HEY2/SMAD3/DOCK4/SMPX/RYR2/CACNA1D/SULF1/HDAC2/YY1/MYOF | 15 |
| GO:0030178 | GO:0030178 | negative regulation of Wnt signaling pathway | 7/439 | 177/18888 | 0.0395480 | 1.7015559 | 1.4465311 | 0.1194359 | 0.4359145 | 0.3823431 | SHISA3/SCYL2/CTHRC1/AMFR/TCF7L2/TMEM170B/APC | 7 |
| GO:0006970 | GO:0006970 | response to osmotic stress | 4/439 | 81/18888 | 0.0493827 | 2.1246942 | 1.5647484 | 0.1196847 | 0.4359145 | 0.3823431 | SCN2A/OXSR1/ATF2/TSC22D2 | 4 |
| GO:0008344 | GO:0008344 | adult locomotory behavior | 4/439 | 81/18888 | 0.0493827 | 2.1246942 | 1.5647484 | 0.1196847 | 0.4359145 | 0.3823431 | NR4A2/PREX2/PUM1/PAFAH1B1 | 4 |
| GO:0032088 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 4/439 | 81/18888 | 0.0493827 | 2.1246942 | 1.5647484 | 0.1196847 | 0.4359145 | 0.3823431 | SIRT1/KLF4/IRAK3/IRAK2 | 4 |
| GO:0043242 | GO:0043242 | negative regulation of protein-containing complex disassembly | 4/439 | 81/18888 | 0.0493827 | 2.1246942 | 1.5647484 | 0.1196847 | 0.4359145 | 0.3823431 | TAOK1/TTBK2/APC/IRAK3 | 4 |
| GO:0043270 | GO:0043270 | positive regulation of monoatomic ion transport | 8/439 | 211/18888 | 0.0379147 | 1.6312818 | 1.4224541 | 0.1198752 | 0.4359145 | 0.3823431 | PPP3CA/ATP2B1/KCNN4/CNTN1/MLLT6/PPP3R1/RYR2/CACNA1D | 8 |
| GO:0045833 | GO:0045833 | negative regulation of lipid metabolic process | 5/439 | 112/18888 | 0.0446429 | 1.9207615 | 1.5075855 | 0.1200806 | 0.4359145 | 0.3823431 | CNR1/APPL2/REST/SIRT1/PROX1 | 5 |
| GO:0051303 | GO:0051303 | establishment of chromosome localization | 5/439 | 112/18888 | 0.0446429 | 1.9207615 | 1.5075855 | 0.1200806 | 0.4359145 | 0.3823431 | RAB11A/SEH1L/CHAMP1/APC/KAT2B | 5 |
| GO:0021695 | GO:0021695 | cerebellar cortex development | 3/439 | 52/18888 | 0.0576923 | 2.4822148 | 1.6509952 | 0.1200836 | 0.4359145 | 0.3823431 | RORA/TTBK2/PROX1 | 3 |
| GO:0035601 | GO:0035601 | protein deacylation | 3/439 | 52/18888 | 0.0576923 | 2.4822148 | 1.6509952 | 0.1200836 | 0.4359145 | 0.3823431 | SPRED1/SIRT1/KAT2B | 3 |
| GO:0051646 | GO:0051646 | mitochondrion localization | 3/439 | 52/18888 | 0.0576923 | 2.4822148 | 1.6509952 | 0.1200836 | 0.4359145 | 0.3823431 | MTM1/RHOT1/OPA1 | 3 |
| GO:1904707 | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 3/439 | 52/18888 | 0.0576923 | 2.4822148 | 1.6509952 | 0.1200836 | 0.4359145 | 0.3823431 | JUN/FGFR2/MAP3K5 | 3 |
| GO:0009913 | GO:0009913 | epidermal cell differentiation | 9/439 | 246/18888 | 0.0365854 | 1.5740874 | 1.3980628 | 0.1211019 | 0.4359145 | 0.3823431 | PPP3CA/HEY2/JAG1/SEC24B/PIP5K1A/KLF4/IL1A/PAFAH1B1/HDAC2 | 9 |
| GO:0003181 | GO:0003181 | atrioventricular valve morphogenesis | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | HEY2/HEY1 | 2 |
| GO:0010460 | GO:0010460 | positive regulation of heart rate | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | HEY2/RYR2 | 2 |
| GO:0014829 | GO:0014829 | vascular associated smooth muscle contraction | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | ATP2B1/DOCK4 | 2 |
| GO:0021697 | GO:0021697 | cerebellar cortex formation | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | RORA/PROX1 | 2 |
| GO:0032967 | GO:0032967 | positive regulation of collagen biosynthetic process | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | RGCC/HDAC2 | 2 |
| GO:0034643 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | RHOT1/OPA1 | 2 |
| GO:0042278 | GO:0042278 | purine nucleoside metabolic process | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | ADK/ENPP4 | 2 |
| GO:0047497 | GO:0047497 | mitochondrion transport along microtubule | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | RHOT1/OPA1 | 2 |
| GO:0048596 | GO:0048596 | embryonic camera-type eye morphogenesis | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | SP3/PROX1 | 2 |
| GO:0048641 | GO:0048641 | regulation of skeletal muscle tissue development | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | MTM1/MEF2C | 2 |
| GO:0060259 | GO:0060259 | regulation of feeding behavior | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | SGIP1/CNR1 | 2 |
| GO:1900078 | GO:1900078 | positive regulation of cellular response to insulin stimulus | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | SIRT1/ADIPOR1 | 2 |
| GO:1900151 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | YBX1/CPEB3 | 2 |
| GO:1900368 | GO:1900368 | regulation of post-transcriptional gene silencing by regulatory ncRNA | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | PUM2/PUM1 | 2 |
| GO:1903020 | GO:1903020 | positive regulation of glycoprotein metabolic process | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | TCF7L2/PLCB1 | 2 |
| GO:1904353 | GO:1904353 | regulation of telomere capping | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | MAPK1/TNKS2 | 2 |
| GO:2000108 | GO:2000108 | positive regulation of leukocyte apoptotic process | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | MEF2C/SIRT1 | 2 |
| GO:2000272 | GO:2000272 | negative regulation of signaling receptor activity | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | CRHBP/CNRIP1 | 2 |
| GO:2000737 | GO:2000737 | negative regulation of stem cell differentiation | 2/439 | 26/18888 | 0.0769231 | 3.3096198 | 1.8178608 | 0.1216531 | 0.4359145 | 0.3823431 | JAG1/REST | 2 |
| GO:0051051 | GO:0051051 | negative regulation of transport | 15/439 | 462/18888 | 0.0324675 | 1.3969174 | 1.3323949 | 0.1222467 | 0.4373903 | 0.3836375 | RAB33B/SYT4/PPP3CA/RAP1B/CNR1/APPL2/PRKCB/SESTD1/EPHA3/REST/YWHAQ/OXSR1/PPP3R1/CRHBP/SCAMP5 | 15 |
| GO:0090092 | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 11/439 | 317/18888 | 0.0347003 | 1.4929830 | 1.3654359 | 0.1222823 | 0.4373903 | 0.3836375 | DLX1/SMURF2/ZEB2/FBN1/UBE2D3/SMAD3/SPRED1/SIRT1/CAV2/SULF1/HDAC2 | 11 |
| GO:0045765 | GO:0045765 | regulation of angiogenesis | 12/439 | 353/18888 | 0.0339943 | 1.4626082 | 1.3534172 | 0.1226293 | 0.4382417 | 0.3843843 | PRKCB/EGLN1/EPHA1/HMGA2/PDCD10/SPRED1/SIRT1/ATF2/KLF4/SULF1/IL1A/RGCC | 12 |
| GO:0034440 | GO:0034440 | lipid oxidation | 5/439 | 113/18888 | 0.0442478 | 1.9037636 | 1.4863854 | 0.1234003 | 0.4395796 | 0.3855578 | CNR1/APPL2/ADIPOR1/PEX5/HADHB | 5 |
| GO:0070252 | GO:0070252 | actin-mediated cell contraction | 5/439 | 113/18888 | 0.0442478 | 1.9037636 | 1.4863854 | 0.1234003 | 0.4395796 | 0.3855578 | SCN2A/ZEB2/RYR2/CACNA1D/FRMD6 | 5 |
| GO:0030500 | GO:0030500 | regulation of bone mineralization | 4/439 | 82/18888 | 0.0487805 | 2.0987833 | 1.5381478 | 0.1236591 | 0.4395796 | 0.3855578 | ATP2B1/MEF2C/BCOR/SMAD3 | 4 |
| GO:0070897 | GO:0070897 | transcription preinitiation complex assembly | 4/439 | 82/18888 | 0.0487805 | 2.0987833 | 1.5381478 | 0.1236591 | 0.4395796 | 0.3855578 | TAF4/GTF2A1/TAF12/MED4 | 4 |
| GO:0070936 | GO:0070936 | protein K48-linked ubiquitination | 4/439 | 82/18888 | 0.0487805 | 2.0987833 | 1.5381478 | 0.1236591 | 0.4395796 | 0.3855578 | UBE2Q2/AMFR/UBE2D3/UBE2E3 | 4 |
| GO:0090049 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 4/439 | 82/18888 | 0.0487805 | 2.0987833 | 1.5381478 | 0.1236591 | 0.4395796 | 0.3855578 | MEOX2/PDCD10/SPRED1/KLF4 | 4 |
| GO:0002757 | GO:0002757 | immune response-activating signaling pathway | 16/439 | 500/18888 | 0.0320000 | 1.3768018 | 1.3172193 | 0.1239014 | 0.4400523 | 0.3859724 | PUM2/MAPK1/VAV3/HCFC2/MEF2C/KCNN4/APPL2/PRKCB/PPP6C/ELF1/PUM1/IRAK3/SOS1/IRAK2/MAPK8/PRNP | 16 |
| GO:0043588 | GO:0043588 | skin development | 11/439 | 318/18888 | 0.0345912 | 1.4882881 | 1.3546001 | 0.1241918 | 0.4406948 | 0.3865359 | PUM2/ASH1L/PPP3CA/FZD3/JAG1/FGFR2/PIP5K1A/KLF4/IL1A/HDAC2/SOS1 | 11 |
| GO:0044818 | GO:0044818 | mitotic G2/M transition checkpoint | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | TAOK1/MBTPS1/SYF2 | 3 |
| GO:0045778 | GO:0045778 | positive regulation of ossification | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | ATP2B1/MEF2C/SMAD3 | 3 |
| GO:0048260 | GO:0048260 | positive regulation of receptor-mediated endocytosis | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | SGIP1/HIP1/HNRNPK | 3 |
| GO:0050433 | GO:0050433 | regulation of catecholamine secretion | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | SYT4/CNR1/PRKCB | 3 |
| GO:0050850 | GO:0050850 | positive regulation of calcium-mediated signaling | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | PPP3CA/CAMTA1/PPP3R1 | 3 |
| GO:1902930 | GO:1902930 | regulation of alcohol biosynthetic process | 3/439 | 53/18888 | 0.0566038 | 2.4353806 | 1.6141709 | 0.1252193 | 0.4419778 | 0.3876613 | MBTPS1/REST/SEC14L2 | 3 |
| GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 6/439 | 146/18888 | 0.0410959 | 1.7681530 | 1.4372871 | 0.1254321 | 0.4419778 | 0.3876613 | VAV3/TFRC/PPP3CA/MEF2C/CD46/IL1A | 6 |
| GO:0045598 | GO:0045598 | regulation of fat cell differentiation | 6/439 | 146/18888 | 0.0410959 | 1.7681530 | 1.4372871 | 0.1254321 | 0.4419778 | 0.3876613 | RORA/SMAD3/JAG1/CREB1/SIRT1/TRIO | 6 |
| GO:0006816 | GO:0006816 | calcium ion transport | 14/439 | 428/18888 | 0.0327103 | 1.4073617 | 1.3149630 | 0.1266426 | 0.4458530 | 0.3910603 | GRIN3A/PPP3CA/ATP2B1/KCNN4/PRKCB/SESTD1/ATP2B2/GPM6A/PPP3R1/ITPR1/RYR2/CACNA1D/PLCB1/PRNP | 14 |
| GO:0048640 | GO:0048640 | negative regulation of developmental growth | 5/439 | 114/18888 | 0.0438596 | 1.8870639 | 1.4654002 | 0.1267624 | 0.4458844 | 0.3910878 | EPHA7/JARID2/WWC2/KCNK2/YY1 | 5 |
| GO:0071772 | GO:0071772 | response to BMP | 7/439 | 180/18888 | 0.0388889 | 1.6731967 | 1.3998834 | 0.1272329 | 0.4467586 | 0.3918546 | DLX1/SMURF2/FBN1/UBE2D3/NFIA/ATF2/SULF1 | 7 |
| GO:0071773 | GO:0071773 | cellular response to BMP stimulus | 7/439 | 180/18888 | 0.0388889 | 1.6731967 | 1.3998834 | 0.1272329 | 0.4467586 | 0.3918546 | DLX1/SMURF2/FBN1/UBE2D3/NFIA/ATF2/SULF1 | 7 |
| GO:0070509 | GO:0070509 | calcium ion import | 4/439 | 83/18888 | 0.0481928 | 2.0734967 | 1.5119256 | 0.1276889 | 0.4479688 | 0.3929161 | PPP3CA/PPP3R1/CACNA1D/PRNP | 4 |
| GO:1904019 | GO:1904019 | epithelial cell apoptotic process | 6/439 | 147/18888 | 0.0408163 | 1.7561248 | 1.4196559 | 0.1283812 | 0.4498517 | 0.3945676 | USP53/TCF7L2/RYR2/ATF2/RGCC/MAP3K5 | 6 |
| GO:0010714 | GO:0010714 | positive regulation of collagen metabolic process | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | RGCC/HDAC2 | 2 |
| GO:0010758 | GO:0010758 | regulation of macrophage chemotaxis | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | MAPK1/AKIRIN1 | 2 |
| GO:0021801 | GO:0021801 | cerebral cortex radial glia-guided migration | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | ZMIZ1/PAFAH1B1 | 2 |
| GO:0022030 | GO:0022030 | telencephalon glial cell migration | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | ZMIZ1/PAFAH1B1 | 2 |
| GO:0039529 | GO:0039529 | RIG-I signaling pathway | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | PUM2/PUM1 | 2 |
| GO:0046037 | GO:0046037 | GMP metabolic process | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | GART/ADK | 2 |
| GO:0060147 | GO:0060147 | regulation of post-transcriptional gene silencing | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | PUM2/PUM1 | 2 |
| GO:0060669 | GO:0060669 | embryonic placenta morphogenesis | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | NCOA1/FGFR2 | 2 |
| GO:0071549 | GO:0071549 | cellular response to dexamethasone stimulus | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | FBXO32/SRD5A1 | 2 |
| GO:2001032 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining | 2/439 | 27/18888 | 0.0740741 | 3.1870413 | 1.7542191 | 0.1294553 | 0.4498517 | 0.3945676 | HMGA2/RIF1 | 2 |
| GO:0001936 | GO:0001936 | regulation of endothelial cell proliferation | 7/439 | 181/18888 | 0.0386740 | 1.6639525 | 1.3845274 | 0.1298879 | 0.4501389 | 0.3948194 | MEF2C/PDCD10/SIRT1/CAV2/PROX1/SULF1/RGCC | 7 |
| GO:0042129 | GO:0042129 | regulation of T cell proliferation | 7/439 | 181/18888 | 0.0386740 | 1.6639525 | 1.3845274 | 0.1298879 | 0.4501389 | 0.3948194 | DLG5/TFRC/PPP3CA/CD46/IL1A/SOS1/PRNP | 7 |
| GO:0048259 | GO:0048259 | regulation of receptor-mediated endocytosis | 5/439 | 115/18888 | 0.0434783 | 1.8706546 | 1.4446257 | 0.1301661 | 0.4501389 | 0.3948194 | SGIP1/DNAJC6/HIP1/PPP3R1/HNRNPK | 5 |
| GO:0031279 | GO:0031279 | regulation of cyclase activity | 3/439 | 54/18888 | 0.0555556 | 2.3902809 | 1.5781762 | 0.1304329 | 0.4501389 | 0.3948194 | ADCYAP1/CACNA1D/MAPK8 | 3 |
| GO:0046605 | GO:0046605 | regulation of centrosome cycle | 3/439 | 54/18888 | 0.0555556 | 2.3902809 | 1.5781762 | 0.1304329 | 0.4501389 | 0.3948194 | CEP120/SIRT1/KAT2B | 3 |
| GO:0070169 | GO:0070169 | positive regulation of biomineral tissue development | 3/439 | 54/18888 | 0.0555556 | 2.3902809 | 1.5781762 | 0.1304329 | 0.4501389 | 0.3948194 | ATP2B1/MEF2C/SMAD3 | 3 |
| GO:0071385 | GO:0071385 | cellular response to glucocorticoid stimulus | 3/439 | 54/18888 | 0.0555556 | 2.3902809 | 1.5781762 | 0.1304329 | 0.4501389 | 0.3948194 | FBXO32/SRD5A1/REST | 3 |
| GO:0099172 | GO:0099172 | presynapse organization | 3/439 | 54/18888 | 0.0555556 | 2.3902809 | 1.5781762 | 0.1304329 | 0.4501389 | 0.3948194 | LRRTM3/SLITRK4/CNTN5 | 3 |
| GO:0044773 | GO:0044773 | mitotic DNA damage checkpoint signaling | 4/439 | 84/18888 | 0.0476190 | 2.0488122 | 1.4860711 | 0.1317732 | 0.4532097 | 0.3975129 | TAOK1/MBTPS1/SYF2/ATF2 | 4 |
| GO:0086001 | GO:0086001 | cardiac muscle cell action potential | 4/439 | 84/18888 | 0.0476190 | 2.0488122 | 1.4860711 | 0.1317732 | 0.4532097 | 0.3975129 | SCN2A/TMEM161B/RYR2/CACNA1D | 4 |
| GO:1902117 | GO:1902117 | positive regulation of organelle assembly | 4/439 | 84/18888 | 0.0476190 | 2.0488122 | 1.4860711 | 0.1317732 | 0.4532097 | 0.3975129 | CNOT2/CNOT6L/CEP120/ATMIN | 4 |
| GO:1905897 | GO:1905897 | regulation of response to endoplasmic reticulum stress | 4/439 | 84/18888 | 0.0476190 | 2.0488122 | 1.4860711 | 0.1317732 | 0.4532097 | 0.3975129 | USP25/SIRT1/OPA1/TMEM33 | 4 |
| GO:1901654 | GO:1901654 | response to ketone | 8/439 | 217/18888 | 0.0368664 | 1.5861772 | 1.3396839 | 0.1342902 | 0.4613829 | 0.4046816 | FBXO32/SRD5A1/NCOA1/CREB1/SLIT2/SIRT1/KLF4/AR | 8 |
| GO:0001508 | GO:0001508 | action potential | 6/439 | 149/18888 | 0.0402685 | 1.7325526 | 1.3847969 | 0.1343789 | 0.4613829 | 0.4046816 | SCN2A/CNR1/USP53/TMEM161B/RYR2/CACNA1D | 6 |
| GO:0010038 | GO:0010038 | response to metal ion | 12/439 | 360/18888 | 0.0333333 | 1.4341686 | 1.2829883 | 0.1355947 | 0.4618018 | 0.4050490 | MAPK1/SYT4/TFRC/PPP3CA/MEF2C/JUN/CREB1/RYR2/CRHBP/IL1A/MAPK8/PRNP | 12 |
| GO:0010559 | GO:0010559 | regulation of glycoprotein biosynthetic process | 3/439 | 55/18888 | 0.0545455 | 2.3468213 | 1.5429750 | 0.1357216 | 0.4618018 | 0.4050490 | TCF7L2/PLCB1/ITM2C | 3 |
| GO:0030857 | GO:0030857 | negative regulation of epithelial cell differentiation | 3/439 | 55/18888 | 0.0545455 | 2.3468213 | 1.5429750 | 0.1357216 | 0.4618018 | 0.4050490 | JAG1/SPRED1/IL1A | 3 |
| GO:1902991 | GO:1902991 | regulation of amyloid precursor protein catabolic process | 3/439 | 55/18888 | 0.0545455 | 2.3468213 | 1.5429750 | 0.1357216 | 0.4618018 | 0.4050490 | LRRTM3/RANBP9/PRNP | 3 |
| GO:1903351 | GO:1903351 | cellular response to dopamine | 3/439 | 55/18888 | 0.0545455 | 2.3468213 | 1.5429750 | 0.1357216 | 0.4618018 | 0.4050490 | NSG1/CAV2/HDAC2 | 3 |
| GO:2000781 | GO:2000781 | positive regulation of double-strand break repair | 4/439 | 85/18888 | 0.0470588 | 2.0247086 | 1.4605741 | 0.1359108 | 0.4618018 | 0.4050490 | MEAF6/SIRT1/EPC1/RIF1 | 4 |
| GO:0045637 | GO:0045637 | regulation of myeloid cell differentiation | 8/439 | 218/18888 | 0.0366972 | 1.5789012 | 1.3261353 | 0.1367753 | 0.4618018 | 0.4050490 | CDK6/PPP3CA/MEF2C/FBN1/JAG1/CREB1/TAL1/MITF | 8 |
| GO:0007006 | GO:0007006 | mitochondrial membrane organization | 5/439 | 117/18888 | 0.0427350 | 1.8386776 | 1.4036914 | 0.1370963 | 0.4618018 | 0.4050490 | ATF2/PEX5/RHOT1/OPA1/COX18 | 5 |
| GO:0051261 | GO:0051261 | protein depolymerization | 5/439 | 117/18888 | 0.0427350 | 1.8386776 | 1.4036914 | 0.1370963 | 0.4618018 | 0.4050490 | DNAJC6/TAOK1/TTBK2/KIF2A/APC | 5 |
| GO:0051928 | GO:0051928 | positive regulation of calcium ion transport | 5/439 | 117/18888 | 0.0427350 | 1.8386776 | 1.4036914 | 0.1370963 | 0.4618018 | 0.4050490 | PPP3CA/ATP2B1/PPP3R1/RYR2/CACNA1D | 5 |
| GO:0001964 | GO:0001964 | startle response | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | GRIN3A/CSMD1 | 2 |
| GO:0003156 | GO:0003156 | regulation of animal organ formation | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | SULF1/AR | 2 |
| GO:0003416 | GO:0003416 | endochondral bone growth | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | FGFR2/ATF2 | 2 |
| GO:0006817 | GO:0006817 | phosphate ion transport | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | SLC17A6/SLC34A2 | 2 |
| GO:0010971 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | RAB11A/CDC25C | 2 |
| GO:0014850 | GO:0014850 | response to muscle activity | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | SRD5A1/RYR2 | 2 |
| GO:0016180 | GO:0016180 | snRNA processing | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | INTS6/INTS10 | 2 |
| GO:0021854 | GO:0021854 | hypothalamus development | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | SRD5A1/NCOA1 | 2 |
| GO:0035308 | GO:0035308 | negative regulation of protein dephosphorylation | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | ARPP19/PPP1R1B | 2 |
| GO:0045830 | GO:0045830 | positive regulation of isotype switching | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | TFRC/RIF1 | 2 |
| GO:0048668 | GO:0048668 | collateral sprouting | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | EPHA7/BDNF | 2 |
| GO:0050857 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | KCNN4/PRKCB | 2 |
| GO:0051446 | GO:0051446 | positive regulation of meiotic cell cycle | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | CDC25C/PLCB1 | 2 |
| GO:0051953 | GO:0051953 | negative regulation of amine transport | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | SYT4/CNR1 | 2 |
| GO:0120255 | GO:0120255 | olefinic compound biosynthetic process | 2/439 | 28/18888 | 0.0714286 | 3.0732184 | 1.6934819 | 0.1373700 | 0.4618018 | 0.4050490 | REST/CREB1 | 2 |
| GO:0009952 | GO:0009952 | anterior/posterior pattern specification | 8/439 | 219/18888 | 0.0365297 | 1.5716916 | 1.3126552 | 0.1392835 | 0.4674536 | 0.4100062 | MEOX2/ETS2/TSHZ1/HEY2/SMAD3/YY1/HEY1/HOXB7 | 8 |
| GO:0050679 | GO:0050679 | positive regulation of epithelial cell proliferation | 8/439 | 219/18888 | 0.0365297 | 1.5716916 | 1.3126552 | 0.1392835 | 0.4674536 | 0.4100062 | CYP7B1/B4GALT1/TCF7L2/FGFR2/SIRT1/CAV2/PROX1/AR | 8 |
| GO:0035050 | GO:0035050 | embryonic heart tube development | 4/439 | 86/18888 | 0.0465116 | 2.0011654 | 1.4354246 | 0.1401005 | 0.4690219 | 0.4113818 | MEF2C/ARL13B/SMAD3/RYR2 | 4 |
| GO:0051851 | GO:0051851 | modulation by host of symbiont process | 4/439 | 86/18888 | 0.0465116 | 2.0011654 | 1.4354246 | 0.1401005 | 0.4690219 | 0.4113818 | JUN/HMGA2/REST/CAV2 | 4 |
| GO:1901379 | GO:1901379 | regulation of potassium ion transmembrane transport | 4/439 | 86/18888 | 0.0465116 | 2.0011654 | 1.4354246 | 0.1401005 | 0.4690219 | 0.4113818 | KCNN4/OXSR1/CACNA1D/PRNP | 4 |
| GO:0042303 | GO:0042303 | molting cycle | 5/439 | 118/18888 | 0.0423729 | 1.8230956 | 1.3835234 | 0.1406217 | 0.4695761 | 0.4118679 | PUM2/FZD3/FGFR2/HDAC2/SOS1 | 5 |
| GO:0042633 | GO:0042633 | hair cycle | 5/439 | 118/18888 | 0.0423729 | 1.8230956 | 1.3835234 | 0.1406217 | 0.4695761 | 0.4118679 | PUM2/FZD3/FGFR2/HDAC2/SOS1 | 5 |
| GO:0007528 | GO:0007528 | neuromuscular junction development | 3/439 | 56/18888 | 0.0535714 | 2.3049138 | 1.5085334 | 0.1410829 | 0.4695761 | 0.4118679 | AGRN/SIX4/UNC13C | 3 |
| GO:0010761 | GO:0010761 | fibroblast migration | 3/439 | 56/18888 | 0.0535714 | 2.3049138 | 1.5085334 | 0.1410829 | 0.4695761 | 0.4118679 | APPL2/ZEB2/PIP5K1A | 3 |
| GO:0014888 | GO:0014888 | striated muscle adaptation | 3/439 | 56/18888 | 0.0535714 | 2.3049138 | 1.5085334 | 0.1410829 | 0.4695761 | 0.4118679 | PPP3CA/HEY2/SMAD3 | 3 |
| GO:0015872 | GO:0015872 | dopamine transport | 3/439 | 56/18888 | 0.0535714 | 2.3049138 | 1.5085334 | 0.1410829 | 0.4695761 | 0.4118679 | SYT4/CNR1/PRKCB | 3 |
| GO:0098732 | GO:0098732 | macromolecule deacylation | 3/439 | 56/18888 | 0.0535714 | 2.3049138 | 1.5085334 | 0.1410829 | 0.4695761 | 0.4118679 | SPRED1/SIRT1/KAT2B | 3 |
| GO:0006906 | GO:0006906 | vesicle fusion | 5/439 | 119/18888 | 0.0420168 | 1.8077755 | 1.3635496 | 0.1441864 | 0.4775833 | 0.4188910 | VAV3/SYT4/RAB12/CAV2/VAMP4 | 5 |
| GO:0010232 | GO:0010232 | vascular transport | 4/439 | 87/18888 | 0.0459770 | 1.9781635 | 1.4106132 | 0.1443412 | 0.4775833 | 0.4188910 | TFRC/SLC6A6/SLC1A2/ATP8A1 | 4 |
| GO:0032370 | GO:0032370 | positive regulation of lipid transport | 4/439 | 87/18888 | 0.0459770 | 1.9781635 | 1.4106132 | 0.1443412 | 0.4775833 | 0.4188910 | ATP8A1/DENND5B/SIRT1/IL1A | 4 |
| GO:0150104 | GO:0150104 | transport across blood-brain barrier | 4/439 | 87/18888 | 0.0459770 | 1.9781635 | 1.4106132 | 0.1443412 | 0.4775833 | 0.4188910 | TFRC/SLC6A6/SLC1A2/ATP8A1 | 4 |
| GO:0003171 | GO:0003171 | atrioventricular valve development | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | HEY2/HEY1 | 2 |
| GO:0003401 | GO:0003401 | axis elongation | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | SIX4/FGFR2 | 2 |
| GO:0015813 | GO:0015813 | L-glutamate transmembrane transport | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | SLC1A2/SLC17A6 | 2 |
| GO:0045672 | GO:0045672 | positive regulation of osteoclast differentiation | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | PPP3CA/CREB1 | 2 |
| GO:0045724 | GO:0045724 | positive regulation of cilium assembly | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | CEP120/ATMIN | 2 |
| GO:0045742 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | HIP1/SOS1 | 2 |
| GO:0060479 | GO:0060479 | lung cell differentiation | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | CREB1/PPP3R1 | 2 |
| GO:0060487 | GO:0060487 | lung epithelial cell differentiation | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | CREB1/PPP3R1 | 2 |
| GO:0072207 | GO:0072207 | metanephric epithelium development | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | CALB1/SOX8 | 2 |
| GO:0090311 | GO:0090311 | regulation of protein deacetylation | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | SPRED1/KAT2B | 2 |
| GO:0098901 | GO:0098901 | regulation of cardiac muscle cell action potential | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | TMEM161B/RYR2 | 2 |
| GO:1901201 | GO:1901201 | regulation of extracellular matrix assembly | 2/439 | 29/18888 | 0.0689655 | 2.9672453 | 1.6354058 | 0.1453875 | 0.4775833 | 0.4188910 | SMAD3/RGCC | 2 |
| GO:0045860 | GO:0045860 | positive regulation of protein kinase activity | 9/439 | 257/18888 | 0.0350195 | 1.5067141 | 1.2616496 | 0.1461229 | 0.4796072 | 0.4206662 | TAB2/ADCYAP1/HMGA2/PDCD10/SIRT1/PROX1/RGCC/MAP3K5/PRNP | 9 |
| GO:0097553 | GO:0097553 | calcium ion transmembrane import into cytosol | 7/439 | 187/18888 | 0.0374332 | 1.6105636 | 1.2943349 | 0.1463894 | 0.4797171 | 0.4207626 | PPP3CA/PPP3R1/ITPR1/RYR2/CACNA1D/PLCB1/PRNP | 7 |
| GO:0007632 | GO:0007632 | visual behavior | 3/439 | 57/18888 | 0.0526316 | 2.2644767 | 1.4748196 | 0.1465140 | 0.4797171 | 0.4207626 | TAFA2/SLC1A2/PPP1R1B | 3 |
| GO:1903350 | GO:1903350 | response to dopamine | 3/439 | 57/18888 | 0.0526316 | 2.2644767 | 1.4748196 | 0.1465140 | 0.4797171 | 0.4207626 | NSG1/CAV2/HDAC2 | 3 |
| GO:0010950 | GO:0010950 | positive regulation of endopeptidase activity | 6/439 | 153/18888 | 0.0392157 | 1.6872571 | 1.3166352 | 0.1467627 | 0.4801408 | 0.4211343 | HIP1/SMAD3/REST/SIRT1/MAP3K5/ST18 | 6 |
| GO:0050000 | GO:0050000 | chromosome localization | 5/439 | 120/18888 | 0.0416667 | 1.7927107 | 1.3437661 | 0.1477897 | 0.4831079 | 0.4237367 | RAB11A/SEH1L/CHAMP1/APC/KAT2B | 5 |
| GO:0032886 | GO:0032886 | regulation of microtubule-based process | 9/439 | 258/18888 | 0.0348837 | 1.5008741 | 1.2495663 | 0.1485185 | 0.4842867 | 0.4247707 | TAOK1/CEP120/RSPH4A/EPHA3/TTBK2/SIRT1/APC/PAFAH1B1/KAT2B | 9 |
| GO:0042593 | GO:0042593 | glucose homeostasis | 9/439 | 258/18888 | 0.0348837 | 1.5008741 | 1.2495663 | 0.1485185 | 0.4842867 | 0.4247707 | PPP3CA/CNR1/APPL2/EPHA5/SMAD3/TCF7L2/CSMD1/SIRT1/ADIPOR1 | 9 |
| GO:0044774 | GO:0044774 | mitotic DNA integrity checkpoint signaling | 4/439 | 88/18888 | 0.0454545 | 1.9556844 | 1.3861309 | 0.1486317 | 0.4842867 | 0.4247707 | TAOK1/MBTPS1/SYF2/ATF2 | 4 |
| GO:0061515 | GO:0061515 | myeloid cell development | 4/439 | 88/18888 | 0.0454545 | 1.9556844 | 1.3861309 | 0.1486317 | 0.4842867 | 0.4247707 | L3MBTL3/FBN1/TAL1/PAFAH1B1 | 4 |
| GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 7/439 | 188/18888 | 0.0372340 | 1.6019968 | 1.2796159 | 0.1492327 | 0.4854585 | 0.4257985 | RAB11A/SEH1L/SMC3/KIF2A/CHAMP1/APC/KAT2B | 7 |
| GO:0048771 | GO:0048771 | tissue remodeling | 7/439 | 188/18888 | 0.0372340 | 1.6019968 | 1.2796159 | 0.1492327 | 0.4854585 | 0.4257985 | TFRC/PPP3CA/MEF2C/CTHRC1/JAG1/IL1A/MITF | 7 |
| GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 9/439 | 259/18888 | 0.0347490 | 1.4950792 | 1.2375340 | 0.1509337 | 0.4898040 | 0.4296100 | SGIP1/DNAJC6/TFRC/SCYL2/HIP1/PPP3R1/CAV2/HNRNPK/AP2B1 | 9 |
| GO:0033500 | GO:0033500 | carbohydrate homeostasis | 9/439 | 259/18888 | 0.0347490 | 1.4950792 | 1.2375340 | 0.1509337 | 0.4898040 | 0.4296100 | PPP3CA/CNR1/APPL2/EPHA5/SMAD3/TCF7L2/CSMD1/SIRT1/ADIPOR1 | 9 |
| GO:0097305 | GO:0097305 | response to alcohol | 9/439 | 259/18888 | 0.0347490 | 1.4950792 | 1.2375340 | 0.1509337 | 0.4898040 | 0.4296100 | GRIN3A/CNR1/PRKCB/CREB1/FGFR2/SLIT2/CRHBP/KLF4/HDAC2 | 9 |
| GO:0030510 | GO:0030510 | regulation of BMP signaling pathway | 5/439 | 121/18888 | 0.0413223 | 1.7778949 | 1.3241693 | 0.1514311 | 0.4901421 | 0.4299065 | DLX1/SMURF2/FBN1/UBE2D3/SULF1 | 5 |
| GO:0046660 | GO:0046660 | female sex differentiation | 5/439 | 121/18888 | 0.0413223 | 1.7778949 | 1.3241693 | 0.1514311 | 0.4901421 | 0.4299065 | TAF4/SRD5A1/CSMD1/SLIT2/SIRT1 | 5 |
| GO:0090174 | GO:0090174 | organelle membrane fusion | 5/439 | 121/18888 | 0.0413223 | 1.7778949 | 1.3241693 | 0.1514311 | 0.4901421 | 0.4299065 | VAV3/SYT4/RAB12/CAV2/VAMP4 | 5 |
| GO:0015804 | GO:0015804 | neutral amino acid transport | 3/439 | 58/18888 | 0.0517241 | 2.2254340 | 1.4418035 | 0.1520123 | 0.4901421 | 0.4299065 | SLC6A6/SLC1A2/SERINC5 | 3 |
| GO:0043331 | GO:0043331 | response to dsRNA | 3/439 | 58/18888 | 0.0517241 | 2.2254340 | 1.4418035 | 0.1520123 | 0.4901421 | 0.4299065 | MAPK1/HCFC2/IRAK3 | 3 |
| GO:0061005 | GO:0061005 | cell differentiation involved in kidney development | 3/439 | 58/18888 | 0.0517241 | 2.2254340 | 1.4418035 | 0.1520123 | 0.4901421 | 0.4299065 | MTSS1/MEF2C/JAG1 | 3 |
| GO:0071868 | GO:0071868 | cellular response to monoamine stimulus | 3/439 | 58/18888 | 0.0517241 | 2.2254340 | 1.4418035 | 0.1520123 | 0.4901421 | 0.4299065 | NSG1/CAV2/HDAC2 | 3 |
| GO:0071870 | GO:0071870 | cellular response to catecholamine stimulus | 3/439 | 58/18888 | 0.0517241 | 2.2254340 | 1.4418035 | 0.1520123 | 0.4901421 | 0.4299065 | NSG1/CAV2/HDAC2 | 3 |
| GO:0001843 | GO:0001843 | neural tube closure | 4/439 | 89/18888 | 0.0449438 | 1.9337104 | 1.3619688 | 0.1529709 | 0.4913923 | 0.4310031 | FZD3/CTHRC1/SEC24B/OPA1 | 4 |
| GO:0006094 | GO:0006094 | gluconeogenesis | 4/439 | 89/18888 | 0.0449438 | 1.9337104 | 1.3619688 | 0.1529709 | 0.4913923 | 0.4310031 | ARPP19/TCF7L2/SIRT1/KAT2B | 4 |
| GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 12/439 | 369/18888 | 0.0325203 | 1.3991888 | 1.1945660 | 0.1533189 | 0.4913923 | 0.4310031 | MAPK1/TAB2/FBXO3/MEF2C/CNR1/FGFR2/IL1A/IRAK3/HDAC2/IRAK2/MAPK8/HADHB | 12 |
| GO:0008535 | GO:0008535 | respiratory chain complex IV assembly | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | COX18/COX16 | 2 |
| GO:0010894 | GO:0010894 | negative regulation of steroid biosynthetic process | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | REST/PROX1 | 2 |
| GO:0038094 | GO:0038094 | Fc-gamma receptor signaling pathway | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | VAV3/APPL2 | 2 |
| GO:0045762 | GO:0045762 | positive regulation of adenylate cyclase activity | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | ADCYAP1/CACNA1D | 2 |
| GO:0046856 | GO:0046856 | phosphatidylinositol dephosphorylation | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | MTM1/MTMR12 | 2 |
| GO:0060441 | GO:0060441 | epithelial tube branching involved in lung morphogenesis | 2/439 | 30/18888 | 0.0666667 | 2.8683371 | 1.5797756 | 0.1534990 | 0.4913923 | 0.4310031 | DLG5/FGFR2 | 2 |
| GO:0045055 | GO:0045055 | regulated exocytosis | 8/439 | 225/18888 | 0.0355556 | 1.5297798 | 1.2331709 | 0.1548097 | 0.4951943 | 0.4343378 | SYT4/RAP1B/PRKCB/REST/CRHBP/SCAMP5/STXBP5/UNC13C | 8 |
| GO:0050770 | GO:0050770 | regulation of axonogenesis | 6/439 | 156/18888 | 0.0384615 | 1.6548099 | 1.2668138 | 0.1563783 | 0.4998144 | 0.4383901 | EPHA7/CDH4/SLIT2/BDNF/PAFAH1B1/SIPA1L1 | 6 |
| GO:0034620 | GO:0034620 | cellular response to unfolded protein | 4/439 | 90/18888 | 0.0444444 | 1.9122248 | 1.3381186 | 0.1573576 | 0.5020443 | 0.4403460 | PARP8/MBTPS1/AMFR/TMEM33 | 4 |
| GO:0060606 | GO:0060606 | tube closure | 4/439 | 90/18888 | 0.0444444 | 1.9122248 | 1.3381186 | 0.1573576 | 0.5020443 | 0.4403460 | FZD3/CTHRC1/SEC24B/OPA1 | 4 |
| GO:0050432 | GO:0050432 | catecholamine secretion | 3/439 | 59/18888 | 0.0508475 | 2.1877148 | 1.4094571 | 0.1575751 | 0.5020443 | 0.4403460 | SYT4/CNR1/PRKCB | 3 |
| GO:0098900 | GO:0098900 | regulation of action potential | 3/439 | 59/18888 | 0.0508475 | 2.1877148 | 1.4094571 | 0.1575751 | 0.5020443 | 0.4403460 | CNR1/TMEM161B/RYR2 | 3 |
| GO:0031503 | GO:0031503 | protein-containing complex localization | 7/439 | 191/18888 | 0.0366492 | 1.5768345 | 1.2359740 | 0.1579166 | 0.5027346 | 0.4409515 | RAB11A/SEH1L/NSG1/HIP1/PPP3R1/GPC6/AP2B1 | 7 |
| GO:1901343 | GO:1901343 | negative regulation of vasculature development | 6/439 | 157/18888 | 0.0382166 | 1.6442697 | 1.2504444 | 0.1596438 | 0.5074303 | 0.4450700 | ANGPTL7/SPRED1/ATF2/KLF4/SULF1/RGCC | 6 |
| GO:2001236 | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 6/439 | 157/18888 | 0.0382166 | 1.6442697 | 1.2504444 | 0.1596438 | 0.5074303 | 0.4450700 | PHIP/TCF7L2/SGK3/IL1A/AR/ITM2C | 6 |
| GO:0042180 | GO:0042180 | cellular ketone metabolic process | 8/439 | 227/18888 | 0.0352423 | 1.5163016 | 1.2071917 | 0.1601622 | 0.5074396 | 0.4450782 | CNR1/APPL2/SRD5A1/REST/CREB1/SIRT1/PROX1/KAT2B | 8 |
| GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 9/439 | 263/18888 | 0.0342205 | 1.4723404 | 1.1899045 | 0.1607875 | 0.5074396 | 0.4450782 | RAB11A/CEP120/E2F8/PHIP/IL1A/RGCC/KAT2B/CDC25C/PLCB1 | 9 |
| GO:0071897 | GO:0071897 | DNA biosynthetic process | 7/439 | 192/18888 | 0.0364583 | 1.5686219 | 1.2215947 | 0.1608618 | 0.5074396 | 0.4450782 | MAPK1/KCNK2/MEAF6/SIRT1/TNKS2/KLF4/RGCC | 7 |
| GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 15/439 | 485/18888 | 0.0309278 | 1.3306719 | 1.1380233 | 0.1611868 | 0.5074396 | 0.4450782 | VAV3/CDK6/ZMIZ1/TFRC/PPP3CA/RIN2/EGFL6/EPHA1/SMAD3/MAP3K8/DOCK1/FBLN2/CD46/IL1A/EDIL3 | 15 |
| GO:0002431 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | VAV3/APPL2 | 2 |
| GO:0003338 | GO:0003338 | metanephros morphogenesis | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | CALB1/SOX8 | 2 |
| GO:0010458 | GO:0010458 | exit from mitosis | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | NFIA/RGCC | 2 |
| GO:0010765 | GO:0010765 | positive regulation of sodium ion transport | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | CNTN1/MLLT6 | 2 |
| GO:0030878 | GO:0030878 | thyroid gland development | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | MAPK1/SMAD3 | 2 |
| GO:0040018 | GO:0040018 | positive regulation of multicellular organism growth | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | CREB1/PEX5 | 2 |
| GO:0051491 | GO:0051491 | positive regulation of filopodium assembly | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | AGRN/GPM6A | 2 |
| GO:0070979 | GO:0070979 | protein K11-linked ubiquitination | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | UBE2D3/UBE2E3 | 2 |
| GO:0098868 | GO:0098868 | bone growth | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | FGFR2/ATF2 | 2 |
| GO:1901186 | GO:1901186 | positive regulation of ERBB signaling pathway | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | HIP1/SOS1 | 2 |
| GO:1902751 | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | RAB11A/CDC25C | 2 |
| GO:1903055 | GO:1903055 | positive regulation of extracellular matrix organization | 2/439 | 31/18888 | 0.0645161 | 2.7758101 | 1.5264002 | 0.1616958 | 0.5074396 | 0.4450782 | SMAD3/RGCC | 2 |
| GO:0060021 | GO:0060021 | roof of mouth development | 4/439 | 91/18888 | 0.0439560 | 1.8912113 | 1.3145722 | 0.1617905 | 0.5074396 | 0.4450782 | MEOX2/TSHZ1/BCOR/SOS1 | 4 |
| GO:0043244 | GO:0043244 | regulation of protein-containing complex disassembly | 5/439 | 124/18888 | 0.0403226 | 1.7348813 | 1.2664635 | 0.1625771 | 0.5094768 | 0.4468650 | TAOK1/TTBK2/GSPT1/APC/IRAK3 | 5 |
| GO:0021915 | GO:0021915 | neural tube development | 6/439 | 158/18888 | 0.0379747 | 1.6338629 | 1.2341909 | 0.1629388 | 0.5094768 | 0.4468650 | FZD3/ARL13B/CTHRC1/SEC24B/PROX1/OPA1 | 6 |
| GO:0046324 | GO:0046324 | regulation of glucose import | 3/439 | 60/18888 | 0.0500000 | 2.1512528 | 1.3777537 | 0.1631997 | 0.5094768 | 0.4468650 | ARPP19/APPL2/SLC1A2 | 3 |
| GO:0071867 | GO:0071867 | response to monoamine | 3/439 | 60/18888 | 0.0500000 | 2.1512528 | 1.3777537 | 0.1631997 | 0.5094768 | 0.4468650 | NSG1/CAV2/HDAC2 | 3 |
| GO:0071869 | GO:0071869 | response to catecholamine | 3/439 | 60/18888 | 0.0500000 | 2.1512528 | 1.3777537 | 0.1631997 | 0.5094768 | 0.4468650 | NSG1/CAV2/HDAC2 | 3 |
| GO:1905517 | GO:1905517 | macrophage migration | 3/439 | 60/18888 | 0.0500000 | 2.1512528 | 1.3777537 | 0.1631997 | 0.5094768 | 0.4468650 | MAPK1/AKIRIN1/B4GALT1 | 3 |
| GO:0048705 | GO:0048705 | skeletal system morphogenesis | 8/439 | 229/18888 | 0.0349345 | 1.5030588 | 1.1814616 | 0.1656005 | 0.5161709 | 0.4527365 | RAB33B/MEF2C/PRKRA/SIX4/SMAD3/FGFR2/ATF2/HOXB7 | 8 |
| GO:0071241 | GO:0071241 | cellular response to inorganic substance | 8/439 | 229/18888 | 0.0349345 | 1.5030588 | 1.1814616 | 0.1656005 | 0.5161709 | 0.4527365 | MAPK1/SYT4/MEF2C/JUN/CREB1/CRHBP/MAPK8/PRNP | 8 |
| GO:0019319 | GO:0019319 | hexose biosynthetic process | 4/439 | 92/18888 | 0.0434783 | 1.8706546 | 1.2913217 | 0.1662684 | 0.5174511 | 0.4538593 | ARPP19/TCF7L2/SIRT1/KAT2B | 4 |
| GO:1904063 | GO:1904063 | negative regulation of cation transmembrane transport | 4/439 | 92/18888 | 0.0434783 | 1.8706546 | 1.2913217 | 0.1662684 | 0.5174511 | 0.4538593 | PPP3CA/SESTD1/OXSR1/PPP3R1 | 4 |
| GO:0030258 | GO:0030258 | lipid modification | 7/439 | 194/18888 | 0.0360825 | 1.5524505 | 1.1930825 | 0.1668260 | 0.5187851 | 0.4550294 | MTM1/CNR1/APPL2/MTMR12/ADIPOR1/PEX5/HADHB | 7 |
| GO:0034762 | GO:0034762 | regulation of transmembrane transport | 15/439 | 489/18888 | 0.0306748 | 1.3197870 | 1.1052117 | 0.1685617 | 0.5227595 | 0.4585154 | ARPP19/PPP3CA/MEF2C/KCNN4/APPL2/PRKCB/SLC1A2/SESTD1/YWHAQ/OXSR1/PPP3R1/RYR2/CRHBP/CACNA1D/PRNP | 15 |
| GO:0008347 | GO:0008347 | glial cell migration | 3/439 | 61/18888 | 0.0491803 | 2.1159864 | 1.3466682 | 0.1688836 | 0.5227595 | 0.4585154 | RRAS2/ZMIZ1/PAFAH1B1 | 3 |
| GO:0010574 | GO:0010574 | regulation of vascular endothelial growth factor production | 3/439 | 61/18888 | 0.0491803 | 2.1159864 | 1.3466682 | 0.1688836 | 0.5227595 | 0.4585154 | RORA/SULF1/IL1A | 3 |
| GO:0016447 | GO:0016447 | somatic recombination of immunoglobulin gene segments | 3/439 | 61/18888 | 0.0491803 | 2.1159864 | 1.3466682 | 0.1688836 | 0.5227595 | 0.4585154 | TFRC/YY1/RIF1 | 3 |
| GO:0086002 | GO:0086002 | cardiac muscle cell action potential involved in contraction | 3/439 | 61/18888 | 0.0491803 | 2.1159864 | 1.3466682 | 0.1688836 | 0.5227595 | 0.4585154 | SCN2A/RYR2/CACNA1D | 3 |
| GO:1903018 | GO:1903018 | regulation of glycoprotein metabolic process | 3/439 | 61/18888 | 0.0491803 | 2.1159864 | 1.3466682 | 0.1688836 | 0.5227595 | 0.4585154 | TCF7L2/PLCB1/ITM2C | 3 |
| GO:0008053 | GO:0008053 | mitochondrial fusion | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | TFRC/OPA1 | 2 |
| GO:0033032 | GO:0033032 | regulation of myeloid cell apoptotic process | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | MEF2C/SIRT1 | 2 |
| GO:0035335 | GO:0035335 | peptidyl-tyrosine dephosphorylation | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | PTPN13/PTPN12 | 2 |
| GO:0048679 | GO:0048679 | regulation of axon regeneration | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | PUM2/KLF4 | 2 |
| GO:0061037 | GO:0061037 | negative regulation of cartilage development | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | PTHLH/EFEMP1 | 2 |
| GO:0097205 | GO:0097205 | renal filtration | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | PPP3CA/SULF1 | 2 |
| GO:1901889 | GO:1901889 | negative regulation of cell junction assembly | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | PTPN13/EPHA7 | 2 |
| GO:1902235 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 2/439 | 32/18888 | 0.0625000 | 2.6890661 | 1.4751092 | 0.1699695 | 0.5229031 | 0.4586413 | SIRT1/OPA1 | 2 |
| GO:0007589 | GO:0007589 | body fluid secretion | 4/439 | 93/18888 | 0.0430108 | 1.8505401 | 1.2683597 | 0.1707902 | 0.5242256 | 0.4598013 | PPP3CA/KCNN4/NCOA1/CREB1 | 4 |
| GO:0014033 | GO:0014033 | neural crest cell differentiation | 4/439 | 93/18888 | 0.0430108 | 1.8505401 | 1.2683597 | 0.1707902 | 0.5242256 | 0.4598013 | MAPK1/MEF2C/JAG1/SOX8 | 4 |
| GO:1904705 | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 4/439 | 93/18888 | 0.0430108 | 1.8505401 | 1.2683597 | 0.1707902 | 0.5242256 | 0.4598013 | MEF2C/JUN/FGFR2/MAP3K5 | 4 |
| GO:0052547 | GO:0052547 | regulation of peptidase activity | 10/439 | 304/18888 | 0.0328947 | 1.4152979 | 1.1260412 | 0.1722101 | 0.5281811 | 0.4632707 | EPHA7/HIP1/SMAD3/REST/SIRT1/SERPINB1/KLF4/MAP3K5/TANK/ST18 | 10 |
| GO:0006606 | GO:0006606 | protein import into nucleus | 6/439 | 161/18888 | 0.0372671 | 1.6034183 | 1.1861091 | 0.1729959 | 0.5293807 | 0.4643229 | KPNA1/PPP3CA/APPL2/SMAD3/PPP3R1/ATF2 | 6 |
| GO:0050657 | GO:0050657 | nucleic acid transport | 6/439 | 161/18888 | 0.0372671 | 1.6034183 | 1.1861091 | 0.1729959 | 0.5293807 | 0.4643229 | SEH1L/YBX1/AHCTF1/RBFOX1/CETN3/NXT2 | 6 |
| GO:0050658 | GO:0050658 | RNA transport | 6/439 | 161/18888 | 0.0372671 | 1.6034183 | 1.1861091 | 0.1729959 | 0.5293807 | 0.4643229 | SEH1L/YBX1/AHCTF1/RBFOX1/CETN3/NXT2 | 6 |
| GO:0031623 | GO:0031623 | receptor internalization | 5/439 | 127/18888 | 0.0393701 | 1.6938999 | 1.2103139 | 0.1740416 | 0.5321758 | 0.4667745 | TFRC/SCYL2/HIP1/PPP3R1/AP2B1 | 5 |
| GO:0002712 | GO:0002712 | regulation of B cell mediated immunity | 3/439 | 62/18888 | 0.0483871 | 2.0818576 | 1.3161769 | 0.1746240 | 0.5327422 | 0.4672712 | TFRC/CD46/RIF1 | 3 |
| GO:0002889 | GO:0002889 | regulation of immunoglobulin mediated immune response | 3/439 | 62/18888 | 0.0483871 | 2.0818576 | 1.3161769 | 0.1746240 | 0.5327422 | 0.4672712 | TFRC/CD46/RIF1 | 3 |
| GO:0097120 | GO:0097120 | receptor localization to synapse | 3/439 | 62/18888 | 0.0483871 | 2.0818576 | 1.3161769 | 0.1746240 | 0.5327422 | 0.4672712 | RAB11A/NSG1/GPC6 | 3 |
| GO:0048704 | GO:0048704 | embryonic skeletal system morphogenesis | 4/439 | 94/18888 | 0.0425532 | 1.8308535 | 1.2456789 | 0.1753546 | 0.5333535 | 0.4678075 | SIX4/SMAD3/FGFR2/HOXB7 | 4 |
| GO:0051492 | GO:0051492 | regulation of stress fiber assembly | 4/439 | 94/18888 | 0.0425532 | 1.8308535 | 1.2456789 | 0.1753546 | 0.5333535 | 0.4678075 | EPHA1/SMAD3/PPFIA1/RGCC | 4 |
| GO:0051781 | GO:0051781 | positive regulation of cell division | 4/439 | 94/18888 | 0.0425532 | 1.8308535 | 1.2456789 | 0.1753546 | 0.5333535 | 0.4678075 | YBX1/FGFR2/TAL1/IL1A | 4 |
| GO:0055006 | GO:0055006 | cardiac cell development | 4/439 | 94/18888 | 0.0425532 | 1.8308535 | 1.2456789 | 0.1753546 | 0.5333535 | 0.4678075 | HEY2/JAG1/PROX1/YY1 | 4 |
| GO:0018108 | GO:0018108 | peptidyl-tyrosine phosphorylation | 9/439 | 269/18888 | 0.0334572 | 1.4395000 | 1.1199128 | 0.1761301 | 0.5353077 | 0.4695215 | RAP2C/EPHA7/CLK4/EPHA1/EPHA3/FGFR2/EFEMP1/HDAC2/PRNP | 9 |
| GO:0043524 | GO:0043524 | negative regulation of neuron apoptotic process | 6/439 | 162/18888 | 0.0370370 | 1.5935206 | 1.1703025 | 0.1764043 | 0.5357365 | 0.4698976 | DLX1/NR4A2/MEF2C/SIX4/SIRT1/BDNF | 6 |
| GO:0001558 | GO:0001558 | regulation of cell growth | 13/439 | 418/18888 | 0.0311005 | 1.3380999 | 1.0782687 | 0.1775295 | 0.5366702 | 0.4707166 | PUM2/TEAD1/SYT4/EPHA7/SMAD3/MEAF6/CDH4/SLIT2/ADIPOR1/BDNF/SGK3/PAFAH1B1/YY1 | 13 |
| GO:0006275 | GO:0006275 | regulation of DNA replication | 5/439 | 128/18888 | 0.0390625 | 1.6806663 | 1.1919283 | 0.1779306 | 0.5366702 | 0.4707166 | INO80D/SMC3/E2F8/MEAF6/YY1 | 5 |
| GO:0002063 | GO:0002063 | chondrocyte development | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | PTHLH/SULF1 | 2 |
| GO:0015012 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | TCF7L2/HS3ST3B1 | 2 |
| GO:0016556 | GO:0016556 | mRNA modification | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | VIRMA/PUS7 | 2 |
| GO:0031128 | GO:0031128 | developmental induction | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | SOX8/AR | 2 |
| GO:0035305 | GO:0035305 | negative regulation of dephosphorylation | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | ARPP19/PPP1R1B | 2 |
| GO:0050858 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | ELF1/PRNP | 2 |
| GO:0051654 | GO:0051654 | establishment of mitochondrion localization | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | RHOT1/OPA1 | 2 |
| GO:0051973 | GO:0051973 | positive regulation of telomerase activity | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | MAPK1/KLF4 | 2 |
| GO:0060795 | GO:0060795 | cell fate commitment involved in formation of primary germ layer | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | ETS2/KLF4 | 2 |
| GO:1905207 | GO:1905207 | regulation of cardiocyte differentiation | 2/439 | 33/18888 | 0.0606061 | 2.6075792 | 1.4257501 | 0.1783122 | 0.5366702 | 0.4707166 | MEF2C/HEY2 | 2 |
| GO:0006650 | GO:0006650 | glycerophospholipid metabolic process | 10/439 | 307/18888 | 0.0325733 | 1.4014677 | 1.0939880 | 0.1795327 | 0.5396125 | 0.4732973 | MTM1/SOCS6/IPMK/SELENOI/MTMR12/PIP5K1A/SERINC5/PAFAH1B1/DDHD1/PLCB1 | 10 |
| GO:0030307 | GO:0030307 | positive regulation of cell growth | 6/439 | 163/18888 | 0.0368098 | 1.5837444 | 1.1546038 | 0.1798399 | 0.5396125 | 0.4732973 | PUM2/TEAD1/SYT4/CDH4/BDNF/PAFAH1B1 | 6 |
| GO:0051017 | GO:0051017 | actin filament bundle assembly | 6/439 | 163/18888 | 0.0368098 | 1.5837444 | 1.1546038 | 0.1798399 | 0.5396125 | 0.4732973 | MTSS1/ZEB2/EPHA1/SMAD3/PPFIA1/RGCC | 6 |
| GO:0014020 | GO:0014020 | primary neural tube formation | 4/439 | 95/18888 | 0.0421053 | 1.8115813 | 1.2232723 | 0.1799602 | 0.5396125 | 0.4732973 | FZD3/CTHRC1/SEC24B/OPA1 | 4 |
| GO:1990874 | GO:1990874 | vascular associated smooth muscle cell proliferation | 4/439 | 95/18888 | 0.0421053 | 1.8115813 | 1.2232723 | 0.1799602 | 0.5396125 | 0.4732973 | MEF2C/JUN/FGFR2/MAP3K5 | 4 |
| GO:0061951 | GO:0061951 | establishment of protein localization to plasma membrane | 3/439 | 63/18888 | 0.0476190 | 2.0488122 | 1.2862573 | 0.1804184 | 0.5405835 | 0.4741489 | RAB11A/NSG1/GORASP2 | 3 |
| GO:0018212 | GO:0018212 | peptidyl-tyrosine modification | 9/439 | 271/18888 | 0.0332103 | 1.4288764 | 1.0969563 | 0.1813887 | 0.5430865 | 0.4763443 | RAP2C/EPHA7/CLK4/EPHA1/EPHA3/FGFR2/EFEMP1/HDAC2/PRNP | 9 |
| GO:0006644 | GO:0006644 | phospholipid metabolic process | 12/439 | 383/18888 | 0.0313316 | 1.3480436 | 1.0614897 | 0.1831373 | 0.5479141 | 0.4805786 | MTM1/SGMS1/SOCS6/IPMK/SELENOI/MTMR12/PIP5K1A/SERINC5/PAFAH1B1/PLPPR4/DDHD1/PLCB1 | 12 |
| GO:0051236 | GO:0051236 | establishment of RNA localization | 6/439 | 164/18888 | 0.0365854 | 1.5740874 | 1.1390112 | 0.1833022 | 0.5480001 | 0.4806541 | SEH1L/YBX1/AHCTF1/RBFOX1/CETN3/NXT2 | 6 |
| GO:0046364 | GO:0046364 | monosaccharide biosynthetic process | 4/439 | 96/18888 | 0.0416667 | 1.7927107 | 1.2011332 | 0.1846060 | 0.5498511 | 0.4822775 | ARPP19/TCF7L2/SIRT1/KAT2B | 4 |
| GO:0031099 | GO:0031099 | regeneration | 7/439 | 200/18888 | 0.0350000 | 1.5058770 | 1.1094452 | 0.1852886 | 0.5498511 | 0.4822775 | PUM2/AKIRIN1/KPNA1/PPP3CA/TM4SF4/KLF4/PTPN12 | 7 |
| GO:0050864 | GO:0050864 | regulation of B cell activation | 5/439 | 130/18888 | 0.0384615 | 1.6548099 | 1.1556358 | 0.1858057 | 0.5498511 | 0.4822775 | VAV3/TFRC/MEF2C/SH3KBP1/RIF1 | 5 |
| GO:0001885 | GO:0001885 | endothelial cell development | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | RAP2C/RAP1B/PLCB1 | 3 |
| GO:0008631 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | PDCD10/SIRT1/MAP3K5 | 3 |
| GO:0030888 | GO:0030888 | regulation of B cell proliferation | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | VAV3/TFRC/MEF2C | 3 |
| GO:0043124 | GO:0043124 | negative regulation of canonical NF-kappaB signal transduction | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | RORA/SIRT1/TANK | 3 |
| GO:0048278 | GO:0048278 | vesicle docking | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | RAB12/CAV2/UNC13C | 3 |
| GO:0062208 | GO:0062208 | positive regulation of pattern recognition receptor signaling pathway | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | PUM2/PUM1/MAPK8 | 3 |
| GO:0070050 | GO:0070050 | neuron cellular homeostasis | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | TAOK1/CNR1/CALB1 | 3 |
| GO:0071384 | GO:0071384 | cellular response to corticosteroid stimulus | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | FBXO32/SRD5A1/REST | 3 |
| GO:2000179 | GO:2000179 | positive regulation of neural precursor cell proliferation | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | FZD3/PROX1/VCAN | 3 |
| GO:2001244 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 3/439 | 64/18888 | 0.0468750 | 2.0167995 | 1.2568884 | 0.1862642 | 0.5498511 | 0.4822775 | PRKRA/SIRT1/PLAGL2 | 3 |
| GO:0003382 | GO:0003382 | epithelial cell morphogenesis | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | FRMD6/AR | 2 |
| GO:0035459 | GO:0035459 | vesicle cargo loading | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | SEC24B/SEC24A | 2 |
| GO:0045939 | GO:0045939 | negative regulation of steroid metabolic process | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | REST/PROX1 | 2 |
| GO:0046320 | GO:0046320 | regulation of fatty acid oxidation | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | CNR1/APPL2 | 2 |
| GO:0070570 | GO:0070570 | regulation of neuron projection regeneration | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | PUM2/KLF4 | 2 |
| GO:0086019 | GO:0086019 | cell-cell signaling involved in cardiac conduction | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | RYR2/CACNA1D | 2 |
| GO:1902253 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2/439 | 34/18888 | 0.0588235 | 2.5308857 | 1.3781859 | 0.1867161 | 0.5498511 | 0.4822775 | SIRT1/HNRNPK | 2 |
| GO:0051494 | GO:0051494 | negative regulation of cytoskeleton organization | 6/439 | 165/18888 | 0.0363636 | 1.5645475 | 1.1235233 | 0.1867909 | 0.5498511 | 0.4822775 | TAOK1/TTBK2/PPFIA1/SLIT2/APC/KAT2B | 6 |
| GO:0021675 | GO:0021675 | nerve development | 4/439 | 97/18888 | 0.0412371 | 1.7742292 | 1.1792551 | 0.1892907 | 0.5568024 | 0.4883746 | SCN2A/SIX4/BDNF/SULF1 | 4 |
| GO:0038127 | GO:0038127 | ERBB signaling pathway | 5/439 | 131/18888 | 0.0381679 | 1.6421777 | 1.1377230 | 0.1897902 | 0.5578641 | 0.4893058 | MAPK1/HIP1/EFEMP1/SOS1/PTPN12 | 5 |
| GO:1903706 | GO:1903706 | regulation of hemopoiesis | 13/439 | 424/18888 | 0.0306604 | 1.3191645 | 1.0253259 | 0.1902615 | 0.5585620 | 0.4899180 | CDK6/ZMIZ1/PPP3CA/KAT6A/MEF2C/FBN1/JAG1/MEAF6/CREB1/CD46/TAL1/SOS1/MITF | 13 |
| GO:0051170 | GO:0051170 | import into nucleus | 6/439 | 166/18888 | 0.0361446 | 1.5551225 | 1.1081387 | 0.1903053 | 0.5585620 | 0.4899180 | KPNA1/PPP3CA/APPL2/SMAD3/PPP3R1/ATF2 | 6 |
| GO:0048588 | GO:0048588 | developmental cell growth | 8/439 | 238/18888 | 0.0336134 | 1.4462204 | 1.0686262 | 0.1910876 | 0.5600412 | 0.4912154 | PUM2/SYT4/EPHA7/CDH4/SLIT2/BDNF/PAFAH1B1/YY1 | 8 |
| GO:0051098 | GO:0051098 | regulation of binding | 8/439 | 238/18888 | 0.0336134 | 1.4462204 | 1.0686262 | 0.1910876 | 0.5600412 | 0.4912154 | JUN/HEY2/HMGA2/TTBK2/BTAF1/TCF7L2/BDNF/MAPK8 | 8 |
| GO:0003018 | GO:0003018 | vascular process in circulatory system | 9/439 | 275/18888 | 0.0327273 | 1.4080928 | 1.0515850 | 0.1921140 | 0.5615446 | 0.4925340 | TFRC/SLC6A6/ATP2B1/SLC1A2/ZEB2/ATP8A1/DOCK4/SLIT2/KAT2B | 9 |
| GO:0002011 | GO:0002011 | morphogenesis of an epithelial sheet | 3/439 | 65/18888 | 0.0461538 | 1.9857719 | 1.2280499 | 0.1921588 | 0.5615446 | 0.4925340 | JAG1/PDCD10/SOS1 | 3 |
| GO:0010573 | GO:0010573 | vascular endothelial growth factor production | 3/439 | 65/18888 | 0.0461538 | 1.9857719 | 1.2280499 | 0.1921588 | 0.5615446 | 0.4925340 | RORA/SULF1/IL1A | 3 |
| GO:0042058 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 3/439 | 65/18888 | 0.0461538 | 1.9857719 | 1.2280499 | 0.1921588 | 0.5615446 | 0.4925340 | HIP1/SOS1/PTPN12 | 3 |
| GO:2000779 | GO:2000779 | regulation of double-strand break repair | 5/439 | 132/18888 | 0.0378788 | 1.6297370 | 1.1199623 | 0.1938052 | 0.5621651 | 0.4930782 | HMGA2/MEAF6/SIRT1/EPC1/RIF1 | 5 |
| GO:0006665 | GO:0006665 | sphingolipid metabolic process | 6/439 | 167/18888 | 0.0359281 | 1.5458104 | 1.0928558 | 0.1938451 | 0.5621651 | 0.4930782 | SGMS1/PRKD3/CREM/PPM1L/SPTSSA/CERS6 | 6 |
| GO:0061572 | GO:0061572 | actin filament bundle organization | 6/439 | 167/18888 | 0.0359281 | 1.5458104 | 1.0928558 | 0.1938451 | 0.5621651 | 0.4930782 | MTSS1/ZEB2/EPHA1/SMAD3/PPFIA1/RGCC | 6 |
| GO:0021510 | GO:0021510 | spinal cord development | 4/439 | 98/18888 | 0.0408163 | 1.7561248 | 1.1576318 | 0.1940129 | 0.5621651 | 0.4930782 | EED/SRD5A1/PROX1/TAL1 | 4 |
| GO:0048534 | GO:0048534 | hematopoietic or lymphoid organ development | 4/439 | 98/18888 | 0.0408163 | 1.7561248 | 1.1576318 | 0.1940129 | 0.5621651 | 0.4930782 | MAPK1/JARID2/SIX4/SLC40A1 | 4 |
| GO:0097529 | GO:0097529 | myeloid leukocyte migration | 8/439 | 239/18888 | 0.0334728 | 1.4401693 | 1.0563753 | 0.1940173 | 0.5621651 | 0.4930782 | MAPK1/VAV3/AKIRIN1/B4GALT1/SLIT2/IL1A/PAFAH1B1/PLCB1 | 8 |
| GO:0022408 | GO:0022408 | negative regulation of cell-cell adhesion | 7/439 | 203/18888 | 0.0344828 | 1.4836227 | 1.0686499 | 0.1948245 | 0.5621651 | 0.4930782 | DLG5/SOCS6/JAG1/KLF4/RGCC/EPCAM/PRNP | 7 |
| GO:0009119 | GO:0009119 | ribonucleoside metabolic process | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | ADK/ENPP4 | 2 |
| GO:0009156 | GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | GART/ADK | 2 |
| GO:0030224 | GO:0030224 | monocyte differentiation | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | CDK6/SP3 | 2 |
| GO:0032212 | GO:0032212 | positive regulation of telomere maintenance via telomerase | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | MAPK1/TNKS2 | 2 |
| GO:0060122 | GO:0060122 | inner ear receptor cell stereocilium organization | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | CTHRC1/SEC24B | 2 |
| GO:0070293 | GO:0070293 | renal absorption | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | MLLT6/OXSR1 | 2 |
| GO:0099174 | GO:0099174 | regulation of presynapse organization | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | LRRTM3/SLITRK4 | 2 |
| GO:1901099 | GO:1901099 | negative regulation of signal transduction in absence of ligand | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | SGK3/IL1A | 2 |
| GO:1905606 | GO:1905606 | regulation of presynapse assembly | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | LRRTM3/SLITRK4 | 2 |
| GO:2001240 | GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2/439 | 35/18888 | 0.0571429 | 2.4585747 | 1.3322931 | 0.1951741 | 0.5621651 | 0.4930782 | SGK3/IL1A | 2 |
| GO:0042476 | GO:0042476 | odontogenesis | 5/439 | 133/18888 | 0.0375940 | 1.6174833 | 1.1023509 | 0.1978499 | 0.5621651 | 0.4930782 | DLX1/PRKCB/BCOR/FGFR2/HDAC2 | 5 |
| GO:0001947 | GO:0001947 | heart looping | 3/439 | 66/18888 | 0.0454545 | 1.9556844 | 1.1997228 | 0.1980996 | 0.5621651 | 0.4930782 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:0016445 | GO:0016445 | somatic diversification of immunoglobulins | 3/439 | 66/18888 | 0.0454545 | 1.9556844 | 1.1997228 | 0.1980996 | 0.5621651 | 0.4930782 | TFRC/YY1/RIF1 | 3 |
| GO:0030219 | GO:0030219 | megakaryocyte differentiation | 3/439 | 66/18888 | 0.0454545 | 1.9556844 | 1.1997228 | 0.1980996 | 0.5621651 | 0.4930782 | SP3/MEF2C/TAL1 | 3 |
| GO:0060042 | GO:0060042 | retina morphogenesis in camera-type eye | 3/439 | 66/18888 | 0.0454545 | 1.9556844 | 1.1997228 | 0.1980996 | 0.5621651 | 0.4930782 | CALB1/PROX1/SOX8 | 3 |
| GO:1905515 | GO:1905515 | non-motile cilium assembly | 3/439 | 66/18888 | 0.0454545 | 1.9556844 | 1.1997228 | 0.1980996 | 0.5621651 | 0.4930782 | ARL13B/CEP350/ATMIN | 3 |
| GO:0009798 | GO:0009798 | axis specification | 4/439 | 99/18888 | 0.0404040 | 1.7383861 | 1.1362572 | 0.1987715 | 0.5621651 | 0.4930782 | ARL13B/ETS2/HEY2/BCOR | 4 |
| GO:0019217 | GO:0019217 | regulation of fatty acid metabolic process | 4/439 | 99/18888 | 0.0404040 | 1.7383861 | 1.1362572 | 0.1987715 | 0.5621651 | 0.4930782 | CNR1/APPL2/SIRT1/KAT2B | 4 |
| GO:0061337 | GO:0061337 | cardiac conduction | 4/439 | 99/18888 | 0.0404040 | 1.7383861 | 1.1362572 | 0.1987715 | 0.5621651 | 0.4930782 | ATP2B1/ATP2B2/RYR2/CACNA1D | 4 |
| GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 4/439 | 99/18888 | 0.0404040 | 1.7383861 | 1.1362572 | 0.1987715 | 0.5621651 | 0.4930782 | RAB11A/RGCC/CDC25C/PLCB1 | 4 |
| GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 10/439 | 316/18888 | 0.0316456 | 1.3615524 | 0.9997993 | 0.2023354 | 0.5621651 | 0.4930782 | TAOK1/E2F8/MBTPS1/SYF2/ATF2/PROX1/KLF4/APC/RGCC/KAT2B | 10 |
| GO:0019935 | GO:0019935 | cyclic-nucleotide-mediated signaling | 4/439 | 100/18888 | 0.0400000 | 1.7210023 | 1.1151254 | 0.2035652 | 0.5621651 | 0.4930782 | PDE10A/EPHA5/ADCYAP1/CREB1 | 4 |
| GO:1903312 | GO:1903312 | negative regulation of mRNA metabolic process | 4/439 | 100/18888 | 0.0400000 | 1.7210023 | 1.1151254 | 0.2035652 | 0.5621651 | 0.4930782 | SRSF10/YBX1/HNRNPK/SFSWAP | 4 |
| GO:1902903 | GO:1902903 | regulation of supramolecular fiber organization | 12/439 | 392/18888 | 0.0306122 | 1.3170936 | 0.9786309 | 0.2036548 | 0.5621651 | 0.4930782 | MTSS1/TAOK1/WASHC4/EPHA1/SMAD3/TTBK2/PPFIA1/SLIT2/PROX1/MEGF9/APC/RGCC | 12 |
| GO:0002021 | GO:0002021 | response to dietary excess | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | SGIP1/APPL2 | 2 |
| GO:0009069 | GO:0009069 | serine family amino acid metabolic process | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | SERINC5/GART | 2 |
| GO:0021799 | GO:0021799 | cerebral cortex radially oriented cell migration | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | ZMIZ1/PAFAH1B1 | 2 |
| GO:0046329 | GO:0046329 | negative regulation of JNK cascade | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | MECOM/PAFAH1B1 | 2 |
| GO:1905168 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | MEAF6/EPC1 | 2 |
| GO:2000780 | GO:2000780 | negative regulation of double-strand break repair | 2/439 | 36/18888 | 0.0555556 | 2.3902809 | 1.2879602 | 0.2036789 | 0.5621651 | 0.4930782 | HMGA2/RIF1 | 2 |
| GO:0046888 | GO:0046888 | negative regulation of hormone secretion | 3/439 | 67/18888 | 0.0447761 | 1.9264951 | 1.1718891 | 0.2040842 | 0.5621651 | 0.4930782 | PPP3CA/REST/CRHBP | 3 |
| GO:0071674 | GO:0071674 | mononuclear cell migration | 7/439 | 206/18888 | 0.0339806 | 1.4620165 | 1.0285058 | 0.2045515 | 0.5621651 | 0.4930782 | MAPK1/AKIRIN1/CYP7B1/OXSR1/SLIT2/STK10/PLCB1 | 7 |
| GO:0043409 | GO:0043409 | negative regulation of MAPK cascade | 6/439 | 170/18888 | 0.0352941 | 1.5185314 | 1.0476040 | 0.2046116 | 0.5621651 | 0.4930782 | ASH1L/MECOM/SPRED1/RANBP9/PAFAH1B1/IRAK3 | 6 |
| GO:0052548 | GO:0052548 | regulation of endopeptidase activity | 9/439 | 280/18888 | 0.0321429 | 1.3829483 | 0.9958561 | 0.2058948 | 0.5621651 | 0.4930782 | EPHA7/HIP1/SMAD3/REST/SIRT1/SERPINB1/KLF4/MAP3K5/ST18 | 9 |
| GO:0031109 | GO:0031109 | microtubule polymerization or depolymerization | 5/439 | 135/18888 | 0.0370370 | 1.5935206 | 1.0675658 | 0.2060252 | 0.5621651 | 0.4930782 | TAOK1/TTBK2/KIF2A/RANBP9/APC | 5 |
| GO:0043269 | GO:0043269 | regulation of monoatomic ion transport | 14/439 | 470/18888 | 0.0297872 | 1.2815974 | 0.9536384 | 0.2070246 | 0.5621651 | 0.4930782 | SLC30A6/PPP3CA/ATP2B1/KCNN4/CNR1/SESTD1/CNTN1/YWHAQ/MLLT6/OXSR1/PPP3R1/RYR2/CACNA1D/PRNP | 14 |
| GO:0030856 | GO:0030856 | regulation of epithelial cell differentiation | 6/439 | 171/18888 | 0.0350877 | 1.5096511 | 1.0327144 | 0.2082479 | 0.5621651 | 0.4930782 | HEY2/JAG1/SPRED1/IL1A/AJAP1/PLCB1 | 6 |
| GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 11/439 | 356/18888 | 0.0308989 | 1.3294259 | 0.9679411 | 0.2082997 | 0.5621651 | 0.4930782 | RAB11A/CDK6/TAOK1/MBTPS1/APPL2/SYF2/KLF4/APC/RGCC/CDC25C/PLCB1 | 11 |
| GO:1990778 | GO:1990778 | protein localization to cell periphery | 11/439 | 356/18888 | 0.0308989 | 1.3294259 | 0.9679411 | 0.2082997 | 0.5621651 | 0.4930782 | RAB11A/RAB12/ARL13B/NSG1/EPHA3/PPFIA1/PIP5K1A/GPC6/AR/GORASP2/PRNP | 11 |
| GO:0010959 | GO:0010959 | regulation of metal ion transport | 12/439 | 394/18888 | 0.0304569 | 1.3104078 | 0.9604896 | 0.2083482 | 0.5621651 | 0.4930782 | SLC30A6/PPP3CA/ATP2B1/KCNN4/SESTD1/CNTN1/MLLT6/OXSR1/PPP3R1/RYR2/CACNA1D/PRNP | 12 |
| GO:0032784 | GO:0032784 | regulation of DNA-templated transcription elongation | 4/439 | 101/18888 | 0.0396040 | 1.7039627 | 1.0942308 | 0.2083927 | 0.5621651 | 0.4930782 | INTS6/CCNT2/INTS10/MED4 | 4 |
| GO:0042632 | GO:0042632 | cholesterol homeostasis | 4/439 | 101/18888 | 0.0396040 | 1.7039627 | 1.0942308 | 0.2083927 | 0.5621651 | 0.4930782 | RORA/CYP7B1/SIRT1/SEC24A | 4 |
| GO:0043255 | GO:0043255 | regulation of carbohydrate biosynthetic process | 4/439 | 101/18888 | 0.0396040 | 1.7039627 | 1.0942308 | 0.2083927 | 0.5621651 | 0.4930782 | ARPP19/TCF7L2/SIRT1/KAT2B | 4 |
| GO:0060761 | GO:0060761 | negative regulation of response to cytokine stimulus | 4/439 | 101/18888 | 0.0396040 | 1.7039627 | 1.0942308 | 0.2083927 | 0.5621651 | 0.4930782 | SLIT2/KLF4/IRAK3/TANK | 4 |
| GO:0006814 | GO:0006814 | sodium ion transport | 8/439 | 244/18888 | 0.0327869 | 1.4106576 | 0.9959386 | 0.2089400 | 0.5621651 | 0.4930782 | SCN2A/SLC6A6/CNTN1/MLLT6/OXSR1/SLC10A4/SLC17A6/SLC34A2 | 8 |
| GO:0043523 | GO:0043523 | regulation of neuron apoptotic process | 8/439 | 244/18888 | 0.0327869 | 1.4106576 | 0.9959386 | 0.2089400 | 0.5621651 | 0.4930782 | EPHA7/DLX1/NR4A2/MEF2C/SIX4/SIRT1/BDNF/PRNP | 8 |
| GO:0006646 | GO:0006646 | phosphatidylethanolamine biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SELENOI | 1 |
| GO:0006702 | GO:0006702 | androgen biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SRD5A1 | 1 |
| GO:0007440 | GO:0007440 | foregut morphogenesis | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SMAD3 | 1 |
| GO:0008627 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SCN2A | 1 |
| GO:0009170 | GO:0009170 | purine deoxyribonucleoside monophosphate metabolic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0009396 | GO:0009396 | folic acid-containing compound biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | GART | 1 |
| GO:0014745 | GO:0014745 | negative regulation of muscle adaptation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SMAD3 | 1 |
| GO:0014866 | GO:0014866 | skeletal myofibril assembly | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PROX1 | 1 |
| GO:0016081 | GO:0016081 | synaptic vesicle docking | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | UNC13C | 1 |
| GO:0021892 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | DLX1 | 1 |
| GO:0030643 | GO:0030643 | intracellular phosphate ion homeostasis | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SLC34A2 | 1 |
| GO:0032070 | GO:0032070 | regulation of deoxyribonuclease activity | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SIRT1 | 1 |
| GO:0032329 | GO:0032329 | serine transport | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SERINC5 | 1 |
| GO:0032353 | GO:0032353 | negative regulation of hormone biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0033004 | GO:0033004 | negative regulation of mast cell activation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | CNR1 | 1 |
| GO:0033572 | GO:0033572 | transferrin transport | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | TFRC | 1 |
| GO:0034651 | GO:0034651 | cortisol biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0035696 | GO:0035696 | monocyte extravasation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0038129 | GO:0038129 | ERBB3 signaling pathway | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | MAPK1 | 1 |
| GO:0044314 | GO:0044314 | protein K27-linked ubiquitination | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | AMFR | 1 |
| GO:0044837 | GO:0044837 | actomyosin contractile ring organization | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | IQGAP2 | 1 |
| GO:0048023 | GO:0048023 | positive regulation of melanin biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ZEB2 | 1 |
| GO:0048340 | GO:0048340 | paraxial mesoderm morphogenesis | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SMAD3 | 1 |
| GO:0048664 | GO:0048664 | neuron fate determination | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PROX1 | 1 |
| GO:0048672 | GO:0048672 | positive regulation of collateral sprouting | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | BDNF | 1 |
| GO:0048733 | GO:0048733 | sebaceous gland development | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ASH1L | 1 |
| GO:0050861 | GO:0050861 | positive regulation of B cell receptor signaling pathway | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PRKCB | 1 |
| GO:0051292 | GO:0051292 | nuclear pore complex assembly | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | AHCTF1 | 1 |
| GO:0051660 | GO:0051660 | establishment of centrosome localization | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PAFAH1B1 | 1 |
| GO:0060052 | GO:0060052 | neurofilament cytoskeleton organization | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ATF2 | 1 |
| GO:0060054 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | B4GALT1 | 1 |
| GO:0060245 | GO:0060245 | detection of cell density | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ATF2 | 1 |
| GO:0060368 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | APPL2 | 1 |
| GO:0060430 | GO:0060430 | lung saccule development | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | CREB1 | 1 |
| GO:0060502 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | FGFR2 | 1 |
| GO:0060525 | GO:0060525 | prostate glandular acinus development | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | FGFR2 | 1 |
| GO:0060717 | GO:0060717 | chorion development | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | E2F8 | 1 |
| GO:0060768 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0060947 | GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | HEY2 | 1 |
| GO:0070922 | GO:0070922 | RISC complex assembly | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | PRKRA | 1 |
| GO:0072172 | GO:0072172 | mesonephric tubule formation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SIX4 | 1 |
| GO:0090085 | GO:0090085 | regulation of protein deubiquitination | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | TANK | 1 |
| GO:0090269 | GO:0090269 | fibroblast growth factor production | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | RGCC | 1 |
| GO:0090270 | GO:0090270 | regulation of fibroblast growth factor production | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | RGCC | 1 |
| GO:0140719 | GO:0140719 | constitutive heterochromatin formation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | RIF1 | 1 |
| GO:1900378 | GO:1900378 | positive regulation of secondary metabolite biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ZEB2 | 1 |
| GO:1902645 | GO:1902645 | tertiary alcohol biosynthetic process | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:1990253 | GO:1990253 | cellular response to leucine starvation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | ATF2 | 1 |
| GO:1990700 | GO:1990700 | nucleolar chromatin organization | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SIRT1 | 1 |
| GO:2000253 | GO:2000253 | positive regulation of feeding behavior | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | SGIP1 | 1 |
| GO:2000739 | GO:2000739 | regulation of mesenchymal stem cell differentiation | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:2000822 | GO:2000822 | regulation of behavioral fear response | 1/439 | 10/18888 | 0.1000000 | 4.3025057 | 1.6113613 | 0.2096054 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:0010972 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 3/439 | 68/18888 | 0.0441176 | 1.8981643 | 1.1445315 | 0.2101100 | 0.5621651 | 0.4930782 | TAOK1/MBTPS1/SYF2 | 3 |
| GO:0042987 | GO:0042987 | amyloid precursor protein catabolic process | 3/439 | 68/18888 | 0.0441176 | 1.8981643 | 1.1445315 | 0.2101100 | 0.5621651 | 0.4930782 | LRRTM3/RANBP9/PRNP | 3 |
| GO:0046513 | GO:0046513 | ceramide biosynthetic process | 3/439 | 68/18888 | 0.0441176 | 1.8981643 | 1.1445315 | 0.2101100 | 0.5621651 | 0.4930782 | SGMS1/SPTSSA/CERS6 | 3 |
| GO:0051055 | GO:0051055 | negative regulation of lipid biosynthetic process | 3/439 | 68/18888 | 0.0441176 | 1.8981643 | 1.1445315 | 0.2101100 | 0.5621651 | 0.4930782 | REST/SIRT1/PROX1 | 3 |
| GO:0051926 | GO:0051926 | negative regulation of calcium ion transport | 3/439 | 68/18888 | 0.0441176 | 1.8981643 | 1.1445315 | 0.2101100 | 0.5621651 | 0.4930782 | PPP3CA/SESTD1/PPP3R1 | 3 |
| GO:0007041 | GO:0007041 | lysosomal transport | 5/439 | 136/18888 | 0.0367647 | 1.5818036 | 1.0503871 | 0.2101543 | 0.5621651 | 0.4930782 | MTM1/HOOK3/PLEKHF2/RAB12/SCYL2 | 5 |
| GO:0051656 | GO:0051656 | establishment of organelle localization | 14/439 | 472/18888 | 0.0296610 | 1.2761669 | 0.9372865 | 0.2113393 | 0.5621651 | 0.4930782 | HOOK3/RAB11A/SEH1L/SYT4/CEP120/PPP6C/PDCD10/CHAMP1/APC/PAFAH1B1/RHOT1/OPA1/KAT2B/UNC13C | 14 |
| GO:0018105 | GO:0018105 | peptidyl-serine phosphorylation | 9/439 | 282/18888 | 0.0319149 | 1.3731401 | 0.9738618 | 0.2115183 | 0.5621651 | 0.4930782 | MAPK1/TFRC/PRKCB/MAST4/TTBK2/PDCD10/BDNF/SGK3/MAPK8 | 9 |
| GO:0090257 | GO:0090257 | regulation of muscle system process | 8/439 | 245/18888 | 0.0326531 | 1.4048998 | 0.9840112 | 0.2119776 | 0.5621651 | 0.4930782 | PPP3CA/JARID2/ATP2B1/FBXO32/SMAD3/DOCK4/RYR2/YY1 | 8 |
| GO:0002052 | GO:0002052 | positive regulation of neuroblast proliferation | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | FZD3/VCAN | 2 |
| GO:0003161 | GO:0003161 | cardiac conduction system development | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | HEY2/HEY1 | 2 |
| GO:0007031 | GO:0007031 | peroxisome organization | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | PEX5/PEX3 | 2 |
| GO:0008207 | GO:0008207 | C21-steroid hormone metabolic process | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | SRD5A1/REST | 2 |
| GO:0010934 | GO:0010934 | macrophage cytokine production | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | SIRT1/IRAK3 | 2 |
| GO:0010935 | GO:0010935 | regulation of macrophage cytokine production | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | SIRT1/IRAK3 | 2 |
| GO:0021696 | GO:0021696 | cerebellar cortex morphogenesis | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | RORA/PROX1 | 2 |
| GO:0022616 | GO:0022616 | DNA strand elongation | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | INO80D/YY1 | 2 |
| GO:0031076 | GO:0031076 | embryonic camera-type eye development | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | SP3/PROX1 | 2 |
| GO:0045191 | GO:0045191 | regulation of isotype switching | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | TFRC/RIF1 | 2 |
| GO:0045773 | GO:0045773 | positive regulation of axon extension | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | CDH4/PAFAH1B1 | 2 |
| GO:0046326 | GO:0046326 | positive regulation of glucose import | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | ARPP19/SLC1A2 | 2 |
| GO:0046677 | GO:0046677 | response to antibiotic | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | MEF2C/SRD5A1 | 2 |
| GO:0048730 | GO:0048730 | epidermis morphogenesis | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | FGFR2/KLF4 | 2 |
| GO:1902275 | GO:1902275 | regulation of chromatin organization | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | L3MBTL3/TAL1 | 2 |
| GO:1905898 | GO:1905898 | positive regulation of response to endoplasmic reticulum stress | 2/439 | 37/18888 | 0.0540541 | 2.3256788 | 1.2450858 | 0.2122240 | 0.5621651 | 0.4930782 | SIRT1/TMEM33 | 2 |
| GO:0050900 | GO:0050900 | leukocyte migration | 12/439 | 396/18888 | 0.0303030 | 1.3037896 | 0.9424447 | 0.2130884 | 0.5621651 | 0.4930782 | MAPK1/VAV3/AKIRIN1/CYP7B1/B4GALT1/OXSR1/SLIT2/IL1A/PAFAH1B1/SOS1/STK10/PLCB1 | 12 |
| GO:0001841 | GO:0001841 | neural tube formation | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | FZD3/CTHRC1/SEC24B/OPA1 | 4 |
| GO:0007200 | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | PRKCB/PRKD3/ITPR1/PLCB1 | 4 |
| GO:0008585 | GO:0008585 | female gonad development | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | TAF4/CSMD1/SLIT2/SIRT1 | 4 |
| GO:0035967 | GO:0035967 | cellular response to topologically incorrect protein | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | PARP8/MBTPS1/AMFR/TMEM33 | 4 |
| GO:0043266 | GO:0043266 | regulation of potassium ion transport | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | KCNN4/OXSR1/CACNA1D/PRNP | 4 |
| GO:0055092 | GO:0055092 | sterol homeostasis | 4/439 | 102/18888 | 0.0392157 | 1.6872571 | 1.0735679 | 0.2132528 | 0.5621651 | 0.4930782 | RORA/CYP7B1/SIRT1/SEC24A | 4 |
| GO:0035270 | GO:0035270 | endocrine system development | 5/439 | 137/18888 | 0.0364964 | 1.5702576 | 1.0333476 | 0.2143101 | 0.5621651 | 0.4930782 | MAPK1/CDK6/SRD5A1/SMAD3/CREB1 | 5 |
| GO:1904375 | GO:1904375 | regulation of protein localization to cell periphery | 5/439 | 137/18888 | 0.0364964 | 1.5702576 | 1.0333476 | 0.2143101 | 0.5621651 | 0.4930782 | EPHA3/PPFIA1/GPC6/AR/PRNP | 5 |
| GO:0050769 | GO:0050769 | positive regulation of neurogenesis | 8/439 | 246/18888 | 0.0325203 | 1.3991888 | 0.9721360 | 0.2150323 | 0.5621651 | 0.4930782 | FZD3/CDH4/SLIT2/VCAN/BDNF/SOX8/PAFAH1B1/HDAC2 | 8 |
| GO:0045926 | GO:0045926 | negative regulation of growth | 8/439 | 247/18888 | 0.0323887 | 1.3935241 | 0.9603124 | 0.2181037 | 0.5621651 | 0.4930782 | EPHA7/JARID2/WWC2/KCNK2/SMAD3/SLIT2/ADIPOR1/YY1 | 8 |
| GO:0002768 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 11/439 | 360/18888 | 0.0305556 | 1.3146545 | 0.9298187 | 0.2183384 | 0.5621651 | 0.4930782 | MAPK1/VAV3/MEF2C/KCNN4/APPL2/PRKCB/ELF1/SOS1/IRAK2/MAPK8/PRNP | 11 |
| GO:0006986 | GO:0006986 | response to unfolded protein | 5/439 | 138/18888 | 0.0362319 | 1.5588789 | 1.0164451 | 0.2184919 | 0.5621651 | 0.4930782 | CREBRF/PARP8/MBTPS1/AMFR/TMEM33 | 5 |
| GO:0030048 | GO:0030048 | actin filament-based movement | 5/439 | 138/18888 | 0.0362319 | 1.5588789 | 1.0164451 | 0.2184919 | 0.5621651 | 0.4930782 | SCN2A/ZEB2/RYR2/CACNA1D/FRMD6 | 5 |
| GO:0048660 | GO:0048660 | regulation of smooth muscle cell proliferation | 6/439 | 174/18888 | 0.0344828 | 1.4836227 | 0.9886106 | 0.2192918 | 0.5621651 | 0.4930782 | MEF2C/JUN/TCF7L2/FGFR2/KLF4/MAP3K5 | 6 |
| GO:0031952 | GO:0031952 | regulation of protein autophosphorylation | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | RAP2C/EPHA7 | 2 |
| GO:0032965 | GO:0032965 | regulation of collagen biosynthetic process | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | RGCC/HDAC2 | 2 |
| GO:0043516 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | SPRED1/SIRT1 | 2 |
| GO:0045738 | GO:0045738 | negative regulation of DNA repair | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | HMGA2/RIF1 | 2 |
| GO:0045823 | GO:0045823 | positive regulation of heart contraction | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | HEY2/RYR2 | 2 |
| GO:0048536 | GO:0048536 | spleen development | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | JARID2/SLC40A1 | 2 |
| GO:0071392 | GO:0071392 | cellular response to estradiol stimulus | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | SRD5A1/CRHBP | 2 |
| GO:1902110 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | ATF2/RHOT1 | 2 |
| GO:1902229 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | SIRT1/HNRNPK | 2 |
| GO:1904358 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 2/439 | 38/18888 | 0.0526316 | 2.2644767 | 1.2035781 | 0.2208029 | 0.5621651 | 0.4930782 | MAPK1/TNKS2 | 2 |
| GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 8/439 | 248/18888 | 0.0322581 | 1.3879051 | 0.9485400 | 0.2211916 | 0.5621651 | 0.4930782 | TAOK1/FZD3/MBTPS1/SYF2/ATF2/KLF4/APC/RGCC | 8 |
| GO:0002562 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 3/439 | 70/18888 | 0.0428571 | 1.8439310 | 1.0911804 | 0.2222756 | 0.5621651 | 0.4930782 | TFRC/YY1/RIF1 | 3 |
| GO:0016444 | GO:0016444 | somatic cell DNA recombination | 3/439 | 70/18888 | 0.0428571 | 1.8439310 | 1.0911804 | 0.2222756 | 0.5621651 | 0.4930782 | TFRC/YY1/RIF1 | 3 |
| GO:1902750 | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 3/439 | 70/18888 | 0.0428571 | 1.8439310 | 1.0911804 | 0.2222756 | 0.5621651 | 0.4930782 | TAOK1/MBTPS1/SYF2 | 3 |
| GO:0002027 | GO:0002027 | regulation of heart rate | 4/439 | 104/18888 | 0.0384615 | 1.6548099 | 1.0329164 | 0.2230658 | 0.5621651 | 0.4930782 | TMEM161B/HEY2/RYR2/CACNA1D | 4 |
| GO:0009408 | GO:0009408 | response to heat | 4/439 | 104/18888 | 0.0384615 | 1.6548099 | 1.0329164 | 0.2230658 | 0.5621651 | 0.4930782 | SIRT1/IL1A/HDAC2/TFEC | 4 |
| GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 4/439 | 104/18888 | 0.0384615 | 1.6548099 | 1.0329164 | 0.2230658 | 0.5621651 | 0.4930782 | TFRC/PPP3CA/CD46/IL1A | 4 |
| GO:0042098 | GO:0042098 | T cell proliferation | 7/439 | 213/18888 | 0.0328638 | 1.4139690 | 0.9372483 | 0.2279368 | 0.5621651 | 0.4930782 | DLG5/TFRC/PPP3CA/CD46/IL1A/SOS1/PRNP | 7 |
| GO:0001820 | GO:0001820 | serotonin secretion | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CNR1 | 1 |
| GO:0001865 | GO:0001865 | NK T cell differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ATF2 | 1 |
| GO:0002924 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CD46 | 1 |
| GO:0003139 | GO:0003139 | secondary heart field specification | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:0006188 | GO:0006188 | IMP biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | GART | 1 |
| GO:0006475 | GO:0006475 | internal protein amino acid acetylation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | KAT2B | 1 |
| GO:0006686 | GO:0006686 | sphingomyelin biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SGMS1 | 1 |
| GO:0007343 | GO:0007343 | egg activation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0007406 | GO:0007406 | negative regulation of neuroblast proliferation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PROX1 | 1 |
| GO:0007614 | GO:0007614 | short-term memory | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CALB1 | 1 |
| GO:0014049 | GO:0014049 | positive regulation of glutamate secretion | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SYT4 | 1 |
| GO:0019065 | GO:0019065 | receptor-mediated endocytosis of virus by host cell | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CAV2 | 1 |
| GO:0019511 | GO:0019511 | peptidyl-proline hydroxylation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | EGLN1 | 1 |
| GO:0021889 | GO:0021889 | olfactory bulb interneuron differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SLIT2 | 1 |
| GO:0031650 | GO:0031650 | regulation of heat generation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CNR1 | 1 |
| GO:0031943 | GO:0031943 | regulation of glucocorticoid metabolic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0032261 | GO:0032261 | purine nucleotide salvage | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0032342 | GO:0032342 | aldosterone biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0032836 | GO:0032836 | glomerular basement membrane development | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SULF1 | 1 |
| GO:0033148 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0033327 | GO:0033327 | Leydig cell differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0033625 | GO:0033625 | positive regulation of integrin activation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | RAP1B | 1 |
| GO:0034085 | GO:0034085 | establishment of sister chromatid cohesion | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SMC3 | 1 |
| GO:0034115 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | KLF4 | 1 |
| GO:0035561 | GO:0035561 | regulation of chromatin binding | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | BTAF1 | 1 |
| GO:0035723 | GO:0035723 | interleukin-15-mediated signaling pathway | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0035878 | GO:0035878 | nail development | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PRKAB1 | 1 |
| GO:0042428 | GO:0042428 | serotonin metabolic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SRD5A1 | 1 |
| GO:0042447 | GO:0042447 | hormone catabolic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SRD5A1 | 1 |
| GO:0042451 | GO:0042451 | purine nucleoside biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0042455 | GO:0042455 | ribonucleoside biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0043278 | GO:0043278 | response to morphine | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PPP1R1B | 1 |
| GO:0045602 | GO:0045602 | negative regulation of endothelial cell differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0046129 | GO:0046129 | purine ribonucleoside biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0048630 | GO:0048630 | skeletal muscle tissue growth | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MTM1 | 1 |
| GO:0048671 | GO:0048671 | negative regulation of collateral sprouting | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | EPHA7 | 1 |
| GO:0051095 | GO:0051095 | regulation of helicase activity | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SIRT1 | 1 |
| GO:0051987 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | KAT2B | 1 |
| GO:0060020 | GO:0060020 | Bergmann glial cell differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MAPK1 | 1 |
| GO:0060159 | GO:0060159 | regulation of dopamine receptor signaling pathway | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CAV2 | 1 |
| GO:0060439 | GO:0060439 | trachea morphogenesis | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MAPK1 | 1 |
| GO:0060767 | GO:0060767 | epithelial cell proliferation involved in prostate gland development | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0060900 | GO:0060900 | embryonic camera-type eye formation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PROX1 | 1 |
| GO:0061370 | GO:0061370 | testosterone biosynthetic process | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CREB1 | 1 |
| GO:0062111 | GO:0062111 | zinc ion import into organelle | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SLC30A6 | 1 |
| GO:0070587 | GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | KLF4 | 1 |
| GO:0070778 | GO:0070778 | L-aspartate transmembrane transport | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SLC1A2 | 1 |
| GO:0070934 | GO:0070934 | CRD-mediated mRNA stabilization | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | YBX1 | 1 |
| GO:0071313 | GO:0071313 | cellular response to caffeine | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | RYR2 | 1 |
| GO:0071349 | GO:0071349 | cellular response to interleukin-12 | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0071350 | GO:0071350 | cellular response to interleukin-15 | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0071476 | GO:0071476 | cellular hypotonic response | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | OXSR1 | 1 |
| GO:0071609 | GO:0071609 | chemokine (C-C motif) ligand 5 production | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADCYAP1 | 1 |
| GO:0071649 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ADCYAP1 | 1 |
| GO:0072015 | GO:0072015 | podocyte development | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0072173 | GO:0072173 | metanephric tubule morphogenesis | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SOX8 | 1 |
| GO:0072178 | GO:0072178 | nephric duct morphogenesis | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | EPHA7 | 1 |
| GO:0072584 | GO:0072584 | caveolin-mediated endocytosis | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MAPK1 | 1 |
| GO:0086016 | GO:0086016 | AV node cell action potential | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | RYR2 | 1 |
| GO:0086027 | GO:0086027 | AV node cell to bundle of His cell signaling | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | RYR2 | 1 |
| GO:0090009 | GO:0090009 | primitive streak formation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ETS2 | 1 |
| GO:0090161 | GO:0090161 | Golgi ribbon formation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | VAMP4 | 1 |
| GO:0090178 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SEC24B | 1 |
| GO:0090557 | GO:0090557 | establishment of endothelial intestinal barrier | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | RAP2C | 1 |
| GO:0098696 | GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | GPC6 | 1 |
| GO:0098885 | GO:0098885 | modification of postsynaptic actin cytoskeleton | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CTTNBP2 | 1 |
| GO:0099519 | GO:0099519 | dense core granule cytoskeletal transport | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SYT4 | 1 |
| GO:0099624 | GO:0099624 | atrial cardiac muscle cell membrane repolarization | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | CACNA1D | 1 |
| GO:1901950 | GO:1901950 | dense core granule transport | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | SYT4 | 1 |
| GO:1903365 | GO:1903365 | regulation of fear response | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:1903897 | GO:1903897 | regulation of PERK-mediated unfolded protein response | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | TMEM33 | 1 |
| GO:1990034 | GO:1990034 | calcium ion export across plasma membrane | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | ATP2B1 | 1 |
| GO:2000344 | GO:2000344 | positive regulation of acrosome reaction | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:2000727 | GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:2001204 | GO:2001204 | regulation of osteoclast development | 1/439 | 11/18888 | 0.0909091 | 3.9113688 | 1.4898907 | 0.2279857 | 0.5621651 | 0.4930782 | FBN1 | 1 |
| GO:0045639 | GO:0045639 | positive regulation of myeloid cell differentiation | 4/439 | 105/18888 | 0.0380952 | 1.6390498 | 1.0129178 | 0.2280161 | 0.5621651 | 0.4930782 | PPP3CA/JAG1/CREB1/TAL1 | 4 |
| GO:0035567 | GO:0035567 | non-canonical Wnt signaling pathway | 3/439 | 71/18888 | 0.0422535 | 1.8179602 | 1.0651566 | 0.2284104 | 0.5621651 | 0.4930782 | SMURF2/FZD3/CTHRC1 | 3 |
| GO:0048488 | GO:0048488 | synaptic vesicle endocytosis | 3/439 | 71/18888 | 0.0422535 | 1.8179602 | 1.0651566 | 0.2284104 | 0.5621651 | 0.4930782 | DNAJC6/VAMP4/AP2B1 | 3 |
| GO:0061371 | GO:0061371 | determination of heart left/right asymmetry | 3/439 | 71/18888 | 0.0422535 | 1.8179602 | 1.0651566 | 0.2284104 | 0.5621651 | 0.4930782 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:1901880 | GO:1901880 | negative regulation of protein depolymerization | 3/439 | 71/18888 | 0.0422535 | 1.8179602 | 1.0651566 | 0.2284104 | 0.5621651 | 0.4930782 | TAOK1/TTBK2/APC | 3 |
| GO:0007340 | GO:0007340 | acrosome reaction | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | B4GALT1/PLCB1 | 2 |
| GO:0014912 | GO:0014912 | negative regulation of smooth muscle cell migration | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | MEF2C/SLIT2 | 2 |
| GO:0016233 | GO:0016233 | telomere capping | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | MAPK1/TNKS2 | 2 |
| GO:0032350 | GO:0032350 | regulation of hormone metabolic process | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | REST/TCF7L2 | 2 |
| GO:0033028 | GO:0033028 | myeloid cell apoptotic process | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | MEF2C/SIRT1 | 2 |
| GO:0038179 | GO:0038179 | neurotrophin signaling pathway | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | BDNF/SOS1 | 2 |
| GO:0042044 | GO:0042044 | fluid transport | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | MLLT6/ITPR1 | 2 |
| GO:0048741 | GO:0048741 | skeletal muscle fiber development | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | PPP3CA/CAV2 | 2 |
| GO:0051349 | GO:0051349 | positive regulation of lyase activity | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | ADCYAP1/CACNA1D | 2 |
| GO:0051938 | GO:0051938 | L-glutamate import | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | SLC1A2/SLC17A6 | 2 |
| GO:1903524 | GO:1903524 | positive regulation of blood circulation | 2/439 | 39/18888 | 0.0512821 | 2.2064132 | 1.1633531 | 0.2294094 | 0.5621651 | 0.4930782 | HEY2/RYR2 | 2 |
| GO:0032204 | GO:0032204 | regulation of telomere maintenance | 4/439 | 106/18888 | 0.0377358 | 1.6235871 | 0.9931308 | 0.2329940 | 0.5621651 | 0.4930782 | MAPK1/INO80D/TNKS2/YY1 | 4 |
| GO:0035303 | GO:0035303 | regulation of dephosphorylation | 4/439 | 106/18888 | 0.0377358 | 1.6235871 | 0.9931308 | 0.2329940 | 0.5621651 | 0.4930782 | ARPP19/MEF2C/CAMTA1/PPP1R1B | 4 |
| GO:0046545 | GO:0046545 | development of primary female sexual characteristics | 4/439 | 106/18888 | 0.0377358 | 1.6235871 | 0.9931308 | 0.2329940 | 0.5621651 | 0.4930782 | TAF4/CSMD1/SLIT2/SIRT1 | 4 |
| GO:0032984 | GO:0032984 | protein-containing complex disassembly | 8/439 | 252/18888 | 0.0317460 | 1.3658748 | 0.9019527 | 0.2337026 | 0.5621651 | 0.4930782 | DNAJC6/TAOK1/TTBK2/GSPT1/KIF2A/PEX5/APC/IRAK3 | 8 |
| GO:0048659 | GO:0048659 | smooth muscle cell proliferation | 6/439 | 178/18888 | 0.0337079 | 1.4502828 | 0.9310775 | 0.2343135 | 0.5621651 | 0.4930782 | MEF2C/JUN/TCF7L2/FGFR2/KLF4/MAP3K5 | 6 |
| GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 10/439 | 328/18888 | 0.0304878 | 1.3117395 | 0.8785514 | 0.2345256 | 0.5621651 | 0.4930782 | VAV3/ZMIZ1/TFRC/PPP3CA/MEF2C/SH3KBP1/MAP3K8/CD46/IL1A/RIF1 | 10 |
| GO:0010569 | GO:0010569 | regulation of double-strand break repair via homologous recombination | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | MEAF6/EPC1/RIF1 | 3 |
| GO:0030032 | GO:0030032 | lamellipodium assembly | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | VAV3/AKIRIN1/SLIT2 | 3 |
| GO:0140238 | GO:0140238 | presynaptic endocytosis | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | DNAJC6/VAMP4/AP2B1 | 3 |
| GO:1901184 | GO:1901184 | regulation of ERBB signaling pathway | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | HIP1/SOS1/PTPN12 | 3 |
| GO:1903053 | GO:1903053 | regulation of extracellular matrix organization | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | ANGPTL7/SMAD3/RGCC | 3 |
| GO:1904888 | GO:1904888 | cranial skeletal system development | 3/439 | 72/18888 | 0.0416667 | 1.7927107 | 1.0395483 | 0.2345768 | 0.5621651 | 0.4930782 | SIX4/SMAD3/FGFR2 | 3 |
| GO:0034284 | GO:0034284 | response to monosaccharide | 7/439 | 215/18888 | 0.0325581 | 1.4008158 | 0.9117680 | 0.2347824 | 0.5621651 | 0.4930782 | PPP3CA/PRKCB/EPHA5/SMAD3/TCF7L2/IL1A/PLCB1 | 7 |
| GO:0060348 | GO:0060348 | bone development | 7/439 | 215/18888 | 0.0325581 | 1.4008158 | 0.9117680 | 0.2347824 | 0.5621651 | 0.4930782 | MEF2C/FBN1/SRD5A1/FGFR2/ATF2/SULF1/PAFAH1B1 | 7 |
| GO:0046165 | GO:0046165 | alcohol biosynthetic process | 5/439 | 142/18888 | 0.0352113 | 1.5149668 | 0.9501593 | 0.2354626 | 0.5621651 | 0.4930782 | IPMK/MBTPS1/REST/SEC14L2/SPTSSA | 5 |
| GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 5/439 | 142/18888 | 0.0352113 | 1.5149668 | 0.9501593 | 0.2354626 | 0.5621651 | 0.4930782 | MAPK1/AKIRIN1/SMAD3/OXSR1/SLIT2 | 5 |
| GO:0008202 | GO:0008202 | steroid metabolic process | 10/439 | 329/18888 | 0.0303951 | 1.3077525 | 0.8686595 | 0.2372921 | 0.5621651 | 0.4930782 | MBTPS1/SRD5A1/RORA/CYP7B1/REST/CREB1/SIRT1/PROX1/SEC14L2/IL1A | 10 |
| GO:0008637 | GO:0008637 | apoptotic mitochondrial changes | 4/439 | 107/18888 | 0.0373832 | 1.6084133 | 0.9735508 | 0.2379983 | 0.5621651 | 0.4930782 | ATF2/RHOT1/OPA1/NDUFS1 | 4 |
| GO:0000266 | GO:0000266 | mitochondrial fission | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | OPA1/DDHD1 | 2 |
| GO:0001953 | GO:0001953 | negative regulation of cell-matrix adhesion | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | JAG1/AJAP1 | 2 |
| GO:0007212 | GO:0007212 | dopamine receptor signaling pathway | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | NSG1/CAV2 | 2 |
| GO:0009167 | GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | GART/ADK | 2 |
| GO:0017004 | GO:0017004 | cytochrome complex assembly | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | COX18/COX16 | 2 |
| GO:0030279 | GO:0030279 | negative regulation of ossification | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | MEF2C/BCOR | 2 |
| GO:0045429 | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | SMAD3/KLF4 | 2 |
| GO:0046676 | GO:0046676 | negative regulation of insulin secretion | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | PPP3CA/REST | 2 |
| GO:0048246 | GO:0048246 | macrophage chemotaxis | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | MAPK1/AKIRIN1 | 2 |
| GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | JARID2/CHAMP1 | 2 |
| GO:1902686 | GO:1902686 | mitochondrial outer membrane permeabilization involved in programmed cell death | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | ATF2/RHOT1 | 2 |
| GO:1902742 | GO:1902742 | apoptotic process involved in development | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | SLIT2/ATF2 | 2 |
| GO:1903115 | GO:1903115 | regulation of actin filament-based movement | 2/439 | 40/18888 | 0.0500000 | 2.1512528 | 1.1243342 | 0.2380376 | 0.5621651 | 0.4930782 | ZEB2/RYR2 | 2 |
| GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint signaling | 5/439 | 143/18888 | 0.0349650 | 1.5043726 | 0.9339081 | 0.2397624 | 0.5621651 | 0.4930782 | TAOK1/MBTPS1/SYF2/ATF2/APC | 5 |
| GO:0006879 | GO:0006879 | intracellular iron ion homeostasis | 3/439 | 73/18888 | 0.0410959 | 1.7681530 | 1.0143420 | 0.2407725 | 0.5621651 | 0.4930782 | TFRC/EGLN1/SLC40A1 | 3 |
| GO:0051865 | GO:0051865 | protein autoubiquitination | 3/439 | 73/18888 | 0.0410959 | 1.7681530 | 1.0143420 | 0.2407725 | 0.5621651 | 0.4930782 | LTN1/AMFR/UBE2D3 | 3 |
| GO:0090307 | GO:0090307 | mitotic spindle assembly | 3/439 | 73/18888 | 0.0410959 | 1.7681530 | 1.0143420 | 0.2407725 | 0.5621651 | 0.4930782 | RAB11A/SMC3/KIF2A | 3 |
| GO:0001776 | GO:0001776 | leukocyte homeostasis | 4/439 | 108/18888 | 0.0370370 | 1.5935206 | 0.9541732 | 0.2430276 | 0.5621651 | 0.4930782 | DOCK10/MEF2C/SLC40A1/SOS1 | 4 |
| GO:0060291 | GO:0060291 | long-term synaptic potentiation | 4/439 | 108/18888 | 0.0370370 | 1.5935206 | 0.9541732 | 0.2430276 | 0.5621651 | 0.4930782 | MAPK1/NSG1/CALB1/PRNP | 4 |
| GO:1901796 | GO:1901796 | regulation of signal transduction by p53 class mediator | 4/439 | 108/18888 | 0.0370370 | 1.5935206 | 0.9541732 | 0.2430276 | 0.5621651 | 0.4930782 | KAT6A/SPRED1/SIRT1/HNRNPK | 4 |
| GO:1902414 | GO:1902414 | protein localization to cell junction | 4/439 | 108/18888 | 0.0370370 | 1.5935206 | 0.9541732 | 0.2430276 | 0.5621651 | 0.4930782 | RAB11A/DLG5/NSG1/GPC6 | 4 |
| GO:1903076 | GO:1903076 | regulation of protein localization to plasma membrane | 4/439 | 108/18888 | 0.0370370 | 1.5935206 | 0.9541732 | 0.2430276 | 0.5621651 | 0.4930782 | EPHA3/PPFIA1/AR/PRNP | 4 |
| GO:0072659 | GO:0072659 | protein localization to plasma membrane | 9/439 | 293/18888 | 0.0307167 | 1.3215888 | 0.8557836 | 0.2434913 | 0.5621651 | 0.4930782 | RAB11A/RAB12/NSG1/EPHA3/PPFIA1/PIP5K1A/AR/GORASP2/PRNP | 9 |
| GO:0002429 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 10/439 | 332/18888 | 0.0301205 | 1.2959355 | 0.8391724 | 0.2456631 | 0.5621651 | 0.4930782 | MAPK1/VAV3/MEF2C/KCNN4/APPL2/PRKCB/ELF1/SOS1/IRAK2/PRNP | 10 |
| GO:0000012 | GO:0000012 | single strand break repair | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SIRT1 | 1 |
| GO:0000101 | GO:0000101 | sulfur amino acid transport | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SLC1A2 | 1 |
| GO:0001765 | GO:0001765 | membrane raft assembly | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CAV2 | 1 |
| GO:0002328 | GO:0002328 | pro-B cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SOS1 | 1 |
| GO:0002645 | GO:0002645 | positive regulation of tolerance induction | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | IRAK3 | 1 |
| GO:0002674 | GO:0002674 | negative regulation of acute inflammatory response | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ASH1L | 1 |
| GO:0003157 | GO:0003157 | endocardium development | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PROX1 | 1 |
| GO:0003207 | GO:0003207 | cardiac chamber formation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:0005984 | GO:0005984 | disaccharide metabolic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | B4GALT1 | 1 |
| GO:0006705 | GO:0006705 | mineralocorticoid biosynthetic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0010635 | GO:0010635 | regulation of mitochondrial fusion | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | TFRC | 1 |
| GO:0010752 | GO:0010752 | regulation of cGMP-mediated signaling | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PDE10A | 1 |
| GO:0010826 | GO:0010826 | negative regulation of centrosome duplication | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | KAT2B | 1 |
| GO:0010936 | GO:0010936 | negative regulation of macrophage cytokine production | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | IRAK3 | 1 |
| GO:0010998 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PDIK1L | 1 |
| GO:0014072 | GO:0014072 | response to isoquinoline alkaloid | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PPP1R1B | 1 |
| GO:0014831 | GO:0014831 | gastro-intestinal system smooth muscle contraction | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SULF1 | 1 |
| GO:0014842 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | AKIRIN1 | 1 |
| GO:0014854 | GO:0014854 | response to inactivity | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | FBXO32 | 1 |
| GO:0015015 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | HS3ST3B1 | 1 |
| GO:0019471 | GO:0019471 | 4-hydroxyproline metabolic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | EGLN1 | 1 |
| GO:0021527 | GO:0021527 | spinal cord association neuron differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | TAL1 | 1 |
| GO:0021670 | GO:0021670 | lateral ventricle development | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CDK6 | 1 |
| GO:0031293 | GO:0031293 | membrane protein intracellular domain proteolysis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | MBTPS1 | 1 |
| GO:0031392 | GO:0031392 | regulation of prostaglandin biosynthetic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SIRT1 | 1 |
| GO:0032351 | GO:0032351 | negative regulation of hormone metabolic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0033083 | GO:0033083 | regulation of immature T cell proliferation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | IL1A | 1 |
| GO:0033084 | GO:0033084 | regulation of immature T cell proliferation in thymus | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | IL1A | 1 |
| GO:0033145 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0034454 | GO:0034454 | microtubule anchoring at centrosome | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | HOOK3 | 1 |
| GO:0034650 | GO:0034650 | cortisol metabolic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0035112 | GO:0035112 | genitalia morphogenesis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | AR | 1 |
| GO:0035812 | GO:0035812 | renal sodium excretion | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | MLLT6 | 1 |
| GO:0035881 | GO:0035881 | amacrine cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | DLX1 | 1 |
| GO:0040034 | GO:0040034 | regulation of development, heterochronic | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0042045 | GO:0042045 | epithelial fluid transport | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ITPR1 | 1 |
| GO:0042416 | GO:0042416 | dopamine biosynthetic process | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | NR4A2 | 1 |
| GO:0042487 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PRKCB | 1 |
| GO:0043174 | GO:0043174 | nucleoside salvage | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ADK | 1 |
| GO:0043380 | GO:0043380 | regulation of memory T cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CD46 | 1 |
| GO:0043696 | GO:0043696 | dedifferentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CDK6 | 1 |
| GO:0043697 | GO:0043697 | cell dedifferentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CDK6 | 1 |
| GO:0044857 | GO:0044857 | plasma membrane raft organization | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CAV2 | 1 |
| GO:0045161 | GO:0045161 | neuronal ion channel clustering | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | AGRN | 1 |
| GO:0045906 | GO:0045906 | negative regulation of vasoconstriction | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | DOCK4 | 1 |
| GO:0046606 | GO:0046606 | negative regulation of centrosome cycle | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | KAT2B | 1 |
| GO:0048484 | GO:0048484 | enteric nervous system development | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SOX8 | 1 |
| GO:0048505 | GO:0048505 | regulation of timing of cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0048548 | GO:0048548 | regulation of pinocytosis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | APPL2 | 1 |
| GO:0050847 | GO:0050847 | progesterone receptor signaling pathway | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | MAPK1 | 1 |
| GO:0060123 | GO:0060123 | regulation of growth hormone secretion | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ADCYAP1 | 1 |
| GO:0060379 | GO:0060379 | cardiac muscle cell myoblast differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0060442 | GO:0060442 | branching involved in prostate gland morphogenesis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | FGFR2 | 1 |
| GO:0060707 | GO:0060707 | trophoblast giant cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | E2F8 | 1 |
| GO:0061303 | GO:0061303 | cornea development in camera-type eye | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ANGPTL7 | 1 |
| GO:0061309 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0062042 | GO:0062042 | regulation of cardiac epithelial to mesenchymal transition | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0070099 | GO:0070099 | regulation of chemokine-mediated signaling pathway | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SLIT2 | 1 |
| GO:0070170 | GO:0070170 | regulation of tooth mineralization | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | BCOR | 1 |
| GO:0070586 | GO:0070586 | cell-cell adhesion involved in gastrulation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | KLF4 | 1 |
| GO:0070671 | GO:0070671 | response to interleukin-12 | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0070672 | GO:0070672 | response to interleukin-15 | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PLCB1 | 1 |
| GO:0071233 | GO:0071233 | cellular response to leucine | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | UBR1 | 1 |
| GO:0071236 | GO:0071236 | cellular response to antibiotic | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | MEF2C | 1 |
| GO:0071257 | GO:0071257 | cellular response to electrical stimulus | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0072310 | GO:0072310 | glomerular epithelial cell development | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | JAG1 | 1 |
| GO:0072497 | GO:0072497 | mesenchymal stem cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | REST | 1 |
| GO:0086067 | GO:0086067 | AV node cell to bundle of His cell communication | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | RYR2 | 1 |
| GO:0090481 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SLC35D1 | 1 |
| GO:0097084 | GO:0097084 | vascular associated smooth muscle cell development | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | HEY2 | 1 |
| GO:0097475 | GO:0097475 | motor neuron migration | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | FZD3 | 1 |
| GO:0098528 | GO:0098528 | skeletal muscle fiber differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SIX4 | 1 |
| GO:0098911 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | RYR2 | 1 |
| GO:0160049 | GO:0160049 | negative regulation of cGAS/STING signaling pathway | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PPP6C | 1 |
| GO:1900152 | GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | YBX1 | 1 |
| GO:1901993 | GO:1901993 | regulation of meiotic cell cycle phase transition | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | CDC25C | 1 |
| GO:1902855 | GO:1902855 | regulation of non-motile cilium assembly | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ATMIN | 1 |
| GO:1903441 | GO:1903441 | protein localization to ciliary membrane | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ARL13B | 1 |
| GO:1904672 | GO:1904672 | regulation of somatic stem cell population maintenance | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | TAL1 | 1 |
| GO:1905205 | GO:1905205 | positive regulation of connective tissue replacement | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PPP3CA | 1 |
| GO:1905456 | GO:1905456 | regulation of lymphoid progenitor cell differentiation | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | SOS1 | 1 |
| GO:1990535 | GO:1990535 | neuron projection maintenance | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | PRNP | 1 |
| GO:2001214 | GO:2001214 | positive regulation of vasculogenesis | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | RIN2 | 1 |
| GO:2001267 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1/439 | 12/18888 | 0.0833333 | 3.5854214 | 1.3819563 | 0.2459396 | 0.5621651 | 0.4930782 | ST18 | 1 |
| GO:0018209 | GO:0018209 | peptidyl-serine modification | 9/439 | 294/18888 | 0.0306122 | 1.3170936 | 0.8452828 | 0.2464793 | 0.5621651 | 0.4930782 | MAPK1/TFRC/PRKCB/MAST4/TTBK2/PDCD10/BDNF/SGK3/MAPK8 | 9 |
| GO:0010591 | GO:0010591 | regulation of lamellipodium assembly | 2/439 | 41/18888 | 0.0487805 | 2.0987833 | 1.0864511 | 0.2466818 | 0.5621651 | 0.4930782 | AKIRIN1/SLIT2 | 2 |
| GO:0010762 | GO:0010762 | regulation of fibroblast migration | 2/439 | 41/18888 | 0.0487805 | 2.0987833 | 1.0864511 | 0.2466818 | 0.5621651 | 0.4930782 | APPL2/ZEB2 | 2 |
| GO:0072210 | GO:0072210 | metanephric nephron development | 2/439 | 41/18888 | 0.0487805 | 2.0987833 | 1.0864511 | 0.2466818 | 0.5621651 | 0.4930782 | IRX2/SOX8 | 2 |
| GO:0090181 | GO:0090181 | regulation of cholesterol metabolic process | 2/439 | 41/18888 | 0.0487805 | 2.0987833 | 1.0864511 | 0.2466818 | 0.5621651 | 0.4930782 | MBTPS1/SEC14L2 | 2 |
| GO:1904407 | GO:1904407 | positive regulation of nitric oxide metabolic process | 2/439 | 41/18888 | 0.0487805 | 2.0987833 | 1.0864511 | 0.2466818 | 0.5621651 | 0.4930782 | SMAD3/KLF4 | 2 |
| GO:0009880 | GO:0009880 | embryonic pattern specification | 3/439 | 74/18888 | 0.0405405 | 1.7442591 | 0.9895250 | 0.2469950 | 0.5621651 | 0.4930782 | MEOX2/SMAD3/FGFR2 | 3 |
| GO:0048663 | GO:0048663 | neuron fate commitment | 3/439 | 74/18888 | 0.0405405 | 1.7442591 | 0.9895250 | 0.2469950 | 0.5621651 | 0.4930782 | DLX1/NFIA/PROX1 | 3 |
| GO:0050709 | GO:0050709 | negative regulation of protein secretion | 3/439 | 74/18888 | 0.0405405 | 1.7442591 | 0.9895250 | 0.2469950 | 0.5621651 | 0.4930782 | SYT4/PPP3CA/REST | 3 |
| GO:0051937 | GO:0051937 | catecholamine transport | 3/439 | 74/18888 | 0.0405405 | 1.7442591 | 0.9895250 | 0.2469950 | 0.5621651 | 0.4930782 | SYT4/CNR1/PRKCB | 3 |
| GO:1902017 | GO:1902017 | regulation of cilium assembly | 3/439 | 74/18888 | 0.0405405 | 1.7442591 | 0.9895250 | 0.2469950 | 0.5621651 | 0.4930782 | RAB11A/CEP120/ATMIN | 3 |
| GO:0006913 | GO:0006913 | nucleocytoplasmic transport | 10/439 | 333/18888 | 0.0300300 | 1.2920438 | 0.8294055 | 0.2484767 | 0.5648983 | 0.4954756 | SEH1L/WASHC4/KPNA1/PPP3CA/APPL2/AHCTF1/SMAD3/PPP3R1/ATF2/NXT2 | 10 |
| GO:0051169 | GO:0051169 | nuclear transport | 10/439 | 333/18888 | 0.0300300 | 1.2920438 | 0.8294055 | 0.2484767 | 0.5648983 | 0.4954756 | SEH1L/WASHC4/KPNA1/PPP3CA/APPL2/AHCTF1/SMAD3/PPP3R1/ATF2/NXT2 | 10 |
| GO:0006109 | GO:0006109 | regulation of carbohydrate metabolic process | 6/439 | 182/18888 | 0.0329670 | 1.4184085 | 0.8749294 | 0.2496434 | 0.5672305 | 0.4975211 | ARPP19/RORA/TCF7L2/SIRT1/ADIPOR1/KAT2B | 6 |
| GO:0006417 | GO:0006417 | regulation of translation | 13/439 | 451/18888 | 0.0288248 | 1.2401901 | 0.7963896 | 0.2524085 | 0.5693057 | 0.4993413 | PUM2/CPEB2/CNOT2/CNOT6L/PDIK1L/YBX1/SECISBP2L/CPEB3/PUS7/GSPT1/PUM1/BZW1/SEPSECS | 13 |
| GO:0007224 | GO:0007224 | smoothened signaling pathway | 5/439 | 146/18888 | 0.0342466 | 1.4734609 | 0.8858902 | 0.2527866 | 0.5693057 | 0.4993413 | DLG5/ARL13B/RORA/TTBK2/FGFR2 | 5 |
| GO:0046467 | GO:0046467 | membrane lipid biosynthetic process | 5/439 | 146/18888 | 0.0342466 | 1.4734609 | 0.8858902 | 0.2527866 | 0.5693057 | 0.4993413 | SGMS1/PRKD3/PPM1L/SPTSSA/CERS6 | 5 |
| GO:0051592 | GO:0051592 | response to calcium ion | 5/439 | 146/18888 | 0.0342466 | 1.4734609 | 0.8858902 | 0.2527866 | 0.5693057 | 0.4993413 | SYT4/PPP3CA/MEF2C/RYR2/CRHBP | 5 |
| GO:0007173 | GO:0007173 | epidermal growth factor receptor signaling pathway | 4/439 | 110/18888 | 0.0363636 | 1.5645475 | 0.9160085 | 0.2531567 | 0.5693057 | 0.4993413 | HIP1/EFEMP1/SOS1/PTPN12 | 4 |
| GO:0006635 | GO:0006635 | fatty acid beta-oxidation | 3/439 | 75/18888 | 0.0400000 | 1.7210023 | 0.9650850 | 0.2532422 | 0.5693057 | 0.4993413 | CNR1/PEX5/HADHB | 3 |
| GO:0051298 | GO:0051298 | centrosome duplication | 3/439 | 75/18888 | 0.0400000 | 1.7210023 | 0.9650850 | 0.2532422 | 0.5693057 | 0.4993413 | CEP120/SIRT1/KAT2B | 3 |
| GO:0002714 | GO:0002714 | positive regulation of B cell mediated immunity | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | TFRC/RIF1 | 2 |
| GO:0002891 | GO:0002891 | positive regulation of immunoglobulin mediated immune response | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | TFRC/RIF1 | 2 |
| GO:0006904 | GO:0006904 | vesicle docking involved in exocytosis | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | RAB12/UNC13C | 2 |
| GO:0009124 | GO:0009124 | nucleoside monophosphate biosynthetic process | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | GART/ADK | 2 |
| GO:0009126 | GO:0009126 | purine nucleoside monophosphate metabolic process | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | GART/ADK | 2 |
| GO:0021983 | GO:0021983 | pituitary gland development | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | SRD5A1/CREB1 | 2 |
| GO:0035794 | GO:0035794 | positive regulation of mitochondrial membrane permeability | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | ATF2/RHOT1 | 2 |
| GO:0043647 | GO:0043647 | inositol phosphate metabolic process | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | IPMK/PLCB1 | 2 |
| GO:0046627 | GO:0046627 | negative regulation of insulin receptor signaling pathway | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | PTPRE/PRKCB | 2 |
| GO:0060563 | GO:0060563 | neuroepithelial cell differentiation | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | DLG5/JAG1 | 2 |
| GO:0070328 | GO:0070328 | triglyceride homeostasis | 2/439 | 42/18888 | 0.0476190 | 2.0488122 | 1.0496394 | 0.2553367 | 0.5693057 | 0.4993413 | RORA/SIRT1 | 2 |
| GO:0002221 | GO:0002221 | pattern recognition receptor signaling pathway | 8/439 | 259/18888 | 0.0308880 | 1.3289593 | 0.8222892 | 0.2561658 | 0.5693057 | 0.4993413 | PUM2/HCFC2/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 8 |
| GO:0035264 | GO:0035264 | multicellular organism growth | 5/439 | 147/18888 | 0.0340136 | 1.4634373 | 0.8701229 | 0.2571671 | 0.5693057 | 0.4993413 | SLC1A2/CREB1/PEX5/SOS1/AR | 5 |
| GO:0051495 | GO:0051495 | positive regulation of cytoskeleton organization | 6/439 | 184/18888 | 0.0326087 | 1.4029910 | 0.8473529 | 0.2574135 | 0.5693057 | 0.4993413 | MTSS1/CEP120/EPHA1/SMAD3/PROX1/RGCC | 6 |
| GO:0002218 | GO:0002218 | activation of innate immune response | 9/439 | 298/18888 | 0.0302013 | 1.2994145 | 0.8036530 | 0.2585541 | 0.5693057 | 0.4993413 | PUM2/HCFC2/PSPC1/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 9 |
| GO:0002200 | GO:0002200 | somatic diversification of immune receptors | 3/439 | 76/18888 | 0.0394737 | 1.6983575 | 0.9410105 | 0.2595118 | 0.5693057 | 0.4993413 | TFRC/YY1/RIF1 | 3 |
| GO:0072594 | GO:0072594 | establishment of protein localization to organelle | 13/439 | 454/18888 | 0.0286344 | 1.2319950 | 0.7718344 | 0.2597475 | 0.5693057 | 0.4993413 | RAB11A/KPNA1/PPP3CA/SPCS3/APPL2/UBE2D3/SMAD3/PPP3R1/RYR2/ATF2/PEX5/PEX3/COX18 | 13 |
| GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 13/439 | 455/18888 | 0.0285714 | 1.2292873 | 0.7636865 | 0.2622108 | 0.5693057 | 0.4993413 | RAB11A/CDK6/TAOK1/MBTPS1/APPL2/SYF2/ATF2/PROX1/KLF4/APC/RGCC/CDC25C/PLCB1 | 13 |
| GO:1902115 | GO:1902115 | regulation of organelle assembly | 7/439 | 223/18888 | 0.0313901 | 1.3505623 | 0.8123272 | 0.2628074 | 0.5693057 | 0.4993413 | MTM1/RAB11A/CNOT2/CNOT6L/CEP120/ATMIN/KAT2B | 7 |
| GO:1905954 | GO:1905954 | positive regulation of lipid localization | 4/439 | 112/18888 | 0.0357143 | 1.5366092 | 0.8786034 | 0.2633716 | 0.5693057 | 0.4993413 | ATP8A1/DENND5B/SIRT1/IL1A | 4 |
| GO:0002024 | GO:0002024 | diet induced thermogenesis | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | APPL2 | 1 |
| GO:0002357 | GO:0002357 | defense response to tumor cell | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | KLF4 | 1 |
| GO:0002863 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CNR1 | 1 |
| GO:0005513 | GO:0005513 | detection of calcium ion | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | RYR2 | 1 |
| GO:0006563 | GO:0006563 | L-serine metabolic process | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | SERINC5 | 1 |
| GO:0006971 | GO:0006971 | hypotonic response | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | OXSR1 | 1 |
| GO:0010225 | GO:0010225 | response to UV-C | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | YY1 | 1 |
| GO:0010642 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PTPN12 | 1 |
| GO:0010764 | GO:0010764 | negative regulation of fibroblast migration | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | ZEB2 | 1 |
| GO:0014744 | GO:0014744 | positive regulation of muscle adaptation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PPP3CA | 1 |
| GO:0014874 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | FBXO32 | 1 |
| GO:0015780 | GO:0015780 | nucleotide-sugar transmembrane transport | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | SLC35D1 | 1 |
| GO:0021702 | GO:0021702 | cerebellar Purkinje cell differentiation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | RORA | 1 |
| GO:0021794 | GO:0021794 | thalamus development | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | SRD5A1 | 1 |
| GO:0031272 | GO:0031272 | regulation of pseudopodium assembly | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | APC | 1 |
| GO:0031274 | GO:0031274 | positive regulation of pseudopodium assembly | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | APC | 1 |
| GO:0032306 | GO:0032306 | regulation of prostaglandin secretion | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IL1A | 1 |
| GO:0032308 | GO:0032308 | positive regulation of prostaglandin secretion | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IL1A | 1 |
| GO:0032341 | GO:0032341 | aldosterone metabolic process | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | REST | 1 |
| GO:0032494 | GO:0032494 | response to peptidoglycan | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IRAK3 | 1 |
| GO:0033079 | GO:0033079 | immature T cell proliferation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IL1A | 1 |
| GO:0033080 | GO:0033080 | immature T cell proliferation in thymus | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IL1A | 1 |
| GO:0034139 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | HCFC2 | 1 |
| GO:0034333 | GO:0034333 | adherens junction assembly | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | DLG5 | 1 |
| GO:0035865 | GO:0035865 | cellular response to potassium ion | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CRHBP | 1 |
| GO:0038180 | GO:0038180 | nerve growth factor signaling pathway | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | BDNF | 1 |
| GO:0043379 | GO:0043379 | memory T cell differentiation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CD46 | 1 |
| GO:0043650 | GO:0043650 | dicarboxylic acid biosynthetic process | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | GLUD1 | 1 |
| GO:0045916 | GO:0045916 | negative regulation of complement activation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CD46 | 1 |
| GO:0045986 | GO:0045986 | negative regulation of smooth muscle contraction | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | DOCK4 | 1 |
| GO:0048680 | GO:0048680 | positive regulation of axon regeneration | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PUM2 | 1 |
| GO:0051036 | GO:0051036 | regulation of endosome size | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | RAB11A | 1 |
| GO:0060100 | GO:0060100 | positive regulation of phagocytosis, engulfment | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | APPL2 | 1 |
| GO:0060134 | GO:0060134 | prepulse inhibition | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | GRIN3A | 1 |
| GO:0060213 | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CPEB3 | 1 |
| GO:0060456 | GO:0060456 | positive regulation of digestive system process | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PPP3CA | 1 |
| GO:0060670 | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | FGFR2 | 1 |
| GO:0061052 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | YY1 | 1 |
| GO:0061517 | GO:0061517 | macrophage proliferation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | MAPK1 | 1 |
| GO:0070278 | GO:0070278 | extracellular matrix constituent secretion | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | RGCC | 1 |
| GO:0070294 | GO:0070294 | renal sodium ion absorption | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | OXSR1 | 1 |
| GO:0070486 | GO:0070486 | leukocyte aggregation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | STK10 | 1 |
| GO:0070493 | GO:0070493 | thrombin-activated receptor signaling pathway | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | IQGAP2 | 1 |
| GO:0070572 | GO:0070572 | positive regulation of neuron projection regeneration | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PUM2 | 1 |
| GO:0070914 | GO:0070914 | UV-damage excision repair | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | SIRT1 | 1 |
| GO:0071679 | GO:0071679 | commissural neuron axon guidance | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | FZD3 | 1 |
| GO:0075509 | GO:0075509 | endocytosis involved in viral entry into host cell | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | CAV2 | 1 |
| GO:0090235 | GO:0090235 | regulation of metaphase plate congression | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | KAT2B | 1 |
| GO:0097499 | GO:0097499 | protein localization to non-motile cilium | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | ARL13B | 1 |
| GO:0098693 | GO:0098693 | regulation of synaptic vesicle cycle | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PPP3R1 | 1 |
| GO:0140896 | GO:0140896 | cGAS/STING signaling pathway | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PPP6C | 1 |
| GO:1900103 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | TMEM33 | 1 |
| GO:1902902 | GO:1902902 | negative regulation of autophagosome assembly | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | MTM1 | 1 |
| GO:1902950 | GO:1902950 | regulation of dendritic spine maintenance | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | PRNP | 1 |
| GO:1903867 | GO:1903867 | extraembryonic membrane development | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | E2F8 | 1 |
| GO:1903977 | GO:1903977 | positive regulation of glial cell migration | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | RRAS2 | 1 |
| GO:1904995 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | KLF4 | 1 |
| GO:1905064 | GO:1905064 | negative regulation of vascular associated smooth muscle cell differentiation | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | HEY2 | 1 |
| GO:1905155 | GO:1905155 | positive regulation of membrane invagination | 1/439 | 13/18888 | 0.0769231 | 3.3096198 | 1.2849790 | 0.2634768 | 0.5693057 | 0.4993413 | APPL2 | 1 |
| GO:0007007 | GO:0007007 | inner mitochondrial membrane organization | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | OPA1/COX18 | 2 |
| GO:0007099 | GO:0007099 | centriole replication | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | CEP120/KAT2B | 2 |
| GO:0007595 | GO:0007595 | lactation | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | NCOA1/CREB1 | 2 |
| GO:0010712 | GO:0010712 | regulation of collagen metabolic process | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | RGCC/HDAC2 | 2 |
| GO:0014904 | GO:0014904 | myotube cell development | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | PPP3CA/CAV2 | 2 |
| GO:0046839 | GO:0046839 | phospholipid dephosphorylation | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | MTM1/MTMR12 | 2 |
| GO:0048821 | GO:0048821 | erythrocyte development | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | L3MBTL3/TAL1 | 2 |
| GO:0055090 | GO:0055090 | acylglycerol homeostasis | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | RORA/SIRT1 | 2 |
| GO:1903307 | GO:1903307 | positive regulation of regulated secretory pathway | 2/439 | 43/18888 | 0.0465116 | 2.0011654 | 1.0138398 | 0.2639971 | 0.5693057 | 0.4993413 | SYT4/SCAMP5 | 2 |
| GO:0006809 | GO:0006809 | nitric oxide biosynthetic process | 3/439 | 77/18888 | 0.0389610 | 1.6763009 | 0.9172902 | 0.2658015 | 0.5719708 | 0.5016789 | RORA/SMAD3/KLF4 | 3 |
| GO:0031016 | GO:0031016 | pancreas development | 3/439 | 77/18888 | 0.0389610 | 1.6763009 | 0.9172902 | 0.2658015 | 0.5719708 | 0.5016789 | CDK6/TCF7L2/PROX1 | 3 |
| GO:0045913 | GO:0045913 | positive regulation of carbohydrate metabolic process | 3/439 | 77/18888 | 0.0389610 | 1.6763009 | 0.9172902 | 0.2658015 | 0.5719708 | 0.5016789 | ARPP19/SIRT1/KAT2B | 3 |
| GO:0045921 | GO:0045921 | positive regulation of exocytosis | 3/439 | 77/18888 | 0.0389610 | 1.6763009 | 0.9172902 | 0.2658015 | 0.5719708 | 0.5016789 | SYT4/SCAMP5/STXBP5 | 3 |
| GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 14/439 | 496/18888 | 0.0282258 | 1.2144169 | 0.7464707 | 0.2659994 | 0.5720905 | 0.5017839 | DLG5/ZMIZ1/SOCS6/EPHA7/TFRC/PPP3CA/JAG1/MAP3K8/CD46/KLF4/IL1A/RGCC/EPCAM/PRNP | 14 |
| GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 6/439 | 187/18888 | 0.0320856 | 1.3804831 | 0.8065868 | 0.2691880 | 0.5749170 | 0.5042630 | PRKCB/EPHA1/HMGA2/SIRT1/KLF4/IL1A | 6 |
| GO:0034612 | GO:0034612 | response to tumor necrosis factor | 8/439 | 263/18888 | 0.0304183 | 1.3087470 | 0.7777854 | 0.2692944 | 0.5749170 | 0.5042630 | MAPK1/MAP4K3/RORA/SIRT1/CRHBP/MAP3K5/TANK/ST18 | 8 |
| GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 7/439 | 225/18888 | 0.0311111 | 1.3385573 | 0.7880614 | 0.2699589 | 0.5749170 | 0.5042630 | MAPK1/MEF2C/IL1A/IRAK3/IRAK2/MAPK8/HADHB | 7 |
| GO:0035107 | GO:0035107 | appendage morphogenesis | 5/439 | 150/18888 | 0.0333333 | 1.4341686 | 0.8235116 | 0.2704150 | 0.5749170 | 0.5042630 | SP8/MBNL1/NFIA/FGFR2/HDAC2 | 5 |
| GO:0035108 | GO:0035108 | limb morphogenesis | 5/439 | 150/18888 | 0.0333333 | 1.4341686 | 0.8235116 | 0.2704150 | 0.5749170 | 0.5042630 | SP8/MBNL1/NFIA/FGFR2/HDAC2 | 5 |
| GO:0006874 | GO:0006874 | intracellular calcium ion homeostasis | 9/439 | 302/18888 | 0.0298013 | 1.2822037 | 0.7626065 | 0.2708144 | 0.5749170 | 0.5042630 | ATP2B1/CNR1/PRKCB/ATP2B2/ITPR1/CAV2/RYR2/CALB1/PLCB1 | 9 |
| GO:0035418 | GO:0035418 | protein localization to synapse | 3/439 | 78/18888 | 0.0384615 | 1.6548099 | 0.8939134 | 0.2721094 | 0.5749170 | 0.5042630 | RAB11A/NSG1/GPC6 | 3 |
| GO:0046323 | GO:0046323 | glucose import | 3/439 | 78/18888 | 0.0384615 | 1.6548099 | 0.8939134 | 0.2721094 | 0.5749170 | 0.5042630 | ARPP19/APPL2/SLC1A2 | 3 |
| GO:0000184 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | GSPT1/PNRC1 | 2 |
| GO:0010799 | GO:0010799 | regulation of peptidyl-threonine phosphorylation | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | MAPK1/SPRED1 | 2 |
| GO:0010828 | GO:0010828 | positive regulation of glucose transmembrane transport | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | ARPP19/SLC1A2 | 2 |
| GO:0014002 | GO:0014002 | astrocyte development | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | CDK6/ZEB2 | 2 |
| GO:0021762 | GO:0021762 | substantia nigra development | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | GLUD1/YWHAQ | 2 |
| GO:0042771 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | SIRT1/HNRNPK | 2 |
| GO:0045022 | GO:0045022 | early endosome to late endosome transport | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | MAPK1/HOOK3 | 2 |
| GO:0045761 | GO:0045761 | regulation of adenylate cyclase activity | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | ADCYAP1/CACNA1D | 2 |
| GO:0046006 | GO:0046006 | regulation of activated T cell proliferation | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | PPP3CA/PRNP | 2 |
| GO:0051602 | GO:0051602 | response to electrical stimulus | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | FZD3/REST | 2 |
| GO:0051972 | GO:0051972 | regulation of telomerase activity | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | MAPK1/KLF4 | 2 |
| GO:0071548 | GO:0071548 | response to dexamethasone | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | FBXO32/SRD5A1 | 2 |
| GO:0120178 | GO:0120178 | steroid hormone biosynthetic process | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | SRD5A1/REST | 2 |
| GO:1905521 | GO:1905521 | regulation of macrophage migration | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | MAPK1/AKIRIN1 | 2 |
| GO:1990776 | GO:1990776 | response to angiotensin | 2/439 | 44/18888 | 0.0454545 | 1.9556844 | 0.9789976 | 0.2726581 | 0.5749170 | 0.5042630 | PPP3CA/SMAD3 | 2 |
| GO:0042770 | GO:0042770 | signal transduction in response to DNA damage | 6/439 | 188/18888 | 0.0319149 | 1.3731401 | 0.7931538 | 0.2731426 | 0.5749170 | 0.5042630 | TAOK1/MBTPS1/SYF2/SPRED1/SIRT1/ATF2 | 6 |
| GO:0042177 | GO:0042177 | negative regulation of protein catabolic process | 4/439 | 114/18888 | 0.0350877 | 1.5096511 | 0.8419268 | 0.2736626 | 0.5749170 | 0.5042630 | MTM1/SMAD3/USP25/IRAK3 | 4 |
| GO:0042752 | GO:0042752 | regulation of circadian rhythm | 4/439 | 114/18888 | 0.0350877 | 1.5096511 | 0.8419268 | 0.2736626 | 0.5749170 | 0.5042630 | PSPC1/RORA/PROX1/MAPK8 | 4 |
| GO:0043473 | GO:0043473 | pigmentation | 4/439 | 114/18888 | 0.0350877 | 1.5096511 | 0.8419268 | 0.2736626 | 0.5749170 | 0.5042630 | RAB11A/MEF2C/ZEB2/MITF | 4 |
| GO:0098876 | GO:0098876 | vesicle-mediated transport to the plasma membrane | 5/439 | 151/18888 | 0.0331126 | 1.4246708 | 0.8081987 | 0.2748639 | 0.5749170 | 0.5042630 | RAB11A/RAB12/NSG1/WIPF3/VAMP4 | 5 |
| GO:0001819 | GO:0001819 | positive regulation of cytokine production | 14/439 | 500/18888 | 0.0280000 | 1.2047016 | 0.7155934 | 0.2755715 | 0.5749170 | 0.5042630 | ADCYAP1/RORA/SMAD3/SIRT1/CD46/ATF2/SCAMP5/SULF1/IL1A/RGCC/IRAK3/HDAC2/TANK/PLCB1 | 14 |
| GO:0060759 | GO:0060759 | regulation of response to cytokine stimulus | 6/439 | 189/18888 | 0.0317460 | 1.3658748 | 0.7797970 | 0.2771111 | 0.5749170 | 0.5042630 | SLIT2/KLF4/PAFAH1B1/IRAK3/IRAK2/TANK | 6 |
| GO:0035304 | GO:0035304 | regulation of protein dephosphorylation | 3/439 | 79/18888 | 0.0379747 | 1.6338629 | 0.8708701 | 0.2784332 | 0.5749170 | 0.5042630 | ARPP19/CAMTA1/PPP1R1B | 3 |
| GO:0097009 | GO:0097009 | energy homeostasis | 3/439 | 79/18888 | 0.0379747 | 1.6338629 | 0.8708701 | 0.2784332 | 0.5749170 | 0.5042630 | SGIP1/APPL2/SIRT1 | 3 |
| GO:0031023 | GO:0031023 | microtubule organizing center organization | 5/439 | 152/18888 | 0.0328947 | 1.4152979 | 0.7929950 | 0.2793280 | 0.5749170 | 0.5042630 | CEP120/SIRT1/CETN3/PAFAH1B1/KAT2B | 5 |
| GO:0035966 | GO:0035966 | response to topologically incorrect protein | 5/439 | 152/18888 | 0.0328947 | 1.4152979 | 0.7929950 | 0.2793280 | 0.5749170 | 0.5042630 | CREBRF/PARP8/MBTPS1/AMFR/TMEM33 | 5 |
| GO:0001921 | GO:0001921 | positive regulation of receptor recycling | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | NSG1 | 1 |
| GO:0002467 | GO:0002467 | germinal center formation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | MEF2C | 1 |
| GO:0003222 | GO:0003222 | ventricular trabecula myocardium morphogenesis | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | HEY2 | 1 |
| GO:0003413 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ATF2 | 1 |
| GO:0006465 | GO:0006465 | signal peptide processing | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SPCS3 | 1 |
| GO:0007638 | GO:0007638 | mechanosensory behavior | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | STRBP | 1 |
| GO:0008212 | GO:0008212 | mineralocorticoid metabolic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | REST | 1 |
| GO:0008298 | GO:0008298 | intracellular mRNA localization | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PUM2 | 1 |
| GO:0009214 | GO:0009214 | cyclic nucleotide catabolic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PDE10A | 1 |
| GO:0009263 | GO:0009263 | deoxyribonucleotide biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ADK | 1 |
| GO:0009265 | GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ADK | 1 |
| GO:0014733 | GO:0014733 | regulation of skeletal muscle adaptation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PPP3CA | 1 |
| GO:0021534 | GO:0021534 | cell proliferation in hindbrain | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | RORA | 1 |
| GO:0021819 | GO:0021819 | layer formation in cerebral cortex | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PAFAH1B1 | 1 |
| GO:0021924 | GO:0021924 | cell proliferation in external granule layer | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | RORA | 1 |
| GO:0021930 | GO:0021930 | cerebellar granule cell precursor proliferation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | RORA | 1 |
| GO:0030252 | GO:0030252 | growth hormone secretion | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ADCYAP1 | 1 |
| GO:0034309 | GO:0034309 | primary alcohol biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | REST | 1 |
| GO:0034616 | GO:0034616 | response to laminar fluid shear stress | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | KLF4 | 1 |
| GO:0035973 | GO:0035973 | aggrephagy | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | WDFY3 | 1 |
| GO:0042541 | GO:0042541 | hemoglobin biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | KLF4 | 1 |
| GO:0042762 | GO:0042762 | regulation of sulfur metabolic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | TCF7L2 | 1 |
| GO:0043353 | GO:0043353 | enucleate erythrocyte differentiation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SP3 | 1 |
| GO:0045348 | GO:0045348 | positive regulation of MHC class II biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SIRT1 | 1 |
| GO:0046385 | GO:0046385 | deoxyribose phosphate biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ADK | 1 |
| GO:0046512 | GO:0046512 | sphingosine biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SPTSSA | 1 |
| GO:0046520 | GO:0046520 | sphingoid biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SPTSSA | 1 |
| GO:0048148 | GO:0048148 | behavioral response to cocaine | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PPP1R1B | 1 |
| GO:0048715 | GO:0048715 | negative regulation of oligodendrocyte differentiation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | DLX1 | 1 |
| GO:0051177 | GO:0051177 | meiotic sister chromatid cohesion | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SMC3 | 1 |
| GO:0051775 | GO:0051775 | response to redox state | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | RYR2 | 1 |
| GO:0070262 | GO:0070262 | peptidyl-serine dephosphorylation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PPP3CA | 1 |
| GO:0070307 | GO:0070307 | lens fiber cell development | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PROX1 | 1 |
| GO:0070986 | GO:0070986 | left/right axis specification | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ARL13B | 1 |
| GO:0071415 | GO:0071415 | cellular response to purine-containing compound | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | RYR2 | 1 |
| GO:0072075 | GO:0072075 | metanephric mesenchyme development | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SIX4 | 1 |
| GO:0072393 | GO:0072393 | microtubule anchoring at microtubule organizing center | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | HOOK3 | 1 |
| GO:0085020 | GO:0085020 | protein K6-linked ubiquitination | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | UBE2D3 | 1 |
| GO:0090175 | GO:0090175 | regulation of establishment of planar polarity | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SEC24B | 1 |
| GO:0090715 | GO:0090715 | immunological memory formation process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | CD46 | 1 |
| GO:0098761 | GO:0098761 | cellular response to interleukin-7 | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | YBX1 | 1 |
| GO:0098814 | GO:0098814 | spontaneous synaptic transmission | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | NSG1 | 1 |
| GO:1900272 | GO:1900272 | negative regulation of long-term synaptic potentiation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PRNP | 1 |
| GO:1903845 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | DLX1 | 1 |
| GO:1903894 | GO:1903894 | regulation of IRE1-mediated unfolded protein response | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | TMEM33 | 1 |
| GO:1904321 | GO:1904321 | response to forskolin | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | CREB1 | 1 |
| GO:1904322 | GO:1904322 | cellular response to forskolin | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | CREB1 | 1 |
| GO:1904936 | GO:1904936 | interneuron migration | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PAFAH1B1 | 1 |
| GO:1905203 | GO:1905203 | regulation of connective tissue replacement | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | PPP3CA | 1 |
| GO:1905208 | GO:1905208 | negative regulation of cardiocyte differentiation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | HEY2 | 1 |
| GO:1905269 | GO:1905269 | positive regulation of chromatin organization | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | TAL1 | 1 |
| GO:2000105 | GO:2000105 | positive regulation of DNA-templated DNA replication | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | E2F8 | 1 |
| GO:2000288 | GO:2000288 | positive regulation of myoblast proliferation | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ATF2 | 1 |
| GO:2000479 | GO:2000479 | regulation of cAMP-dependent protein kinase activity | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SIRT1 | 1 |
| GO:2001140 | GO:2001140 | positive regulation of phospholipid transport | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | ATP8A1 | 1 |
| GO:2001279 | GO:2001279 | regulation of unsaturated fatty acid biosynthetic process | 1/439 | 14/18888 | 0.0714286 | 3.0732184 | 1.1970283 | 0.2806070 | 0.5749170 | 0.5042630 | SIRT1 | 1 |
| GO:1904018 | GO:1904018 | positive regulation of vasculature development | 6/439 | 190/18888 | 0.0315789 | 1.3586860 | 0.7665156 | 0.2810931 | 0.5749170 | 0.5042630 | PRKCB/EPHA1/HMGA2/SIRT1/KLF4/IL1A | 6 |
| GO:2001242 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 6/439 | 190/18888 | 0.0315789 | 1.3586860 | 0.7665156 | 0.2810931 | 0.5749170 | 0.5042630 | SGMS1/PRKRA/SIRT1/HNRNPK/PLAGL2/OPA1 | 6 |
| GO:0001825 | GO:0001825 | blastocyst formation | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | CNOT2/SP3 | 2 |
| GO:0008038 | GO:0008038 | neuron recognition | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | CNR1/EPHA3 | 2 |
| GO:0021587 | GO:0021587 | cerebellum morphogenesis | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | RORA/PROX1 | 2 |
| GO:0032941 | GO:0032941 | secretion by tissue | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | PPP3CA/KCNN4 | 2 |
| GO:1902108 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | ATF2/RHOT1 | 2 |
| GO:1903573 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 2/439 | 45/18888 | 0.0444444 | 1.9122248 | 0.9450623 | 0.2813150 | 0.5749170 | 0.5042630 | USP25/OPA1 | 2 |
| GO:0007612 | GO:0007612 | learning | 5/439 | 153/18888 | 0.0326797 | 1.4060476 | 0.7778989 | 0.2838065 | 0.5794204 | 0.5082129 | TAFA2/PPP1R1B/ATP8A1/CSMD1/PLCB1 | 5 |
| GO:0016525 | GO:0016525 | negative regulation of angiogenesis | 5/439 | 153/18888 | 0.0326797 | 1.4060476 | 0.7778989 | 0.2838065 | 0.5794204 | 0.5082129 | SPRED1/ATF2/KLF4/SULF1/RGCC | 5 |
| GO:0000819 | GO:0000819 | sister chromatid segregation | 7/439 | 229/18888 | 0.0305677 | 1.3151764 | 0.7402094 | 0.2844142 | 0.5803664 | 0.5090427 | RAB11A/SEH1L/SMC3/KIF2A/CHAMP1/APC/KAT2B | 7 |
| GO:0014032 | GO:0014032 | neural crest cell development | 3/439 | 80/18888 | 0.0375000 | 1.6134396 | 0.8481504 | 0.2847708 | 0.5805055 | 0.5091647 | MAPK1/JAG1/SOX8 | 3 |
| GO:0051966 | GO:0051966 | regulation of synaptic transmission, glutamatergic | 3/439 | 80/18888 | 0.0375000 | 1.6134396 | 0.8481504 | 0.2847708 | 0.5805055 | 0.5091647 | MEF2C/CNR1/PLPPR4 | 3 |
| GO:0000075 | GO:0000075 | cell cycle checkpoint signaling | 6/439 | 191/18888 | 0.0314136 | 1.3515725 | 0.7533086 | 0.2850881 | 0.5808579 | 0.5094738 | TAOK1/MBTPS1/SYF2/ATF2/PROX1/APC | 6 |
| GO:0002685 | GO:0002685 | regulation of leukocyte migration | 7/439 | 230/18888 | 0.0304348 | 1.3094583 | 0.7283846 | 0.2880574 | 0.5830774 | 0.5114205 | MAPK1/AKIRIN1/OXSR1/SLIT2/IL1A/STK10/PLCB1 | 7 |
| GO:0097191 | GO:0097191 | extrinsic apoptotic signaling pathway | 7/439 | 230/18888 | 0.0304348 | 1.3094583 | 0.7283846 | 0.2880574 | 0.5830774 | 0.5114205 | PHIP/SMAD3/TCF7L2/SGK3/IL1A/AR/ITM2C | 7 |
| GO:0097530 | GO:0097530 | granulocyte migration | 5/439 | 154/18888 | 0.0324675 | 1.3969174 | 0.7629088 | 0.2882988 | 0.5830774 | 0.5114205 | MAPK1/VAV3/AKIRIN1/SLIT2/IL1A | 5 |
| GO:0006006 | GO:0006006 | glucose metabolic process | 6/439 | 192/18888 | 0.0312500 | 1.3445330 | 0.7401751 | 0.2890954 | 0.5830774 | 0.5114205 | ARPP19/RORA/TCF7L2/SIRT1/ADIPOR1/KAT2B | 6 |
| GO:0001824 | GO:0001824 | blastocyst development | 4/439 | 117/18888 | 0.0341880 | 1.4709421 | 0.7882139 | 0.2892210 | 0.5830774 | 0.5114205 | CNOT2/SP3/BCOR/KLF4 | 4 |
| GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 4/439 | 117/18888 | 0.0341880 | 1.4709421 | 0.7882139 | 0.2892210 | 0.5830774 | 0.5114205 | RAB11A/RGCC/CDC25C/PLCB1 | 4 |
| GO:0046651 | GO:0046651 | lymphocyte proliferation | 9/439 | 308/18888 | 0.0292208 | 1.2572257 | 0.7020923 | 0.2895185 | 0.5830774 | 0.5114205 | VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 9 |
| GO:0032892 | GO:0032892 | positive regulation of organic acid transport | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | SYT4/IL1A | 2 |
| GO:0042398 | GO:0042398 | cellular modified amino acid biosynthetic process | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | SLC1A2/GART | 2 |
| GO:0045601 | GO:0045601 | regulation of endothelial cell differentiation | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | JAG1/PLCB1 | 2 |
| GO:0045646 | GO:0045646 | regulation of erythrocyte differentiation | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | CDK6/TAL1 | 2 |
| GO:0048483 | GO:0048483 | autonomic nervous system development | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | FZD3/SOX8 | 2 |
| GO:0048713 | GO:0048713 | regulation of oligodendrocyte differentiation | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | DLX1/HDAC2 | 2 |
| GO:0070849 | GO:0070849 | response to epidermal growth factor | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | MAPK1/PTPN12 | 2 |
| GO:0071763 | GO:0071763 | nuclear membrane organization | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | PRKCB/PAFAH1B1 | 2 |
| GO:0099601 | GO:0099601 | regulation of neurotransmitter receptor activity | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | MEF2C/CRHBP | 2 |
| GO:1902622 | GO:1902622 | regulation of neutrophil migration | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | SLIT2/IL1A | 2 |
| GO:1905710 | GO:1905710 | positive regulation of membrane permeability | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | ATF2/RHOT1 | 2 |
| GO:2001239 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2/439 | 46/18888 | 0.0434783 | 1.8706546 | 0.9119871 | 0.2899633 | 0.5830774 | 0.5114205 | SGK3/IL1A | 2 |
| GO:0015931 | GO:0015931 | nucleobase-containing compound transport | 7/439 | 231/18888 | 0.0303030 | 1.3037896 | 0.7166141 | 0.2917116 | 0.5830774 | 0.5114205 | SEH1L/SLC35D1/YBX1/AHCTF1/RBFOX1/CETN3/NXT2 | 7 |
| GO:0008037 | GO:0008037 | cell recognition | 5/439 | 155/18888 | 0.0322581 | 1.3879051 | 0.7480230 | 0.2928040 | 0.5830774 | 0.5114205 | CNR1/EPHA3/B4GALT1/VCAN/CNTNAP3 | 5 |
| GO:0045807 | GO:0045807 | positive regulation of endocytosis | 5/439 | 155/18888 | 0.0322581 | 1.3879051 | 0.7480230 | 0.2928040 | 0.5830774 | 0.5114205 | SGIP1/PPP3CA/APPL2/HIP1/HNRNPK | 5 |
| GO:2000181 | GO:2000181 | negative regulation of blood vessel morphogenesis | 5/439 | 155/18888 | 0.0322581 | 1.3879051 | 0.7480230 | 0.2928040 | 0.5830774 | 0.5114205 | SPRED1/ATF2/KLF4/SULF1/RGCC | 5 |
| GO:1904659 | GO:1904659 | glucose transmembrane transport | 4/439 | 118/18888 | 0.0338983 | 1.4584765 | 0.7706431 | 0.2944350 | 0.5830774 | 0.5114205 | ARPP19/APPL2/PRKCB/SLC1A2 | 4 |
| GO:0019318 | GO:0019318 | hexose metabolic process | 7/439 | 232/18888 | 0.0301724 | 1.2981698 | 0.7048971 | 0.2953764 | 0.5830774 | 0.5114205 | ARPP19/RORA/B4GALT1/TCF7L2/SIRT1/ADIPOR1/KAT2B | 7 |
| GO:0002040 | GO:0002040 | sprouting angiogenesis | 6/439 | 194/18888 | 0.0309278 | 1.3306719 | 0.7141251 | 0.2971450 | 0.5830774 | 0.5114205 | MEOX2/E2F8/PDCD10/SPRED1/SLIT2/KLF4 | 6 |
| GO:0071466 | GO:0071466 | cellular response to xenobiotic stimulus | 6/439 | 194/18888 | 0.0309278 | 1.3306719 | 0.7141251 | 0.2971450 | 0.5830774 | 0.5114205 | TFRC/MEF2C/RORA/REST/CRHBP/PRNP | 6 |
| GO:0032368 | GO:0032368 | regulation of lipid transport | 5/439 | 156/18888 | 0.0320513 | 1.3790082 | 0.7332401 | 0.2973214 | 0.5830774 | 0.5114205 | ATP8A1/DENND5B/SIRT1/IL1A/SEC24A | 5 |
| GO:0002713 | GO:0002713 | negative regulation of B cell mediated immunity | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CD46 | 1 |
| GO:0002890 | GO:0002890 | negative regulation of immunoglobulin mediated immune response | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CD46 | 1 |
| GO:0003198 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | HEY2 | 1 |
| GO:0010820 | GO:0010820 | positive regulation of T cell chemotaxis | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | OXSR1 | 1 |
| GO:0016558 | GO:0016558 | protein import into peroxisome matrix | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PEX5 | 1 |
| GO:0021694 | GO:0021694 | cerebellar Purkinje cell layer formation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | RORA | 1 |
| GO:0032688 | GO:0032688 | negative regulation of interferon-beta production | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | YY1 | 1 |
| GO:0032933 | GO:0032933 | SREBP signaling pathway | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | AMFR | 1 |
| GO:0033689 | GO:0033689 | negative regulation of osteoblast proliferation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SMAD3 | 1 |
| GO:0034501 | GO:0034501 | protein localization to kinetochore | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CHAMP1 | 1 |
| GO:0035358 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SIRT1 | 1 |
| GO:0036446 | GO:0036446 | myofibroblast differentiation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | ZEB2 | 1 |
| GO:0042559 | GO:0042559 | pteridine-containing compound biosynthetic process | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | GART | 1 |
| GO:0043101 | GO:0043101 | purine-containing compound salvage | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | ADK | 1 |
| GO:0043201 | GO:0043201 | response to leucine | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | UBR1 | 1 |
| GO:0043518 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SIRT1 | 1 |
| GO:0043558 | GO:0043558 | regulation of translational initiation in response to stress | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PDIK1L | 1 |
| GO:0044771 | GO:0044771 | meiotic cell cycle phase transition | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CDC25C | 1 |
| GO:0044849 | GO:0044849 | estrous cycle | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | NCOA1 | 1 |
| GO:0045176 | GO:0045176 | apical protein localization | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | DLG5 | 1 |
| GO:0045472 | GO:0045472 | response to ether | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PLCB1 | 1 |
| GO:0046007 | GO:0046007 | negative regulation of activated T cell proliferation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PRNP | 1 |
| GO:0048070 | GO:0048070 | regulation of developmental pigmentation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | ZEB2 | 1 |
| GO:0051284 | GO:0051284 | positive regulation of sequestering of calcium ion | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | RYR2 | 1 |
| GO:0055057 | GO:0055057 | neuroblast division | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | FGFR2 | 1 |
| GO:0060033 | GO:0060033 | anatomical structure regression | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SLC17A6 | 1 |
| GO:0060099 | GO:0060099 | regulation of phagocytosis, engulfment | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | APPL2 | 1 |
| GO:0060211 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CPEB3 | 1 |
| GO:0060413 | GO:0060413 | atrial septum morphogenesis | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | HEY2 | 1 |
| GO:0060766 | GO:0060766 | negative regulation of androgen receptor signaling pathway | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SIRT1 | 1 |
| GO:0070207 | GO:0070207 | protein homotrimerization | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SLC1A2 | 1 |
| GO:0070885 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PRNP | 1 |
| GO:0072148 | GO:0072148 | epithelial cell fate commitment | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PROX1 | 1 |
| GO:0072176 | GO:0072176 | nephric duct development | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | EPHA7 | 1 |
| GO:0090030 | GO:0090030 | regulation of steroid hormone biosynthetic process | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | REST | 1 |
| GO:0098760 | GO:0098760 | response to interleukin-7 | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | YBX1 | 1 |
| GO:0106057 | GO:0106057 | negative regulation of calcineurin-mediated signaling | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | PRNP | 1 |
| GO:1900153 | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CPEB3 | 1 |
| GO:1901160 | GO:1901160 | primary amino compound metabolic process | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SRD5A1 | 1 |
| GO:1901985 | GO:1901985 | positive regulation of protein acetylation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | TAOK1 | 1 |
| GO:1902166 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | SIRT1 | 1 |
| GO:1903083 | GO:1903083 | protein localization to condensed chromosome | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | CHAMP1 | 1 |
| GO:1905153 | GO:1905153 | regulation of membrane invagination | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | APPL2 | 1 |
| GO:2000767 | GO:2000767 | positive regulation of cytoplasmic translation | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | YBX1 | 1 |
| GO:2001034 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | RIF1 | 1 |
| GO:2001138 | GO:2001138 | regulation of phospholipid transport | 1/439 | 15/18888 | 0.0666667 | 2.8683371 | 1.1166260 | 0.2973398 | 0.5830774 | 0.5114205 | ATP8A1 | 1 |
| GO:0036465 | GO:0036465 | synaptic vesicle recycling | 3/439 | 82/18888 | 0.0365854 | 1.5740874 | 0.8036447 | 0.2974796 | 0.5830774 | 0.5114205 | DNAJC6/VAMP4/AP2B1 | 3 |
| GO:0140029 | GO:0140029 | exocytic process | 3/439 | 82/18888 | 0.0365854 | 1.5740874 | 0.8036447 | 0.2974796 | 0.5830774 | 0.5114205 | RAB12/STXBP5/UNC13C | 3 |
| GO:0140056 | GO:0140056 | organelle localization by membrane tethering | 3/439 | 82/18888 | 0.0365854 | 1.5740874 | 0.8036447 | 0.2974796 | 0.5830774 | 0.5114205 | RAB12/CAV2/UNC13C | 3 |
| GO:1904427 | GO:1904427 | positive regulation of calcium ion transmembrane transport | 3/439 | 82/18888 | 0.0365854 | 1.5740874 | 0.8036447 | 0.2974796 | 0.5830774 | 0.5114205 | PPP3CA/PPP3R1/RYR2 | 3 |
| GO:0001881 | GO:0001881 | receptor recycling | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | NSG1/PEX5 | 2 |
| GO:0016339 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | CDH4/CDH19 | 2 |
| GO:0045292 | GO:0045292 | mRNA cis splicing, via spliceosome | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | SFSWAP/CLNS1A | 2 |
| GO:0048806 | GO:0048806 | genitalia development | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | SRD5A1/AR | 2 |
| GO:0050798 | GO:0050798 | activated T cell proliferation | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | PPP3CA/PRNP | 2 |
| GO:0050919 | GO:0050919 | negative chemotaxis | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | EPHA7/SLIT2 | 2 |
| GO:0055078 | GO:0055078 | sodium ion homeostasis | 2/439 | 47/18888 | 0.0425532 | 1.8308535 | 0.8797287 | 0.2985988 | 0.5832823 | 0.5116002 | MLLT6/IL1A | 2 |
| GO:0007249 | GO:0007249 | canonical NF-kappaB signal transduction | 9/439 | 311/18888 | 0.0289389 | 1.2450981 | 0.6722947 | 0.2989971 | 0.5834938 | 0.5117858 | PELI2/TAB2/TFRC/PRKCB/RORA/SIRT1/IL1A/IRAK2/TANK | 9 |
| GO:0034504 | GO:0034504 | protein localization to nucleus | 9/439 | 311/18888 | 0.0289389 | 1.2450981 | 0.6722947 | 0.2989971 | 0.5834938 | 0.5117858 | TFRC/KPNA1/PPP3CA/APPL2/SIX4/SMAD3/TCF7L2/PPP3R1/ATF2 | 9 |
| GO:0051702 | GO:0051702 | biological process involved in interaction with symbiont | 4/439 | 119/18888 | 0.0336134 | 1.4462204 | 0.7532336 | 0.2996610 | 0.5845060 | 0.5126736 | JUN/HMGA2/REST/CAV2 | 4 |
| GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 6/439 | 195/18888 | 0.0307692 | 1.3238479 | 0.7012070 | 0.3011863 | 0.5871965 | 0.5150334 | TAOK1/MBTPS1/SYF2/KLF4/APC/RGCC | 6 |
| GO:0110053 | GO:0110053 | regulation of actin filament organization | 8/439 | 273/18888 | 0.0293040 | 1.2608075 | 0.6695720 | 0.3028976 | 0.5899613 | 0.5174585 | MTSS1/WASHC4/EPHA1/SMAD3/PPFIA1/SLIT2/MEGF9/RGCC | 8 |
| GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 8/439 | 273/18888 | 0.0293040 | 1.2608075 | 0.6695720 | 0.3028976 | 0.5899613 | 0.5174585 | TAOK1/MBTPS1/SYF2/ATF2/PROX1/KLF4/APC/RGCC | 8 |
| GO:0072332 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 3/439 | 83/18888 | 0.0361446 | 1.5551225 | 0.7818412 | 0.3038467 | 0.5909666 | 0.5183403 | JMY/SIRT1/HNRNPK | 3 |
| GO:0086003 | GO:0086003 | cardiac muscle cell contraction | 3/439 | 83/18888 | 0.0361446 | 1.5551225 | 0.7818412 | 0.3038467 | 0.5909666 | 0.5183403 | SCN2A/RYR2/CACNA1D | 3 |
| GO:0070661 | GO:0070661 | leukocyte proliferation | 10/439 | 352/18888 | 0.0284091 | 1.2223028 | 0.6494347 | 0.3038544 | 0.5909666 | 0.5183403 | MAPK1/VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 10 |
| GO:0000723 | GO:0000723 | telomere maintenance | 5/439 | 158/18888 | 0.0316456 | 1.3615524 | 0.7039767 | 0.3063899 | 0.5943473 | 0.5213055 | MAPK1/INO80D/TNKS2/YY1/RIF1 | 5 |
| GO:0006865 | GO:0006865 | amino acid transport | 5/439 | 158/18888 | 0.0316456 | 1.3615524 | 0.7039767 | 0.3063899 | 0.5943473 | 0.5213055 | SYT4/SLC6A6/SLC1A2/SLC17A6/SERINC5 | 5 |
| GO:0002673 | GO:0002673 | regulation of acute inflammatory response | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | ASH1L/CNR1 | 2 |
| GO:0007520 | GO:0007520 | myoblast fusion | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | ADAMTS5/DOCK1 | 2 |
| GO:0021575 | GO:0021575 | hindbrain morphogenesis | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | RORA/PROX1 | 2 |
| GO:0031670 | GO:0031670 | cellular response to nutrient | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | NCOA1/KAT2B | 2 |
| GO:0032964 | GO:0032964 | collagen biosynthetic process | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | RGCC/HDAC2 | 2 |
| GO:0046189 | GO:0046189 | phenol-containing compound biosynthetic process | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | NR4A2/ZEB2 | 2 |
| GO:0098534 | GO:0098534 | centriole assembly | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | CEP120/KAT2B | 2 |
| GO:1902003 | GO:1902003 | regulation of amyloid-beta formation | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | LRRTM3/PRNP | 2 |
| GO:1902116 | GO:1902116 | negative regulation of organelle assembly | 2/439 | 48/18888 | 0.0416667 | 1.7927107 | 0.8482468 | 0.3072173 | 0.5943473 | 0.5213055 | MTM1/KAT2B | 2 |
| GO:0034470 | GO:0034470 | ncRNA processing | 12/439 | 433/18888 | 0.0277136 | 1.1923803 | 0.6247049 | 0.3079445 | 0.5954081 | 0.5222359 | PUM2/INTS6/PRKRA/TSNAX/INTS10/SMAD3/PUS7/PUM1/DDX17/KAT2B/NOP58/SEPSECS | 12 |
| GO:0008645 | GO:0008645 | hexose transmembrane transport | 4/439 | 121/18888 | 0.0330579 | 1.4223159 | 0.7188861 | 0.3101447 | 0.5954081 | 0.5222359 | ARPP19/APPL2/PRKCB/SLC1A2 | 4 |
| GO:0046209 | GO:0046209 | nitric oxide metabolic process | 3/439 | 84/18888 | 0.0357143 | 1.5366092 | 0.7603262 | 0.3102198 | 0.5954081 | 0.5222359 | RORA/SMAD3/KLF4 | 3 |
| GO:0008643 | GO:0008643 | carbohydrate transport | 5/439 | 159/18888 | 0.0314465 | 1.3529892 | 0.6894933 | 0.3109394 | 0.5954081 | 0.5222359 | ARPP19/SLC35D1/APPL2/PRKCB/SLC1A2 | 5 |
| GO:0032943 | GO:0032943 | mononuclear cell proliferation | 9/439 | 315/18888 | 0.0285714 | 1.2292873 | 0.6330262 | 0.3117514 | 0.5954081 | 0.5222359 | VAV3/DLG5/TFRC/PPP3CA/MEF2C/CD46/IL1A/SOS1/PRNP | 9 |
| GO:0043410 | GO:0043410 | positive regulation of MAPK cascade | 13/439 | 475/18888 | 0.0273684 | 1.1775279 | 0.6044751 | 0.3130421 | 0.5954081 | 0.5222359 | PELI2/NRK/TAOK1/MEF2C/RAP1B/ADCYAP1/PDCD10/FGFR2/CAV2/IL1A/MAP3K5/AR/PLCB1 | 13 |
| GO:0061157 | GO:0061157 | mRNA destabilization | 6/439 | 198/18888 | 0.0303030 | 1.3037896 | 0.6628697 | 0.3133697 | 0.5954081 | 0.5222359 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0002864 | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | CNR1 | 1 |
| GO:0003096 | GO:0003096 | renal sodium ion transport | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | OXSR1 | 1 |
| GO:0006206 | GO:0006206 | pyrimidine nucleobase metabolic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | MAPK1 | 1 |
| GO:0006474 | GO:0006474 | N-terminal protein amino acid acetylation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | KAT2B | 1 |
| GO:0006517 | GO:0006517 | protein deglycosylation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | OGA | 1 |
| GO:0006704 | GO:0006704 | glucocorticoid biosynthetic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | REST | 1 |
| GO:0006750 | GO:0006750 | glutathione biosynthetic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SLC1A2 | 1 |
| GO:0009084 | GO:0009084 | glutamine family amino acid biosynthetic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | GLUD1 | 1 |
| GO:0009151 | GO:0009151 | purine deoxyribonucleotide metabolic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | ADK | 1 |
| GO:0010819 | GO:0010819 | regulation of T cell chemotaxis | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | OXSR1 | 1 |
| GO:0010832 | GO:0010832 | negative regulation of myotube differentiation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | BDNF | 1 |
| GO:0030033 | GO:0030033 | microvillus assembly | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | STK26 | 1 |
| GO:0030242 | GO:0030242 | autophagy of peroxisome | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | PEX5 | 1 |
| GO:0030728 | GO:0030728 | ovulation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SIRT1 | 1 |
| GO:0031269 | GO:0031269 | pseudopodium assembly | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | APC | 1 |
| GO:0032354 | GO:0032354 | response to follicle-stimulating hormone | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SRD5A1 | 1 |
| GO:0032793 | GO:0032793 | positive regulation of CREB transcription factor activity | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | EPHA5 | 1 |
| GO:0042448 | GO:0042448 | progesterone metabolic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SRD5A1 | 1 |
| GO:0043455 | GO:0043455 | regulation of secondary metabolic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | ZEB2 | 1 |
| GO:0043517 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SPRED1 | 1 |
| GO:0045869 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | HMGA2 | 1 |
| GO:0046325 | GO:0046325 | negative regulation of glucose import | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | APPL2 | 1 |
| GO:0048021 | GO:0048021 | regulation of melanin biosynthetic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | ZEB2 | 1 |
| GO:0048172 | GO:0048172 | regulation of short-term neuronal synaptic plasticity | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SYT4 | 1 |
| GO:0060841 | GO:0060841 | venous blood vessel development | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | PROX1 | 1 |
| GO:0061101 | GO:0061101 | neuroendocrine cell differentiation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | JAG1 | 1 |
| GO:0071501 | GO:0071501 | cellular response to sterol depletion | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | AMFR | 1 |
| GO:0072350 | GO:0072350 | tricarboxylic acid metabolic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | GLUD1 | 1 |
| GO:0072520 | GO:0072520 | seminiferous tubule development | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | AR | 1 |
| GO:1900034 | GO:1900034 | regulation of cellular response to heat | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | SIRT1 | 1 |
| GO:1900376 | GO:1900376 | regulation of secondary metabolite biosynthetic process | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | ZEB2 | 1 |
| GO:1904948 | GO:1904948 | midbrain dopaminergic neuron differentiation | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | NR4A2 | 1 |
| GO:2000232 | GO:2000232 | regulation of rRNA processing | 1/439 | 16/18888 | 0.0625000 | 2.6890661 | 1.0426175 | 0.3136842 | 0.5954081 | 0.5222359 | KAT2B | 1 |
| GO:0070507 | GO:0070507 | regulation of microtubule cytoskeleton organization | 5/439 | 160/18888 | 0.0312500 | 1.3445330 | 0.6751068 | 0.3154983 | 0.5961564 | 0.5228923 | TAOK1/EPHA3/TTBK2/APC/PAFAH1B1 | 5 |
| GO:0006376 | GO:0006376 | mRNA splice site recognition | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | SRSF10/SFSWAP | 2 |
| GO:0006911 | GO:0006911 | phagocytosis, engulfment | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | APPL2/DOCK1 | 2 |
| GO:0008542 | GO:0008542 | visual learning | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | TAFA2/PPP1R1B | 2 |
| GO:0031648 | GO:0031648 | protein destabilization | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | SIRT1/PRNP | 2 |
| GO:0035272 | GO:0035272 | exocrine system development | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | IGSF3/FGFR2 | 2 |
| GO:0042181 | GO:0042181 | ketone biosynthetic process | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | REST/CREB1 | 2 |
| GO:0042551 | GO:0042551 | neuron maturation | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | NR4A2/AGRN | 2 |
| GO:0048546 | GO:0048546 | digestive tract morphogenesis | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | SMAD3/FGFR2 | 2 |
| GO:0051489 | GO:0051489 | regulation of filopodium assembly | 2/439 | 49/18888 | 0.0408163 | 1.7561248 | 0.8175041 | 0.3158151 | 0.5961564 | 0.5228923 | AGRN/GPM6A | 2 |
| GO:0007492 | GO:0007492 | endoderm development | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | HMGA2/SMAD3/BRD3 | 3 |
| GO:0008589 | GO:0008589 | regulation of smoothened signaling pathway | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | DLG5/RORA/FGFR2 | 3 |
| GO:0048041 | GO:0048041 | focal adhesion assembly | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | SMAD3/EPHA3/PIP5K1A | 3 |
| GO:0051149 | GO:0051149 | positive regulation of muscle cell differentiation | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | MEF2C/SIRT1/PROX1 | 3 |
| GO:0051591 | GO:0051591 | response to cAMP | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | RAP1B/SRD5A1/CRHBP | 3 |
| GO:0061053 | GO:0061053 | somite development | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | MEOX2/SIX4/SMAD3 | 3 |
| GO:2001057 | GO:2001057 | reactive nitrogen species metabolic process | 3/439 | 85/18888 | 0.0352941 | 1.5185314 | 0.7390917 | 0.3165970 | 0.5961564 | 0.5228923 | RORA/SMAD3/KLF4 | 3 |
| GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 7/439 | 238/18888 | 0.0294118 | 1.2654429 | 0.6356930 | 0.3175649 | 0.5976994 | 0.5242456 | MAPK1/MEF2C/IL1A/IRAK3/IRAK2/MAPK8/HADHB | 7 |
| GO:0002758 | GO:0002758 | innate immune response-activating signaling pathway | 8/439 | 278/18888 | 0.0287770 | 1.2381311 | 0.6170107 | 0.3200446 | 0.6009278 | 0.5270772 | PUM2/HCFC2/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 8 |
| GO:0071322 | GO:0071322 | cellular response to carbohydrate stimulus | 5/439 | 161/18888 | 0.0310559 | 1.3361819 | 0.6608159 | 0.3200657 | 0.6009278 | 0.5270772 | PPP3CA/PRKCB/EPHA5/SMAD3/PLCB1 | 5 |
| GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 4/439 | 123/18888 | 0.0325203 | 1.3991888 | 0.6851474 | 0.3206631 | 0.6009278 | 0.5270772 | MAPK1/AKIRIN1/OXSR1/SLIT2 | 4 |
| GO:0015749 | GO:0015749 | monosaccharide transmembrane transport | 4/439 | 123/18888 | 0.0325203 | 1.3991888 | 0.6851474 | 0.3206631 | 0.6009278 | 0.5270772 | ARPP19/APPL2/PRKCB/SLC1A2 | 4 |
| GO:0009743 | GO:0009743 | response to carbohydrate | 7/439 | 239/18888 | 0.0292887 | 1.2601481 | 0.6243372 | 0.3212927 | 0.6009278 | 0.5270772 | PPP3CA/PRKCB/EPHA5/SMAD3/TCF7L2/IL1A/PLCB1 | 7 |
| GO:0006900 | GO:0006900 | vesicle budding from membrane | 3/439 | 86/18888 | 0.0348837 | 1.5008741 | 0.7181300 | 0.3229764 | 0.6009278 | 0.5270772 | PPP6C/SEC24B/SEC24A | 3 |
| GO:0034243 | GO:0034243 | regulation of transcription elongation by RNA polymerase II | 3/439 | 86/18888 | 0.0348837 | 1.5008741 | 0.7181300 | 0.3229764 | 0.6009278 | 0.5270772 | INTS6/INTS10/MED4 | 3 |
| GO:0048678 | GO:0048678 | response to axon injury | 3/439 | 86/18888 | 0.0348837 | 1.5008741 | 0.7181300 | 0.3229764 | 0.6009278 | 0.5270772 | PUM2/KCNK2/KLF4 | 3 |
| GO:0048864 | GO:0048864 | stem cell development | 3/439 | 86/18888 | 0.0348837 | 1.5008741 | 0.7181300 | 0.3229764 | 0.6009278 | 0.5270772 | MAPK1/JAG1/SOX8 | 3 |
| GO:0022602 | GO:0022602 | ovulation cycle process | 2/439 | 50/18888 | 0.0400000 | 1.7210023 | 0.7874656 | 0.3243883 | 0.6009278 | 0.5270772 | SLIT2/SIRT1 | 2 |
| GO:0043114 | GO:0043114 | regulation of vascular permeability | 2/439 | 50/18888 | 0.0400000 | 1.7210023 | 0.7874656 | 0.3243883 | 0.6009278 | 0.5270772 | ZEB2/SLIT2 | 2 |
| GO:0061082 | GO:0061082 | myeloid leukocyte cytokine production | 2/439 | 50/18888 | 0.0400000 | 1.7210023 | 0.7874656 | 0.3243883 | 0.6009278 | 0.5270772 | SIRT1/IRAK3 | 2 |
| GO:0072599 | GO:0072599 | establishment of protein localization to endoplasmic reticulum | 2/439 | 50/18888 | 0.0400000 | 1.7210023 | 0.7874656 | 0.3243883 | 0.6009278 | 0.5270772 | SPCS3/RYR2 | 2 |
| GO:1903313 | GO:1903313 | positive regulation of mRNA metabolic process | 7/439 | 240/18888 | 0.0291667 | 1.2548975 | 0.6130309 | 0.3250278 | 0.6009278 | 0.5270772 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1/CLNS1A | 7 |
| GO:0034502 | GO:0034502 | protein localization to chromosome | 4/439 | 124/18888 | 0.0322581 | 1.3879051 | 0.6684992 | 0.3259326 | 0.6009278 | 0.5270772 | JARID2/TNKS2/CHAMP1/BRD3 | 4 |
| GO:0043200 | GO:0043200 | response to amino acid | 4/439 | 124/18888 | 0.0322581 | 1.3879051 | 0.6684992 | 0.3259326 | 0.6009278 | 0.5270772 | GDF10/SLC1A2/CPEB3/UBR1 | 4 |
| GO:0046486 | GO:0046486 | glycerolipid metabolic process | 11/439 | 400/18888 | 0.0275000 | 1.1831891 | 0.5712312 | 0.3277551 | 0.6009278 | 0.5270772 | MTM1/SOCS6/IPMK/SELENOI/MTMR12/PIP5K1A/SIRT1/SERINC5/PAFAH1B1/DDHD1/PLCB1 | 11 |
| GO:0071356 | GO:0071356 | cellular response to tumor necrosis factor | 7/439 | 241/18888 | 0.0290456 | 1.2496905 | 0.6017738 | 0.3287700 | 0.6009278 | 0.5270772 | MAPK1/RORA/SIRT1/CRHBP/MAP3K5/TANK/ST18 | 7 |
| GO:0002753 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway | 5/439 | 163/18888 | 0.0306748 | 1.3197870 | 0.6325153 | 0.3292232 | 0.6009278 | 0.5270772 | PUM2/HCFC2/PPP6C/PUM1/MAPK8 | 5 |
| GO:0170033 | GO:0170033 | L-amino acid metabolic process | 5/439 | 163/18888 | 0.0306748 | 1.3197870 | 0.6325153 | 0.3292232 | 0.6009278 | 0.5270772 | GLUD1/EGLN1/GPT2/SERINC5/GART | 5 |
| GO:0002312 | GO:0002312 | B cell activation involved in immune response | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | TFRC/DOCK10/RIF1 | 3 |
| GO:0008306 | GO:0008306 | associative learning | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | TAFA2/PPP1R1B/CSMD1 | 3 |
| GO:0008543 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | FGFR2/SULF1/SOS1 | 3 |
| GO:0015844 | GO:0015844 | monoamine transport | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | SYT4/CNR1/PRKCB | 3 |
| GO:0033077 | GO:0033077 | T cell differentiation in thymus | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | CDK6/IL1A/SOS1 | 3 |
| GO:0055013 | GO:0055013 | cardiac muscle cell development | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | HEY2/PROX1/YY1 | 3 |
| GO:0071277 | GO:0071277 | cellular response to calcium ion | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | SYT4/MEF2C/CRHBP | 3 |
| GO:1901879 | GO:1901879 | regulation of protein depolymerization | 3/439 | 87/18888 | 0.0344828 | 1.4836227 | 0.6974340 | 0.3293562 | 0.6009278 | 0.5270772 | TAOK1/TTBK2/APC | 3 |
| GO:0002921 | GO:0002921 | negative regulation of humoral immune response | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | CD46 | 1 |
| GO:0003128 | GO:0003128 | heart field specification | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | MEF2C | 1 |
| GO:0006103 | GO:0006103 | 2-oxoglutarate metabolic process | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | GPT2 | 1 |
| GO:0006415 | GO:0006415 | translational termination | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | GSPT1 | 1 |
| GO:0006544 | GO:0006544 | glycine metabolic process | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | GART | 1 |
| GO:0006878 | GO:0006878 | intracellular copper ion homeostasis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PRNP | 1 |
| GO:0007000 | GO:0007000 | nucleolus organization | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SIRT1 | 1 |
| GO:0031054 | GO:0031054 | pre-miRNA processing | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PRKRA | 1 |
| GO:0031268 | GO:0031268 | pseudopodium organization | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | APC | 1 |
| GO:0031573 | GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | ATF2 | 1 |
| GO:0032310 | GO:0032310 | prostaglandin secretion | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | IL1A | 1 |
| GO:0033151 | GO:0033151 | V(D)J recombination | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | YY1 | 1 |
| GO:0033623 | GO:0033623 | regulation of integrin activation | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | RAP1B | 1 |
| GO:0035092 | GO:0035092 | sperm DNA condensation | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | EPC1 | 1 |
| GO:0042693 | GO:0042693 | muscle cell fate commitment | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | MEF2C | 1 |
| GO:0043649 | GO:0043649 | dicarboxylic acid catabolic process | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | GLUD1 | 1 |
| GO:0043923 | GO:0043923 | positive regulation by host of viral transcription | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | JUN | 1 |
| GO:0045217 | GO:0045217 | cell-cell junction maintenance | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | MTSS1 | 1 |
| GO:0046112 | GO:0046112 | nucleobase biosynthetic process | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | GART | 1 |
| GO:0048557 | GO:0048557 | embryonic digestive tract morphogenesis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | FGFR2 | 1 |
| GO:0051782 | GO:0051782 | negative regulation of cell division | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | E2F8 | 1 |
| GO:0055089 | GO:0055089 | fatty acid homeostasis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SIRT1 | 1 |
| GO:0060221 | GO:0060221 | retinal rod cell differentiation | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SOX8 | 1 |
| GO:0061003 | GO:0061003 | positive regulation of dendritic spine morphogenesis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PAFAH1B1 | 1 |
| GO:0070206 | GO:0070206 | protein trimerization | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SLC1A2 | 1 |
| GO:0070920 | GO:0070920 | regulation of regulatory ncRNA processing | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PRKRA | 1 |
| GO:0072074 | GO:0072074 | kidney mesenchyme development | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SIX4 | 1 |
| GO:0072077 | GO:0072077 | renal vesicle morphogenesis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SOX8 | 1 |
| GO:0080154 | GO:0080154 | regulation of fertilization | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PLCB1 | 1 |
| GO:0090209 | GO:0090209 | negative regulation of triglyceride metabolic process | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SIRT1 | 1 |
| GO:0098712 | GO:0098712 | L-glutamate import across plasma membrane | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SLC1A2 | 1 |
| GO:0120305 | GO:0120305 | regulation of pigmentation | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | ZEB2 | 1 |
| GO:1900120 | GO:1900120 | regulation of receptor binding | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | BDNF | 1 |
| GO:1901163 | GO:1901163 | regulation of trophoblast cell migration | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | SMURF2 | 1 |
| GO:1901550 | GO:1901550 | regulation of endothelial cell development | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PLCB1 | 1 |
| GO:1902170 | GO:1902170 | cellular response to reactive nitrogen species | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | MAP3K5 | 1 |
| GO:1903140 | GO:1903140 | regulation of establishment of endothelial barrier | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PLCB1 | 1 |
| GO:1904889 | GO:1904889 | regulation of excitatory synapse assembly | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PTPN13 | 1 |
| GO:1905962 | GO:1905962 | glutamatergic neuron differentiation | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | PROX1 | 1 |
| GO:1990403 | GO:1990403 | embryonic brain development | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | TUBB2B | 1 |
| GO:2000369 | GO:2000369 | regulation of clathrin-dependent endocytosis | 1/439 | 17/18888 | 0.0588235 | 2.5308857 | 0.9740856 | 0.3296492 | 0.6009278 | 0.5270772 | DNAJC6 | 1 |
| GO:0050779 | GO:0050779 | RNA destabilization | 6/439 | 202/18888 | 0.0297030 | 1.2779720 | 0.6126972 | 0.3297337 | 0.6009278 | 0.5270772 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0000077 | GO:0000077 | DNA damage checkpoint signaling | 4/439 | 125/18888 | 0.0320000 | 1.3768018 | 0.6519949 | 0.3312076 | 0.6033406 | 0.5291936 | TAOK1/MBTPS1/SYF2/ATF2 | 4 |
| GO:0001974 | GO:0001974 | blood vessel remodeling | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | MEF2C/JAG1 | 2 |
| GO:0010665 | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | HEY2/MAP3K5 | 2 |
| GO:0030865 | GO:0030865 | cortical cytoskeleton organization | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | IQGAP2/PAFAH1B1 | 2 |
| GO:0035987 | GO:0035987 | endodermal cell differentiation | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | HMGA2/BRD3 | 2 |
| GO:0045214 | GO:0045214 | sarcomere organization | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | SIX4/PROX1 | 2 |
| GO:0048286 | GO:0048286 | lung alveolus development | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | CREB1/FGFR2 | 2 |
| GO:0061097 | GO:0061097 | regulation of protein tyrosine kinase activity | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | RAP2C/PRNP | 2 |
| GO:0089718 | GO:0089718 | amino acid import across plasma membrane | 2/439 | 51/18888 | 0.0392157 | 1.6872571 | 0.7580988 | 0.3329336 | 0.6042963 | 0.5300318 | SLC6A6/SLC1A2 | 2 |
| GO:0061014 | GO:0061014 | positive regulation of mRNA catabolic process | 6/439 | 203/18888 | 0.0295567 | 1.2716766 | 0.6003175 | 0.3338426 | 0.6054001 | 0.5309999 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0098739 | GO:0098739 | import across plasma membrane | 6/439 | 203/18888 | 0.0295567 | 1.2716766 | 0.6003175 | 0.3338426 | 0.6054001 | 0.5309999 | PPP3CA/SLC6A6/SLC1A2/PPP3R1/CACNA1D/PRNP | 6 |
| GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 10/439 | 362/18888 | 0.0276243 | 1.1885375 | 0.5587126 | 0.3341697 | 0.6057202 | 0.5312807 | VAV3/ZMIZ1/TFRC/PPP3CA/MEF2C/SH3KBP1/MAP3K8/CD46/IL1A/RIF1 | 10 |
| GO:0046889 | GO:0046889 | positive regulation of lipid biosynthetic process | 3/439 | 88/18888 | 0.0340909 | 1.4667633 | 0.6769965 | 0.3357347 | 0.6082830 | 0.5335285 | CREB1/IL1A/KAT2B | 3 |
| GO:0098659 | GO:0098659 | inorganic cation import across plasma membrane | 4/439 | 126/18888 | 0.0317460 | 1.3658748 | 0.6356317 | 0.3364870 | 0.6090975 | 0.5342430 | PPP3CA/PPP3R1/CACNA1D/PRNP | 4 |
| GO:0099587 | GO:0099587 | inorganic ion import across plasma membrane | 4/439 | 126/18888 | 0.0317460 | 1.3658748 | 0.6356317 | 0.3364870 | 0.6090975 | 0.5342430 | PPP3CA/PPP3R1/CACNA1D/PRNP | 4 |
| GO:0055001 | GO:0055001 | muscle cell development | 6/439 | 204/18888 | 0.0294118 | 1.2654429 | 0.5880016 | 0.3379577 | 0.6109326 | 0.5358525 | PPP3CA/SIX4/HEY2/CAV2/PROX1/YY1 | 6 |
| GO:0000387 | GO:0000387 | spliceosomal snRNP assembly | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | SRSF10/CLNS1A | 2 |
| GO:0010823 | GO:0010823 | negative regulation of mitochondrion organization | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | TFRC/OPA1 | 2 |
| GO:0045332 | GO:0045332 | phospholipid translocation | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | KCNN4/ATP8A1 | 2 |
| GO:0051155 | GO:0051155 | positive regulation of striated muscle cell differentiation | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | MEF2C/PROX1 | 2 |
| GO:0071470 | GO:0071470 | cellular response to osmotic stress | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | SCN2A/OXSR1 | 2 |
| GO:1904752 | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 2/439 | 52/18888 | 0.0384615 | 1.6548099 | 0.7293734 | 0.3414476 | 0.6109326 | 0.5358525 | MEF2C/DOCK4 | 2 |
| GO:0003014 | GO:0003014 | renal system process | 4/439 | 127/18888 | 0.0314961 | 1.3551199 | 0.6194072 | 0.3417698 | 0.6109326 | 0.5358525 | PPP3CA/MLLT6/OXSR1/SULF1 | 4 |
| GO:0006029 | GO:0006029 | proteoglycan metabolic process | 3/439 | 89/18888 | 0.0337079 | 1.4502828 | 0.6568109 | 0.3421102 | 0.6109326 | 0.5358525 | TCF7L2/SULF1/HS3ST3B1 | 3 |
| GO:0072384 | GO:0072384 | organelle transport along microtubule | 3/439 | 89/18888 | 0.0337079 | 1.4502828 | 0.6568109 | 0.3421102 | 0.6109326 | 0.5358525 | PAFAH1B1/RHOT1/OPA1 | 3 |
| GO:0007338 | GO:0007338 | single fertilization | 5/439 | 166/18888 | 0.0301205 | 1.2959355 | 0.5907480 | 0.3430057 | 0.6109326 | 0.5358525 | ASH1L/B4GALT1/CD46/AR/PLCB1 | 5 |
| GO:0010639 | GO:0010639 | negative regulation of organelle organization | 10/439 | 365/18888 | 0.0273973 | 1.1787687 | 0.5319974 | 0.3433782 | 0.6109326 | 0.5358525 | MTM1/TAOK1/TFRC/TTBK2/PPFIA1/SLIT2/TNKS2/APC/OPA1/KAT2B | 10 |
| GO:0042391 | GO:0042391 | regulation of membrane potential | 12/439 | 446/18888 | 0.0269058 | 1.1576249 | 0.5196554 | 0.3437012 | 0.6109326 | 0.5358525 | GRIN3A/PPP3CA/SCN2A/MEF2C/KCNN4/CNR1/USP53/TMEM161B/KCNK2/RYR2/CACNA1D/NDUFS1 | 12 |
| GO:0001522 | GO:0001522 | pseudouridine synthesis | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PUS7 | 1 |
| GO:0001710 | GO:0001710 | mesodermal cell fate commitment | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | KLF4 | 1 |
| GO:0001946 | GO:0001946 | lymphangiogenesis | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PROX1 | 1 |
| GO:0002923 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | CD46 | 1 |
| GO:0006044 | GO:0006044 | N-acetylglucosamine metabolic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | OGA | 1 |
| GO:0006991 | GO:0006991 | response to sterol depletion | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | AMFR | 1 |
| GO:0007096 | GO:0007096 | regulation of exit from mitosis | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | RGCC | 1 |
| GO:0010002 | GO:0010002 | cardioblast differentiation | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | REST | 1 |
| GO:0010042 | GO:0010042 | response to manganese ion | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | TFRC | 1 |
| GO:0010421 | GO:0010421 | hydrogen peroxide-mediated programmed cell death | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PDCD10 | 1 |
| GO:0019184 | GO:0019184 | nonribosomal peptide biosynthetic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SLC1A2 | 1 |
| GO:0019896 | GO:0019896 | axonal transport of mitochondrion | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | OPA1 | 1 |
| GO:0020027 | GO:0020027 | hemoglobin metabolic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | KLF4 | 1 |
| GO:0030011 | GO:0030011 | maintenance of cell polarity | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | DLG5 | 1 |
| GO:0030949 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PRKCB | 1 |
| GO:0032328 | GO:0032328 | alanine transport | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SLC6A6 | 1 |
| GO:0032780 | GO:0032780 | negative regulation of ATP-dependent activity | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SIRT1 | 1 |
| GO:0035234 | GO:0035234 | ectopic germ cell programmed cell death | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | IL1A | 1 |
| GO:0035864 | GO:0035864 | response to potassium ion | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | CRHBP | 1 |
| GO:0042053 | GO:0042053 | regulation of dopamine metabolic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | NR4A2 | 1 |
| GO:0042069 | GO:0042069 | regulation of catecholamine metabolic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | NR4A2 | 1 |
| GO:0042481 | GO:0042481 | regulation of odontogenesis | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PRKCB | 1 |
| GO:0042753 | GO:0042753 | positive regulation of circadian rhythm | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | RORA | 1 |
| GO:0043116 | GO:0043116 | negative regulation of vascular permeability | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SLIT2 | 1 |
| GO:0043173 | GO:0043173 | nucleotide salvage | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | ADK | 1 |
| GO:0044070 | GO:0044070 | regulation of monoatomic anion transport | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PRNP | 1 |
| GO:0045836 | GO:0045836 | positive regulation of meiotic nuclear division | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | PLCB1 | 1 |
| GO:0045945 | GO:0045945 | positive regulation of transcription by RNA polymerase III | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | AR | 1 |
| GO:0046040 | GO:0046040 | IMP metabolic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | GART | 1 |
| GO:0046184 | GO:0046184 | aldehyde biosynthetic process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | REST | 1 |
| GO:0050862 | GO:0050862 | positive regulation of T cell receptor signaling pathway | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | KCNN4 | 1 |
| GO:0060088 | GO:0060088 | auditory receptor cell stereocilium organization | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SEC24B | 1 |
| GO:0061450 | GO:0061450 | trophoblast cell migration | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SMURF2 | 1 |
| GO:0071243 | GO:0071243 | cellular response to arsenic-containing substance | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | CPEB2 | 1 |
| GO:0072087 | GO:0072087 | renal vesicle development | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | SOX8 | 1 |
| GO:0080009 | GO:0080009 | mRNA methylation | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | VIRMA | 1 |
| GO:0090713 | GO:0090713 | immunological memory process | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | CD46 | 1 |
| GO:1905209 | GO:1905209 | positive regulation of cardiocyte differentiation | 1/439 | 18/18888 | 0.0555556 | 2.3902809 | 0.9102909 | 0.3452437 | 0.6109326 | 0.5358525 | MEF2C | 1 |
| GO:0071621 | GO:0071621 | granulocyte chemotaxis | 4/439 | 128/18888 | 0.0312500 | 1.3445330 | 0.6033187 | 0.3470549 | 0.6138677 | 0.5384269 | MAPK1/VAV3/AKIRIN1/SLIT2 | 4 |
| GO:0031647 | GO:0031647 | regulation of protein stability | 9/439 | 326/18888 | 0.0276074 | 1.1878083 | 0.5276411 | 0.3473854 | 0.6139125 | 0.5384662 | MAPK1/PRKRA/HIP1/SMAD3/PDCD10/CREB1/USP25/SIRT1/PRNP | 9 |
| GO:0055074 | GO:0055074 | calcium ion homeostasis | 9/439 | 326/18888 | 0.0276074 | 1.1878083 | 0.5276411 | 0.3473854 | 0.6139125 | 0.5384662 | ATP2B1/CNR1/PRKCB/ATP2B2/ITPR1/CAV2/RYR2/CALB1/PLCB1 | 9 |
| GO:0043122 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 8/439 | 286/18888 | 0.0279720 | 1.2034981 | 0.5349225 | 0.3478349 | 0.6144370 | 0.5389263 | PELI2/TAB2/TFRC/PRKCB/RORA/SIRT1/IL1A/TANK | 8 |
| GO:0002088 | GO:0002088 | lens development in camera-type eye | 3/439 | 90/18888 | 0.0333333 | 1.4341686 | 0.6368705 | 0.3484810 | 0.6150384 | 0.5394537 | SMAD3/SPRED1/PROX1 | 3 |
| GO:0046849 | GO:0046849 | bone remodeling | 3/439 | 90/18888 | 0.0333333 | 1.4341686 | 0.6368705 | 0.3484810 | 0.6150384 | 0.5394537 | TFRC/CTHRC1/MITF | 3 |
| GO:0002204 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | TFRC/RIF1 | 2 |
| GO:0002208 | GO:0002208 | somatic diversification of immunoglobulins involved in immune response | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | TFRC/RIF1 | 2 |
| GO:0002639 | GO:0002639 | positive regulation of immunoglobulin production | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | TFRC/RIF1 | 2 |
| GO:0010662 | GO:0010662 | regulation of striated muscle cell apoptotic process | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | HEY2/MAP3K5 | 2 |
| GO:0045190 | GO:0045190 | isotype switching | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | TFRC/RIF1 | 2 |
| GO:1901799 | GO:1901799 | negative regulation of proteasomal protein catabolic process | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | MTM1/USP25 | 2 |
| GO:1902743 | GO:1902743 | regulation of lamellipodium organization | 2/439 | 53/18888 | 0.0377358 | 1.6235871 | 0.7012608 | 0.3499272 | 0.6157005 | 0.5400345 | AKIRIN1/SLIT2 | 2 |
| GO:0033044 | GO:0033044 | regulation of chromosome organization | 7/439 | 247/18888 | 0.0283401 | 1.2193336 | 0.5352373 | 0.3513488 | 0.6176617 | 0.5417547 | MAPK1/INO80D/TNKS2/TAL1/APC/YY1/KAT2B | 7 |
| GO:0051924 | GO:0051924 | regulation of calcium ion transport | 7/439 | 247/18888 | 0.0283401 | 1.2193336 | 0.5352373 | 0.3513488 | 0.6176617 | 0.5417547 | PPP3CA/ATP2B1/SESTD1/PPP3R1/RYR2/CACNA1D/PRNP | 7 |
| GO:1903169 | GO:1903169 | regulation of calcium ion transmembrane transport | 5/439 | 168/18888 | 0.0297619 | 1.2805076 | 0.5633441 | 0.3522168 | 0.6183105 | 0.5423238 | PPP3CA/SESTD1/PPP3R1/RYR2/PRNP | 5 |
| GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 9/439 | 328/18888 | 0.0274390 | 1.1805656 | 0.5088740 | 0.3539339 | 0.6183105 | 0.5423238 | CDK6/ZMIZ1/PPP3CA/FBN1/CREB1/CD46/TAL1/SOS1/MITF | 9 |
| GO:0009615 | GO:0009615 | response to virus | 11/439 | 409/18888 | 0.0268949 | 1.1571531 | 0.4956473 | 0.3539802 | 0.6183105 | 0.5423238 | CDK6/HCFC2/PRKRA/HMGA2/SMAD3/ATF2/SERINC5/DDX17/IRAK3/IRF2/TANK | 11 |
| GO:0008016 | GO:0008016 | regulation of heart contraction | 6/439 | 208/18888 | 0.0288462 | 1.2411074 | 0.5393630 | 0.3544692 | 0.6183105 | 0.5423238 | ATP2B1/TMEM161B/HEY2/ATP2B2/RYR2/CACNA1D | 6 |
| GO:0010660 | GO:0010660 | regulation of muscle cell apoptotic process | 3/439 | 91/18888 | 0.0329670 | 1.4184085 | 0.6171692 | 0.3548454 | 0.6183105 | 0.5423238 | HEY2/SIRT1/MAP3K5 | 3 |
| GO:0014910 | GO:0014910 | regulation of smooth muscle cell migration | 3/439 | 91/18888 | 0.0329670 | 1.4184085 | 0.6171692 | 0.3548454 | 0.6183105 | 0.5423238 | MEF2C/DOCK4/SLIT2 | 3 |
| GO:0033273 | GO:0033273 | response to vitamin | 3/439 | 91/18888 | 0.0329670 | 1.4184085 | 0.6171692 | 0.3548454 | 0.6183105 | 0.5423238 | PRKCB/SRSF2/IL1A | 3 |
| GO:0097581 | GO:0097581 | lamellipodium organization | 3/439 | 91/18888 | 0.0329670 | 1.4184085 | 0.6171692 | 0.3548454 | 0.6183105 | 0.5423238 | VAV3/AKIRIN1/SLIT2 | 3 |
| GO:1902904 | GO:1902904 | negative regulation of supramolecular fiber organization | 5/439 | 169/18888 | 0.0295858 | 1.2729307 | 0.5497709 | 0.3568271 | 0.6183105 | 0.5423238 | TAOK1/TTBK2/PPFIA1/SLIT2/APC | 5 |
| GO:0043393 | GO:0043393 | regulation of protein binding | 4/439 | 130/18888 | 0.0307692 | 1.3238479 | 0.5715403 | 0.3576283 | 0.6183105 | 0.5423238 | TTBK2/TCF7L2/BDNF/MAPK8 | 4 |
| GO:0055007 | GO:0055007 | cardiac muscle cell differentiation | 4/439 | 130/18888 | 0.0307692 | 1.3238479 | 0.5715403 | 0.3576283 | 0.6183105 | 0.5423238 | MEF2C/HEY2/PROX1/YY1 | 4 |
| GO:0016197 | GO:0016197 | endosomal transport | 8/439 | 289/18888 | 0.0276817 | 1.1910050 | 0.5047499 | 0.3583418 | 0.6183105 | 0.5423238 | MAPK1/HOOK3/RAB11A/WASHC4/RAB12/NSG1/WIPF3/VAMP4 | 8 |
| GO:0002762 | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | CDK6/FBN1 | 2 |
| GO:0031103 | GO:0031103 | axon regeneration | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | PUM2/KLF4 | 2 |
| GO:0032092 | GO:0032092 | positive regulation of protein binding | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | TCF7L2/BDNF | 2 |
| GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | APC/KAT2B | 2 |
| GO:0035306 | GO:0035306 | positive regulation of dephosphorylation | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | MEF2C/CAMTA1 | 2 |
| GO:0042304 | GO:0042304 | regulation of fatty acid biosynthetic process | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | SIRT1/KAT2B | 2 |
| GO:0048146 | GO:0048146 | positive regulation of fibroblast proliferation | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | CDK6/ZMIZ1 | 2 |
| GO:0050873 | GO:0050873 | brown fat cell differentiation | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | EBF2/SIRT1 | 2 |
| GO:1904645 | GO:1904645 | response to amyloid-beta | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | HDAC2/PRNP | 2 |
| GO:1904738 | GO:1904738 | vascular associated smooth muscle cell migration | 2/439 | 54/18888 | 0.0370370 | 1.5935206 | 0.6737344 | 0.3583693 | 0.6183105 | 0.5423238 | MEF2C/DOCK4 | 2 |
| GO:0060047 | GO:0060047 | heart contraction | 7/439 | 249/18888 | 0.0281124 | 1.2095398 | 0.5134311 | 0.3589138 | 0.6183105 | 0.5423238 | SCN2A/ATP2B1/TMEM161B/HEY2/ATP2B2/RYR2/CACNA1D | 7 |
| GO:0003417 | GO:0003417 | growth plate cartilage development | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | ATF2 | 1 |
| GO:0006684 | GO:0006684 | sphingomyelin metabolic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SGMS1 | 1 |
| GO:0007620 | GO:0007620 | copulation | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | CNR1 | 1 |
| GO:0009163 | GO:0009163 | nucleoside biosynthetic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | ADK | 1 |
| GO:0010663 | GO:0010663 | positive regulation of striated muscle cell apoptotic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | MAP3K5 | 1 |
| GO:0010666 | GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | MAP3K5 | 1 |
| GO:0010801 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SPRED1 | 1 |
| GO:0021692 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | RORA | 1 |
| GO:0030540 | GO:0030540 | female genitalia development | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SRD5A1 | 1 |
| GO:0031053 | GO:0031053 | primary miRNA processing | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SMAD3 | 1 |
| GO:0032305 | GO:0032305 | positive regulation of icosanoid secretion | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | IL1A | 1 |
| GO:0032695 | GO:0032695 | negative regulation of interleukin-12 production | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | IRAK3 | 1 |
| GO:0033003 | GO:0033003 | regulation of mast cell activation | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | CNR1 | 1 |
| GO:0034404 | GO:0034404 | nucleobase-containing small molecule biosynthetic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | ADK | 1 |
| GO:0036342 | GO:0036342 | post-anal tail morphogenesis | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | FZD3 | 1 |
| GO:0036499 | GO:0036499 | PERK-mediated unfolded protein response | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | TMEM33 | 1 |
| GO:0045091 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | HMGA2 | 1 |
| GO:0045721 | GO:0045721 | negative regulation of gluconeogenesis | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | TCF7L2 | 1 |
| GO:0045780 | GO:0045780 | positive regulation of bone resorption | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | TFRC | 1 |
| GO:0046653 | GO:0046653 | tetrahydrofolate metabolic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | GART | 1 |
| GO:0046931 | GO:0046931 | pore complex assembly | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | AHCTF1 | 1 |
| GO:0048339 | GO:0048339 | paraxial mesoderm development | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SMAD3 | 1 |
| GO:0055003 | GO:0055003 | cardiac myofibril assembly | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | PROX1 | 1 |
| GO:0060438 | GO:0060438 | trachea development | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | MAPK1 | 1 |
| GO:0086014 | GO:0086014 | atrial cardiac muscle cell action potential | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | RYR2 | 1 |
| GO:0086026 | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | RYR2 | 1 |
| GO:0086066 | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | RYR2 | 1 |
| GO:0097154 | GO:0097154 | GABAergic neuron differentiation | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | DLX1 | 1 |
| GO:1900242 | GO:1900242 | regulation of synaptic vesicle endocytosis | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | VAMP4 | 1 |
| GO:1901978 | GO:1901978 | positive regulation of cell cycle checkpoint | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | PROX1 | 1 |
| GO:1902514 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SESTD1 | 1 |
| GO:1902931 | GO:1902931 | negative regulation of alcohol biosynthetic process | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | REST | 1 |
| GO:2000641 | GO:2000641 | regulation of early endosome to late endosome transport | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | MAPK1 | 1 |
| GO:2000774 | GO:2000774 | positive regulation of cellular senescence | 1/439 | 19/18888 | 0.0526316 | 2.2644767 | 0.8506297 | 0.3604763 | 0.6183105 | 0.5423238 | SIRT1 | 1 |
| GO:0022406 | GO:0022406 | membrane docking | 3/439 | 92/18888 | 0.0326087 | 1.4029910 | 0.5977008 | 0.3612020 | 0.6192913 | 0.5431840 | RAB12/CAV2/UNC13C | 3 |
| GO:0051028 | GO:0051028 | mRNA transport | 4/439 | 131/18888 | 0.0305344 | 1.3137422 | 0.5558457 | 0.3629145 | 0.6208095 | 0.5445156 | SEH1L/AHCTF1/CETN3/NXT2 | 4 |
| GO:0051983 | GO:0051983 | regulation of chromosome segregation | 4/439 | 131/18888 | 0.0305344 | 1.3137422 | 0.5558457 | 0.3629145 | 0.6208095 | 0.5445156 | PUM2/PUM1/APC/KAT2B | 4 |
| GO:0140694 | GO:0140694 | non-membrane-bounded organelle assembly | 11/439 | 413/18888 | 0.0266344 | 1.1459458 | 0.4625959 | 0.3657442 | 0.6208095 | 0.5445156 | PUM2/RAB11A/CNOT2/SMC3/PSPC1/CNOT6L/CEP120/SIX4/PROX1/KIF2A/KAT2B | 11 |
| GO:0006469 | GO:0006469 | negative regulation of protein kinase activity | 5/439 | 171/18888 | 0.0292398 | 1.2580426 | 0.5228760 | 0.3660539 | 0.6208095 | 0.5445156 | EPHA1/SPRED1/SIRT1/APC/IRAK3 | 5 |
| GO:0006820 | GO:0006820 | monoatomic anion transport | 5/439 | 171/18888 | 0.0292398 | 1.2580426 | 0.5228760 | 0.3660539 | 0.6208095 | 0.5445156 | SLC1A2/SLC17A6/CLNS1A/OSTM1/PRNP | 5 |
| GO:0007034 | GO:0007034 | vacuolar transport | 5/439 | 171/18888 | 0.0292398 | 1.2580426 | 0.5228760 | 0.3660539 | 0.6208095 | 0.5445156 | MTM1/HOOK3/PLEKHF2/RAB12/SCYL2 | 5 |
| GO:0010720 | GO:0010720 | positive regulation of cell development | 12/439 | 454/18888 | 0.0264317 | 1.1372262 | 0.4565438 | 0.3660885 | 0.6208095 | 0.5445156 | ZMIZ1/PPP3CA/FZD3/CREB1/CDH4/SLIT2/CD46/VCAN/BDNF/SOX8/PAFAH1B1/HDAC2 | 12 |
| GO:0002686 | GO:0002686 | negative regulation of leukocyte migration | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | SLIT2/PLCB1 | 2 |
| GO:0006998 | GO:0006998 | nuclear envelope organization | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | PRKCB/PAFAH1B1 | 2 |
| GO:0010659 | GO:0010659 | cardiac muscle cell apoptotic process | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | HEY2/MAP3K5 | 2 |
| GO:0032210 | GO:0032210 | regulation of telomere maintenance via telomerase | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | MAPK1/TNKS2 | 2 |
| GO:0045071 | GO:0045071 | negative regulation of viral genome replication | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | HMGA2/PROX1 | 2 |
| GO:0085029 | GO:0085029 | extracellular matrix assembly | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | SMAD3/RGCC | 2 |
| GO:1900087 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 2/439 | 55/18888 | 0.0363636 | 1.5645475 | 0.6467694 | 0.3667711 | 0.6208095 | 0.5445156 | RGCC/PLCB1 | 2 |
| GO:0030198 | GO:0030198 | extracellular matrix organization | 9/439 | 332/18888 | 0.0271084 | 1.1663419 | 0.4716891 | 0.3670783 | 0.6208095 | 0.5445156 | ADAMTS5/EGFL6/ANGPTL7/SMAD3/B4GALT1/CAV2/SULF1/RGCC/ADAMTSL3 | 9 |
| GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 3/439 | 93/18888 | 0.0322581 | 1.3879051 | 0.5784597 | 0.3675490 | 0.6208095 | 0.5445156 | MAPK1/AKIRIN1/OXSR1 | 3 |
| GO:0015807 | GO:0015807 | L-amino acid transport | 3/439 | 93/18888 | 0.0322581 | 1.3879051 | 0.5784597 | 0.3675490 | 0.6208095 | 0.5445156 | SLC1A2/SLC17A6/SERINC5 | 3 |
| GO:0032465 | GO:0032465 | regulation of cytokinesis | 3/439 | 93/18888 | 0.0322581 | 1.3879051 | 0.5784597 | 0.3675490 | 0.6208095 | 0.5445156 | RAB11A/E2F8/AHCTF1 | 3 |
| GO:0033138 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 3/439 | 93/18888 | 0.0322581 | 1.3879051 | 0.5784597 | 0.3675490 | 0.6208095 | 0.5445156 | TFRC/PDCD10/BDNF | 3 |
| GO:0042475 | GO:0042475 | odontogenesis of dentin-containing tooth | 3/439 | 93/18888 | 0.0322581 | 1.3879051 | 0.5784597 | 0.3675490 | 0.6208095 | 0.5445156 | DLX1/PRKCB/HDAC2 | 3 |
| GO:0006888 | GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4/439 | 132/18888 | 0.0303030 | 1.3037896 | 0.5402778 | 0.3681992 | 0.6208095 | 0.5445156 | TMED7/PPP6C/SEC24B/SEC24A | 4 |
| GO:0016049 | GO:0016049 | cell growth | 13/439 | 496/18888 | 0.0262097 | 1.1276729 | 0.4444801 | 0.3688380 | 0.6208095 | 0.5445156 | PUM2/TEAD1/SYT4/EPHA7/SMAD3/MEAF6/CDH4/SLIT2/ADIPOR1/BDNF/SGK3/PAFAH1B1/YY1 | 13 |
| GO:0005996 | GO:0005996 | monosaccharide metabolic process | 7/439 | 252/18888 | 0.0277778 | 1.1951405 | 0.4810593 | 0.3702870 | 0.6208095 | 0.5445156 | ARPP19/RORA/B4GALT1/TCF7L2/SIRT1/ADIPOR1/KAT2B | 7 |
| GO:0043062 | GO:0043062 | extracellular structure organization | 9/439 | 333/18888 | 0.0270270 | 1.1628394 | 0.4624645 | 0.3703727 | 0.6208095 | 0.5445156 | ADAMTS5/EGFL6/ANGPTL7/SMAD3/B4GALT1/CAV2/SULF1/RGCC/ADAMTSL3 | 9 |
| GO:0009266 | GO:0009266 | response to temperature stimulus | 5/439 | 172/18888 | 0.0290698 | 1.2507284 | 0.5095521 | 0.3706691 | 0.6208095 | 0.5445156 | APPL2/SIRT1/IL1A/HDAC2/TFEC | 5 |
| GO:0045229 | GO:0045229 | external encapsulating structure organization | 9/439 | 334/18888 | 0.0269461 | 1.1593578 | 0.4532681 | 0.3736701 | 0.6208095 | 0.5445156 | ADAMTS5/EGFL6/ANGPTL7/SMAD3/B4GALT1/CAV2/SULF1/RGCC/ADAMTSL3 | 9 |
| GO:0051952 | GO:0051952 | regulation of amine transport | 3/439 | 94/18888 | 0.0319149 | 1.3731401 | 0.5594401 | 0.3738851 | 0.6208095 | 0.5445156 | SYT4/CNR1/PRKCB | 3 |
| GO:1900182 | GO:1900182 | positive regulation of protein localization to nucleus | 3/439 | 94/18888 | 0.0319149 | 1.3731401 | 0.5594401 | 0.3738851 | 0.6208095 | 0.5445156 | TFRC/SMAD3/TCF7L2 | 3 |
| GO:0051896 | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 7/439 | 253/18888 | 0.0276680 | 1.1904166 | 0.4703571 | 0.3740834 | 0.6208095 | 0.5445156 | MTM1/PTPN13/VAV3/HIP1/TCF7L2/PIP5K1A/SIRT1 | 7 |
| GO:0009116 | GO:0009116 | nucleoside metabolic process | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | ADK/ENPP4 | 2 |
| GO:0034204 | GO:0034204 | lipid translocation | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | KCNN4/ATP8A1 | 2 |
| GO:0034205 | GO:0034205 | amyloid-beta formation | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | LRRTM3/PRNP | 2 |
| GO:0170038 | GO:0170038 | proteinogenic amino acid biosynthetic process | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | GLUD1/SERINC5 | 2 |
| GO:1901016 | GO:1901016 | regulation of potassium ion transmembrane transporter activity | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | OXSR1/CACNA1D | 2 |
| GO:2000648 | GO:2000648 | positive regulation of stem cell proliferation | 2/439 | 56/18888 | 0.0357143 | 1.5366092 | 0.6203421 | 0.3751299 | 0.6208095 | 0.5445156 | HMGA2/EPCAM | 2 |
| GO:0034764 | GO:0034764 | positive regulation of transmembrane transport | 6/439 | 213/18888 | 0.0281690 | 1.2119734 | 0.4799194 | 0.3751868 | 0.6208095 | 0.5445156 | ARPP19/PPP3CA/KCNN4/SLC1A2/PPP3R1/RYR2 | 6 |
| GO:0045216 | GO:0045216 | cell-cell junction organization | 6/439 | 213/18888 | 0.0281690 | 1.2119734 | 0.4799194 | 0.3751868 | 0.6208095 | 0.5445156 | DLG5/MTSS1/SMAD3/CDH4/APC/CDH19 | 6 |
| GO:0002093 | GO:0002093 | auditory receptor cell morphogenesis | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SEC24B | 1 |
| GO:0002643 | GO:0002643 | regulation of tolerance induction | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | IRAK3 | 1 |
| GO:0006607 | GO:0006607 | NLS-bearing protein import into nucleus | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KPNA1 | 1 |
| GO:0006670 | GO:0006670 | sphingosine metabolic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SPTSSA | 1 |
| GO:0006700 | GO:0006700 | C21-steroid hormone biosynthetic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | REST | 1 |
| GO:0009070 | GO:0009070 | serine family amino acid biosynthetic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SERINC5 | 1 |
| GO:0014048 | GO:0014048 | regulation of glutamate secretion | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SYT4 | 1 |
| GO:0015810 | GO:0015810 | aspartate transmembrane transport | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SLC1A2 | 1 |
| GO:0015812 | GO:0015812 | gamma-aminobutyric acid transport | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SLC6A6 | 1 |
| GO:0030813 | GO:0030813 | positive regulation of nucleotide catabolic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KAT2B | 1 |
| GO:0031998 | GO:0031998 | regulation of fatty acid beta-oxidation | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | CNR1 | 1 |
| GO:0032303 | GO:0032303 | regulation of icosanoid secretion | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | IL1A | 1 |
| GO:0032332 | GO:0032332 | positive regulation of chondrocyte differentiation | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SMAD3 | 1 |
| GO:0032515 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | PPP1R1B | 1 |
| GO:0033123 | GO:0033123 | positive regulation of purine nucleotide catabolic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KAT2B | 1 |
| GO:0034122 | GO:0034122 | negative regulation of toll-like receptor signaling pathway | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | IRAK3 | 1 |
| GO:0034755 | GO:0034755 | iron ion transmembrane transport | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SLC40A1 | 1 |
| GO:0036498 | GO:0036498 | IRE1-mediated unfolded protein response | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | TMEM33 | 1 |
| GO:0038092 | GO:0038092 | nodal signaling pathway | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | SMAD3 | 1 |
| GO:0038166 | GO:0038166 | angiotensin-activated signaling pathway | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | PPP3CA | 1 |
| GO:0039692 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | HMGA2 | 1 |
| GO:0042454 | GO:0042454 | ribonucleoside catabolic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | ENPP4 | 1 |
| GO:0042985 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | ITM2C | 1 |
| GO:0044794 | GO:0044794 | positive regulation by host of viral process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | CAV2 | 1 |
| GO:0045655 | GO:0045655 | regulation of monocyte differentiation | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | CDK6 | 1 |
| GO:0045821 | GO:0045821 | positive regulation of glycolytic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KAT2B | 1 |
| GO:0048311 | GO:0048311 | mitochondrion distribution | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | MTM1 | 1 |
| GO:0055070 | GO:0055070 | copper ion homeostasis | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | PRNP | 1 |
| GO:0055093 | GO:0055093 | response to hyperoxia | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | HDAC2 | 1 |
| GO:0060749 | GO:0060749 | mammary gland alveolus development | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | AR | 1 |
| GO:0061377 | GO:0061377 | mammary gland lobule development | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | AR | 1 |
| GO:0071474 | GO:0071474 | cellular hyperosmotic response | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | OXSR1 | 1 |
| GO:0071731 | GO:0071731 | response to nitric oxide | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | EGLN1 | 1 |
| GO:0071786 | GO:0071786 | endoplasmic reticulum tubular network organization | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | TMEM33 | 1 |
| GO:0072567 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KLF4 | 1 |
| GO:0090201 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | OPA1 | 1 |
| GO:0090308 | GO:0090308 | regulation of DNA methylation-dependent heterochromatin formation | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | L3MBTL3 | 1 |
| GO:0097254 | GO:0097254 | renal tubular secretion | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | MLLT6 | 1 |
| GO:0097284 | GO:0097284 | hepatocyte apoptotic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | ATF2 | 1 |
| GO:0097468 | GO:0097468 | programmed cell death in response to reactive oxygen species | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | PDCD10 | 1 |
| GO:0097494 | GO:0097494 | regulation of vesicle size | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | RAB11A | 1 |
| GO:0140131 | GO:0140131 | positive regulation of lymphocyte chemotaxis | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | OXSR1 | 1 |
| GO:1900037 | GO:1900037 | regulation of cellular response to hypoxia | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KCNK2 | 1 |
| GO:1900227 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | MAPK8 | 1 |
| GO:1902004 | GO:1902004 | positive regulation of amyloid-beta formation | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | LRRTM3 | 1 |
| GO:1902236 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | OPA1 | 1 |
| GO:1990182 | GO:1990182 | exosomal secretion | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | RAB11A | 1 |
| GO:2000269 | GO:2000269 | regulation of fibroblast apoptotic process | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | API5 | 1 |
| GO:2000341 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production | 1/439 | 20/18888 | 0.0500000 | 2.1512528 | 0.7946028 | 0.3753552 | 0.6208095 | 0.5445156 | KLF4 | 1 |
| GO:0031570 | GO:0031570 | DNA integrity checkpoint signaling | 4/439 | 134/18888 | 0.0298507 | 1.2843301 | 0.5095133 | 0.3787600 | 0.6259262 | 0.5490035 | TAOK1/MBTPS1/SYF2/ATF2 | 4 |
| GO:0051384 | GO:0051384 | response to glucocorticoid | 4/439 | 134/18888 | 0.0298507 | 1.2843301 | 0.5095133 | 0.3787600 | 0.6259262 | 0.5490035 | FBXO32/SRD5A1/REST/SLIT2 | 4 |
| GO:0033555 | GO:0033555 | multicellular organismal response to stress | 3/439 | 95/18888 | 0.0315789 | 1.3586860 | 0.5406367 | 0.3802087 | 0.6273950 | 0.5502918 | PPP3CA/NR4A2/MEF2C | 3 |
| GO:0060395 | GO:0060395 | SMAD protein signal transduction | 3/439 | 95/18888 | 0.0315789 | 1.3586860 | 0.5406367 | 0.3802087 | 0.6273950 | 0.5502918 | ZMIZ1/JUN/SMAD3 | 3 |
| GO:0071901 | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 3/439 | 95/18888 | 0.0315789 | 1.3586860 | 0.5406367 | 0.3802087 | 0.6273950 | 0.5502918 | SIRT1/APC/IRAK3 | 3 |
| GO:0045862 | GO:0045862 | positive regulation of proteolysis | 9/439 | 336/18888 | 0.0267857 | 1.1524569 | 0.4349593 | 0.3802724 | 0.6273950 | 0.5502918 | L3MBTL3/HIP1/SMAD3/REST/SIRT1/HDAC2/MAP3K5/TANK/ST18 | 9 |
| GO:0001933 | GO:0001933 | negative regulation of protein phosphorylation | 8/439 | 296/18888 | 0.0270270 | 1.1628394 | 0.4355816 | 0.3829760 | 0.6302424 | 0.5527892 | PTPN13/EPHA1/SPRED1/SLIT2/SIRT1/APC/IRAK3/PRNP | 8 |
| GO:0010658 | GO:0010658 | striated muscle cell apoptotic process | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | HEY2/MAP3K5 | 2 |
| GO:0031124 | GO:0031124 | mRNA 3'-end processing | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | VIRMA/RPRD1A | 2 |
| GO:0031663 | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | MAPK1/IRAK2 | 2 |
| GO:0046902 | GO:0046902 | regulation of mitochondrial membrane permeability | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | ATF2/RHOT1 | 2 |
| GO:0060632 | GO:0060632 | regulation of microtubule-based movement | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | RSPH4A/APC | 2 |
| GO:0170034 | GO:0170034 | L-amino acid biosynthetic process | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | GLUD1/SERINC5 | 2 |
| GO:0170040 | GO:0170040 | proteinogenic amino acid catabolic process | 2/439 | 57/18888 | 0.0350877 | 1.5096511 | 0.5944305 | 0.3834432 | 0.6302424 | 0.5527892 | GLUD1/GPT2 | 2 |
| GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 11/439 | 419/18888 | 0.0262530 | 1.1295361 | 0.4136219 | 0.3834815 | 0.6302424 | 0.5527892 | DLG5/ZMIZ1/SOCS6/TFRC/PPP3CA/MAP3K8/CD46/KLF4/IL1A/STK10/PRNP | 11 |
| GO:0045936 | GO:0045936 | negative regulation of phosphate metabolic process | 10/439 | 378/18888 | 0.0264550 | 1.1382290 | 0.4187639 | 0.3836999 | 0.6302424 | 0.5527892 | ARPP19/PTPN13/PPP1R1B/EPHA1/SPRED1/SLIT2/SIRT1/APC/IRAK3/PRNP | 10 |
| GO:0006354 | GO:0006354 | DNA-templated transcription elongation | 4/439 | 135/18888 | 0.0296296 | 1.2748165 | 0.4943126 | 0.3840344 | 0.6302424 | 0.5527892 | INTS6/CCNT2/INTS10/MED4 | 4 |
| GO:0010927 | GO:0010927 | cellular component assembly involved in morphogenesis | 4/439 | 135/18888 | 0.0296296 | 1.2748165 | 0.4943126 | 0.3840344 | 0.6302424 | 0.5527892 | SIX4/CNTN1/PROX1/PAFAH1B1 | 4 |
| GO:0030218 | GO:0030218 | erythrocyte differentiation | 4/439 | 135/18888 | 0.0296296 | 1.2748165 | 0.4943126 | 0.3840344 | 0.6302424 | 0.5527892 | CDK6/SP3/L3MBTL3/TAL1 | 4 |
| GO:1902905 | GO:1902905 | positive regulation of supramolecular fiber organization | 5/439 | 175/18888 | 0.0285714 | 1.2292873 | 0.4700616 | 0.3845139 | 0.6307722 | 0.5532539 | MTSS1/EPHA1/SMAD3/PROX1/RGCC | 5 |
| GO:0001960 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 3/439 | 96/18888 | 0.0312500 | 1.3445330 | 0.5220442 | 0.3865185 | 0.6327172 | 0.5549599 | SLIT2/IRAK3/TANK | 3 |
| GO:0007044 | GO:0007044 | cell-substrate junction assembly | 3/439 | 96/18888 | 0.0312500 | 1.3445330 | 0.5220442 | 0.3865185 | 0.6327172 | 0.5549599 | SMAD3/EPHA3/PIP5K1A | 3 |
| GO:0031110 | GO:0031110 | regulation of microtubule polymerization or depolymerization | 3/439 | 96/18888 | 0.0312500 | 1.3445330 | 0.5220442 | 0.3865185 | 0.6327172 | 0.5549599 | TAOK1/TTBK2/APC | 3 |
| GO:0010563 | GO:0010563 | negative regulation of phosphorus metabolic process | 10/439 | 379/18888 | 0.0263852 | 1.1352258 | 0.4102182 | 0.3868215 | 0.6327172 | 0.5549599 | ARPP19/PTPN13/PPP1R1B/EPHA1/SPRED1/SLIT2/SIRT1/APC/IRAK3/PRNP | 10 |
| GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 5/439 | 176/18888 | 0.0284091 | 1.2223028 | 0.4570549 | 0.3891266 | 0.6327172 | 0.5549599 | RNF138/MEAF6/EPC1/YY1/RIF1 | 5 |
| GO:0006662 | GO:0006662 | glycerol ether metabolic process | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | PAFAH1B1 | 1 |
| GO:0006907 | GO:0006907 | pinocytosis | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | APPL2 | 1 |
| GO:0030502 | GO:0030502 | negative regulation of bone mineralization | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | BCOR | 1 |
| GO:0032011 | GO:0032011 | ARF protein signal transduction | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | ARFGEF3 | 1 |
| GO:0032012 | GO:0032012 | regulation of ARF protein signal transduction | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | ARFGEF3 | 1 |
| GO:0032402 | GO:0032402 | melanosome transport | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | RAB11A | 1 |
| GO:0032495 | GO:0032495 | response to muramyl dipeptide | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | JAG1 | 1 |
| GO:0035809 | GO:0035809 | regulation of urine volume | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | MLLT6 | 1 |
| GO:0045056 | GO:0045056 | transcytosis | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | RAB11A | 1 |
| GO:0046485 | GO:0046485 | ether lipid metabolic process | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | PAFAH1B1 | 1 |
| GO:0061050 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | YY1 | 1 |
| GO:0061577 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | SESTD1 | 1 |
| GO:0090043 | GO:0090043 | regulation of tubulin deacetylation | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | KAT2B | 1 |
| GO:0090141 | GO:0090141 | positive regulation of mitochondrial fission | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | DDHD1 | 1 |
| GO:0097049 | GO:0097049 | motor neuron apoptotic process | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | ATF2 | 1 |
| GO:0097734 | GO:0097734 | extracellular exosome biogenesis | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | RAB11A | 1 |
| GO:0140354 | GO:0140354 | lipid import into cell | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | PLPPR4 | 1 |
| GO:0141087 | GO:0141087 | positive regulation of inflammasome-mediated signaling pathway | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | MAPK8 | 1 |
| GO:1902683 | GO:1902683 | regulation of receptor localization to synapse | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | GPC6 | 1 |
| GO:1903975 | GO:1903975 | regulation of glial cell migration | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | RRAS2 | 1 |
| GO:2001135 | GO:2001135 | regulation of endocytic recycling | 1/439 | 21/18888 | 0.0476190 | 2.0488122 | 0.7417940 | 0.3898888 | 0.6327172 | 0.5549599 | RAB11A | 1 |
| GO:0050867 | GO:0050867 | positive regulation of cell activation | 10/439 | 380/18888 | 0.0263158 | 1.1322383 | 0.4016953 | 0.3899450 | 0.6327172 | 0.5549599 | VAV3/ZMIZ1/TFRC/PPP3CA/MEF2C/SH3KBP1/MAP3K8/CD46/IL1A/RIF1 | 10 |
| GO:0006310 | GO:0006310 | DNA recombination | 9/439 | 339/18888 | 0.0265487 | 1.1422581 | 0.4077032 | 0.3901914 | 0.6328618 | 0.5550867 | INO80D/TFRC/KPNA1/RNF138/MEAF6/EPC1/YY1/SMARCAD1/RIF1 | 9 |
| GO:0002381 | GO:0002381 | immunoglobulin production involved in immunoglobulin-mediated immune response | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | TFRC/RIF1 | 2 |
| GO:0006826 | GO:0006826 | iron ion transport | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | TFRC/SLC40A1 | 2 |
| GO:0016073 | GO:0016073 | snRNA metabolic process | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | INTS6/INTS10 | 2 |
| GO:0032786 | GO:0032786 | positive regulation of DNA-templated transcription, elongation | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | CCNT2/MED4 | 2 |
| GO:0048008 | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | HIP1/PTPN12 | 2 |
| GO:0051339 | GO:0051339 | regulation of lyase activity | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | ADCYAP1/CACNA1D | 2 |
| GO:0086065 | GO:0086065 | cell communication involved in cardiac conduction | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | RYR2/CACNA1D | 2 |
| GO:0099024 | GO:0099024 | plasma membrane invagination | 2/439 | 58/18888 | 0.0344828 | 1.4836227 | 0.5690138 | 0.3917086 | 0.6328970 | 0.5551176 | APPL2/DOCK1 | 2 |
| GO:0006643 | GO:0006643 | membrane lipid metabolic process | 6/439 | 217/18888 | 0.0276498 | 1.1896329 | 0.4333982 | 0.3917859 | 0.6328970 | 0.5551176 | SGMS1/PRKD3/CREM/PPM1L/SPTSSA/CERS6 | 6 |
| GO:0071805 | GO:0071805 | potassium ion transmembrane transport | 6/439 | 217/18888 | 0.0276498 | 1.1896329 | 0.4333982 | 0.3917859 | 0.6328970 | 0.5551176 | KCNN4/KCNK2/OXSR1/SLC17A6/CACNA1D/PRNP | 6 |
| GO:0043491 | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 8/439 | 299/18888 | 0.0267559 | 1.1511721 | 0.4064494 | 0.3935647 | 0.6350291 | 0.5569877 | MTM1/PTPN13/VAV3/HIP1/PREX2/TCF7L2/PIP5K1A/SIRT1 | 8 |
| GO:0001959 | GO:0001959 | regulation of cytokine-mediated signaling pathway | 5/439 | 177/18888 | 0.0282486 | 1.2153971 | 0.4441251 | 0.3937370 | 0.6350291 | 0.5569877 | SLIT2/PAFAH1B1/IRAK3/IRAK2/TANK | 5 |
| GO:0010634 | GO:0010634 | positive regulation of epithelial cell migration | 5/439 | 177/18888 | 0.0282486 | 1.2153971 | 0.4441251 | 0.3937370 | 0.6350291 | 0.5569877 | RAB11A/RIN2/DOCK1/SIRT1/PROX1 | 5 |
| GO:0072331 | GO:0072331 | signal transduction by p53 class mediator | 5/439 | 177/18888 | 0.0282486 | 1.2153971 | 0.4441251 | 0.3937370 | 0.6350291 | 0.5569877 | KAT6A/JMY/SPRED1/SIRT1/HNRNPK | 5 |
| GO:0034219 | GO:0034219 | carbohydrate transmembrane transport | 4/439 | 137/18888 | 0.0291971 | 1.2562060 | 0.4642637 | 0.3945664 | 0.6361119 | 0.5579374 | ARPP19/APPL2/PRKCB/SLC1A2 | 4 |
| GO:0050863 | GO:0050863 | regulation of T cell activation | 10/439 | 382/18888 | 0.0261780 | 1.1263104 | 0.3847174 | 0.3961965 | 0.6382284 | 0.5597938 | DLG5/ZMIZ1/SOCS6/TFRC/PPP3CA/MAP3K8/CD46/IL1A/SOS1/PRNP | 10 |
| GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 10/439 | 382/18888 | 0.0261780 | 1.1263104 | 0.3847174 | 0.3961965 | 0.6382284 | 0.5597938 | DLG5/ZMIZ1/SOCS6/TFRC/PPP3CA/MAP3K8/CD46/KLF4/IL1A/PRNP | 10 |
| GO:0010657 | GO:0010657 | muscle cell apoptotic process | 3/439 | 98/18888 | 0.0306122 | 1.3170936 | 0.4854723 | 0.3990909 | 0.6396687 | 0.5610571 | HEY2/SIRT1/MAP3K5 | 3 |
| GO:0014909 | GO:0014909 | smooth muscle cell migration | 3/439 | 98/18888 | 0.0306122 | 1.3170936 | 0.4854723 | 0.3990909 | 0.6396687 | 0.5610571 | MEF2C/DOCK4/SLIT2 | 3 |
| GO:1904064 | GO:1904064 | positive regulation of cation transmembrane transport | 4/439 | 138/18888 | 0.0289855 | 1.2471031 | 0.4494118 | 0.3998224 | 0.6396687 | 0.5610571 | PPP3CA/KCNN4/PPP3R1/RYR2 | 4 |
| GO:0009161 | GO:0009161 | ribonucleoside monophosphate metabolic process | 2/439 | 59/18888 | 0.0338983 | 1.4584765 | 0.5440725 | 0.3999238 | 0.6396687 | 0.5610571 | GART/ADK | 2 |
| GO:0009948 | GO:0009948 | anterior/posterior axis specification | 2/439 | 59/18888 | 0.0338983 | 1.4584765 | 0.5440725 | 0.3999238 | 0.6396687 | 0.5610571 | ETS2/HEY2 | 2 |
| GO:0010921 | GO:0010921 | regulation of phosphatase activity | 2/439 | 59/18888 | 0.0338983 | 1.4584765 | 0.5440725 | 0.3999238 | 0.6396687 | 0.5610571 | MEF2C/PPP1R1B | 2 |
| GO:0038066 | GO:0038066 | p38MAPK cascade | 2/439 | 59/18888 | 0.0338983 | 1.4584765 | 0.5440725 | 0.3999238 | 0.6396687 | 0.5610571 | ATF2/MAP3K5 | 2 |
| GO:0003015 | GO:0003015 | heart process | 7/439 | 260/18888 | 0.0269231 | 1.1583669 | 0.3966389 | 0.4006963 | 0.6396687 | 0.5610571 | SCN2A/ATP2B1/TMEM161B/HEY2/ATP2B2/RYR2/CACNA1D | 7 |
| GO:1903034 | GO:1903034 | regulation of response to wounding | 5/439 | 179/18888 | 0.0279330 | 1.2018172 | 0.4184917 | 0.4029488 | 0.6396687 | 0.5610571 | PUM2/SMAD3/KLF4/AJAP1/ENPP4 | 5 |
| GO:0001759 | GO:0001759 | organ induction | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | AR | 1 |
| GO:0002089 | GO:0002089 | lens morphogenesis in camera-type eye | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PROX1 | 1 |
| GO:0003228 | GO:0003228 | atrial cardiac muscle tissue development | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PROX1 | 1 |
| GO:0006883 | GO:0006883 | intracellular sodium ion homeostasis | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | IL1A | 1 |
| GO:0007398 | GO:0007398 | ectoderm development | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | ETS2 | 1 |
| GO:0008090 | GO:0008090 | retrograde axonal transport | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PAFAH1B1 | 1 |
| GO:0009713 | GO:0009713 | catechol-containing compound biosynthetic process | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | NR4A2 | 1 |
| GO:0010881 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | RYR2 | 1 |
| GO:0010923 | GO:0010923 | negative regulation of phosphatase activity | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PPP1R1B | 1 |
| GO:0010988 | GO:0010988 | regulation of low-density lipoprotein particle clearance | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | HNRNPK | 1 |
| GO:0030449 | GO:0030449 | regulation of complement activation | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | CD46 | 1 |
| GO:0032069 | GO:0032069 | regulation of nuclease activity | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | SIRT1 | 1 |
| GO:0032401 | GO:0032401 | establishment of melanosome localization | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | RAB11A | 1 |
| GO:0032700 | GO:0032700 | negative regulation of interleukin-17 production | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PRNP | 1 |
| GO:0034260 | GO:0034260 | negative regulation of GTPase activity | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | CPEB2 | 1 |
| GO:0034312 | GO:0034312 | diol biosynthetic process | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | SPTSSA | 1 |
| GO:0035235 | GO:0035235 | ionotropic glutamate receptor signaling pathway | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | GRIN3A | 1 |
| GO:0036480 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | MAP3K5 | 1 |
| GO:0042423 | GO:0042423 | catecholamine biosynthetic process | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | NR4A2 | 1 |
| GO:0042953 | GO:0042953 | lipoprotein transport | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PRKCB | 1 |
| GO:0043555 | GO:0043555 | regulation of translation in response to stress | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PDIK1L | 1 |
| GO:0046519 | GO:0046519 | sphingoid metabolic process | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | SPTSSA | 1 |
| GO:0048485 | GO:0048485 | sympathetic nervous system development | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | FZD3 | 1 |
| GO:0051904 | GO:0051904 | pigment granule transport | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | RAB11A | 1 |
| GO:0060445 | GO:0060445 | branching involved in salivary gland morphogenesis | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | FGFR2 | 1 |
| GO:0061318 | GO:0061318 | renal filtration cell differentiation | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | JAG1 | 1 |
| GO:0072112 | GO:0072112 | podocyte differentiation | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | JAG1 | 1 |
| GO:0086012 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | CACNA1D | 1 |
| GO:0097062 | GO:0097062 | dendritic spine maintenance | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | PRNP | 1 |
| GO:0140861 | GO:0140861 | DNA repair-dependent chromatin remodeling | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | SIRT1 | 1 |
| GO:0150105 | GO:0150105 | protein localization to cell-cell junction | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | DLG5 | 1 |
| GO:1900118 | GO:1900118 | negative regulation of execution phase of apoptosis | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | FZD3 | 1 |
| GO:1902473 | GO:1902473 | regulation of protein localization to synapse | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | GPC6 | 1 |
| GO:1902644 | GO:1902644 | tertiary alcohol metabolic process | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | REST | 1 |
| GO:2000725 | GO:2000725 | regulation of cardiac muscle cell differentiation | 1/439 | 22/18888 | 0.0454545 | 1.9556844 | 0.6918521 | 0.4040849 | 0.6396687 | 0.5610571 | MEF2C | 1 |
| GO:0031400 | GO:0031400 | negative regulation of protein modification process | 11/439 | 426/18888 | 0.0258216 | 1.1109756 | 0.3573719 | 0.4042680 | 0.6397068 | 0.5610905 | ARPP19/PTPN13/PPP1R1B/EPHA1/SPRED1/SLIT2/SIRT1/APC/IRAK3/HDAC2/PRNP | 11 |
| GO:0001101 | GO:0001101 | response to acid chemical | 4/439 | 139/18888 | 0.0287770 | 1.2381311 | 0.4346722 | 0.4050705 | 0.6401617 | 0.5614895 | GDF10/SLC1A2/CPEB3/UBR1 | 4 |
| GO:0007098 | GO:0007098 | centrosome cycle | 4/439 | 139/18888 | 0.0287770 | 1.2381311 | 0.4346722 | 0.4050705 | 0.6401617 | 0.5614895 | CEP120/SIRT1/CETN3/KAT2B | 4 |
| GO:0006835 | GO:0006835 | dicarboxylic acid transport | 3/439 | 99/18888 | 0.0303030 | 1.3037896 | 0.4674832 | 0.4053509 | 0.6401617 | 0.5614895 | SYT4/SLC1A2/SLC17A6 | 3 |
| GO:0050773 | GO:0050773 | regulation of dendrite development | 3/439 | 99/18888 | 0.0303030 | 1.3037896 | 0.4674832 | 0.4053509 | 0.6401617 | 0.5614895 | CSMD3/PPP3CA/PAFAH1B1 | 3 |
| GO:0060349 | GO:0060349 | bone morphogenesis | 3/439 | 99/18888 | 0.0303030 | 1.3037896 | 0.4674832 | 0.4053509 | 0.6401617 | 0.5614895 | MEF2C/FGFR2/ATF2 | 3 |
| GO:1905475 | GO:1905475 | regulation of protein localization to membrane | 5/439 | 180/18888 | 0.0277778 | 1.1951405 | 0.4057862 | 0.4075490 | 0.6419143 | 0.5630267 | EPHA3/PPFIA1/GPC6/AR/PRNP | 5 |
| GO:0001706 | GO:0001706 | endoderm formation | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | HMGA2/BRD3 | 2 |
| GO:0006695 | GO:0006695 | cholesterol biosynthetic process | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | MBTPS1/SEC14L2 | 2 |
| GO:0006940 | GO:0006940 | regulation of smooth muscle contraction | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | ATP2B1/DOCK4 | 2 |
| GO:0046173 | GO:0046173 | polyol biosynthetic process | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | IPMK/SPTSSA | 2 |
| GO:0060350 | GO:0060350 | endochondral bone morphogenesis | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | MEF2C/ATF2 | 2 |
| GO:0071168 | GO:0071168 | protein localization to chromatin | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | JARID2/BRD3 | 2 |
| GO:0097300 | GO:0097300 | programmed necrotic cell death | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | IPMK/MAP3K5 | 2 |
| GO:0099518 | GO:0099518 | vesicle cytoskeletal trafficking | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | SYT4/PAFAH1B1 | 2 |
| GO:1902653 | GO:1902653 | secondary alcohol biosynthetic process | 2/439 | 60/18888 | 0.0333333 | 1.4341686 | 0.5195882 | 0.4080867 | 0.6419143 | 0.5630267 | MBTPS1/SEC14L2 | 2 |
| GO:1903522 | GO:1903522 | regulation of blood circulation | 7/439 | 262/18888 | 0.0267176 | 1.1495244 | 0.3759502 | 0.4083013 | 0.6419143 | 0.5630267 | ATP2B1/TMEM161B/HEY2/ATP2B2/DOCK4/RYR2/CACNA1D | 7 |
| GO:0032412 | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 6/439 | 221/18888 | 0.0271493 | 1.1681011 | 0.3877544 | 0.4083749 | 0.6419143 | 0.5630267 | MEF2C/OXSR1/RYR2/CRHBP/CACNA1D/PRNP | 6 |
| GO:0016032 | GO:0016032 | viral process | 11/439 | 428/18888 | 0.0257009 | 1.1057842 | 0.3414712 | 0.4102175 | 0.6438775 | 0.5647487 | HCFC2/TFRC/CCNT2/SPCS3/JUN/HMGA2/REST/NFIA/CAV2/CD46/PROX1 | 11 |
| GO:0051056 | GO:0051056 | regulation of small GTPase mediated signal transduction | 8/439 | 304/18888 | 0.0263158 | 1.1322383 | 0.3585518 | 0.4112250 | 0.6438775 | 0.5647487 | VAV3/CHN2/PREX2/SLIT2/TRIO/SIPA1L1/ARFGEF3/SOS1 | 8 |
| GO:0000041 | GO:0000041 | transition metal ion transport | 3/439 | 100/18888 | 0.0300000 | 1.2907517 | 0.4496860 | 0.4115917 | 0.6438775 | 0.5647487 | SLC30A6/TFRC/SLC40A1 | 3 |
| GO:0006493 | GO:0006493 | protein O-linked glycosylation | 3/439 | 100/18888 | 0.0300000 | 1.2907517 | 0.4496860 | 0.4115917 | 0.6438775 | 0.5647487 | OGA/GALNT7/TET2 | 3 |
| GO:0007029 | GO:0007029 | endoplasmic reticulum organization | 3/439 | 100/18888 | 0.0300000 | 1.2907517 | 0.4496860 | 0.4115917 | 0.6438775 | 0.5647487 | CAV2/PEX5/TMEM33 | 3 |
| GO:0048661 | GO:0048661 | positive regulation of smooth muscle cell proliferation | 3/439 | 100/18888 | 0.0300000 | 1.2907517 | 0.4496860 | 0.4115917 | 0.6438775 | 0.5647487 | JUN/FGFR2/MAP3K5 | 3 |
| GO:0090630 | GO:0090630 | activation of GTPase activity | 3/439 | 100/18888 | 0.0300000 | 1.2907517 | 0.4496860 | 0.4115917 | 0.6438775 | 0.5647487 | EPHA1/PIP5K1A/SIPA1L1 | 3 |
| GO:0000725 | GO:0000725 | recombinational repair | 5/439 | 181/18888 | 0.0276243 | 1.1885375 | 0.3931536 | 0.4121446 | 0.6438775 | 0.5647487 | RNF138/MEAF6/EPC1/YY1/RIF1 | 5 |
| GO:0051092 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 4/439 | 141/18888 | 0.0283688 | 1.2205690 | 0.4055230 | 0.4155399 | 0.6438775 | 0.5647487 | TFRC/IRAK3/IRAK2/AR | 4 |
| GO:0031102 | GO:0031102 | neuron projection regeneration | 2/439 | 61/18888 | 0.0327869 | 1.4106576 | 0.4955432 | 0.4161953 | 0.6438775 | 0.5647487 | PUM2/KLF4 | 2 |
| GO:0045744 | GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 2/439 | 61/18888 | 0.0327869 | 1.4106576 | 0.4955432 | 0.4161953 | 0.6438775 | 0.5647487 | PPP3CA/SLIT2 | 2 |
| GO:0048010 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2/439 | 61/18888 | 0.0327869 | 1.4106576 | 0.4955432 | 0.4161953 | 0.6438775 | 0.5647487 | PRKCB/SULF1 | 2 |
| GO:0097035 | GO:0097035 | regulation of membrane lipid distribution | 2/439 | 61/18888 | 0.0327869 | 1.4106576 | 0.4955432 | 0.4161953 | 0.6438775 | 0.5647487 | KCNN4/ATP8A1 | 2 |
| GO:0170035 | GO:0170035 | L-amino acid catabolic process | 2/439 | 61/18888 | 0.0327869 | 1.4106576 | 0.4955432 | 0.4161953 | 0.6438775 | 0.5647487 | GLUD1/GPT2 | 2 |
| GO:0033673 | GO:0033673 | negative regulation of kinase activity | 5/439 | 182/18888 | 0.0274725 | 1.1820071 | 0.3805930 | 0.4167350 | 0.6438775 | 0.5647487 | EPHA1/SPRED1/SIRT1/APC/IRAK3 | 5 |
| GO:0033108 | GO:0033108 | mitochondrial respiratory chain complex assembly | 3/439 | 101/18888 | 0.0297030 | 1.2779720 | 0.4320762 | 0.4178121 | 0.6438775 | 0.5647487 | COX18/COX16/NDUFS1 | 3 |
| GO:0002689 | GO:0002689 | negative regulation of leukocyte chemotaxis | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SLIT2 | 1 |
| GO:0003283 | GO:0003283 | atrial septum development | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | HEY2 | 1 |
| GO:0006658 | GO:0006658 | phosphatidylserine metabolic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SERINC5 | 1 |
| GO:0006837 | GO:0006837 | serotonin transport | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | CNR1 | 1 |
| GO:0009162 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | ADK | 1 |
| GO:0010866 | GO:0010866 | regulation of triglyceride biosynthetic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SIRT1 | 1 |
| GO:0010893 | GO:0010893 | positive regulation of steroid biosynthetic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | IL1A | 1 |
| GO:0018126 | GO:0018126 | protein hydroxylation | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | EGLN1 | 1 |
| GO:0031338 | GO:0031338 | regulation of vesicle fusion | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SYT4 | 1 |
| GO:0033762 | GO:0033762 | response to glucagon | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | CREB1 | 1 |
| GO:0034105 | GO:0034105 | positive regulation of tissue remodeling | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PPP3CA | 1 |
| GO:0034472 | GO:0034472 | snRNA 3'-end processing | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | INTS6 | 1 |
| GO:0035493 | GO:0035493 | SNARE complex assembly | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | VAMP4 | 1 |
| GO:0035855 | GO:0035855 | megakaryocyte development | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | TAL1 | 1 |
| GO:0036303 | GO:0036303 | lymph vessel morphogenesis | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PROX1 | 1 |
| GO:0038128 | GO:0038128 | ERBB2 signaling pathway | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | MAPK1 | 1 |
| GO:0044872 | GO:0044872 | lipoprotein localization | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PRKCB | 1 |
| GO:0045591 | GO:0045591 | positive regulation of regulatory T cell differentiation | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | CD46 | 1 |
| GO:0045723 | GO:0045723 | positive regulation of fatty acid biosynthetic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | KAT2B | 1 |
| GO:0045736 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | APC | 1 |
| GO:0045932 | GO:0045932 | negative regulation of muscle contraction | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | DOCK4 | 1 |
| GO:0046794 | GO:0046794 | transport of virus | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | CAV2 | 1 |
| GO:0048015 | GO:0048015 | phosphatidylinositol-mediated signaling | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PLCB1 | 1 |
| GO:0051905 | GO:0051905 | establishment of pigment granule localization | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | RAB11A | 1 |
| GO:0072311 | GO:0072311 | glomerular epithelial cell differentiation | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | JAG1 | 1 |
| GO:0072574 | GO:0072574 | hepatocyte proliferation | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PROX1 | 1 |
| GO:0072575 | GO:0072575 | epithelial cell proliferation involved in liver morphogenesis | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | PROX1 | 1 |
| GO:0090042 | GO:0090042 | tubulin deacetylation | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | KAT2B | 1 |
| GO:0097164 | GO:0097164 | ammonium ion metabolic process | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SRD5A1 | 1 |
| GO:0140112 | GO:0140112 | extracellular vesicle biogenesis | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | RAB11A | 1 |
| GO:1902254 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | SIRT1 | 1 |
| GO:1904030 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | APC | 1 |
| GO:2000042 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | RIF1 | 1 |
| GO:2000114 | GO:2000114 | regulation of establishment of cell polarity | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | RAP1B | 1 |
| GO:2000193 | GO:2000193 | positive regulation of fatty acid transport | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | IL1A | 1 |
| GO:2000311 | GO:2000311 | regulation of AMPA receptor activity | 1/439 | 23/18888 | 0.0434783 | 1.8706546 | 0.6444790 | 0.4179515 | 0.6438775 | 0.5647487 | MEF2C | 1 |
| GO:0043161 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 10/439 | 389/18888 | 0.0257069 | 1.1060426 | 0.3259931 | 0.4181044 | 0.6438775 | 0.5647487 | MTM1/FBXO3/LTN1/APPBP2/SMURF2/UBE2D3/USP25/SIRT1/APC/UBR1 | 10 |
| GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 7/439 | 265/18888 | 0.0264151 | 1.1365109 | 0.3452176 | 0.4196994 | 0.6460866 | 0.5666863 | MAPK1/MEF2C/IL1A/IRAK3/IRAK2/MAPK8/HADHB | 7 |
| GO:0051053 | GO:0051053 | negative regulation of DNA metabolic process | 4/439 | 142/18888 | 0.0281690 | 1.2119734 | 0.3911097 | 0.4207595 | 0.6474708 | 0.5679004 | KCNK2/HMGA2/TNKS2/RIF1 | 4 |
| GO:0061025 | GO:0061025 | membrane fusion | 5/439 | 183/18888 | 0.0273224 | 1.1755480 | 0.3681035 | 0.4213197 | 0.6480851 | 0.5684392 | VAV3/SYT4/RAB12/CAV2/VAMP4 | 5 |
| GO:0030098 | GO:0030098 | lymphocyte differentiation | 11/439 | 432/18888 | 0.0254630 | 1.0955454 | 0.3098920 | 0.4221219 | 0.6490709 | 0.5693038 | CDK6/ZMIZ1/SP3/DOCK10/KLF6/RORA/CD46/ATF2/IL1A/SOS1/YY1 | 11 |
| GO:0034765 | GO:0034765 | regulation of monoatomic ion transmembrane transport | 9/439 | 349/18888 | 0.0257880 | 1.1095287 | 0.3185846 | 0.4233105 | 0.6505993 | 0.5706444 | PPP3CA/KCNN4/SESTD1/YWHAQ/OXSR1/PPP3R1/RYR2/CACNA1D/PRNP | 9 |
| GO:0000768 | GO:0000768 | syncytium formation by plasma membrane fusion | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | ADAMTS5/DOCK1 | 2 |
| GO:0002090 | GO:0002090 | regulation of receptor internalization | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | HIP1/PPP3R1 | 2 |
| GO:0002763 | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | PPP3CA/CREB1 | 2 |
| GO:0072348 | GO:0072348 | sulfur compound transport | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | SLC6A6/SLC1A2 | 2 |
| GO:0140253 | GO:0140253 | cell-cell fusion | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | ADAMTS5/DOCK1 | 2 |
| GO:1903078 | GO:1903078 | positive regulation of protein localization to plasma membrane | 2/439 | 62/18888 | 0.0322581 | 1.3879051 | 0.4719213 | 0.4242477 | 0.6505993 | 0.5706444 | EPHA3/PRNP | 2 |
| GO:2001235 | GO:2001235 | positive regulation of apoptotic signaling pathway | 4/439 | 143/18888 | 0.0279720 | 1.2034981 | 0.3768018 | 0.4259680 | 0.6509377 | 0.5709413 | PRKRA/SIRT1/PLAGL2/ITM2C | 4 |
| GO:0000209 | GO:0000209 | protein polyubiquitination | 7/439 | 267/18888 | 0.0262172 | 1.1279977 | 0.3249255 | 0.4272879 | 0.6509377 | 0.5709413 | PELI2/UBE2Q2/AMFR/UBE2D3/TNKS2/ARIH1/UBE2E3 | 7 |
| GO:1904062 | GO:1904062 | regulation of monoatomic cation transmembrane transport | 8/439 | 309/18888 | 0.0258900 | 1.1139173 | 0.3114478 | 0.4288705 | 0.6509377 | 0.5709413 | PPP3CA/KCNN4/SESTD1/OXSR1/PPP3R1/RYR2/CACNA1D/PRNP | 8 |
| GO:0015914 | GO:0015914 | phospholipid transport | 3/439 | 103/18888 | 0.0291262 | 1.2531570 | 0.3974022 | 0.4301868 | 0.6509377 | 0.5709413 | KCNN4/ATP8A1/PRELID3B | 3 |
| GO:0031123 | GO:0031123 | RNA 3'-end processing | 3/439 | 103/18888 | 0.0291262 | 1.2531570 | 0.3974022 | 0.4301868 | 0.6509377 | 0.5709413 | INTS6/VIRMA/RPRD1A | 3 |
| GO:0035282 | GO:0035282 | segmentation | 3/439 | 103/18888 | 0.0291262 | 1.2531570 | 0.3974022 | 0.4301868 | 0.6509377 | 0.5709413 | MEOX2/IRX2/SMAD3 | 3 |
| GO:0150115 | GO:0150115 | cell-substrate junction organization | 3/439 | 103/18888 | 0.0291262 | 1.2531570 | 0.3974022 | 0.4301868 | 0.6509377 | 0.5709413 | SMAD3/EPHA3/PIP5K1A | 3 |
| GO:2000045 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 5/439 | 185/18888 | 0.0270270 | 1.1628394 | 0.3433341 | 0.4304697 | 0.6509377 | 0.5709413 | APPL2/KLF4/APC/RGCC/PLCB1 | 5 |
| GO:0034101 | GO:0034101 | erythrocyte homeostasis | 4/439 | 144/18888 | 0.0277778 | 1.1951405 | 0.3625975 | 0.4311647 | 0.6509377 | 0.5709413 | CDK6/SP3/L3MBTL3/TAL1 | 4 |
| GO:0000395 | GO:0000395 | mRNA 5'-splice site recognition | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SFSWAP | 1 |
| GO:0001779 | GO:0001779 | natural killer cell differentiation | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SP3 | 1 |
| GO:0002320 | GO:0002320 | lymphoid progenitor cell differentiation | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SOS1 | 1 |
| GO:0003091 | GO:0003091 | renal water homeostasis | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | MLLT6 | 1 |
| GO:0003148 | GO:0003148 | outflow tract septum morphogenesis | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | FGFR2 | 1 |
| GO:0003323 | GO:0003323 | type B pancreatic cell development | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | CDK6 | 1 |
| GO:0006706 | GO:0006706 | steroid catabolic process | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SRD5A1 | 1 |
| GO:0010839 | GO:0010839 | negative regulation of keratinocyte proliferation | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | FGFR2 | 1 |
| GO:0032288 | GO:0032288 | myelin assembly | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | CNTN1 | 1 |
| GO:0032400 | GO:0032400 | melanosome localization | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | RAB11A | 1 |
| GO:0032528 | GO:0032528 | microvillus organization | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | STK26 | 1 |
| GO:0034114 | GO:0034114 | regulation of heterotypic cell-cell adhesion | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | KLF4 | 1 |
| GO:0035162 | GO:0035162 | embryonic hemopoiesis | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | TAL1 | 1 |
| GO:0040037 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SULF1 | 1 |
| GO:0042430 | GO:0042430 | indole-containing compound metabolic process | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SRD5A1 | 1 |
| GO:0042438 | GO:0042438 | melanin biosynthetic process | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | ZEB2 | 1 |
| GO:0046039 | GO:0046039 | GTP metabolic process | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | OPA1 | 1 |
| GO:0046426 | GO:0046426 | negative regulation of receptor signaling pathway via JAK-STAT | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | ADIPOR1 | 1 |
| GO:0046885 | GO:0046885 | regulation of hormone biosynthetic process | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | REST | 1 |
| GO:0050855 | GO:0050855 | regulation of B cell receptor signaling pathway | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | PRKCB | 1 |
| GO:0051152 | GO:0051152 | positive regulation of smooth muscle cell differentiation | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SIRT1 | 1 |
| GO:0051957 | GO:0051957 | positive regulation of amino acid transport | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SYT4 | 1 |
| GO:0060706 | GO:0060706 | cell differentiation involved in embryonic placenta development | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | E2F8 | 1 |
| GO:0060907 | GO:0060907 | positive regulation of macrophage cytokine production | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SIRT1 | 1 |
| GO:0071294 | GO:0071294 | cellular response to zinc ion | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | CREB1 | 1 |
| GO:0072273 | GO:0072273 | metanephric nephron morphogenesis | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SOX8 | 1 |
| GO:0090103 | GO:0090103 | cochlea morphogenesis | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | CTHRC1 | 1 |
| GO:1903861 | GO:1903861 | positive regulation of dendrite extension | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | SYT4 | 1 |
| GO:1904292 | GO:1904292 | regulation of ERAD pathway | 1/439 | 24/18888 | 0.0416667 | 1.7927107 | 0.5994194 | 0.4314961 | 0.6509377 | 0.5709413 | USP25 | 1 |
| GO:0032615 | GO:0032615 | interleukin-12 production | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | IRAK3/PLCB1 | 2 |
| GO:0032623 | GO:0032623 | interleukin-2 production | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | IL1A/PRNP | 2 |
| GO:0032655 | GO:0032655 | regulation of interleukin-12 production | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | IRAK3/PLCB1 | 2 |
| GO:0032663 | GO:0032663 | regulation of interleukin-2 production | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | IL1A/PRNP | 2 |
| GO:0033059 | GO:0033059 | cellular pigmentation | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | RAB11A/ZEB2 | 2 |
| GO:0045428 | GO:0045428 | regulation of nitric oxide biosynthetic process | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | SMAD3/KLF4 | 2 |
| GO:0051893 | GO:0051893 | regulation of focal adhesion assembly | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | SMAD3/EPHA3 | 2 |
| GO:0090109 | GO:0090109 | regulation of cell-substrate junction assembly | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | SMAD3/EPHA3 | 2 |
| GO:1904356 | GO:1904356 | regulation of telomere maintenance via telomere lengthening | 2/439 | 63/18888 | 0.0317460 | 1.3658748 | 0.4487068 | 0.4322421 | 0.6509377 | 0.5709413 | MAPK1/TNKS2 | 2 |
| GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 8/439 | 310/18888 | 0.0258065 | 1.1103241 | 0.3021196 | 0.4323948 | 0.6509377 | 0.5709413 | DLG5/SOCS6/JAG1/KLF4/RGCC/AJAP1/EPCAM/PRNP | 8 |
| GO:0030217 | GO:0030217 | T cell differentiation | 8/439 | 310/18888 | 0.0258065 | 1.1103241 | 0.3021196 | 0.4323948 | 0.6509377 | 0.5709413 | CDK6/ZMIZ1/SP3/RORA/CD46/ATF2/IL1A/SOS1 | 8 |
| GO:1905952 | GO:1905952 | regulation of lipid localization | 5/439 | 186/18888 | 0.0268817 | 1.1565876 | 0.3310526 | 0.4350338 | 0.6546657 | 0.5742110 | ATP8A1/DENND5B/SIRT1/IL1A/SEC24A | 5 |
| GO:0003333 | GO:0003333 | amino acid transmembrane transport | 3/439 | 104/18888 | 0.0288462 | 1.2411074 | 0.3803299 | 0.4363389 | 0.6559087 | 0.5753014 | SLC6A6/SLC1A2/SLC17A6 | 3 |
| GO:0042100 | GO:0042100 | B cell proliferation | 3/439 | 104/18888 | 0.0288462 | 1.2411074 | 0.3803299 | 0.4363389 | 0.6559087 | 0.5753014 | VAV3/TFRC/MEF2C | 3 |
| GO:0032006 | GO:0032006 | regulation of TOR signaling | 4/439 | 145/18888 | 0.0275862 | 1.1868981 | 0.3484951 | 0.4363488 | 0.6559087 | 0.5753014 | MTM1/SEH1L/SIRT1/UBR1 | 4 |
| GO:0006302 | GO:0006302 | double-strand break repair | 8/439 | 312/18888 | 0.0256410 | 1.1032066 | 0.2835541 | 0.4394364 | 0.6574498 | 0.5766531 | RNF138/HMGA2/MEAF6/SIRT1/EPC1/YY1/SMARCAD1/RIF1 | 8 |
| GO:0034142 | GO:0034142 | toll-like receptor 4 signaling pathway | 2/439 | 64/18888 | 0.0312500 | 1.3445330 | 0.4258849 | 0.4401768 | 0.6574498 | 0.5766531 | APPL2/IRAK2 | 2 |
| GO:0040014 | GO:0040014 | regulation of multicellular organism growth | 2/439 | 64/18888 | 0.0312500 | 1.3445330 | 0.4258849 | 0.4401768 | 0.6574498 | 0.5766531 | CREB1/PEX5 | 2 |
| GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 2/439 | 64/18888 | 0.0312500 | 1.3445330 | 0.4258849 | 0.4401768 | 0.6574498 | 0.5766531 | CYP7B1/OXSR1 | 2 |
| GO:0048814 | GO:0048814 | regulation of dendrite morphogenesis | 2/439 | 64/18888 | 0.0312500 | 1.3445330 | 0.4258849 | 0.4401768 | 0.6574498 | 0.5766531 | PPP3CA/PAFAH1B1 | 2 |
| GO:0022898 | GO:0022898 | regulation of transmembrane transporter activity | 6/439 | 229/18888 | 0.0262009 | 1.1272941 | 0.2989572 | 0.4414095 | 0.6574498 | 0.5766531 | MEF2C/OXSR1/RYR2/CRHBP/CACNA1D/PRNP | 6 |
| GO:0050920 | GO:0050920 | regulation of chemotaxis | 6/439 | 229/18888 | 0.0262009 | 1.1272941 | 0.2989572 | 0.4414095 | 0.6574498 | 0.5766531 | MAPK1/AKIRIN1/SMAD3/OXSR1/SLIT2/TUBB2B | 6 |
| GO:0050852 | GO:0050852 | T cell receptor signaling pathway | 4/439 | 146/18888 | 0.0273973 | 1.1787687 | 0.3344932 | 0.4415196 | 0.6574498 | 0.5766531 | MAPK1/KCNN4/ELF1/PRNP | 4 |
| GO:0015837 | GO:0015837 | amine transport | 3/439 | 105/18888 | 0.0285714 | 1.2292873 | 0.3634290 | 0.4424661 | 0.6574498 | 0.5766531 | SYT4/CNR1/PRKCB | 3 |
| GO:0000910 | GO:0000910 | cytokinesis | 5/439 | 188/18888 | 0.0265957 | 1.1442834 | 0.3066916 | 0.4441377 | 0.6574498 | 0.5766531 | RAB11A/E2F8/AHCTF1/IQGAP2/APC | 5 |
| GO:0001919 | GO:0001919 | regulation of receptor recycling | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | NSG1 | 1 |
| GO:0006582 | GO:0006582 | melanin metabolic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ZEB2 | 1 |
| GO:0007190 | GO:0007190 | activation of adenylate cyclase activity | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ADCYAP1 | 1 |
| GO:0008211 | GO:0008211 | glucocorticoid metabolic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | REST | 1 |
| GO:0009164 | GO:0009164 | nucleoside catabolic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ENPP4 | 1 |
| GO:0010561 | GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ITM2C | 1 |
| GO:0010623 | GO:0010623 | programmed cell death involved in cell development | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | IL1A | 1 |
| GO:0010842 | GO:0010842 | retina layer formation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | CALB1 | 1 |
| GO:0016973 | GO:0016973 | poly(A)+ mRNA export from nucleus | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | NXT2 | 1 |
| GO:0031445 | GO:0031445 | regulation of heterochromatin formation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | L3MBTL3 | 1 |
| GO:0031954 | GO:0031954 | positive regulation of protein autophosphorylation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RAP2C | 1 |
| GO:0035994 | GO:0035994 | response to muscle stretch | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RYR2 | 1 |
| GO:0036315 | GO:0036315 | cellular response to sterol | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RORA | 1 |
| GO:0043501 | GO:0043501 | skeletal muscle adaptation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | PPP3CA | 1 |
| GO:0043576 | GO:0043576 | regulation of respiratory gaseous exchange | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | NR4A2 | 1 |
| GO:0045662 | GO:0045662 | negative regulation of myoblast differentiation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | SOX8 | 1 |
| GO:0046697 | GO:0046697 | decidualization | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ASH1L | 1 |
| GO:0046716 | GO:0046716 | muscle cell cellular homeostasis | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | MTM1 | 1 |
| GO:0048011 | GO:0048011 | neurotrophin TRK receptor signaling pathway | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | SOS1 | 1 |
| GO:0050927 | GO:0050927 | positive regulation of positive chemotaxis | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | SMAD3 | 1 |
| GO:0051875 | GO:0051875 | pigment granule localization | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RAB11A | 1 |
| GO:0060586 | GO:0060586 | multicellular organismal-level iron ion homeostasis | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | SLC40A1 | 1 |
| GO:0072576 | GO:0072576 | liver morphogenesis | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | PROX1 | 1 |
| GO:0086064 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RYR2 | 1 |
| GO:0090335 | GO:0090335 | regulation of brown fat cell differentiation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | SIRT1 | 1 |
| GO:0099633 | GO:0099633 | protein localization to postsynaptic specialization membrane | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | GPC6 | 1 |
| GO:0099645 | GO:0099645 | neurotransmitter receptor localization to postsynaptic specialization membrane | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | GPC6 | 1 |
| GO:0120261 | GO:0120261 | regulation of heterochromatin organization | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | L3MBTL3 | 1 |
| GO:1901017 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | OXSR1 | 1 |
| GO:1901071 | GO:1901071 | glucosamine-containing compound metabolic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | OGA | 1 |
| GO:1901659 | GO:1901659 | glycosyl compound biosynthetic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ADK | 1 |
| GO:1905063 | GO:1905063 | regulation of vascular associated smooth muscle cell differentiation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | HEY2 | 1 |
| GO:1905563 | GO:1905563 | negative regulation of vascular endothelial cell proliferation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | MEF2C | 1 |
| GO:2000291 | GO:2000291 | regulation of myoblast proliferation | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | ATF2 | 1 |
| GO:2000353 | GO:2000353 | positive regulation of endothelial cell apoptotic process | 1/439 | 25/18888 | 0.0400000 | 1.7210023 | 0.5564531 | 0.4447263 | 0.6574498 | 0.5766531 | RGCC | 1 |
| GO:0170039 | GO:0170039 | proteinogenic amino acid metabolic process | 4/439 | 147/18888 | 0.0272109 | 1.1707498 | 0.3205900 | 0.4466763 | 0.6599396 | 0.5788368 | GLUD1/GPT2/SERINC5/GART | 4 |
| GO:0010324 | GO:0010324 | membrane invagination | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | APPL2/DOCK1 | 2 |
| GO:0010812 | GO:0010812 | negative regulation of cell-substrate adhesion | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | JAG1/AJAP1 | 2 |
| GO:0030166 | GO:0030166 | proteoglycan biosynthetic process | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | TCF7L2/HS3ST3B1 | 2 |
| GO:0030225 | GO:0030225 | macrophage differentiation | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | L3MBTL3/SIRT1 | 2 |
| GO:0033363 | GO:0033363 | secretory granule organization | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | CREB1/PAFAH1B1 | 2 |
| GO:0043462 | GO:0043462 | regulation of ATP-dependent activity | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | SIRT1/RYR2 | 2 |
| GO:0050435 | GO:0050435 | amyloid-beta metabolic process | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | LRRTM3/PRNP | 2 |
| GO:0080164 | GO:0080164 | regulation of nitric oxide metabolic process | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | SMAD3/KLF4 | 2 |
| GO:0098930 | GO:0098930 | axonal transport | 2/439 | 65/18888 | 0.0307692 | 1.3238479 | 0.4034416 | 0.4480504 | 0.6599396 | 0.5788368 | PAFAH1B1/OPA1 | 2 |
| GO:0009062 | GO:0009062 | fatty acid catabolic process | 3/439 | 106/18888 | 0.0283019 | 1.2176903 | 0.3466957 | 0.4485672 | 0.6603783 | 0.5792216 | CNR1/PEX5/HADHB | 3 |
| GO:0032200 | GO:0032200 | telomere organization | 5/439 | 189/18888 | 0.0264550 | 1.1382290 | 0.2946105 | 0.4486765 | 0.6603783 | 0.5792216 | MAPK1/INO80D/TNKS2/YY1/RIF1 | 5 |
| GO:1903038 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 4/439 | 148/18888 | 0.0270270 | 1.1628394 | 0.3067841 | 0.4518183 | 0.6605381 | 0.5793618 | DLG5/SOCS6/KLF4/PRNP | 4 |
| GO:0046942 | GO:0046942 | carboxylic acid transport | 9/439 | 358/18888 | 0.0251397 | 1.0816355 | 0.2405527 | 0.4530463 | 0.6605381 | 0.5793618 | SLC35D1/SLC16A4/SYT4/SLC6A6/SLC1A2/SLC10A4/SLC17A6/SERINC5/IL1A | 9 |
| GO:0030308 | GO:0030308 | negative regulation of cell growth | 5/439 | 190/18888 | 0.0263158 | 1.1322383 | 0.2825947 | 0.4532058 | 0.6605381 | 0.5793618 | EPHA7/SMAD3/SLIT2/ADIPOR1/YY1 | 5 |
| GO:0042326 | GO:0042326 | negative regulation of phosphorylation | 8/439 | 316/18888 | 0.0253165 | 1.0892419 | 0.2467804 | 0.4534844 | 0.6605381 | 0.5793618 | PTPN13/EPHA1/SPRED1/SLIT2/SIRT1/APC/IRAK3/PRNP | 8 |
| GO:0019722 | GO:0019722 | calcium-mediated signaling | 6/439 | 232/18888 | 0.0258621 | 1.1127170 | 0.2664719 | 0.4537135 | 0.6605381 | 0.5793618 | PPP3CA/CAMTA1/PPP3R1/ITPR1/RYR2/PRNP | 6 |
| GO:0007631 | GO:0007631 | feeding behavior | 3/439 | 107/18888 | 0.0280374 | 1.2063100 | 0.3301263 | 0.4546413 | 0.6605381 | 0.5793618 | SGIP1/CNR1/NEGR1 | 3 |
| GO:0019751 | GO:0019751 | polyol metabolic process | 3/439 | 107/18888 | 0.0280374 | 1.2063100 | 0.3301263 | 0.4546413 | 0.6605381 | 0.5793618 | IPMK/SPTSSA/PLCB1 | 3 |
| GO:0001756 | GO:0001756 | somitogenesis | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | MEOX2/SMAD3 | 2 |
| GO:0006949 | GO:0006949 | syncytium formation | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | ADAMTS5/DOCK1 | 2 |
| GO:0042446 | GO:0042446 | hormone biosynthetic process | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | SRD5A1/REST | 2 |
| GO:0046530 | GO:0046530 | photoreceptor cell differentiation | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | DLX1/SOX8 | 2 |
| GO:0046854 | GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | SOCS6/PIP5K1A | 2 |
| GO:0051898 | GO:0051898 | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 2/439 | 66/18888 | 0.0303030 | 1.3037896 | 0.3813637 | 0.4558614 | 0.6605381 | 0.5793618 | MTM1/SIRT1 | 2 |
| GO:0015849 | GO:0015849 | organic acid transport | 9/439 | 359/18888 | 0.0250696 | 1.0786226 | 0.2320043 | 0.4563387 | 0.6605381 | 0.5793618 | SLC35D1/SLC16A4/SYT4/SLC6A6/SLC1A2/SLC10A4/SLC17A6/SERINC5/IL1A | 9 |
| GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 4/439 | 149/18888 | 0.0268456 | 1.1550351 | 0.2930740 | 0.4569448 | 0.6605381 | 0.5793618 | MAPK1/AKIRIN1/OXSR1/IL1A | 4 |
| GO:0008277 | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 4/439 | 149/18888 | 0.0268456 | 1.1550351 | 0.2930740 | 0.4569448 | 0.6605381 | 0.5793618 | PPP3CA/ADCYAP1/SLIT2/PLCB1 | 4 |
| GO:0010821 | GO:0010821 | regulation of mitochondrion organization | 4/439 | 149/18888 | 0.0268456 | 1.1550351 | 0.2930740 | 0.4569448 | 0.6605381 | 0.5793618 | TFRC/RHOT1/OPA1/DDHD1 | 4 |
| GO:0000244 | GO:0000244 | spliceosomal tri-snRNP complex assembly | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SRSF10 | 1 |
| GO:0001835 | GO:0001835 | blastocyst hatching | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | BCOR | 1 |
| GO:0002026 | GO:0002026 | regulation of the force of heart contraction | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | RYR2 | 1 |
| GO:0002053 | GO:0002053 | positive regulation of mesenchymal cell proliferation | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | FGFR2 | 1 |
| GO:0006929 | GO:0006929 | substrate-dependent cell migration | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SLIT2 | 1 |
| GO:0008045 | GO:0008045 | motor neuron axon guidance | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SLIT2 | 1 |
| GO:0009065 | GO:0009065 | glutamine family amino acid catabolic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | GLUD1 | 1 |
| GO:0010882 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | RYR2 | 1 |
| GO:0018904 | GO:0018904 | ether metabolic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | PAFAH1B1 | 1 |
| GO:0022010 | GO:0022010 | central nervous system myelination | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | CNTN1 | 1 |
| GO:0022038 | GO:0022038 | corpus callosum development | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | PAFAH1B1 | 1 |
| GO:0032291 | GO:0032291 | axon ensheathment in central nervous system | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | CNTN1 | 1 |
| GO:0032469 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | ITPR1 | 1 |
| GO:0032878 | GO:0032878 | regulation of establishment or maintenance of cell polarity | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | RAP1B | 1 |
| GO:0032958 | GO:0032958 | inositol phosphate biosynthetic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | IPMK | 1 |
| GO:0033598 | GO:0033598 | mammary gland epithelial cell proliferation | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | MAPK1 | 1 |
| GO:0033622 | GO:0033622 | integrin activation | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | RAP1B | 1 |
| GO:0034138 | GO:0034138 | toll-like receptor 3 signaling pathway | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | HCFC2 | 1 |
| GO:0035188 | GO:0035188 | hatching | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | BCOR | 1 |
| GO:0035988 | GO:0035988 | chondrocyte proliferation | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | HMGA2 | 1 |
| GO:0044346 | GO:0044346 | fibroblast apoptotic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | API5 | 1 |
| GO:0044550 | GO:0044550 | secondary metabolite biosynthetic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | ZEB2 | 1 |
| GO:0045717 | GO:0045717 | negative regulation of fatty acid biosynthetic process | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SIRT1 | 1 |
| GO:0048143 | GO:0048143 | astrocyte activation | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | ZEB2 | 1 |
| GO:0050926 | GO:0050926 | regulation of positive chemotaxis | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SMAD3 | 1 |
| GO:0051894 | GO:0051894 | positive regulation of focal adhesion assembly | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | SMAD3 | 1 |
| GO:0060065 | GO:0060065 | uterus development | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | ASH1L | 1 |
| GO:0062009 | GO:0062009 | secondary palate development | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | TSHZ1 | 1 |
| GO:0070102 | GO:0070102 | interleukin-6-mediated signaling pathway | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | ST18 | 1 |
| GO:0071280 | GO:0071280 | cellular response to copper ion | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | PRNP | 1 |
| GO:0071684 | GO:0071684 | organism emergence from protective structure | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | BCOR | 1 |
| GO:0072010 | GO:0072010 | glomerular epithelium development | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | JAG1 | 1 |
| GO:1901623 | GO:1901623 | regulation of lymphocyte chemotaxis | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | OXSR1 | 1 |
| GO:1902455 | GO:1902455 | negative regulation of stem cell population maintenance | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | HDAC2 | 1 |
| GO:1903421 | GO:1903421 | regulation of synaptic vesicle recycling | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | VAMP4 | 1 |
| GO:1903588 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | PDCD10 | 1 |
| GO:1904754 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration | 1/439 | 26/18888 | 0.0384615 | 1.6548099 | 0.5153893 | 0.4576492 | 0.6605381 | 0.5793618 | DOCK4 | 1 |
| GO:0006939 | GO:0006939 | smooth muscle contraction | 3/439 | 108/18888 | 0.0277778 | 1.1951405 | 0.3137175 | 0.4606874 | 0.6646849 | 0.5829989 | ATP2B1/DOCK4/SULF1 | 3 |
| GO:0007033 | GO:0007033 | vacuole organization | 6/439 | 234/18888 | 0.0256410 | 1.1032066 | 0.2450511 | 0.4618822 | 0.6659420 | 0.5841016 | MTM1/HOOK3/RAB33B/MBTPS1/CLVS2/ATF2 | 6 |
| GO:0018205 | GO:0018205 | peptidyl-lysine modification | 4/439 | 150/18888 | 0.0266667 | 1.1473349 | 0.2794582 | 0.4620552 | 0.6659420 | 0.5841016 | ZMIZ1/SIRT1/HDAC2/KAT2B | 4 |
| GO:0071326 | GO:0071326 | cellular response to monosaccharide stimulus | 4/439 | 150/18888 | 0.0266667 | 1.1473349 | 0.2794582 | 0.4620552 | 0.6659420 | 0.5841016 | PPP3CA/EPHA5/SMAD3/PLCB1 | 4 |
| GO:0006956 | GO:0006956 | complement activation | 2/439 | 67/18888 | 0.0298507 | 1.2843301 | 0.3596385 | 0.4636084 | 0.6672246 | 0.5852266 | CD46/RGCC | 2 |
| GO:0008652 | GO:0008652 | amino acid biosynthetic process | 2/439 | 67/18888 | 0.0298507 | 1.2843301 | 0.3596385 | 0.4636084 | 0.6672246 | 0.5852266 | GLUD1/SERINC5 | 2 |
| GO:0016126 | GO:0016126 | sterol biosynthetic process | 2/439 | 67/18888 | 0.0298507 | 1.2843301 | 0.3596385 | 0.4636084 | 0.6672246 | 0.5852266 | MBTPS1/SEC14L2 | 2 |
| GO:0097192 | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 2/439 | 67/18888 | 0.0298507 | 1.2843301 | 0.3596385 | 0.4636084 | 0.6672246 | 0.5852266 | SGK3/IL1A | 2 |
| GO:0090150 | GO:0090150 | establishment of protein localization to membrane | 7/439 | 277/18888 | 0.0252708 | 1.0872758 | 0.2257232 | 0.4650098 | 0.6690023 | 0.5867858 | RAB11A/NSG1/PEX5/PEX3/COX18/GORASP2/PRNP | 7 |
| GO:0006260 | GO:0006260 | DNA replication | 7/439 | 278/18888 | 0.0251799 | 1.0833647 | 0.2160026 | 0.4687543 | 0.6696580 | 0.5873609 | INO80D/SMC3/E2F8/MEAF6/NFIA/YY1/PRIM2 | 7 |
| GO:0006541 | GO:0006541 | glutamine metabolic process | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | GLUD1 | 1 |
| GO:0006972 | GO:0006972 | hyperosmotic response | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | OXSR1 | 1 |
| GO:0007141 | GO:0007141 | male meiosis I | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | FOXJ3 | 1 |
| GO:0007205 | GO:0007205 | protein kinase C-activating G protein-coupled receptor signaling pathway | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PRKD3 | 1 |
| GO:0007289 | GO:0007289 | spermatid nucleus differentiation | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | EPC1 | 1 |
| GO:0010818 | GO:0010818 | T cell chemotaxis | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | OXSR1 | 1 |
| GO:0010875 | GO:0010875 | positive regulation of cholesterol efflux | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | SIRT1 | 1 |
| GO:0031579 | GO:0031579 | membrane raft organization | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | CAV2 | 1 |
| GO:0033081 | GO:0033081 | regulation of T cell differentiation in thymus | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | SOS1 | 1 |
| GO:0034377 | GO:0034377 | plasma lipoprotein particle assembly | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PLAGL2 | 1 |
| GO:0036296 | GO:0036296 | response to increased oxygen levels | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | HDAC2 | 1 |
| GO:0042104 | GO:0042104 | positive regulation of activated T cell proliferation | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PPP3CA | 1 |
| GO:0042983 | GO:0042983 | amyloid precursor protein biosynthetic process | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | ITM2C | 1 |
| GO:0042984 | GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | ITM2C | 1 |
| GO:0045940 | GO:0045940 | positive regulation of steroid metabolic process | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | IL1A | 1 |
| GO:0048207 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PPP6C | 1 |
| GO:0048208 | GO:0048208 | COPII vesicle coating | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PPP6C | 1 |
| GO:0048745 | GO:0048745 | smooth muscle tissue development | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PROX1 | 1 |
| GO:0051984 | GO:0051984 | positive regulation of chromosome segregation | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | KAT2B | 1 |
| GO:0060384 | GO:0060384 | innervation | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | SULF1 | 1 |
| GO:0061098 | GO:0061098 | positive regulation of protein tyrosine kinase activity | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PRNP | 1 |
| GO:0071108 | GO:0071108 | protein K48-linked deubiquitination | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | USP25 | 1 |
| GO:1902410 | GO:1902410 | mitotic cytokinetic process | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | IQGAP2 | 1 |
| GO:1903077 | GO:1903077 | negative regulation of protein localization to plasma membrane | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | PPFIA1 | 1 |
| GO:1903859 | GO:1903859 | regulation of dendrite extension | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | SYT4 | 1 |
| GO:1904753 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration | 1/439 | 27/18888 | 0.0370370 | 1.5935206 | 0.4760611 | 0.4702720 | 0.6696580 | 0.5873609 | MEF2C | 1 |
| GO:0006303 | GO:0006303 | double-strand break repair via nonhomologous end joining | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | HMGA2/RIF1 | 2 |
| GO:0006919 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | HIP1/SMAD3 | 2 |
| GO:0034394 | GO:0034394 | protein localization to cell surface | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | RAB11A/BDNF | 2 |
| GO:0045668 | GO:0045668 | negative regulation of osteoblast differentiation | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | CDK6/SMAD3 | 2 |
| GO:0046847 | GO:0046847 | filopodium assembly | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | AGRN/GPM6A | 2 |
| GO:0072577 | GO:0072577 | endothelial cell apoptotic process | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | RGCC/MAP3K5 | 2 |
| GO:0150116 | GO:0150116 | regulation of cell-substrate junction organization | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | SMAD3/EPHA3 | 2 |
| GO:1902808 | GO:1902808 | positive regulation of cell cycle G1/S phase transition | 2/439 | 68/18888 | 0.0294118 | 1.2654429 | 0.3382541 | 0.4712901 | 0.6696580 | 0.5873609 | RGCC/PLCB1 | 2 |
| GO:0048144 | GO:0048144 | fibroblast proliferation | 3/439 | 110/18888 | 0.0272727 | 1.1734106 | 0.2813680 | 0.4726919 | 0.6714127 | 0.5889000 | CDK6/ZMIZ1/E2F8 | 3 |
| GO:0030595 | GO:0030595 | leukocyte chemotaxis | 6/439 | 237/18888 | 0.0253165 | 1.0892419 | 0.2132650 | 0.4740766 | 0.6717362 | 0.5891837 | MAPK1/VAV3/AKIRIN1/CYP7B1/OXSR1/SLIT2 | 6 |
| GO:0048872 | GO:0048872 | homeostasis of number of cells | 8/439 | 322/18888 | 0.0248447 | 1.0689455 | 0.1924873 | 0.4744381 | 0.6717362 | 0.5891837 | CDK6/SP3/DOCK10/MEF2C/L3MBTL3/SLC40A1/TAL1/SOS1 | 8 |
| GO:0060326 | GO:0060326 | cell chemotaxis | 8/439 | 322/18888 | 0.0248447 | 1.0689455 | 0.1924873 | 0.4744381 | 0.6717362 | 0.5891837 | MAPK1/VAV3/AKIRIN1/CYP7B1/DOCK4/OXSR1/PIP5K1A/SLIT2 | 8 |
| GO:0045089 | GO:0045089 | positive regulation of innate immune response | 9/439 | 365/18888 | 0.0246575 | 1.0608918 | 0.1812079 | 0.4760204 | 0.6717362 | 0.5891837 | PUM2/HCFC2/PSPC1/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 9 |
| GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 3/439 | 111/18888 | 0.0270270 | 1.1628394 | 0.2654209 | 0.4786485 | 0.6717362 | 0.5891837 | SIRT1/CAV2/PROX1 | 3 |
| GO:0006672 | GO:0006672 | ceramide metabolic process | 3/439 | 111/18888 | 0.0270270 | 1.1628394 | 0.2654209 | 0.4786485 | 0.6717362 | 0.5891837 | SGMS1/SPTSSA/CERS6 | 3 |
| GO:0007040 | GO:0007040 | lysosome organization | 3/439 | 111/18888 | 0.0270270 | 1.1628394 | 0.2654209 | 0.4786485 | 0.6717362 | 0.5891837 | HOOK3/MBTPS1/CLVS2 | 3 |
| GO:0007218 | GO:0007218 | neuropeptide signaling pathway | 3/439 | 111/18888 | 0.0270270 | 1.1628394 | 0.2654209 | 0.4786485 | 0.6717362 | 0.5891837 | PNOC/ADCYAP1/NXPH2 | 3 |
| GO:0080171 | GO:0080171 | lytic vacuole organization | 3/439 | 111/18888 | 0.0270270 | 1.1628394 | 0.2654209 | 0.4786485 | 0.6717362 | 0.5891837 | HOOK3/MBTPS1/CLVS2 | 3 |
| GO:0019229 | GO:0019229 | regulation of vasoconstriction | 2/439 | 69/18888 | 0.0289855 | 1.2471031 | 0.3171990 | 0.4789055 | 0.6717362 | 0.5891837 | ATP2B1/DOCK4 | 2 |
| GO:0038034 | GO:0038034 | signal transduction in absence of ligand | 2/439 | 69/18888 | 0.0289855 | 1.2471031 | 0.3171990 | 0.4789055 | 0.6717362 | 0.5891837 | SGK3/IL1A | 2 |
| GO:0043525 | GO:0043525 | positive regulation of neuron apoptotic process | 2/439 | 69/18888 | 0.0289855 | 1.2471031 | 0.3171990 | 0.4789055 | 0.6717362 | 0.5891837 | EPHA7/PRNP | 2 |
| GO:0051445 | GO:0051445 | regulation of meiotic cell cycle | 2/439 | 69/18888 | 0.0289855 | 1.2471031 | 0.3171990 | 0.4789055 | 0.6717362 | 0.5891837 | CDC25C/PLCB1 | 2 |
| GO:1901607 | GO:1901607 | alpha-amino acid biosynthetic process | 2/439 | 69/18888 | 0.0289855 | 1.2471031 | 0.3171990 | 0.4789055 | 0.6717362 | 0.5891837 | GLUD1/SERINC5 | 2 |
| GO:0051650 | GO:0051650 | establishment of vesicle localization | 5/439 | 196/18888 | 0.0255102 | 1.0975780 | 0.2118260 | 0.4801549 | 0.6717362 | 0.5891837 | RAB11A/SYT4/PPP6C/PAFAH1B1/UNC13C | 5 |
| GO:0009101 | GO:0009101 | glycoprotein biosynthetic process | 8/439 | 324/18888 | 0.0246914 | 1.0623471 | 0.1746145 | 0.4813833 | 0.6717362 | 0.5891837 | OGA/GALNT7/B4GALT1/TCF7L2/HS3ST3B1/TET2/PLCB1/ITM2C | 8 |
| GO:0009411 | GO:0009411 | response to UV | 4/439 | 154/18888 | 0.0259740 | 1.1175339 | 0.2259102 | 0.4823229 | 0.6717362 | 0.5891837 | MAP4K3/SIRT1/YY1/MAPK8 | 4 |
| GO:0034767 | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 4/439 | 154/18888 | 0.0259740 | 1.1175339 | 0.2259102 | 0.4823229 | 0.6717362 | 0.5891837 | PPP3CA/KCNN4/PPP3R1/RYR2 | 4 |
| GO:0001675 | GO:0001675 | acrosome assembly | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | PAFAH1B1 | 1 |
| GO:0001702 | GO:0001702 | gastrulation with mouth forming second | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | ETS2 | 1 |
| GO:0001778 | GO:0001778 | plasma membrane repair | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | MYOF | 1 |
| GO:0001963 | GO:0001963 | synaptic transmission, dopaminergic | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | CRHBP | 1 |
| GO:0002675 | GO:0002675 | positive regulation of acute inflammatory response | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | CNR1 | 1 |
| GO:0003272 | GO:0003272 | endocardial cushion formation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | HEY2 | 1 |
| GO:0006760 | GO:0006760 | folic acid-containing compound metabolic process | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | GART | 1 |
| GO:0010039 | GO:0010039 | response to iron ion | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | TFRC | 1 |
| GO:0010592 | GO:0010592 | positive regulation of lamellipodium assembly | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | AKIRIN1 | 1 |
| GO:0010800 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | MAPK1 | 1 |
| GO:0010922 | GO:0010922 | positive regulation of phosphatase activity | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | MEF2C | 1 |
| GO:0014047 | GO:0014047 | glutamate secretion | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SYT4 | 1 |
| GO:0015732 | GO:0015732 | prostaglandin transport | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | IL1A | 1 |
| GO:0015740 | GO:0015740 | C4-dicarboxylate transport | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SLC1A2 | 1 |
| GO:0016188 | GO:0016188 | synaptic vesicle maturation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | UNC13C | 1 |
| GO:0021544 | GO:0021544 | subpallium development | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | DLX1 | 1 |
| GO:0021680 | GO:0021680 | cerebellar Purkinje cell layer development | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | RORA | 1 |
| GO:0030194 | GO:0030194 | positive regulation of blood coagulation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | ENPP4 | 1 |
| GO:0030325 | GO:0030325 | adrenal gland development | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SMAD3 | 1 |
| GO:0031365 | GO:0031365 | N-terminal protein amino acid modification | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | KAT2B | 1 |
| GO:0032703 | GO:0032703 | negative regulation of interleukin-2 production | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | PRNP | 1 |
| GO:0034698 | GO:0034698 | response to gonadotropin | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SRD5A1 | 1 |
| GO:0043507 | GO:0043507 | positive regulation of JUN kinase activity | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | MAP3K5 | 1 |
| GO:0044342 | GO:0044342 | type B pancreatic cell proliferation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SERPINB1 | 1 |
| GO:0045116 | GO:0045116 | protein neddylation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | UBA3 | 1 |
| GO:0045686 | GO:0045686 | negative regulation of glial cell differentiation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | DLX1 | 1 |
| GO:0046337 | GO:0046337 | phosphatidylethanolamine metabolic process | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SELENOI | 1 |
| GO:0048714 | GO:0048714 | positive regulation of oligodendrocyte differentiation | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | HDAC2 | 1 |
| GO:0050995 | GO:0050995 | negative regulation of lipid catabolic process | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | CNR1 | 1 |
| GO:0050999 | GO:0050999 | regulation of nitric-oxide synthase activity | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | IL1A | 1 |
| GO:0060402 | GO:0060402 | calcium ion transport into cytosol | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | RYR2 | 1 |
| GO:0071577 | GO:0071577 | zinc ion transmembrane transport | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SLC30A6 | 1 |
| GO:0086010 | GO:0086010 | membrane depolarization during action potential | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | CACNA1D | 1 |
| GO:0090025 | GO:0090025 | regulation of monocyte chemotaxis | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | SLIT2 | 1 |
| GO:0090314 | GO:0090314 | positive regulation of protein targeting to membrane | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | PRNP | 1 |
| GO:0090594 | GO:0090594 | inflammatory response to wounding | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | IL1A | 1 |
| GO:1900048 | GO:1900048 | positive regulation of hemostasis | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | ENPP4 | 1 |
| GO:1903019 | GO:1903019 | negative regulation of glycoprotein metabolic process | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | ITM2C | 1 |
| GO:1903672 | GO:1903672 | positive regulation of sprouting angiogenesis | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | KLF4 | 1 |
| GO:1904357 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening | 1/439 | 28/18888 | 0.0357143 | 1.5366092 | 0.4383223 | 0.4826017 | 0.6717362 | 0.5891837 | TNKS2 | 1 |
| GO:0014013 | GO:0014013 | regulation of gliogenesis | 3/439 | 112/18888 | 0.0267857 | 1.1524569 | 0.2496214 | 0.4845735 | 0.6742476 | 0.5913864 | DLX1/SOX8/HDAC2 | 3 |
| GO:0071479 | GO:0071479 | cellular response to ionizing radiation | 2/439 | 70/18888 | 0.0285714 | 1.2292873 | 0.2964625 | 0.4864535 | 0.6761619 | 0.5930655 | SIRT1/TANK | 2 |
| GO:1903051 | GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 2/439 | 70/18888 | 0.0285714 | 1.2292873 | 0.2964625 | 0.4864535 | 0.6761619 | 0.5930655 | MTM1/USP25 | 2 |
| GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 2/439 | 70/18888 | 0.0285714 | 1.2292873 | 0.2964625 | 0.4864535 | 0.6761619 | 0.5930655 | OXSR1/STK10 | 2 |
| GO:0030183 | GO:0030183 | B cell differentiation | 4/439 | 155/18888 | 0.0258065 | 1.1103241 | 0.2127452 | 0.4873432 | 0.6771648 | 0.5939452 | SP3/DOCK10/KLF6/YY1 | 4 |
| GO:0006813 | GO:0006813 | potassium ion transport | 6/439 | 241/18888 | 0.0248963 | 1.0711632 | 0.1715091 | 0.4902112 | 0.6809148 | 0.5972343 | KCNN4/KCNK2/OXSR1/SLC17A6/CACNA1D/PRNP | 6 |
| GO:0018958 | GO:0018958 | phenol-containing compound metabolic process | 3/439 | 113/18888 | 0.0265487 | 1.1422581 | 0.2339665 | 0.4904662 | 0.6810339 | 0.5973387 | NR4A2/ZEB2/SRD5A1 | 3 |
| GO:0007043 | GO:0007043 | cell-cell junction assembly | 4/439 | 156/18888 | 0.0256410 | 1.1032066 | 0.1996664 | 0.4923438 | 0.6816616 | 0.5978893 | DLG5/CDH4/APC/CDH19 | 4 |
| GO:0031960 | GO:0031960 | response to corticosteroid | 4/439 | 156/18888 | 0.0256410 | 1.1032066 | 0.1996664 | 0.4923438 | 0.6816616 | 0.5978893 | FBXO32/SRD5A1/REST/SLIT2 | 4 |
| GO:0007004 | GO:0007004 | telomere maintenance via telomerase | 2/439 | 71/18888 | 0.0281690 | 1.2119734 | 0.2760341 | 0.4939330 | 0.6816616 | 0.5978893 | MAPK1/TNKS2 | 2 |
| GO:0032091 | GO:0032091 | negative regulation of protein binding | 2/439 | 71/18888 | 0.0281690 | 1.2119734 | 0.2760341 | 0.4939330 | 0.6816616 | 0.5978893 | TTBK2/MAPK8 | 2 |
| GO:0048662 | GO:0048662 | negative regulation of smooth muscle cell proliferation | 2/439 | 71/18888 | 0.0281690 | 1.2119734 | 0.2760341 | 0.4939330 | 0.6816616 | 0.5978893 | MEF2C/KLF4 | 2 |
| GO:0090559 | GO:0090559 | regulation of membrane permeability | 2/439 | 71/18888 | 0.0281690 | 1.2119734 | 0.2760341 | 0.4939330 | 0.6816616 | 0.5978893 | ATF2/RHOT1 | 2 |
| GO:0003094 | GO:0003094 | glomerular filtration | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | SULF1 | 1 |
| GO:0003309 | GO:0003309 | type B pancreatic cell differentiation | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | CDK6 | 1 |
| GO:0006829 | GO:0006829 | zinc ion transport | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | SLC30A6 | 1 |
| GO:0006833 | GO:0006833 | water transport | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | MLLT6 | 1 |
| GO:0009312 | GO:0009312 | oligosaccharide biosynthetic process | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | B4GALT1 | 1 |
| GO:0019076 | GO:0019076 | viral release from host cell | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | CAV2 | 1 |
| GO:0022011 | GO:0022011 | myelination in peripheral nervous system | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | PPP3R1 | 1 |
| GO:0032292 | GO:0032292 | peripheral nervous system axon ensheathment | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | PPP3R1 | 1 |
| GO:0034656 | GO:0034656 | nucleobase-containing small molecule catabolic process | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | ENPP4 | 1 |
| GO:0035891 | GO:0035891 | exit from host cell | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | CAV2 | 1 |
| GO:0060765 | GO:0060765 | regulation of androgen receptor signaling pathway | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | SIRT1 | 1 |
| GO:0072344 | GO:0072344 | rescue of stalled ribosome | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | LTN1 | 1 |
| GO:0099623 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | CACNA1D | 1 |
| GO:1902430 | GO:1902430 | negative regulation of amyloid-beta formation | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | PRNP | 1 |
| GO:1904376 | GO:1904376 | negative regulation of protein localization to cell periphery | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | PPFIA1 | 1 |
| GO:2000273 | GO:2000273 | positive regulation of signaling receptor activity | 1/439 | 29/18888 | 0.0344828 | 1.4836227 | 0.4020440 | 0.4946451 | 0.6816616 | 0.5978893 | HDAC2 | 1 |
| GO:0030705 | GO:0030705 | cytoskeleton-dependent intracellular transport | 5/439 | 200/18888 | 0.0250000 | 1.0756264 | 0.1658573 | 0.4978712 | 0.6858725 | 0.6015828 | HOOK3/SYT4/PAFAH1B1/RHOT1/OPA1 | 5 |
| GO:0043112 | GO:0043112 | receptor metabolic process | 2/439 | 72/18888 | 0.0277778 | 1.1951405 | 0.2559041 | 0.5013432 | 0.6897111 | 0.6049496 | NSG1/PEX5 | 2 |
| GO:0043954 | GO:0043954 | cellular component maintenance | 2/439 | 72/18888 | 0.0277778 | 1.1951405 | 0.2559041 | 0.5013432 | 0.6897111 | 0.6049496 | MTSS1/PRNP | 2 |
| GO:0061512 | GO:0061512 | protein localization to cilium | 2/439 | 72/18888 | 0.0277778 | 1.1951405 | 0.2559041 | 0.5013432 | 0.6897111 | 0.6049496 | RAB11A/ARL13B | 2 |
| GO:0140895 | GO:0140895 | cell surface toll-like receptor signaling pathway | 2/439 | 72/18888 | 0.0277778 | 1.1951405 | 0.2559041 | 0.5013432 | 0.6897111 | 0.6049496 | APPL2/IRAK2 | 2 |
| GO:0032355 | GO:0032355 | response to estradiol | 3/439 | 115/18888 | 0.0260870 | 1.1223928 | 0.2030791 | 0.5021515 | 0.6905324 | 0.6056700 | SRD5A1/NCOA1/CRHBP | 3 |
| GO:1905039 | GO:1905039 | carboxylic acid transmembrane transport | 4/439 | 158/18888 | 0.0253165 | 1.0892419 | 0.1737625 | 0.5022834 | 0.6905324 | 0.6056700 | SLC35D1/SLC6A6/SLC1A2/SLC17A6 | 4 |
| GO:0002438 | GO:0002438 | acute inflammatory response to antigenic stimulus | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | CNR1 | 1 |
| GO:0002507 | GO:0002507 | tolerance induction | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | IRAK3 | 1 |
| GO:0006359 | GO:0006359 | regulation of transcription by RNA polymerase III | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | AR | 1 |
| GO:0007588 | GO:0007588 | excretion | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | MLLT6 | 1 |
| GO:0008209 | GO:0008209 | androgen metabolic process | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | SRD5A1 | 1 |
| GO:0010955 | GO:0010955 | negative regulation of protein processing | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | PRNP | 1 |
| GO:0015721 | GO:0015721 | bile acid and bile salt transport | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | SLC10A4 | 1 |
| GO:0034067 | GO:0034067 | protein localization to Golgi apparatus | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | RAB33B | 1 |
| GO:0039694 | GO:0039694 | viral RNA genome replication | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | HMGA2 | 1 |
| GO:0050820 | GO:0050820 | positive regulation of coagulation | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | ENPP4 | 1 |
| GO:0060037 | GO:0060037 | pharyngeal system development | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | SIX4 | 1 |
| GO:0065005 | GO:0065005 | protein-lipid complex assembly | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | PLAGL2 | 1 |
| GO:0090140 | GO:0090140 | regulation of mitochondrial fission | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | DDHD1 | 1 |
| GO:1900101 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | TMEM33 | 1 |
| GO:1901021 | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | RYR2 | 1 |
| GO:1901380 | GO:1901380 | negative regulation of potassium ion transmembrane transport | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | OXSR1 | 1 |
| GO:1901798 | GO:1901798 | positive regulation of signal transduction by p53 class mediator | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | SPRED1 | 1 |
| GO:1902230 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | SIRT1 | 1 |
| GO:1903318 | GO:1903318 | negative regulation of protein maturation | 1/439 | 30/18888 | 0.0333333 | 1.4341686 | 0.3671120 | 0.5064088 | 0.6917138 | 0.6067062 | PRNP | 1 |
| GO:1903825 | GO:1903825 | organic acid transmembrane transport | 4/439 | 159/18888 | 0.0251572 | 1.0823914 | 0.1609349 | 0.5072213 | 0.6925885 | 0.6074734 | SLC35D1/SLC6A6/SLC1A2/SLC17A6 | 4 |
| GO:0006368 | GO:0006368 | transcription elongation by RNA polymerase II | 3/439 | 116/18888 | 0.0258621 | 1.1127170 | 0.1878410 | 0.5079426 | 0.6929388 | 0.6077806 | INTS6/INTS10/MED4 | 3 |
| GO:0044344 | GO:0044344 | cellular response to fibroblast growth factor stimulus | 3/439 | 116/18888 | 0.0258621 | 1.1127170 | 0.1878410 | 0.5079426 | 0.6929388 | 0.6077806 | FGFR2/SULF1/SOS1 | 3 |
| GO:0043254 | GO:0043254 | regulation of protein-containing complex assembly | 10/439 | 418/18888 | 0.0239234 | 1.0293076 | 0.0934678 | 0.5080649 | 0.6929388 | 0.6077806 | DNAJC6/TFRC/RAP1B/SLIT2/MEGF9/PEX5/TAL1/ANKRA2/STXBP5/MAPK8 | 10 |
| GO:0019226 | GO:0019226 | transmission of nerve impulse | 2/439 | 73/18888 | 0.0273973 | 1.1787687 | 0.2360631 | 0.5086832 | 0.6929388 | 0.6077806 | SCN2A/PAFAH1B1 | 2 |
| GO:0032732 | GO:0032732 | positive regulation of interleukin-1 production | 2/439 | 73/18888 | 0.0273973 | 1.1787687 | 0.2360631 | 0.5086832 | 0.6929388 | 0.6077806 | SMAD3/HDAC2 | 2 |
| GO:0042130 | GO:0042130 | negative regulation of T cell proliferation | 2/439 | 73/18888 | 0.0273973 | 1.1787687 | 0.2360631 | 0.5086832 | 0.6929388 | 0.6077806 | DLG5/PRNP | 2 |
| GO:0140962 | GO:0140962 | multicellular organismal-level chemical homeostasis | 2/439 | 73/18888 | 0.0273973 | 1.1787687 | 0.2360631 | 0.5086832 | 0.6929388 | 0.6077806 | SLC40A1/MLLT6 | 2 |
| GO:0070371 | GO:0070371 | ERK1 and ERK2 cascade | 8/439 | 332/18888 | 0.0240964 | 1.0367484 | 0.1042059 | 0.5089171 | 0.6930228 | 0.6078543 | MAPK1/EPHA7/RAP1B/ADCYAP1/FGFR2/SPRED1/RANBP9/IL1A | 8 |
| GO:0009749 | GO:0009749 | response to glucose | 5/439 | 203/18888 | 0.0246305 | 1.0597305 | 0.1319850 | 0.5110077 | 0.6956343 | 0.6101449 | PPP3CA/PRKCB/EPHA5/SMAD3/TCF7L2 | 5 |
| GO:0051346 | GO:0051346 | negative regulation of hydrolase activity | 5/439 | 204/18888 | 0.0245098 | 1.0545357 | 0.1208060 | 0.5153557 | 0.6969988 | 0.6113417 | CPEB2/PPP1R1B/EGLN1/SERPINB1/KLF4 | 5 |
| GO:0014015 | GO:0014015 | positive regulation of gliogenesis | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | SOX8/HDAC2 | 2 |
| GO:0014823 | GO:0014823 | response to activity | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | SRD5A1/RYR2 | 2 |
| GO:0030330 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | SPRED1/SIRT1 | 2 |
| GO:0070373 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | SPRED1/RANBP9 | 2 |
| GO:1902475 | GO:1902475 | L-alpha-amino acid transmembrane transport | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | SLC1A2/SLC17A6 | 2 |
| GO:1904377 | GO:1904377 | positive regulation of protein localization to cell periphery | 2/439 | 74/18888 | 0.0270270 | 1.1628394 | 0.2165021 | 0.5159523 | 0.6969988 | 0.6113417 | EPHA3/PRNP | 2 |
| GO:0007605 | GO:0007605 | sensory perception of sound | 4/439 | 161/18888 | 0.0248447 | 1.0689455 | 0.1355227 | 0.5170308 | 0.6969988 | 0.6113417 | USP53/ATP2B2/CNTN5/CACNA1D | 4 |
| GO:0000002 | GO:0000002 | mitochondrial genome maintenance | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | OPA1 | 1 |
| GO:0001516 | GO:0001516 | prostaglandin biosynthetic process | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | SIRT1 | 1 |
| GO:0001945 | GO:0001945 | lymph vessel development | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | PROX1 | 1 |
| GO:0002313 | GO:0002313 | mature B cell differentiation involved in immune response | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | DOCK10 | 1 |
| GO:0003298 | GO:0003298 | physiological muscle hypertrophy | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | YY1 | 1 |
| GO:0003301 | GO:0003301 | physiological cardiac muscle hypertrophy | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | YY1 | 1 |
| GO:0007064 | GO:0007064 | mitotic sister chromatid cohesion | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | SMC3 | 1 |
| GO:0010804 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | TANK | 1 |
| GO:0010880 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | RYR2 | 1 |
| GO:0010996 | GO:0010996 | response to auditory stimulus | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | USP53 | 1 |
| GO:0032682 | GO:0032682 | negative regulation of chemokine production | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | KLF4 | 1 |
| GO:0033238 | GO:0033238 | regulation of amine metabolic process | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | NR4A2 | 1 |
| GO:0034063 | GO:0034063 | stress granule assembly | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | PUM2 | 1 |
| GO:0034311 | GO:0034311 | diol metabolic process | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | SPTSSA | 1 |
| GO:0034315 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | WASHC4 | 1 |
| GO:0036258 | GO:0036258 | multivesicular body assembly | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | RAB11A | 1 |
| GO:0046457 | GO:0046457 | prostanoid biosynthetic process | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | SIRT1 | 1 |
| GO:0061049 | GO:0061049 | cell growth involved in cardiac muscle cell development | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | YY1 | 1 |
| GO:0065002 | GO:0065002 | intracellular protein transmembrane transport | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | PEX5 | 1 |
| GO:0070198 | GO:0070198 | protein localization to chromosome, telomeric region | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | TNKS2 | 1 |
| GO:0070536 | GO:0070536 | protein K63-linked deubiquitination | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | USP25 | 1 |
| GO:0097345 | GO:0097345 | mitochondrial outer membrane permeabilization | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | RHOT1 | 1 |
| GO:0150117 | GO:0150117 | positive regulation of cell-substrate junction organization | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | SMAD3 | 1 |
| GO:1900745 | GO:1900745 | positive regulation of p38MAPK cascade | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | MAP3K5 | 1 |
| GO:1901185 | GO:1901185 | negative regulation of ERBB signaling pathway | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | PTPN12 | 1 |
| GO:2000191 | GO:2000191 | regulation of fatty acid transport | 1/439 | 31/18888 | 0.0322581 | 1.3879051 | 0.3334244 | 0.5178992 | 0.6969988 | 0.6113417 | IL1A | 1 |
| GO:0006334 | GO:0006334 | nucleosome assembly | 3/439 | 118/18888 | 0.0254237 | 1.0938574 | 0.1577628 | 0.5194183 | 0.6985760 | 0.6127250 | HIRA/KAT6A/SPTY2D1 | 3 |
| GO:0051224 | GO:0051224 | negative regulation of protein transport | 3/439 | 118/18888 | 0.0254237 | 1.0938574 | 0.1577628 | 0.5194183 | 0.6985760 | 0.6127250 | SYT4/PPP3CA/REST | 3 |
| GO:0048469 | GO:0048469 | cell maturation | 5/439 | 205/18888 | 0.0243902 | 1.0493916 | 0.1096817 | 0.5196876 | 0.6987046 | 0.6128379 | NR4A2/AGRN/L3MBTL3/TAL1/SOX8 | 5 |
| GO:0006935 | GO:0006935 | chemotaxis | 11/439 | 466/18888 | 0.0236052 | 1.0156129 | 0.0526425 | 0.5221981 | 0.7018454 | 0.6155927 | MAPK1/VAV3/AKIRIN1/EPHA7/SMAD3/CYP7B1/DOCK4/OXSR1/PIP5K1A/SLIT2/TUBB2B | 11 |
| GO:0002637 | GO:0002637 | regulation of immunoglobulin production | 2/439 | 75/18888 | 0.0266667 | 1.1473349 | 0.1972125 | 0.5231498 | 0.7025407 | 0.6162025 | TFRC/RIF1 | 2 |
| GO:0045806 | GO:0045806 | negative regulation of endocytosis | 2/439 | 75/18888 | 0.0266667 | 1.1473349 | 0.1972125 | 0.5231498 | 0.7025407 | 0.6162025 | EPHA3/SCAMP5 | 2 |
| GO:0007059 | GO:0007059 | chromosome segregation | 10/439 | 423/18888 | 0.0236407 | 1.0171408 | 0.0549990 | 0.5232392 | 0.7025407 | 0.6162025 | PUM2/RAB11A/SEH1L/SMC3/KIF2A/CHAMP1/PUM1/APC/KAT2B/SMARCAD1 | 10 |
| GO:0016051 | GO:0016051 | carbohydrate biosynthetic process | 5/439 | 206/18888 | 0.0242718 | 1.0442975 | 0.0986117 | 0.5240031 | 0.7033318 | 0.6168964 | ARPP19/B4GALT1/TCF7L2/SIRT1/KAT2B | 5 |
| GO:0048675 | GO:0048675 | axon extension | 3/439 | 119/18888 | 0.0252101 | 1.0846653 | 0.1429176 | 0.5251017 | 0.7045713 | 0.6179836 | CDH4/SLIT2/PAFAH1B1 | 3 |
| GO:0042330 | GO:0042330 | taxis | 11/439 | 468/18888 | 0.0235043 | 1.0112727 | 0.0380920 | 0.5279507 | 0.7050297 | 0.6183857 | MAPK1/VAV3/AKIRIN1/EPHA7/SMAD3/CYP7B1/DOCK4/OXSR1/PIP5K1A/SLIT2/TUBB2B | 11 |
| GO:0002819 | GO:0002819 | regulation of adaptive immune response | 5/439 | 207/18888 | 0.0241546 | 1.0392526 | 0.0875953 | 0.5283019 | 0.7050297 | 0.6183857 | TFRC/MEF2C/SIRT1/CD46/RIF1 | 5 |
| GO:0009566 | GO:0009566 | fertilization | 5/439 | 207/18888 | 0.0241546 | 1.0392526 | 0.0875953 | 0.5283019 | 0.7050297 | 0.6183857 | ASH1L/B4GALT1/CD46/AR/PLCB1 | 5 |
| GO:0001958 | GO:0001958 | endochondral ossification | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | MEF2C | 1 |
| GO:0010644 | GO:0010644 | cell communication by electrical coupling | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | RYR2 | 1 |
| GO:0010667 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | HEY2 | 1 |
| GO:0019082 | GO:0019082 | viral protein processing | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | SPCS3 | 1 |
| GO:0021532 | GO:0021532 | neural tube patterning | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | ARL13B | 1 |
| GO:0034505 | GO:0034505 | tooth mineralization | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | BCOR | 1 |
| GO:0034694 | GO:0034694 | response to prostaglandin | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | YY1 | 1 |
| GO:0036075 | GO:0036075 | replacement ossification | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | MEF2C | 1 |
| GO:0036257 | GO:0036257 | multivesicular body organization | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | RAB11A | 1 |
| GO:0045777 | GO:0045777 | positive regulation of blood pressure | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | CNR1 | 1 |
| GO:0046685 | GO:0046685 | response to arsenic-containing substance | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | CPEB2 | 1 |
| GO:0051642 | GO:0051642 | centrosome localization | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | PAFAH1B1 | 1 |
| GO:0060219 | GO:0060219 | camera-type eye photoreceptor cell differentiation | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | SOX8 | 1 |
| GO:0061036 | GO:0061036 | positive regulation of cartilage development | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | SMAD3 | 1 |
| GO:0061842 | GO:0061842 | microtubule organizing center localization | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | PAFAH1B1 | 1 |
| GO:0080111 | GO:0080111 | DNA demethylation | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | TET2 | 1 |
| GO:1902992 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | PRNP | 1 |
| GO:1903580 | GO:1903580 | positive regulation of ATP metabolic process | 1/439 | 32/18888 | 0.0312500 | 1.3445330 | 0.3008904 | 0.5291227 | 0.7050297 | 0.6183857 | KAT2B | 1 |
| GO:0002224 | GO:0002224 | toll-like receptor signaling pathway | 2/439 | 76/18888 | 0.0263158 | 1.1322383 | 0.1781862 | 0.5302752 | 0.7058642 | 0.6191175 | IRAK3/IRAK2 | 2 |
| GO:0008088 | GO:0008088 | axo-dendritic transport | 2/439 | 76/18888 | 0.0263158 | 1.1322383 | 0.1781862 | 0.5302752 | 0.7058642 | 0.6191175 | PAFAH1B1/OPA1 | 2 |
| GO:0009123 | GO:0009123 | nucleoside monophosphate metabolic process | 2/439 | 76/18888 | 0.0263158 | 1.1322383 | 0.1781862 | 0.5302752 | 0.7058642 | 0.6191175 | GART/ADK | 2 |
| GO:0007265 | GO:0007265 | Ras protein signal transduction | 3/439 | 120/18888 | 0.0250000 | 1.0756264 | 0.1281984 | 0.5307480 | 0.7062599 | 0.6194646 | RRAS2/SOS1/RALGPS2 | 3 |
| GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 4/439 | 164/18888 | 0.0243902 | 1.0493916 | 0.0979949 | 0.5315721 | 0.7071227 | 0.6202214 | RAB11A/SMC3/KIF2A/PAFAH1B1 | 4 |
| GO:0009746 | GO:0009746 | response to hexose | 5/439 | 208/18888 | 0.0240385 | 1.0342562 | 0.0766319 | 0.5325835 | 0.7079999 | 0.6209908 | PPP3CA/PRKCB/EPHA5/SMAD3/TCF7L2 | 5 |
| GO:0043123 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 5/439 | 208/18888 | 0.0240385 | 1.0342562 | 0.0766319 | 0.5325835 | 0.7079999 | 0.6209908 | PELI2/TAB2/TFRC/PRKCB/IL1A | 5 |
| GO:0031929 | GO:0031929 | TOR signaling | 4/439 | 165/18888 | 0.0242424 | 1.0430317 | 0.0856387 | 0.5363713 | 0.7113926 | 0.6239665 | MTM1/SEH1L/SIRT1/UBR1 | 4 |
| GO:0030239 | GO:0030239 | myofibril assembly | 2/439 | 77/18888 | 0.0259740 | 1.1175339 | 0.1594153 | 0.5373278 | 0.7113926 | 0.6239665 | SIX4/PROX1 | 2 |
| GO:0032890 | GO:0032890 | regulation of organic acid transport | 2/439 | 77/18888 | 0.0259740 | 1.1175339 | 0.1594153 | 0.5373278 | 0.7113926 | 0.6239665 | SYT4/IL1A | 2 |
| GO:0061045 | GO:0061045 | negative regulation of wound healing | 2/439 | 77/18888 | 0.0259740 | 1.1175339 | 0.1594153 | 0.5373278 | 0.7113926 | 0.6239665 | SMAD3/AJAP1 | 2 |
| GO:0008654 | GO:0008654 | phospholipid biosynthetic process | 6/439 | 253/18888 | 0.0237154 | 1.0203571 | 0.0502850 | 0.5375604 | 0.7113926 | 0.6239665 | MTM1/SGMS1/SOCS6/SELENOI/PIP5K1A/SERINC5 | 6 |
| GO:0050870 | GO:0050870 | positive regulation of T cell activation | 6/439 | 253/18888 | 0.0237154 | 1.0203571 | 0.0502850 | 0.5375604 | 0.7113926 | 0.6239665 | ZMIZ1/TFRC/PPP3CA/MAP3K8/CD46/IL1A | 6 |
| GO:0000038 | GO:0000038 | very long-chain fatty acid metabolic process | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | PEX5 | 1 |
| GO:0006536 | GO:0006536 | glutamate metabolic process | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | GLUD1 | 1 |
| GO:0010464 | GO:0010464 | regulation of mesenchymal cell proliferation | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | FGFR2 | 1 |
| GO:0016242 | GO:0016242 | negative regulation of macroautophagy | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | MTM1 | 1 |
| GO:0017145 | GO:0017145 | stem cell division | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | PAFAH1B1 | 1 |
| GO:0019934 | GO:0019934 | cGMP-mediated signaling | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | PDE10A | 1 |
| GO:0021591 | GO:0021591 | ventricular system development | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | CDK6 | 1 |
| GO:0030511 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | ZEB2 | 1 |
| GO:0031069 | GO:0031069 | hair follicle morphogenesis | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | FGFR2 | 1 |
| GO:0034121 | GO:0034121 | regulation of toll-like receptor signaling pathway | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | IRAK3 | 1 |
| GO:0043094 | GO:0043094 | cellular metabolic compound salvage | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | ADK | 1 |
| GO:0045648 | GO:0045648 | positive regulation of erythrocyte differentiation | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | TAL1 | 1 |
| GO:0045671 | GO:0045671 | negative regulation of osteoclast differentiation | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | FBN1 | 1 |
| GO:0048566 | GO:0048566 | embryonic digestive tract development | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | FGFR2 | 1 |
| GO:0050891 | GO:0050891 | multicellular organismal-level water homeostasis | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | MLLT6 | 1 |
| GO:0051497 | GO:0051497 | negative regulation of stress fiber assembly | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | PPFIA1 | 1 |
| GO:0060055 | GO:0060055 | angiogenesis involved in wound healing | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | B4GALT1 | 1 |
| GO:0060351 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | ATF2 | 1 |
| GO:0061436 | GO:0061436 | establishment of skin barrier | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | KLF4 | 1 |
| GO:0072539 | GO:0072539 | T-helper 17 cell differentiation | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | RORA | 1 |
| GO:1900117 | GO:1900117 | regulation of execution phase of apoptosis | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | FZD3 | 1 |
| GO:1903846 | GO:1903846 | positive regulation of cellular response to transforming growth factor beta stimulus | 1/439 | 33/18888 | 0.0303030 | 1.3037896 | 0.2694288 | 0.5400856 | 0.7113926 | 0.6239665 | ZEB2 | 1 |
| GO:0001678 | GO:0001678 | intracellular glucose homeostasis | 4/439 | 166/18888 | 0.0240964 | 1.0367484 | 0.0733573 | 0.5411457 | 0.7125557 | 0.6249868 | PPP3CA/EPHA5/SMAD3/SIRT1 | 4 |
| GO:0030326 | GO:0030326 | embryonic limb morphogenesis | 3/439 | 122/18888 | 0.0245902 | 1.0579932 | 0.0991285 | 0.5419268 | 0.7131176 | 0.6254796 | SP8/MBNL1/HDAC2 | 3 |
| GO:0035113 | GO:0035113 | embryonic appendage morphogenesis | 3/439 | 122/18888 | 0.0245902 | 1.0579932 | 0.0991285 | 0.5419268 | 0.7131176 | 0.6254796 | SP8/MBNL1/HDAC2 | 3 |
| GO:0009100 | GO:0009100 | glycoprotein metabolic process | 9/439 | 386/18888 | 0.0233161 | 1.0031749 | 0.0097217 | 0.5434117 | 0.7148377 | 0.6269883 | OGA/GALNT7/B4GALT1/TCF7L2/SULF1/HS3ST3B1/TET2/PLCB1/ITM2C | 9 |
| GO:0006278 | GO:0006278 | RNA-templated DNA biosynthetic process | 2/439 | 78/18888 | 0.0256410 | 1.1032066 | 0.1408924 | 0.5443072 | 0.7155480 | 0.6276113 | MAPK1/TNKS2 | 2 |
| GO:2000242 | GO:2000242 | negative regulation of reproductive process | 2/439 | 78/18888 | 0.0256410 | 1.1032066 | 0.1408924 | 0.5443072 | 0.7155480 | 0.6276113 | SULF1/IL1A | 2 |
| GO:1902806 | GO:1902806 | regulation of cell cycle G1/S phase transition | 5/439 | 211/18888 | 0.0236967 | 1.0195511 | 0.0440541 | 0.5453221 | 0.7162032 | 0.6281860 | APPL2/KLF4/APC/RGCC/PLCB1 | 5 |
| GO:0045834 | GO:0045834 | positive regulation of lipid metabolic process | 3/439 | 123/18888 | 0.0243902 | 1.0493916 | 0.0847733 | 0.5474584 | 0.7162032 | 0.6281860 | CREB1/IL1A/KAT2B | 3 |
| GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 5/439 | 212/18888 | 0.0235849 | 1.0147419 | 0.0332972 | 0.5495318 | 0.7162032 | 0.6281860 | TFRC/DOCK10/RORA/CD46/RIF1 | 5 |
| GO:0007156 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 4/439 | 168/18888 | 0.0238095 | 1.0244061 | 0.0490149 | 0.5506189 | 0.7162032 | 0.6281860 | PCDH9/CDH4/CADM2/CDH19 | 4 |
| GO:0006891 | GO:0006891 | intra-Golgi vesicle-mediated transport | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | RAB33B | 1 |
| GO:0007435 | GO:0007435 | salivary gland morphogenesis | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | FGFR2 | 1 |
| GO:0010664 | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | HEY2 | 1 |
| GO:0032743 | GO:0032743 | positive regulation of interleukin-2 production | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | IL1A | 1 |
| GO:0034383 | GO:0034383 | low-density lipoprotein particle clearance | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | HNRNPK | 1 |
| GO:0042558 | GO:0042558 | pteridine-containing compound metabolic process | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | GART | 1 |
| GO:0046475 | GO:0046475 | glycerophospholipid catabolic process | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | PLCB1 | 1 |
| GO:0048199 | GO:0048199 | vesicle targeting, to, from or within Golgi | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | PPP6C | 1 |
| GO:0050775 | GO:0050775 | positive regulation of dendrite morphogenesis | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | PAFAH1B1 | 1 |
| GO:0051450 | GO:0051450 | myoblast proliferation | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | ATF2 | 1 |
| GO:0060074 | GO:0060074 | synapse maturation | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | NFIA | 1 |
| GO:0060914 | GO:0060914 | heart formation | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | MEF2C | 1 |
| GO:0086004 | GO:0086004 | regulation of cardiac muscle cell contraction | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | RYR2 | 1 |
| GO:0090022 | GO:0090022 | regulation of neutrophil chemotaxis | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | SLIT2 | 1 |
| GO:0090151 | GO:0090151 | establishment of protein localization to mitochondrial membrane | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | COX18 | 1 |
| GO:0090313 | GO:0090313 | regulation of protein targeting to membrane | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | PRNP | 1 |
| GO:1900225 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | MAPK8 | 1 |
| GO:1901658 | GO:1901658 | glycosyl compound catabolic process | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | ENPP4 | 1 |
| GO:1901797 | GO:1901797 | negative regulation of signal transduction by p53 class mediator | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | SIRT1 | 1 |
| GO:1902176 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | SIRT1 | 1 |
| GO:1902624 | GO:1902624 | positive regulation of neutrophil migration | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | IL1A | 1 |
| GO:1903749 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | UBE2D3 | 1 |
| GO:1903955 | GO:1903955 | positive regulation of protein targeting to mitochondrion | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | UBE2D3 | 1 |
| GO:1904861 | GO:1904861 | excitatory synapse assembly | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | PTPN13 | 1 |
| GO:2000279 | GO:2000279 | negative regulation of DNA biosynthetic process | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | KCNK2 | 1 |
| GO:2000677 | GO:2000677 | regulation of transcription regulatory region DNA binding | 1/439 | 34/18888 | 0.0294118 | 1.2654429 | 0.2389660 | 0.5507937 | 0.7162032 | 0.6281860 | HEY2 | 1 |
| GO:0002752 | GO:0002752 | cell surface pattern recognition receptor signaling pathway | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | APPL2/IRAK2 | 2 |
| GO:0043297 | GO:0043297 | apical junction assembly | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | DLG5/APC | 2 |
| GO:0045685 | GO:0045685 | regulation of glial cell differentiation | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | DLX1/HDAC2 | 2 |
| GO:0055002 | GO:0055002 | striated muscle cell development | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | SIX4/PROX1 | 2 |
| GO:0070972 | GO:0070972 | protein localization to endoplasmic reticulum | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | SPCS3/RYR2 | 2 |
| GO:1903533 | GO:1903533 | regulation of protein targeting | 2/439 | 79/18888 | 0.0253165 | 1.0892419 | 0.1226103 | 0.5512131 | 0.7162032 | 0.6281860 | UBE2D3/PRNP | 2 |
| GO:0006821 | GO:0006821 | chloride transport | 3/439 | 124/18888 | 0.0241935 | 1.0409288 | 0.0705350 | 0.5529508 | 0.7179974 | 0.6297597 | SLC17A6/CLNS1A/OSTM1 | 3 |
| GO:0071774 | GO:0071774 | response to fibroblast growth factor | 3/439 | 124/18888 | 0.0241935 | 1.0409288 | 0.0705350 | 0.5529508 | 0.7179974 | 0.6297597 | FGFR2/SULF1/SOS1 | 3 |
| GO:0051348 | GO:0051348 | negative regulation of transferase activity | 5/439 | 213/18888 | 0.0234742 | 1.0099779 | 0.0225904 | 0.5537228 | 0.7187679 | 0.6304355 | EPHA1/SPRED1/SIRT1/APC/IRAK3 | 5 |
| GO:0015698 | GO:0015698 | inorganic anion transport | 4/439 | 169/18888 | 0.0236686 | 1.0183445 | 0.0369519 | 0.5553169 | 0.7206047 | 0.6320466 | SLC17A6/CLNS1A/SLC34A2/OSTM1 | 4 |
| GO:0002833 | GO:0002833 | positive regulation of response to biotic stimulus | 9/439 | 390/18888 | 0.0230769 | 0.9928859 | -0.0218986 | 0.5558921 | 0.7211186 | 0.6324973 | PUM2/HCFC2/PSPC1/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 9 |
| GO:1903036 | GO:1903036 | positive regulation of response to wounding | 2/439 | 80/18888 | 0.0250000 | 1.0756264 | 0.1045622 | 0.5580449 | 0.7236780 | 0.6347421 | PUM2/ENPP4 | 2 |
| GO:0072676 | GO:0072676 | lymphocyte migration | 3/439 | 125/18888 | 0.0240000 | 1.0326014 | 0.0564114 | 0.5584035 | 0.7239097 | 0.6349454 | CYP7B1/OXSR1/STK10 | 3 |
| GO:0007009 | GO:0007009 | plasma membrane organization | 4/439 | 170/18888 | 0.0235294 | 1.0123543 | 0.0249597 | 0.5599886 | 0.7241047 | 0.6351164 | MTSS1/CAV2/AR/MYOF | 4 |
| GO:0000132 | GO:0000132 | establishment of mitotic spindle orientation | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | PAFAH1B1 | 1 |
| GO:0001893 | GO:0001893 | maternal placenta development | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | ASH1L | 1 |
| GO:0002719 | GO:0002719 | negative regulation of cytokine production involved in immune response | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | IRAK3 | 1 |
| GO:0008340 | GO:0008340 | determination of adult lifespan | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | SCN2A | 1 |
| GO:0010613 | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | PPP3CA | 1 |
| GO:0019228 | GO:0019228 | neuronal action potential | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | SCN2A | 1 |
| GO:0021772 | GO:0021772 | olfactory bulb development | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | SLIT2 | 1 |
| GO:0030947 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | PRKCB | 1 |
| GO:0032228 | GO:0032228 | regulation of synaptic transmission, GABAergic | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | CNR1 | 1 |
| GO:0036314 | GO:0036314 | response to sterol | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | RORA | 1 |
| GO:0061081 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | SIRT1 | 1 |
| GO:0071398 | GO:0071398 | cellular response to fatty acid | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | PLCB1 | 1 |
| GO:0086005 | GO:0086005 | ventricular cardiac muscle cell action potential | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | RYR2 | 1 |
| GO:0098810 | GO:0098810 | neurotransmitter reuptake | 1/439 | 35/18888 | 0.0285714 | 1.2292873 | 0.2094359 | 0.5612531 | 0.7241047 | 0.6351164 | SLC1A2 | 1 |
| GO:0051648 | GO:0051648 | vesicle localization | 5/439 | 215/18888 | 0.0232558 | 1.0005827 | 0.0013256 | 0.5620473 | 0.7248969 | 0.6358113 | RAB11A/SYT4/PPP6C/PAFAH1B1/UNC13C | 5 |
| GO:0006402 | GO:0006402 | mRNA catabolic process | 8/439 | 348/18888 | 0.0229885 | 0.9890818 | -0.0317113 | 0.5624498 | 0.7251836 | 0.6360627 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/GSPT1/PUM1/PNRC1 | 8 |
| GO:0033135 | GO:0033135 | regulation of peptidyl-serine phosphorylation | 3/439 | 126/18888 | 0.0238095 | 1.0244061 | 0.0424006 | 0.5638161 | 0.7264797 | 0.6371995 | TFRC/PDCD10/BDNF | 3 |
| GO:0072089 | GO:0072089 | stem cell proliferation | 3/439 | 126/18888 | 0.0238095 | 1.0244061 | 0.0424006 | 0.5638161 | 0.7264797 | 0.6371995 | MECOM/HMGA2/EPCAM | 3 |
| GO:0032409 | GO:0032409 | regulation of transporter activity | 6/439 | 260/18888 | 0.0230769 | 0.9928859 | -0.0178176 | 0.5643000 | 0.7268704 | 0.6375423 | MEF2C/OXSR1/RYR2/CRHBP/CACNA1D/PRNP | 6 |
| GO:0051897 | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4/439 | 171/18888 | 0.0233918 | 1.0064341 | 0.0130375 | 0.5646338 | 0.7270522 | 0.6377017 | VAV3/HIP1/TCF7L2/SIRT1 | 4 |
| GO:0051304 | GO:0051304 | chromosome separation | 2/439 | 81/18888 | 0.0246914 | 1.0623471 | 0.0867414 | 0.5648025 | 0.7270522 | 0.6377017 | APC/SMARCAD1 | 2 |
| GO:0009612 | GO:0009612 | response to mechanical stimulus | 5/439 | 216/18888 | 0.0231481 | 0.9959504 | -0.0092336 | 0.5661803 | 0.7281270 | 0.6386444 | STRBP/USP53/KCNK2/RYR2/MAPK8 | 5 |
| GO:1901605 | GO:1901605 | alpha-amino acid metabolic process | 5/439 | 216/18888 | 0.0231481 | 0.9959504 | -0.0092336 | 0.5661803 | 0.7281270 | 0.6386444 | GLUD1/EGLN1/GPT2/SERINC5/GART | 5 |
| GO:1903828 | GO:1903828 | negative regulation of protein localization | 5/439 | 216/18888 | 0.0231481 | 0.9959504 | -0.0092336 | 0.5661803 | 0.7281270 | 0.6386444 | SYT4/PPP3CA/TTBK2/REST/PPFIA1 | 5 |
| GO:0001569 | GO:0001569 | branching involved in blood vessel morphogenesis | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PPP3R1 | 1 |
| GO:0002068 | GO:0002068 | glandular epithelial cell development | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | CDK6 | 1 |
| GO:0006516 | GO:0006516 | glycoprotein catabolic process | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | OGA | 1 |
| GO:0010770 | GO:0010770 | positive regulation of cell morphogenesis | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PAFAH1B1 | 1 |
| GO:0010984 | GO:0010984 | regulation of lipoprotein particle clearance | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | HNRNPK | 1 |
| GO:0014742 | GO:0014742 | positive regulation of muscle hypertrophy | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PPP3CA | 1 |
| GO:0014808 | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | RYR2 | 1 |
| GO:0032205 | GO:0032205 | negative regulation of telomere maintenance | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | TNKS2 | 1 |
| GO:0032232 | GO:0032232 | negative regulation of actin filament bundle assembly | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PPFIA1 | 1 |
| GO:0032435 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | MTM1 | 1 |
| GO:0032717 | GO:0032717 | negative regulation of interleukin-8 production | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | KLF4 | 1 |
| GO:0032790 | GO:0032790 | ribosome disassembly | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | LTN1 | 1 |
| GO:0034143 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | APPL2 | 1 |
| GO:0035883 | GO:0035883 | enteroendocrine cell differentiation | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | CDK6 | 1 |
| GO:0040020 | GO:0040020 | regulation of meiotic nuclear division | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PLCB1 | 1 |
| GO:0045589 | GO:0045589 | regulation of regulatory T cell differentiation | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | CD46 | 1 |
| GO:0048026 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | CLNS1A | 1 |
| GO:0048665 | GO:0048665 | neuron fate specification | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | NFIA | 1 |
| GO:0071425 | GO:0071425 | hematopoietic stem cell proliferation | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | MECOM | 1 |
| GO:1902745 | GO:1902745 | positive regulation of lamellipodium organization | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | AKIRIN1 | 1 |
| GO:1904385 | GO:1904385 | cellular response to angiotensin | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PPP3CA | 1 |
| GO:1904893 | GO:1904893 | negative regulation of receptor signaling pathway via STAT | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | ADIPOR1 | 1 |
| GO:1905476 | GO:1905476 | negative regulation of protein localization to membrane | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | PPFIA1 | 1 |
| GO:2000406 | GO:2000406 | positive regulation of T cell migration | 1/439 | 36/18888 | 0.0277778 | 1.1951405 | 0.1807787 | 0.5714695 | 0.7291243 | 0.6395191 | OXSR1 | 1 |
| GO:0043406 | GO:0043406 | positive regulation of MAP kinase activity | 2/439 | 82/18888 | 0.0243902 | 1.0493916 | 0.0691416 | 0.5714856 | 0.7291243 | 0.6395191 | PDCD10/MAP3K5 | 2 |
| GO:1903131 | GO:1903131 | mononuclear cell differentiation | 11/439 | 484/18888 | 0.0227273 | 0.9778422 | -0.0761764 | 0.5730996 | 0.7309518 | 0.6411220 | CDK6/ZMIZ1/SP3/DOCK10/KLF6/RORA/CD46/ATF2/IL1A/SOS1/YY1 | 11 |
| GO:0050821 | GO:0050821 | protein stabilization | 5/439 | 218/18888 | 0.0229358 | 0.9868132 | -0.0302080 | 0.5743863 | 0.7322984 | 0.6423032 | PRKRA/HIP1/SMAD3/PDCD10/CREB1 | 5 |
| GO:0046683 | GO:0046683 | response to organophosphorus | 3/439 | 128/18888 | 0.0234375 | 1.0083998 | 0.0147090 | 0.5745194 | 0.7322984 | 0.6423032 | RAP1B/SRD5A1/CRHBP | 3 |
| GO:0070372 | GO:0070372 | regulation of ERK1 and ERK2 cascade | 7/439 | 308/18888 | 0.0227273 | 0.9778422 | -0.0604793 | 0.5770055 | 0.7343845 | 0.6441329 | EPHA7/RAP1B/ADCYAP1/FGFR2/SPRED1/RANBP9/IL1A | 7 |
| GO:0010833 | GO:0010833 | telomere maintenance via telomere lengthening | 2/439 | 83/18888 | 0.0240964 | 1.0367484 | 0.0517568 | 0.5780939 | 0.7343845 | 0.6441329 | MAPK1/TNKS2 | 2 |
| GO:0032371 | GO:0032371 | regulation of sterol transport | 2/439 | 83/18888 | 0.0240964 | 1.0367484 | 0.0517568 | 0.5780939 | 0.7343845 | 0.6441329 | SIRT1/SEC24A | 2 |
| GO:0032374 | GO:0032374 | regulation of cholesterol transport | 2/439 | 83/18888 | 0.0240964 | 1.0367484 | 0.0517568 | 0.5780939 | 0.7343845 | 0.6441329 | SIRT1/SEC24A | 2 |
| GO:0140115 | GO:0140115 | export across plasma membrane | 2/439 | 83/18888 | 0.0240964 | 1.0367484 | 0.0517568 | 0.5780939 | 0.7343845 | 0.6441329 | ATP2B1/SLC40A1 | 2 |
| GO:1901657 | GO:1901657 | glycosyl compound metabolic process | 2/439 | 83/18888 | 0.0240964 | 1.0367484 | 0.0517568 | 0.5780939 | 0.7343845 | 0.6441329 | ADK/ENPP4 | 2 |
| GO:0019079 | GO:0019079 | viral genome replication | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | HMGA2/NFIA/PROX1 | 3 |
| GO:0032612 | GO:0032612 | interleukin-1 production | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | SMAD3/SERPINB1/HDAC2 | 3 |
| GO:0032652 | GO:0032652 | regulation of interleukin-1 production | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | SMAD3/SERPINB1/HDAC2 | 3 |
| GO:0050868 | GO:0050868 | negative regulation of T cell activation | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | DLG5/SOCS6/PRNP | 3 |
| GO:0051209 | GO:0051209 | release of sequestered calcium ion into cytosol | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | ITPR1/RYR2/PLCB1 | 3 |
| GO:0051225 | GO:0051225 | spindle assembly | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | RAB11A/SMC3/KIF2A | 3 |
| GO:1990266 | GO:1990266 | neutrophil migration | 3/439 | 129/18888 | 0.0232558 | 1.0005827 | 0.0010244 | 0.5798094 | 0.7343845 | 0.6441329 | VAV3/SLIT2/IL1A | 3 |
| GO:0002335 | GO:0002335 | mature B cell differentiation | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | DOCK10 | 1 |
| GO:0006270 | GO:0006270 | DNA replication initiation | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | PRIM2 | 1 |
| GO:0007431 | GO:0007431 | salivary gland development | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | FGFR2 | 1 |
| GO:0021988 | GO:0021988 | olfactory lobe development | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | SLIT2 | 1 |
| GO:0033280 | GO:0033280 | response to vitamin D | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | PRKCB | 1 |
| GO:0035510 | GO:0035510 | DNA dealkylation | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | TET2 | 1 |
| GO:0043267 | GO:0043267 | negative regulation of potassium ion transport | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | OXSR1 | 1 |
| GO:0044058 | GO:0044058 | regulation of digestive system process | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | PPP3CA | 1 |
| GO:0044546 | GO:0044546 | NLRP3 inflammasome complex assembly | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | MAPK8 | 1 |
| GO:0045880 | GO:0045880 | positive regulation of smoothened signaling pathway | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | DLG5 | 1 |
| GO:0070269 | GO:0070269 | pyroptosis | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | ZEB2 | 1 |
| GO:0072529 | GO:0072529 | pyrimidine-containing compound catabolic process | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | TET2 | 1 |
| GO:0097484 | GO:0097484 | dendrite extension | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | SYT4 | 1 |
| GO:0141085 | GO:0141085 | regulation of inflammasome-mediated signaling pathway | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | MAPK8 | 1 |
| GO:1901381 | GO:1901381 | positive regulation of potassium ion transmembrane transport | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | KCNN4 | 1 |
| GO:1903514 | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1/439 | 37/18888 | 0.0270270 | 1.1628394 | 0.1529398 | 0.5814486 | 0.7343845 | 0.6441329 | RYR2 | 1 |
| GO:0002028 | GO:0002028 | regulation of sodium ion transport | 2/439 | 84/18888 | 0.0238095 | 1.0244061 | 0.0345812 | 0.5846275 | 0.7377049 | 0.6470452 | CNTN1/MLLT6 | 2 |
| GO:0006446 | GO:0006446 | regulation of translational initiation | 2/439 | 84/18888 | 0.0238095 | 1.0244061 | 0.0345812 | 0.5846275 | 0.7377049 | 0.6470452 | PDIK1L/BZW1 | 2 |
| GO:0072527 | GO:0072527 | pyrimidine-containing compound metabolic process | 2/439 | 84/18888 | 0.0238095 | 1.0244061 | 0.0345812 | 0.5846275 | 0.7377049 | 0.6470452 | MAPK1/TET2 | 2 |
| GO:0051283 | GO:0051283 | negative regulation of sequestering of calcium ion | 3/439 | 130/18888 | 0.0230769 | 0.9928859 | -0.0125552 | 0.5850577 | 0.7378018 | 0.6471303 | ITPR1/RYR2/PLCB1 | 3 |
| GO:0006936 | GO:0006936 | muscle contraction | 8/439 | 355/18888 | 0.0225352 | 0.9695787 | -0.0892577 | 0.5850710 | 0.7378018 | 0.6471303 | SCN2A/ATP2B1/DOCK4/SMPX/RYR2/CACNA1D/SULF1/MYOF | 8 |
| GO:0055088 | GO:0055088 | lipid homeostasis | 4/439 | 176/18888 | 0.0227273 | 0.9778422 | -0.0455565 | 0.5874491 | 0.7405687 | 0.6495571 | RORA/CYP7B1/SIRT1/SEC24A | 4 |
| GO:0002821 | GO:0002821 | positive regulation of adaptive immune response | 3/439 | 131/18888 | 0.0229008 | 0.9853066 | -0.0260317 | 0.5902642 | 0.7406463 | 0.6496251 | TFRC/SIRT1/RIF1 | 3 |
| GO:0006661 | GO:0006661 | phosphatidylinositol biosynthetic process | 3/439 | 131/18888 | 0.0229008 | 0.9853066 | -0.0260317 | 0.5902642 | 0.7406463 | 0.6496251 | MTM1/SOCS6/PIP5K1A | 3 |
| GO:0007052 | GO:0007052 | mitotic spindle organization | 3/439 | 131/18888 | 0.0229008 | 0.9853066 | -0.0260317 | 0.5902642 | 0.7406463 | 0.6496251 | RAB11A/SMC3/KIF2A | 3 |
| GO:0010595 | GO:0010595 | positive regulation of endothelial cell migration | 3/439 | 131/18888 | 0.0229008 | 0.9853066 | -0.0260317 | 0.5902642 | 0.7406463 | 0.6496251 | RIN2/SIRT1/PROX1 | 3 |
| GO:0072329 | GO:0072329 | monocarboxylic acid catabolic process | 3/439 | 131/18888 | 0.0229008 | 0.9853066 | -0.0260317 | 0.5902642 | 0.7406463 | 0.6496251 | CNR1/PEX5/HADHB | 3 |
| GO:0002292 | GO:0002292 | T cell differentiation involved in immune response | 2/439 | 85/18888 | 0.0235294 | 1.0123543 | 0.0176092 | 0.5910860 | 0.7406463 | 0.6496251 | RORA/CD46 | 2 |
| GO:0045069 | GO:0045069 | regulation of viral genome replication | 2/439 | 85/18888 | 0.0235294 | 1.0123543 | 0.0176092 | 0.5910860 | 0.7406463 | 0.6496251 | HMGA2/PROX1 | 2 |
| GO:2000134 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2/439 | 85/18888 | 0.0235294 | 1.0123543 | 0.0176092 | 0.5910860 | 0.7406463 | 0.6496251 | KLF4/APC | 2 |
| GO:0007339 | GO:0007339 | binding of sperm to zona pellucida | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | B4GALT1 | 1 |
| GO:0010661 | GO:0010661 | positive regulation of muscle cell apoptotic process | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | MAP3K5 | 1 |
| GO:0034391 | GO:0034391 | regulation of smooth muscle cell apoptotic process | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | SIRT1 | 1 |
| GO:0035633 | GO:0035633 | maintenance of blood-brain barrier | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | ZEB2 | 1 |
| GO:0042401 | GO:0042401 | biogenic amine biosynthetic process | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | NR4A2 | 1 |
| GO:0044743 | GO:0044743 | protein transmembrane import into intracellular organelle | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | PEX5 | 1 |
| GO:0045652 | GO:0045652 | regulation of megakaryocyte differentiation | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | MEF2C | 1 |
| GO:0045981 | GO:0045981 | positive regulation of nucleotide metabolic process | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | KAT2B | 1 |
| GO:0048846 | GO:0048846 | axon extension involved in axon guidance | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | SLIT2 | 1 |
| GO:0071711 | GO:0071711 | basement membrane organization | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | CAV2 | 1 |
| GO:1900544 | GO:1900544 | positive regulation of purine nucleotide metabolic process | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | KAT2B | 1 |
| GO:1902284 | GO:1902284 | neuron projection extension involved in neuron projection guidance | 1/439 | 38/18888 | 0.0263158 | 1.1322383 | 0.1258696 | 0.5911957 | 0.7406463 | 0.6496251 | SLIT2 | 1 |
| GO:0002262 | GO:0002262 | myeloid cell homeostasis | 4/439 | 177/18888 | 0.0225989 | 0.9723177 | -0.0570779 | 0.5919280 | 0.7406463 | 0.6496251 | CDK6/SP3/L3MBTL3/TAL1 | 4 |
| GO:0030216 | GO:0030216 | keratinocyte differentiation | 4/439 | 177/18888 | 0.0225989 | 0.9723177 | -0.0570779 | 0.5919280 | 0.7406463 | 0.6496251 | PPP3CA/JAG1/PIP5K1A/IL1A | 4 |
| GO:0050806 | GO:0050806 | positive regulation of synaptic transmission | 4/439 | 177/18888 | 0.0225989 | 0.9723177 | -0.0570779 | 0.5919280 | 0.7406463 | 0.6496251 | MAPK1/NSG1/CALB1/PRNP | 4 |
| GO:1990138 | GO:1990138 | neuron projection extension | 4/439 | 177/18888 | 0.0225989 | 0.9723177 | -0.0570779 | 0.5919280 | 0.7406463 | 0.6496251 | SYT4/CDH4/SLIT2/PAFAH1B1 | 4 |
| GO:0051282 | GO:0051282 | regulation of sequestering of calcium ion | 3/439 | 132/18888 | 0.0227273 | 0.9778422 | -0.0394068 | 0.5954285 | 0.7447946 | 0.6532637 | ITPR1/RYR2/PLCB1 | 3 |
| GO:0071230 | GO:0071230 | cellular response to amino acid stimulus | 2/439 | 86/18888 | 0.0232558 | 1.0005827 | 0.0008355 | 0.5974696 | 0.7471155 | 0.6552993 | CPEB3/UBR1 | 2 |
| GO:0043086 | GO:0043086 | negative regulation of catalytic activity | 10/439 | 449/18888 | 0.0222717 | 0.9582418 | -0.1381413 | 0.5993279 | 0.7474592 | 0.6556008 | CPEB2/PPP1R1B/EGLN1/EPHA1/SPRED1/SIRT1/SERPINB1/KLF4/APC/IRAK3 | 10 |
| GO:1904950 | GO:1904950 | negative regulation of establishment of protein localization | 3/439 | 133/18888 | 0.0225564 | 0.9704900 | -0.0526822 | 0.6005504 | 0.7474592 | 0.6556008 | SYT4/PPP3CA/REST | 3 |
| GO:0009309 | GO:0009309 | amine biosynthetic process | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | NR4A2 | 1 |
| GO:0018208 | GO:0018208 | peptidyl-proline modification | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | EGLN1 | 1 |
| GO:0032373 | GO:0032373 | positive regulation of sterol transport | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SIRT1 | 1 |
| GO:0032376 | GO:0032376 | positive regulation of cholesterol transport | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SIRT1 | 1 |
| GO:0032438 | GO:0032438 | melanosome organization | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | ZEB2 | 1 |
| GO:0034390 | GO:0034390 | smooth muscle cell apoptotic process | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SIRT1 | 1 |
| GO:0040036 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SULF1 | 1 |
| GO:0050685 | GO:0050685 | positive regulation of mRNA processing | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | CLNS1A | 1 |
| GO:0051954 | GO:0051954 | positive regulation of amine transport | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SYT4 | 1 |
| GO:0060306 | GO:0060306 | regulation of membrane repolarization | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | CACNA1D | 1 |
| GO:0060416 | GO:0060416 | response to growth hormone | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | SRD5A1 | 1 |
| GO:0097242 | GO:0097242 | amyloid-beta clearance | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | RAB11A | 1 |
| GO:0140632 | GO:0140632 | canonical inflammasome complex assembly | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | MAPK8 | 1 |
| GO:1901223 | GO:1901223 | negative regulation of non-canonical NF-kappaB signal transduction | 1/439 | 39/18888 | 0.0256410 | 1.1032066 | 0.0995229 | 0.6007164 | 0.7474592 | 0.6556008 | ADIPOR1 | 1 |
| GO:0072330 | GO:0072330 | monocarboxylic acid biosynthetic process | 5/439 | 225/18888 | 0.0222222 | 0.9561124 | -0.1021574 | 0.6024516 | 0.7493864 | 0.6572912 | CYP7B1/SIRT1/PROX1/KAT2B/PRKAB1 | 5 |
| GO:0034103 | GO:0034103 | regulation of tissue remodeling | 2/439 | 87/18888 | 0.0229885 | 0.9890818 | -0.0157452 | 0.6037781 | 0.7505725 | 0.6583315 | TFRC/PPP3CA | 2 |
| GO:0098586 | GO:0098586 | cellular response to virus | 2/439 | 87/18888 | 0.0229885 | 0.9890818 | -0.0157452 | 0.6037781 | 0.7505725 | 0.6583315 | SMAD3/ATF2 | 2 |
| GO:0015711 | GO:0015711 | organic anion transport | 10/439 | 451/18888 | 0.0221729 | 0.9539924 | -0.1525458 | 0.6049464 | 0.7517925 | 0.6594016 | SLC22A10/SLC35D1/SLC16A4/SYT4/SLC6A6/SLC1A2/SLC10A4/SLC17A6/SERINC5/IL1A | 10 |
| GO:0002702 | GO:0002702 | positive regulation of production of molecular mediator of immune response | 3/439 | 134/18888 | 0.0223881 | 0.9632475 | -0.0658596 | 0.6056295 | 0.7521769 | 0.6597387 | TFRC/SIRT1/RIF1 | 3 |
| GO:0043405 | GO:0043405 | regulation of MAP kinase activity | 3/439 | 134/18888 | 0.0223881 | 0.9632475 | -0.0658596 | 0.6056295 | 0.7521769 | 0.6597387 | PDCD10/IRAK3/MAP3K5 | 3 |
| GO:0098813 | GO:0098813 | nuclear chromosome segregation | 7/439 | 317/18888 | 0.0220820 | 0.9500801 | -0.1382652 | 0.6074107 | 0.7541333 | 0.6614547 | RAB11A/SEH1L/SMC3/KIF2A/CHAMP1/APC/KAT2B | 7 |
| GO:0000281 | GO:0000281 | mitotic cytokinesis | 2/439 | 88/18888 | 0.0227273 | 0.9778422 | -0.0321378 | 0.6100117 | 0.7541333 | 0.6614547 | IQGAP2/APC | 2 |
| GO:0006901 | GO:0006901 | vesicle coating | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | PPP6C | 1 |
| GO:0009595 | GO:0009595 | detection of biotic stimulus | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | ATF2 | 1 |
| GO:0030513 | GO:0030513 | positive regulation of BMP signaling pathway | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | SULF1 | 1 |
| GO:0035886 | GO:0035886 | vascular associated smooth muscle cell differentiation | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | HEY2 | 1 |
| GO:0040001 | GO:0040001 | establishment of mitotic spindle localization | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | PAFAH1B1 | 1 |
| GO:0042307 | GO:0042307 | positive regulation of protein import into nucleus | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | SMAD3 | 1 |
| GO:0044060 | GO:0044060 | regulation of endocrine process | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | CRHBP | 1 |
| GO:0045923 | GO:0045923 | positive regulation of fatty acid metabolic process | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | KAT2B | 1 |
| GO:0048753 | GO:0048753 | pigment granule organization | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | ZEB2 | 1 |
| GO:0051125 | GO:0051125 | regulation of actin nucleation | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | WASHC4 | 1 |
| GO:0071354 | GO:0071354 | cellular response to interleukin-6 | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | ST18 | 1 |
| GO:0086091 | GO:0086091 | regulation of heart rate by cardiac conduction | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | CACNA1D | 1 |
| GO:0099622 | GO:0099622 | cardiac muscle cell membrane repolarization | 1/439 | 40/18888 | 0.0250000 | 1.0756264 | 0.0738581 | 0.6100159 | 0.7541333 | 0.6614547 | CACNA1D | 1 |
| GO:0038061 | GO:0038061 | non-canonical NF-kappaB signal transduction | 3/439 | 135/18888 | 0.0222222 | 0.9561124 | -0.0789407 | 0.6106658 | 0.7547049 | 0.6619560 | TAB2/AMFR/ADIPOR1 | 3 |
| GO:0043488 | GO:0043488 | regulation of mRNA stability | 6/439 | 273/18888 | 0.0219780 | 0.9456056 | -0.1396468 | 0.6118994 | 0.7559973 | 0.6630896 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0035725 | GO:0035725 | sodium ion transmembrane transport | 4/439 | 182/18888 | 0.0219780 | 0.9456056 | -0.1137434 | 0.6138872 | 0.7582204 | 0.6650395 | SCN2A/SLC6A6/SLC17A6/SLC34A2 | 4 |
| GO:0051651 | GO:0051651 | maintenance of location in cell | 5/439 | 228/18888 | 0.0219298 | 0.9435320 | -0.1323249 | 0.6141539 | 0.7583171 | 0.6651243 | ITPR1/SIRT1/RYR2/PAFAH1B1/PLCB1 | 5 |
| GO:0051208 | GO:0051208 | sequestering of calcium ion | 3/439 | 136/18888 | 0.0220588 | 0.9490821 | -0.0919270 | 0.6156589 | 0.7598742 | 0.6664901 | ITPR1/RYR2/PLCB1 | 3 |
| GO:0042310 | GO:0042310 | vasoconstriction | 2/439 | 89/18888 | 0.0224719 | 0.9668552 | -0.0483471 | 0.6161704 | 0.7598742 | 0.6664901 | ATP2B1/DOCK4 | 2 |
| GO:0050672 | GO:0050672 | negative regulation of lymphocyte proliferation | 2/439 | 89/18888 | 0.0224719 | 0.9668552 | -0.0483471 | 0.6161704 | 0.7598742 | 0.6664901 | DLG5/PRNP | 2 |
| GO:2000106 | GO:2000106 | regulation of leukocyte apoptotic process | 2/439 | 89/18888 | 0.0224719 | 0.9668552 | -0.0483471 | 0.6161704 | 0.7598742 | 0.6664901 | MEF2C/SIRT1 | 2 |
| GO:0000731 | GO:0000731 | DNA synthesis involved in DNA repair | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | SIRT1 | 1 |
| GO:0003352 | GO:0003352 | regulation of cilium movement | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | RSPH4A | 1 |
| GO:0009394 | GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | ADK | 1 |
| GO:0032570 | GO:0032570 | response to progesterone | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | NCOA1 | 1 |
| GO:0032781 | GO:0032781 | positive regulation of ATP-dependent activity | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | RYR2 | 1 |
| GO:0042417 | GO:0042417 | dopamine metabolic process | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | NR4A2 | 1 |
| GO:0043506 | GO:0043506 | regulation of JUN kinase activity | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | MAP3K5 | 1 |
| GO:0045066 | GO:0045066 | regulatory T cell differentiation | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | CD46 | 1 |
| GO:0071542 | GO:0071542 | dopaminergic neuron differentiation | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | NR4A2 | 1 |
| GO:0120033 | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | SLIT2 | 1 |
| GO:1900016 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | APPL2 | 1 |
| GO:1904994 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell | 1/439 | 41/18888 | 0.0243902 | 1.0493916 | 0.0488373 | 0.6190992 | 0.7606887 | 0.6672044 | KLF4 | 1 |
| GO:0009416 | GO:0009416 | response to light stimulus | 7/439 | 321/18888 | 0.0218069 | 0.9382411 | -0.1721505 | 0.6205492 | 0.7620780 | 0.6684230 | MAP4K3/TAFA2/SLC1A2/PPP1R1B/SIRT1/YY1/MAPK8 | 7 |
| GO:0007368 | GO:0007368 | determination of left/right symmetry | 3/439 | 137/18888 | 0.0218978 | 0.9421545 | -0.1048201 | 0.6206088 | 0.7620780 | 0.6684230 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:0009953 | GO:0009953 | dorsal/ventral pattern formation | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | SP8/ARL13B | 2 |
| GO:0010507 | GO:0010507 | negative regulation of autophagy | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | MTM1/TAB2 | 2 |
| GO:0032945 | GO:0032945 | negative regulation of mononuclear cell proliferation | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | DLG5/PRNP | 2 |
| GO:0034644 | GO:0034644 | cellular response to UV | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | SIRT1/YY1 | 2 |
| GO:0048145 | GO:0048145 | regulation of fibroblast proliferation | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | CDK6/ZMIZ1 | 2 |
| GO:1901606 | GO:1901606 | alpha-amino acid catabolic process | 2/439 | 90/18888 | 0.0222222 | 0.9561124 | -0.0643776 | 0.6222542 | 0.7627021 | 0.6689704 | GLUD1/GPT2 | 2 |
| GO:0010212 | GO:0010212 | response to ionizing radiation | 3/439 | 138/18888 | 0.0217391 | 0.9353273 | -0.1176216 | 0.6255151 | 0.7640169 | 0.6701236 | SIRT1/IL1A/TANK | 3 |
| GO:0016482 | GO:0016482 | cytosolic transport | 3/439 | 138/18888 | 0.0217391 | 0.9353273 | -0.1176216 | 0.6255151 | 0.7640169 | 0.6701236 | SRSF10/SYT4/WIPF3 | 3 |
| GO:0034728 | GO:0034728 | nucleosome organization | 3/439 | 138/18888 | 0.0217391 | 0.9353273 | -0.1176216 | 0.6255151 | 0.7640169 | 0.6701236 | HIRA/KAT6A/SPTY2D1 | 3 |
| GO:0061041 | GO:0061041 | regulation of wound healing | 3/439 | 138/18888 | 0.0217391 | 0.9353273 | -0.1176216 | 0.6255151 | 0.7640169 | 0.6701236 | SMAD3/AJAP1/ENPP4 | 3 |
| GO:0045861 | GO:0045861 | negative regulation of proteolysis | 5/439 | 231/18888 | 0.0216450 | 0.9312783 | -0.1621087 | 0.6256533 | 0.7640169 | 0.6701236 | MTM1/USP25/SERPINB1/KLF4/PRNP | 5 |
| GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 6/439 | 277/18888 | 0.0216606 | 0.9319507 | -0.1759973 | 0.6259536 | 0.7640169 | 0.6701236 | ZMIZ1/TFRC/PPP3CA/MAP3K8/CD46/IL1A | 6 |
| GO:0050954 | GO:0050954 | sensory perception of mechanical stimulus | 4/439 | 185/18888 | 0.0216216 | 0.9302715 | -0.1470171 | 0.6267065 | 0.7640169 | 0.6701236 | USP53/ATP2B2/CNTN5/CACNA1D | 4 |
| GO:0001662 | GO:0001662 | behavioral fear response | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | MEF2C | 1 |
| GO:0002691 | GO:0002691 | regulation of cellular extravasation | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PLCB1 | 1 |
| GO:0006040 | GO:0006040 | amino sugar metabolic process | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | OGA | 1 |
| GO:0006958 | GO:0006958 | complement activation, classical pathway | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | CD46 | 1 |
| GO:0009262 | GO:0009262 | deoxyribonucleotide metabolic process | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | ADK | 1 |
| GO:0009409 | GO:0009409 | response to cold | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | APPL2 | 1 |
| GO:0019692 | GO:0019692 | deoxyribose phosphate metabolic process | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | ADK | 1 |
| GO:0030866 | GO:0030866 | cortical actin cytoskeleton organization | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | IQGAP2 | 1 |
| GO:0032733 | GO:0032733 | positive regulation of interleukin-10 production | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | CD46 | 1 |
| GO:0032735 | GO:0032735 | positive regulation of interleukin-12 production | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PLCB1 | 1 |
| GO:0044319 | GO:0044319 | wound healing, spreading of cells | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PDCD10 | 1 |
| GO:0051294 | GO:0051294 | establishment of spindle orientation | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PAFAH1B1 | 1 |
| GO:0071364 | GO:0071364 | cellular response to epidermal growth factor stimulus | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PTPN12 | 1 |
| GO:0090505 | GO:0090505 | epiboly involved in wound healing | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | PDCD10 | 1 |
| GO:0141084 | GO:0141084 | inflammasome-mediated signaling pathway | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | MAPK8 | 1 |
| GO:1904706 | GO:1904706 | negative regulation of vascular associated smooth muscle cell proliferation | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | MEF2C | 1 |
| GO:2000008 | GO:2000008 | regulation of protein localization to cell surface | 1/439 | 42/18888 | 0.0238095 | 1.0244061 | 0.0244254 | 0.6279715 | 0.7640169 | 0.6701236 | BDNF | 1 |
| GO:0006400 | GO:0006400 | tRNA modification | 2/439 | 91/18888 | 0.0219780 | 0.9456056 | -0.0802338 | 0.6282634 | 0.7640169 | 0.6701236 | PUS7/SEPSECS | 2 |
| GO:0097006 | GO:0097006 | regulation of plasma lipoprotein particle levels | 2/439 | 91/18888 | 0.0219780 | 0.9456056 | -0.0802338 | 0.6282634 | 0.7640169 | 0.6701236 | HNRNPK/PLAGL2 | 2 |
| GO:0030516 | GO:0030516 | regulation of axon extension | 2/439 | 92/18888 | 0.0217391 | 0.9353273 | -0.0959200 | 0.6341981 | 0.7700119 | 0.6753819 | CDH4/PAFAH1B1 | 2 |
| GO:0002700 | GO:0002700 | regulation of production of molecular mediator of immune response | 4/439 | 187/18888 | 0.0213904 | 0.9203221 | -0.1689094 | 0.6351011 | 0.7700119 | 0.6753819 | TFRC/SIRT1/IRAK3/RIF1 | 4 |
| GO:0008217 | GO:0008217 | regulation of blood pressure | 4/439 | 187/18888 | 0.0213904 | 0.9203221 | -0.1689094 | 0.6351011 | 0.7700119 | 0.6753819 | ATP2B1/CNR1/SMAD3/AR | 4 |
| GO:0002209 | GO:0002209 | behavioral defense response | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | MEF2C | 1 |
| GO:0003351 | GO:0003351 | epithelial cilium movement involved in extracellular fluid movement | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | RSPH4A | 1 |
| GO:0010518 | GO:0010518 | positive regulation of phospholipase activity | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | FGFR2 | 1 |
| GO:0016266 | GO:0016266 | O-glycan processing | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | GALNT7 | 1 |
| GO:0032506 | GO:0032506 | cytokinetic process | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | IQGAP2 | 1 |
| GO:0032691 | GO:0032691 | negative regulation of interleukin-1 beta production | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | SERPINB1 | 1 |
| GO:0032768 | GO:0032768 | regulation of monooxygenase activity | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | IL1A | 1 |
| GO:0045124 | GO:0045124 | regulation of bone resorption | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | TFRC | 1 |
| GO:0045740 | GO:0045740 | positive regulation of DNA replication | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | E2F8 | 1 |
| GO:0051955 | GO:0051955 | regulation of amino acid transport | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | SYT4 | 1 |
| GO:0070296 | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | RYR2 | 1 |
| GO:0090504 | GO:0090504 | epiboly | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | PDCD10 | 1 |
| GO:1900026 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | DOCK1 | 1 |
| GO:1904646 | GO:1904646 | cellular response to amyloid-beta | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | PRNP | 1 |
| GO:2000403 | GO:2000403 | positive regulation of lymphocyte migration | 1/439 | 43/18888 | 0.0232558 | 1.0005827 | 0.0005901 | 0.6366376 | 0.7700119 | 0.6753819 | OXSR1 | 1 |
| GO:0034249 | GO:0034249 | negative regulation of amide metabolic process | 5/439 | 234/18888 | 0.0213675 | 0.9193388 | -0.1915199 | 0.6369451 | 0.7701524 | 0.6755051 | CPEB2/YBX1/CPEB3/PUS7/PRNP | 5 |
| GO:0008203 | GO:0008203 | cholesterol metabolic process | 3/439 | 141/18888 | 0.0212766 | 0.9154267 | -0.1554906 | 0.6399720 | 0.7729878 | 0.6779921 | MBTPS1/CYP7B1/SEC14L2 | 3 |
| GO:0048525 | GO:0048525 | negative regulation of viral process | 2/439 | 93/18888 | 0.0215054 | 0.9252700 | -0.1114403 | 0.6400585 | 0.7729878 | 0.6779921 | HMGA2/PROX1 | 2 |
| GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 2/439 | 93/18888 | 0.0215054 | 0.9252700 | -0.1114403 | 0.6400585 | 0.7729878 | 0.6779921 | OXSR1/SLIT2 | 2 |
| GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 2/439 | 93/18888 | 0.0215054 | 0.9252700 | -0.1114403 | 0.6400585 | 0.7729878 | 0.6779921 | TNKS2/APC | 2 |
| GO:0062013 | GO:0062013 | positive regulation of small molecule metabolic process | 3/439 | 142/18888 | 0.0211268 | 0.9089801 | -0.1679398 | 0.6447032 | 0.7764804 | 0.6810554 | ARPP19/SIRT1/KAT2B | 3 |
| GO:0006284 | GO:0006284 | base-excision repair | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | HMGA2 | 1 |
| GO:0031018 | GO:0031018 | endocrine pancreas development | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | CDK6 | 1 |
| GO:0032689 | GO:0032689 | negative regulation of type II interferon production | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | PRNP | 1 |
| GO:0035307 | GO:0035307 | positive regulation of protein dephosphorylation | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | CAMTA1 | 1 |
| GO:0043268 | GO:0043268 | positive regulation of potassium ion transport | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | KCNN4 | 1 |
| GO:0070741 | GO:0070741 | response to interleukin-6 | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | ST18 | 1 |
| GO:0090199 | GO:0090199 | regulation of release of cytochrome c from mitochondria | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | OPA1 | 1 |
| GO:0097178 | GO:0097178 | ruffle assembly | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | PIP5K1A | 1 |
| GO:1901976 | GO:1901976 | regulation of cell cycle checkpoint | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | PROX1 | 1 |
| GO:1904037 | GO:1904037 | positive regulation of epithelial cell apoptotic process | 1/439 | 44/18888 | 0.0227273 | 0.9778422 | -0.0226983 | 0.6451022 | 0.7764804 | 0.6810554 | RGCC | 1 |
| GO:0043648 | GO:0043648 | dicarboxylic acid metabolic process | 2/439 | 94/18888 | 0.0212766 | 0.9154267 | -0.1267987 | 0.6458449 | 0.7764804 | 0.6810554 | GLUD1/GPT2 | 2 |
| GO:0045104 | GO:0045104 | intermediate filament cytoskeleton organization | 2/439 | 94/18888 | 0.0212766 | 0.9154267 | -0.1267987 | 0.6458449 | 0.7764804 | 0.6810554 | MTM1/ATF2 | 2 |
| GO:0097194 | GO:0097194 | execution phase of apoptosis | 2/439 | 94/18888 | 0.0212766 | 0.9154267 | -0.1267987 | 0.6458449 | 0.7764804 | 0.6810554 | TAOK1/FZD3 | 2 |
| GO:1902807 | GO:1902807 | negative regulation of cell cycle G1/S phase transition | 2/439 | 94/18888 | 0.0212766 | 0.9154267 | -0.1267987 | 0.6458449 | 0.7764804 | 0.6810554 | KLF4/APC | 2 |
| GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 4/439 | 190/18888 | 0.0210526 | 0.9057907 | -0.2013263 | 0.6474627 | 0.7779605 | 0.6823537 | ZMIZ1/PPP3CA/CREB1/CD46 | 4 |
| GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 4/439 | 190/18888 | 0.0210526 | 0.9057907 | -0.2013263 | 0.6474627 | 0.7779605 | 0.6823537 | ZMIZ1/PPP3CA/CREB1/CD46 | 4 |
| GO:0060972 | GO:0060972 | left/right pattern formation | 3/439 | 143/18888 | 0.0209790 | 0.9026236 | -0.1803045 | 0.6493904 | 0.7800439 | 0.6841810 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:0006575 | GO:0006575 | cellular modified amino acid metabolic process | 4/439 | 191/18888 | 0.0209424 | 0.9010483 | -0.2120222 | 0.6515212 | 0.7801665 | 0.6842886 | SLC1A2/EGLN1/SERINC5/GART | 4 |
| GO:0006941 | GO:0006941 | striated muscle contraction | 4/439 | 191/18888 | 0.0209424 | 0.9010483 | -0.2120222 | 0.6515212 | 0.7801665 | 0.6842886 | SCN2A/SMPX/RYR2/CACNA1D | 4 |
| GO:0045103 | GO:0045103 | intermediate filament-based process | 2/439 | 95/18888 | 0.0210526 | 0.9057907 | -0.1419989 | 0.6515575 | 0.7801665 | 0.6842886 | MTM1/ATF2 | 2 |
| GO:0071229 | GO:0071229 | cellular response to acid chemical | 2/439 | 95/18888 | 0.0210526 | 0.9057907 | -0.1419989 | 0.6515575 | 0.7801665 | 0.6842886 | CPEB3/UBR1 | 2 |
| GO:0090316 | GO:0090316 | positive regulation of intracellular protein transport | 2/439 | 95/18888 | 0.0210526 | 0.9057907 | -0.1419989 | 0.6515575 | 0.7801665 | 0.6842886 | SMAD3/PDCD10 | 2 |
| GO:0043487 | GO:0043487 | regulation of RNA stability | 6/439 | 285/18888 | 0.0210526 | 0.9057907 | -0.2472021 | 0.6531656 | 0.7801665 | 0.6842886 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0001504 | GO:0001504 | neurotransmitter uptake | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | SLC1A2 | 1 |
| GO:0002347 | GO:0002347 | response to tumor cell | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | KLF4 | 1 |
| GO:0007020 | GO:0007020 | microtubule nucleation | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | RANBP9 | 1 |
| GO:0010463 | GO:0010463 | mesenchymal cell proliferation | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | FGFR2 | 1 |
| GO:0014014 | GO:0014014 | negative regulation of gliogenesis | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | DLX1 | 1 |
| GO:0019432 | GO:0019432 | triglyceride biosynthetic process | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | SIRT1 | 1 |
| GO:0030261 | GO:0030261 | chromosome condensation | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | HMGA2 | 1 |
| GO:0032309 | GO:0032309 | icosanoid secretion | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | IL1A | 1 |
| GO:0032480 | GO:0032480 | negative regulation of type I interferon production | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | YY1 | 1 |
| GO:0034331 | GO:0034331 | cell junction maintenance | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | MTSS1 | 1 |
| GO:0042149 | GO:0042149 | cellular response to glucose starvation | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | SIRT1 | 1 |
| GO:0044786 | GO:0044786 | cell cycle DNA replication | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | E2F8 | 1 |
| GO:1900744 | GO:1900744 | regulation of p38MAPK cascade | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | MAP3K5 | 1 |
| GO:1903214 | GO:1903214 | regulation of protein targeting to mitochondrion | 1/439 | 45/18888 | 0.0222222 | 0.9561124 | -0.0454675 | 0.6533701 | 0.7801665 | 0.6842886 | UBE2D3 | 1 |
| GO:1900180 | GO:1900180 | regulation of protein localization to nucleus | 3/439 | 144/18888 | 0.0208333 | 0.8963554 | -0.1925858 | 0.6540335 | 0.7807270 | 0.6847802 | TFRC/SMAD3/TCF7L2 | 3 |
| GO:0002695 | GO:0002695 | negative regulation of leukocyte activation | 4/439 | 192/18888 | 0.0208333 | 0.8963554 | -0.2226642 | 0.6555486 | 0.7820717 | 0.6859596 | DLG5/SOCS6/CNR1/PRNP | 4 |
| GO:0002822 | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4/439 | 192/18888 | 0.0208333 | 0.8963554 | -0.2226642 | 0.6555486 | 0.7820717 | 0.6859596 | TFRC/MEF2C/CD46/RIF1 | 4 |
| GO:0000245 | GO:0000245 | spliceosomal complex assembly | 2/439 | 96/18888 | 0.0208333 | 0.8963554 | -0.1570447 | 0.6571966 | 0.7835731 | 0.6872765 | SRSF10/SFSWAP | 2 |
| GO:0072091 | GO:0072091 | regulation of stem cell proliferation | 2/439 | 96/18888 | 0.0208333 | 0.8963554 | -0.1570447 | 0.6571966 | 0.7835731 | 0.6872765 | HMGA2/EPCAM | 2 |
| GO:0060048 | GO:0060048 | cardiac muscle contraction | 3/439 | 145/18888 | 0.0206897 | 0.8901736 | -0.2047852 | 0.6586325 | 0.7845566 | 0.6881391 | SCN2A/RYR2/CACNA1D | 3 |
| GO:0071333 | GO:0071333 | cellular response to glucose stimulus | 3/439 | 145/18888 | 0.0206897 | 0.8901736 | -0.2047852 | 0.6586325 | 0.7845566 | 0.6881391 | PPP3CA/EPHA5/SMAD3 | 3 |
| GO:0002701 | GO:0002701 | negative regulation of production of molecular mediator of immune response | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | IRAK3 | 1 |
| GO:0002920 | GO:0002920 | regulation of humoral immune response | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | CD46 | 1 |
| GO:0006858 | GO:0006858 | extracellular transport | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | RSPH4A | 1 |
| GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint signaling | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | APC | 1 |
| GO:0031146 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | FBXO3 | 1 |
| GO:0045047 | GO:0045047 | protein targeting to ER | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | SPCS3 | 1 |
| GO:0045687 | GO:0045687 | positive regulation of glial cell differentiation | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | HDAC2 | 1 |
| GO:0047496 | GO:0047496 | vesicle transport along microtubule | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | PAFAH1B1 | 1 |
| GO:0051205 | GO:0051205 | protein insertion into membrane | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | COX18 | 1 |
| GO:0071173 | GO:0071173 | spindle assembly checkpoint signaling | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | APC | 1 |
| GO:0071174 | GO:0071174 | mitotic spindle checkpoint signaling | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | APC | 1 |
| GO:0090207 | GO:0090207 | regulation of triglyceride metabolic process | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | SIRT1 | 1 |
| GO:2000785 | GO:2000785 | regulation of autophagosome assembly | 1/439 | 46/18888 | 0.0217391 | 0.9353273 | -0.0677429 | 0.6614458 | 0.7845566 | 0.6881391 | MTM1 | 1 |
| GO:0046394 | GO:0046394 | carboxylic acid biosynthetic process | 7/439 | 334/18888 | 0.0209581 | 0.9017228 | -0.2795341 | 0.6615310 | 0.7845566 | 0.6881391 | GLUD1/CYP7B1/SIRT1/PROX1/SERINC5/KAT2B/PRKAB1 | 7 |
| GO:0071214 | GO:0071214 | cellular response to abiotic stimulus | 7/439 | 334/18888 | 0.0209581 | 0.9017228 | -0.2795341 | 0.6615310 | 0.7845566 | 0.6881391 | SCN2A/REST/OXSR1/SIRT1/YY1/MAPK8/TANK | 7 |
| GO:0104004 | GO:0104004 | cellular response to environmental stimulus | 7/439 | 334/18888 | 0.0209581 | 0.9017228 | -0.2795341 | 0.6615310 | 0.7845566 | 0.6881391 | SCN2A/REST/OXSR1/SIRT1/YY1/MAPK8/TANK | 7 |
| GO:0045638 | GO:0045638 | negative regulation of myeloid cell differentiation | 2/439 | 97/18888 | 0.0206186 | 0.8871146 | -0.1719397 | 0.6627626 | 0.7857857 | 0.6892172 | CDK6/FBN1 | 2 |
| GO:0098656 | GO:0098656 | monoatomic anion transmembrane transport | 3/439 | 146/18888 | 0.0205479 | 0.8840765 | -0.2169038 | 0.6631873 | 0.7860576 | 0.6894557 | SLC1A2/SLC17A6/PRNP | 3 |
| GO:0001818 | GO:0001818 | negative regulation of cytokine production | 8/439 | 381/18888 | 0.0209974 | 0.9034133 | -0.2937915 | 0.6638072 | 0.7865607 | 0.6898970 | ATP2B1/APPL2/SERPINB1/KLF4/RGCC/IRAK3/YY1/PRNP | 8 |
| GO:0009799 | GO:0009799 | specification of symmetry | 3/439 | 147/18888 | 0.0204082 | 0.8780624 | -0.2289430 | 0.6676980 | 0.7896216 | 0.6925816 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:0009855 | GO:0009855 | determination of bilateral symmetry | 3/439 | 147/18888 | 0.0204082 | 0.8780624 | -0.2289430 | 0.6676980 | 0.7896216 | 0.6925816 | MEF2C/ARL13B/SMAD3 | 3 |
| GO:0070664 | GO:0070664 | negative regulation of leukocyte proliferation | 2/439 | 98/18888 | 0.0204082 | 0.8780624 | -0.1866873 | 0.6682558 | 0.7896216 | 0.6925816 | DLG5/PRNP | 2 |
| GO:0006513 | GO:0006513 | protein monoubiquitination | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | UBE2D3 | 1 |
| GO:0010830 | GO:0010830 | regulation of myotube differentiation | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | BDNF | 1 |
| GO:0010837 | GO:0010837 | regulation of keratinocyte proliferation | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | FGFR2 | 1 |
| GO:0014003 | GO:0014003 | oligodendrocyte development | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | CNTN1 | 1 |
| GO:0031577 | GO:0031577 | spindle checkpoint signaling | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | APC | 1 |
| GO:0043666 | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | PPP1R1B | 1 |
| GO:0072538 | GO:0072538 | T-helper 17 type immune response | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | RORA | 1 |
| GO:0140353 | GO:0140353 | lipid export from cell | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | IL1A | 1 |
| GO:0140894 | GO:0140894 | endolysosomal toll-like receptor signaling pathway | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | HCFC2 | 1 |
| GO:1902175 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | SIRT1 | 1 |
| GO:1903747 | GO:1903747 | regulation of establishment of protein localization to mitochondrion | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | UBE2D3 | 1 |
| GO:1904262 | GO:1904262 | negative regulation of TORC1 signaling | 1/439 | 47/18888 | 0.0212766 | 0.9154267 | -0.0895483 | 0.6693338 | 0.7896216 | 0.6925816 | SEH1L | 1 |
| GO:0061013 | GO:0061013 | regulation of mRNA catabolic process | 6/439 | 290/18888 | 0.0206897 | 0.8901736 | -0.2907368 | 0.6695446 | 0.7896388 | 0.6925968 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/PUM1 | 6 |
| GO:0016053 | GO:0016053 | organic acid biosynthetic process | 7/439 | 337/18888 | 0.0207715 | 0.8936955 | -0.3037457 | 0.6705985 | 0.7906499 | 0.6934836 | GLUD1/CYP7B1/SIRT1/PROX1/SERINC5/KAT2B/PRKAB1 | 7 |
| GO:0042060 | GO:0042060 | wound healing | 9/439 | 430/18888 | 0.0209302 | 0.9005244 | -0.3218738 | 0.6717582 | 0.7917853 | 0.6944795 | VAV3/PPP3CA/SMAD3/PDCD10/B4GALT1/IL1A/AJAP1/ENPP4/MYOF | 9 |
| GO:0060078 | GO:0060078 | regulation of postsynaptic membrane potential | 3/439 | 148/18888 | 0.0202703 | 0.8721295 | -0.2409038 | 0.6721644 | 0.7918003 | 0.6944926 | GRIN3A/PPP3CA/MEF2C | 3 |
| GO:0071331 | GO:0071331 | cellular response to hexose stimulus | 3/439 | 148/18888 | 0.0202703 | 0.8721295 | -0.2409038 | 0.6721644 | 0.7918003 | 0.6944926 | PPP3CA/EPHA5/SMAD3 | 3 |
| GO:0009314 | GO:0009314 | response to radiation | 9/439 | 431/18888 | 0.0208817 | 0.8984351 | -0.3290252 | 0.6744148 | 0.7926687 | 0.6952543 | MAP4K3/TAFA2/SLC1A2/PPP1R1B/SIRT1/IL1A/YY1/MAPK8/TANK | 9 |
| GO:0007051 | GO:0007051 | spindle organization | 4/439 | 197/18888 | 0.0203046 | 0.8736052 | -0.2750891 | 0.6752150 | 0.7926687 | 0.6952543 | RAB11A/SMC3/CEP120/KIF2A | 4 |
| GO:0031334 | GO:0031334 | positive regulation of protein-containing complex assembly | 4/439 | 197/18888 | 0.0203046 | 0.8736052 | -0.2750891 | 0.6752150 | 0.7926687 | 0.6952543 | TFRC/RAP1B/TAL1/MAPK8 | 4 |
| GO:0072523 | GO:0072523 | purine-containing compound catabolic process | 3/439 | 149/18888 | 0.0201342 | 0.8662763 | -0.2527875 | 0.6765867 | 0.7926687 | 0.6952543 | PDE10A/KAT2B/ENPP4 | 3 |
| GO:0002861 | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | CNR1 | 1 |
| GO:0031295 | GO:0031295 | T cell costimulation | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | MAP3K8 | 1 |
| GO:0032620 | GO:0032620 | interleukin-17 production | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | PRNP | 1 |
| GO:0032660 | GO:0032660 | regulation of interleukin-17 production | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | PRNP | 1 |
| GO:0032968 | GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | MED4 | 1 |
| GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | APC | 1 |
| GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | APC | 1 |
| GO:0042311 | GO:0042311 | vasodilation | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | KAT2B | 1 |
| GO:0042596 | GO:0042596 | fear response | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | MEF2C | 1 |
| GO:0043407 | GO:0043407 | negative regulation of MAP kinase activity | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | IRAK3 | 1 |
| GO:0045776 | GO:0045776 | negative regulation of blood pressure | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | CNR1 | 1 |
| GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | APC | 1 |
| GO:0090329 | GO:0090329 | regulation of DNA-templated DNA replication | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | E2F8 | 1 |
| GO:0120163 | GO:0120163 | negative regulation of cold-induced thermogenesis | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | ADAMTS5 | 1 |
| GO:1903587 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | PDCD10 | 1 |
| GO:1990090 | GO:1990090 | cellular response to nerve growth factor stimulus | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | BDNF | 1 |
| GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 1/439 | 48/18888 | 0.0208333 | 0.8963554 | -0.1109058 | 0.6770384 | 0.7926687 | 0.6952543 | APC | 1 |
| GO:0002220 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 2/439 | 100/18888 | 0.0200000 | 0.8605011 | -0.2157534 | 0.6790251 | 0.7945325 | 0.6968890 | APPL2/IRAK2 | 2 |
| GO:1903035 | GO:1903035 | negative regulation of response to wounding | 2/439 | 100/18888 | 0.0200000 | 0.8605011 | -0.2157534 | 0.6790251 | 0.7945325 | 0.6968890 | SMAD3/AJAP1 | 2 |
| GO:0048193 | GO:0048193 | Golgi vesicle transport | 6/439 | 294/18888 | 0.0204082 | 0.8780624 | -0.3250516 | 0.6822904 | 0.7980796 | 0.7000002 | RAB33B/TMED7/RAB12/PPP6C/SEC24B/SEC24A | 6 |
| GO:0021700 | GO:0021700 | developmental maturation | 7/439 | 341/18888 | 0.0205279 | 0.8832123 | -0.3357104 | 0.6824533 | 0.7980796 | 0.7000002 | NR4A2/AGRN/L3MBTL3/NFIA/TAL1/SOX8/UNC13C | 7 |
| GO:0034446 | GO:0034446 | substrate adhesion-dependent cell spreading | 2/439 | 101/18888 | 0.0198020 | 0.8519813 | -0.2300784 | 0.6843022 | 0.7982280 | 0.7001304 | EPHA1/DOCK1 | 2 |
| GO:1990868 | GO:1990868 | response to chemokine | 2/439 | 101/18888 | 0.0198020 | 0.8519813 | -0.2300784 | 0.6843022 | 0.7982280 | 0.7001304 | OXSR1/SLIT2 | 2 |
| GO:1990869 | GO:1990869 | cellular response to chemokine | 2/439 | 101/18888 | 0.0198020 | 0.8519813 | -0.2300784 | 0.6843022 | 0.7982280 | 0.7001304 | OXSR1/SLIT2 | 2 |
| GO:0006479 | GO:0006479 | protein methylation | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | GSPT1 | 1 |
| GO:0008213 | GO:0008213 | protein alkylation | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | GSPT1 | 1 |
| GO:0031294 | GO:0031294 | lymphocyte costimulation | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | MAP3K8 | 1 |
| GO:0044788 | GO:0044788 | modulation by host of viral process | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | CAV2 | 1 |
| GO:0045910 | GO:0045910 | negative regulation of DNA recombination | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | RIF1 | 1 |
| GO:0046427 | GO:0046427 | positive regulation of receptor signaling pathway via JAK-STAT | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | ADIPOR1 | 1 |
| GO:0070266 | GO:0070266 | necroptotic process | 1/439 | 49/18888 | 0.0204082 | 0.8780624 | -0.1318360 | 0.6845639 | 0.7982280 | 0.7001304 | IPMK | 1 |
| GO:0008630 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 2/439 | 102/18888 | 0.0196078 | 0.8436286 | -0.2442686 | 0.6895080 | 0.8023814 | 0.7037734 | SIRT1/HNRNPK | 2 |
| GO:0035296 | GO:0035296 | regulation of tube diameter | 3/439 | 152/18888 | 0.0197368 | 0.8491788 | -0.2879872 | 0.6895891 | 0.8023814 | 0.7037734 | ATP2B1/DOCK4/KAT2B | 3 |
| GO:0097746 | GO:0097746 | blood vessel diameter maintenance | 3/439 | 152/18888 | 0.0197368 | 0.8491788 | -0.2879872 | 0.6895891 | 0.8023814 | 0.7037734 | ATP2B1/DOCK4/KAT2B | 3 |
| GO:1902652 | GO:1902652 | secondary alcohol metabolic process | 3/439 | 152/18888 | 0.0197368 | 0.8491788 | -0.2879872 | 0.6895891 | 0.8023814 | 0.7037734 | MBTPS1/CYP7B1/SEC14L2 | 3 |
| GO:0050728 | GO:0050728 | negative regulation of inflammatory response | 4/439 | 201/18888 | 0.0199005 | 0.8562200 | -0.3161214 | 0.6903795 | 0.8023814 | 0.7037734 | ASH1L/RORA/SMAD3/KLF4 | 4 |
| GO:0001754 | GO:0001754 | eye photoreceptor cell differentiation | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | SOX8 | 1 |
| GO:0006693 | GO:0006693 | prostaglandin metabolic process | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | SIRT1 | 1 |
| GO:0014911 | GO:0014911 | positive regulation of smooth muscle cell migration | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | DOCK4 | 1 |
| GO:0021515 | GO:0021515 | cell differentiation in spinal cord | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | TAL1 | 1 |
| GO:0032924 | GO:0032924 | activin receptor signaling pathway | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | SMAD3 | 1 |
| GO:0033120 | GO:0033120 | positive regulation of RNA splicing | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | CLNS1A | 1 |
| GO:0043154 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | KLF4 | 1 |
| GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | APC | 1 |
| GO:0071827 | GO:0071827 | plasma lipoprotein particle organization | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | PLAGL2 | 1 |
| GO:0140374 | GO:0140374 | antiviral innate immune response | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | HCFC2 | 1 |
| GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | APC | 1 |
| GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | APC | 1 |
| GO:1990089 | GO:1990089 | response to nerve growth factor | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | BDNF | 1 |
| GO:2000404 | GO:2000404 | regulation of T cell migration | 1/439 | 50/18888 | 0.0200000 | 0.8605011 | -0.1523581 | 0.6919144 | 0.8023814 | 0.7037734 | OXSR1 | 1 |
| GO:0016054 | GO:0016054 | organic acid catabolic process | 5/439 | 250/18888 | 0.0200000 | 0.8605011 | -0.3425061 | 0.6935279 | 0.8037893 | 0.7050082 | GLUD1/CNR1/GPT2/PEX5/HADHB | 5 |
| GO:0046395 | GO:0046395 | carboxylic acid catabolic process | 5/439 | 250/18888 | 0.0200000 | 0.8605011 | -0.3425061 | 0.6935279 | 0.8037893 | 0.7050082 | GLUD1/CNR1/GPT2/PEX5/HADHB | 5 |
| GO:0035150 | GO:0035150 | regulation of tube size | 3/439 | 153/18888 | 0.0196078 | 0.8436286 | -0.2995737 | 0.6938353 | 0.8039139 | 0.7051176 | ATP2B1/DOCK4/KAT2B | 3 |
| GO:0045088 | GO:0045088 | regulation of innate immune response | 9/439 | 440/18888 | 0.0204545 | 0.8800580 | -0.3926905 | 0.6977403 | 0.8067549 | 0.7076094 | PUM2/HCFC2/PSPC1/APPL2/PPP6C/PUM1/IRAK3/IRAK2/MAPK8 | 9 |
| GO:0015748 | GO:0015748 | organophosphate ester transport | 3/439 | 154/18888 | 0.0194805 | 0.8381505 | -0.3110885 | 0.6980375 | 0.8067549 | 0.7076094 | KCNN4/ATP8A1/PRELID3B | 3 |
| GO:0006110 | GO:0006110 | regulation of glycolytic process | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | KAT2B | 1 |
| GO:0006120 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | NDUFS1 | 1 |
| GO:0006636 | GO:0006636 | unsaturated fatty acid biosynthetic process | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | SIRT1 | 1 |
| GO:0006692 | GO:0006692 | prostanoid metabolic process | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | SIRT1 | 1 |
| GO:0010043 | GO:0010043 | response to zinc ion | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | CREB1 | 1 |
| GO:0030811 | GO:0030811 | regulation of nucleotide catabolic process | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | KAT2B | 1 |
| GO:0032692 | GO:0032692 | negative regulation of interleukin-1 production | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | SERPINB1 | 1 |
| GO:0033121 | GO:0033121 | regulation of purine nucleotide catabolic process | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | KAT2B | 1 |
| GO:0035036 | GO:0035036 | sperm-egg recognition | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | B4GALT1 | 1 |
| GO:0039532 | GO:0039532 | negative regulation of cytoplasmic pattern recognition receptor signaling pathway | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | PPP6C | 1 |
| GO:0046850 | GO:0046850 | regulation of bone remodeling | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | TFRC | 1 |
| GO:2001238 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1/439 | 51/18888 | 0.0196078 | 0.8436286 | -0.1724900 | 0.6990940 | 0.8067549 | 0.7076094 | ITM2C | 1 |
| GO:0022600 | GO:0022600 | digestive system process | 2/439 | 104/18888 | 0.0192308 | 0.8274049 | -0.2722565 | 0.6997079 | 0.8067692 | 0.7076219 | PPP3CA/KCNN4 | 2 |
| GO:0032642 | GO:0032642 | regulation of chemokine production | 2/439 | 104/18888 | 0.0192308 | 0.8274049 | -0.2722565 | 0.6997079 | 0.8067692 | 0.7076219 | ADCYAP1/KLF4 | 2 |
| GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 2/439 | 104/18888 | 0.0192308 | 0.8274049 | -0.2722565 | 0.6997079 | 0.8067692 | 0.7076219 | APC/KAT2B | 2 |
| GO:0016125 | GO:0016125 | sterol metabolic process | 3/439 | 155/18888 | 0.0193548 | 0.8327430 | -0.3225327 | 0.7021959 | 0.8094060 | 0.7099347 | MBTPS1/CYP7B1/SEC14L2 | 3 |
| GO:0032602 | GO:0032602 | chemokine production | 2/439 | 105/18888 | 0.0190476 | 0.8195249 | -0.2860598 | 0.7047028 | 0.8113573 | 0.7116462 | ADCYAP1/KLF4 | 2 |
| GO:0090100 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2/439 | 105/18888 | 0.0190476 | 0.8195249 | -0.2860598 | 0.7047028 | 0.8113573 | 0.7116462 | ZEB2/SULF1 | 2 |
| GO:1905477 | GO:1905477 | positive regulation of protein localization to membrane | 2/439 | 105/18888 | 0.0190476 | 0.8195249 | -0.2860598 | 0.7047028 | 0.8113573 | 0.7116462 | EPHA3/PRNP | 2 |
| GO:0006890 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | RAB33B | 1 |
| GO:0010332 | GO:0010332 | response to gamma radiation | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | IL1A | 1 |
| GO:0010517 | GO:0010517 | regulation of phospholipase activity | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | FGFR2 | 1 |
| GO:0060324 | GO:0060324 | face development | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | MAPK1 | 1 |
| GO:0070988 | GO:0070988 | demethylation | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | TET2 | 1 |
| GO:0101023 | GO:0101023 | vascular endothelial cell proliferation | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | MEF2C | 1 |
| GO:1904263 | GO:1904263 | positive regulation of TORC1 signaling | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | SEH1L | 1 |
| GO:1905562 | GO:1905562 | regulation of vascular endothelial cell proliferation | 1/439 | 52/18888 | 0.0192308 | 0.8274049 | -0.1922485 | 0.7061067 | 0.8113573 | 0.7116462 | MEF2C | 1 |
| GO:0046718 | GO:0046718 | symbiont entry into host cell | 3/439 | 156/18888 | 0.0192308 | 0.8274049 | -0.3339073 | 0.7063107 | 0.8113600 | 0.7116486 | TFRC/CAV2/CD46 | 3 |
| GO:0045017 | GO:0045017 | glycerolipid biosynthetic process | 5/439 | 254/18888 | 0.0196850 | 0.8469499 | -0.3788128 | 0.7066905 | 0.8115646 | 0.7118280 | MTM1/SOCS6/SELENOI/PIP5K1A/SIRT1 | 5 |
| GO:0017148 | GO:0017148 | negative regulation of translation | 4/439 | 206/18888 | 0.0194175 | 0.8354380 | -0.3663353 | 0.7086211 | 0.8135496 | 0.7135690 | CPEB2/YBX1/CPEB3/PUS7 | 4 |
| GO:0097306 | GO:0097306 | cellular response to alcohol | 2/439 | 106/18888 | 0.0188679 | 0.8117935 | -0.2997394 | 0.7096285 | 0.8144738 | 0.7143797 | CREB1/KLF4 | 2 |
| GO:0002066 | GO:0002066 | columnar/cuboidal epithelial cell development | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | CDK6 | 1 |
| GO:0007157 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | CDH4 | 1 |
| GO:0045197 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | DLG5 | 1 |
| GO:0060193 | GO:0060193 | positive regulation of lipase activity | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | FGFR2 | 1 |
| GO:0071825 | GO:0071825 | protein-lipid complex organization | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | PLAGL2 | 1 |
| GO:1904894 | GO:1904894 | positive regulation of receptor signaling pathway via STAT | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | ADIPOR1 | 1 |
| GO:2000059 | GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 1/439 | 53/18888 | 0.0188679 | 0.8117935 | -0.2116494 | 0.7129563 | 0.8166627 | 0.7162996 | MTM1 | 1 |
| GO:0007189 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3/439 | 158/18888 | 0.0189873 | 0.8169315 | -0.3564517 | 0.7144096 | 0.8174835 | 0.7170195 | CNR1/ADCYAP1/PTHLH | 3 |
| GO:0030593 | GO:0030593 | neutrophil chemotaxis | 2/439 | 107/18888 | 0.0186916 | 0.8042067 | -0.3132981 | 0.7144854 | 0.8174835 | 0.7170195 | VAV3/SLIT2 | 2 |
| GO:0032963 | GO:0032963 | collagen metabolic process | 2/439 | 107/18888 | 0.0186916 | 0.8042067 | -0.3132981 | 0.7144854 | 0.8174835 | 0.7170195 | RGCC/HDAC2 | 2 |
| GO:0060079 | GO:0060079 | excitatory postsynaptic potential | 2/439 | 107/18888 | 0.0186916 | 0.8042067 | -0.3132981 | 0.7144854 | 0.8174835 | 0.7170195 | PPP3CA/MEF2C | 2 |
| GO:0002699 | GO:0002699 | positive regulation of immune effector process | 5/439 | 257/18888 | 0.0194553 | 0.8370634 | -0.4056902 | 0.7163007 | 0.8191734 | 0.7185017 | TFRC/APPL2/SIRT1/CD46/RIF1 | 5 |
| GO:0009895 | GO:0009895 | negative regulation of catabolic process | 7/439 | 353/18888 | 0.0198300 | 0.8531881 | -0.4295163 | 0.7163696 | 0.8191734 | 0.7185017 | MTM1/TAB2/YBX1/CNR1/SMAD3/USP25/IRAK3 | 7 |
| GO:0006631 | GO:0006631 | fatty acid metabolic process | 8/439 | 401/18888 | 0.0199501 | 0.8583553 | -0.4422489 | 0.7179079 | 0.8206993 | 0.7198401 | CNR1/APPL2/SIRT1/ADIPOR1/PEX5/KAT2B/HADHB/PRKAB1 | 8 |
| GO:0009395 | GO:0009395 | phospholipid catabolic process | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | PLCB1 | 1 |
| GO:0010656 | GO:0010656 | negative regulation of muscle cell apoptotic process | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | HEY2 | 1 |
| GO:0010874 | GO:0010874 | regulation of cholesterol efflux | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | SIRT1 | 1 |
| GO:0010883 | GO:0010883 | regulation of lipid storage | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | SIRT1 | 1 |
| GO:0086009 | GO:0086009 | membrane repolarization | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | CACNA1D | 1 |
| GO:0120009 | GO:0120009 | intermembrane lipid transfer | 1/439 | 54/18888 | 0.0185185 | 0.7967603 | -0.2307074 | 0.7196466 | 0.8212870 | 0.7203556 | PRELID3B | 1 |
| GO:0002181 | GO:0002181 | cytoplasmic translation | 3/439 | 160/18888 | 0.0187500 | 0.8067198 | -0.3787293 | 0.7223352 | 0.8241215 | 0.7228418 | CPEB2/YBX1/CPEB3 | 3 |
| GO:0046474 | GO:0046474 | glycerophospholipid biosynthetic process | 4/439 | 210/18888 | 0.0190476 | 0.8195249 | -0.4056851 | 0.7226433 | 0.8242395 | 0.7229452 | MTM1/SOCS6/SELENOI/PIP5K1A | 4 |
| GO:0032760 | GO:0032760 | positive regulation of tumor necrosis factor production | 2/439 | 109/18888 | 0.0183486 | 0.7894506 | -0.3400622 | 0.7239950 | 0.8255471 | 0.7240922 | IL1A/HDAC2 | 2 |
| GO:0006401 | GO:0006401 | RNA catabolic process | 8/439 | 404/18888 | 0.0198020 | 0.8519813 | -0.4639130 | 0.7255031 | 0.8264009 | 0.7248410 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/GSPT1/PUM1/PNRC1 | 8 |
| GO:0001836 | GO:0001836 | release of cytochrome c from mitochondria | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | OPA1 | 1 |
| GO:0002043 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | PDCD10 | 1 |
| GO:0007140 | GO:0007140 | male meiotic nuclear division | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | FOXJ3 | 1 |
| GO:0034381 | GO:0034381 | plasma lipoprotein particle clearance | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | HNRNPK | 1 |
| GO:0046460 | GO:0046460 | neutral lipid biosynthetic process | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | SIRT1 | 1 |
| GO:0046463 | GO:0046463 | acylglycerol biosynthetic process | 1/439 | 55/18888 | 0.0181818 | 0.7822738 | -0.2494363 | 0.7261813 | 0.8264009 | 0.7248410 | SIRT1 | 1 |
| GO:0032611 | GO:0032611 | interleukin-1 beta production | 2/439 | 110/18888 | 0.0181818 | 0.7822738 | -0.3532725 | 0.7286488 | 0.8287401 | 0.7268928 | SMAD3/SERPINB1 | 2 |
| GO:0032651 | GO:0032651 | regulation of interleukin-1 beta production | 2/439 | 110/18888 | 0.0181818 | 0.7822738 | -0.3532725 | 0.7286488 | 0.8287401 | 0.7268928 | SMAD3/SERPINB1 | 2 |
| GO:0120254 | GO:0120254 | olefinic compound metabolic process | 3/439 | 162/18888 | 0.0185185 | 0.7967603 | -0.4007475 | 0.7300887 | 0.8301432 | 0.7281234 | SRD5A1/REST/CREB1 | 3 |
| GO:0002455 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | CD46 | 1 |
| GO:0002823 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | CD46 | 1 |
| GO:0006584 | GO:0006584 | catecholamine metabolic process | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | NR4A2 | 1 |
| GO:0007187 | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | CNR1 | 1 |
| GO:0009712 | GO:0009712 | catechol-containing compound metabolic process | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | NR4A2 | 1 |
| GO:0031529 | GO:0031529 | ruffle organization | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | PIP5K1A | 1 |
| GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | APC | 1 |
| GO:0045912 | GO:0045912 | negative regulation of carbohydrate metabolic process | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | TCF7L2 | 1 |
| GO:0061178 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1/439 | 56/18888 | 0.0178571 | 0.7683046 | -0.2678493 | 0.7325641 | 0.8304366 | 0.7283808 | EPHA5 | 1 |
| GO:0015850 | GO:0015850 | organic hydroxy compound transport | 6/439 | 311/18888 | 0.0192926 | 0.8300654 | -0.4661241 | 0.7328275 | 0.8304366 | 0.7283808 | SYT4/CNR1/PRKCB/SLC10A4/SIRT1/SEC24A | 6 |
| GO:0044403 | GO:0044403 | biological process involved in symbiotic interaction | 6/439 | 311/18888 | 0.0192926 | 0.8300654 | -0.4661241 | 0.7328275 | 0.8304366 | 0.7283808 | TFRC/JUN/HMGA2/REST/CAV2/CD46 | 6 |
| GO:0099111 | GO:0099111 | microtubule-based transport | 4/439 | 213/18888 | 0.0187793 | 0.8079823 | -0.4347385 | 0.7328283 | 0.8304366 | 0.7283808 | RSPH4A/PAFAH1B1/RHOT1/OPA1 | 4 |
| GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 2/439 | 111/18888 | 0.0180180 | 0.7752263 | -0.3663712 | 0.7332359 | 0.8304366 | 0.7283808 | VAV3/DOCK1 | 2 |
| GO:0009063 | GO:0009063 | amino acid catabolic process | 2/439 | 111/18888 | 0.0180180 | 0.7752263 | -0.3663712 | 0.7332359 | 0.8304366 | 0.7283808 | GLUD1/GPT2 | 2 |
| GO:0007292 | GO:0007292 | female gamete generation | 3/439 | 163/18888 | 0.0184049 | 0.7918722 | -0.4116615 | 0.7339013 | 0.8304890 | 0.7284267 | ZMIZ1/SIRT1/SOS1 | 3 |
| GO:0034250 | GO:0034250 | positive regulation of amide metabolic process | 3/439 | 163/18888 | 0.0184049 | 0.7918722 | -0.4116615 | 0.7339013 | 0.8304890 | 0.7284267 | LRRTM3/YBX1/CPEB3 | 3 |
| GO:0044409 | GO:0044409 | symbiont entry into host | 3/439 | 163/18888 | 0.0184049 | 0.7918722 | -0.4116615 | 0.7339013 | 0.8304890 | 0.7284267 | TFRC/CAV2/CD46 | 3 |
| GO:0006869 | GO:0006869 | lipid transport | 9/439 | 456/18888 | 0.0197368 | 0.8491788 | -0.5029051 | 0.7365428 | 0.8320528 | 0.7297983 | KCNN4/ATP8A1/DENND5B/SLC10A4/SIRT1/IL1A/SEC24A/PRELID3B/PLPPR4 | 9 |
| GO:0016579 | GO:0016579 | protein deubiquitination | 2/439 | 112/18888 | 0.0178571 | 0.7683046 | -0.3793606 | 0.7377571 | 0.8320528 | 0.7297983 | USP25/TANK | 2 |
| GO:1902106 | GO:1902106 | negative regulation of leukocyte differentiation | 2/439 | 112/18888 | 0.0178571 | 0.7683046 | -0.3793606 | 0.7377571 | 0.8320528 | 0.7297983 | CDK6/FBN1 | 2 |
| GO:0001541 | GO:0001541 | ovarian follicle development | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | TAF4 | 1 |
| GO:0001755 | GO:0001755 | neural crest cell migration | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | SOX8 | 1 |
| GO:0002707 | GO:0002707 | negative regulation of lymphocyte mediated immunity | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | CD46 | 1 |
| GO:0006749 | GO:0006749 | glutathione metabolic process | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | SLC1A2 | 1 |
| GO:0019748 | GO:0019748 | secondary metabolic process | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | ZEB2 | 1 |
| GO:0035088 | GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | DLG5 | 1 |
| GO:0044088 | GO:0044088 | regulation of vacuole organization | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | MTM1 | 1 |
| GO:0046148 | GO:0046148 | pigment biosynthetic process | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | ZEB2 | 1 |
| GO:0051058 | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | SLIT2 | 1 |
| GO:0051293 | GO:0051293 | establishment of spindle localization | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | PAFAH1B1 | 1 |
| GO:0060986 | GO:0060986 | endocrine hormone secretion | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | CRHBP | 1 |
| GO:0061245 | GO:0061245 | establishment or maintenance of bipolar cell polarity | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | DLG5 | 1 |
| GO:0061900 | GO:0061900 | glial cell activation | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | ZEB2 | 1 |
| GO:0070542 | GO:0070542 | response to fatty acid | 1/439 | 57/18888 | 0.0175439 | 0.7548256 | -0.2859587 | 0.7387984 | 0.8320528 | 0.7297983 | PLCB1 | 1 |
| GO:0050866 | GO:0050866 | negative regulation of cell activation | 4/439 | 215/18888 | 0.0186047 | 0.8004662 | -0.4538957 | 0.7394611 | 0.8323332 | 0.7300443 | DLG5/SOCS6/CNR1/PRNP | 4 |
| GO:0070374 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4/439 | 215/18888 | 0.0186047 | 0.8004662 | -0.4538957 | 0.7394611 | 0.8323332 | 0.7300443 | RAP1B/ADCYAP1/FGFR2/IL1A | 4 |
| GO:0051250 | GO:0051250 | negative regulation of lymphocyte activation | 3/439 | 165/18888 | 0.0181818 | 0.7822738 | -0.4333037 | 0.7413992 | 0.8342814 | 0.7317530 | DLG5/SOCS6/PRNP | 3 |
| GO:0009145 | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2/439 | 113/18888 | 0.0176991 | 0.7615054 | -0.3922429 | 0.7422127 | 0.8344968 | 0.7319420 | ADK/NDUFS1 | 2 |
| GO:0036503 | GO:0036503 | ERAD pathway | 2/439 | 113/18888 | 0.0176991 | 0.7615054 | -0.3922429 | 0.7422127 | 0.8344968 | 0.7319420 | AMFR/USP25 | 2 |
| GO:1903557 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 2/439 | 113/18888 | 0.0176991 | 0.7615054 | -0.3922429 | 0.7422127 | 0.8344968 | 0.7319420 | IL1A/HDAC2 | 2 |
| GO:0042306 | GO:0042306 | regulation of protein import into nucleus | 1/439 | 58/18888 | 0.0172414 | 0.7418113 | -0.3037759 | 0.7448877 | 0.8365573 | 0.7337492 | SMAD3 | 1 |
| GO:0042733 | GO:0042733 | embryonic digit morphogenesis | 1/439 | 58/18888 | 0.0172414 | 0.7418113 | -0.3037759 | 0.7448877 | 0.8365573 | 0.7337492 | HDAC2 | 1 |
| GO:0048168 | GO:0048168 | regulation of neuronal synaptic plasticity | 1/439 | 58/18888 | 0.0172414 | 0.7418113 | -0.3037759 | 0.7448877 | 0.8365573 | 0.7337492 | SYT4 | 1 |
| GO:0061756 | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 1/439 | 58/18888 | 0.0172414 | 0.7418113 | -0.3037759 | 0.7448877 | 0.8365573 | 0.7337492 | KLF4 | 1 |
| GO:0006633 | GO:0006633 | fatty acid biosynthetic process | 3/439 | 166/18888 | 0.0180723 | 0.7775613 | -0.4440334 | 0.7450848 | 0.8365573 | 0.7337492 | SIRT1/KAT2B/PRKAB1 | 3 |
| GO:0000045 | GO:0000045 | autophagosome assembly | 2/439 | 114/18888 | 0.0175439 | 0.7548256 | -0.4050201 | 0.7466036 | 0.8376853 | 0.7347386 | MTM1/RAB33B | 2 |
| GO:2001243 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 2/439 | 114/18888 | 0.0175439 | 0.7548256 | -0.4050201 | 0.7466036 | 0.8376853 | 0.7347386 | SIRT1/OPA1 | 2 |
| GO:0032386 | GO:0032386 | regulation of intracellular transport | 5/439 | 267/18888 | 0.0187266 | 0.8057127 | -0.4932033 | 0.7467140 | 0.8376853 | 0.7347386 | MAPK1/RAB11A/SMAD3/PDCD10/SEC24B | 5 |
| GO:0006937 | GO:0006937 | regulation of muscle contraction | 3/439 | 167/18888 | 0.0179641 | 0.7729052 | -0.4547034 | 0.7487285 | 0.8391400 | 0.7360145 | ATP2B1/DOCK4/RYR2 | 3 |
| GO:0007062 | GO:0007062 | sister chromatid cohesion | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | SMC3 | 1 |
| GO:0007566 | GO:0007566 | embryo implantation | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | SMURF2 | 1 |
| GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | APC | 1 |
| GO:0032608 | GO:0032608 | interferon-beta production | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | YY1 | 1 |
| GO:0032648 | GO:0032648 | regulation of interferon-beta production | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | YY1 | 1 |
| GO:0043616 | GO:0043616 | keratinocyte proliferation | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | FGFR2 | 1 |
| GO:0045604 | GO:0045604 | regulation of epidermal cell differentiation | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | HEY2 | 1 |
| GO:0050881 | GO:0050881 | musculoskeletal movement | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | ITPR1 | 1 |
| GO:0051932 | GO:0051932 | synaptic transmission, GABAergic | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | CNR1 | 1 |
| GO:0090497 | GO:0090497 | mesenchymal cell migration | 1/439 | 59/18888 | 0.0169492 | 0.7292383 | -0.3213121 | 0.7508353 | 0.8391400 | 0.7360145 | SOX8 | 1 |
| GO:0051099 | GO:0051099 | positive regulation of binding | 2/439 | 115/18888 | 0.0173913 | 0.7482619 | -0.4176942 | 0.7509302 | 0.8391400 | 0.7360145 | TCF7L2/BDNF | 2 |
| GO:0099565 | GO:0099565 | chemical synaptic transmission, postsynaptic | 2/439 | 115/18888 | 0.0173913 | 0.7482619 | -0.4176942 | 0.7509302 | 0.8391400 | 0.7360145 | PPP3CA/MEF2C | 2 |
| GO:1904035 | GO:1904035 | regulation of epithelial cell apoptotic process | 2/439 | 115/18888 | 0.0173913 | 0.7482619 | -0.4176942 | 0.7509302 | 0.8391400 | 0.7360145 | TCF7L2/RGCC | 2 |
| GO:0019058 | GO:0019058 | viral life cycle | 6/439 | 319/18888 | 0.0188088 | 0.8092487 | -0.5300244 | 0.7545512 | 0.8429523 | 0.7393583 | TFRC/HMGA2/NFIA/CAV2/CD46/PROX1 | 6 |
| GO:0071887 | GO:0071887 | leukocyte apoptotic process | 2/439 | 116/18888 | 0.0172414 | 0.7418113 | -0.4302672 | 0.7551931 | 0.8431842 | 0.7395617 | MEF2C/SIRT1 | 2 |
| GO:0001961 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | PAFAH1B1 | 1 |
| GO:0010257 | GO:0010257 | NADH dehydrogenase complex assembly | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | NDUFS1 | 1 |
| GO:0014009 | GO:0014009 | glial cell proliferation | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | NFIA | 1 |
| GO:0032981 | GO:0032981 | mitochondrial respiratory chain complex I assembly | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | NDUFS1 | 1 |
| GO:0043030 | GO:0043030 | regulation of macrophage activation | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | RORA | 1 |
| GO:0043113 | GO:0043113 | receptor clustering | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | AGRN | 1 |
| GO:0046456 | GO:0046456 | icosanoid biosynthetic process | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | SIRT1 | 1 |
| GO:0051289 | GO:0051289 | protein homotetramerization | 1/439 | 60/18888 | 0.0166667 | 0.7170843 | -0.3385774 | 0.7566446 | 0.8431842 | 0.7395617 | APPL2 | 1 |
| GO:0071695 | GO:0071695 | anatomical structure maturation | 5/439 | 271/18888 | 0.0184502 | 0.7938202 | -0.5273551 | 0.7581845 | 0.8446662 | 0.7408616 | NR4A2/AGRN/L3MBTL3/TAL1/SOX8 | 5 |
| GO:0033209 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2/439 | 117/18888 | 0.0170940 | 0.7354711 | -0.4427410 | 0.7593930 | 0.8455444 | 0.7416319 | TANK/ST18 | 2 |
| GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 2/439 | 117/18888 | 0.0170940 | 0.7354711 | -0.4427410 | 0.7593930 | 0.8455444 | 0.7416319 | IQGAP2/APC | 2 |
| GO:0050878 | GO:0050878 | regulation of body fluid levels | 7/439 | 370/18888 | 0.0189189 | 0.8139876 | -0.5574079 | 0.7600992 | 0.8460966 | 0.7421162 | VAV3/PPP3CA/KCNN4/NCOA1/CREB1/MLLT6/ENPP4 | 7 |
| GO:0002820 | GO:0002820 | negative regulation of adaptive immune response | 1/439 | 61/18888 | 0.0163934 | 0.7053288 | -0.3555817 | 0.7623188 | 0.8473953 | 0.7432553 | CD46 | 1 |
| GO:0006383 | GO:0006383 | transcription by RNA polymerase III | 1/439 | 61/18888 | 0.0163934 | 0.7053288 | -0.3555817 | 0.7623188 | 0.8473953 | 0.7432553 | AR | 1 |
| GO:0043470 | GO:0043470 | regulation of carbohydrate catabolic process | 1/439 | 61/18888 | 0.0163934 | 0.7053288 | -0.3555817 | 0.7623188 | 0.8473953 | 0.7432553 | KAT2B | 1 |
| GO:0050879 | GO:0050879 | multicellular organismal movement | 1/439 | 61/18888 | 0.0163934 | 0.7053288 | -0.3555817 | 0.7623188 | 0.8473953 | 0.7432553 | ITPR1 | 1 |
| GO:0071709 | GO:0071709 | membrane assembly | 1/439 | 61/18888 | 0.0163934 | 0.7053288 | -0.3555817 | 0.7623188 | 0.8473953 | 0.7432553 | CAV2 | 1 |
| GO:0010970 | GO:0010970 | transport along microtubule | 3/439 | 172/18888 | 0.0174419 | 0.7504370 | -0.5071836 | 0.7663257 | 0.8497999 | 0.7453644 | PAFAH1B1/RHOT1/OPA1 | 3 |
| GO:0044272 | GO:0044272 | sulfur compound biosynthetic process | 3/439 | 172/18888 | 0.0174419 | 0.7504370 | -0.5071836 | 0.7663257 | 0.8497999 | 0.7453644 | SLC1A2/TCF7L2/HS3ST3B1 | 3 |
| GO:0006066 | GO:0006066 | alcohol metabolic process | 7/439 | 373/18888 | 0.0187668 | 0.8074407 | -0.5794077 | 0.7672879 | 0.8497999 | 0.7453644 | IPMK/MBTPS1/CYP7B1/REST/SEC14L2/SPTSSA/PLCB1 | 7 |
| GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 2/439 | 119/18888 | 0.0168067 | 0.7231102 | -0.4673984 | 0.7676062 | 0.8497999 | 0.7453644 | ZMIZ1/CD46 | 2 |
| GO:1903707 | GO:1903707 | negative regulation of hemopoiesis | 2/439 | 119/18888 | 0.0168067 | 0.7231102 | -0.4673984 | 0.7676062 | 0.8497999 | 0.7453644 | CDK6/FBN1 | 2 |
| GO:0031330 | GO:0031330 | negative regulation of cellular catabolic process | 4/439 | 224/18888 | 0.0178571 | 0.7683046 | -0.5381042 | 0.7677710 | 0.8497999 | 0.7453644 | MTM1/TAB2/YBX1/CNR1 | 4 |
| GO:0032731 | GO:0032731 | positive regulation of interleukin-1 beta production | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | SMAD3 | 1 |
| GO:0033619 | GO:0033619 | membrane protein proteolysis | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | MBTPS1 | 1 |
| GO:0034113 | GO:0034113 | heterotypic cell-cell adhesion | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | KLF4 | 1 |
| GO:0046824 | GO:0046824 | positive regulation of nucleocytoplasmic transport | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | SMAD3 | 1 |
| GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | APC | 1 |
| GO:0051653 | GO:0051653 | spindle localization | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | PAFAH1B1 | 1 |
| GO:0071715 | GO:0071715 | icosanoid transport | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | IL1A | 1 |
| GO:1900024 | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | DOCK1 | 1 |
| GO:1903670 | GO:1903670 | regulation of sprouting angiogenesis | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | KLF4 | 1 |
| GO:2000351 | GO:2000351 | regulation of endothelial cell apoptotic process | 1/439 | 62/18888 | 0.0161290 | 0.6939525 | -0.3723342 | 0.7678609 | 0.8497999 | 0.7453644 | RGCC | 1 |
| GO:0016241 | GO:0016241 | regulation of macroautophagy | 3/439 | 173/18888 | 0.0173410 | 0.7460993 | -0.5175108 | 0.7697224 | 0.8516258 | 0.7469659 | MTM1/SIRT1/MAPK8 | 3 |
| GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 6/439 | 325/18888 | 0.0184615 | 0.7943087 | -0.5769800 | 0.7699816 | 0.8516784 | 0.7470120 | ZMIZ1/TFRC/PPP3CA/MAP3K8/CD46/IL1A | 6 |
| GO:0006486 | GO:0006486 | protein glycosylation | 4/439 | 225/18888 | 0.0177778 | 0.7648899 | -0.5472669 | 0.7707632 | 0.8518405 | 0.7471542 | OGA/GALNT7/B4GALT1/TET2 | 4 |
| GO:0043413 | GO:0043413 | macromolecule glycosylation | 4/439 | 225/18888 | 0.0177778 | 0.7648899 | -0.5472669 | 0.7707632 | 0.8518405 | 0.7471542 | OGA/GALNT7/B4GALT1/TET2 | 4 |
| GO:0050730 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 4/439 | 225/18888 | 0.0177778 | 0.7648899 | -0.5472669 | 0.7707632 | 0.8518405 | 0.7471542 | RAP2C/EPHA7/HDAC2/PRNP | 4 |
| GO:0002718 | GO:0002718 | regulation of cytokine production involved in immune response | 2/439 | 120/18888 | 0.0166667 | 0.7170843 | -0.4795855 | 0.7716208 | 0.8523201 | 0.7475749 | SIRT1/IRAK3 | 2 |
| GO:0072655 | GO:0072655 | establishment of protein localization to mitochondrion | 2/439 | 120/18888 | 0.0166667 | 0.7170843 | -0.4795855 | 0.7716208 | 0.8523201 | 0.7475749 | UBE2D3/COX18 | 2 |
| GO:0007259 | GO:0007259 | receptor signaling pathway via JAK-STAT | 3/439 | 174/18888 | 0.0172414 | 0.7418113 | -0.5277835 | 0.7730789 | 0.8534435 | 0.7485603 | SOCS6/ADIPOR1/HDAC2 | 3 |
| GO:0051784 | GO:0051784 | negative regulation of nuclear division | 1/439 | 63/18888 | 0.0158730 | 0.6829374 | -0.3888437 | 0.7732741 | 0.8534435 | 0.7485603 | APC | 1 |
| GO:2000117 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 1/439 | 63/18888 | 0.0158730 | 0.6829374 | -0.3888437 | 0.7732741 | 0.8534435 | 0.7485603 | KLF4 | 1 |
| GO:0007163 | GO:0007163 | establishment or maintenance of cell polarity | 4/439 | 226/18888 | 0.0176991 | 0.7615054 | -0.5563921 | 0.7737252 | 0.8537072 | 0.7487915 | DLG5/RAP1B/CDC42BPB/PAFAH1B1 | 4 |
| GO:0002698 | GO:0002698 | negative regulation of immune effector process | 2/439 | 121/18888 | 0.0165289 | 0.7111580 | -0.4916805 | 0.7755748 | 0.8552790 | 0.7501701 | CD46/IRAK3 | 2 |
| GO:1905037 | GO:1905037 | autophagosome organization | 2/439 | 121/18888 | 0.0165289 | 0.7111580 | -0.4916805 | 0.7755748 | 0.8552790 | 0.7501701 | MTM1/RAB33B | 2 |
| GO:0022900 | GO:0022900 | electron transport chain | 3/439 | 175/18888 | 0.0171429 | 0.7375724 | -0.5380023 | 0.7763952 | 0.8559491 | 0.7507579 | PUM2/SRD5A1/NDUFS1 | 3 |
| GO:0010803 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 1/439 | 64/18888 | 0.0156250 | 0.6722665 | -0.4051186 | 0.7785614 | 0.8573977 | 0.7520285 | TANK | 1 |
| GO:0021545 | GO:0021545 | cranial nerve development | 1/439 | 64/18888 | 0.0156250 | 0.6722665 | -0.4051186 | 0.7785614 | 0.8573977 | 0.7520285 | SIX4 | 1 |
| GO:0022617 | GO:0022617 | extracellular matrix disassembly | 1/439 | 64/18888 | 0.0156250 | 0.6722665 | -0.4051186 | 0.7785614 | 0.8573977 | 0.7520285 | ADAMTS5 | 1 |
| GO:0070534 | GO:0070534 | protein K63-linked ubiquitination | 1/439 | 64/18888 | 0.0156250 | 0.6722665 | -0.4051186 | 0.7785614 | 0.8573977 | 0.7520285 | UBE2E3 | 1 |
| GO:0002367 | GO:0002367 | cytokine production involved in immune response | 2/439 | 122/18888 | 0.0163934 | 0.7053288 | -0.5036851 | 0.7794689 | 0.8581622 | 0.7526991 | SIRT1/IRAK3 | 2 |
| GO:0098742 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 5/439 | 279/18888 | 0.0179211 | 0.7710584 | -0.5942822 | 0.7799502 | 0.8584572 | 0.7529578 | PCDH9/CDH4/CADM2/KLF4/CDH19 | 5 |
| GO:0022904 | GO:0022904 | respiratory electron transport chain | 2/439 | 123/18888 | 0.0162602 | 0.6995944 | -0.5156008 | 0.7833038 | 0.8604944 | 0.7547446 | PUM2/NDUFS1 | 2 |
| GO:0071482 | GO:0071482 | cellular response to light stimulus | 2/439 | 123/18888 | 0.0162602 | 0.6995944 | -0.5156008 | 0.7833038 | 0.8604944 | 0.7547446 | SIRT1/YY1 | 2 |
| GO:0032613 | GO:0032613 | interleukin-10 production | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | CD46 | 1 |
| GO:0032653 | GO:0032653 | regulation of interleukin-10 production | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | CD46 | 1 |
| GO:0044091 | GO:0044091 | membrane biogenesis | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | CAV2 | 1 |
| GO:0045682 | GO:0045682 | regulation of epidermis development | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | HEY2 | 1 |
| GO:0046503 | GO:0046503 | glycerolipid catabolic process | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | PLCB1 | 1 |
| GO:0090303 | GO:0090303 | positive regulation of wound healing | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | ENPP4 | 1 |
| GO:1904036 | GO:1904036 | negative regulation of epithelial cell apoptotic process | 1/439 | 65/18888 | 0.0153846 | 0.6619240 | -0.4211667 | 0.7837256 | 0.8604944 | 0.7547446 | TCF7L2 | 1 |
| GO:0044242 | GO:0044242 | cellular lipid catabolic process | 4/439 | 230/18888 | 0.0173913 | 0.7482619 | -0.5925264 | 0.7852731 | 0.8619582 | 0.7560285 | CNR1/PEX5/HADHB/PLCB1 | 4 |
| GO:0002286 | GO:0002286 | T cell activation involved in immune response | 2/439 | 124/18888 | 0.0161290 | 0.6939525 | -0.5274293 | 0.7870801 | 0.8625025 | 0.7565060 | RORA/CD46 | 2 |
| GO:0006413 | GO:0006413 | translational initiation | 2/439 | 124/18888 | 0.0161290 | 0.6939525 | -0.5274293 | 0.7870801 | 0.8625025 | 0.7565060 | PDIK1L/BZW1 | 2 |
| GO:0010951 | GO:0010951 | negative regulation of endopeptidase activity | 2/439 | 124/18888 | 0.0161290 | 0.6939525 | -0.5274293 | 0.7870801 | 0.8625025 | 0.7565060 | SERPINB1/KLF4 | 2 |
| GO:0032479 | GO:0032479 | regulation of type I interferon production | 2/439 | 124/18888 | 0.0161290 | 0.6939525 | -0.5274293 | 0.7870801 | 0.8625025 | 0.7565060 | YY1/TANK | 2 |
| GO:0032606 | GO:0032606 | type I interferon production | 2/439 | 124/18888 | 0.0161290 | 0.6939525 | -0.5274293 | 0.7870801 | 0.8625025 | 0.7565060 | YY1/TANK | 2 |
| GO:0030837 | GO:0030837 | negative regulation of actin filament polymerization | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | SLIT2 | 1 |
| GO:0035773 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | EPHA5 | 1 |
| GO:0042531 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | HDAC2 | 1 |
| GO:0045453 | GO:0045453 | bone resorption | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | TFRC | 1 |
| GO:0048255 | GO:0048255 | mRNA stabilization | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | YBX1 | 1 |
| GO:0050771 | GO:0050771 | negative regulation of axonogenesis | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | EPHA7 | 1 |
| GO:0050994 | GO:0050994 | regulation of lipid catabolic process | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | CNR1 | 1 |
| GO:0070613 | GO:0070613 | regulation of protein processing | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | PRNP | 1 |
| GO:0071806 | GO:0071806 | protein transmembrane transport | 1/439 | 66/18888 | 0.0151515 | 0.6518948 | -0.4369955 | 0.7887697 | 0.8625025 | 0.7565060 | PEX5 | 1 |
| GO:0015718 | GO:0015718 | monocarboxylic acid transport | 3/439 | 179/18888 | 0.0167598 | 0.7210903 | -0.5783518 | 0.7892650 | 0.8628097 | 0.7567753 | SLC16A4/SLC10A4/IL1A | 3 |
| GO:0031331 | GO:0031331 | positive regulation of cellular catabolic process | 8/439 | 432/18888 | 0.0185185 | 0.7967603 | -0.6591875 | 0.7897143 | 0.8630664 | 0.7570005 | PUM2/CNOT2/CNOT6L/YBX1/CPEB3/SIRT1/PUM1/KAT2B | 8 |
| GO:0002824 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2/439 | 125/18888 | 0.0160000 | 0.6884009 | -0.5391721 | 0.7907984 | 0.8637820 | 0.7576282 | TFRC/RIF1 | 2 |
| GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 2/439 | 125/18888 | 0.0160000 | 0.6884009 | -0.5391721 | 0.7907984 | 0.8637820 | 0.7576282 | RORA/ATF2 | 2 |
| GO:0009451 | GO:0009451 | RNA modification | 3/439 | 180/18888 | 0.0166667 | 0.7170843 | -0.5883110 | 0.7923849 | 0.8652800 | 0.7589421 | VIRMA/PUS7/SEPSECS | 3 |
| GO:0006903 | GO:0006903 | vesicle targeting | 1/439 | 67/18888 | 0.0149254 | 0.6421650 | -0.4526121 | 0.7936964 | 0.8660071 | 0.7595799 | PPP6C | 1 |
| GO:0042776 | GO:0042776 | proton motive force-driven mitochondrial ATP synthesis | 1/439 | 67/18888 | 0.0149254 | 0.6421650 | -0.4526121 | 0.7936964 | 0.8660071 | 0.7595799 | NDUFS1 | 1 |
| GO:0060760 | GO:0060760 | positive regulation of response to cytokine stimulus | 1/439 | 67/18888 | 0.0149254 | 0.6421650 | -0.4526121 | 0.7936964 | 0.8660071 | 0.7595799 | PAFAH1B1 | 1 |
| GO:0009142 | GO:0009142 | nucleoside triphosphate biosynthetic process | 2/439 | 126/18888 | 0.0158730 | 0.6829374 | -0.5508306 | 0.7944594 | 0.8663854 | 0.7599117 | ADK/NDUFS1 | 2 |
| GO:0060271 | GO:0060271 | cilium assembly | 7/439 | 385/18888 | 0.0181818 | 0.7822738 | -0.6658055 | 0.7944737 | 0.8663854 | 0.7599117 | RAB11A/CEP120/ARL13B/CEP350/ATMIN/RSPH4A/TTBK2 | 7 |
| GO:0071478 | GO:0071478 | cellular response to radiation | 3/439 | 181/18888 | 0.0165746 | 0.7131225 | -0.5982202 | 0.7954663 | 0.8672328 | 0.7606549 | SIRT1/YY1/TANK | 3 |
| GO:0022618 | GO:0022618 | protein-RNA complex assembly | 4/439 | 234/18888 | 0.0170940 | 0.7354711 | -0.6280909 | 0.7963478 | 0.8679587 | 0.7612916 | SRSF10/PRKRA/SFSWAP/CLNS1A | 4 |
| GO:0070585 | GO:0070585 | protein localization to mitochondrion | 2/439 | 127/18888 | 0.0157480 | 0.6775600 | -0.5624063 | 0.7980637 | 0.8685942 | 0.7618490 | UBE2D3/COX18 | 2 |
| GO:0002704 | GO:0002704 | negative regulation of leukocyte mediated immunity | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | CD46 | 1 |
| GO:0006687 | GO:0006687 | glycosphingolipid metabolic process | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | CREM | 1 |
| GO:0009311 | GO:0009311 | oligosaccharide metabolic process | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | B4GALT1 | 1 |
| GO:0016925 | GO:0016925 | protein sumoylation | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | ZMIZ1 | 1 |
| GO:0032715 | GO:0032715 | negative regulation of interleukin-6 production | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | IRAK3 | 1 |
| GO:0045576 | GO:0045576 | mast cell activation | 1/439 | 68/18888 | 0.0147059 | 0.6327214 | -0.4680234 | 0.7985084 | 0.8685942 | 0.7618490 | CNR1 | 1 |
| GO:0051235 | GO:0051235 | maintenance of location | 6/439 | 337/18888 | 0.0178042 | 0.7660248 | -0.6685418 | 0.7986577 | 0.8685942 | 0.7618490 | FBN1/ITPR1/SIRT1/RYR2/PAFAH1B1/PLCB1 | 6 |
| GO:0045580 | GO:0045580 | regulation of T cell differentiation | 3/439 | 183/18888 | 0.0163934 | 0.7053288 | -0.6178908 | 0.8015149 | 0.8713363 | 0.7642541 | ZMIZ1/CD46/SOS1 | 3 |
| GO:0002708 | GO:0002708 | positive regulation of lymphocyte mediated immunity | 2/439 | 128/18888 | 0.0156250 | 0.6722665 | -0.5739007 | 0.8016121 | 0.8713363 | 0.7642541 | TFRC/RIF1 | 2 |
| GO:0030193 | GO:0030193 | regulation of blood coagulation | 1/439 | 69/18888 | 0.0144928 | 0.6235515 | -0.4832358 | 0.8032085 | 0.8723646 | 0.7651560 | ENPP4 | 1 |
| GO:0044458 | GO:0044458 | motile cilium assembly | 1/439 | 69/18888 | 0.0144928 | 0.6235515 | -0.4832358 | 0.8032085 | 0.8723646 | 0.7651560 | ATMIN | 1 |
| GO:0060191 | GO:0060191 | regulation of lipase activity | 1/439 | 69/18888 | 0.0144928 | 0.6235515 | -0.4832358 | 0.8032085 | 0.8723646 | 0.7651560 | FGFR2 | 1 |
| GO:0006909 | GO:0006909 | phagocytosis | 4/439 | 237/18888 | 0.0168776 | 0.7261613 | -0.6544030 | 0.8043491 | 0.8733677 | 0.7660358 | VAV3/APPL2/DOCK1/PIP5K1A | 4 |
| GO:0002456 | GO:0002456 | T cell mediated immunity | 2/439 | 129/18888 | 0.0155039 | 0.6670551 | -0.5853150 | 0.8051050 | 0.8739527 | 0.7665490 | JAG1/CD46 | 2 |
| GO:0016042 | GO:0016042 | lipid catabolic process | 6/439 | 340/18888 | 0.0176471 | 0.7592657 | -0.6909652 | 0.8053798 | 0.8740152 | 0.7666038 | CNR1/SRD5A1/PEX5/PAFAH1B1/HADHB/PLCB1 | 6 |
| GO:0002548 | GO:0002548 | monocyte chemotaxis | 1/439 | 70/18888 | 0.0142857 | 0.6146437 | -0.4982555 | 0.8077991 | 0.8756960 | 0.7680781 | SLIT2 | 1 |
| GO:0050918 | GO:0050918 | positive chemotaxis | 1/439 | 70/18888 | 0.0142857 | 0.6146437 | -0.4982555 | 0.8077991 | 0.8756960 | 0.7680781 | SMAD3 | 1 |
| GO:0050922 | GO:0050922 | negative regulation of chemotaxis | 1/439 | 70/18888 | 0.0142857 | 0.6146437 | -0.4982555 | 0.8077991 | 0.8756960 | 0.7680781 | SLIT2 | 1 |
| GO:1903317 | GO:1903317 | regulation of protein maturation | 1/439 | 70/18888 | 0.0142857 | 0.6146437 | -0.4982555 | 0.8077991 | 0.8756960 | 0.7680781 | PRNP | 1 |
| GO:0031348 | GO:0031348 | negative regulation of defense response | 5/439 | 291/18888 | 0.0171821 | 0.7392621 | -0.6914431 | 0.8097312 | 0.8775541 | 0.7697078 | ASH1L/RORA/SMAD3/KLF4/IRAK3 | 5 |
| GO:0002706 | GO:0002706 | regulation of lymphocyte mediated immunity | 3/439 | 186/18888 | 0.0161290 | 0.6939525 | -0.6470362 | 0.8103063 | 0.8779409 | 0.7700470 | TFRC/CD46/RIF1 | 3 |
| GO:0016236 | GO:0016236 | macroautophagy | 6/439 | 343/18888 | 0.0174927 | 0.7526249 | -0.7132092 | 0.8119267 | 0.8786630 | 0.7706804 | MTM1/RAB33B/SIRT1/PEX5/WDFY3/MAPK8 | 6 |
| GO:0070646 | GO:0070646 | protein modification by small protein removal | 2/439 | 131/18888 | 0.0152672 | 0.6568711 | -0.6079090 | 0.8119274 | 0.8786630 | 0.7706804 | USP25/TANK | 2 |
| GO:0045600 | GO:0045600 | positive regulation of fat cell differentiation | 1/439 | 71/18888 | 0.0140845 | 0.6059867 | -0.5130884 | 0.8122829 | 0.8786630 | 0.7706804 | CREB1 | 1 |
| GO:0070830 | GO:0070830 | bicellular tight junction assembly | 1/439 | 71/18888 | 0.0140845 | 0.6059867 | -0.5130884 | 0.8122829 | 0.8786630 | 0.7706804 | APC | 1 |
| GO:0071677 | GO:0071677 | positive regulation of mononuclear cell migration | 1/439 | 71/18888 | 0.0140845 | 0.6059867 | -0.5130884 | 0.8122829 | 0.8786630 | 0.7706804 | OXSR1 | 1 |
| GO:1900046 | GO:1900046 | regulation of hemostasis | 1/439 | 71/18888 | 0.0140845 | 0.6059867 | -0.5130884 | 0.8122829 | 0.8786630 | 0.7706804 | ENPP4 | 1 |
| GO:0070085 | GO:0070085 | glycosylation | 4/439 | 241/18888 | 0.0165975 | 0.7141088 | -0.6890205 | 0.8146192 | 0.8803240 | 0.7721372 | OGA/GALNT7/B4GALT1/TET2 | 4 |
| GO:0010466 | GO:0010466 | negative regulation of peptidase activity | 2/439 | 132/18888 | 0.0151515 | 0.6518948 | -0.6190913 | 0.8152582 | 0.8803240 | 0.7721372 | SERPINB1/KLF4 | 2 |
| GO:0030301 | GO:0030301 | cholesterol transport | 2/439 | 132/18888 | 0.0151515 | 0.6518948 | -0.6190913 | 0.8152582 | 0.8803240 | 0.7721372 | SIRT1/SEC24A | 2 |
| GO:0006024 | GO:0006024 | glycosaminoglycan biosynthetic process | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | HS3ST3B1 | 1 |
| GO:0006406 | GO:0006406 | mRNA export from nucleus | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | NXT2 | 1 |
| GO:0006487 | GO:0006487 | protein N-linked glycosylation | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | B4GALT1 | 1 |
| GO:0010822 | GO:0010822 | positive regulation of mitochondrion organization | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | DDHD1 | 1 |
| GO:0032008 | GO:0032008 | positive regulation of TOR signaling | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | SEH1L | 1 |
| GO:0032413 | GO:0032413 | negative regulation of ion transmembrane transporter activity | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | OXSR1 | 1 |
| GO:0032722 | GO:0032722 | positive regulation of chemokine production | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | ADCYAP1 | 1 |
| GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | APPL2 | 1 |
| GO:0051341 | GO:0051341 | regulation of oxidoreductase activity | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | IL1A | 1 |
| GO:1903578 | GO:1903578 | regulation of ATP metabolic process | 1/439 | 72/18888 | 0.0138889 | 0.5975702 | -0.5277400 | 0.8166624 | 0.8803240 | 0.7721372 | KAT2B | 1 |
| GO:0009150 | GO:0009150 | purine ribonucleotide metabolic process | 8/439 | 446/18888 | 0.0179372 | 0.7717499 | -0.7524917 | 0.8173447 | 0.8808235 | 0.7725754 | PDE10A/RORA/PTHLH/GART/OPA1/ADK/KAT2B/NDUFS1 | 8 |
| GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 2/439 | 133/18888 | 0.0150376 | 0.6469933 | -0.6301987 | 0.8185362 | 0.8813380 | 0.7730267 | ZMIZ1/CD46 | 2 |
| GO:0048565 | GO:0048565 | digestive tract development | 2/439 | 133/18888 | 0.0150376 | 0.6469933 | -0.6301987 | 0.8185362 | 0.8813380 | 0.7730267 | SMAD3/FGFR2 | 2 |
| GO:0032640 | GO:0032640 | tumor necrosis factor production | 3/439 | 189/18888 | 0.0158730 | 0.6829374 | -0.6757624 | 0.8187671 | 0.8813380 | 0.7730267 | IL1A/IRAK3/HDAC2 | 3 |
| GO:0032680 | GO:0032680 | regulation of tumor necrosis factor production | 3/439 | 189/18888 | 0.0158730 | 0.6829374 | -0.6757624 | 0.8187671 | 0.8813380 | 0.7730267 | IL1A/IRAK3/HDAC2 | 3 |
| GO:0006520 | GO:0006520 | amino acid metabolic process | 5/439 | 295/18888 | 0.0169492 | 0.7292383 | -0.7230210 | 0.8189172 | 0.8813380 | 0.7730267 | GLUD1/EGLN1/GPT2/SERINC5/GART | 5 |
| GO:0006360 | GO:0006360 | transcription by RNA polymerase I | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | SPTY2D1 | 1 |
| GO:0009988 | GO:0009988 | cell-cell recognition | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | B4GALT1 | 1 |
| GO:0032481 | GO:0032481 | positive regulation of type I interferon production | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | TANK | 1 |
| GO:0045109 | GO:0045109 | intermediate filament organization | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | MTM1 | 1 |
| GO:0071260 | GO:0071260 | cellular response to mechanical stimulus | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | MAPK8 | 1 |
| GO:0170041 | GO:0170041 | non-proteinogenic amino acid metabolic process | 1/439 | 73/18888 | 0.0136986 | 0.5893843 | -0.5422158 | 0.8209398 | 0.8820993 | 0.7736944 | EGLN1 | 1 |
| GO:0008033 | GO:0008033 | tRNA processing | 2/439 | 134/18888 | 0.0149254 | 0.6421650 | -0.6412326 | 0.8217620 | 0.8825115 | 0.7740559 | PUS7/SEPSECS | 2 |
| GO:0045727 | GO:0045727 | positive regulation of translation | 2/439 | 134/18888 | 0.0149254 | 0.6421650 | -0.6412326 | 0.8217620 | 0.8825115 | 0.7740559 | YBX1/CPEB3 | 2 |
| GO:0071826 | GO:0071826 | protein-RNA complex organization | 4/439 | 244/18888 | 0.0163934 | 0.7053288 | -0.7146450 | 0.8220291 | 0.8825627 | 0.7741009 | SRSF10/PRKRA/SFSWAP/CLNS1A | 4 |
| GO:0097696 | GO:0097696 | receptor signaling pathway via STAT | 3/439 | 191/18888 | 0.0157068 | 0.6757862 | -0.6946875 | 0.8242279 | 0.8837567 | 0.7751481 | SOCS6/ADIPOR1/HDAC2 | 3 |
| GO:0009154 | GO:0009154 | purine ribonucleotide catabolic process | 2/439 | 135/18888 | 0.0148148 | 0.6374083 | -0.6521939 | 0.8249364 | 0.8837567 | 0.7751481 | PDE10A/KAT2B | 2 |
| GO:0009064 | GO:0009064 | glutamine family amino acid metabolic process | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | GLUD1 | 1 |
| GO:0033344 | GO:0033344 | cholesterol efflux | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | SIRT1 | 1 |
| GO:0042093 | GO:0042093 | T-helper cell differentiation | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | RORA | 1 |
| GO:0050818 | GO:0050818 | regulation of coagulation | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | ENPP4 | 1 |
| GO:0051881 | GO:0051881 | regulation of mitochondrial membrane potential | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | NDUFS1 | 1 |
| GO:0072678 | GO:0072678 | T cell migration | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | OXSR1 | 1 |
| GO:1905818 | GO:1905818 | regulation of chromosome separation | 1/439 | 74/18888 | 0.0135135 | 0.5814197 | -0.5565208 | 0.8251178 | 0.8837567 | 0.7751481 | APC | 1 |
| GO:0022604 | GO:0022604 | regulation of cell morphogenesis | 4/439 | 246/18888 | 0.0162602 | 0.6995944 | -0.7315712 | 0.8268323 | 0.8853574 | 0.7765521 | SYT4/PHIP/SH3KBP1/PAFAH1B1 | 4 |
| GO:0007586 | GO:0007586 | digestion | 2/439 | 136/18888 | 0.0147059 | 0.6327214 | -0.6630841 | 0.8280600 | 0.8862003 | 0.7772914 | PPP3CA/KCNN4 | 2 |
| GO:0030833 | GO:0030833 | regulation of actin filament polymerization | 2/439 | 136/18888 | 0.0147059 | 0.6327214 | -0.6630841 | 0.8280600 | 0.8862003 | 0.7772914 | SLIT2/MEGF9 | 2 |
| GO:0043489 | GO:0043489 | RNA stabilization | 1/439 | 75/18888 | 0.0133333 | 0.5736674 | -0.5706600 | 0.8291984 | 0.8867112 | 0.7777396 | YBX1 | 1 |
| GO:0045123 | GO:0045123 | cellular extravasation | 1/439 | 75/18888 | 0.0133333 | 0.5736674 | -0.5706600 | 0.8291984 | 0.8867112 | 0.7777396 | PLCB1 | 1 |
| GO:1901019 | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 1/439 | 75/18888 | 0.0133333 | 0.5736674 | -0.5706600 | 0.8291984 | 0.8867112 | 0.7777396 | RYR2 | 1 |
| GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 5/439 | 301/18888 | 0.0166113 | 0.7147019 | -0.7696703 | 0.8320254 | 0.8883764 | 0.7792001 | TFRC/DOCK10/RORA/CD46/RIF1 | 5 |
| GO:0002377 | GO:0002377 | immunoglobulin production | 3/439 | 194/18888 | 0.0154639 | 0.6653359 | -0.7227468 | 0.8321559 | 0.8883764 | 0.7792001 | TFRC/YY1/RIF1 | 3 |
| GO:0071706 | GO:0071706 | tumor necrosis factor superfamily cytokine production | 3/439 | 194/18888 | 0.0154639 | 0.6653359 | -0.7227468 | 0.8321559 | 0.8883764 | 0.7792001 | IL1A/IRAK3/HDAC2 | 3 |
| GO:1903555 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 3/439 | 194/18888 | 0.0154639 | 0.6653359 | -0.7227468 | 0.8321559 | 0.8883764 | 0.7792001 | IL1A/IRAK3/HDAC2 | 3 |
| GO:0002294 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | RORA | 1 |
| GO:0006023 | GO:0006023 | aminoglycan biosynthetic process | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | HS3ST3B1 | 1 |
| GO:0006081 | GO:0006081 | cellular aldehyde metabolic process | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | REST | 1 |
| GO:0015986 | GO:0015986 | proton motive force-driven ATP synthesis | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | NDUFS1 | 1 |
| GO:0031343 | GO:0031343 | positive regulation of cell killing | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | MAPK8 | 1 |
| GO:0051057 | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | SOS1 | 1 |
| GO:1902373 | GO:1902373 | negative regulation of mRNA catabolic process | 1/439 | 76/18888 | 0.0131579 | 0.5661192 | -0.5846381 | 0.8331840 | 0.8883764 | 0.7792001 | YBX1 | 1 |
| GO:0007188 | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4/439 | 249/18888 | 0.0160643 | 0.6911656 | -0.7567308 | 0.8338355 | 0.8888356 | 0.7796028 | CNR1/ADCYAP1/PTHLH/CACNA1D | 4 |
| GO:0051260 | GO:0051260 | protein homooligomerization | 3/439 | 195/18888 | 0.0153846 | 0.6619240 | -0.7320143 | 0.8347295 | 0.8895528 | 0.7802319 | APPL2/SLC1A2/PRNP | 3 |
| GO:0032102 | GO:0032102 | negative regulation of response to external stimulus | 8/439 | 456/18888 | 0.0175439 | 0.7548256 | -0.8175206 | 0.8353185 | 0.8899449 | 0.7805758 | GRIN3A/ASH1L/RORA/SMAD3/SLIT2/KLF4/IRAK3/AJAP1 | 8 |
| GO:0009144 | GO:0009144 | purine nucleoside triphosphate metabolic process | 4/439 | 250/18888 | 0.0160000 | 0.6884009 | -0.7650571 | 0.8361170 | 0.8899918 | 0.7806170 | OPA1/ADK/KAT2B/NDUFS1 | 4 |
| GO:0002287 | GO:0002287 | alpha-beta T cell activation involved in immune response | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | RORA | 1 |
| GO:0002293 | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | RORA | 1 |
| GO:0007585 | GO:0007585 | respiratory gaseous exchange by respiratory system | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | NR4A2 | 1 |
| GO:0043536 | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | SIRT1 | 1 |
| GO:0055117 | GO:0055117 | regulation of cardiac muscle contraction | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | RYR2 | 1 |
| GO:0120192 | GO:0120192 | tight junction assembly | 1/439 | 77/18888 | 0.0129870 | 0.5587670 | -0.5984595 | 0.8370769 | 0.8899918 | 0.7806170 | APC | 1 |
| GO:0061982 | GO:0061982 | meiosis I cell cycle process | 2/439 | 139/18888 | 0.0143885 | 0.6190656 | -0.6953379 | 0.8371320 | 0.8899918 | 0.7806170 | CDC25C/FOXJ3 | 2 |
| GO:0008360 | GO:0008360 | regulation of cell shape | 2/439 | 140/18888 | 0.0142857 | 0.6146437 | -0.7059540 | 0.8400586 | 0.8924469 | 0.7827704 | PHIP/SH3KBP1 | 2 |
| GO:0032388 | GO:0032388 | positive regulation of intracellular transport | 2/439 | 140/18888 | 0.0142857 | 0.6146437 | -0.7059540 | 0.8400586 | 0.8924469 | 0.7827704 | SMAD3/PDCD10 | 2 |
| GO:0010506 | GO:0010506 | regulation of autophagy | 6/439 | 357/18888 | 0.0168067 | 0.7231102 | -0.8147399 | 0.8402235 | 0.8924469 | 0.7827704 | MTM1/TAB2/DRAM1/ITPR1/SIRT1/MAPK8 | 6 |
| GO:0002263 | GO:0002263 | cell activation involved in immune response | 5/439 | 305/18888 | 0.0163934 | 0.7053288 | -0.8003078 | 0.8403284 | 0.8924469 | 0.7827704 | TFRC/DOCK10/RORA/CD46/RIF1 | 5 |
| GO:0032720 | GO:0032720 | negative regulation of tumor necrosis factor production | 1/439 | 78/18888 | 0.0128205 | 0.5516033 | -0.6121286 | 0.8408791 | 0.8925607 | 0.7828701 | IRAK3 | 1 |
| GO:0042509 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1/439 | 78/18888 | 0.0128205 | 0.5516033 | -0.6121286 | 0.8408791 | 0.8925607 | 0.7828701 | HDAC2 | 1 |
| GO:0009261 | GO:0009261 | ribonucleotide catabolic process | 2/439 | 141/18888 | 0.0141844 | 0.6102845 | -0.7165041 | 0.8429375 | 0.8945096 | 0.7845796 | PDE10A/KAT2B | 2 |
| GO:0051607 | GO:0051607 | defense response to virus | 5/439 | 307/18888 | 0.0162866 | 0.7007338 | -0.8154918 | 0.8443521 | 0.8957746 | 0.7856891 | HCFC2/SERINC5/DDX17/IRF2/TANK | 5 |
| GO:0016239 | GO:0016239 | positive regulation of macroautophagy | 1/439 | 79/18888 | 0.0126582 | 0.5446210 | -0.6256494 | 0.8445928 | 0.8957937 | 0.7857058 | SIRT1 | 1 |
| GO:0044782 | GO:0044782 | cilium organization | 7/439 | 412/18888 | 0.0169903 | 0.7310082 | -0.8515515 | 0.8467797 | 0.8978765 | 0.7875327 | RAB11A/CEP120/ARL13B/CEP350/ATMIN/RSPH4A/TTBK2 | 7 |
| GO:0002534 | GO:0002534 | cytokine production involved in inflammatory response | 1/439 | 80/18888 | 0.0125000 | 0.5378132 | -0.6390260 | 0.8482200 | 0.8982203 | 0.7878342 | APPL2 | 1 |
| GO:0032272 | GO:0032272 | negative regulation of protein polymerization | 1/439 | 80/18888 | 0.0125000 | 0.5378132 | -0.6390260 | 0.8482200 | 0.8982203 | 0.7878342 | SLIT2 | 1 |
| GO:0042440 | GO:0042440 | pigment metabolic process | 1/439 | 80/18888 | 0.0125000 | 0.5378132 | -0.6390260 | 0.8482200 | 0.8982203 | 0.7878342 | ZEB2 | 1 |
| GO:1900015 | GO:1900015 | regulation of cytokine production involved in inflammatory response | 1/439 | 80/18888 | 0.0125000 | 0.5378132 | -0.6390260 | 0.8482200 | 0.8982203 | 0.7878342 | APPL2 | 1 |
| GO:1903556 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 1/439 | 80/18888 | 0.0125000 | 0.5378132 | -0.6390260 | 0.8482200 | 0.8982203 | 0.7878342 | IRAK3 | 1 |
| GO:1903900 | GO:1903900 | regulation of viral life cycle | 2/439 | 143/18888 | 0.0139860 | 0.6017490 | -0.7374107 | 0.8485550 | 0.8983386 | 0.7879380 | HMGA2/PROX1 | 2 |
| GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 5/439 | 310/18888 | 0.0161290 | 0.6939525 | -0.8381032 | 0.8502310 | 0.8998762 | 0.7892867 | TFRC/SIRT1/IRAK3/YY1/RIF1 | 5 |
| GO:0006195 | GO:0006195 | purine nucleotide catabolic process | 2/439 | 144/18888 | 0.0138889 | 0.5975702 | -0.7477691 | 0.8512947 | 0.9004368 | 0.7897783 | PDE10A/KAT2B | 2 |
| GO:0002720 | GO:0002720 | positive regulation of cytokine production involved in immune response | 1/439 | 81/18888 | 0.0123457 | 0.5311735 | -0.6522622 | 0.8517627 | 0.9004368 | 0.7897783 | SIRT1 | 1 |
| GO:0019233 | GO:0019233 | sensory perception of pain | 1/439 | 81/18888 | 0.0123457 | 0.5311735 | -0.6522622 | 0.8517627 | 0.9004368 | 0.7897783 | PNOC | 1 |
| GO:0051701 | GO:0051701 | biological process involved in interaction with host | 3/439 | 202/18888 | 0.0148515 | 0.6389860 | -0.7957358 | 0.8518111 | 0.9004368 | 0.7897783 | TFRC/CAV2/CD46 | 3 |
| GO:0009259 | GO:0009259 | ribonucleotide metabolic process | 8/439 | 466/18888 | 0.0171674 | 0.7386276 | -0.8812754 | 0.8518794 | 0.9004368 | 0.7897783 | PDE10A/RORA/PTHLH/GART/OPA1/ADK/KAT2B/NDUFS1 | 8 |
| GO:0051259 | GO:0051259 | protein complex oligomerization | 4/439 | 258/18888 | 0.0155039 | 0.6670551 | -0.8306213 | 0.8534418 | 0.9018513 | 0.7910190 | APPL2/SLC1A2/OPA1/PRNP | 4 |
| GO:0015918 | GO:0015918 | sterol transport | 2/439 | 145/18888 | 0.0137931 | 0.5934491 | -0.7580655 | 0.8539893 | 0.9019561 | 0.7911109 | SIRT1/SEC24A | 2 |
| GO:0055123 | GO:0055123 | digestive system development | 2/439 | 145/18888 | 0.0137931 | 0.5934491 | -0.7580655 | 0.8539893 | 0.9019561 | 0.7911109 | SMAD3/FGFR2 | 2 |
| GO:0007260 | GO:0007260 | tyrosine phosphorylation of STAT protein | 1/439 | 82/18888 | 0.0121951 | 0.5246958 | -0.6653615 | 0.8552229 | 0.9030220 | 0.7920458 | HDAC2 | 1 |
| GO:0006289 | GO:0006289 | nucleotide-excision repair | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | SIRT1 | 1 |
| GO:0031424 | GO:0031424 | keratinization | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | IL1A | 1 |
| GO:0032414 | GO:0032414 | positive regulation of ion transmembrane transporter activity | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | RYR2 | 1 |
| GO:0051279 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | RYR2 | 1 |
| GO:0060337 | GO:0060337 | type I interferon-mediated signaling pathway | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | TANK | 1 |
| GO:0120193 | GO:0120193 | tight junction organization | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | APC | 1 |
| GO:0150076 | GO:0150076 | neuroinflammatory response | 1/439 | 83/18888 | 0.0120482 | 0.5183742 | -0.6783276 | 0.8586025 | 0.9049284 | 0.7937179 | ZEB2 | 1 |
| GO:0031333 | GO:0031333 | negative regulation of protein-containing complex assembly | 2/439 | 147/18888 | 0.0136054 | 0.5853749 | -0.7784759 | 0.8592454 | 0.9053688 | 0.7941042 | SLIT2/PEX5 | 2 |
| GO:0032259 | GO:0032259 | methylation | 4/439 | 262/18888 | 0.0152672 | 0.6568711 | -0.8627312 | 0.8615067 | 0.9074566 | 0.7959355 | VIRMA/ASH1L/MECOM/GSPT1 | 4 |
| GO:0002437 | GO:0002437 | inflammatory response to antigenic stimulus | 1/439 | 84/18888 | 0.0119048 | 0.5122031 | -0.6911637 | 0.8619034 | 0.9074566 | 0.7959355 | CNR1 | 1 |
| GO:0071357 | GO:0071357 | cellular response to type I interferon | 1/439 | 84/18888 | 0.0119048 | 0.5122031 | -0.6911637 | 0.8619034 | 0.9074566 | 0.7959355 | TANK | 1 |
| GO:0033157 | GO:0033157 | regulation of intracellular protein transport | 2/439 | 149/18888 | 0.0134228 | 0.5775175 | -0.7986490 | 0.8643282 | 0.9097715 | 0.7979659 | SMAD3/PDCD10 | 2 |
| GO:0016064 | GO:0016064 | immunoglobulin mediated immune response | 3/439 | 208/18888 | 0.0144231 | 0.6205537 | -0.8488303 | 0.8652091 | 0.9104606 | 0.7985703 | TFRC/CD46/RIF1 | 3 |
| GO:0002705 | GO:0002705 | positive regulation of leukocyte mediated immunity | 2/439 | 150/18888 | 0.0133333 | 0.5736674 | -0.8086486 | 0.8668060 | 0.9119026 | 0.7998351 | TFRC/RIF1 | 2 |
| GO:0044282 | GO:0044282 | small molecule catabolic process | 6/439 | 373/18888 | 0.0160858 | 0.6920921 | -0.9264901 | 0.8682509 | 0.9131839 | 0.8009589 | GLUD1/CNR1/GPT2/PEX5/ENPP4/HADHB | 6 |
| GO:0009141 | GO:0009141 | nucleoside triphosphate metabolic process | 4/439 | 266/18888 | 0.0150376 | 0.6469933 | -0.8944126 | 0.8691902 | 0.9138956 | 0.8015831 | OPA1/ADK/KAT2B/NDUFS1 | 4 |
| GO:0007018 | GO:0007018 | microtubule-based movement | 7/439 | 426/18888 | 0.0164319 | 0.7069845 | -0.9435900 | 0.8693818 | 0.9138956 | 0.8015831 | ASH1L/RSPH4A/KIF2A/APC/PAFAH1B1/RHOT1/OPA1 | 7 |
| GO:0009152 | GO:0009152 | purine ribonucleotide biosynthetic process | 3/439 | 211/18888 | 0.0142180 | 0.6117307 | -0.8748792 | 0.8715004 | 0.9158834 | 0.8033266 | GART/ADK/NDUFS1 | 3 |
| GO:0019693 | GO:0019693 | ribose phosphate metabolic process | 8/439 | 480/18888 | 0.0166667 | 0.7170843 | -0.9685047 | 0.8728028 | 0.9170127 | 0.8043171 | PDE10A/RORA/PTHLH/GART/OPA1/ADK/KAT2B/NDUFS1 | 8 |
| GO:0019724 | GO:0019724 | B cell mediated immunity | 3/439 | 212/18888 | 0.0141509 | 0.6088451 | -0.8834909 | 0.8735392 | 0.9172074 | 0.8044880 | TFRC/CD46/RIF1 | 3 |
| GO:0033627 | GO:0033627 | cell adhesion mediated by integrin | 1/439 | 88/18888 | 0.0113636 | 0.4889211 | -0.7412722 | 0.8743558 | 0.9172074 | 0.8044880 | FBN1 | 1 |
| GO:0045185 | GO:0045185 | maintenance of protein location | 1/439 | 88/18888 | 0.0113636 | 0.4889211 | -0.7412722 | 0.8743558 | 0.9172074 | 0.8044880 | FBN1 | 1 |
| GO:0045824 | GO:0045824 | negative regulation of innate immune response | 1/439 | 88/18888 | 0.0113636 | 0.4889211 | -0.7412722 | 0.8743558 | 0.9172074 | 0.8044880 | IRAK3 | 1 |
| GO:1901264 | GO:1901264 | carbohydrate derivative transport | 1/439 | 88/18888 | 0.0113636 | 0.4889211 | -0.7412722 | 0.8743558 | 0.9172074 | 0.8044880 | SLC35D1 | 1 |
| GO:1902369 | GO:1902369 | negative regulation of RNA catabolic process | 1/439 | 88/18888 | 0.0113636 | 0.4889211 | -0.7412722 | 0.8743558 | 0.9172074 | 0.8044880 | YBX1 | 1 |
| GO:0008064 | GO:0008064 | regulation of actin polymerization or depolymerization | 2/439 | 154/18888 | 0.0129870 | 0.5587670 | -0.8480871 | 0.8763080 | 0.9187762 | 0.8058640 | SLIT2/MEGF9 | 2 |
| GO:0030010 | GO:0030010 | establishment of cell polarity | 2/439 | 154/18888 | 0.0129870 | 0.5587670 | -0.8480871 | 0.8763080 | 0.9187762 | 0.8058640 | RAP1B/PAFAH1B1 | 2 |
| GO:0016101 | GO:0016101 | diterpenoid metabolic process | 1/439 | 89/18888 | 0.0112360 | 0.4834276 | -0.7535050 | 0.8772897 | 0.9195660 | 0.8065567 | SRD5A1 | 1 |
| GO:0007286 | GO:0007286 | spermatid development | 3/439 | 214/18888 | 0.0140187 | 0.6031550 | -0.9006094 | 0.8775311 | 0.9195795 | 0.8065685 | STRBP/EPC1/PAFAH1B1 | 3 |
| GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 3/439 | 215/18888 | 0.0139535 | 0.6003496 | -0.9091169 | 0.8794850 | 0.9213696 | 0.8081387 | ZMIZ1/CD46/SOS1 | 3 |
| GO:0006096 | GO:0006096 | glycolytic process | 1/439 | 90/18888 | 0.0111111 | 0.4780562 | -0.7656257 | 0.8801553 | 0.9213696 | 0.8081387 | KAT2B | 1 |
| GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1/439 | 90/18888 | 0.0111111 | 0.4780562 | -0.7656257 | 0.8801553 | 0.9213696 | 0.8081387 | APC | 1 |
| GO:0034340 | GO:0034340 | response to type I interferon | 1/439 | 90/18888 | 0.0111111 | 0.4780562 | -0.7656257 | 0.8801553 | 0.9213696 | 0.8081387 | TANK | 1 |
| GO:1901136 | GO:1901136 | carbohydrate derivative catabolic process | 4/439 | 273/18888 | 0.0146520 | 0.6304038 | -0.9488655 | 0.8817568 | 0.9228061 | 0.8093986 | OGA/PDE10A/KAT2B/ENPP4 | 4 |
| GO:0001510 | GO:0001510 | RNA methylation | 1/439 | 91/18888 | 0.0109890 | 0.4728028 | -0.7776369 | 0.8829541 | 0.9234081 | 0.8099266 | VIRMA | 1 |
| GO:1900542 | GO:1900542 | regulation of purine nucleotide metabolic process | 1/439 | 91/18888 | 0.0109890 | 0.4728028 | -0.7776369 | 0.8829541 | 0.9234081 | 0.8099266 | KAT2B | 1 |
| GO:0030832 | GO:0030832 | regulation of actin filament length | 2/439 | 157/18888 | 0.0127389 | 0.5480899 | -0.8770992 | 0.8830205 | 0.9234081 | 0.8099266 | SLIT2/MEGF9 | 2 |
| GO:1903046 | GO:1903046 | meiotic cell cycle process | 3/439 | 218/18888 | 0.0137615 | 0.5920879 | -0.9344369 | 0.8851814 | 0.9249954 | 0.8113188 | CDC25C/FOXJ3/PLCB1 | 3 |
| GO:0006140 | GO:0006140 | regulation of nucleotide metabolic process | 1/439 | 92/18888 | 0.0108696 | 0.4676637 | -0.7895409 | 0.8856877 | 0.9249954 | 0.8113188 | KAT2B | 1 |
| GO:0032411 | GO:0032411 | positive regulation of transporter activity | 1/439 | 92/18888 | 0.0108696 | 0.4676637 | -0.7895409 | 0.8856877 | 0.9249954 | 0.8113188 | RYR2 | 1 |
| GO:0046032 | GO:0046032 | ADP catabolic process | 1/439 | 92/18888 | 0.0108696 | 0.4676637 | -0.7895409 | 0.8856877 | 0.9249954 | 0.8113188 | KAT2B | 1 |
| GO:0051262 | GO:0051262 | protein tetramerization | 1/439 | 92/18888 | 0.0108696 | 0.4676637 | -0.7895409 | 0.8856877 | 0.9249954 | 0.8113188 | APPL2 | 1 |
| GO:0002460 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6/439 | 385/18888 | 0.0155844 | 0.6705204 | -1.0075467 | 0.8864889 | 0.9253518 | 0.8116314 | TFRC/MEF2C/RORA/JAG1/CD46/RIF1 | 6 |
| GO:0002697 | GO:0002697 | regulation of immune effector process | 6/439 | 385/18888 | 0.0155844 | 0.6705204 | -1.0075467 | 0.8864889 | 0.9253518 | 0.8116314 | TFRC/APPL2/SIRT1/CD46/IRAK3/RIF1 | 6 |
| GO:0006405 | GO:0006405 | RNA export from nucleus | 1/439 | 93/18888 | 0.0107527 | 0.4626350 | -0.8013403 | 0.8883576 | 0.9261013 | 0.8122888 | NXT2 | 1 |
| GO:0050886 | GO:0050886 | endocrine process | 1/439 | 93/18888 | 0.0107527 | 0.4626350 | -0.8013403 | 0.8883576 | 0.9261013 | 0.8122888 | CRHBP | 1 |
| GO:0051899 | GO:0051899 | membrane depolarization | 1/439 | 93/18888 | 0.0107527 | 0.4626350 | -0.8013403 | 0.8883576 | 0.9261013 | 0.8122888 | CACNA1D | 1 |
| GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1/439 | 93/18888 | 0.0107527 | 0.4626350 | -0.8013403 | 0.8883576 | 0.9261013 | 0.8122888 | APC | 1 |
| GO:1903432 | GO:1903432 | regulation of TORC1 signaling | 1/439 | 93/18888 | 0.0107527 | 0.4626350 | -0.8013403 | 0.8883576 | 0.9261013 | 0.8122888 | SEH1L | 1 |
| GO:0006261 | GO:0006261 | DNA-templated DNA replication | 2/439 | 160/18888 | 0.0125000 | 0.5378132 | -0.9056474 | 0.8893951 | 0.9269427 | 0.8130268 | E2F8/PRIM2 | 2 |
| GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 1/439 | 94/18888 | 0.0106383 | 0.4577134 | -0.8130374 | 0.8909652 | 0.9273782 | 0.8134088 | APC | 1 |
| GO:0019364 | GO:0019364 | pyridine nucleotide catabolic process | 1/439 | 94/18888 | 0.0106383 | 0.4577134 | -0.8130374 | 0.8909652 | 0.9273782 | 0.8134088 | KAT2B | 1 |
| GO:0019646 | GO:0019646 | aerobic electron transport chain | 1/439 | 94/18888 | 0.0106383 | 0.4577134 | -0.8130374 | 0.8909652 | 0.9273782 | 0.8134088 | NDUFS1 | 1 |
| GO:0019915 | GO:0019915 | lipid storage | 1/439 | 94/18888 | 0.0106383 | 0.4577134 | -0.8130374 | 0.8909652 | 0.9273782 | 0.8134088 | SIRT1 | 1 |
| GO:0043367 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 1/439 | 94/18888 | 0.0106383 | 0.4577134 | -0.8130374 | 0.8909652 | 0.9273782 | 0.8134088 | RORA | 1 |
| GO:0048515 | GO:0048515 | spermatid differentiation | 3/439 | 222/18888 | 0.0135135 | 0.5814197 | -0.9677362 | 0.8924032 | 0.9286347 | 0.8145109 | STRBP/EPC1/PAFAH1B1 | 3 |
| GO:0009137 | GO:0009137 | purine nucleoside diphosphate catabolic process | 1/439 | 95/18888 | 0.0105263 | 0.4528953 | -0.8246345 | 0.8935121 | 0.9288279 | 0.8146803 | KAT2B | 1 |
| GO:0009181 | GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1/439 | 95/18888 | 0.0105263 | 0.4528953 | -0.8246345 | 0.8935121 | 0.9288279 | 0.8146803 | KAT2B | 1 |
| GO:0030641 | GO:0030641 | regulation of cellular pH | 1/439 | 95/18888 | 0.0105263 | 0.4528953 | -0.8246345 | 0.8935121 | 0.9288279 | 0.8146803 | MAPK1 | 1 |
| GO:0046785 | GO:0046785 | microtubule polymerization | 1/439 | 95/18888 | 0.0105263 | 0.4528953 | -0.8246345 | 0.8935121 | 0.9288279 | 0.8146803 | RANBP9 | 1 |
| GO:0006364 | GO:0006364 | rRNA processing | 3/439 | 224/18888 | 0.0133929 | 0.5762284 | -0.9841942 | 0.8958594 | 0.9306925 | 0.8163157 | DDX17/KAT2B/NOP58 | 3 |
| GO:0003073 | GO:0003073 | regulation of systemic arterial blood pressure | 1/439 | 96/18888 | 0.0104167 | 0.4481777 | -0.8361337 | 0.8959997 | 0.9306925 | 0.8163157 | AR | 1 |
| GO:0032410 | GO:0032410 | negative regulation of transporter activity | 1/439 | 96/18888 | 0.0104167 | 0.4481777 | -0.8361337 | 0.8959997 | 0.9306925 | 0.8163157 | OXSR1 | 1 |
| GO:0050731 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 2/439 | 164/18888 | 0.0121951 | 0.5246958 | -0.9430215 | 0.8973944 | 0.9319007 | 0.8173755 | HDAC2/PRNP | 2 |
| GO:0035082 | GO:0035082 | axoneme assembly | 1/439 | 97/18888 | 0.0103093 | 0.4435573 | -0.8475371 | 0.8984292 | 0.9322535 | 0.8176849 | RSPH4A | 1 |
| GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 1/439 | 97/18888 | 0.0103093 | 0.4435573 | -0.8475371 | 0.8984292 | 0.9322535 | 0.8176849 | APC | 1 |
| GO:0072526 | GO:0072526 | pyridine-containing compound catabolic process | 1/439 | 97/18888 | 0.0103093 | 0.4435573 | -0.8475371 | 0.8984292 | 0.9322535 | 0.8176849 | KAT2B | 1 |
| GO:0009260 | GO:0009260 | ribonucleotide biosynthetic process | 3/439 | 226/18888 | 0.0132743 | 0.5711291 | -1.0005276 | 0.8992157 | 0.9326849 | 0.8180633 | GART/ADK/NDUFS1 | 3 |
| GO:0060294 | GO:0060294 | cilium movement involved in cell motility | 2/439 | 165/18888 | 0.0121212 | 0.5215158 | -0.9522460 | 0.8993085 | 0.9326849 | 0.8180633 | ASH1L/RSPH4A | 2 |
| GO:0006576 | GO:0006576 | biogenic amine metabolic process | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | NR4A2 | 1 |
| GO:0006942 | GO:0006942 | regulation of striated muscle contraction | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | RYR2 | 1 |
| GO:0009191 | GO:0009191 | ribonucleoside diphosphate catabolic process | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | KAT2B | 1 |
| GO:0030101 | GO:0030101 | natural killer cell activation | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | SP3 | 1 |
| GO:0042147 | GO:0042147 | retrograde transport, endosome to Golgi | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | WIPF3 | 1 |
| GO:0046031 | GO:0046031 | ADP metabolic process | 1/439 | 98/18888 | 0.0102041 | 0.4390312 | -0.8588468 | 0.9008021 | 0.9327915 | 0.8181568 | KAT2B | 1 |
| GO:2000058 | GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 2/439 | 166/18888 | 0.0120482 | 0.5183742 | -0.9614241 | 0.9011892 | 0.9329523 | 0.8182978 | MTM1/L3MBTL3 | 2 |
| GO:1903050 | GO:1903050 | regulation of proteolysis involved in protein catabolic process | 3/439 | 228/18888 | 0.0131579 | 0.5661192 | -1.0167388 | 0.9024744 | 0.9339897 | 0.8192077 | MTM1/L3MBTL3/USP25 | 3 |
| GO:0009166 | GO:0009166 | nucleotide catabolic process | 2/439 | 167/18888 | 0.0119760 | 0.5152701 | -0.9705565 | 0.9030372 | 0.9339897 | 0.8192077 | PDE10A/KAT2B | 2 |
| GO:0030041 | GO:0030041 | actin filament polymerization | 2/439 | 167/18888 | 0.0119760 | 0.5152701 | -0.9705565 | 0.9030372 | 0.9339897 | 0.8192077 | SLIT2/MEGF9 | 2 |
| GO:0038202 | GO:0038202 | TORC1 signaling | 1/439 | 99/18888 | 0.0101010 | 0.4345965 | -0.8700647 | 0.9031197 | 0.9339897 | 0.8192077 | SEH1L | 1 |
| GO:0050792 | GO:0050792 | regulation of viral process | 2/439 | 168/18888 | 0.0119048 | 0.5122031 | -0.9796436 | 0.9048530 | 0.9353691 | 0.8204176 | HMGA2/PROX1 | 2 |
| GO:0006304 | GO:0006304 | DNA modification | 1/439 | 100/18888 | 0.0100000 | 0.4302506 | -0.8811928 | 0.9053833 | 0.9353691 | 0.8204176 | TET2 | 1 |
| GO:0006721 | GO:0006721 | terpenoid metabolic process | 1/439 | 100/18888 | 0.0100000 | 0.4302506 | -0.8811928 | 0.9053833 | 0.9353691 | 0.8204176 | SRD5A1 | 1 |
| GO:0050764 | GO:0050764 | regulation of phagocytosis | 1/439 | 100/18888 | 0.0100000 | 0.4302506 | -0.8811928 | 0.9053833 | 0.9353691 | 0.8204176 | APPL2 | 1 |
| GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 2/439 | 169/18888 | 0.0118343 | 0.5091723 | -0.9886862 | 0.9066370 | 0.9364238 | 0.8213427 | ADCYAP1/RYR2 | 2 |
| GO:0006754 | GO:0006754 | ATP biosynthetic process | 1/439 | 101/18888 | 0.0099010 | 0.4259907 | -0.8922330 | 0.9075941 | 0.9369314 | 0.8217880 | NDUFS1 | 1 |
| GO:0032755 | GO:0032755 | positive regulation of interleukin-6 production | 1/439 | 101/18888 | 0.0099010 | 0.4259907 | -0.8922330 | 0.9075941 | 0.9369314 | 0.8217880 | IL1A | 1 |
| GO:0001539 | GO:0001539 | cilium or flagellum-dependent cell motility | 2/439 | 170/18888 | 0.0117647 | 0.5061771 | -0.9976846 | 0.9083897 | 0.9372270 | 0.8220472 | ASH1L/RSPH4A | 2 |
| GO:0060285 | GO:0060285 | cilium-dependent cell motility | 2/439 | 170/18888 | 0.0117647 | 0.5061771 | -0.9976846 | 0.9083897 | 0.9372270 | 0.8220472 | ASH1L/RSPH4A | 2 |
| GO:0051321 | GO:0051321 | meiotic cell cycle | 4/439 | 291/18888 | 0.0137457 | 0.5914097 | -1.0835287 | 0.9093663 | 0.9372270 | 0.8220472 | SMC3/CDC25C/FOXJ3/PLCB1 | 4 |
| GO:0009134 | GO:0009134 | nucleoside diphosphate catabolic process | 1/439 | 102/18888 | 0.0098039 | 0.4218143 | -0.9031869 | 0.9097534 | 0.9372270 | 0.8220472 | KAT2B | 1 |
| GO:0032677 | GO:0032677 | regulation of interleukin-8 production | 1/439 | 102/18888 | 0.0098039 | 0.4218143 | -0.9031869 | 0.9097534 | 0.9372270 | 0.8220472 | KLF4 | 1 |
| GO:0042773 | GO:0042773 | ATP synthesis coupled electron transport | 1/439 | 102/18888 | 0.0098039 | 0.4218143 | -0.9031869 | 0.9097534 | 0.9372270 | 0.8220472 | NDUFS1 | 1 |
| GO:0042775 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1/439 | 102/18888 | 0.0098039 | 0.4218143 | -0.9031869 | 0.9097534 | 0.9372270 | 0.8220472 | NDUFS1 | 1 |
| GO:2000060 | GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 1/439 | 102/18888 | 0.0098039 | 0.4218143 | -0.9031869 | 0.9097534 | 0.9372270 | 0.8220472 | L3MBTL3 | 1 |
| GO:0051168 | GO:0051168 | nuclear export | 2/439 | 171/18888 | 0.0116959 | 0.5032170 | -1.0066395 | 0.9101116 | 0.9372270 | 0.8220472 | WASHC4/NXT2 | 2 |
| GO:0046390 | GO:0046390 | ribose phosphate biosynthetic process | 3/439 | 233/18888 | 0.0128755 | 0.5539707 | -1.0567471 | 0.9102095 | 0.9372270 | 0.8220472 | GART/ADK/NDUFS1 | 3 |
| GO:0046434 | GO:0046434 | organophosphate catabolic process | 3/439 | 234/18888 | 0.0128205 | 0.5516033 | -1.0646618 | 0.9116883 | 0.9382086 | 0.8229082 | PDE10A/KAT2B/PLCB1 | 3 |
| GO:0032637 | GO:0032637 | interleukin-8 production | 1/439 | 103/18888 | 0.0097087 | 0.4177190 | -0.9140563 | 0.9118623 | 0.9382086 | 0.8229082 | KLF4 | 1 |
| GO:0042274 | GO:0042274 | ribosomal small subunit biogenesis | 1/439 | 103/18888 | 0.0097087 | 0.4177190 | -0.9140563 | 0.9118623 | 0.9382086 | 0.8229082 | NOP58 | 1 |
| GO:0006885 | GO:0006885 | regulation of pH | 1/439 | 105/18888 | 0.0095238 | 0.4097624 | -0.9355486 | 0.9159338 | 0.9419161 | 0.8261600 | MAPK1 | 1 |
| GO:1901222 | GO:1901222 | regulation of non-canonical NF-kappaB signal transduction | 1/439 | 105/18888 | 0.0095238 | 0.4097624 | -0.9355486 | 0.9159338 | 0.9419161 | 0.8261600 | ADIPOR1 | 1 |
| GO:0002532 | GO:0002532 | production of molecular mediator involved in inflammatory response | 1/439 | 106/18888 | 0.0094340 | 0.4058968 | -0.9461746 | 0.9178986 | 0.9426383 | 0.8267935 | APPL2 | 1 |
| GO:0006626 | GO:0006626 | protein targeting to mitochondrion | 1/439 | 106/18888 | 0.0094340 | 0.4058968 | -0.9461746 | 0.9178986 | 0.9426383 | 0.8267935 | UBE2D3 | 1 |
| GO:0034308 | GO:0034308 | primary alcohol metabolic process | 1/439 | 106/18888 | 0.0094340 | 0.4058968 | -0.9461746 | 0.9178986 | 0.9426383 | 0.8267935 | REST | 1 |
| GO:0046425 | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 1/439 | 106/18888 | 0.0094340 | 0.4058968 | -0.9461746 | 0.9178986 | 0.9426383 | 0.8267935 | ADIPOR1 | 1 |
| GO:0032635 | GO:0032635 | interleukin-6 production | 2/439 | 176/18888 | 0.0113636 | 0.4889211 | -1.0507793 | 0.9182759 | 0.9426383 | 0.8267935 | IL1A/IRAK3 | 2 |
| GO:0032675 | GO:0032675 | regulation of interleukin-6 production | 2/439 | 176/18888 | 0.0113636 | 0.4889211 | -1.0507793 | 0.9182759 | 0.9426383 | 0.8267935 | IL1A/IRAK3 | 2 |
| GO:1901292 | GO:1901292 | nucleoside phosphate catabolic process | 2/439 | 176/18888 | 0.0113636 | 0.4889211 | -1.0507793 | 0.9182759 | 0.9426383 | 0.8267935 | PDE10A/KAT2B | 2 |
| GO:0042445 | GO:0042445 | hormone metabolic process | 3/439 | 240/18888 | 0.0125000 | 0.5378132 | -1.1115637 | 0.9201058 | 0.9442759 | 0.8282299 | SRD5A1/REST/TCF7L2 | 3 |
| GO:0006641 | GO:0006641 | triglyceride metabolic process | 1/439 | 108/18888 | 0.0092593 | 0.3983802 | -0.9671939 | 0.9216918 | 0.9454214 | 0.8292345 | SIRT1 | 1 |
| GO:0140888 | GO:0140888 | interferon-mediated signaling pathway | 1/439 | 108/18888 | 0.0092593 | 0.3983802 | -0.9671939 | 0.9216918 | 0.9454214 | 0.8292345 | TANK | 1 |
| GO:1902476 | GO:1902476 | chloride transmembrane transport | 1/439 | 109/18888 | 0.0091743 | 0.3947253 | -0.9775903 | 0.9235224 | 0.9470576 | 0.8306697 | SLC17A6 | 1 |
| GO:0009205 | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3/439 | 244/18888 | 0.0122951 | 0.5289966 | -1.1422910 | 0.9253042 | 0.9476413 | 0.8311817 | OPA1/KAT2B/NDUFS1 | 3 |
| GO:0009135 | GO:0009135 | purine nucleoside diphosphate metabolic process | 1/439 | 110/18888 | 0.0090909 | 0.3911369 | -0.9879129 | 0.9253102 | 0.9476413 | 0.8311817 | KAT2B | 1 |
| GO:0009179 | GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1/439 | 110/18888 | 0.0090909 | 0.3911369 | -0.9879129 | 0.9253102 | 0.9476413 | 0.8311817 | KAT2B | 1 |
| GO:0031341 | GO:0031341 | regulation of cell killing | 1/439 | 110/18888 | 0.0090909 | 0.3911369 | -0.9879129 | 0.9253102 | 0.9476413 | 0.8311817 | MAPK8 | 1 |
| GO:0042116 | GO:0042116 | macrophage activation | 1/439 | 110/18888 | 0.0090909 | 0.3911369 | -0.9879129 | 0.9253102 | 0.9476413 | 0.8311817 | RORA | 1 |
| GO:0043414 | GO:0043414 | macromolecule methylation | 2/439 | 181/18888 | 0.0110497 | 0.4754150 | -1.0939071 | 0.9257400 | 0.9476413 | 0.8311817 | VIRMA/GSPT1 | 2 |
| GO:0046631 | GO:0046631 | alpha-beta T cell activation | 2/439 | 181/18888 | 0.0110497 | 0.4754150 | -1.0939071 | 0.9257400 | 0.9476413 | 0.8311817 | RORA/ATF2 | 2 |
| GO:0042176 | GO:0042176 | regulation of protein catabolic process | 5/439 | 362/18888 | 0.0138122 | 0.5942687 | -1.2023454 | 0.9260440 | 0.9477114 | 0.8312431 | MTM1/SMAD3/USP25/APC/IRAK3 | 5 |
| GO:0016485 | GO:0016485 | protein processing | 3/439 | 245/18888 | 0.0122449 | 0.5268374 | -1.1499074 | 0.9265545 | 0.9479927 | 0.8314899 | MBTPS1/SPCS3/PRNP | 3 |
| GO:0030203 | GO:0030203 | glycosaminoglycan metabolic process | 1/439 | 111/18888 | 0.0090090 | 0.3876131 | -0.9981633 | 0.9270563 | 0.9481236 | 0.8316047 | HS3ST3B1 | 1 |
| GO:0006839 | GO:0006839 | mitochondrial transport | 2/439 | 182/18888 | 0.0109890 | 0.4728028 | -1.1024163 | 0.9271537 | 0.9481236 | 0.8316047 | ATF2/RHOT1 | 2 |
| GO:0002703 | GO:0002703 | regulation of leukocyte mediated immunity | 3/439 | 246/18888 | 0.0121951 | 0.5246958 | -1.1574981 | 0.9277857 | 0.9485288 | 0.8319601 | TFRC/CD46/RIF1 | 3 |
| GO:0009206 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1/439 | 112/18888 | 0.0089286 | 0.3841523 | -1.0083426 | 0.9287617 | 0.9490445 | 0.8324124 | NDUFS1 | 1 |
| GO:0046822 | GO:0046822 | regulation of nucleocytoplasmic transport | 1/439 | 112/18888 | 0.0089286 | 0.3841523 | -1.0083426 | 0.9287617 | 0.9490445 | 0.8324124 | SMAD3 | 1 |
| GO:0006664 | GO:0006664 | glycolipid metabolic process | 1/439 | 113/18888 | 0.0088496 | 0.3807527 | -1.0184523 | 0.9304273 | 0.9505051 | 0.8336935 | CREM | 1 |
| GO:1903509 | GO:1903509 | liposaccharide metabolic process | 1/439 | 114/18888 | 0.0087719 | 0.3774128 | -1.0284935 | 0.9320541 | 0.9519253 | 0.8349392 | CREM | 1 |
| GO:0015908 | GO:0015908 | fatty acid transport | 1/439 | 115/18888 | 0.0086957 | 0.3741309 | -1.0384675 | 0.9336429 | 0.9528422 | 0.8357434 | IL1A | 1 |
| GO:0033559 | GO:0033559 | unsaturated fatty acid metabolic process | 1/439 | 115/18888 | 0.0086957 | 0.3741309 | -1.0384675 | 0.9336429 | 0.9528422 | 0.8357434 | SIRT1 | 1 |
| GO:0009199 | GO:0009199 | ribonucleoside triphosphate metabolic process | 3/439 | 251/18888 | 0.0119522 | 0.5142437 | -1.1950735 | 0.9336622 | 0.9528422 | 0.8357434 | OPA1/KAT2B/NDUFS1 | 3 |
| GO:0022412 | GO:0022412 | cellular process involved in reproduction in multicellular organism | 7/439 | 482/18888 | 0.0145228 | 0.6248452 | -1.2870091 | 0.9340628 | 0.9530093 | 0.8358900 | STRBP/ZMIZ1/SLIT2/EPC1/PAFAH1B1/SOS1/FOXJ3 | 7 |
| GO:0061136 | GO:0061136 | regulation of proteasomal protein catabolic process | 2/439 | 189/18888 | 0.0105820 | 0.4552916 | -1.1609489 | 0.9363611 | 0.9551120 | 0.8377343 | MTM1/USP25 | 2 |
| GO:0006090 | GO:0006090 | pyruvate metabolic process | 1/439 | 118/18888 | 0.0084746 | 0.3646191 | -1.0679978 | 0.9381903 | 0.9560086 | 0.8385207 | KAT2B | 1 |
| GO:0009201 | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1/439 | 118/18888 | 0.0084746 | 0.3646191 | -1.0679978 | 0.9381903 | 0.9560086 | 0.8385207 | NDUFS1 | 1 |
| GO:0009308 | GO:0009308 | amine metabolic process | 1/439 | 118/18888 | 0.0084746 | 0.3646191 | -1.0679978 | 0.9381903 | 0.9560086 | 0.8385207 | NR4A2 | 1 |
| GO:0050830 | GO:0050830 | defense response to Gram-positive bacterium | 1/439 | 118/18888 | 0.0084746 | 0.3646191 | -1.0679978 | 0.9381903 | 0.9560086 | 0.8385207 | SEH1L | 1 |
| GO:0006164 | GO:0006164 | purine nucleotide biosynthetic process | 3/439 | 256/18888 | 0.0117188 | 0.5041999 | -1.2320383 | 0.9390959 | 0.9565128 | 0.8389629 | GART/ADK/NDUFS1 | 3 |
| GO:0002832 | GO:0002832 | negative regulation of response to biotic stimulus | 1/439 | 119/18888 | 0.0084034 | 0.3615551 | -1.0777144 | 0.9396360 | 0.9565128 | 0.8389629 | IRAK3 | 1 |
| GO:0032609 | GO:0032609 | type II interferon production | 1/439 | 119/18888 | 0.0084034 | 0.3615551 | -1.0777144 | 0.9396360 | 0.9565128 | 0.8389629 | PRNP | 1 |
| GO:0032649 | GO:0032649 | regulation of type II interferon production | 1/439 | 119/18888 | 0.0084034 | 0.3615551 | -1.0777144 | 0.9396360 | 0.9565128 | 0.8389629 | PRNP | 1 |
| GO:0009185 | GO:0009185 | ribonucleoside diphosphate metabolic process | 1/439 | 120/18888 | 0.0083333 | 0.3585421 | -1.0873694 | 0.9410479 | 0.9573296 | 0.8396793 | KAT2B | 1 |
| GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 1/439 | 120/18888 | 0.0083333 | 0.3585421 | -1.0873694 | 0.9410479 | 0.9573296 | 0.8396793 | RORA | 1 |
| GO:0006959 | GO:0006959 | humoral immune response | 3/439 | 258/18888 | 0.0116279 | 0.5002914 | -1.2466588 | 0.9411520 | 0.9573296 | 0.8396793 | MEF2C/CD46/RGCC | 3 |
| GO:0050777 | GO:0050777 | negative regulation of immune response | 2/439 | 194/18888 | 0.0103093 | 0.4435573 | -1.2017041 | 0.9422511 | 0.9582054 | 0.8404475 | CD46/IRAK3 | 2 |
| GO:0009636 | GO:0009636 | response to toxic substance | 3/439 | 260/18888 | 0.0115385 | 0.4964430 | -1.2611872 | 0.9431438 | 0.9588708 | 0.8410311 | PTPN13/SRD5A1/ARHGAP33 | 3 |
| GO:0006022 | GO:0006022 | aminoglycan metabolic process | 1/439 | 122/18888 | 0.0081967 | 0.3526644 | -1.1064986 | 0.9437736 | 0.9590265 | 0.8411677 | HS3ST3B1 | 1 |
| GO:1904892 | GO:1904892 | regulation of receptor signaling pathway via STAT | 1/439 | 122/18888 | 0.0081967 | 0.3526644 | -1.1064986 | 0.9437736 | 0.9590265 | 0.8411677 | ADIPOR1 | 1 |
| GO:0008154 | GO:0008154 | actin polymerization or depolymerization | 2/439 | 196/18888 | 0.0102041 | 0.4390312 | -1.2177726 | 0.9444591 | 0.9594808 | 0.8415662 | SLIT2/MEGF9 | 2 |
| GO:0140013 | GO:0140013 | meiotic nuclear division | 2/439 | 197/18888 | 0.0101523 | 0.4368026 | -1.2257582 | 0.9455328 | 0.9603291 | 0.8423102 | FOXJ3/PLCB1 | 2 |
| GO:0072522 | GO:0072522 | purine-containing compound biosynthetic process | 3/439 | 264/18888 | 0.0113636 | 0.4889211 | -1.2899734 | 0.9469412 | 0.9614524 | 0.8432954 | GART/ADK/NDUFS1 | 3 |
| GO:0022613 | GO:0022613 | ribonucleoprotein complex biogenesis | 7/439 | 499/18888 | 0.0140281 | 0.6035579 | -1.3844533 | 0.9471166 | 0.9614524 | 0.8432954 | SRSF10/PRKRA/SFSWAP/DDX17/CLNS1A/KAT2B/NOP58 | 7 |
| GO:0006690 | GO:0006690 | icosanoid metabolic process | 1/439 | 125/18888 | 0.0080000 | 0.3442005 | -1.1347555 | 0.9476282 | 0.9614866 | 0.8433254 | SIRT1 | 1 |
| GO:0032434 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1/439 | 125/18888 | 0.0080000 | 0.3442005 | -1.1347555 | 0.9476282 | 0.9614866 | 0.8433254 | MTM1 | 1 |
| GO:0006605 | GO:0006605 | protein targeting | 4/439 | 327/18888 | 0.0122324 | 0.5263004 | -1.3329184 | 0.9480230 | 0.9616447 | 0.8434641 | SPCS3/UBE2D3/YWHAQ/PRNP | 4 |
| GO:0016072 | GO:0016072 | rRNA metabolic process | 3/439 | 266/18888 | 0.0112782 | 0.4852450 | -1.3042341 | 0.9487504 | 0.9617598 | 0.8435651 | DDX17/KAT2B/NOP58 | 3 |
| GO:0001578 | GO:0001578 | microtubule bundle formation | 1/439 | 126/18888 | 0.0079365 | 0.3414687 | -1.1440617 | 0.9488535 | 0.9617598 | 0.8435651 | RSPH4A | 1 |
| GO:0006805 | GO:0006805 | xenobiotic metabolic process | 1/439 | 126/18888 | 0.0079365 | 0.3414687 | -1.1440617 | 0.9488535 | 0.9617598 | 0.8435651 | RORA | 1 |
| GO:0009132 | GO:0009132 | nucleoside diphosphate metabolic process | 1/439 | 127/18888 | 0.0078740 | 0.3387800 | -1.1533130 | 0.9500502 | 0.9627303 | 0.8444164 | KAT2B | 1 |
| GO:0006399 | GO:0006399 | tRNA metabolic process | 2/439 | 202/18888 | 0.0099010 | 0.4259907 | -1.2652135 | 0.9506116 | 0.9630566 | 0.8447025 | PUS7/SEPSECS | 2 |
| GO:0006612 | GO:0006612 | protein targeting to membrane | 1/439 | 128/18888 | 0.0078125 | 0.3361333 | -1.1625103 | 0.9512191 | 0.9634295 | 0.8450296 | PRNP | 1 |
| GO:0097237 | GO:0097237 | cellular response to toxic substance | 1/439 | 129/18888 | 0.0077519 | 0.3335276 | -1.1716544 | 0.9523606 | 0.9642556 | 0.8457542 | PTPN13 | 1 |
| GO:0032271 | GO:0032271 | regulation of protein polymerization | 2/439 | 204/18888 | 0.0098039 | 0.4218143 | -1.2807809 | 0.9525139 | 0.9642556 | 0.8457542 | SLIT2/MEGF9 | 2 |
| GO:0098661 | GO:0098661 | inorganic anion transmembrane transport | 1/439 | 130/18888 | 0.0076923 | 0.3309620 | -1.1807462 | 0.9534754 | 0.9647436 | 0.8461822 | SLC17A6 | 1 |
| GO:1903322 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 1/439 | 130/18888 | 0.0076923 | 0.3309620 | -1.1807462 | 0.9534754 | 0.9647436 | 0.8461822 | TANK | 1 |
| GO:0007127 | GO:0007127 | meiosis I | 1/439 | 131/18888 | 0.0076336 | 0.3284355 | -1.1897864 | 0.9545643 | 0.9651172 | 0.8465099 | FOXJ3 | 1 |
| GO:1901875 | GO:1901875 | positive regulation of post-translational protein modification | 1/439 | 131/18888 | 0.0076336 | 0.3284355 | -1.1897864 | 0.9545643 | 0.9651172 | 0.8465099 | TANK | 1 |
| GO:1903052 | GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 1/439 | 131/18888 | 0.0076336 | 0.3284355 | -1.1897864 | 0.9545643 | 0.9651172 | 0.8465099 | L3MBTL3 | 1 |
| GO:0003341 | GO:0003341 | cilium movement | 2/439 | 209/18888 | 0.0095694 | 0.4117230 | -1.3191844 | 0.9569688 | 0.9673053 | 0.8484291 | ASH1L/RSPH4A | 2 |
| GO:0006720 | GO:0006720 | isoprenoid metabolic process | 1/439 | 135/18888 | 0.0074074 | 0.3187041 | -1.2254472 | 0.9586712 | 0.9687827 | 0.8497249 | SRD5A1 | 1 |
| GO:0006639 | GO:0006639 | acylglycerol metabolic process | 1/439 | 136/18888 | 0.0073529 | 0.3163607 | -1.2342411 | 0.9596387 | 0.9692736 | 0.8501555 | SIRT1 | 1 |
| GO:0030168 | GO:0030168 | platelet activation | 1/439 | 136/18888 | 0.0073529 | 0.3163607 | -1.2342411 | 0.9596387 | 0.9692736 | 0.8501555 | VAV3 | 1 |
| GO:0006638 | GO:0006638 | neutral lipid metabolic process | 1/439 | 137/18888 | 0.0072993 | 0.3140515 | -1.2429879 | 0.9605836 | 0.9699845 | 0.8507790 | SIRT1 | 1 |
| GO:0043467 | GO:0043467 | regulation of generation of precursor metabolites and energy | 1/439 | 140/18888 | 0.0071429 | 0.3073218 | -1.2689525 | 0.9632879 | 0.9724712 | 0.8529601 | KAT2B | 1 |
| GO:0030317 | GO:0030317 | flagellated sperm motility | 1/439 | 141/18888 | 0.0070922 | 0.3051422 | -1.2775176 | 0.9641475 | 0.9728509 | 0.8532932 | ASH1L | 1 |
| GO:0097722 | GO:0097722 | sperm motility | 1/439 | 141/18888 | 0.0070922 | 0.3051422 | -1.2775176 | 0.9641475 | 0.9728509 | 0.8532932 | ASH1L | 1 |
| GO:0051258 | GO:0051258 | protein polymerization | 3/439 | 287/18888 | 0.0104530 | 0.4497393 | -1.4490009 | 0.9645725 | 0.9729293 | 0.8533619 | SLIT2/MEGF9/RANBP9 | 3 |
| GO:0007601 | GO:0007601 | visual perception | 2/439 | 219/18888 | 0.0091324 | 0.3929229 | -1.3939035 | 0.9647087 | 0.9729293 | 0.8533619 | EFEMP1/OPA1 | 2 |
| GO:0046034 | GO:0046034 | ATP metabolic process | 2/439 | 220/18888 | 0.0090909 | 0.3911369 | -1.4012301 | 0.9654047 | 0.9733873 | 0.8537636 | KAT2B/NDUFS1 | 2 |
| GO:0050953 | GO:0050953 | sensory perception of light stimulus | 2/439 | 223/18888 | 0.0089686 | 0.3858750 | -1.4230579 | 0.9674145 | 0.9751693 | 0.8553267 | EFEMP1/OPA1 | 2 |
| GO:0009165 | GO:0009165 | nucleotide biosynthetic process | 3/439 | 293/18888 | 0.0102389 | 0.4405296 | -1.4888131 | 0.9681696 | 0.9756861 | 0.8557799 | GART/ADK/NDUFS1 | 3 |
| GO:1901293 | GO:1901293 | nucleoside phosphate biosynthetic process | 3/439 | 295/18888 | 0.0101695 | 0.4375430 | -1.5019413 | 0.9692901 | 0.9763482 | 0.8563606 | GART/ADK/NDUFS1 | 3 |
| GO:0007596 | GO:0007596 | blood coagulation | 2/439 | 226/18888 | 0.0088496 | 0.3807527 | -1.4446631 | 0.9693118 | 0.9763482 | 0.8563606 | VAV3/ENPP4 | 2 |
| GO:0006119 | GO:0006119 | oxidative phosphorylation | 1/439 | 148/18888 | 0.0067568 | 0.2907098 | -1.3362796 | 0.9696281 | 0.9764223 | 0.8564257 | NDUFS1 | 1 |
| GO:0050727 | GO:0050727 | regulation of inflammatory response | 5/439 | 425/18888 | 0.0117647 | 0.5061771 | -1.5883341 | 0.9710405 | 0.9775999 | 0.8574585 | ASH1L/CNR1/RORA/SMAD3/KLF4 | 5 |
| GO:0050817 | GO:0050817 | coagulation | 2/439 | 231/18888 | 0.0086580 | 0.3725113 | -1.4801929 | 0.9722402 | 0.9784547 | 0.8582083 | VAV3/ENPP4 | 2 |
| GO:0010508 | GO:0010508 | positive regulation of autophagy | 1/439 | 152/18888 | 0.0065789 | 0.2830596 | -1.3689694 | 0.9723758 | 0.9784547 | 0.8582083 | SIRT1 | 1 |
| GO:0050729 | GO:0050729 | positive regulation of inflammatory response | 1/439 | 153/18888 | 0.0065359 | 0.2812095 | -1.3770462 | 0.9730231 | 0.9788612 | 0.8585648 | CNR1 | 1 |
| GO:0007599 | GO:0007599 | hemostasis | 2/439 | 233/18888 | 0.0085837 | 0.3693138 | -1.4942422 | 0.9733345 | 0.9789297 | 0.8586249 | VAV3/ENPP4 | 2 |
| GO:0002449 | GO:0002449 | lymphocyte mediated immunity | 4/439 | 372/18888 | 0.0107527 | 0.4626350 | -1.6147102 | 0.9750484 | 0.9804085 | 0.8599219 | TFRC/JAG1/CD46/RIF1 | 4 |
| GO:0016052 | GO:0016052 | carbohydrate catabolic process | 1/439 | 158/18888 | 0.0063291 | 0.2723105 | -1.4168801 | 0.9760393 | 0.9811597 | 0.8605808 | KAT2B | 1 |
| GO:0002274 | GO:0002274 | myeloid leukocyte activation | 2/439 | 241/18888 | 0.0082988 | 0.3570544 | -1.5495500 | 0.9773099 | 0.9821916 | 0.8614859 | CNR1/RORA | 2 |
| GO:1902600 | GO:1902600 | proton transmembrane transport | 1/439 | 161/18888 | 0.0062112 | 0.2672364 | -1.4403567 | 0.9776850 | 0.9823232 | 0.8616014 | SLC17A6 | 1 |
| GO:0045333 | GO:0045333 | cellular respiration | 2/439 | 245/18888 | 0.0081633 | 0.3512250 | -1.5766911 | 0.9790765 | 0.9831270 | 0.8623064 | PUM2/NDUFS1 | 2 |
| GO:0019362 | GO:0019362 | pyridine nucleotide metabolic process | 1/439 | 164/18888 | 0.0060976 | 0.2623479 | -1.4635296 | 0.9792179 | 0.9831270 | 0.8623064 | KAT2B | 1 |
| GO:0046496 | GO:0046496 | nicotinamide nucleotide metabolic process | 1/439 | 164/18888 | 0.0060976 | 0.2623479 | -1.4635296 | 0.9792179 | 0.9831270 | 0.8623064 | KAT2B | 1 |
| GO:0042254 | GO:0042254 | ribosome biogenesis | 3/439 | 319/18888 | 0.0094044 | 0.4046244 | -1.6543198 | 0.9801321 | 0.9837993 | 0.8628961 | DDX17/KAT2B/NOP58 | 3 |
| GO:0072524 | GO:0072524 | pyridine-containing compound metabolic process | 1/439 | 170/18888 | 0.0058824 | 0.2530886 | -1.5090067 | 0.9819757 | 0.9854041 | 0.8643036 | KAT2B | 1 |
| GO:0006790 | GO:0006790 | sulfur compound metabolic process | 3/439 | 326/18888 | 0.0092025 | 0.3959361 | -1.6970969 | 0.9825332 | 0.9857177 | 0.8645787 | SLC1A2/TCF7L2/HS3ST3B1 | 3 |
| GO:0042742 | GO:0042742 | defense response to bacterium | 3/439 | 330/18888 | 0.0090909 | 0.3911369 | -1.7212279 | 0.9837782 | 0.9864771 | 0.8652448 | ADAMTS5/TAB2/SEH1L | 3 |
| GO:1903008 | GO:1903008 | organelle disassembly | 1/439 | 175/18888 | 0.0057143 | 0.2458575 | -1.5460662 | 0.9839927 | 0.9864771 | 0.8652448 | LTN1 | 1 |
| GO:0001894 | GO:0001894 | tissue homeostasis | 2/439 | 259/18888 | 0.0077220 | 0.3322398 | -1.6691792 | 0.9842708 | 0.9864771 | 0.8652448 | TFRC/ZEB2 | 2 |
| GO:0060249 | GO:0060249 | anatomical structure homeostasis | 2/439 | 259/18888 | 0.0077220 | 0.3322398 | -1.6691792 | 0.9842708 | 0.9864771 | 0.8652448 | TFRC/ZEB2 | 2 |
| GO:0009060 | GO:0009060 | aerobic respiration | 1/439 | 199/18888 | 0.0050251 | 0.2162063 | -1.7145991 | 0.9909483 | 0.9929223 | 0.8708979 | NDUFS1 | 1 |
| GO:0045732 | GO:0045732 | positive regulation of protein catabolic process | 1/439 | 205/18888 | 0.0048780 | 0.2098783 | -1.7545871 | 0.9921516 | 0.9938805 | 0.8717384 | APC | 1 |
| GO:0007281 | GO:0007281 | germ cell development | 3/439 | 371/18888 | 0.0080863 | 0.3479115 | -1.9567508 | 0.9924984 | 0.9939804 | 0.8718260 | STRBP/EPC1/PAFAH1B1 | 3 |
| GO:0001906 | GO:0001906 | cell killing | 1/439 | 226/18888 | 0.0044248 | 0.1903764 | -1.8887986 | 0.9952378 | 0.9964163 | 0.8739625 | MAPK8 | 1 |
| GO:0002443 | GO:0002443 | leukocyte mediated immunity | 4/439 | 469/18888 | 0.0085288 | 0.3669514 | -2.1414984 | 0.9954258 | 0.9964163 | 0.8739625 | TFRC/JAG1/CD46/RIF1 | 4 |
| GO:0072593 | GO:0072593 | reactive oxygen species metabolic process | 1/439 | 238/18888 | 0.0042017 | 0.1807776 | -1.9619062 | 0.9964214 | 0.9970424 | 0.8745117 | NDUFS1 | 1 |
| GO:1903320 | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 1/439 | 241/18888 | 0.0041494 | 0.1785272 | -1.9798147 | 0.9966683 | 0.9970424 | 0.8745117 | TANK | 1 |
| GO:0015980 | GO:0015980 | energy derivation by oxidation of organic compounds | 2/439 | 338/18888 | 0.0059172 | 0.2545861 | -2.1330999 | 0.9969811 | 0.9970424 | 0.8745117 | PUM2/NDUFS1 | 2 |
| GO:1901873 | GO:1901873 | regulation of post-translational protein modification | 1/439 | 246/18888 | 0.0040650 | 0.1748986 | -2.0093517 | 0.9970424 | 0.9970424 | 0.8745117 | TANK | 1 |
# Visualización del análisis funcional
barplot(go_results_miR_520d_5p_predicted, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
Combined
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_520d_5p_combined <- combined_targets_miR_520d_5p$target_symbol %>% unique()
go_results_miR_520d_5p_combined <- enrichGO(
gene = gene_symbols_miR_520d_5p_combined,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
# Visualización del análisis funcional
barplot(go_results_miR_520d_5p_combined, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
5: Exportar resultados
write.csv(filter_val_hsa_miR_520d_5p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/updated/validated_targets.csv", row.names = FALSE)
write.csv(filter_pre_hsa_miR_520d_5p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/updated/predicted_targets.csv", row.names = FALSE)
write.csv(combined_targets_miR_520d_5p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/updated/combined_targets.csv", row.names = FALSE)
write.csv(summary_targets_miR_520d_5p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/updated/summary_targets.csv", row.names = FALSE)hsa-miR-655-3p
1. Validated
# The default is to search validated interactions in human
val_hsa_miR_655_3p <- get_multimir(org = "hsa",
mirna = 'hsa-miR-655-3p',
table = "validated",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE)Searching mirecords ...
Searching mirtarbase ...
Searching tarbase ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.# Check which types of associations were returned
table(val_hsa_miR_655_3p@data$type)
validated
319 # Detailed information of the validated miRNA-target interaction
head(val_hsa_miR_655_3p@data)# A tibble: 6 × 11
database mature_mirna_acc mature_mirna_id target_symbol target_entrez
<chr> <chr> <chr> <chr> <chr>
1 mirtarbase MIMAT0003331 hsa-miR-655-3p TGFBR2 7048
2 mirtarbase MIMAT0003331 hsa-miR-655-3p TGFBR2 7048
3 mirtarbase MIMAT0003331 hsa-miR-655-3p CAPRIN2 65981
4 mirtarbase MIMAT0003331 hsa-miR-655-3p CAPRIN2 65981
5 mirtarbase MIMAT0003331 hsa-miR-655-3p CAPRIN2 65981
6 mirtarbase MIMAT0003331 hsa-miR-655-3p CAPRIN2 65981
# ℹ 6 more variables: target_ensembl <chr>, experiment <chr>,
# support_type <chr>, pubmed_id <chr>, DB.link <chr>, type <chr># Filter with the updated databases, experiment, support_type y type
filter_val_hsa_miR_655_3p <- val_hsa_miR_655_3p@data[
val_hsa_miR_655_3p@data[["database"]] %in% c("mirtarbase", "tarbase") & # Filtrar por bases de datos específicas
grepl("Luciferase|Western blot|qRT-PCR", val_hsa_miR_655_3p@data[["experiment"]], ignore.case = TRUE) & # Filtro por experimentos específicos
val_hsa_miR_655_3p@data[["support_type"]] %in% c("Functional MTI", "Functional MTI (Weak)") & # Filtro por soporte funcional
val_hsa_miR_655_3p@data[["type"]] == "validated", # Filtro por tipo validado
]
# Table with kable
filter_val_hsa_miR_655_3p |>
kable(format = "html") |>
kable_styling("striped")| database | mature_mirna_acc | mature_mirna_id | target_symbol | target_entrez | target_ensembl | experiment | support_type | pubmed_id | DB.link | type |
|---|---|---|---|---|---|---|---|---|---|---|
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | TGFBR2 | 7048 | ENSG00000163513 | Luciferase reporter assay/Western blot//qRT-PCR | Functional MTI | 23690952 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=TGFBR2&opt=adv | validated |
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | ZEB1 | 6935 | ENSG00000148516 | Luciferase reporter assay/Western blot//qRT-PCR | Functional MTI | 23690952 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=ZEB1&opt=adv | validated |
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | ADAM10 | 102 | ENSG00000137845 | Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 27259866 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=ADAM10&opt=adv | validated |
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | PRRX1 | 5396 | ENSG00000116132 | Immunohistochemistry//Luciferase reporter assay//Western blot | Functional MTI | 26820102 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=PRRX1&opt=adv | validated |
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | MAGI2 | 9863 | ENSG00000187391 | Luciferase reporter assay//Microarray//qRT-PCR//Western blot | Functional MTI | 24258346 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=MAGI2&opt=adv | validated |
| mirtarbase | MIMAT0003331 | hsa-miR-655-3p | PTTG1 | 9232 | ENSG00000164611 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 24314023 | http://mirtarbase.mbc.nctu.edu.tw/php/search.php?org=hsa&mirnas=hsa-miR-655-3p&targets=PTTG1&opt=adv | validated |
2. Predicted
# Conserved Sites
# The default is to search validated interactions in human
pre_hsa_miR_655_3p <- get_multimir(org = "hsa",
mirna = 'hsa-miR-655-3p',
table = "predicted",
predicted.cutoff = 10,
predicted.cutoff.type = "p",
predicted.site = "conserved",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE)Searching diana_microt ...
Searching elmmo ...
Searching microcosm ...
Searching miranda ...
Searching mirdb ...
Searching pictar ...
Searching pita ...
Searching targetscan ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.# Check which types of associations were returned
table(pre_hsa_miR_655_3p@data$type)
predicted
4453 dim(pre_hsa_miR_655_3p@data)[1] 4453 9# Detailed information of the validated miRNA-target interaction
head(pre_hsa_miR_655_3p@data)# A tibble: 6 × 9
database mature_mirna_acc mature_mirna_id target_symbol target_entrez
<chr> <chr> <chr> <chr> <chr>
1 diana_microt MIMAT0003331 hsa-miR-655-3p INO80D 54891
2 diana_microt MIMAT0003331 hsa-miR-655-3p INO80D 54891
3 diana_microt MIMAT0003331 hsa-miR-655-3p CD47 961
4 diana_microt MIMAT0003331 hsa-miR-655-3p POU2F1 5451
5 diana_microt MIMAT0003331 hsa-miR-655-3p ZNF521 25925
6 diana_microt MIMAT0003331 hsa-miR-655-3p CLCF1 23529
# ℹ 4 more variables: target_ensembl <chr>, score <chr>, DB.link <chr>,
# type <chr># Filter with the updated databases (targetscan)
filter_pre_hsa_miR_655_3p <- pre_hsa_miR_655_3p@data[pre_hsa_miR_655_3p@data[["database"]] == "targetscan",]
dim(filter_pre_hsa_miR_655_3p)[1] 34 9# Table with kable
filter_pre_hsa_miR_655_3p |>
kable(format = "html") |>
kable_styling("striped")| database | mature_mirna_acc | mature_mirna_id | target_symbol | target_entrez | target_ensembl | score | DB.link | type |
|---|---|---|---|---|---|---|---|---|
| targetscan | MIMAT0003331 | hsa-miR-655-3p | ADM | 133 | ENSG00000148926 | -0.366 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=ADM&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | GTF2F2 | 2963 | ENSG00000188342 | -0.367 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=GTF2F2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | C2orf76 | 130355 | ENSG00000186132 | -0.375 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=C2orf76&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | TAF13 | 6884 | ENSG00000197780 | -0.375 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=TAF13&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | TSPAN7 | 7102 | ENSG00000156298 | -0.388 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=TSPAN7&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RPL38 | 6169 | ENSG00000172809 | -0.39 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RPL38&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | BRAT1 | 221927 | ENSG00000106009 | -0.394 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=BRAT1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RBM24 | 221662 | ENSG00000112183 | -0.396 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RBM24&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | PRRX2 | 51450 | ENSG00000167157 | -0.403 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=PRRX2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RGS1 | 5996 | ENSG00000090104 | -0.403 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RGS1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | SNRNP40 | 9410 | ENSG00000060688 | -0.407 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=SNRNP40&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | ING2 | 3622 | ENSG00000168556 | -0.41 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=ING2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | SRSF5 | 6430 | ENSG00000100650 | -0.417 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=SRSF5&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | SRSF7 | 6432 | ENSG00000115875 | -0.418 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=SRSF7&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | C11orf58 | 10944 | ENSG00000110696 | -0.419 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=C11orf58&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | NOA1 | 84273 | ENSG00000084092 | -0.433 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=NOA1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | KHDRBS2 | 202559 | ENSG00000112232 | -0.44 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=KHDRBS2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | KCTD1 | 284252 | ENSG00000134504 | -0.443 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=KCTD1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RILPL2 | 196383 | ENSG00000150977 | -0.446 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RILPL2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | GPR162 | 27239 | ENSG00000250510 | -0.447 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=GPR162&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | C18orf32 | 497661 | ENSG00000177576 | -0.451 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=C18orf32&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | IFNW1 | 3467 | ENSG00000177047 | -0.463 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=IFNW1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RRP9 | 9136 | ENSG00000114767 | -0.469 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RRP9&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | PTX3 | 5806 | ENSG00000163661 | -0.469 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=PTX3&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | RNF130 | 55819 | ENSG00000113269 | -0.471 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=RNF130&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | EIF1B | 10289 | ENSG00000114784 | -0.481 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=EIF1B&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | KCNJ13 | 3769 | ENSG00000115474 | -0.482 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=KCNJ13&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | PPBP | 5473 | ENSG00000163736 | -0.488 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=PPBP&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | TOB1 | 10140 | ENSG00000141232 | -0.496 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=TOB1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | AGO2 | 27161 | ENSG00000123908 | -0.551 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=AGO2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | CAMTA1 | 23261 | ENSG00000171735 | -0.574 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=CAMTA1&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | ATP5MC2 | 517 | ENSG00000135390 | -0.631 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=ATP5MC2&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | CORT | 1325 | ENSG00000241563 | -0.639 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=CORT&mirg=hsa-miR-655 | predicted |
| targetscan | MIMAT0003331 | hsa-miR-655-3p | PTTG1 | 9232 | ENSG00000164611 | -0.716 | http://www.targetscan.org/cgi-bin/targetscan/vert_61/targetscan.cgi?species=Human&gid=PTTG1&mirg=hsa-miR-655 | predicted |
3. Filter and Combine
combined_targets_miR_655_3p <- filter_val_hsa_miR_655_3p %>%
mutate(type = "validated") %>%
bind_rows(
filter_pre_hsa_miR_655_3p %>% mutate(type = "predicted") # Agregar etiquetas de origen
) %>%
distinct()4. Resumir targets por miRNA
summary_targets_miR_655_3p <- combined_targets_miR_655_3p %>%
group_by(mature_mirna_id, type) %>%
summarise(
num_targets = n(),
top_targets = paste0(unique(target_symbol)[1:20], collapse = ", ")
)`summarise()` has grouped output by 'mature_mirna_id'. You can override using
the `.groups` argument.# Table with kable
summary_targets_miR_655_3p |>
kable(format = "html") |>
kable_styling("striped")| mature_mirna_id | type | num_targets | top_targets |
|---|---|---|---|
| hsa-miR-655-3p | predicted | 34 | ADM, GTF2F2, C2orf76, TAF13, TSPAN7, RPL38, BRAT1, RBM24, PRRX2, RGS1, SNRNP40, ING2, SRSF5, SRSF7, C11orf58, NOA1, KHDRBS2, KCTD1, RILPL2, GPR162 |
| hsa-miR-655-3p | validated | 6 | TGFBR2, ZEB1, ADAM10, PRRX1, MAGI2, PTTG1, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA |
5: Análisis funcional
Validated
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_655_3p_validated <- filter_val_hsa_miR_655_3p$target_symbol %>% unique()
go_results_miR_655_3p_validated <- enrichGO(
gene = gene_symbols_miR_655_3p_validated,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
go_results_miR_655_3p_validated@result |>
kable(format = "html") |>
kable_styling("striped")| ID | Description | GeneRatio | BgRatio | RichFactor | FoldEnrichment | zScore | pvalue | p.adjust | qvalue | geneID | Count | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO:0010464 | GO:0010464 | regulation of mesenchymal cell proliferation | 3/6 | 33/18888 | 0.0909091 | 286.181818 | 29.227970 | 0.0000001 | 0.0000395 | 0.0000139 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0010463 | GO:0010463 | mesenchymal cell proliferation | 3/6 | 45/18888 | 0.0666667 | 209.866667 | 25.005382 | 0.0000003 | 0.0000513 | 0.0000180 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048704 | GO:0048704 | embryonic skeletal system morphogenesis | 3/6 | 94/18888 | 0.0319149 | 100.468085 | 17.233409 | 0.0000024 | 0.0003212 | 0.0001127 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048706 | GO:0048706 | embryonic skeletal system development | 3/6 | 128/18888 | 0.0234375 | 73.781250 | 14.727913 | 0.0000060 | 0.0006110 | 0.0002144 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048839 | GO:0048839 | inner ear development | 3/6 | 196/18888 | 0.0153061 | 48.183673 | 11.836547 | 0.0000215 | 0.0015524 | 0.0005447 | ZEB1/ADAM10/PRRX1 | 3 |
| GO:0051216 | GO:0051216 | cartilage development | 3/6 | 209/18888 | 0.0143541 | 45.186603 | 11.450384 | 0.0000261 | 0.0015524 | 0.0005447 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0002053 | GO:0002053 | positive regulation of mesenchymal cell proliferation | 2/6 | 26/18888 | 0.0769231 | 242.153846 | 21.934115 | 0.0000272 | 0.0015524 | 0.0005447 | TGFBR2/PRRX1 | 2 |
| GO:0043583 | GO:0043583 | ear development | 3/6 | 223/18888 | 0.0134529 | 42.349776 | 11.072475 | 0.0000316 | 0.0015524 | 0.0005447 | ZEB1/ADAM10/PRRX1 | 3 |
| GO:0048705 | GO:0048705 | skeletal system morphogenesis | 3/6 | 229/18888 | 0.0131004 | 41.240175 | 10.921104 | 0.0000342 | 0.0015524 | 0.0005447 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0061448 | GO:0061448 | connective tissue development | 3/6 | 288/18888 | 0.0104167 | 32.791667 | 9.691393 | 0.0000678 | 0.0027567 | 0.0009673 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048562 | GO:0048562 | embryonic organ morphogenesis | 3/6 | 297/18888 | 0.0101010 | 31.797980 | 9.536350 | 0.0000743 | 0.0027567 | 0.0009673 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048701 | GO:0048701 | embryonic cranial skeleton morphogenesis | 2/6 | 45/18888 | 0.0444444 | 139.911111 | 16.630348 | 0.0000828 | 0.0027831 | 0.0009765 | TGFBR2/PRRX1 | 2 |
| GO:0090092 | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3/6 | 317/18888 | 0.0094637 | 29.791798 | 9.215394 | 0.0000902 | 0.0027831 | 0.0009765 | TGFBR2/ZEB1/MAGI2 | 3 |
| GO:0032924 | GO:0032924 | activin receptor signaling pathway | 2/6 | 50/18888 | 0.0400000 | 125.920000 | 15.766406 | 0.0001023 | 0.0027831 | 0.0009765 | TGFBR2/MAGI2 | 2 |
| GO:0090102 | GO:0090102 | cochlea development | 2/6 | 50/18888 | 0.0400000 | 125.920000 | 15.766406 | 0.0001023 | 0.0027831 | 0.0009765 | ZEB1/ADAM10 | 2 |
| GO:0141091 | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 3/6 | 388/18888 | 0.0077320 | 24.340206 | 8.280714 | 0.0001643 | 0.0041894 | 0.0014700 | TGFBR2/ZEB1/MAGI2 | 3 |
| GO:0007178 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 3/6 | 417/18888 | 0.0071942 | 22.647482 | 7.968257 | 0.0002033 | 0.0048242 | 0.0016927 | TGFBR2/ZEB1/MAGI2 | 3 |
| GO:1904888 | GO:1904888 | cranial skeletal system development | 2/6 | 72/18888 | 0.0277778 | 87.444444 | 13.100045 | 0.0002128 | 0.0048242 | 0.0016927 | TGFBR2/PRRX1 | 2 |
| GO:0048568 | GO:0048568 | embryonic organ development | 3/6 | 455/18888 | 0.0065934 | 20.756044 | 7.603977 | 0.0002631 | 0.0054967 | 0.0019287 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0048844 | GO:0048844 | artery morphogenesis | 2/6 | 81/18888 | 0.0246914 | 77.728395 | 12.335932 | 0.0002694 | 0.0054967 | 0.0019287 | TGFBR2/PRRX1 | 2 |
| GO:0060021 | GO:0060021 | roof of mouth development | 2/6 | 91/18888 | 0.0219780 | 69.186813 | 11.622778 | 0.0003401 | 0.0066070 | 0.0023182 | TGFBR2/PRRX1 | 2 |
| GO:0060395 | GO:0060395 | SMAD protein signal transduction | 2/6 | 95/18888 | 0.0210526 | 66.273684 | 11.369333 | 0.0003706 | 0.0067127 | 0.0023553 | TGFBR2/MAGI2 | 2 |
| GO:0072091 | GO:0072091 | regulation of stem cell proliferation | 2/6 | 96/18888 | 0.0208333 | 65.583333 | 11.308440 | 0.0003784 | 0.0067127 | 0.0023553 | TGFBR2/PRRX1 | 2 |
| GO:0042472 | GO:0042472 | inner ear morphogenesis | 2/6 | 106/18888 | 0.0188679 | 59.396226 | 10.747314 | 0.0004612 | 0.0078397 | 0.0027508 | ZEB1/PRRX1 | 2 |
| GO:0060840 | GO:0060840 | artery development | 2/6 | 113/18888 | 0.0176991 | 55.716814 | 10.399278 | 0.0005239 | 0.0085496 | 0.0029998 | TGFBR2/PRRX1 | 2 |
| GO:0072089 | GO:0072089 | stem cell proliferation | 2/6 | 126/18888 | 0.0158730 | 49.968254 | 9.830904 | 0.0006507 | 0.0099893 | 0.0035050 | TGFBR2/PRRX1 | 2 |
| GO:0042471 | GO:0042471 | ear morphogenesis | 2/6 | 127/18888 | 0.0157480 | 49.574803 | 9.790797 | 0.0006611 | 0.0099893 | 0.0035050 | ZEB1/PRRX1 | 2 |
| GO:0007224 | GO:0007224 | smoothened signaling pathway | 2/6 | 146/18888 | 0.0136986 | 43.123288 | 9.108017 | 0.0008722 | 0.0127093 | 0.0044594 | TGFBR2/PRRX1 | 2 |
| GO:0007219 | GO:0007219 | Notch signaling pathway | 2/6 | 183/18888 | 0.0109290 | 34.404372 | 8.094371 | 0.0013650 | 0.0185644 | 0.0065138 | TGFBR2/ADAM10 | 2 |
| GO:0045580 | GO:0045580 | regulation of T cell differentiation | 2/6 | 183/18888 | 0.0109290 | 34.404372 | 8.094371 | 0.0013650 | 0.0185644 | 0.0065138 | TGFBR2/ZEB1 | 2 |
| GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 2/6 | 215/18888 | 0.0093023 | 29.283721 | 7.435015 | 0.0018772 | 0.0247059 | 0.0086687 | TGFBR2/ZEB1 | 2 |
| GO:0002274 | GO:0002274 | myeloid leukocyte activation | 2/6 | 241/18888 | 0.0082988 | 26.124481 | 6.997361 | 0.0023511 | 0.0291432 | 0.0102257 | TGFBR2/ADAM10 | 2 |
| GO:0060560 | GO:0060560 | developmental growth involved in morphogenesis | 2/6 | 243/18888 | 0.0082305 | 25.909465 | 6.966577 | 0.0023897 | 0.0291432 | 0.0102257 | TGFBR2/MAGI2 | 2 |
| GO:0007179 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 2/6 | 245/18888 | 0.0081633 | 25.697959 | 6.936164 | 0.0024286 | 0.0291432 | 0.0102257 | TGFBR2/ZEB1 | 2 |
| GO:0090596 | GO:0090596 | sensory organ morphogenesis | 2/6 | 278/18888 | 0.0071942 | 22.647482 | 6.481712 | 0.0031138 | 0.0308461 | 0.0108232 | ZEB1/PRRX1 | 2 |
| GO:0048664 | GO:0048664 | neuron fate determination | 1/6 | 10/18888 | 0.1000000 | 314.800000 | 17.693268 | 0.0031728 | 0.0308461 | 0.0108232 | PRRX1 | 1 |
| GO:2000563 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation | 1/6 | 10/18888 | 0.1000000 | 314.800000 | 17.693268 | 0.0031728 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0001865 | GO:0001865 | NK T cell differentiation | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0045602 | GO:0045602 | negative regulation of endothelial cell differentiation | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | ZEB1 | 1 |
| GO:0060433 | GO:0060433 | bronchus development | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0060439 | GO:0060439 | trachea morphogenesis | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0072015 | GO:0072015 | podocyte development | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | MAGI2 | 1 |
| GO:0098696 | GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | ADAM10 | 1 |
| GO:1901998 | GO:1901998 | toxin transport | 1/6 | 11/18888 | 0.0909091 | 286.181818 | 16.864940 | 0.0034897 | 0.0308461 | 0.0108232 | ADAM10 | 1 |
| GO:0071560 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 2/6 | 302/18888 | 0.0066225 | 20.847682 | 6.198026 | 0.0036632 | 0.0308461 | 0.0108232 | TGFBR2/ZEB1 | 2 |
| GO:0002645 | GO:0002645 | positive regulation of tolerance induction | 1/6 | 12/18888 | 0.0833333 | 262.333333 | 16.142231 | 0.0038064 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0042117 | GO:0042117 | monocyte activation | 1/6 | 12/18888 | 0.0833333 | 262.333333 | 16.142231 | 0.0038064 | 0.0308461 | 0.0108232 | ADAM10 | 1 |
| GO:0062042 | GO:0062042 | regulation of cardiac epithelial to mesenchymal transition | 1/6 | 12/18888 | 0.0833333 | 262.333333 | 16.142231 | 0.0038064 | 0.0308461 | 0.0108232 | TGFBR2 | 1 |
| GO:0072310 | GO:0072310 | glomerular epithelial cell development | 1/6 | 12/18888 | 0.0833333 | 262.333333 | 16.142231 | 0.0038064 | 0.0308461 | 0.0108232 | MAGI2 | 1 |
| GO:0071559 | GO:0071559 | response to transforming growth factor beta | 2/6 | 309/18888 | 0.0064725 | 20.375404 | 6.121417 | 0.0038314 | 0.0308461 | 0.0108232 | TGFBR2/ZEB1 | 2 |
| GO:0030217 | GO:0030217 | T cell differentiation | 2/6 | 310/18888 | 0.0064516 | 20.309677 | 6.110679 | 0.0038558 | 0.0308461 | 0.0108232 | TGFBR2/ZEB1 | 2 |
| GO:0002664 | GO:0002664 | regulation of T cell tolerance induction | 1/6 | 13/18888 | 0.0769231 | 242.153846 | 15.504419 | 0.0041231 | 0.0317397 | 0.0111367 | TGFBR2 | 1 |
| GO:0038180 | GO:0038180 | nerve growth factor signaling pathway | 1/6 | 13/18888 | 0.0769231 | 242.153846 | 15.504419 | 0.0041231 | 0.0317397 | 0.0111367 | MAGI2 | 1 |
| GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 2/6 | 328/18888 | 0.0060976 | 19.195122 | 5.925650 | 0.0043063 | 0.0325362 | 0.0114162 | TGFBR2/ZEB1 | 2 |
| GO:0003413 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 1/6 | 14/18888 | 0.0714286 | 224.857143 | 14.936062 | 0.0044396 | 0.0329339 | 0.0115558 | TGFBR2 | 1 |
| GO:0002517 | GO:0002517 | T cell tolerance induction | 1/6 | 15/18888 | 0.0666667 | 209.866667 | 14.425385 | 0.0047561 | 0.0330575 | 0.0115991 | TGFBR2 | 1 |
| GO:0003198 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 1/6 | 15/18888 | 0.0666667 | 209.866667 | 14.425385 | 0.0047561 | 0.0330575 | 0.0115991 | TGFBR2 | 1 |
| GO:0010820 | GO:0010820 | positive regulation of T cell chemotaxis | 1/6 | 15/18888 | 0.0666667 | 209.866667 | 14.425385 | 0.0047561 | 0.0330575 | 0.0115991 | ADAM10 | 1 |
| GO:0043010 | GO:0043010 | camera-type eye development | 2/6 | 346/18888 | 0.0057803 | 18.196532 | 5.754847 | 0.0047804 | 0.0330575 | 0.0115991 | TGFBR2/ZEB1 | 2 |
| GO:0003214 | GO:0003214 | cardiac left ventricle morphogenesis | 1/6 | 16/18888 | 0.0625000 | 196.750000 | 13.963231 | 0.0050725 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0010819 | GO:0010819 | regulation of T cell chemotaxis | 1/6 | 16/18888 | 0.0625000 | 196.750000 | 13.963231 | 0.0050725 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:1901342 | GO:1901342 | regulation of vasculature development | 2/6 | 362/18888 | 0.0055249 | 17.392265 | 5.613524 | 0.0052215 | 0.0334817 | 0.0117480 | TGFBR2/ADAM10 | 2 |
| GO:0032926 | GO:0032926 | negative regulation of activin receptor signaling pathway | 1/6 | 17/18888 | 0.0588235 | 185.176471 | 13.542357 | 0.0053888 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0050863 | GO:0050863 | regulation of T cell activation | 2/6 | 382/18888 | 0.0052356 | 16.481675 | 5.449121 | 0.0057987 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0003417 | GO:0003417 | growth plate cartilage development | 1/6 | 19/18888 | 0.0526316 | 165.684211 | 12.802283 | 0.0060212 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0032516 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1/6 | 19/18888 | 0.0526316 | 165.684211 | 12.802283 | 0.0060212 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0043011 | GO:0043011 | myeloid dendritic cell differentiation | 1/6 | 19/18888 | 0.0526316 | 165.684211 | 12.802283 | 0.0060212 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0046931 | GO:0046931 | pore complex assembly | 1/6 | 19/18888 | 0.0526316 | 165.684211 | 12.802283 | 0.0060212 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0060438 | GO:0060438 | trachea development | 1/6 | 19/18888 | 0.0526316 | 165.684211 | 12.802283 | 0.0060212 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0001654 | GO:0001654 | eye development | 2/6 | 393/18888 | 0.0050891 | 16.020356 | 5.363922 | 0.0061283 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0150063 | GO:0150063 | visual system development | 2/6 | 397/18888 | 0.0050378 | 15.858942 | 5.333792 | 0.0062503 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0002643 | GO:0002643 | regulation of tolerance induction | 1/6 | 20/18888 | 0.0500000 | 157.400000 | 12.474465 | 0.0063373 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0140131 | GO:0140131 | positive regulation of lymphocyte chemotaxis | 1/6 | 20/18888 | 0.0500000 | 157.400000 | 12.474465 | 0.0063373 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0001701 | GO:0001701 | in utero embryonic development | 2/6 | 401/18888 | 0.0049875 | 15.700748 | 5.304098 | 0.0063734 | 0.0334817 | 0.0117480 | TGFBR2/ADAM10 | 2 |
| GO:0048880 | GO:0048880 | sensory system development | 2/6 | 403/18888 | 0.0049628 | 15.622829 | 5.289411 | 0.0064354 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0042474 | GO:0042474 | middle ear morphogenesis | 1/6 | 21/18888 | 0.0476190 | 149.904762 | 12.170262 | 0.0066533 | 0.0334817 | 0.0117480 | PRRX1 | 1 |
| GO:1902683 | GO:1902683 | regulation of receptor localization to synapse | 1/6 | 21/18888 | 0.0476190 | 149.904762 | 12.170262 | 0.0066533 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0035739 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation | 1/6 | 22/18888 | 0.0454545 | 143.090909 | 11.886961 | 0.0069692 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0061318 | GO:0061318 | renal filtration cell differentiation | 1/6 | 22/18888 | 0.0454545 | 143.090909 | 11.886961 | 0.0069692 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0072112 | GO:0072112 | podocyte differentiation | 1/6 | 22/18888 | 0.0454545 | 143.090909 | 11.886961 | 0.0069692 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:1902473 | GO:1902473 | regulation of protein localization to synapse | 1/6 | 22/18888 | 0.0454545 | 143.090909 | 11.886961 | 0.0069692 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:2000561 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation | 1/6 | 22/18888 | 0.0454545 | 143.090909 | 11.886961 | 0.0069692 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:1903706 | GO:1903706 | regulation of hemopoiesis | 2/6 | 424/18888 | 0.0047170 | 14.849057 | 5.141305 | 0.0071031 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0072311 | GO:0072311 | glomerular epithelial cell differentiation | 1/6 | 23/18888 | 0.0434783 | 136.869565 | 11.622266 | 0.0072850 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0030098 | GO:0030098 | lymphocyte differentiation | 2/6 | 432/18888 | 0.0046296 | 14.574074 | 5.087641 | 0.0073656 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0003148 | GO:0003148 | outflow tract septum morphogenesis | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0010839 | GO:0010839 | negative regulation of keratinocyte proliferation | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | ZEB1 | 1 |
| GO:0035162 | GO:0035162 | embryonic hemopoiesis | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0046641 | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0090103 | GO:0090103 | cochlea morphogenesis | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | ZEB1 | 1 |
| GO:0097150 | GO:0097150 | neuronal stem cell population maintenance | 1/6 | 24/18888 | 0.0416667 | 131.166667 | 11.374220 | 0.0076007 | 0.0334817 | 0.0117480 | PRRX1 | 1 |
| GO:0099633 | GO:0099633 | protein localization to postsynaptic specialization membrane | 1/6 | 25/18888 | 0.0400000 | 125.920000 | 11.141142 | 0.0079164 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0099645 | GO:0099645 | neurotransmitter receptor localization to postsynaptic specialization membrane | 1/6 | 25/18888 | 0.0400000 | 125.920000 | 11.141142 | 0.0079164 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0002092 | GO:0002092 | positive regulation of receptor internalization | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0003181 | GO:0003181 | atrioventricular valve morphogenesis | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0032925 | GO:0032925 | regulation of activin receptor signaling pathway | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0048596 | GO:0048596 | embryonic camera-type eye morphogenesis | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | ZEB1 | 1 |
| GO:0062009 | GO:0062009 | secondary palate development | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0072010 | GO:0072010 | glomerular epithelium development | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:1901623 | GO:1901623 | regulation of lymphocyte chemotaxis | 1/6 | 26/18888 | 0.0384615 | 121.076923 | 10.921580 | 0.0082319 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0010975 | GO:0010975 | regulation of neuron projection development | 2/6 | 460/18888 | 0.0043478 | 13.686957 | 4.910553 | 0.0083193 | 0.0334817 | 0.0117480 | PRRX1/MAGI2 | 2 |
| GO:0010818 | GO:0010818 | T cell chemotaxis | 1/6 | 27/18888 | 0.0370370 | 116.592593 | 10.714272 | 0.0085474 | 0.0334817 | 0.0117480 | ADAM10 | 1 |
| GO:0033081 | GO:0033081 | regulation of T cell differentiation in thymus | 1/6 | 27/18888 | 0.0370370 | 116.592593 | 10.714272 | 0.0085474 | 0.0334817 | 0.0117480 | ZEB1 | 1 |
| GO:0007389 | GO:0007389 | pattern specification process | 2/6 | 474/18888 | 0.0042194 | 13.282700 | 4.827720 | 0.0088163 | 0.0334817 | 0.0117480 | TGFBR2/ZEB1 | 2 |
| GO:0001773 | GO:0001773 | myeloid dendritic cell activation | 1/6 | 28/18888 | 0.0357143 | 112.428571 | 10.518114 | 0.0088628 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0003272 | GO:0003272 | endocardial cushion formation | 1/6 | 28/18888 | 0.0357143 | 112.428571 | 10.518114 | 0.0088628 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0003416 | GO:0003416 | endochondral bone growth | 1/6 | 28/18888 | 0.0357143 | 112.428571 | 10.518114 | 0.0088628 | 0.0334817 | 0.0117480 | TGFBR2 | 1 |
| GO:0010922 | GO:0010922 | positive regulation of phosphatase activity | 1/6 | 28/18888 | 0.0357143 | 112.428571 | 10.518114 | 0.0088628 | 0.0334817 | 0.0117480 | MAGI2 | 1 |
| GO:0003171 | GO:0003171 | atrioventricular valve development | 1/6 | 29/18888 | 0.0344828 | 108.551724 | 10.332137 | 0.0091781 | 0.0337409 | 0.0118389 | TGFBR2 | 1 |
| GO:0003401 | GO:0003401 | axis elongation | 1/6 | 29/18888 | 0.0344828 | 108.551724 | 10.332137 | 0.0091781 | 0.0337409 | 0.0118389 | MAGI2 | 1 |
| GO:1903131 | GO:1903131 | mononuclear cell differentiation | 2/6 | 484/18888 | 0.0041322 | 13.008264 | 4.770676 | 0.0091795 | 0.0337409 | 0.0118389 | TGFBR2/ZEB1 | 2 |
| GO:0002507 | GO:0002507 | tolerance induction | 1/6 | 30/18888 | 0.0333333 | 104.933333 | 10.155488 | 0.0094934 | 0.0342769 | 0.0120270 | TGFBR2 | 1 |
| GO:0070723 | GO:0070723 | response to cholesterol | 1/6 | 30/18888 | 0.0333333 | 104.933333 | 10.155488 | 0.0094934 | 0.0342769 | 0.0120270 | TGFBR2 | 1 |
| GO:0016049 | GO:0016049 | cell growth | 2/6 | 496/18888 | 0.0040323 | 12.693548 | 4.704417 | 0.0096243 | 0.0344449 | 0.0120859 | TGFBR2/ADAM10 | 2 |
| GO:0098868 | GO:0098868 | bone growth | 1/6 | 31/18888 | 0.0322581 | 101.548387 | 9.987408 | 0.0098085 | 0.0347988 | 0.0122101 | TGFBR2 | 1 |
| GO:0002063 | GO:0002063 | chondrocyte development | 1/6 | 33/18888 | 0.0303030 | 95.393939 | 9.674331 | 0.0104385 | 0.0364011 | 0.0127723 | TGFBR2 | 1 |
| GO:0060351 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1/6 | 33/18888 | 0.0303030 | 95.393939 | 9.674331 | 0.0104385 | 0.0364011 | 0.0127723 | TGFBR2 | 1 |
| GO:0070570 | GO:0070570 | regulation of neuron projection regeneration | 1/6 | 34/18888 | 0.0294118 | 92.588235 | 9.528192 | 0.0107534 | 0.0371814 | 0.0130461 | PRRX1 | 1 |
| GO:0036314 | GO:0036314 | response to sterol | 1/6 | 35/18888 | 0.0285714 | 89.942857 | 9.388322 | 0.0110682 | 0.0374537 | 0.0131416 | TGFBR2 | 1 |
| GO:0048048 | GO:0048048 | embryonic eye morphogenesis | 1/6 | 35/18888 | 0.0285714 | 89.942857 | 9.388322 | 0.0110682 | 0.0374537 | 0.0131416 | ZEB1 | 1 |
| GO:0001569 | GO:0001569 | branching involved in blood vessel morphogenesis | 1/6 | 36/18888 | 0.0277778 | 87.444444 | 9.254282 | 0.0113830 | 0.0374537 | 0.0131416 | TGFBR2 | 1 |
| GO:0016486 | GO:0016486 | peptide hormone processing | 1/6 | 36/18888 | 0.0277778 | 87.444444 | 9.254282 | 0.0113830 | 0.0374537 | 0.0131416 | ADAM10 | 1 |
| GO:0060317 | GO:0060317 | cardiac epithelial to mesenchymal transition | 1/6 | 36/18888 | 0.0277778 | 87.444444 | 9.254282 | 0.0113830 | 0.0374537 | 0.0131416 | TGFBR2 | 1 |
| GO:2000406 | GO:2000406 | positive regulation of T cell migration | 1/6 | 36/18888 | 0.0277778 | 87.444444 | 9.254282 | 0.0113830 | 0.0374537 | 0.0131416 | ADAM10 | 1 |
| GO:0031076 | GO:0031076 | embryonic camera-type eye development | 1/6 | 37/18888 | 0.0270270 | 85.081081 | 9.125677 | 0.0116976 | 0.0375798 | 0.0131859 | ZEB1 | 1 |
| GO:0045880 | GO:0045880 | positive regulation of smoothened signaling pathway | 1/6 | 37/18888 | 0.0270270 | 85.081081 | 9.125677 | 0.0116976 | 0.0375798 | 0.0131859 | PRRX1 | 1 |
| GO:0060391 | GO:0060391 | positive regulation of SMAD protein signal transduction | 1/6 | 37/18888 | 0.0270270 | 85.081081 | 9.125677 | 0.0116976 | 0.0375798 | 0.0131859 | TGFBR2 | 1 |
| GO:0003180 | GO:0003180 | aortic valve morphogenesis | 1/6 | 38/18888 | 0.0263158 | 82.842105 | 9.002146 | 0.0120122 | 0.0379920 | 0.0133305 | TGFBR2 | 1 |
| GO:0035909 | GO:0035909 | aorta morphogenesis | 1/6 | 38/18888 | 0.0263158 | 82.842105 | 9.002146 | 0.0120122 | 0.0379920 | 0.0133305 | TGFBR2 | 1 |
| GO:0038179 | GO:0038179 | neurotrophin signaling pathway | 1/6 | 39/18888 | 0.0256410 | 80.717949 | 8.883362 | 0.0123267 | 0.0386868 | 0.0135743 | MAGI2 | 1 |
| GO:0140448 | GO:0140448 | signaling receptor ligand precursor processing | 1/6 | 40/18888 | 0.0250000 | 78.700000 | 8.769029 | 0.0126411 | 0.0393706 | 0.0138143 | ADAM10 | 1 |
| GO:0003203 | GO:0003203 | endocardial cushion morphogenesis | 1/6 | 41/18888 | 0.0243902 | 76.780488 | 8.658872 | 0.0129554 | 0.0400439 | 0.0140505 | TGFBR2 | 1 |
| GO:0001709 | GO:0001709 | cell fate determination | 1/6 | 42/18888 | 0.0238095 | 74.952381 | 8.552643 | 0.0132696 | 0.0404538 | 0.0141943 | PRRX1 | 1 |
| GO:0003176 | GO:0003176 | aortic valve development | 1/6 | 43/18888 | 0.0232558 | 73.209302 | 8.450111 | 0.0135837 | 0.0404538 | 0.0141943 | TGFBR2 | 1 |
| GO:0046640 | GO:0046640 | regulation of alpha-beta T cell proliferation | 1/6 | 43/18888 | 0.0232558 | 73.209302 | 8.450111 | 0.0135837 | 0.0404538 | 0.0141943 | TGFBR2 | 1 |
| GO:0060412 | GO:0060412 | ventricular septum morphogenesis | 1/6 | 43/18888 | 0.0232558 | 73.209302 | 8.450111 | 0.0135837 | 0.0404538 | 0.0141943 | TGFBR2 | 1 |
| GO:2000403 | GO:2000403 | positive regulation of lymphocyte migration | 1/6 | 43/18888 | 0.0232558 | 73.209302 | 8.450111 | 0.0135837 | 0.0404538 | 0.0141943 | ADAM10 | 1 |
| GO:0035307 | GO:0035307 | positive regulation of protein dephosphorylation | 1/6 | 44/18888 | 0.0227273 | 71.545455 | 8.351067 | 0.0138978 | 0.0405022 | 0.0142113 | MAGI2 | 1 |
| GO:0060443 | GO:0060443 | mammary gland morphogenesis | 1/6 | 44/18888 | 0.0227273 | 71.545455 | 8.351067 | 0.0138978 | 0.0405022 | 0.0142113 | TGFBR2 | 1 |
| GO:1903539 | GO:1903539 | protein localization to postsynaptic membrane | 1/6 | 44/18888 | 0.0227273 | 71.545455 | 8.351067 | 0.0138978 | 0.0405022 | 0.0142113 | ADAM10 | 1 |
| GO:0062237 | GO:0062237 | protein localization to postsynapse | 1/6 | 45/18888 | 0.0222222 | 69.955556 | 8.255314 | 0.0142118 | 0.0406343 | 0.0142577 | ADAM10 | 1 |
| GO:0097028 | GO:0097028 | dendritic cell differentiation | 1/6 | 45/18888 | 0.0222222 | 69.955556 | 8.255314 | 0.0142118 | 0.0406343 | 0.0142577 | TGFBR2 | 1 |
| GO:0045601 | GO:0045601 | regulation of endothelial cell differentiation | 1/6 | 46/18888 | 0.0217391 | 68.434783 | 8.162675 | 0.0145257 | 0.0406343 | 0.0142577 | ZEB1 | 1 |
| GO:0046633 | GO:0046633 | alpha-beta T cell proliferation | 1/6 | 46/18888 | 0.0217391 | 68.434783 | 8.162675 | 0.0145257 | 0.0406343 | 0.0142577 | TGFBR2 | 1 |
| GO:2000516 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 1/6 | 46/18888 | 0.0217391 | 68.434783 | 8.162675 | 0.0145257 | 0.0406343 | 0.0142577 | TGFBR2 | 1 |
| GO:0006509 | GO:0006509 | membrane protein ectodomain proteolysis | 1/6 | 47/18888 | 0.0212766 | 66.978723 | 8.072982 | 0.0148395 | 0.0406343 | 0.0142577 | ADAM10 | 1 |
| GO:0010837 | GO:0010837 | regulation of keratinocyte proliferation | 1/6 | 47/18888 | 0.0212766 | 66.978723 | 8.072982 | 0.0148395 | 0.0406343 | 0.0142577 | ZEB1 | 1 |
| GO:0043666 | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1/6 | 47/18888 | 0.0212766 | 66.978723 | 8.072982 | 0.0148395 | 0.0406343 | 0.0142577 | MAGI2 | 1 |
| GO:1905314 | GO:1905314 | semi-lunar valve development | 1/6 | 47/18888 | 0.0212766 | 66.978723 | 8.072982 | 0.0148395 | 0.0406343 | 0.0142577 | TGFBR2 | 1 |
| GO:0035850 | GO:0035850 | epithelial cell differentiation involved in kidney development | 1/6 | 48/18888 | 0.0208333 | 65.583333 | 7.986082 | 0.0151532 | 0.0406744 | 0.0142717 | MAGI2 | 1 |
| GO:0072583 | GO:0072583 | clathrin-dependent endocytosis | 1/6 | 48/18888 | 0.0208333 | 65.583333 | 7.986082 | 0.0151532 | 0.0406744 | 0.0142717 | MAGI2 | 1 |
| GO:1990090 | GO:1990090 | cellular response to nerve growth factor stimulus | 1/6 | 48/18888 | 0.0208333 | 65.583333 | 7.986082 | 0.0151532 | 0.0406744 | 0.0142717 | MAGI2 | 1 |
| GO:0051150 | GO:0051150 | regulation of smooth muscle cell differentiation | 1/6 | 49/18888 | 0.0204082 | 64.244898 | 7.901831 | 0.0154669 | 0.0412450 | 0.0144719 | ZEB1 | 1 |
| GO:0060071 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1/6 | 50/18888 | 0.0200000 | 62.960000 | 7.820097 | 0.0157804 | 0.0412719 | 0.0144814 | MAGI2 | 1 |
| GO:1990089 | GO:1990089 | response to nerve growth factor | 1/6 | 50/18888 | 0.0200000 | 62.960000 | 7.820097 | 0.0157804 | 0.0412719 | 0.0144814 | MAGI2 | 1 |
| GO:2000404 | GO:2000404 | regulation of T cell migration | 1/6 | 50/18888 | 0.0200000 | 62.960000 | 7.820097 | 0.0157804 | 0.0412719 | 0.0144814 | ADAM10 | 1 |
| GO:0003197 | GO:0003197 | endocardial cushion development | 1/6 | 52/18888 | 0.0192308 | 60.538461 | 7.663692 | 0.0164073 | 0.0426381 | 0.0149607 | TGFBR2 | 1 |
| GO:0048260 | GO:0048260 | positive regulation of receptor-mediated endocytosis | 1/6 | 53/18888 | 0.0188679 | 59.396226 | 7.588799 | 0.0167206 | 0.0431773 | 0.0151499 | MAGI2 | 1 |
| GO:0035306 | GO:0035306 | positive regulation of dephosphorylation | 1/6 | 54/18888 | 0.0185185 | 58.296296 | 7.515974 | 0.0170338 | 0.0434363 | 0.0152408 | MAGI2 | 1 |
| GO:0046638 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1/6 | 54/18888 | 0.0185185 | 58.296296 | 7.515974 | 0.0170338 | 0.0434363 | 0.0152408 | TGFBR2 | 1 |
| GO:0030857 | GO:0030857 | negative regulation of epithelial cell differentiation | 1/6 | 55/18888 | 0.0181818 | 57.236364 | 7.445124 | 0.0173470 | 0.0436887 | 0.0153294 | ZEB1 | 1 |
| GO:0060425 | GO:0060425 | lung morphogenesis | 1/6 | 55/18888 | 0.0181818 | 57.236364 | 7.445124 | 0.0173470 | 0.0436887 | 0.0153294 | TGFBR2 | 1 |
| GO:2000648 | GO:2000648 | positive regulation of stem cell proliferation | 1/6 | 56/18888 | 0.0178571 | 56.214286 | 7.376161 | 0.0176601 | 0.0442043 | 0.0155103 | PRRX1 | 1 |
| GO:0034332 | GO:0034332 | adherens junction organization | 1/6 | 57/18888 | 0.0175439 | 55.228070 | 7.309001 | 0.0179730 | 0.0447134 | 0.0156889 | ADAM10 | 1 |
| GO:0061005 | GO:0061005 | cell differentiation involved in kidney development | 1/6 | 58/18888 | 0.0172414 | 54.275862 | 7.243566 | 0.0182859 | 0.0449011 | 0.0157548 | MAGI2 | 1 |
| GO:0072132 | GO:0072132 | mesenchyme morphogenesis | 1/6 | 58/18888 | 0.0172414 | 54.275862 | 7.243566 | 0.0182859 | 0.0449011 | 0.0157548 | TGFBR2 | 1 |
| GO:0010718 | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1/6 | 59/18888 | 0.0169492 | 53.355932 | 7.179784 | 0.0185987 | 0.0449011 | 0.0157548 | TGFBR2 | 1 |
| GO:0010921 | GO:0010921 | regulation of phosphatase activity | 1/6 | 59/18888 | 0.0169492 | 53.355932 | 7.179784 | 0.0185987 | 0.0449011 | 0.0157548 | MAGI2 | 1 |
| GO:0043616 | GO:0043616 | keratinocyte proliferation | 1/6 | 59/18888 | 0.0169492 | 53.355932 | 7.179784 | 0.0185987 | 0.0449011 | 0.0157548 | ZEB1 | 1 |
| GO:0043113 | GO:0043113 | receptor clustering | 1/6 | 60/18888 | 0.0166667 | 52.466667 | 7.117585 | 0.0189115 | 0.0451221 | 0.0158323 | MAGI2 | 1 |
| GO:0060350 | GO:0060350 | endochondral bone morphogenesis | 1/6 | 60/18888 | 0.0166667 | 52.466667 | 7.117585 | 0.0189115 | 0.0451221 | 0.0158323 | TGFBR2 | 1 |
| GO:0003179 | GO:0003179 | heart valve morphogenesis | 1/6 | 61/18888 | 0.0163934 | 51.606557 | 7.056905 | 0.0192241 | 0.0452896 | 0.0158911 | TGFBR2 | 1 |
| GO:0031102 | GO:0031102 | neuron projection regeneration | 1/6 | 61/18888 | 0.0163934 | 51.606557 | 7.056905 | 0.0192241 | 0.0452896 | 0.0158911 | PRRX1 | 1 |
| GO:0002090 | GO:0002090 | regulation of receptor internalization | 1/6 | 62/18888 | 0.0161290 | 50.774194 | 6.997681 | 0.0195367 | 0.0452896 | 0.0158911 | MAGI2 | 1 |
| GO:0033619 | GO:0033619 | membrane protein proteolysis | 1/6 | 62/18888 | 0.0161290 | 50.774194 | 6.997681 | 0.0195367 | 0.0452896 | 0.0158911 | ADAM10 | 1 |
| GO:0097120 | GO:0097120 | receptor localization to synapse | 1/6 | 62/18888 | 0.0161290 | 50.774194 | 6.997681 | 0.0195367 | 0.0452896 | 0.0158911 | ADAM10 | 1 |
| GO:0022617 | GO:0022617 | extracellular matrix disassembly | 1/6 | 64/18888 | 0.0156250 | 49.187500 | 6.883377 | 0.0201616 | 0.0462130 | 0.0162151 | ADAM10 | 1 |
| GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 1/6 | 64/18888 | 0.0156250 | 49.187500 | 6.883377 | 0.0201616 | 0.0462130 | 0.0162151 | ADAM10 | 1 |
| GO:0035904 | GO:0035904 | aorta development | 1/6 | 65/18888 | 0.0153846 | 48.430769 | 6.828189 | 0.0204739 | 0.0466667 | 0.0163743 | TGFBR2 | 1 |
| GO:0001947 | GO:0001947 | heart looping | 1/6 | 66/18888 | 0.0151515 | 47.696970 | 6.774245 | 0.0207861 | 0.0468549 | 0.0164403 | TGFBR2 | 1 |
| GO:0051898 | GO:0051898 | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/6 | 66/18888 | 0.0151515 | 47.696970 | 6.774245 | 0.0207861 | 0.0468549 | 0.0164403 | MAGI2 | 1 |
| GO:0045143 | GO:0045143 | homologous chromosome segregation | 1/6 | 67/18888 | 0.0149254 | 46.985075 | 6.721498 | 0.0210983 | 0.0472972 | 0.0165955 | PTTG1 | 1 |
| GO:0042987 | GO:0042987 | amyloid precursor protein catabolic process | 1/6 | 68/18888 | 0.0147059 | 46.294118 | 6.669904 | 0.0214103 | 0.0474932 | 0.0166643 | ADAM10 | 1 |
| GO:0048645 | GO:0048645 | animal organ formation | 1/6 | 69/18888 | 0.0144928 | 45.623188 | 6.619421 | 0.0217223 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:2000379 | GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1/6 | 70/18888 | 0.0142857 | 44.971429 | 6.570009 | 0.0220342 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 1/6 | 70/18888 | 0.0142857 | 44.971429 | 6.570009 | 0.0220342 | 0.0474932 | 0.0166643 | ADAM10 | 1 |
| GO:0003208 | GO:0003208 | cardiac ventricle morphogenesis | 1/6 | 71/18888 | 0.0140845 | 44.338028 | 6.521631 | 0.0223460 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0032835 | GO:0032835 | glomerulus development | 1/6 | 71/18888 | 0.0140845 | 44.338028 | 6.521631 | 0.0223460 | 0.0474932 | 0.0166643 | MAGI2 | 1 |
| GO:0035567 | GO:0035567 | non-canonical Wnt signaling pathway | 1/6 | 71/18888 | 0.0140845 | 44.338028 | 6.521631 | 0.0223460 | 0.0474932 | 0.0166643 | MAGI2 | 1 |
| GO:0061371 | GO:0061371 | determination of heart left/right asymmetry | 1/6 | 71/18888 | 0.0140845 | 44.338028 | 6.521631 | 0.0223460 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0071677 | GO:0071677 | positive regulation of mononuclear cell migration | 1/6 | 71/18888 | 0.0140845 | 44.338028 | 6.521631 | 0.0223460 | 0.0474932 | 0.0166643 | ADAM10 | 1 |
| GO:0003143 | GO:0003143 | embryonic heart tube morphogenesis | 1/6 | 72/18888 | 0.0138889 | 43.722222 | 6.474251 | 0.0226578 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0060411 | GO:0060411 | cardiac septum morphogenesis | 1/6 | 72/18888 | 0.0138889 | 43.722222 | 6.474251 | 0.0226578 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0003170 | GO:0003170 | heart valve development | 1/6 | 73/18888 | 0.0136986 | 43.123288 | 6.427835 | 0.0229694 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 1/6 | 73/18888 | 0.0136986 | 43.123288 | 6.427835 | 0.0229694 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0003281 | GO:0003281 | ventricular septum development | 1/6 | 74/18888 | 0.0135135 | 42.540540 | 6.382349 | 0.0232810 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0014823 | GO:0014823 | response to activity | 1/6 | 74/18888 | 0.0135135 | 42.540540 | 6.382349 | 0.0232810 | 0.0474932 | 0.0166643 | ZEB1 | 1 |
| GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 1/6 | 74/18888 | 0.0135135 | 42.540540 | 6.382349 | 0.0232810 | 0.0474932 | 0.0166643 | TGFBR2 | 1 |
| GO:0048663 | GO:0048663 | neuron fate commitment | 1/6 | 74/18888 | 0.0135135 | 42.540540 | 6.382349 | 0.0232810 | 0.0474932 | 0.0166643 | PRRX1 | 1 |
| GO:0072678 | GO:0072678 | T cell migration | 1/6 | 74/18888 | 0.0135135 | 42.540540 | 6.382349 | 0.0232810 | 0.0474932 | 0.0166643 | ADAM10 | 1 |
| GO:0060390 | GO:0060390 | regulation of SMAD protein signal transduction | 1/6 | 75/18888 | 0.0133333 | 41.973333 | 6.337763 | 0.0235925 | 0.0478892 | 0.0168032 | TGFBR2 | 1 |
| GO:0035418 | GO:0035418 | protein localization to synapse | 1/6 | 78/18888 | 0.0128205 | 40.358974 | 6.209116 | 0.0245264 | 0.0490529 | 0.0172115 | ADAM10 | 1 |
| GO:0051145 | GO:0051145 | smooth muscle cell differentiation | 1/6 | 78/18888 | 0.0128205 | 40.358974 | 6.209116 | 0.0245264 | 0.0490529 | 0.0172115 | ZEB1 | 1 |
| GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1/6 | 78/18888 | 0.0128205 | 40.358974 | 6.209116 | 0.0245264 | 0.0490529 | 0.0172115 | TGFBR2 | 1 |
| GO:0035304 | GO:0035304 | regulation of protein dephosphorylation | 1/6 | 79/18888 | 0.0126582 | 39.848101 | 6.167847 | 0.0248376 | 0.0494329 | 0.0173449 | MAGI2 | 1 |
| GO:0003151 | GO:0003151 | outflow tract morphogenesis | 1/6 | 81/18888 | 0.0123457 | 38.864198 | 6.087579 | 0.0254597 | 0.0504250 | 0.0176930 | TGFBR2 | 1 |
| GO:0032147 | GO:0032147 | activation of protein kinase activity | 1/6 | 82/18888 | 0.0121951 | 38.390244 | 6.048534 | 0.0257706 | 0.0507942 | 0.0178225 | TGFBR2 | 1 |
| GO:0001570 | GO:0001570 | vasculogenesis | 1/6 | 83/18888 | 0.0120482 | 37.927711 | 6.010186 | 0.0260814 | 0.0509149 | 0.0178649 | TGFBR2 | 1 |
| GO:2000736 | GO:2000736 | regulation of stem cell differentiation | 1/6 | 83/18888 | 0.0120482 | 37.927711 | 6.010186 | 0.0260814 | 0.0509149 | 0.0178649 | TGFBR2 | 1 |
| GO:0008589 | GO:0008589 | regulation of smoothened signaling pathway | 1/6 | 85/18888 | 0.0117647 | 37.035294 | 5.935497 | 0.0267028 | 0.0518797 | 0.0182034 | PRRX1 | 1 |
| GO:0035050 | GO:0035050 | embryonic heart tube development | 1/6 | 86/18888 | 0.0116279 | 36.604651 | 5.899118 | 0.0270134 | 0.0519880 | 0.0182414 | TGFBR2 | 1 |
| GO:0071230 | GO:0071230 | cellular response to amino acid stimulus | 1/6 | 86/18888 | 0.0116279 | 36.604651 | 5.899118 | 0.0270134 | 0.0519880 | 0.0182414 | ZEB1 | 1 |
| GO:0033077 | GO:0033077 | T cell differentiation in thymus | 1/6 | 87/18888 | 0.0114943 | 36.183908 | 5.863357 | 0.0273239 | 0.0523387 | 0.0183645 | ZEB1 | 1 |
| GO:0099072 | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 1/6 | 88/18888 | 0.0113636 | 35.772727 | 5.828198 | 0.0276343 | 0.0526859 | 0.0184863 | ADAM10 | 1 |
| GO:0002088 | GO:0002088 | lens development in camera-type eye | 1/6 | 90/18888 | 0.0111111 | 34.977778 | 5.759616 | 0.0282549 | 0.0536185 | 0.0188135 | TGFBR2 | 1 |
| GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 1/6 | 93/18888 | 0.0107527 | 33.849462 | 5.660851 | 0.0291851 | 0.0548734 | 0.0192538 | ADAM10 | 1 |
| GO:0045132 | GO:0045132 | meiotic chromosome segregation | 1/6 | 93/18888 | 0.0107527 | 33.849462 | 5.660851 | 0.0291851 | 0.0548734 | 0.0192538 | PTTG1 | 1 |
| GO:0045666 | GO:0045666 | positive regulation of neuron differentiation | 1/6 | 94/18888 | 0.0106383 | 33.489362 | 5.628966 | 0.0294950 | 0.0552017 | 0.0193690 | ZEB1 | 1 |
| GO:0071229 | GO:0071229 | cellular response to acid chemical | 1/6 | 95/18888 | 0.0105263 | 33.136842 | 5.597577 | 0.0298049 | 0.0555269 | 0.0194831 | ZEB1 | 1 |
| GO:0042982 | GO:0042982 | amyloid precursor protein metabolic process | 1/6 | 96/18888 | 0.0104167 | 32.791667 | 5.566671 | 0.0301146 | 0.0558489 | 0.0195961 | ADAM10 | 1 |
| GO:0060349 | GO:0060349 | bone morphogenesis | 1/6 | 99/18888 | 0.0101010 | 31.797980 | 5.476727 | 0.0310434 | 0.0573108 | 0.0201091 | TGFBR2 | 1 |
| GO:0008593 | GO:0008593 | regulation of Notch signaling pathway | 1/6 | 100/18888 | 0.0100000 | 31.480000 | 5.447633 | 0.0313528 | 0.0576214 | 0.0202180 | ADAM10 | 1 |
| GO:0099175 | GO:0099175 | regulation of postsynapse organization | 1/6 | 103/18888 | 0.0097087 | 30.563107 | 5.362857 | 0.0322806 | 0.0590604 | 0.0207230 | ADAM10 | 1 |
| GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 1/6 | 104/18888 | 0.0096154 | 30.269231 | 5.335401 | 0.0325897 | 0.0593597 | 0.0208280 | TGFBR2 | 1 |
| GO:0090100 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1/6 | 105/18888 | 0.0095238 | 29.980952 | 5.308330 | 0.0328987 | 0.0596563 | 0.0209320 | TGFBR2 | 1 |
| GO:0035303 | GO:0035303 | regulation of dephosphorylation | 1/6 | 106/18888 | 0.0094340 | 29.698113 | 5.281636 | 0.0332076 | 0.0599500 | 0.0210351 | MAGI2 | 1 |
| GO:0003279 | GO:0003279 | cardiac septum development | 1/6 | 108/18888 | 0.0092593 | 29.148148 | 5.229342 | 0.0338252 | 0.0605293 | 0.0212384 | TGFBR2 | 1 |
| GO:1902414 | GO:1902414 | protein localization to cell junction | 1/6 | 108/18888 | 0.0092593 | 29.148148 | 5.229342 | 0.0338252 | 0.0605293 | 0.0212384 | ADAM10 | 1 |
| GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 1/6 | 111/18888 | 0.0090090 | 28.360360 | 5.153512 | 0.0347510 | 0.0619145 | 0.0217244 | ADAM10 | 1 |
| GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 1/6 | 115/18888 | 0.0086957 | 27.373913 | 5.056963 | 0.0359843 | 0.0635566 | 0.0223006 | TGFBR2 | 1 |
| GO:0048259 | GO:0048259 | regulation of receptor-mediated endocytosis | 1/6 | 115/18888 | 0.0086957 | 27.373913 | 5.056963 | 0.0359843 | 0.0635566 | 0.0223006 | MAGI2 | 1 |
| GO:0002062 | GO:0002062 | chondrocyte differentiation | 1/6 | 116/18888 | 0.0086207 | 27.137931 | 5.033592 | 0.0362924 | 0.0638245 | 0.0223946 | TGFBR2 | 1 |
| GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 1/6 | 119/18888 | 0.0084034 | 26.453782 | 4.965218 | 0.0372162 | 0.0650496 | 0.0228244 | TGFBR2 | 1 |
| GO:0010717 | GO:0010717 | regulation of epithelial to mesenchymal transition | 1/6 | 120/18888 | 0.0083333 | 26.233333 | 4.942986 | 0.0375240 | 0.0650496 | 0.0228244 | TGFBR2 | 1 |
| GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 1/6 | 120/18888 | 0.0083333 | 26.233333 | 4.942986 | 0.0375240 | 0.0650496 | 0.0228244 | TGFBR2 | 1 |
| GO:0072009 | GO:0072009 | nephron epithelium development | 1/6 | 121/18888 | 0.0082645 | 26.016529 | 4.921023 | 0.0378317 | 0.0650496 | 0.0228244 | MAGI2 | 1 |
| GO:0030326 | GO:0030326 | embryonic limb morphogenesis | 1/6 | 122/18888 | 0.0081967 | 25.803279 | 4.899325 | 0.0381393 | 0.0650496 | 0.0228244 | PRRX1 | 1 |
| GO:0035113 | GO:0035113 | embryonic appendage morphogenesis | 1/6 | 122/18888 | 0.0081967 | 25.803279 | 4.899325 | 0.0381393 | 0.0650496 | 0.0228244 | PRRX1 | 1 |
| GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 1/6 | 123/18888 | 0.0081301 | 25.593496 | 4.877886 | 0.0384468 | 0.0650496 | 0.0228244 | ADAM10 | 1 |
| GO:0045446 | GO:0045446 | endothelial cell differentiation | 1/6 | 123/18888 | 0.0081301 | 25.593496 | 4.877886 | 0.0384468 | 0.0650496 | 0.0228244 | ZEB1 | 1 |
| GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 1/6 | 123/18888 | 0.0081301 | 25.593496 | 4.877886 | 0.0384468 | 0.0650496 | 0.0228244 | ADAM10 | 1 |
| GO:0043200 | GO:0043200 | response to amino acid | 1/6 | 124/18888 | 0.0080645 | 25.387097 | 4.856701 | 0.0387543 | 0.0650496 | 0.0228244 | ZEB1 | 1 |
| GO:0022612 | GO:0022612 | gland morphogenesis | 1/6 | 125/18888 | 0.0080000 | 25.184000 | 4.835764 | 0.0390616 | 0.0650496 | 0.0228244 | TGFBR2 | 1 |
| GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 1/6 | 125/18888 | 0.0080000 | 25.184000 | 4.835764 | 0.0390616 | 0.0650496 | 0.0228244 | TGFBR2 | 1 |
| GO:0072676 | GO:0072676 | lymphocyte migration | 1/6 | 125/18888 | 0.0080000 | 25.184000 | 4.835764 | 0.0390616 | 0.0650496 | 0.0228244 | ADAM10 | 1 |
| GO:0003206 | GO:0003206 | cardiac chamber morphogenesis | 1/6 | 127/18888 | 0.0078740 | 24.787402 | 4.794618 | 0.0396761 | 0.0652736 | 0.0229030 | TGFBR2 | 1 |
| GO:0003231 | GO:0003231 | cardiac ventricle development | 1/6 | 127/18888 | 0.0078740 | 24.787402 | 4.794618 | 0.0396761 | 0.0652736 | 0.0229030 | TGFBR2 | 1 |
| GO:0031623 | GO:0031623 | receptor internalization | 1/6 | 127/18888 | 0.0078740 | 24.787402 | 4.794618 | 0.0396761 | 0.0652736 | 0.0229030 | MAGI2 | 1 |
| GO:0007127 | GO:0007127 | meiosis I | 1/6 | 131/18888 | 0.0076336 | 24.030534 | 4.715102 | 0.0409041 | 0.0670236 | 0.0235171 | PTTG1 | 1 |
| GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 1/6 | 133/18888 | 0.0075188 | 23.669173 | 4.676663 | 0.0415176 | 0.0674869 | 0.0236796 | TGFBR2 | 1 |
| GO:0048593 | GO:0048593 | camera-type eye morphogenesis | 1/6 | 133/18888 | 0.0075188 | 23.669173 | 4.676663 | 0.0415176 | 0.0674869 | 0.0236796 | ZEB1 | 1 |
| GO:0030879 | GO:0030879 | mammary gland development | 1/6 | 135/18888 | 0.0074074 | 23.318518 | 4.639060 | 0.0421308 | 0.0682118 | 0.0239340 | TGFBR2 | 1 |
| GO:0007368 | GO:0007368 | determination of left/right symmetry | 1/6 | 137/18888 | 0.0072993 | 22.978102 | 4.602262 | 0.0427437 | 0.0686592 | 0.0240909 | TGFBR2 | 1 |
| GO:1904375 | GO:1904375 | regulation of protein localization to cell periphery | 1/6 | 137/18888 | 0.0072993 | 22.978102 | 4.602262 | 0.0427437 | 0.0686592 | 0.0240909 | ADAM10 | 1 |
| GO:0001101 | GO:0001101 | response to acid chemical | 1/6 | 139/18888 | 0.0071942 | 22.647482 | 4.566241 | 0.0433562 | 0.0690990 | 0.0242453 | ZEB1 | 1 |
| GO:0061982 | GO:0061982 | meiosis I cell cycle process | 1/6 | 139/18888 | 0.0071942 | 22.647482 | 4.566241 | 0.0433562 | 0.0690990 | 0.0242453 | PTTG1 | 1 |
| GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 1/6 | 142/18888 | 0.0070423 | 22.169014 | 4.513606 | 0.0442744 | 0.0699568 | 0.0245462 | ADAM10 | 1 |
| GO:0003158 | GO:0003158 | endothelium development | 1/6 | 143/18888 | 0.0069930 | 22.013986 | 4.496420 | 0.0445803 | 0.0699568 | 0.0245462 | ZEB1 | 1 |
| GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 1/6 | 143/18888 | 0.0069930 | 22.013986 | 4.496420 | 0.0445803 | 0.0699568 | 0.0245462 | TGFBR2 | 1 |
| GO:0060972 | GO:0060972 | left/right pattern formation | 1/6 | 143/18888 | 0.0069930 | 22.013986 | 4.496420 | 0.0445803 | 0.0699568 | 0.0245462 | TGFBR2 | 1 |
| GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 1/6 | 146/18888 | 0.0068493 | 21.561644 | 4.445897 | 0.0454975 | 0.0707866 | 0.0248374 | TGFBR2 | 1 |
| GO:0009799 | GO:0009799 | specification of symmetry | 1/6 | 147/18888 | 0.0068027 | 21.414966 | 4.429392 | 0.0458031 | 0.0707866 | 0.0248374 | TGFBR2 | 1 |
| GO:0009855 | GO:0009855 | determination of bilateral symmetry | 1/6 | 147/18888 | 0.0068027 | 21.414966 | 4.429392 | 0.0458031 | 0.0707866 | 0.0248374 | TGFBR2 | 1 |
| GO:1904019 | GO:1904019 | epithelial cell apoptotic process | 1/6 | 147/18888 | 0.0068027 | 21.414966 | 4.429392 | 0.0458031 | 0.0707866 | 0.0248374 | TGFBR2 | 1 |
| GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 1/6 | 149/18888 | 0.0067114 | 21.127517 | 4.396866 | 0.0464140 | 0.0711249 | 0.0249561 | ADAM10 | 1 |
| GO:2000377 | GO:2000377 | regulation of reactive oxygen species metabolic process | 1/6 | 149/18888 | 0.0067114 | 21.127517 | 4.396866 | 0.0464140 | 0.0711249 | 0.0249561 | TGFBR2 | 1 |
| GO:0035107 | GO:0035107 | appendage morphogenesis | 1/6 | 150/18888 | 0.0066667 | 20.986667 | 4.380841 | 0.0467193 | 0.0711249 | 0.0249561 | PRRX1 | 1 |
| GO:0035108 | GO:0035108 | limb morphogenesis | 1/6 | 150/18888 | 0.0066667 | 20.986667 | 4.380841 | 0.0467193 | 0.0711249 | 0.0249561 | PRRX1 | 1 |
| GO:0072073 | GO:0072073 | kidney epithelium development | 1/6 | 152/18888 | 0.0065789 | 20.710526 | 4.349253 | 0.0473297 | 0.0717863 | 0.0251882 | MAGI2 | 1 |
| GO:0045807 | GO:0045807 | positive regulation of endocytosis | 1/6 | 155/18888 | 0.0064516 | 20.309677 | 4.302990 | 0.0482447 | 0.0729031 | 0.0255800 | MAGI2 | 1 |
| GO:0048754 | GO:0048754 | branching morphogenesis of an epithelial tube | 1/6 | 157/18888 | 0.0063694 | 20.050955 | 4.272865 | 0.0488543 | 0.0735519 | 0.0258077 | TGFBR2 | 1 |
| GO:0072006 | GO:0072006 | nephron development | 1/6 | 158/18888 | 0.0063291 | 19.924051 | 4.258012 | 0.0491590 | 0.0737385 | 0.0258731 | MAGI2 | 1 |
| GO:0010976 | GO:0010976 | positive regulation of neuron projection development | 1/6 | 161/18888 | 0.0062112 | 19.552795 | 4.214260 | 0.0500725 | 0.0742894 | 0.0260665 | MAGI2 | 1 |
| GO:0050657 | GO:0050657 | nucleic acid transport | 1/6 | 161/18888 | 0.0062112 | 19.552795 | 4.214260 | 0.0500725 | 0.0742894 | 0.0260665 | TGFBR2 | 1 |
| GO:0050658 | GO:0050658 | RNA transport | 1/6 | 161/18888 | 0.0062112 | 19.552795 | 4.214260 | 0.0500725 | 0.0742894 | 0.0260665 | TGFBR2 | 1 |
| GO:0048592 | GO:0048592 | eye morphogenesis | 1/6 | 162/18888 | 0.0061728 | 19.432099 | 4.199938 | 0.0503769 | 0.0744702 | 0.0261299 | ZEB1 | 1 |
| GO:0030307 | GO:0030307 | positive regulation of cell growth | 1/6 | 163/18888 | 0.0061350 | 19.312883 | 4.185745 | 0.0506811 | 0.0745592 | 0.0261611 | ADAM10 | 1 |
| GO:0051236 | GO:0051236 | establishment of RNA localization | 1/6 | 164/18888 | 0.0060976 | 19.195122 | 4.171677 | 0.0509853 | 0.0745592 | 0.0261611 | TGFBR2 | 1 |
| GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 1/6 | 164/18888 | 0.0060976 | 19.195122 | 4.171677 | 0.0509853 | 0.0745592 | 0.0261611 | TGFBR2 | 1 |
| GO:0051147 | GO:0051147 | regulation of muscle cell differentiation | 1/6 | 165/18888 | 0.0060606 | 19.078788 | 4.157734 | 0.0512894 | 0.0747360 | 0.0262232 | ZEB1 | 1 |
| GO:0003205 | GO:0003205 | cardiac chamber development | 1/6 | 168/18888 | 0.0059524 | 18.738095 | 4.116630 | 0.0522013 | 0.0757940 | 0.0265944 | TGFBR2 | 1 |
| GO:0030856 | GO:0030856 | regulation of epithelial cell differentiation | 1/6 | 171/18888 | 0.0058480 | 18.409357 | 4.076578 | 0.0531124 | 0.0768434 | 0.0269626 | ZEB1 | 1 |
| GO:0050680 | GO:0050680 | negative regulation of epithelial cell proliferation | 1/6 | 173/18888 | 0.0057803 | 18.196532 | 4.050439 | 0.0537194 | 0.0774470 | 0.0271744 | ZEB1 | 1 |
| GO:0010634 | GO:0010634 | positive regulation of epithelial cell migration | 1/6 | 177/18888 | 0.0056497 | 17.785311 | 3.999453 | 0.0549324 | 0.0786400 | 0.0275930 | TGFBR2 | 1 |
| GO:0017015 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1/6 | 177/18888 | 0.0056497 | 17.785311 | 3.999453 | 0.0549324 | 0.0786400 | 0.0275930 | ZEB1 | 1 |
| GO:0035265 | GO:0035265 | organ growth | 1/6 | 180/18888 | 0.0055556 | 17.488889 | 3.962298 | 0.0558413 | 0.0789889 | 0.0277154 | TGFBR2 | 1 |
| GO:1903844 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 1/6 | 180/18888 | 0.0055556 | 17.488889 | 3.962298 | 0.0558413 | 0.0789889 | 0.0277154 | ZEB1 | 1 |
| GO:1905475 | GO:1905475 | regulation of protein localization to membrane | 1/6 | 180/18888 | 0.0055556 | 17.488889 | 3.962298 | 0.0558413 | 0.0789889 | 0.0277154 | ADAM10 | 1 |
| GO:0042129 | GO:0042129 | regulation of T cell proliferation | 1/6 | 181/18888 | 0.0055249 | 17.392265 | 3.950111 | 0.0561441 | 0.0789889 | 0.0277154 | TGFBR2 | 1 |
| GO:0046631 | GO:0046631 | alpha-beta T cell activation | 1/6 | 181/18888 | 0.0055249 | 17.392265 | 3.950111 | 0.0561441 | 0.0789889 | 0.0277154 | TGFBR2 | 1 |
| GO:0019827 | GO:0019827 | stem cell population maintenance | 1/6 | 182/18888 | 0.0054945 | 17.296703 | 3.938022 | 0.0564468 | 0.0791419 | 0.0277691 | PRRX1 | 1 |
| GO:0048736 | GO:0048736 | appendage development | 1/6 | 186/18888 | 0.0053763 | 16.924731 | 3.890610 | 0.0576569 | 0.0798898 | 0.0280315 | PRRX1 | 1 |
| GO:0060173 | GO:0060173 | limb development | 1/6 | 186/18888 | 0.0053763 | 16.924731 | 3.890610 | 0.0576569 | 0.0798898 | 0.0280315 | PRRX1 | 1 |
| GO:0098727 | GO:0098727 | maintenance of cell number | 1/6 | 186/18888 | 0.0053763 | 16.924731 | 3.890610 | 0.0576569 | 0.0798898 | 0.0280315 | PRRX1 | 1 |
| GO:0001837 | GO:0001837 | epithelial to mesenchymal transition | 1/6 | 187/18888 | 0.0053476 | 16.834225 | 3.878987 | 0.0579593 | 0.0798898 | 0.0280315 | TGFBR2 | 1 |
| GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 1/6 | 187/18888 | 0.0053476 | 16.834225 | 3.878987 | 0.0579593 | 0.0798898 | 0.0280315 | TGFBR2 | 1 |
| GO:0061138 | GO:0061138 | morphogenesis of a branching epithelium | 1/6 | 189/18888 | 0.0052910 | 16.656085 | 3.856009 | 0.0585637 | 0.0800574 | 0.0280903 | TGFBR2 | 1 |
| GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 1/6 | 190/18888 | 0.0052632 | 16.568421 | 3.844651 | 0.0588657 | 0.0800574 | 0.0280903 | TGFBR2 | 1 |
| GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 1/6 | 190/18888 | 0.0052632 | 16.568421 | 3.844651 | 0.0588657 | 0.0800574 | 0.0280903 | TGFBR2 | 1 |
| GO:1904018 | GO:1904018 | positive regulation of vasculature development | 1/6 | 190/18888 | 0.0052632 | 16.568421 | 3.844651 | 0.0588657 | 0.0800574 | 0.0280903 | TGFBR2 | 1 |
| GO:0031503 | GO:0031503 | protein-containing complex localization | 1/6 | 191/18888 | 0.0052356 | 16.481675 | 3.833379 | 0.0591677 | 0.0802008 | 0.0281406 | ADAM10 | 1 |
| GO:0030324 | GO:0030324 | lung development | 1/6 | 193/18888 | 0.0051813 | 16.310881 | 3.811090 | 0.0597715 | 0.0807509 | 0.0283336 | TGFBR2 | 1 |
| GO:0045664 | GO:0045664 | regulation of neuron differentiation | 1/6 | 196/18888 | 0.0051020 | 16.061225 | 3.778275 | 0.0606765 | 0.0810392 | 0.0284348 | ZEB1 | 1 |
| GO:0099173 | GO:0099173 | postsynapse organization | 1/6 | 196/18888 | 0.0051020 | 16.061225 | 3.778275 | 0.0606765 | 0.0810392 | 0.0284348 | ADAM10 | 1 |
| GO:0002520 | GO:0002520 | immune system development | 1/6 | 197/18888 | 0.0050761 | 15.979695 | 3.767497 | 0.0609780 | 0.0810392 | 0.0284348 | TGFBR2 | 1 |
| GO:0030323 | GO:0030323 | respiratory tube development | 1/6 | 197/18888 | 0.0050761 | 15.979695 | 3.767497 | 0.0609780 | 0.0810392 | 0.0284348 | TGFBR2 | 1 |
| GO:0140013 | GO:0140013 | meiotic nuclear division | 1/6 | 197/18888 | 0.0050761 | 15.979695 | 3.767497 | 0.0609780 | 0.0810392 | 0.0284348 | PTTG1 | 1 |
| GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1/6 | 198/18888 | 0.0050505 | 15.898990 | 3.756798 | 0.0612795 | 0.0811754 | 0.0284826 | MAGI2 | 1 |
| GO:0006403 | GO:0006403 | RNA localization | 1/6 | 200/18888 | 0.0050000 | 15.740000 | 3.735633 | 0.0618821 | 0.0811830 | 0.0284853 | TGFBR2 | 1 |
| GO:0007369 | GO:0007369 | gastrulation | 1/6 | 200/18888 | 0.0050000 | 15.740000 | 3.735633 | 0.0618821 | 0.0811830 | 0.0284853 | TGFBR2 | 1 |
| GO:0031099 | GO:0031099 | regeneration | 1/6 | 200/18888 | 0.0050000 | 15.740000 | 3.735633 | 0.0618821 | 0.0811830 | 0.0284853 | PRRX1 | 1 |
| GO:0001763 | GO:0001763 | morphogenesis of a branching structure | 1/6 | 206/18888 | 0.0048544 | 15.281553 | 3.673927 | 0.0636881 | 0.0830183 | 0.0291292 | TGFBR2 | 1 |
| GO:0071674 | GO:0071674 | mononuclear cell migration | 1/6 | 206/18888 | 0.0048544 | 15.281553 | 3.673927 | 0.0636881 | 0.0830183 | 0.0291292 | ADAM10 | 1 |
| GO:0006470 | GO:0006470 | protein dephosphorylation | 1/6 | 210/18888 | 0.0047619 | 14.990476 | 3.634211 | 0.0648904 | 0.0843162 | 0.0295846 | MAGI2 | 1 |
| GO:0042098 | GO:0042098 | T cell proliferation | 1/6 | 213/18888 | 0.0046948 | 14.779343 | 3.605132 | 0.0657914 | 0.0849458 | 0.0298055 | TGFBR2 | 1 |
| GO:0045216 | GO:0045216 | cell-cell junction organization | 1/6 | 213/18888 | 0.0046948 | 14.779343 | 3.605132 | 0.0657914 | 0.0849458 | 0.0298055 | ADAM10 | 1 |
| GO:0060348 | GO:0060348 | bone development | 1/6 | 215/18888 | 0.0046512 | 14.641860 | 3.586071 | 0.0663916 | 0.0854503 | 0.0299826 | TGFBR2 | 1 |
| GO:0002064 | GO:0002064 | epithelial cell development | 1/6 | 216/18888 | 0.0046296 | 14.574074 | 3.576636 | 0.0666916 | 0.0855665 | 0.0300233 | MAGI2 | 1 |
| GO:1903046 | GO:1903046 | meiotic cell cycle process | 1/6 | 218/18888 | 0.0045872 | 14.440367 | 3.557954 | 0.0672913 | 0.0860653 | 0.0301984 | PTTG1 | 1 |
| GO:0060541 | GO:0060541 | respiratory system development | 1/6 | 220/18888 | 0.0045455 | 14.309091 | 3.539517 | 0.0678907 | 0.0865606 | 0.0303722 | TGFBR2 | 1 |
| GO:0050920 | GO:0050920 | regulation of chemotaxis | 1/6 | 229/18888 | 0.0043668 | 13.746725 | 3.459436 | 0.0705841 | 0.0897143 | 0.0314787 | ADAM10 | 1 |
| GO:0002685 | GO:0002685 | regulation of leukocyte migration | 1/6 | 230/18888 | 0.0043478 | 13.686957 | 3.450817 | 0.0708829 | 0.0898144 | 0.0315138 | ADAM10 | 1 |
| GO:0015931 | GO:0015931 | nucleobase-containing compound transport | 1/6 | 231/18888 | 0.0043290 | 13.627706 | 3.442252 | 0.0711817 | 0.0899138 | 0.0315487 | TGFBR2 | 1 |
| GO:0030595 | GO:0030595 | leukocyte chemotaxis | 1/6 | 237/18888 | 0.0042194 | 13.282700 | 3.391955 | 0.0729727 | 0.0914207 | 0.0320774 | ADAM10 | 1 |
| GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 1/6 | 237/18888 | 0.0042194 | 13.282700 | 3.391955 | 0.0729727 | 0.0914207 | 0.0320774 | TGFBR2 | 1 |
| GO:0048588 | GO:0048588 | developmental cell growth | 1/6 | 238/18888 | 0.0042017 | 13.226891 | 3.383750 | 0.0732710 | 0.0914207 | 0.0320774 | TGFBR2 | 1 |
| GO:0072593 | GO:0072593 | reactive oxygen species metabolic process | 1/6 | 238/18888 | 0.0042017 | 13.226891 | 3.383750 | 0.0732710 | 0.0914207 | 0.0320774 | TGFBR2 | 1 |
| GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 1/6 | 239/18888 | 0.0041841 | 13.171548 | 3.375593 | 0.0735691 | 0.0915128 | 0.0321098 | TGFBR2 | 1 |
| GO:0042445 | GO:0042445 | hormone metabolic process | 1/6 | 240/18888 | 0.0041667 | 13.116667 | 3.367486 | 0.0738672 | 0.0916043 | 0.0321419 | ADAM10 | 1 |
| GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 1/6 | 241/18888 | 0.0041494 | 13.062241 | 3.359427 | 0.0741652 | 0.0916951 | 0.0321737 | TGFBR2 | 1 |
| GO:0050807 | GO:0050807 | regulation of synapse organization | 1/6 | 243/18888 | 0.0041152 | 12.954733 | 3.343451 | 0.0747609 | 0.0921524 | 0.0323342 | ADAM10 | 1 |
| GO:0016485 | GO:0016485 | protein processing | 1/6 | 245/18888 | 0.0040816 | 12.848980 | 3.327662 | 0.0753563 | 0.0926065 | 0.0324935 | ADAM10 | 1 |
| GO:0048863 | GO:0048863 | stem cell differentiation | 1/6 | 248/18888 | 0.0040323 | 12.693548 | 3.304322 | 0.0762488 | 0.0934220 | 0.0327796 | TGFBR2 | 1 |
| GO:0050803 | GO:0050803 | regulation of synapse structure or activity | 1/6 | 249/18888 | 0.0040161 | 12.642570 | 3.296631 | 0.0765461 | 0.0935055 | 0.0328089 | ADAM10 | 1 |
| GO:0050870 | GO:0050870 | positive regulation of T cell activation | 1/6 | 253/18888 | 0.0039526 | 12.442688 | 3.266305 | 0.0777347 | 0.0943922 | 0.0331201 | TGFBR2 | 1 |
| GO:0051896 | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/6 | 253/18888 | 0.0039526 | 12.442688 | 3.266305 | 0.0777347 | 0.0943922 | 0.0331201 | MAGI2 | 1 |
| GO:0045860 | GO:0045860 | positive regulation of protein kinase activity | 1/6 | 257/18888 | 0.0038911 | 12.249027 | 3.236656 | 0.0789220 | 0.0954183 | 0.0334801 | TGFBR2 | 1 |
| GO:0045927 | GO:0045927 | positive regulation of growth | 1/6 | 258/18888 | 0.0038760 | 12.201550 | 3.229347 | 0.0792187 | 0.0954183 | 0.0334801 | ADAM10 | 1 |
| GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 1/6 | 259/18888 | 0.0038610 | 12.154440 | 3.222078 | 0.0795152 | 0.0954183 | 0.0334801 | MAGI2 | 1 |
| GO:0097305 | GO:0097305 | response to alcohol | 1/6 | 259/18888 | 0.0038610 | 12.154440 | 3.222078 | 0.0795152 | 0.0954183 | 0.0334801 | TGFBR2 | 1 |
| GO:0034612 | GO:0034612 | response to tumor necrosis factor | 1/6 | 263/18888 | 0.0038023 | 11.969582 | 3.193397 | 0.0807006 | 0.0965567 | 0.0338796 | ADAM10 | 1 |
| GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 1/6 | 267/18888 | 0.0037453 | 11.790262 | 3.165332 | 0.0818847 | 0.0976870 | 0.0342762 | TGFBR2 | 1 |
| GO:0003007 | GO:0003007 | heart morphogenesis | 1/6 | 269/18888 | 0.0037175 | 11.702602 | 3.151523 | 0.0824763 | 0.0978207 | 0.0343231 | TGFBR2 | 1 |
| GO:0048762 | GO:0048762 | mesenchymal cell differentiation | 1/6 | 269/18888 | 0.0037175 | 11.702602 | 3.151523 | 0.0824763 | 0.0978207 | 0.0343231 | TGFBR2 | 1 |
| GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 1/6 | 277/18888 | 0.0036101 | 11.364621 | 3.097716 | 0.0848395 | 0.1003319 | 0.0352042 | TGFBR2 | 1 |
| GO:0098742 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 1/6 | 279/18888 | 0.0035842 | 11.283154 | 3.084608 | 0.0854295 | 0.1007377 | 0.0353465 | TGFBR2 | 1 |
| GO:0045165 | GO:0045165 | cell fate commitment | 1/6 | 289/18888 | 0.0034602 | 10.892734 | 3.021020 | 0.0883747 | 0.1039103 | 0.0364598 | PRRX1 | 1 |
| GO:0030100 | GO:0030100 | regulation of endocytosis | 1/6 | 291/18888 | 0.0034364 | 10.817869 | 3.008676 | 0.0889628 | 0.1040024 | 0.0364921 | MAGI2 | 1 |
| GO:0051321 | GO:0051321 | meiotic cell cycle | 1/6 | 291/18888 | 0.0034364 | 10.817869 | 3.008676 | 0.0889628 | 0.1040024 | 0.0364921 | PTTG1 | 1 |
| GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 1/6 | 298/18888 | 0.0033557 | 10.563758 | 2.966403 | 0.0910187 | 0.1061018 | 0.0372287 | TGFBR2 | 1 |
| GO:0043491 | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/6 | 299/18888 | 0.0033445 | 10.528428 | 2.960479 | 0.0913120 | 0.1061405 | 0.0372423 | MAGI2 | 1 |
| GO:0033674 | GO:0033674 | positive regulation of kinase activity | 1/6 | 303/18888 | 0.0033003 | 10.389439 | 2.937060 | 0.0924848 | 0.1071983 | 0.0376134 | TGFBR2 | 1 |
| GO:0046651 | GO:0046651 | lymphocyte proliferation | 1/6 | 308/18888 | 0.0032468 | 10.220779 | 2.908394 | 0.0939489 | 0.1085868 | 0.0381006 | TGFBR2 | 1 |
| GO:0016311 | GO:0016311 | dephosphorylation | 1/6 | 309/18888 | 0.0032362 | 10.187702 | 2.902740 | 0.0942415 | 0.1086173 | 0.0381113 | MAGI2 | 1 |
| GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 1/6 | 310/18888 | 0.0032258 | 10.154839 | 2.897111 | 0.0945340 | 0.1086475 | 0.0381219 | ADAM10 | 1 |
| GO:0032943 | GO:0032943 | mononuclear cell proliferation | 1/6 | 315/18888 | 0.0031746 | 9.993651 | 2.869349 | 0.0959954 | 0.1100172 | 0.0386025 | TGFBR2 | 1 |
| GO:0098813 | GO:0098813 | nuclear chromosome segregation | 1/6 | 317/18888 | 0.0031546 | 9.930599 | 2.858418 | 0.0965794 | 0.1103764 | 0.0387286 | PTTG1 | 1 |
| GO:0001822 | GO:0001822 | kidney development | 1/6 | 319/18888 | 0.0031348 | 9.868339 | 2.847583 | 0.0971630 | 0.1107333 | 0.0388538 | MAGI2 | 1 |
| GO:0060326 | GO:0060326 | cell chemotaxis | 1/6 | 322/18888 | 0.0031056 | 9.776397 | 2.831510 | 0.0980380 | 0.1114192 | 0.0390945 | ADAM10 | 1 |
| GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 1/6 | 325/18888 | 0.0030769 | 9.686154 | 2.815647 | 0.0989122 | 0.1121005 | 0.0393335 | TGFBR2 | 1 |
| GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 1/6 | 328/18888 | 0.0030488 | 9.597561 | 2.799989 | 0.0997857 | 0.1127772 | 0.0395710 | TGFBR2 | 1 |
| GO:0072001 | GO:0072001 | renal system development | 1/6 | 329/18888 | 0.0030395 | 9.568389 | 2.794814 | 0.1000768 | 0.1127937 | 0.0395767 | MAGI2 | 1 |
| GO:0030198 | GO:0030198 | extracellular matrix organization | 1/6 | 332/18888 | 0.0030120 | 9.481928 | 2.779422 | 0.1009493 | 0.1134637 | 0.0398118 | ADAM10 | 1 |
| GO:0043062 | GO:0043062 | extracellular structure organization | 1/6 | 333/18888 | 0.0030030 | 9.453454 | 2.774335 | 0.1012400 | 0.1134778 | 0.0398168 | ADAM10 | 1 |
| GO:0045229 | GO:0045229 | external encapsulating structure organization | 1/6 | 334/18888 | 0.0029940 | 9.425150 | 2.769269 | 0.1015307 | 0.1134918 | 0.0398217 | ADAM10 | 1 |
| GO:0060562 | GO:0060562 | epithelial tube morphogenesis | 1/6 | 335/18888 | 0.0029851 | 9.397015 | 2.764225 | 0.1018212 | 0.1135056 | 0.0398265 | TGFBR2 | 1 |
| GO:0060485 | GO:0060485 | mesenchyme development | 1/6 | 336/18888 | 0.0029762 | 9.369048 | 2.759202 | 0.1021117 | 0.1135193 | 0.0398313 | TGFBR2 | 1 |
| GO:0070661 | GO:0070661 | leukocyte proliferation | 1/6 | 352/18888 | 0.0028409 | 8.943182 | 2.681581 | 0.1067486 | 0.1183506 | 0.0415265 | TGFBR2 | 1 |
| GO:0045765 | GO:0045765 | regulation of angiogenesis | 1/6 | 353/18888 | 0.0028329 | 8.917847 | 2.676895 | 0.1070377 | 0.1183506 | 0.0415265 | TGFBR2 | 1 |
| GO:1990778 | GO:1990778 | protein localization to cell periphery | 1/6 | 356/18888 | 0.0028090 | 8.842697 | 2.662946 | 0.1079046 | 0.1189867 | 0.0417497 | ADAM10 | 1 |
| GO:0031346 | GO:0031346 | positive regulation of cell projection organization | 1/6 | 360/18888 | 0.0027778 | 8.744444 | 2.644602 | 0.1090595 | 0.1199360 | 0.0420828 | MAGI2 | 1 |
| GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 1/6 | 362/18888 | 0.0027624 | 8.696133 | 2.635537 | 0.1096364 | 0.1202464 | 0.0421917 | TGFBR2 | 1 |
| GO:0090287 | GO:0090287 | regulation of cellular response to growth factor stimulus | 1/6 | 373/18888 | 0.0026810 | 8.439678 | 2.586901 | 0.1128041 | 0.1233890 | 0.0432944 | ZEB1 | 1 |
| GO:0010631 | GO:0010631 | epithelial cell migration | 1/6 | 375/18888 | 0.0026667 | 8.394667 | 2.578273 | 0.1133791 | 0.1236691 | 0.0433927 | TGFBR2 | 1 |
| GO:0051347 | GO:0051347 | positive regulation of transferase activity | 1/6 | 376/18888 | 0.0026596 | 8.372340 | 2.573984 | 0.1136664 | 0.1236691 | 0.0433927 | TGFBR2 | 1 |
| GO:0090132 | GO:0090132 | epithelium migration | 1/6 | 378/18888 | 0.0026455 | 8.328042 | 2.565451 | 0.1142409 | 0.1239635 | 0.0434960 | TGFBR2 | 1 |
| GO:0050867 | GO:0050867 | positive regulation of cell activation | 1/6 | 380/18888 | 0.0026316 | 8.284211 | 2.556982 | 0.1148151 | 0.1241992 | 0.0435787 | TGFBR2 | 1 |
| GO:0030336 | GO:0030336 | negative regulation of cell migration | 1/6 | 381/18888 | 0.0026247 | 8.262467 | 2.552770 | 0.1151020 | 0.1241992 | 0.0435787 | MAGI2 | 1 |
| GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 1/6 | 382/18888 | 0.0026178 | 8.240838 | 2.548574 | 0.1153889 | 0.1241992 | 0.0435787 | TGFBR2 | 1 |
| GO:0090130 | GO:0090130 | tissue migration | 1/6 | 383/18888 | 0.0026110 | 8.219321 | 2.544394 | 0.1156757 | 0.1241992 | 0.0435787 | TGFBR2 | 1 |
| GO:0050900 | GO:0050900 | leukocyte migration | 1/6 | 396/18888 | 0.0025253 | 7.949495 | 2.491392 | 0.1193972 | 0.1275237 | 0.0447452 | ADAM10 | 1 |
| GO:2000146 | GO:2000146 | negative regulation of cell motility | 1/6 | 396/18888 | 0.0025253 | 7.949495 | 2.491392 | 0.1193972 | 0.1275237 | 0.0447452 | MAGI2 | 1 |
| GO:0050678 | GO:0050678 | regulation of epithelial cell proliferation | 1/6 | 407/18888 | 0.0024570 | 7.734644 | 2.448399 | 0.1225359 | 0.1304971 | 0.0457884 | ZEB1 | 1 |
| GO:0030900 | GO:0030900 | forebrain development | 1/6 | 408/18888 | 0.0024510 | 7.715686 | 2.444571 | 0.1228208 | 0.1304971 | 0.0457884 | ZEB1 | 1 |
| GO:0001558 | GO:0001558 | regulation of cell growth | 1/6 | 418/18888 | 0.0023923 | 7.531100 | 2.406989 | 0.1256653 | 0.1331278 | 0.0467115 | ADAM10 | 1 |
| GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 1/6 | 419/18888 | 0.0023866 | 7.513127 | 2.403300 | 0.1259493 | 0.1331278 | 0.0467115 | TGFBR2 | 1 |
| GO:0007059 | GO:0007059 | chromosome segregation | 1/6 | 423/18888 | 0.0023641 | 7.442080 | 2.388663 | 0.1270847 | 0.1339807 | 0.0470108 | PTTG1 | 1 |
| GO:0042692 | GO:0042692 | muscle cell differentiation | 1/6 | 428/18888 | 0.0023364 | 7.355140 | 2.370633 | 0.1285021 | 0.1350757 | 0.0473950 | ZEB1 | 1 |
| GO:0003002 | GO:0003002 | regionalization | 1/6 | 429/18888 | 0.0023310 | 7.337995 | 2.367062 | 0.1287854 | 0.1350757 | 0.0473950 | TGFBR2 | 1 |
| GO:0040013 | GO:0040013 | negative regulation of locomotion | 1/6 | 431/18888 | 0.0023202 | 7.303944 | 2.359954 | 0.1293517 | 0.1353217 | 0.0474813 | MAGI2 | 1 |
| GO:0030099 | GO:0030099 | myeloid cell differentiation | 1/6 | 439/18888 | 0.0022779 | 7.170843 | 2.331973 | 0.1316138 | 0.1373361 | 0.0481881 | TGFBR2 | 1 |
| GO:0009410 | GO:0009410 | response to xenobiotic stimulus | 1/6 | 444/18888 | 0.0022523 | 7.090090 | 2.314839 | 0.1330251 | 0.1384547 | 0.0485806 | TGFBR2 | 1 |
| GO:0000280 | GO:0000280 | nuclear division | 1/6 | 446/18888 | 0.0022422 | 7.058296 | 2.308060 | 0.1335891 | 0.1386879 | 0.0486624 | PTTG1 | 1 |
| GO:0048732 | GO:0048732 | gland development | 1/6 | 449/18888 | 0.0022272 | 7.011136 | 2.297969 | 0.1344345 | 0.1392114 | 0.0488461 | TGFBR2 | 1 |
| GO:0010720 | GO:0010720 | positive regulation of cell development | 1/6 | 454/18888 | 0.0022026 | 6.933921 | 2.281356 | 0.1358420 | 0.1403127 | 0.0492325 | TGFBR2 | 1 |
| GO:0006935 | GO:0006935 | chemotaxis | 1/6 | 466/18888 | 0.0021459 | 6.755365 | 2.242490 | 0.1392122 | 0.1429256 | 0.0501493 | ADAM10 | 1 |
| GO:0016055 | GO:0016055 | Wnt signaling pathway | 1/6 | 466/18888 | 0.0021459 | 6.755365 | 2.242490 | 0.1392122 | 0.1429256 | 0.0501493 | MAGI2 | 1 |
| GO:0042330 | GO:0042330 | taxis | 1/6 | 468/18888 | 0.0021368 | 6.726496 | 2.236146 | 0.1397728 | 0.1429256 | 0.0501493 | ADAM10 | 1 |
| GO:0198738 | GO:0198738 | cell-cell signaling by wnt | 1/6 | 468/18888 | 0.0021368 | 6.726496 | 2.236146 | 0.1397728 | 0.1429256 | 0.0501493 | MAGI2 | 1 |
| GO:0045859 | GO:0045859 | regulation of protein kinase activity | 1/6 | 470/18888 | 0.0021277 | 6.697872 | 2.229839 | 0.1403332 | 0.1431398 | 0.0502245 | TGFBR2 | 1 |
| GO:0050673 | GO:0050673 | epithelial cell proliferation | 1/6 | 482/18888 | 0.0020747 | 6.531120 | 2.192755 | 0.1436888 | 0.1458334 | 0.0511696 | ZEB1 | 1 |
| GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 1/6 | 482/18888 | 0.0020747 | 6.531120 | 2.192755 | 0.1436888 | 0.1458334 | 0.0511696 | MAGI2 | 1 |
| GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 1/6 | 485/18888 | 0.0020619 | 6.490722 | 2.183680 | 0.1445260 | 0.1463191 | 0.0513400 | TGFBR2 | 1 |
| GO:0031667 | GO:0031667 | response to nutrient levels | 1/6 | 490/18888 | 0.0020408 | 6.424490 | 2.168726 | 0.1459198 | 0.1473645 | 0.0517069 | ZEB1 | 1 |
| GO:0048285 | GO:0048285 | organelle fission | 1/6 | 493/18888 | 0.0020284 | 6.385395 | 2.159854 | 0.1467552 | 0.1474781 | 0.0517467 | PTTG1 | 1 |
| GO:0050808 | GO:0050808 | synapse organization | 1/6 | 493/18888 | 0.0020284 | 6.385395 | 2.159854 | 0.1467552 | 0.1474781 | 0.0517467 | ADAM10 | 1 |
| GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 1/6 | 496/18888 | 0.0020161 | 6.346774 | 2.151054 | 0.1475899 | 0.1479525 | 0.0519132 | TGFBR2 | 1 |
| GO:0001667 | GO:0001667 | ameboidal-type cell migration | 1/6 | 498/18888 | 0.0020080 | 6.321285 | 2.145228 | 0.1481460 | 0.1481460 | 0.0519810 | TGFBR2 | 1 |
# Visualización del análisis funcional
barplot(go_results_miR_655_3p_validated, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos validados")
Predicted
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_655_3p_predicted <- filter_pre_hsa_miR_655_3p$target_symbol %>% unique()
go_results_miR_655_3p_predicted <- enrichGO(
gene = gene_symbols_miR_655_3p_predicted,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
go_results_miR_655_3p_predicted@result |>
kable(format = "html") |>
kable_styling("striped")| ID | Description | GeneRatio | BgRatio | RichFactor | FoldEnrichment | zScore | pvalue | p.adjust | qvalue | geneID | Count | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO:0060213 | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/32 | 13/18888 | 0.1538462 | 90.807692 | 13.3436127 | 0.0002144 | 0.0254869 | 0.0207149 | TOB1/AGO2 | 2 |
| GO:0000377 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5/32 | 337/18888 | 0.0148368 | 8.757418 | 5.9194342 | 0.0002379 | 0.0254869 | 0.0207149 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0000398 | GO:0000398 | mRNA splicing, via spliceosome | 5/32 | 337/18888 | 0.0148368 | 8.757418 | 5.9194342 | 0.0002379 | 0.0254869 | 0.0207149 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0000375 | GO:0000375 | RNA splicing, via transesterification reactions | 5/32 | 341/18888 | 0.0146628 | 8.654692 | 5.8762434 | 0.0002512 | 0.0254869 | 0.0207149 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0060211 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/32 | 15/18888 | 0.1333333 | 78.700000 | 12.4016044 | 0.0002880 | 0.0254869 | 0.0207149 | TOB1/AGO2 | 2 |
| GO:1900153 | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/32 | 15/18888 | 0.1333333 | 78.700000 | 12.4016044 | 0.0002880 | 0.0254869 | 0.0207149 | TOB1/AGO2 | 2 |
| GO:1903311 | GO:1903311 | regulation of mRNA metabolic process | 5/32 | 404/18888 | 0.0123762 | 7.305074 | 5.2773343 | 0.0005463 | 0.0414407 | 0.0336816 | RBM24/SRSF7/KHDRBS2/TOB1/AGO2 | 5 |
| GO:1903312 | GO:1903312 | negative regulation of mRNA metabolic process | 3/32 | 100/18888 | 0.0300000 | 17.707500 | 6.9008548 | 0.0006388 | 0.0424029 | 0.0344637 | RBM24/SRSF7/TOB1 | 3 |
| GO:1900151 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/32 | 26/18888 | 0.0769231 | 45.403846 | 9.3335119 | 0.0008811 | 0.0433323 | 0.0352191 | TOB1/AGO2 | 2 |
| GO:0048024 | GO:0048024 | regulation of mRNA splicing, via spliceosome | 3/32 | 112/18888 | 0.0267857 | 15.810268 | 6.4759290 | 0.0008881 | 0.0433323 | 0.0352191 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:0006417 | GO:0006417 | regulation of translation | 5/32 | 451/18888 | 0.0110865 | 6.543792 | 4.9088723 | 0.0008977 | 0.0433323 | 0.0352191 | RPL38/RBM24/EIF1B/TOB1/AGO2 | 5 |
| GO:1903019 | GO:1903019 | negative regulation of glycoprotein metabolic process | 2/32 | 28/18888 | 0.0714286 | 42.160714 | 8.9788924 | 0.0010226 | 0.0452499 | 0.0367776 | PTX3/AGO2 | 2 |
| GO:0008380 | GO:0008380 | RNA splicing | 5/32 | 484/18888 | 0.0103306 | 6.097624 | 4.6802177 | 0.0012302 | 0.0494412 | 0.0401842 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0000289 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2/32 | 32/18888 | 0.0625000 | 36.890625 | 8.3707220 | 0.0013362 | 0.0494412 | 0.0401842 | TOB1/AGO2 | 2 |
| GO:0022613 | GO:0022613 | ribonucleoprotein complex biogenesis | 5/32 | 499/18888 | 0.0100200 | 5.914329 | 4.5831821 | 0.0014084 | 0.0494412 | 0.0401842 | RPL38/SRSF5/NOA1/RRP9/AGO2 | 5 |
| GO:0050684 | GO:0050684 | regulation of mRNA processing | 3/32 | 134/18888 | 0.0223881 | 13.214552 | 5.8454061 | 0.0014898 | 0.0494412 | 0.0401842 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:0043484 | GO:0043484 | regulation of RNA splicing | 3/32 | 186/18888 | 0.0161290 | 9.520161 | 4.8105192 | 0.0037776 | 0.1111499 | 0.0903389 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:0000381 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 2/32 | 55/18888 | 0.0363636 | 21.463636 | 6.2608903 | 0.0039045 | 0.1111499 | 0.0903389 | RBM24/KHDRBS2 | 2 |
| GO:0061157 | GO:0061157 | mRNA destabilization | 3/32 | 198/18888 | 0.0151515 | 8.943182 | 4.6286479 | 0.0044992 | 0.1111499 | 0.0903389 | RBM24/TOB1/AGO2 | 3 |
| GO:0050779 | GO:0050779 | RNA destabilization | 3/32 | 202/18888 | 0.0148515 | 8.766089 | 4.5714248 | 0.0047571 | 0.1111499 | 0.0903389 | RBM24/TOB1/AGO2 | 3 |
| GO:1903018 | GO:1903018 | regulation of glycoprotein metabolic process | 2/32 | 61/18888 | 0.0327869 | 19.352459 | 5.9142586 | 0.0047812 | 0.1111499 | 0.0903389 | PTX3/AGO2 | 2 |
| GO:0061014 | GO:0061014 | positive regulation of mRNA catabolic process | 3/32 | 203/18888 | 0.0147783 | 8.722906 | 4.5573663 | 0.0048229 | 0.1111499 | 0.0903389 | RBM24/TOB1/AGO2 | 3 |
| GO:0042255 | GO:0042255 | ribosome assembly | 2/32 | 62/18888 | 0.0322581 | 19.040323 | 5.8612846 | 0.0049354 | 0.1111499 | 0.0903389 | RPL38/NOA1 | 2 |
| GO:0017148 | GO:0017148 | negative regulation of translation | 3/32 | 206/18888 | 0.0145631 | 8.595874 | 4.5157653 | 0.0050237 | 0.1111499 | 0.0903389 | RBM24/TOB1/AGO2 | 3 |
| GO:0000288 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/32 | 67/18888 | 0.0298507 | 17.619403 | 5.6138805 | 0.0057403 | 0.1219230 | 0.0990949 | TOB1/AGO2 | 2 |
| GO:0000380 | GO:0000380 | alternative mRNA splicing, via spliceosome | 2/32 | 73/18888 | 0.0273973 | 16.171233 | 5.3500999 | 0.0067799 | 0.1342053 | 0.1090775 | RBM24/KHDRBS2 | 2 |
| GO:0022618 | GO:0022618 | protein-RNA complex assembly | 3/32 | 234/18888 | 0.0128205 | 7.567308 | 4.1642903 | 0.0071439 | 0.1342053 | 0.1090775 | RPL38/SRSF5/AGO2 | 3 |
| GO:0034249 | GO:0034249 | negative regulation of amide metabolic process | 3/32 | 234/18888 | 0.0128205 | 7.567308 | 4.1642903 | 0.0071439 | 0.1342053 | 0.1090775 | RBM24/TOB1/AGO2 | 3 |
| GO:1902373 | GO:1902373 | negative regulation of mRNA catabolic process | 2/32 | 76/18888 | 0.0263158 | 15.532895 | 5.2296561 | 0.0073295 | 0.1342053 | 0.1090775 | RBM24/TOB1 | 2 |
| GO:1903313 | GO:1903313 | positive regulation of mRNA metabolic process | 3/32 | 240/18888 | 0.0125000 | 7.378125 | 4.0965118 | 0.0076575 | 0.1342865 | 0.1091435 | RBM24/TOB1/AGO2 | 3 |
| GO:0071826 | GO:0071826 | protein-RNA complex organization | 3/32 | 244/18888 | 0.0122951 | 7.257172 | 4.0526133 | 0.0080118 | 0.1342865 | 0.1091435 | RPL38/SRSF5/AGO2 | 3 |
| GO:0007193 | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 2/32 | 80/18888 | 0.0250000 | 14.756250 | 5.0793184 | 0.0080926 | 0.1342865 | 0.1091435 | RGS1/CORT | 2 |
| GO:0007188 | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3/32 | 249/18888 | 0.0120482 | 7.111446 | 3.9991162 | 0.0084681 | 0.1362597 | 0.1107473 | ADM/RGS1/CORT | 3 |
| GO:0006446 | GO:0006446 | regulation of translational initiation | 2/32 | 84/18888 | 0.0238095 | 14.053571 | 4.9394156 | 0.0088900 | 0.1388407 | 0.1128451 | EIF1B/AGO2 | 2 |
| GO:1902369 | GO:1902369 | negative regulation of RNA catabolic process | 2/32 | 88/18888 | 0.0227273 | 13.414773 | 4.8087575 | 0.0097212 | 0.1474845 | 0.1198704 | RBM24/TOB1 | 2 |
| GO:0043488 | GO:0043488 | regulation of mRNA stability | 3/32 | 273/18888 | 0.0109890 | 6.486264 | 3.7614750 | 0.0108705 | 0.1603394 | 0.1303185 | RBM24/TOB1/AGO2 | 3 |
| GO:0043487 | GO:0043487 | regulation of RNA stability | 3/32 | 285/18888 | 0.0105263 | 6.213158 | 3.6531164 | 0.0122055 | 0.1751656 | 0.1423688 | RBM24/TOB1/AGO2 | 3 |
| GO:0061013 | GO:0061013 | regulation of mRNA catabolic process | 3/32 | 290/18888 | 0.0103448 | 6.106034 | 3.6097848 | 0.0127885 | 0.1787028 | 0.1452436 | RBM24/TOB1/AGO2 | 3 |
| GO:0042254 | GO:0042254 | ribosome biogenesis | 3/32 | 319/18888 | 0.0094044 | 5.550940 | 3.3770223 | 0.0164842 | 0.2085809 | 0.1695276 | RPL38/NOA1/RRP9 | 3 |
| GO:0061668 | GO:0061668 | mitochondrial ribosome assembly | 1/32 | 10/18888 | 0.1000000 | 59.025000 | 7.5608192 | 0.0168174 | 0.2085809 | 0.1695276 | NOA1 | 1 |
| GO:0070922 | GO:0070922 | RISC complex assembly | 1/32 | 10/18888 | 0.1000000 | 59.025000 | 7.5608192 | 0.0168174 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0022605 | GO:0022605 | mammalian oogenesis stage | 1/32 | 11/18888 | 0.0909091 | 53.659091 | 7.1967250 | 0.0184840 | 0.2085809 | 0.1695276 | PTX3 | 1 |
| GO:0006413 | GO:0006413 | translational initiation | 2/32 | 124/18888 | 0.0161290 | 9.520161 | 3.9212781 | 0.0186485 | 0.2085809 | 0.1695276 | EIF1B/AGO2 | 2 |
| GO:0000956 | GO:0000956 | nuclear-transcribed mRNA catabolic process | 2/32 | 126/18888 | 0.0158730 | 9.369048 | 3.8828753 | 0.0192171 | 0.2085809 | 0.1695276 | TOB1/AGO2 | 2 |
| GO:0001547 | GO:0001547 | antral ovarian follicle growth | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | PTX3 | 1 |
| GO:0045906 | GO:0045906 | negative regulation of vasoconstriction | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0097084 | GO:0097084 | vascular associated smooth muscle cell development | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0098528 | GO:0098528 | skeletal muscle fiber differentiation | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:1900152 | GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | TOB1 | 1 |
| GO:2001214 | GO:2001214 | positive regulation of vasculogenesis | 1/32 | 12/18888 | 0.0833333 | 49.187500 | 6.8786265 | 0.0201478 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0007127 | GO:0007127 | meiosis I | 2/32 | 131/18888 | 0.0152672 | 9.011450 | 3.7905026 | 0.0206704 | 0.2085809 | 0.1695276 | ING2/PTTG1 | 2 |
| GO:0006402 | GO:0006402 | mRNA catabolic process | 3/32 | 348/18888 | 0.0086207 | 5.088362 | 3.1711428 | 0.0207231 | 0.2085809 | 0.1695276 | RBM24/TOB1/AGO2 | 3 |
| GO:0060670 | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 1/32 | 13/18888 | 0.0769231 | 45.403846 | 6.5975164 | 0.0218089 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0061982 | GO:0061982 | meiosis I cell cycle process | 2/32 | 139/18888 | 0.0143885 | 8.492806 | 3.6525361 | 0.0230884 | 0.2085809 | 0.1695276 | ING2/PTTG1 | 2 |
| GO:0002031 | GO:0002031 | G protein-coupled receptor internalization | 1/32 | 14/18888 | 0.0714286 | 42.160714 | 6.3466806 | 0.0234673 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0032352 | GO:0032352 | positive regulation of hormone metabolic process | 1/32 | 15/18888 | 0.0666667 | 39.350000 | 6.1209978 | 0.0251230 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:1902166 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/32 | 15/18888 | 0.0666667 | 39.350000 | 6.1209978 | 0.0251230 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0006367 | GO:0006367 | transcription initiation at RNA polymerase II promoter | 2/32 | 149/18888 | 0.0134228 | 7.922819 | 3.4948987 | 0.0262669 | 0.2085809 | 0.1695276 | GTF2F2/TAF13 | 2 |
| GO:0042448 | GO:0042448 | progesterone metabolic process | 1/32 | 16/18888 | 0.0625000 | 36.890625 | 5.9164847 | 0.0267759 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0072520 | GO:0072520 | seminiferous tubule development | 1/32 | 16/18888 | 0.0625000 | 36.890625 | 5.9164847 | 0.0267759 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:2001212 | GO:2001212 | regulation of vasculogenesis | 1/32 | 16/18888 | 0.0625000 | 36.890625 | 5.9164847 | 0.0267759 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0008228 | GO:0008228 | opsonization | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | PTX3 | 1 |
| GO:0010831 | GO:0010831 | positive regulation of myotube differentiation | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:0031054 | GO:0031054 | pre-miRNA processing | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0044793 | GO:0044793 | negative regulation by host of viral process | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | PTX3 | 1 |
| GO:1901163 | GO:1901163 | regulation of trophoblast cell migration | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:1902165 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/32 | 17/18888 | 0.0588235 | 34.720588 | 5.7299897 | 0.0284262 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0002181 | GO:0002181 | cytoplasmic translation | 2/32 | 160/18888 | 0.0125000 | 7.378125 | 3.3376363 | 0.0299564 | 0.2085809 | 0.1695276 | RPL38/RBM24 | 2 |
| GO:0043116 | GO:0043116 | negative regulation of vascular permeability | 1/32 | 18/18888 | 0.0555556 | 32.791667 | 5.5589823 | 0.0300737 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0061450 | GO:0061450 | trophoblast cell migration | 1/32 | 18/18888 | 0.0555556 | 32.791667 | 5.5589823 | 0.0300737 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0006401 | GO:0006401 | RNA catabolic process | 3/32 | 404/18888 | 0.0074257 | 4.383045 | 2.8316014 | 0.0304636 | 0.2085809 | 0.1695276 | RBM24/TOB1/AGO2 | 3 |
| GO:0008356 | GO:0008356 | asymmetric cell division | 1/32 | 19/18888 | 0.0526316 | 31.065790 | 5.4014040 | 0.0317185 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0061158 | GO:0061158 | 3'-UTR-mediated mRNA destabilization | 1/32 | 19/18888 | 0.0526316 | 31.065790 | 5.4014040 | 0.0317185 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:0002029 | GO:0002029 | desensitization of G protein-coupled receptor signaling pathway | 1/32 | 20/18888 | 0.0500000 | 29.512500 | 5.2555607 | 0.0333606 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0006700 | GO:0006700 | C21-steroid hormone biosynthetic process | 1/32 | 20/18888 | 0.0500000 | 29.512500 | 5.2555607 | 0.0333606 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0033141 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1/32 | 20/18888 | 0.0500000 | 29.512500 | 5.2555607 | 0.0333606 | 0.2085809 | 0.1695276 | IFNW1 | 1 |
| GO:0042985 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1/32 | 20/18888 | 0.0500000 | 29.512500 | 5.2555607 | 0.0333606 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:2001014 | GO:2001014 | regulation of skeletal muscle cell differentiation | 1/32 | 20/18888 | 0.0500000 | 29.512500 | 5.2555607 | 0.0333606 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:0022401 | GO:0022401 | negative adaptation of signaling pathway | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0035809 | GO:0035809 | regulation of urine volume | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0042474 | GO:0042474 | middle ear morphogenesis | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | RPL38 | 1 |
| GO:0070886 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | CAMTA1 | 1 |
| GO:0106058 | GO:0106058 | positive regulation of calcineurin-mediated signaling | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | CAMTA1 | 1 |
| GO:2000738 | GO:2000738 | positive regulation of stem cell differentiation | 1/32 | 21/18888 | 0.0476190 | 28.107143 | 5.1200436 | 0.0350000 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:0031331 | GO:0031331 | positive regulation of cellular catabolic process | 3/32 | 432/18888 | 0.0069444 | 4.098958 | 2.6842349 | 0.0361016 | 0.2085809 | 0.1695276 | RBM24/TOB1/AGO2 | 3 |
| GO:0010566 | GO:0010566 | regulation of ketone biosynthetic process | 1/32 | 22/18888 | 0.0454545 | 26.829545 | 4.9936705 | 0.0366367 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0045947 | GO:0045947 | negative regulation of translational initiation | 1/32 | 22/18888 | 0.0454545 | 26.829545 | 4.9936705 | 0.0366367 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0048025 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 1/32 | 22/18888 | 0.0454545 | 26.829545 | 4.9936705 | 0.0366367 | 0.2085809 | 0.1695276 | SRSF7 | 1 |
| GO:0060713 | GO:0060713 | labyrinthine layer morphogenesis | 1/32 | 22/18888 | 0.0454545 | 26.829545 | 4.9936705 | 0.0366367 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0010893 | GO:0010893 | positive regulation of steroid biosynthetic process | 1/32 | 23/18888 | 0.0434783 | 25.663044 | 4.8754407 | 0.0382708 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0033139 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein | 1/32 | 23/18888 | 0.0434783 | 25.663044 | 4.8754407 | 0.0382708 | 0.2085809 | 0.1695276 | IFNW1 | 1 |
| GO:0046597 | GO:0046597 | negative regulation of viral entry into host cell | 1/32 | 23/18888 | 0.0434783 | 25.663044 | 4.8754407 | 0.0382708 | 0.2085809 | 0.1695276 | PTX3 | 1 |
| GO:1902254 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1/32 | 23/18888 | 0.0434783 | 25.663044 | 4.8754407 | 0.0382708 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0007565 | GO:0007565 | female pregnancy | 2/32 | 183/18888 | 0.0109290 | 6.450820 | 3.0523912 | 0.0382900 | 0.2085809 | 0.1695276 | ADM/AGO2 | 2 |
| GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 2/32 | 187/18888 | 0.0106952 | 6.312834 | 3.0077819 | 0.0398208 | 0.2085809 | 0.1695276 | ADM/AGO2 | 2 |
| GO:0023058 | GO:0023058 | adaptation of signaling pathway | 1/32 | 24/18888 | 0.0416667 | 24.593750 | 4.7645007 | 0.0399021 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0042501 | GO:0042501 | serine phosphorylation of STAT protein | 1/32 | 24/18888 | 0.0416667 | 24.593750 | 4.7645007 | 0.0399021 | 0.2085809 | 0.1695276 | IFNW1 | 1 |
| GO:0046885 | GO:0046885 | regulation of hormone biosynthetic process | 1/32 | 24/18888 | 0.0416667 | 24.593750 | 4.7645007 | 0.0399021 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0050686 | GO:0050686 | negative regulation of mRNA processing | 1/32 | 24/18888 | 0.0416667 | 24.593750 | 4.7645007 | 0.0399021 | 0.2085809 | 0.1695276 | SRSF7 | 1 |
| GO:0006352 | GO:0006352 | DNA-templated transcription initiation | 2/32 | 189/18888 | 0.0105820 | 6.246032 | 2.9859623 | 0.0405949 | 0.2085809 | 0.1695276 | GTF2F2/TAF13 | 2 |
| GO:1904018 | GO:1904018 | positive regulation of vasculature development | 2/32 | 190/18888 | 0.0105263 | 6.213158 | 2.9751701 | 0.0409841 | 0.2085809 | 0.1695276 | ADM/AGO2 | 2 |
| GO:0010561 | GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1/32 | 25/18888 | 0.0400000 | 23.610000 | 4.6601176 | 0.0415308 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0002026 | GO:0002026 | regulation of the force of heart contraction | 1/32 | 26/18888 | 0.0384615 | 22.701923 | 4.5616580 | 0.0431568 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0010460 | GO:0010460 | positive regulation of heart rate | 1/32 | 26/18888 | 0.0384615 | 22.701923 | 4.5616580 | 0.0431568 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0070935 | GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1/32 | 26/18888 | 0.0384615 | 22.701923 | 4.5616580 | 0.0431568 | 0.2085809 | 0.1695276 | RBM24 | 1 |
| GO:1902455 | GO:1902455 | negative regulation of stem cell population maintenance | 1/32 | 26/18888 | 0.0384615 | 22.701923 | 4.5616580 | 0.0431568 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0140013 | GO:0140013 | meiotic nuclear division | 2/32 | 197/18888 | 0.0101523 | 5.992386 | 2.9017278 | 0.0437483 | 0.2085809 | 0.1695276 | ING2/PTTG1 | 2 |
| GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2/32 | 198/18888 | 0.0101010 | 5.962121 | 2.8915254 | 0.0441488 | 0.2085809 | 0.1695276 | ING2/TOB1 | 2 |
| GO:0007141 | GO:0007141 | male meiosis I | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | ING2 | 1 |
| GO:0033119 | GO:0033119 | negative regulation of RNA splicing | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | SRSF7 | 1 |
| GO:0042983 | GO:0042983 | amyloid precursor protein biosynthetic process | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0042984 | GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | AGO2 | 1 |
| GO:0045940 | GO:0045940 | positive regulation of steroid metabolic process | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0060669 | GO:0060669 | embryonic placenta morphogenesis | 1/32 | 27/18888 | 0.0370370 | 21.861111 | 4.4685709 | 0.0447801 | 0.2085809 | 0.1695276 | ADM | 1 |
| GO:0120255 | GO:0120255 | olefinic compound biosynthetic process | 1/32 | 28/18888 | 0.0357143 | 21.080357 | 4.3803751 | 0.0464007 | 0.2114048 | 0.1718227 | ADM | 1 |
| GO:1903901 | GO:1903901 | negative regulation of viral life cycle | 1/32 | 28/18888 | 0.0357143 | 21.080357 | 4.3803751 | 0.0464007 | 0.2114048 | 0.1718227 | PTX3 | 1 |
| GO:0044703 | GO:0044703 | multi-organism reproductive process | 2/32 | 204/18888 | 0.0098039 | 5.786765 | 2.8317436 | 0.0465807 | 0.2114048 | 0.1718227 | ADM/AGO2 | 2 |
| GO:0006910 | GO:0006910 | phagocytosis, recognition | 1/32 | 29/18888 | 0.0344828 | 20.353448 | 4.2966474 | 0.0480187 | 0.2160842 | 0.1756260 | PTX3 | 1 |
| GO:0008209 | GO:0008209 | androgen metabolic process | 1/32 | 30/18888 | 0.0333333 | 19.675000 | 4.2170147 | 0.0496340 | 0.2189779 | 0.1779779 | ADM | 1 |
| GO:1902230 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1/32 | 30/18888 | 0.0333333 | 19.675000 | 4.2170147 | 0.0496340 | 0.2189779 | 0.1779779 | ING2 | 1 |
| GO:0044706 | GO:0044706 | multi-multicellular organism process | 2/32 | 212/18888 | 0.0094340 | 5.568396 | 2.7556335 | 0.0498989 | 0.2189779 | 0.1779779 | ADM/AGO2 | 2 |
| GO:1903046 | GO:1903046 | meiotic cell cycle process | 2/32 | 218/18888 | 0.0091743 | 5.415138 | 2.7010463 | 0.0524428 | 0.2272714 | 0.1847185 | ING2/PTTG1 | 2 |
| GO:0017145 | GO:0017145 | stem cell division | 1/32 | 33/18888 | 0.0303030 | 17.886364 | 3.9995537 | 0.0544641 | 0.2272714 | 0.1847185 | ING2 | 1 |
| GO:0030511 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1/32 | 33/18888 | 0.0303030 | 17.886364 | 3.9995537 | 0.0544641 | 0.2272714 | 0.1847185 | ING2 | 1 |
| GO:1903846 | GO:1903846 | positive regulation of cellular response to transforming growth factor beta stimulus | 1/32 | 33/18888 | 0.0303030 | 17.886364 | 3.9995537 | 0.0544641 | 0.2272714 | 0.1847185 | ING2 | 1 |
| GO:2000765 | GO:2000765 | regulation of cytoplasmic translation | 1/32 | 33/18888 | 0.0303030 | 17.886364 | 3.9995537 | 0.0544641 | 0.2272714 | 0.1847185 | RBM24 | 1 |
| GO:0031330 | GO:0031330 | negative regulation of cellular catabolic process | 2/32 | 224/18888 | 0.0089286 | 5.270089 | 2.6484410 | 0.0550327 | 0.2272714 | 0.1847185 | RBM24/TOB1 | 2 |
| GO:0002323 | GO:0002323 | natural killer cell activation involved in immune response | 1/32 | 34/18888 | 0.0294118 | 17.360294 | 3.9333311 | 0.0560688 | 0.2272714 | 0.1847185 | IFNW1 | 1 |
| GO:0003382 | GO:0003382 | epithelial cell morphogenesis | 1/32 | 34/18888 | 0.0294118 | 17.360294 | 3.9333311 | 0.0560688 | 0.2272714 | 0.1847185 | RILPL2 | 1 |
| GO:1901797 | GO:1901797 | negative regulation of signal transduction by p53 class mediator | 1/32 | 34/18888 | 0.0294118 | 17.360294 | 3.9333311 | 0.0560688 | 0.2272714 | 0.1847185 | ING2 | 1 |
| GO:1902253 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1/32 | 34/18888 | 0.0294118 | 17.360294 | 3.9333311 | 0.0560688 | 0.2272714 | 0.1847185 | ING2 | 1 |
| GO:0008406 | GO:0008406 | gonad development | 2/32 | 233/18888 | 0.0085837 | 5.066524 | 2.5729736 | 0.0590014 | 0.2373467 | 0.1929074 | ING2/PTX3 | 2 |
| GO:0008207 | GO:0008207 | C21-steroid hormone metabolic process | 1/32 | 37/18888 | 0.0270270 | 15.952703 | 3.7504645 | 0.0608672 | 0.2427090 | 0.1972657 | ADM | 1 |
| GO:0045137 | GO:0045137 | development of primary sexual characteristics | 2/32 | 238/18888 | 0.0084034 | 4.960084 | 2.5327082 | 0.0612486 | 0.2427090 | 0.1972657 | ING2/PTX3 | 2 |
| GO:0045823 | GO:0045823 | positive regulation of heart contraction | 1/32 | 38/18888 | 0.0263158 | 15.532895 | 3.6941961 | 0.0624614 | 0.2438750 | 0.1982134 | ADM | 1 |
| GO:1902229 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1/32 | 38/18888 | 0.0263158 | 15.532895 | 3.6941961 | 0.0624614 | 0.2438750 | 0.1982134 | ING2 | 1 |
| GO:0032350 | GO:0032350 | regulation of hormone metabolic process | 1/32 | 39/18888 | 0.0256410 | 15.134615 | 3.6400206 | 0.0640530 | 0.2464647 | 0.2003182 | ADM | 1 |
| GO:1903524 | GO:1903524 | positive regulation of blood circulation | 1/32 | 39/18888 | 0.0256410 | 15.134615 | 3.6400206 | 0.0640530 | 0.2464647 | 0.2003182 | ADM | 1 |
| GO:0035886 | GO:0035886 | vascular associated smooth muscle cell differentiation | 1/32 | 40/18888 | 0.0250000 | 14.756250 | 3.5878073 | 0.0656419 | 0.2472047 | 0.2009197 | ADM | 1 |
| GO:0045429 | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1/32 | 40/18888 | 0.0250000 | 14.756250 | 3.5878073 | 0.0656419 | 0.2472047 | 0.2009197 | PTX3 | 1 |
| GO:0070884 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 1/32 | 40/18888 | 0.0250000 | 14.756250 | 3.5878073 | 0.0656419 | 0.2472047 | 0.2009197 | CAMTA1 | 1 |
| GO:0106056 | GO:0106056 | regulation of calcineurin-mediated signaling | 1/32 | 41/18888 | 0.0243902 | 14.396342 | 3.5374370 | 0.0672283 | 0.2496379 | 0.2028973 | CAMTA1 | 1 |
| GO:1904407 | GO:1904407 | positive regulation of nitric oxide metabolic process | 1/32 | 41/18888 | 0.0243902 | 14.396342 | 3.5374370 | 0.0672283 | 0.2496379 | 0.2028973 | PTX3 | 1 |
| GO:0045663 | GO:0045663 | positive regulation of myoblast differentiation | 1/32 | 43/18888 | 0.0232558 | 13.726744 | 3.4417963 | 0.0703932 | 0.2582227 | 0.2098747 | RBM24 | 1 |
| GO:0006959 | GO:0006959 | humoral immune response | 2/32 | 258/18888 | 0.0077519 | 4.575581 | 2.3822196 | 0.0705252 | 0.2582227 | 0.2098747 | IFNW1/PPBP | 2 |
| GO:0035307 | GO:0035307 | positive regulation of protein dephosphorylation | 1/32 | 44/18888 | 0.0227273 | 13.414773 | 3.3963330 | 0.0719717 | 0.2582227 | 0.2098747 | CAMTA1 | 1 |
| GO:0042771 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/32 | 44/18888 | 0.0227273 | 13.414773 | 3.3963330 | 0.0719717 | 0.2582227 | 0.2098747 | ING2 | 1 |
| GO:0120178 | GO:0120178 | steroid hormone biosynthetic process | 1/32 | 44/18888 | 0.0227273 | 13.414773 | 3.3963330 | 0.0719717 | 0.2582227 | 0.2098747 | ADM | 1 |
| GO:0033173 | GO:0033173 | calcineurin-NFAT signaling cascade | 1/32 | 45/18888 | 0.0222222 | 13.116667 | 3.3523248 | 0.0735476 | 0.2603586 | 0.2116107 | CAMTA1 | 1 |
| GO:0035196 | GO:0035196 | miRNA processing | 1/32 | 45/18888 | 0.0222222 | 13.116667 | 3.3523248 | 0.0735476 | 0.2603586 | 0.2116107 | AGO2 | 1 |
| GO:0042789 | GO:0042789 | mRNA transcription by RNA polymerase II | 1/32 | 46/18888 | 0.0217391 | 12.831522 | 3.3096930 | 0.0751210 | 0.2624291 | 0.2132936 | TAF13 | 1 |
| GO:1990573 | GO:1990573 | potassium ion import across plasma membrane | 1/32 | 46/18888 | 0.0217391 | 12.831522 | 3.3096930 | 0.0751210 | 0.2624291 | 0.2132936 | KCNJ13 | 1 |
| GO:0010830 | GO:0010830 | regulation of myotube differentiation | 1/32 | 47/18888 | 0.0212766 | 12.558511 | 3.2683648 | 0.0766917 | 0.2635200 | 0.2141802 | RBM24 | 1 |
| GO:0060711 | GO:0060711 | labyrinthine layer development | 1/32 | 47/18888 | 0.0212766 | 12.558511 | 3.2683648 | 0.0766917 | 0.2635200 | 0.2141802 | ADM | 1 |
| GO:0097720 | GO:0097720 | calcineurin-mediated signaling | 1/32 | 48/18888 | 0.0208333 | 12.296875 | 3.2282725 | 0.0782599 | 0.2635200 | 0.2141802 | CAMTA1 | 1 |
| GO:1902459 | GO:1902459 | positive regulation of stem cell population maintenance | 1/32 | 48/18888 | 0.0208333 | 12.296875 | 3.2282725 | 0.0782599 | 0.2635200 | 0.2141802 | ING2 | 1 |
| GO:0006376 | GO:0006376 | mRNA splice site recognition | 1/32 | 49/18888 | 0.0204082 | 12.045918 | 3.1893534 | 0.0798255 | 0.2635200 | 0.2141802 | SRSF5 | 1 |
| GO:0042181 | GO:0042181 | ketone biosynthetic process | 1/32 | 49/18888 | 0.0204082 | 12.045918 | 3.1893534 | 0.0798255 | 0.2635200 | 0.2141802 | ADM | 1 |
| GO:0044788 | GO:0044788 | modulation by host of viral process | 1/32 | 49/18888 | 0.0204082 | 12.045918 | 3.1893534 | 0.0798255 | 0.2635200 | 0.2141802 | PTX3 | 1 |
| GO:0046596 | GO:0046596 | regulation of viral entry into host cell | 1/32 | 49/18888 | 0.0204082 | 12.045918 | 3.1893534 | 0.0798255 | 0.2635200 | 0.2141802 | PTX3 | 1 |
| GO:0009299 | GO:0009299 | mRNA transcription | 1/32 | 50/18888 | 0.0200000 | 11.805000 | 3.1515491 | 0.0813885 | 0.2635200 | 0.2141802 | TAF13 | 1 |
| GO:0022602 | GO:0022602 | ovulation cycle process | 1/32 | 50/18888 | 0.0200000 | 11.805000 | 3.1515491 | 0.0813885 | 0.2635200 | 0.2141802 | PTX3 | 1 |
| GO:0043114 | GO:0043114 | regulation of vascular permeability | 1/32 | 50/18888 | 0.0200000 | 11.805000 | 3.1515491 | 0.0813885 | 0.2635200 | 0.2141802 | ADM | 1 |
| GO:0043330 | GO:0043330 | response to exogenous dsRNA | 1/32 | 50/18888 | 0.0200000 | 11.805000 | 3.1515491 | 0.0813885 | 0.2635200 | 0.2141802 | IFNW1 | 1 |
| GO:0050885 | GO:0050885 | neuromuscular process controlling balance | 1/32 | 51/18888 | 0.0196078 | 11.573529 | 3.1148052 | 0.0829489 | 0.2669447 | 0.2169637 | CAMTA1 | 1 |
| GO:0003197 | GO:0003197 | endocardial cushion development | 1/32 | 52/18888 | 0.0192308 | 11.350962 | 3.0790711 | 0.0845068 | 0.2671018 | 0.2170914 | RBM24 | 1 |
| GO:0051155 | GO:0051155 | positive regulation of striated muscle cell differentiation | 1/32 | 52/18888 | 0.0192308 | 11.350962 | 3.0790711 | 0.0845068 | 0.2671018 | 0.2170914 | RBM24 | 1 |
| GO:0051646 | GO:0051646 | mitochondrion localization | 1/32 | 52/18888 | 0.0192308 | 11.350962 | 3.0790711 | 0.0845068 | 0.2671018 | 0.2170914 | BRAT1 | 1 |
| GO:0007548 | GO:0007548 | sex differentiation | 2/32 | 288/18888 | 0.0069444 | 4.098958 | 2.1831682 | 0.0852379 | 0.2678186 | 0.2176740 | ING2/PTX3 | 2 |
| GO:0050850 | GO:0050850 | positive regulation of calcium-mediated signaling | 1/32 | 53/18888 | 0.0188679 | 11.136793 | 3.0442995 | 0.0860621 | 0.2688175 | 0.2184858 | CAMTA1 | 1 |
| GO:0051321 | GO:0051321 | meiotic cell cycle | 2/32 | 291/18888 | 0.0068729 | 4.056701 | 2.1647598 | 0.0867578 | 0.2694059 | 0.2189641 | ING2/PTTG1 | 2 |
| GO:0035306 | GO:0035306 | positive regulation of dephosphorylation | 1/32 | 54/18888 | 0.0185185 | 10.930556 | 3.0104460 | 0.0876148 | 0.2704854 | 0.2198414 | CAMTA1 | 1 |
| GO:0007140 | GO:0007140 | male meiotic nuclear division | 1/32 | 55/18888 | 0.0181818 | 10.731818 | 2.9774692 | 0.0891650 | 0.2705522 | 0.2198957 | ING2 | 1 |
| GO:0010559 | GO:0010559 | regulation of glycoprotein biosynthetic process | 1/32 | 55/18888 | 0.0181818 | 10.731818 | 2.9774692 | 0.0891650 | 0.2705522 | 0.2198957 | AGO2 | 1 |
| GO:2000772 | GO:2000772 | regulation of cellular senescence | 1/32 | 55/18888 | 0.0181818 | 10.731818 | 2.9774692 | 0.0891650 | 0.2705522 | 0.2198957 | ING2 | 1 |
| GO:0052372 | GO:0052372 | modulation by symbiont of entry into host | 1/32 | 56/18888 | 0.0178571 | 10.540179 | 2.9453302 | 0.0907127 | 0.2736843 | 0.2224414 | PTX3 | 1 |
| GO:0001541 | GO:0001541 | ovarian follicle development | 1/32 | 57/18888 | 0.0175439 | 10.355263 | 2.9139926 | 0.0922578 | 0.2767733 | 0.2249521 | PTX3 | 1 |
| GO:0043331 | GO:0043331 | response to dsRNA | 1/32 | 58/18888 | 0.0172414 | 10.176724 | 2.8834220 | 0.0938003 | 0.2798201 | 0.2274283 | IFNW1 | 1 |
| GO:0048608 | GO:0048608 | reproductive structure development | 2/32 | 307/18888 | 0.0065147 | 3.845277 | 2.0705746 | 0.0950022 | 0.2812540 | 0.2285938 | ING2/PTX3 | 2 |
| GO:0007566 | GO:0007566 | embryo implantation | 1/32 | 59/18888 | 0.0169492 | 10.004237 | 2.8535863 | 0.0953403 | 0.2812540 | 0.2285938 | AGO2 | 1 |
| GO:0061458 | GO:0061458 | reproductive system development | 2/32 | 311/18888 | 0.0064309 | 3.795820 | 2.0480158 | 0.0970984 | 0.2848578 | 0.2315228 | ING2/PTX3 | 2 |
| GO:0031102 | GO:0031102 | neuron projection regeneration | 1/32 | 61/18888 | 0.0163934 | 9.676229 | 2.7959995 | 0.0984128 | 0.2855583 | 0.2320922 | ADM | 1 |
| GO:0045744 | GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 1/32 | 61/18888 | 0.0163934 | 9.676229 | 2.7959995 | 0.0984128 | 0.2855583 | 0.2320922 | ADM | 1 |
| GO:0060261 | GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 1/32 | 62/18888 | 0.0161290 | 9.520161 | 2.7681928 | 0.0999452 | 0.2877960 | 0.2339110 | TAF13 | 1 |
| GO:0090092 | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2/32 | 317/18888 | 0.0063091 | 3.723975 | 2.0148687 | 0.1002679 | 0.2877960 | 0.2339110 | ING2/TOB1 | 2 |
| GO:0045428 | GO:0045428 | regulation of nitric oxide biosynthetic process | 1/32 | 63/18888 | 0.0158730 | 9.369048 | 2.7410093 | 0.1014751 | 0.2881458 | 0.2341952 | PTX3 | 1 |
| GO:0061951 | GO:0061951 | establishment of protein localization to plasma membrane | 1/32 | 63/18888 | 0.0158730 | 9.369048 | 2.7410093 | 0.1014751 | 0.2881458 | 0.2341952 | RILPL2 | 1 |
| GO:0043903 | GO:0043903 | regulation of biological process involved in symbiotic interaction | 1/32 | 65/18888 | 0.0153846 | 9.080769 | 2.6884171 | 0.1045273 | 0.2925510 | 0.2377756 | PTX3 | 1 |
| GO:0080164 | GO:0080164 | regulation of nitric oxide metabolic process | 1/32 | 65/18888 | 0.0153846 | 9.080769 | 2.6884171 | 0.1045273 | 0.2925510 | 0.2377756 | PTX3 | 1 |
| GO:0031100 | GO:0031100 | animal organ regeneration | 1/32 | 66/18888 | 0.0151515 | 8.943182 | 2.6629639 | 0.1060496 | 0.2925510 | 0.2377756 | ADM | 1 |
| GO:0042446 | GO:0042446 | hormone biosynthetic process | 1/32 | 66/18888 | 0.0151515 | 8.943182 | 2.6629639 | 0.1060496 | 0.2925510 | 0.2377756 | ADM | 1 |
| GO:0048255 | GO:0048255 | mRNA stabilization | 1/32 | 66/18888 | 0.0151515 | 8.943182 | 2.6629639 | 0.1060496 | 0.2925510 | 0.2377756 | RBM24 | 1 |
| GO:0009620 | GO:0009620 | response to fungus | 1/32 | 67/18888 | 0.0149254 | 8.809701 | 2.6380449 | 0.1075695 | 0.2925510 | 0.2377756 | PTX3 | 1 |
| GO:0045143 | GO:0045143 | homologous chromosome segregation | 1/32 | 67/18888 | 0.0149254 | 8.809701 | 2.6380449 | 0.1075695 | 0.2925510 | 0.2377756 | PTTG1 | 1 |
| GO:0045668 | GO:0045668 | negative regulation of osteoblast differentiation | 1/32 | 68/18888 | 0.0147059 | 8.680147 | 2.6136407 | 0.1090868 | 0.2925510 | 0.2377756 | TOB1 | 1 |
| GO:0051123 | GO:0051123 | RNA polymerase II preinitiation complex assembly | 1/32 | 68/18888 | 0.0147059 | 8.680147 | 2.6136407 | 0.1090868 | 0.2925510 | 0.2377756 | TAF13 | 1 |
| GO:0070918 | GO:0070918 | regulatory ncRNA processing | 1/32 | 68/18888 | 0.0147059 | 8.680147 | 2.6136407 | 0.1090868 | 0.2925510 | 0.2377756 | AGO2 | 1 |
| GO:2000144 | GO:2000144 | positive regulation of DNA-templated transcription initiation | 1/32 | 68/18888 | 0.0147059 | 8.680147 | 2.6136407 | 0.1090868 | 0.2925510 | 0.2377756 | TAF13 | 1 |
| GO:0019229 | GO:0019229 | regulation of vasoconstriction | 1/32 | 69/18888 | 0.0144928 | 8.554348 | 2.5897327 | 0.1106016 | 0.2951230 | 0.2398660 | ADM | 1 |
| GO:0019933 | GO:0019933 | cAMP-mediated signaling | 1/32 | 71/18888 | 0.0140845 | 8.313380 | 2.5433366 | 0.1136238 | 0.3011560 | 0.2447695 | ADM | 1 |
| GO:0030514 | GO:0030514 | negative regulation of BMP signaling pathway | 1/32 | 72/18888 | 0.0138889 | 8.197917 | 2.5208158 | 0.1151312 | 0.3011560 | 0.2447695 | TOB1 | 1 |
| GO:0042698 | GO:0042698 | ovulation cycle | 1/32 | 72/18888 | 0.0138889 | 8.197917 | 2.5208158 | 0.1151312 | 0.3011560 | 0.2447695 | PTX3 | 1 |
| GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 1/32 | 72/18888 | 0.0138889 | 8.197917 | 2.5208158 | 0.1151312 | 0.3011560 | 0.2447695 | PTX3 | 1 |
| GO:0045661 | GO:0045661 | regulation of myoblast differentiation | 1/32 | 73/18888 | 0.0136986 | 8.085616 | 2.4987261 | 0.1166361 | 0.3016731 | 0.2451897 | RBM24 | 1 |
| GO:2000036 | GO:2000036 | regulation of stem cell population maintenance | 1/32 | 73/18888 | 0.0136986 | 8.085616 | 2.4987261 | 0.1166361 | 0.3016731 | 0.2451897 | ING2 | 1 |
| GO:0032496 | GO:0032496 | response to lipopolysaccharide | 2/32 | 348/18888 | 0.0057471 | 3.392241 | 1.8555448 | 0.1170942 | 0.3016731 | 0.2451897 | ADM/PPBP | 2 |
| GO:0060260 | GO:0060260 | regulation of transcription initiation by RNA polymerase II | 1/32 | 74/18888 | 0.0135135 | 7.976351 | 2.4770532 | 0.1181385 | 0.3016731 | 0.2451897 | TAF13 | 1 |
| GO:0043489 | GO:0043489 | RNA stabilization | 1/32 | 75/18888 | 0.0133333 | 7.870000 | 2.4557833 | 0.1196384 | 0.3016731 | 0.2451897 | RBM24 | 1 |
| GO:0060390 | GO:0060390 | regulation of SMAD protein signal transduction | 1/32 | 75/18888 | 0.0133333 | 7.870000 | 2.4557833 | 0.1196384 | 0.3016731 | 0.2451897 | TOB1 | 1 |
| GO:0009895 | GO:0009895 | negative regulation of catabolic process | 2/32 | 353/18888 | 0.0056657 | 3.344193 | 1.8315385 | 0.1198739 | 0.3016731 | 0.2451897 | RBM24/TOB1 | 2 |
| GO:0045765 | GO:0045765 | regulation of angiogenesis | 2/32 | 353/18888 | 0.0056657 | 3.344193 | 1.8315385 | 0.1198739 | 0.3016731 | 0.2451897 | ADM/AGO2 | 2 |
| GO:0015986 | GO:0015986 | proton motive force-driven ATP synthesis | 1/32 | 76/18888 | 0.0131579 | 7.766447 | 2.4349033 | 0.1211359 | 0.3034110 | 0.2466023 | ATP5MC2 | 1 |
| GO:0006809 | GO:0006809 | nitric oxide biosynthetic process | 1/32 | 77/18888 | 0.0129870 | 7.665584 | 2.4144007 | 0.1226308 | 0.3042849 | 0.2473126 | PTX3 | 1 |
| GO:0035914 | GO:0035914 | skeletal muscle cell differentiation | 1/32 | 77/18888 | 0.0129870 | 7.665584 | 2.4144007 | 0.1226308 | 0.3042849 | 0.2473126 | RBM24 | 1 |
| GO:0051145 | GO:0051145 | smooth muscle cell differentiation | 1/32 | 78/18888 | 0.0128205 | 7.567308 | 2.3942636 | 0.1241234 | 0.3063710 | 0.2490081 | ADM | 1 |
| GO:1901342 | GO:1901342 | regulation of vasculature development | 2/32 | 362/18888 | 0.0055249 | 3.261050 | 1.7893911 | 0.1249197 | 0.3063710 | 0.2490081 | ADM/AGO2 | 2 |
| GO:0035304 | GO:0035304 | regulation of protein dephosphorylation | 1/32 | 79/18888 | 0.0126582 | 7.471519 | 2.3744806 | 0.1256134 | 0.3063710 | 0.2490081 | CAMTA1 | 1 |
| GO:0050810 | GO:0050810 | regulation of steroid biosynthetic process | 1/32 | 81/18888 | 0.0123457 | 7.287037 | 2.3359334 | 0.1285862 | 0.3063710 | 0.2490081 | ADM | 1 |
| GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 2/32 | 369/18888 | 0.0054201 | 3.199187 | 1.7575119 | 0.1288806 | 0.3063710 | 0.2490081 | ADM/PPBP | 2 |
| GO:0007281 | GO:0007281 | germ cell development | 2/32 | 371/18888 | 0.0053908 | 3.181941 | 1.7485428 | 0.1300179 | 0.3063710 | 0.2490081 | ING2/PTX3 | 2 |
| GO:0061844 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 1/32 | 82/18888 | 0.0121951 | 7.198171 | 2.3171489 | 0.1300689 | 0.3063710 | 0.2490081 | PPBP | 1 |
| GO:0070897 | GO:0070897 | transcription preinitiation complex assembly | 1/32 | 82/18888 | 0.0121951 | 7.198171 | 2.3171489 | 0.1300689 | 0.3063710 | 0.2490081 | TAF13 | 1 |
| GO:2000142 | GO:2000142 | regulation of DNA-templated transcription initiation | 1/32 | 82/18888 | 0.0121951 | 7.198171 | 2.3171489 | 0.1300689 | 0.3063710 | 0.2490081 | TAF13 | 1 |
| GO:0090287 | GO:0090287 | regulation of cellular response to growth factor stimulus | 2/32 | 373/18888 | 0.0053619 | 3.164879 | 1.7396343 | 0.1311576 | 0.3063710 | 0.2490081 | ING2/TOB1 | 2 |
| GO:0001570 | GO:0001570 | vasculogenesis | 1/32 | 83/18888 | 0.0120482 | 7.111446 | 2.2986774 | 0.1315491 | 0.3063710 | 0.2490081 | ADM | 1 |
| GO:0060337 | GO:0060337 | type I interferon-mediated signaling pathway | 1/32 | 83/18888 | 0.0120482 | 7.111446 | 2.2986774 | 0.1315491 | 0.3063710 | 0.2490081 | IFNW1 | 1 |
| GO:0072332 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1/32 | 83/18888 | 0.0120482 | 7.111446 | 2.2986774 | 0.1315491 | 0.3063710 | 0.2490081 | ING2 | 1 |
| GO:2000736 | GO:2000736 | regulation of stem cell differentiation | 1/32 | 83/18888 | 0.0120482 | 7.111446 | 2.2986774 | 0.1315491 | 0.3063710 | 0.2490081 | RBM24 | 1 |
| GO:0046209 | GO:0046209 | nitric oxide metabolic process | 1/32 | 84/18888 | 0.0119048 | 7.026786 | 2.2805099 | 0.1330270 | 0.3071188 | 0.2496158 | PTX3 | 1 |
| GO:0071357 | GO:0071357 | cellular response to type I interferon | 1/32 | 84/18888 | 0.0119048 | 7.026786 | 2.2805099 | 0.1330270 | 0.3071188 | 0.2496158 | IFNW1 | 1 |
| GO:0051149 | GO:0051149 | positive regulation of muscle cell differentiation | 1/32 | 85/18888 | 0.0117647 | 6.944118 | 2.2626375 | 0.1345024 | 0.3078481 | 0.2502086 | RBM24 | 1 |
| GO:2001057 | GO:2001057 | reactive nitrogen species metabolic process | 1/32 | 85/18888 | 0.0117647 | 6.944118 | 2.2626375 | 0.1345024 | 0.3078481 | 0.2502086 | PTX3 | 1 |
| GO:0051851 | GO:0051851 | modulation by host of symbiont process | 1/32 | 86/18888 | 0.0116279 | 6.863372 | 2.2450517 | 0.1359753 | 0.3080230 | 0.2503508 | PTX3 | 1 |
| GO:0009791 | GO:0009791 | post-embryonic development | 1/32 | 87/18888 | 0.0114943 | 6.784483 | 2.2277445 | 0.1374458 | 0.3080230 | 0.2503508 | AGO2 | 1 |
| GO:0098586 | GO:0098586 | cellular response to virus | 1/32 | 87/18888 | 0.0114943 | 6.784483 | 2.2277445 | 0.1374458 | 0.3080230 | 0.2503508 | IFNW1 | 1 |
| GO:0009100 | GO:0009100 | glycoprotein metabolic process | 2/32 | 386/18888 | 0.0051813 | 3.058290 | 1.6831492 | 0.1386240 | 0.3080230 | 0.2503508 | PTX3/AGO2 | 2 |
| GO:0001892 | GO:0001892 | embryonic placenta development | 1/32 | 88/18888 | 0.0113636 | 6.707386 | 2.2107080 | 0.1389139 | 0.3080230 | 0.2503508 | ADM | 1 |
| GO:0046889 | GO:0046889 | positive regulation of lipid biosynthetic process | 1/32 | 88/18888 | 0.0113636 | 6.707386 | 2.2107080 | 0.1389139 | 0.3080230 | 0.2503508 | ADM | 1 |
| GO:0141091 | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 2/32 | 388/18888 | 0.0051546 | 3.042526 | 1.6746700 | 0.1397812 | 0.3080230 | 0.2503508 | ING2/TOB1 | 2 |
| GO:0001843 | GO:0001843 | neural tube closure | 1/32 | 89/18888 | 0.0112360 | 6.632022 | 2.1939347 | 0.1403796 | 0.3080230 | 0.2503508 | ADM | 1 |
| GO:0042310 | GO:0042310 | vasoconstriction | 1/32 | 89/18888 | 0.0112360 | 6.632022 | 2.1939347 | 0.1403796 | 0.3080230 | 0.2503508 | ADM | 1 |
| GO:2000243 | GO:2000243 | positive regulation of reproductive process | 1/32 | 89/18888 | 0.0112360 | 6.632022 | 2.1939347 | 0.1403796 | 0.3080230 | 0.2503508 | AGO2 | 1 |
| GO:0034340 | GO:0034340 | response to type I interferon | 1/32 | 90/18888 | 0.0111111 | 6.558333 | 2.1774175 | 0.1418429 | 0.3086826 | 0.2508869 | IFNW1 | 1 |
| GO:0060606 | GO:0060606 | tube closure | 1/32 | 90/18888 | 0.0111111 | 6.558333 | 2.1774175 | 0.1418429 | 0.3086826 | 0.2508869 | ADM | 1 |
| GO:0033138 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1/32 | 93/18888 | 0.0107527 | 6.346774 | 2.1293343 | 0.1462182 | 0.3114940 | 0.2531718 | IFNW1 | 1 |
| GO:0042475 | GO:0042475 | odontogenesis of dentin-containing tooth | 1/32 | 93/18888 | 0.0107527 | 6.346774 | 2.1293343 | 0.1462182 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0045132 | GO:0045132 | meiotic chromosome segregation | 1/32 | 93/18888 | 0.0107527 | 6.346774 | 2.1293343 | 0.1462182 | 0.3114940 | 0.2531718 | PTTG1 | 1 |
| GO:0048525 | GO:0048525 | negative regulation of viral process | 1/32 | 93/18888 | 0.0107527 | 6.346774 | 2.1293343 | 0.1462182 | 0.3114940 | 0.2531718 | PTX3 | 1 |
| GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 1/32 | 93/18888 | 0.0107527 | 6.346774 | 2.1293343 | 0.1462182 | 0.3114940 | 0.2531718 | PPBP | 1 |
| GO:0050848 | GO:0050848 | regulation of calcium-mediated signaling | 1/32 | 94/18888 | 0.0106383 | 6.279255 | 2.1137746 | 0.1476718 | 0.3114940 | 0.2531718 | CAMTA1 | 1 |
| GO:0051781 | GO:0051781 | positive regulation of cell division | 1/32 | 94/18888 | 0.0106383 | 6.279255 | 2.1137746 | 0.1476718 | 0.3114940 | 0.2531718 | PPBP | 1 |
| GO:0014020 | GO:0014020 | primary neural tube formation | 1/32 | 95/18888 | 0.0105263 | 6.213158 | 2.0984389 | 0.1491231 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0060395 | GO:0060395 | SMAD protein signal transduction | 1/32 | 95/18888 | 0.0105263 | 6.213158 | 2.0984389 | 0.1491231 | 0.3114940 | 0.2531718 | TOB1 | 1 |
| GO:0000245 | GO:0000245 | spliceosomal complex assembly | 1/32 | 96/18888 | 0.0104167 | 6.148438 | 2.0833213 | 0.1505719 | 0.3114940 | 0.2531718 | SRSF5 | 1 |
| GO:0003073 | GO:0003073 | regulation of systemic arterial blood pressure | 1/32 | 96/18888 | 0.0104167 | 6.148438 | 2.0833213 | 0.1505719 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0042982 | GO:0042982 | amyloid precursor protein metabolic process | 1/32 | 96/18888 | 0.0104167 | 6.148438 | 2.0833213 | 0.1505719 | 0.3114940 | 0.2531718 | AGO2 | 1 |
| GO:0051153 | GO:0051153 | regulation of striated muscle cell differentiation | 1/32 | 97/18888 | 0.0103093 | 6.085051 | 2.0684164 | 0.1520183 | 0.3114940 | 0.2531718 | RBM24 | 1 |
| GO:0030101 | GO:0030101 | natural killer cell activation | 1/32 | 98/18888 | 0.0102041 | 6.022959 | 2.0537189 | 0.1534624 | 0.3114940 | 0.2531718 | IFNW1 | 1 |
| GO:0140694 | GO:0140694 | non-membrane-bounded organelle assembly | 2/32 | 413/18888 | 0.0048426 | 2.858354 | 1.5730511 | 0.1544258 | 0.3114940 | 0.2531718 | RPL38/NOA1 | 2 |
| GO:0035278 | GO:0035278 | miRNA-mediated gene silencing by inhibition of translation | 1/32 | 99/18888 | 0.0101010 | 5.962121 | 2.0392235 | 0.1549041 | 0.3114940 | 0.2531718 | AGO2 | 1 |
| GO:0019935 | GO:0019935 | cyclic-nucleotide-mediated signaling | 1/32 | 100/18888 | 0.0100000 | 5.902500 | 2.0249254 | 0.1563434 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0035279 | GO:0035279 | miRNA-mediated gene silencing by mRNA destabilization | 1/32 | 100/18888 | 0.0100000 | 5.902500 | 2.0249254 | 0.1563434 | 0.3114940 | 0.2531718 | AGO2 | 1 |
| GO:0050764 | GO:0050764 | regulation of phagocytosis | 1/32 | 100/18888 | 0.0100000 | 5.902500 | 2.0249254 | 0.1563434 | 0.3114940 | 0.2531718 | PTX3 | 1 |
| GO:0007178 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 2/32 | 417/18888 | 0.0047962 | 2.830935 | 1.5574980 | 0.1567977 | 0.3114940 | 0.2531718 | ING2/TOB1 | 2 |
| GO:0006754 | GO:0006754 | ATP biosynthetic process | 1/32 | 101/18888 | 0.0099010 | 5.844059 | 2.0108197 | 0.1577803 | 0.3114940 | 0.2531718 | ATP5MC2 | 1 |
| GO:1990868 | GO:1990868 | response to chemokine | 1/32 | 101/18888 | 0.0099010 | 5.844059 | 2.0108197 | 0.1577803 | 0.3114940 | 0.2531718 | PPBP | 1 |
| GO:1990869 | GO:1990869 | cellular response to chemokine | 1/32 | 101/18888 | 0.0099010 | 5.844059 | 2.0108197 | 0.1577803 | 0.3114940 | 0.2531718 | PPBP | 1 |
| GO:0001841 | GO:0001841 | neural tube formation | 1/32 | 102/18888 | 0.0098039 | 5.786765 | 1.9969018 | 0.1592149 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0008585 | GO:0008585 | female gonad development | 1/32 | 102/18888 | 0.0098039 | 5.786765 | 1.9969018 | 0.1592149 | 0.3114940 | 0.2531718 | PTX3 | 1 |
| GO:0008630 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1/32 | 102/18888 | 0.0098039 | 5.786765 | 1.9969018 | 0.1592149 | 0.3114940 | 0.2531718 | ING2 | 1 |
| GO:0042274 | GO:0042274 | ribosomal small subunit biogenesis | 1/32 | 103/18888 | 0.0097087 | 5.730582 | 1.9831672 | 0.1606471 | 0.3114940 | 0.2531718 | RRP9 | 1 |
| GO:0002027 | GO:0002027 | regulation of heart rate | 1/32 | 104/18888 | 0.0096154 | 5.675481 | 1.9696116 | 0.1620769 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0019218 | GO:0019218 | regulation of steroid metabolic process | 1/32 | 104/18888 | 0.0096154 | 5.675481 | 1.9696116 | 0.1620769 | 0.3114940 | 0.2531718 | ADM | 1 |
| GO:0042100 | GO:0042100 | B cell proliferation | 1/32 | 104/18888 | 0.0096154 | 5.675481 | 1.9696116 | 0.1620769 | 0.3114940 | 0.2531718 | IFNW1 | 1 |
| GO:1990830 | GO:1990830 | cellular response to leukemia inhibitory factor | 1/32 | 104/18888 | 0.0096154 | 5.675481 | 1.9696116 | 0.1620769 | 0.3114940 | 0.2531718 | SRSF7 | 1 |
| GO:0042692 | GO:0042692 | muscle cell differentiation | 2/32 | 428/18888 | 0.0046729 | 2.758178 | 1.5156554 | 0.1633578 | 0.3114940 | 0.2531718 | ADM/RBM24 | 2 |
| GO:0090100 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1/32 | 105/18888 | 0.0095238 | 5.621429 | 1.9562309 | 0.1635044 | 0.3114940 | 0.2531718 | ING2 | 1 |
| GO:0035303 | GO:0035303 | regulation of dephosphorylation | 1/32 | 106/18888 | 0.0094340 | 5.568396 | 1.9430209 | 0.1649295 | 0.3114940 | 0.2531718 | CAMTA1 | 1 |
| GO:0046425 | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 1/32 | 106/18888 | 0.0094340 | 5.568396 | 1.9430209 | 0.1649295 | 0.3114940 | 0.2531718 | IFNW1 | 1 |
| GO:0046545 | GO:0046545 | development of primary female sexual characteristics | 1/32 | 106/18888 | 0.0094340 | 5.568396 | 1.9430209 | 0.1649295 | 0.3114940 | 0.2531718 | PTX3 | 1 |
| GO:1990823 | GO:1990823 | response to leukemia inhibitory factor | 1/32 | 106/18888 | 0.0094340 | 5.568396 | 1.9430209 | 0.1649295 | 0.3114940 | 0.2531718 | SRSF7 | 1 |
| GO:0030593 | GO:0030593 | neutrophil chemotaxis | 1/32 | 107/18888 | 0.0093458 | 5.516355 | 1.9299778 | 0.1663522 | 0.3114940 | 0.2531718 | PPBP | 1 |
| GO:0034470 | GO:0034470 | ncRNA processing | 2/32 | 433/18888 | 0.0046189 | 2.726328 | 1.4970693 | 0.1663569 | 0.3114940 | 0.2531718 | RRP9/AGO2 | 2 |
| GO:0010586 | GO:0010586 | miRNA metabolic process | 1/32 | 108/18888 | 0.0092593 | 5.465278 | 1.9170978 | 0.1677726 | 0.3114940 | 0.2531718 | AGO2 | 1 |
| GO:0140888 | GO:0140888 | interferon-mediated signaling pathway | 1/32 | 108/18888 | 0.0092593 | 5.465278 | 1.9170978 | 0.1677726 | 0.3114940 | 0.2531718 | IFNW1 | 1 |
| GO:1901796 | GO:1901796 | regulation of signal transduction by p53 class mediator | 1/32 | 108/18888 | 0.0092593 | 5.465278 | 1.9170978 | 0.1677726 | 0.3114940 | 0.2531718 | ING2 | 1 |
| GO:0048477 | GO:0048477 | oogenesis | 1/32 | 110/18888 | 0.0090909 | 5.365909 | 1.8918124 | 0.1706064 | 0.3156516 | 0.2565510 | PTX3 | 1 |
| GO:0045445 | GO:0045445 | myoblast differentiation | 1/32 | 111/18888 | 0.0090090 | 5.317568 | 1.8794000 | 0.1720198 | 0.3160641 | 0.2568863 | RBM24 | 1 |
| GO:0090398 | GO:0090398 | cellular senescence | 1/32 | 111/18888 | 0.0090090 | 5.317568 | 1.8794000 | 0.1720198 | 0.3160641 | 0.2568863 | ING2 | 1 |
| GO:0009206 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1/32 | 112/18888 | 0.0089286 | 5.270089 | 1.8671367 | 0.1734309 | 0.3167852 | 0.2574724 | ATP5MC2 | 1 |
| GO:0000280 | GO:0000280 | nuclear division | 2/32 | 446/18888 | 0.0044843 | 2.646861 | 1.4499468 | 0.1742020 | 0.3167852 | 0.2574724 | ING2/PTTG1 | 2 |
| GO:0001503 | GO:0001503 | ossification | 2/32 | 446/18888 | 0.0044843 | 2.646861 | 1.4499468 | 0.1742020 | 0.3167852 | 0.2574724 | RPL38/TOB1 | 2 |
| GO:0009145 | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1/32 | 113/18888 | 0.0088496 | 5.223451 | 1.8550193 | 0.1748396 | 0.3168595 | 0.2575327 | ATP5MC2 | 1 |
| GO:2001243 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 1/32 | 114/18888 | 0.0087719 | 5.177632 | 1.8430446 | 0.1762460 | 0.3183219 | 0.2587213 | ING2 | 1 |
| GO:0006368 | GO:0006368 | transcription elongation by RNA polymerase II | 1/32 | 116/18888 | 0.0086207 | 5.088362 | 1.8195113 | 0.1790518 | 0.3222933 | 0.2619492 | GTF2F2 | 1 |
| GO:0048568 | GO:0048568 | embryonic organ development | 2/32 | 455/18888 | 0.0043956 | 2.594505 | 1.4182912 | 0.1796706 | 0.3223145 | 0.2619664 | ADM/RPL38 | 2 |
| GO:0009201 | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1/32 | 118/18888 | 0.0084746 | 5.002119 | 1.7965136 | 0.1818484 | 0.3240319 | 0.2633622 | ATP5MC2 | 1 |
| GO:1904659 | GO:1904659 | glucose transmembrane transport | 1/32 | 118/18888 | 0.0084746 | 5.002119 | 1.7965136 | 0.1818484 | 0.3240319 | 0.2633622 | PPBP | 1 |
| GO:0051702 | GO:0051702 | biological process involved in interaction with symbiont | 1/32 | 119/18888 | 0.0084034 | 4.960084 | 1.7852088 | 0.1832432 | 0.3254253 | 0.2644947 | PTX3 | 1 |
| GO:0008645 | GO:0008645 | hexose transmembrane transport | 1/32 | 121/18888 | 0.0082645 | 4.878099 | 1.7629738 | 0.1860260 | 0.3270854 | 0.2658440 | PPBP | 1 |
| GO:0030510 | GO:0030510 | regulation of BMP signaling pathway | 1/32 | 121/18888 | 0.0082645 | 4.878099 | 1.7629738 | 0.1860260 | 0.3270854 | 0.2658440 | TOB1 | 1 |
| GO:0046660 | GO:0046660 | female sex differentiation | 1/32 | 121/18888 | 0.0082645 | 4.878099 | 1.7629738 | 0.1860260 | 0.3270854 | 0.2658440 | PTX3 | 1 |
| GO:1904892 | GO:1904892 | regulation of receptor signaling pathway via STAT | 1/32 | 122/18888 | 0.0081967 | 4.838115 | 1.7520388 | 0.1874139 | 0.3275667 | 0.2662352 | IFNW1 | 1 |
| GO:0001838 | GO:0001838 | embryonic epithelial tube formation | 1/32 | 123/18888 | 0.0081301 | 4.798781 | 1.7412221 | 0.1887995 | 0.3275667 | 0.2662352 | ADM | 1 |
| GO:0015749 | GO:0015749 | monosaccharide transmembrane transport | 1/32 | 123/18888 | 0.0081301 | 4.798781 | 1.7412221 | 0.1887995 | 0.3275667 | 0.2662352 | PPBP | 1 |
| GO:0045834 | GO:0045834 | positive regulation of lipid metabolic process | 1/32 | 123/18888 | 0.0081301 | 4.798781 | 1.7412221 | 0.1887995 | 0.3275667 | 0.2662352 | ADM | 1 |
| GO:0002286 | GO:0002286 | T cell activation involved in immune response | 1/32 | 124/18888 | 0.0080645 | 4.760081 | 1.7305214 | 0.1901829 | 0.3275667 | 0.2662352 | IFNW1 | 1 |
| GO:0009142 | GO:0009142 | nucleoside triphosphate biosynthetic process | 1/32 | 126/18888 | 0.0079365 | 4.684524 | 1.7094593 | 0.1929427 | 0.3275667 | 0.2662352 | ATP5MC2 | 1 |
| GO:0033135 | GO:0033135 | regulation of peptidyl-serine phosphorylation | 1/32 | 126/18888 | 0.0079365 | 4.684524 | 1.7094593 | 0.1929427 | 0.3275667 | 0.2662352 | IFNW1 | 1 |
| GO:0098659 | GO:0098659 | inorganic cation import across plasma membrane | 1/32 | 126/18888 | 0.0079365 | 4.684524 | 1.7094593 | 0.1929427 | 0.3275667 | 0.2662352 | KCNJ13 | 1 |
| GO:0099587 | GO:0099587 | inorganic ion import across plasma membrane | 1/32 | 126/18888 | 0.0079365 | 4.684524 | 1.7094593 | 0.1929427 | 0.3275667 | 0.2662352 | KCNJ13 | 1 |
| GO:0003014 | GO:0003014 | renal system process | 1/32 | 127/18888 | 0.0078740 | 4.647638 | 1.6990935 | 0.1943192 | 0.3275667 | 0.2662352 | ADM | 1 |
| GO:0030512 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1/32 | 127/18888 | 0.0078740 | 4.647638 | 1.6990935 | 0.1943192 | 0.3275667 | 0.2662352 | ING2 | 1 |
| GO:0031623 | GO:0031623 | receptor internalization | 1/32 | 127/18888 | 0.0078740 | 4.647638 | 1.6990935 | 0.1943192 | 0.3275667 | 0.2662352 | ADM | 1 |
| GO:0042471 | GO:0042471 | ear morphogenesis | 1/32 | 127/18888 | 0.0078740 | 4.647638 | 1.6990935 | 0.1943192 | 0.3275667 | 0.2662352 | RPL38 | 1 |
| GO:0071621 | GO:0071621 | granulocyte chemotaxis | 1/32 | 128/18888 | 0.0078125 | 4.611328 | 1.6888350 | 0.1956934 | 0.3287134 | 0.2671672 | PPBP | 1 |
| GO:0022412 | GO:0022412 | cellular process involved in reproduction in multicellular organism | 2/32 | 482/18888 | 0.0041494 | 2.449170 | 1.3276845 | 0.1962376 | 0.3287134 | 0.2671672 | ING2/PTX3 | 2 |
| GO:1990266 | GO:1990266 | neutrophil migration | 1/32 | 129/18888 | 0.0077519 | 4.575581 | 1.6786818 | 0.1970654 | 0.3290620 | 0.2674505 | PPBP | 1 |
| GO:0051028 | GO:0051028 | mRNA transport | 1/32 | 131/18888 | 0.0076336 | 4.505725 | 1.6586835 | 0.1998025 | 0.3322791 | 0.2700653 | SRSF7 | 1 |
| GO:0019730 | GO:0019730 | antimicrobial humoral response | 1/32 | 132/18888 | 0.0075758 | 4.471591 | 1.6488346 | 0.2011676 | 0.3322791 | 0.2700653 | PPBP | 1 |
| GO:0014902 | GO:0014902 | myotube differentiation | 1/32 | 133/18888 | 0.0075188 | 4.437970 | 1.6390834 | 0.2025305 | 0.3322791 | 0.2700653 | RBM24 | 1 |
| GO:0042476 | GO:0042476 | odontogenesis | 1/32 | 133/18888 | 0.0075188 | 4.437970 | 1.6390834 | 0.2025305 | 0.3322791 | 0.2700653 | ADM | 1 |
| GO:0048285 | GO:0048285 | organelle fission | 2/32 | 493/18888 | 0.0040568 | 2.394523 | 1.2925015 | 0.2030475 | 0.3322791 | 0.2700653 | ING2/PTTG1 | 2 |
| GO:0045727 | GO:0045727 | positive regulation of translation | 1/32 | 134/18888 | 0.0074627 | 4.404851 | 1.6294282 | 0.2038912 | 0.3322791 | 0.2700653 | AGO2 | 1 |
| GO:0051384 | GO:0051384 | response to glucocorticoid | 1/32 | 134/18888 | 0.0074627 | 4.404851 | 1.6294282 | 0.2038912 | 0.3322791 | 0.2700653 | ADM | 1 |
| GO:0006354 | GO:0006354 | DNA-templated transcription elongation | 1/32 | 135/18888 | 0.0074074 | 4.372222 | 1.6198671 | 0.2052496 | 0.3322791 | 0.2700653 | GTF2F2 | 1 |
| GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 1/32 | 135/18888 | 0.0074074 | 4.372222 | 1.6198671 | 0.2052496 | 0.3322791 | 0.2700653 | ING2 | 1 |
| GO:0072175 | GO:0072175 | epithelial tube formation | 1/32 | 135/18888 | 0.0074074 | 4.372222 | 1.6198671 | 0.2052496 | 0.3322791 | 0.2700653 | ADM | 1 |
| GO:0034219 | GO:0034219 | carbohydrate transmembrane transport | 1/32 | 137/18888 | 0.0072993 | 4.308394 | 1.6010209 | 0.2079597 | 0.3346260 | 0.2719728 | PPBP | 1 |
| GO:0090288 | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1/32 | 137/18888 | 0.0072993 | 4.308394 | 1.6010209 | 0.2079597 | 0.3346260 | 0.2719728 | TOB1 | 1 |
| GO:0010212 | GO:0010212 | response to ionizing radiation | 1/32 | 138/18888 | 0.0072464 | 4.277174 | 1.5917325 | 0.2093114 | 0.3357835 | 0.2729135 | BRAT1 | 1 |
| GO:0007498 | GO:0007498 | mesoderm development | 1/32 | 140/18888 | 0.0071429 | 4.216071 | 1.5734173 | 0.2120080 | 0.3390851 | 0.2755970 | RPL38 | 1 |
| GO:0030317 | GO:0030317 | flagellated sperm motility | 1/32 | 141/18888 | 0.0070922 | 4.186170 | 1.5643875 | 0.2133530 | 0.3391929 | 0.2756846 | ING2 | 1 |
| GO:0097722 | GO:0097722 | sperm motility | 1/32 | 141/18888 | 0.0070922 | 4.186170 | 1.5643875 | 0.2133530 | 0.3391929 | 0.2756846 | ING2 | 1 |
| GO:0062013 | GO:0062013 | positive regulation of small molecule metabolic process | 1/32 | 142/18888 | 0.0070423 | 4.156690 | 1.5554409 | 0.2146957 | 0.3403088 | 0.2765915 | ADM | 1 |
| GO:1903900 | GO:1903900 | regulation of viral life cycle | 1/32 | 143/18888 | 0.0069930 | 4.127622 | 1.5465761 | 0.2160363 | 0.3414145 | 0.2774902 | PTX3 | 1 |
| GO:0010565 | GO:0010565 | regulation of cellular ketone metabolic process | 1/32 | 144/18888 | 0.0069444 | 4.098958 | 1.5377918 | 0.2173746 | 0.3425101 | 0.2783807 | ADM | 1 |
| GO:0008277 | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 1/32 | 149/18888 | 0.0067114 | 3.961409 | 1.4950306 | 0.2240331 | 0.3488781 | 0.2835564 | ADM | 1 |
| GO:0008584 | GO:0008584 | male gonad development | 1/32 | 149/18888 | 0.0067114 | 3.961409 | 1.4950306 | 0.2240331 | 0.3488781 | 0.2835564 | ING2 | 1 |
| GO:0035148 | GO:0035148 | tube formation | 1/32 | 149/18888 | 0.0067114 | 3.961409 | 1.4950306 | 0.2240331 | 0.3488781 | 0.2835564 | ADM | 1 |
| GO:0001890 | GO:0001890 | placenta development | 1/32 | 150/18888 | 0.0066667 | 3.935000 | 1.4867016 | 0.2253582 | 0.3488781 | 0.2835564 | ADM | 1 |
| GO:0016331 | GO:0016331 | morphogenesis of embryonic epithelium | 1/32 | 150/18888 | 0.0066667 | 3.935000 | 1.4867016 | 0.2253582 | 0.3488781 | 0.2835564 | ADM | 1 |
| GO:0046546 | GO:0046546 | development of primary male sexual characteristics | 1/32 | 150/18888 | 0.0066667 | 3.935000 | 1.4867016 | 0.2253582 | 0.3488781 | 0.2835564 | ING2 | 1 |
| GO:0035296 | GO:0035296 | regulation of tube diameter | 1/32 | 152/18888 | 0.0065789 | 3.883224 | 1.4702574 | 0.2280018 | 0.3508854 | 0.2851879 | ADM | 1 |
| GO:0097746 | GO:0097746 | blood vessel diameter maintenance | 1/32 | 152/18888 | 0.0065789 | 3.883224 | 1.4702574 | 0.2280018 | 0.3508854 | 0.2851879 | ADM | 1 |
| GO:0035150 | GO:0035150 | regulation of tube size | 1/32 | 153/18888 | 0.0065359 | 3.857843 | 1.4621400 | 0.2293203 | 0.3508854 | 0.2851879 | ADM | 1 |
| GO:0097530 | GO:0097530 | granulocyte migration | 1/32 | 154/18888 | 0.0064935 | 3.832792 | 1.4540908 | 0.2306367 | 0.3508854 | 0.2851879 | PPBP | 1 |
| GO:0008037 | GO:0008037 | cell recognition | 1/32 | 155/18888 | 0.0064516 | 3.808064 | 1.4461088 | 0.2319508 | 0.3508854 | 0.2851879 | PTX3 | 1 |
| GO:0030183 | GO:0030183 | B cell differentiation | 1/32 | 155/18888 | 0.0064516 | 3.808064 | 1.4461088 | 0.2319508 | 0.3508854 | 0.2851879 | IFNW1 | 1 |
| GO:0045807 | GO:0045807 | positive regulation of endocytosis | 1/32 | 155/18888 | 0.0064516 | 3.808064 | 1.4461088 | 0.2319508 | 0.3508854 | 0.2851879 | PTX3 | 1 |
| GO:0031960 | GO:0031960 | response to corticosteroid | 1/32 | 156/18888 | 0.0064103 | 3.783654 | 1.4381929 | 0.2332628 | 0.3508854 | 0.2851879 | ADM | 1 |
| GO:0045667 | GO:0045667 | regulation of osteoblast differentiation | 1/32 | 156/18888 | 0.0064103 | 3.783654 | 1.4381929 | 0.2332628 | 0.3508854 | 0.2851879 | TOB1 | 1 |
| GO:0046718 | GO:0046718 | symbiont entry into host cell | 1/32 | 156/18888 | 0.0064103 | 3.783654 | 1.4381929 | 0.2332628 | 0.3508854 | 0.2851879 | PTX3 | 1 |
| GO:0007189 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1/32 | 158/18888 | 0.0063291 | 3.735759 | 1.4225556 | 0.2358803 | 0.3525228 | 0.2865187 | ADM | 1 |
| GO:0021915 | GO:0021915 | neural tube development | 1/32 | 158/18888 | 0.0063291 | 3.735759 | 1.4225556 | 0.2358803 | 0.3525228 | 0.2865187 | ADM | 1 |
| GO:0008643 | GO:0008643 | carbohydrate transport | 1/32 | 159/18888 | 0.0062893 | 3.712264 | 1.4148322 | 0.2371858 | 0.3525228 | 0.2865187 | PPBP | 1 |
| GO:0007605 | GO:0007605 | sensory perception of sound | 1/32 | 161/18888 | 0.0062112 | 3.666149 | 1.3995711 | 0.2397903 | 0.3525228 | 0.2865187 | RPL38 | 1 |
| GO:0050657 | GO:0050657 | nucleic acid transport | 1/32 | 161/18888 | 0.0062112 | 3.666149 | 1.3995711 | 0.2397903 | 0.3525228 | 0.2865187 | SRSF7 | 1 |
| GO:0050658 | GO:0050658 | RNA transport | 1/32 | 161/18888 | 0.0062112 | 3.666149 | 1.3995711 | 0.2397903 | 0.3525228 | 0.2865187 | SRSF7 | 1 |
| GO:1902600 | GO:1902600 | proton transmembrane transport | 1/32 | 161/18888 | 0.0062112 | 3.666149 | 1.3995711 | 0.2397903 | 0.3525228 | 0.2865187 | ATP5MC2 | 1 |
| GO:0120254 | GO:0120254 | olefinic compound metabolic process | 1/32 | 162/18888 | 0.0061728 | 3.643518 | 1.3920315 | 0.2410893 | 0.3525228 | 0.2865187 | ADM | 1 |
| GO:0007292 | GO:0007292 | female gamete generation | 1/32 | 163/18888 | 0.0061350 | 3.621166 | 1.3845513 | 0.2423862 | 0.3525228 | 0.2865187 | PTX3 | 1 |
| GO:0030307 | GO:0030307 | positive regulation of cell growth | 1/32 | 163/18888 | 0.0061350 | 3.621166 | 1.3845513 | 0.2423862 | 0.3525228 | 0.2865187 | BRAT1 | 1 |
| GO:0034250 | GO:0034250 | positive regulation of amide metabolic process | 1/32 | 163/18888 | 0.0061350 | 3.621166 | 1.3845513 | 0.2423862 | 0.3525228 | 0.2865187 | AGO2 | 1 |
| GO:0044409 | GO:0044409 | symbiont entry into host | 1/32 | 163/18888 | 0.0061350 | 3.621166 | 1.3845513 | 0.2423862 | 0.3525228 | 0.2865187 | PTX3 | 1 |
| GO:0051236 | GO:0051236 | establishment of RNA localization | 1/32 | 164/18888 | 0.0060976 | 3.599085 | 1.3771297 | 0.2436809 | 0.3525228 | 0.2865187 | SRSF7 | 1 |
| GO:0050905 | GO:0050905 | neuromuscular process | 1/32 | 165/18888 | 0.0060606 | 3.577273 | 1.3697658 | 0.2449735 | 0.3525228 | 0.2865187 | CAMTA1 | 1 |
| GO:0051147 | GO:0051147 | regulation of muscle cell differentiation | 1/32 | 165/18888 | 0.0060606 | 3.577273 | 1.3697658 | 0.2449735 | 0.3525228 | 0.2865187 | RBM24 | 1 |
| GO:0060294 | GO:0060294 | cilium movement involved in cell motility | 1/32 | 165/18888 | 0.0060606 | 3.577273 | 1.3697658 | 0.2449735 | 0.3525228 | 0.2865187 | ING2 | 1 |
| GO:0030509 | GO:0030509 | BMP signaling pathway | 1/32 | 168/18888 | 0.0059524 | 3.513393 | 1.3480121 | 0.2488384 | 0.3559885 | 0.2893355 | TOB1 | 1 |
| GO:0050792 | GO:0050792 | regulation of viral process | 1/32 | 168/18888 | 0.0059524 | 3.513393 | 1.3480121 | 0.2488384 | 0.3559885 | 0.2893355 | PTX3 | 1 |
| GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 1/32 | 169/18888 | 0.0059172 | 3.492604 | 1.3408708 | 0.2501224 | 0.3559885 | 0.2893355 | ADM | 1 |
| GO:0001539 | GO:0001539 | cilium or flagellum-dependent cell motility | 1/32 | 170/18888 | 0.0058824 | 3.472059 | 1.3337832 | 0.2514043 | 0.3559885 | 0.2893355 | ING2 | 1 |
| GO:0007519 | GO:0007519 | skeletal muscle tissue development | 1/32 | 170/18888 | 0.0058824 | 3.472059 | 1.3337832 | 0.2514043 | 0.3559885 | 0.2893355 | RBM24 | 1 |
| GO:0060285 | GO:0060285 | cilium-dependent cell motility | 1/32 | 170/18888 | 0.0058824 | 3.472059 | 1.3337832 | 0.2514043 | 0.3559885 | 0.2893355 | ING2 | 1 |
| GO:0046661 | GO:0046661 | male sex differentiation | 1/32 | 173/18888 | 0.0057803 | 3.411850 | 1.3128348 | 0.2552373 | 0.3604549 | 0.2929656 | ING2 | 1 |
| GO:0007259 | GO:0007259 | receptor signaling pathway via JAK-STAT | 1/32 | 174/18888 | 0.0057471 | 3.392241 | 1.3059544 | 0.2565108 | 0.3612924 | 0.2936463 | IFNW1 | 1 |
| GO:0017015 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1/32 | 177/18888 | 0.0056497 | 3.334746 | 1.2856105 | 0.2603185 | 0.3647206 | 0.2964326 | ING2 | 1 |
| GO:0072331 | GO:0072331 | signal transduction by p53 class mediator | 1/32 | 177/18888 | 0.0056497 | 3.334746 | 1.2856105 | 0.2603185 | 0.3647206 | 0.2964326 | ING2 | 1 |
| GO:0071772 | GO:0071772 | response to BMP | 1/32 | 180/18888 | 0.0055556 | 3.279167 | 1.2656987 | 0.2641072 | 0.3671229 | 0.2983851 | TOB1 | 1 |
| GO:0071773 | GO:0071773 | cellular response to BMP stimulus | 1/32 | 180/18888 | 0.0055556 | 3.279167 | 1.2656987 | 0.2641072 | 0.3671229 | 0.2983851 | TOB1 | 1 |
| GO:1903844 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 1/32 | 180/18888 | 0.0055556 | 3.279167 | 1.2656987 | 0.2641072 | 0.3671229 | 0.2983851 | ING2 | 1 |
| GO:0019827 | GO:0019827 | stem cell population maintenance | 1/32 | 182/18888 | 0.0054945 | 3.243132 | 1.2526557 | 0.2666226 | 0.3686891 | 0.2996581 | ING2 | 1 |
| GO:0060538 | GO:0060538 | skeletal muscle organ development | 1/32 | 182/18888 | 0.0054945 | 3.243132 | 1.2526557 | 0.2666226 | 0.3686891 | 0.2996581 | RBM24 | 1 |
| GO:0006694 | GO:0006694 | steroid biosynthetic process | 1/32 | 185/18888 | 0.0054054 | 3.190541 | 1.2334263 | 0.2703801 | 0.3715295 | 0.3019667 | ADM | 1 |
| GO:0050954 | GO:0050954 | sensory perception of mechanical stimulus | 1/32 | 185/18888 | 0.0054054 | 3.190541 | 1.2334263 | 0.2703801 | 0.3715295 | 0.3019667 | RPL38 | 1 |
| GO:0051302 | GO:0051302 | regulation of cell division | 1/32 | 186/18888 | 0.0053763 | 3.173387 | 1.2271036 | 0.2716285 | 0.3715295 | 0.3019667 | PPBP | 1 |
| GO:0098727 | GO:0098727 | maintenance of cell number | 1/32 | 186/18888 | 0.0053763 | 3.173387 | 1.2271036 | 0.2716285 | 0.3715295 | 0.3019667 | ING2 | 1 |
| GO:0008217 | GO:0008217 | regulation of blood pressure | 1/32 | 187/18888 | 0.0053476 | 3.156417 | 1.2208234 | 0.2728747 | 0.3715295 | 0.3019667 | ADM | 1 |
| GO:0046890 | GO:0046890 | regulation of lipid biosynthetic process | 1/32 | 187/18888 | 0.0053476 | 3.156417 | 1.2208234 | 0.2728747 | 0.3715295 | 0.3019667 | ADM | 1 |
| GO:0061138 | GO:0061138 | morphogenesis of a branching epithelium | 1/32 | 189/18888 | 0.0052910 | 3.123016 | 1.2083887 | 0.2753611 | 0.3739559 | 0.3039388 | ADM | 1 |
| GO:2001242 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 1/32 | 190/18888 | 0.0052632 | 3.106579 | 1.2022330 | 0.2766012 | 0.3746817 | 0.3045287 | ING2 | 1 |
| GO:0097696 | GO:0097696 | receptor signaling pathway via STAT | 1/32 | 191/18888 | 0.0052356 | 3.090314 | 1.1961179 | 0.2778392 | 0.3754011 | 0.3051134 | IFNW1 | 1 |
| GO:0006006 | GO:0006006 | glucose metabolic process | 1/32 | 192/18888 | 0.0052083 | 3.074219 | 1.1900426 | 0.2790752 | 0.3761141 | 0.3056929 | BRAT1 | 1 |
| GO:0051260 | GO:0051260 | protein homooligomerization | 1/32 | 195/18888 | 0.0051282 | 3.026923 | 1.1720517 | 0.2827709 | 0.3801300 | 0.3089568 | KCTD1 | 1 |
| GO:0006403 | GO:0006403 | RNA localization | 1/32 | 200/18888 | 0.0050000 | 2.951250 | 1.1428210 | 0.2888896 | 0.3863989 | 0.3140520 | SRSF7 | 1 |
| GO:0031099 | GO:0031099 | regeneration | 1/32 | 200/18888 | 0.0050000 | 2.951250 | 1.1428210 | 0.2888896 | 0.3863989 | 0.3140520 | ADM | 1 |
| GO:0051701 | GO:0051701 | biological process involved in interaction with host | 1/32 | 202/18888 | 0.0049505 | 2.922030 | 1.1313821 | 0.2913229 | 0.3886745 | 0.3159015 | PTX3 | 1 |
| GO:0098739 | GO:0098739 | import across plasma membrane | 1/32 | 203/18888 | 0.0049261 | 2.907636 | 1.1257153 | 0.2925365 | 0.3889781 | 0.3161483 | KCNJ13 | 1 |
| GO:0051346 | GO:0051346 | negative regulation of hydrolase activity | 1/32 | 204/18888 | 0.0049020 | 2.893382 | 1.1200829 | 0.2937481 | 0.3889781 | 0.3161483 | PTX3 | 1 |
| GO:0055001 | GO:0055001 | muscle cell development | 1/32 | 204/18888 | 0.0049020 | 2.893382 | 1.1200829 | 0.2937481 | 0.3889781 | 0.3161483 | ADM | 1 |
| GO:0001763 | GO:0001763 | morphogenesis of a branching structure | 1/32 | 206/18888 | 0.0048544 | 2.865291 | 1.1089202 | 0.2961653 | 0.3912034 | 0.3179569 | ADM | 1 |
| GO:0008016 | GO:0008016 | regulation of heart contraction | 1/32 | 208/18888 | 0.0048077 | 2.837740 | 1.0978906 | 0.2985744 | 0.3924332 | 0.3189565 | ADM | 1 |
| GO:0043123 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 1/32 | 208/18888 | 0.0048077 | 2.837740 | 1.0978906 | 0.2985744 | 0.3924332 | 0.3189565 | C18orf32 | 1 |
| GO:0003341 | GO:0003341 | cilium movement | 1/32 | 209/18888 | 0.0047847 | 2.824163 | 1.0924249 | 0.2997760 | 0.3930397 | 0.3194494 | ING2 | 1 |
| GO:0006470 | GO:0006470 | protein dephosphorylation | 1/32 | 210/18888 | 0.0047619 | 2.810714 | 1.0869913 | 0.3009756 | 0.3936405 | 0.3199378 | CAMTA1 | 1 |
| GO:0009152 | GO:0009152 | purine ribonucleotide biosynthetic process | 1/32 | 211/18888 | 0.0047393 | 2.797393 | 1.0815896 | 0.3021732 | 0.3938602 | 0.3201164 | ATP5MC2 | 1 |
| GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 1/32 | 212/18888 | 0.0047170 | 2.784198 | 1.0762193 | 0.3033688 | 0.3938602 | 0.3201164 | IFNW1 | 1 |
| GO:0042594 | GO:0042594 | response to starvation | 1/32 | 212/18888 | 0.0047170 | 2.784198 | 1.0762193 | 0.3033688 | 0.3938602 | 0.3201164 | ADM | 1 |
| GO:0007286 | GO:0007286 | spermatid development | 1/32 | 214/18888 | 0.0046729 | 2.758178 | 1.0655716 | 0.3057541 | 0.3950254 | 0.3210633 | ING2 | 1 |
| GO:2000241 | GO:2000241 | regulation of reproductive process | 1/32 | 214/18888 | 0.0046729 | 2.758178 | 1.0655716 | 0.3057541 | 0.3950254 | 0.3210633 | AGO2 | 1 |
| GO:0002064 | GO:0002064 | epithelial cell development | 1/32 | 216/18888 | 0.0046296 | 2.732639 | 1.0550455 | 0.3081314 | 0.3971306 | 0.3227744 | RILPL2 | 1 |
| GO:0071805 | GO:0071805 | potassium ion transmembrane transport | 1/32 | 217/18888 | 0.0046083 | 2.720046 | 1.0498273 | 0.3093172 | 0.3976935 | 0.3232319 | KCNJ13 | 1 |
| GO:0040029 | GO:0040029 | epigenetic regulation of gene expression | 1/32 | 220/18888 | 0.0045455 | 2.682955 | 1.0343476 | 0.3128625 | 0.4003133 | 0.3253612 | ING2 | 1 |
| GO:0046034 | GO:0046034 | ATP metabolic process | 1/32 | 220/18888 | 0.0045455 | 2.682955 | 1.0343476 | 0.3128625 | 0.4003133 | 0.3253612 | ATP5MC2 | 1 |
| GO:0048515 | GO:0048515 | spermatid differentiation | 1/32 | 222/18888 | 0.0045045 | 2.658784 | 1.0241707 | 0.3152163 | 0.4023554 | 0.3270210 | ING2 | 1 |
| GO:0043583 | GO:0043583 | ear development | 1/32 | 223/18888 | 0.0044843 | 2.646861 | 1.0191241 | 0.3163903 | 0.4028854 | 0.3274517 | RPL38 | 1 |
| GO:0006364 | GO:0006364 | rRNA processing | 1/32 | 224/18888 | 0.0044643 | 2.635045 | 1.0141051 | 0.3175623 | 0.4034104 | 0.3278785 | RRP9 | 1 |
| GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 1/32 | 225/18888 | 0.0044444 | 2.623333 | 1.0091133 | 0.3187323 | 0.4039305 | 0.3283011 | PPBP | 1 |
| GO:0009260 | GO:0009260 | ribonucleotide biosynthetic process | 1/32 | 226/18888 | 0.0044248 | 2.611726 | 1.0041485 | 0.3199005 | 0.4044456 | 0.3287198 | ATP5MC2 | 1 |
| GO:0042180 | GO:0042180 | cellular ketone metabolic process | 1/32 | 227/18888 | 0.0044053 | 2.600220 | 0.9992104 | 0.3210666 | 0.4049558 | 0.3291344 | ADM | 1 |
| GO:0043547 | GO:0043547 | positive regulation of GTPase activity | 1/32 | 230/18888 | 0.0043478 | 2.566304 | 0.9845533 | 0.3245535 | 0.4083837 | 0.3319206 | RGS1 | 1 |
| GO:0015931 | GO:0015931 | nucleobase-containing compound transport | 1/32 | 231/18888 | 0.0043290 | 2.555195 | 0.9797191 | 0.3257120 | 0.4083934 | 0.3319284 | SRSF7 | 1 |
| GO:0019318 | GO:0019318 | hexose metabolic process | 1/32 | 232/18888 | 0.0043103 | 2.544181 | 0.9749102 | 0.3268685 | 0.4083934 | 0.3319284 | BRAT1 | 1 |
| GO:0019722 | GO:0019722 | calcium-mediated signaling | 1/32 | 232/18888 | 0.0043103 | 2.544181 | 0.9749102 | 0.3268685 | 0.4083934 | 0.3319284 | CAMTA1 | 1 |
| GO:0046390 | GO:0046390 | ribose phosphate biosynthetic process | 1/32 | 233/18888 | 0.0042918 | 2.533262 | 0.9701264 | 0.3280231 | 0.4088739 | 0.3323189 | ATP5MC2 | 1 |
| GO:0006909 | GO:0006909 | phagocytosis | 1/32 | 237/18888 | 0.0042194 | 2.490506 | 0.9512368 | 0.3326224 | 0.4126693 | 0.3354038 | PTX3 | 1 |
| GO:0030595 | GO:0030595 | leukocyte chemotaxis | 1/32 | 237/18888 | 0.0042194 | 2.490506 | 0.9512368 | 0.3326224 | 0.4126693 | 0.3354038 | PPBP | 1 |
| GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 1/32 | 238/18888 | 0.0042017 | 2.480042 | 0.9465745 | 0.3337674 | 0.4130636 | 0.3357242 | PPBP | 1 |
| GO:0097529 | GO:0097529 | myeloid leukocyte migration | 1/32 | 239/18888 | 0.0041841 | 2.469665 | 0.9419358 | 0.3349105 | 0.4130636 | 0.3357242 | PPBP | 1 |
| GO:0042445 | GO:0042445 | hormone metabolic process | 1/32 | 240/18888 | 0.0041667 | 2.459375 | 0.9373204 | 0.3360518 | 0.4130636 | 0.3357242 | ADM | 1 |
| GO:0065004 | GO:0065004 | protein-DNA complex assembly | 1/32 | 240/18888 | 0.0041667 | 2.459375 | 0.9373204 | 0.3360518 | 0.4130636 | 0.3357242 | TAF13 | 1 |
| GO:0006813 | GO:0006813 | potassium ion transport | 1/32 | 241/18888 | 0.0041494 | 2.449170 | 0.9327282 | 0.3371911 | 0.4135069 | 0.3360845 | KCNJ13 | 1 |
| GO:0009205 | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1/32 | 244/18888 | 0.0040984 | 2.419057 | 0.9190878 | 0.3405978 | 0.4157642 | 0.3379191 | ATP5MC2 | 1 |
| GO:2001234 | GO:2001234 | negative regulation of apoptotic signaling pathway | 1/32 | 244/18888 | 0.0040984 | 2.419057 | 0.9190878 | 0.3405978 | 0.4157642 | 0.3379191 | ING2 | 1 |
| GO:0007179 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 1/32 | 245/18888 | 0.0040816 | 2.409184 | 0.9145858 | 0.3417295 | 0.4161889 | 0.3382644 | ING2 | 1 |
| GO:0048863 | GO:0048863 | stem cell differentiation | 1/32 | 248/18888 | 0.0040323 | 2.380040 | 0.9012107 | 0.3451136 | 0.4193485 | 0.3408324 | RBM24 | 1 |
| GO:0060047 | GO:0060047 | heart contraction | 1/32 | 249/18888 | 0.0040161 | 2.370482 | 0.8967954 | 0.3462379 | 0.4197541 | 0.3411620 | ADM | 1 |
| GO:0009144 | GO:0009144 | purine nucleoside triphosphate metabolic process | 1/32 | 250/18888 | 0.0040000 | 2.361000 | 0.8924013 | 0.3473603 | 0.4201556 | 0.3414883 | ATP5MC2 | 1 |
| GO:0009199 | GO:0009199 | ribonucleoside triphosphate metabolic process | 1/32 | 251/18888 | 0.0039841 | 2.351594 | 0.8880281 | 0.3484808 | 0.4205529 | 0.3418113 | ATP5MC2 | 1 |
| GO:0005996 | GO:0005996 | monosaccharide metabolic process | 1/32 | 252/18888 | 0.0039683 | 2.342262 | 0.8836756 | 0.3495995 | 0.4209463 | 0.3421310 | BRAT1 | 1 |
| GO:0006164 | GO:0006164 | purine nucleotide biosynthetic process | 1/32 | 256/18888 | 0.0039063 | 2.305664 | 0.8664697 | 0.3540555 | 0.4251251 | 0.3455274 | ATP5MC2 | 1 |
| GO:0001649 | GO:0001649 | osteoblast differentiation | 1/32 | 257/18888 | 0.0038911 | 2.296693 | 0.8622182 | 0.3551649 | 0.4251251 | 0.3455274 | TOB1 | 1 |
| GO:0045927 | GO:0045927 | positive regulation of growth | 1/32 | 258/18888 | 0.0038760 | 2.287791 | 0.8579864 | 0.3562725 | 0.4251251 | 0.3455274 | BRAT1 | 1 |
| GO:0051259 | GO:0051259 | protein complex oligomerization | 1/32 | 258/18888 | 0.0038760 | 2.287791 | 0.8579864 | 0.3562725 | 0.4251251 | 0.3455274 | KCTD1 | 1 |
| GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 1/32 | 259/18888 | 0.0038610 | 2.278958 | 0.8537740 | 0.3573782 | 0.4254884 | 0.3458227 | ADM | 1 |
| GO:0003015 | GO:0003015 | heart process | 1/32 | 260/18888 | 0.0038462 | 2.270192 | 0.8495809 | 0.3584821 | 0.4258478 | 0.3461148 | ADM | 1 |
| GO:1903522 | GO:1903522 | regulation of blood circulation | 1/32 | 262/18888 | 0.0038168 | 2.252863 | 0.8412518 | 0.3606843 | 0.4275075 | 0.3474637 | ADM | 1 |
| GO:0072522 | GO:0072522 | purine-containing compound biosynthetic process | 1/32 | 264/18888 | 0.0037879 | 2.235796 | 0.8329976 | 0.3628792 | 0.4288727 | 0.3485733 | ATP5MC2 | 1 |
| GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 1/32 | 265/18888 | 0.0037736 | 2.227358 | 0.8288983 | 0.3639739 | 0.4288727 | 0.3485733 | PPBP | 1 |
| GO:0009141 | GO:0009141 | nucleoside triphosphate metabolic process | 1/32 | 266/18888 | 0.0037594 | 2.218985 | 0.8248172 | 0.3650668 | 0.4288727 | 0.3485733 | ATP5MC2 | 1 |
| GO:0016072 | GO:0016072 | rRNA metabolic process | 1/32 | 266/18888 | 0.0037594 | 2.218985 | 0.8248172 | 0.3650668 | 0.4288727 | 0.3485733 | RRP9 | 1 |
| GO:0032868 | GO:0032868 | response to insulin | 1/32 | 269/18888 | 0.0037175 | 2.194238 | 0.8126818 | 0.3683345 | 0.4317564 | 0.3509171 | ADM | 1 |
| GO:0003018 | GO:0003018 | vascular process in circulatory system | 1/32 | 275/18888 | 0.0036364 | 2.146364 | 0.7888824 | 0.3748212 | 0.4383922 | 0.3563105 | ADM | 1 |
| GO:0090150 | GO:0090150 | establishment of protein localization to membrane | 1/32 | 277/18888 | 0.0036101 | 2.130866 | 0.7810845 | 0.3769691 | 0.4392548 | 0.3570115 | RILPL2 | 1 |
| GO:0042113 | GO:0042113 | B cell activation | 1/32 | 278/18888 | 0.0035971 | 2.123201 | 0.7772103 | 0.3780403 | 0.4392548 | 0.3570115 | IFNW1 | 1 |
| GO:0090596 | GO:0090596 | sensory organ morphogenesis | 1/32 | 278/18888 | 0.0035971 | 2.123201 | 0.7772103 | 0.3780403 | 0.4392548 | 0.3570115 | RPL38 | 1 |
| GO:0018105 | GO:0018105 | peptidyl-serine phosphorylation | 1/32 | 282/18888 | 0.0035461 | 2.093085 | 0.7618750 | 0.3823075 | 0.4432430 | 0.3602530 | IFNW1 | 1 |
| GO:0043122 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 1/32 | 286/18888 | 0.0034965 | 2.063811 | 0.7467916 | 0.3865463 | 0.4471810 | 0.3634537 | C18orf32 | 1 |
| GO:0030100 | GO:0030100 | regulation of endocytosis | 1/32 | 291/18888 | 0.0034364 | 2.028351 | 0.7282792 | 0.3918052 | 0.4522795 | 0.3675976 | PTX3 | 1 |
| GO:0009165 | GO:0009165 | nucleotide biosynthetic process | 1/32 | 293/18888 | 0.0034130 | 2.014505 | 0.7209774 | 0.3938965 | 0.4527252 | 0.3679598 | ATP5MC2 | 1 |
| GO:0072659 | GO:0072659 | protein localization to plasma membrane | 1/32 | 293/18888 | 0.0034130 | 2.014505 | 0.7209774 | 0.3938965 | 0.4527252 | 0.3679598 | RILPL2 | 1 |
| GO:0018209 | GO:0018209 | peptidyl-serine modification | 1/32 | 294/18888 | 0.0034014 | 2.007653 | 0.7173481 | 0.3949396 | 0.4529436 | 0.3681374 | IFNW1 | 1 |
| GO:1901293 | GO:1901293 | nucleoside phosphate biosynthetic process | 1/32 | 295/18888 | 0.0033898 | 2.000847 | 0.7137331 | 0.3959809 | 0.4531591 | 0.3683125 | ATP5MC2 | 1 |
| GO:0048511 | GO:0048511 | rhythmic process | 1/32 | 297/18888 | 0.0033670 | 1.987374 | 0.7065455 | 0.3980583 | 0.4535814 | 0.3686557 | PTX3 | 1 |
| GO:0048562 | GO:0048562 | embryonic organ morphogenesis | 1/32 | 297/18888 | 0.0033670 | 1.987374 | 0.7065455 | 0.3980583 | 0.4535814 | 0.3686557 | RPL38 | 1 |
| GO:0043087 | GO:0043087 | regulation of GTPase activity | 1/32 | 298/18888 | 0.0033557 | 1.980705 | 0.7029726 | 0.3990944 | 0.4537882 | 0.3688238 | RGS1 | 1 |
| GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 1/32 | 301/18888 | 0.0033223 | 1.960964 | 0.6923364 | 0.4021923 | 0.4563336 | 0.3708926 | IFNW1 | 1 |
| GO:0071560 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 1/32 | 302/18888 | 0.0033113 | 1.954470 | 0.6888181 | 0.4032215 | 0.4565258 | 0.3710489 | ING2 | 1 |
| GO:0002263 | GO:0002263 | cell activation involved in immune response | 1/32 | 305/18888 | 0.0032787 | 1.935246 | 0.6783433 | 0.4062988 | 0.4590312 | 0.3730852 | IFNW1 | 1 |
| GO:0051607 | GO:0051607 | defense response to virus | 1/32 | 307/18888 | 0.0032573 | 1.922638 | 0.6714256 | 0.4083418 | 0.4597273 | 0.3736509 | IFNW1 | 1 |
| GO:0046651 | GO:0046651 | lymphocyte proliferation | 1/32 | 308/18888 | 0.0032468 | 1.916396 | 0.6679861 | 0.4093608 | 0.4597273 | 0.3736509 | IFNW1 | 1 |
| GO:0016311 | GO:0016311 | dephosphorylation | 1/32 | 309/18888 | 0.0032362 | 1.910194 | 0.6645594 | 0.4103780 | 0.4597273 | 0.3736509 | CAMTA1 | 1 |
| GO:0071559 | GO:0071559 | response to transforming growth factor beta | 1/32 | 309/18888 | 0.0032362 | 1.910194 | 0.6645594 | 0.4103780 | 0.4597273 | 0.3736509 | ING2 | 1 |
| GO:0007249 | GO:0007249 | canonical NF-kappaB signal transduction | 1/32 | 311/18888 | 0.0032154 | 1.897910 | 0.6577440 | 0.4124074 | 0.4600596 | 0.3739209 | C18orf32 | 1 |
| GO:0044403 | GO:0044403 | biological process involved in symbiotic interaction | 1/32 | 311/18888 | 0.0032154 | 1.897910 | 0.6577440 | 0.4124074 | 0.4600596 | 0.3739209 | PTX3 | 1 |
| GO:0001666 | GO:0001666 | response to hypoxia | 1/32 | 313/18888 | 0.0031949 | 1.885783 | 0.6509785 | 0.4144301 | 0.4603815 | 0.3741826 | ADM | 1 |
| GO:0051146 | GO:0051146 | striated muscle cell differentiation | 1/32 | 313/18888 | 0.0031949 | 1.885783 | 0.6509785 | 0.4144301 | 0.4603815 | 0.3741826 | RBM24 | 1 |
| GO:0032943 | GO:0032943 | mononuclear cell proliferation | 1/32 | 315/18888 | 0.0031746 | 1.873809 | 0.6442623 | 0.4164460 | 0.4616551 | 0.3752178 | IFNW1 | 1 |
| GO:0098813 | GO:0098813 | nuclear chromosome segregation | 1/32 | 317/18888 | 0.0031546 | 1.861987 | 0.6375945 | 0.4184551 | 0.4629160 | 0.3762426 | PTTG1 | 1 |
| GO:0019058 | GO:0019058 | viral life cycle | 1/32 | 319/18888 | 0.0031348 | 1.850313 | 0.6309745 | 0.4204576 | 0.4632012 | 0.3764744 | PTX3 | 1 |
| GO:0097193 | GO:0097193 | intrinsic apoptotic signaling pathway | 1/32 | 319/18888 | 0.0031348 | 1.850313 | 0.6309745 | 0.4204576 | 0.4632012 | 0.3764744 | ING2 | 1 |
| GO:0060326 | GO:0060326 | cell chemotaxis | 1/32 | 322/18888 | 0.0031056 | 1.833074 | 0.6211326 | 0.4234488 | 0.4655307 | 0.3783677 | PPBP | 1 |
| GO:0009101 | GO:0009101 | glycoprotein biosynthetic process | 1/32 | 324/18888 | 0.0030864 | 1.821759 | 0.6146290 | 0.4254346 | 0.4667475 | 0.3793566 | AGO2 | 1 |
| GO:0019216 | GO:0019216 | regulation of lipid metabolic process | 1/32 | 326/18888 | 0.0030675 | 1.810583 | 0.6081707 | 0.4274138 | 0.4679520 | 0.3803356 | ADM | 1 |
| GO:0036293 | GO:0036293 | response to decreased oxygen levels | 1/32 | 327/18888 | 0.0030581 | 1.805046 | 0.6049584 | 0.4284009 | 0.4680676 | 0.3804296 | ADM | 1 |
| GO:0008202 | GO:0008202 | steroid metabolic process | 1/32 | 329/18888 | 0.0030395 | 1.794073 | 0.5985670 | 0.4303702 | 0.4692537 | 0.3813936 | ADM | 1 |
| GO:0042742 | GO:0042742 | defense response to bacterium | 1/32 | 330/18888 | 0.0030303 | 1.788636 | 0.5953877 | 0.4313523 | 0.4693608 | 0.3814807 | PPBP | 1 |
| GO:0062012 | GO:0062012 | regulation of small molecule metabolic process | 1/32 | 331/18888 | 0.0030211 | 1.783233 | 0.5922193 | 0.4323329 | 0.4694658 | 0.3815660 | ADM | 1 |
| GO:0030198 | GO:0030198 | extracellular matrix organization | 1/32 | 332/18888 | 0.0030120 | 1.777861 | 0.5890617 | 0.4333118 | 0.4695685 | 0.3816495 | PTX3 | 1 |
| GO:0043062 | GO:0043062 | extracellular structure organization | 1/32 | 333/18888 | 0.0030030 | 1.772523 | 0.5859148 | 0.4342890 | 0.4696690 | 0.3817312 | PTX3 | 1 |
| GO:0045229 | GO:0045229 | external encapsulating structure organization | 1/32 | 334/18888 | 0.0029940 | 1.767216 | 0.5827786 | 0.4352647 | 0.4697673 | 0.3818111 | PTX3 | 1 |
| GO:0060562 | GO:0060562 | epithelial tube morphogenesis | 1/32 | 335/18888 | 0.0029851 | 1.761940 | 0.5796528 | 0.4362386 | 0.4698635 | 0.3818893 | ADM | 1 |
| GO:0060485 | GO:0060485 | mesenchyme development | 1/32 | 336/18888 | 0.0029762 | 1.756696 | 0.5765376 | 0.4372110 | 0.4699576 | 0.3819657 | RBM24 | 1 |
| GO:0048545 | GO:0048545 | response to steroid hormone | 1/32 | 338/18888 | 0.0029586 | 1.746302 | 0.5703383 | 0.4391509 | 0.4710891 | 0.3828854 | ADM | 1 |
| GO:0034765 | GO:0034765 | regulation of monoatomic ion transmembrane transport | 1/32 | 349/18888 | 0.0028653 | 1.691261 | 0.5369615 | 0.4497049 | 0.4814381 | 0.3912967 | KCNJ13 | 1 |
| GO:0070661 | GO:0070661 | leukocyte proliferation | 1/32 | 352/18888 | 0.0028409 | 1.676847 | 0.5280624 | 0.4525497 | 0.4835089 | 0.3929797 | IFNW1 | 1 |
| GO:0070482 | GO:0070482 | response to oxygen levels | 1/32 | 354/18888 | 0.0028249 | 1.667373 | 0.5221765 | 0.4544383 | 0.4845517 | 0.3938274 | ADM | 1 |
| GO:1990778 | GO:1990778 | protein localization to cell periphery | 1/32 | 356/18888 | 0.0028090 | 1.658006 | 0.5163274 | 0.4563207 | 0.4855837 | 0.3946661 | RILPL2 | 1 |
| GO:0007517 | GO:0007517 | muscle organ development | 1/32 | 359/18888 | 0.0027855 | 1.644150 | 0.5076217 | 0.4591323 | 0.4875985 | 0.3963037 | RBM24 | 1 |
| GO:0050878 | GO:0050878 | regulation of body fluid levels | 1/32 | 370/18888 | 0.0027027 | 1.595270 | 0.4763758 | 0.4693218 | 0.4974249 | 0.4042902 | ADM | 1 |
| GO:0030336 | GO:0030336 | negative regulation of cell migration | 1/32 | 381/18888 | 0.0026247 | 1.549213 | 0.4461354 | 0.4793252 | 0.5070153 | 0.4120850 | ING2 | 1 |
| GO:0060271 | GO:0060271 | cilium assembly | 1/32 | 385/18888 | 0.0025974 | 1.533117 | 0.4353749 | 0.4829173 | 0.5097994 | 0.4143478 | RILPL2 | 1 |
| GO:0050900 | GO:0050900 | leukocyte migration | 1/32 | 396/18888 | 0.0025253 | 1.490530 | 0.4063995 | 0.4926722 | 0.5170137 | 0.4202114 | PPBP | 1 |
| GO:2000146 | GO:2000146 | negative regulation of cell motility | 1/32 | 396/18888 | 0.0025253 | 1.490530 | 0.4063995 | 0.4926722 | 0.5170137 | 0.4202114 | ING2 | 1 |
| GO:2001233 | GO:2001233 | regulation of apoptotic signaling pathway | 1/32 | 396/18888 | 0.0025253 | 1.490530 | 0.4063995 | 0.4926722 | 0.5170137 | 0.4202114 | ING2 | 1 |
| GO:0001701 | GO:0001701 | in utero embryonic development | 1/32 | 401/18888 | 0.0024938 | 1.471945 | 0.3935158 | 0.4970471 | 0.5205760 | 0.4231067 | ADM | 1 |
| GO:0009615 | GO:0009615 | response to virus | 1/32 | 409/18888 | 0.0024450 | 1.443154 | 0.3732577 | 0.5039711 | 0.5267886 | 0.4281561 | IFNW1 | 1 |
| GO:0044782 | GO:0044782 | cilium organization | 1/32 | 412/18888 | 0.0024272 | 1.432646 | 0.3657705 | 0.5065436 | 0.5284375 | 0.4294962 | RILPL2 | 1 |
| GO:0001558 | GO:0001558 | regulation of cell growth | 1/32 | 418/18888 | 0.0023923 | 1.412081 | 0.3509695 | 0.5116501 | 0.5327181 | 0.4329753 | BRAT1 | 1 |
| GO:0007059 | GO:0007059 | chromosome segregation | 1/32 | 423/18888 | 0.0023641 | 1.395390 | 0.3388075 | 0.5158664 | 0.5360568 | 0.4356890 | PTTG1 | 1 |
| GO:0007018 | GO:0007018 | microtubule-based movement | 1/32 | 426/18888 | 0.0023474 | 1.385563 | 0.3315835 | 0.5183792 | 0.5376159 | 0.4369561 | ING2 | 1 |
| GO:0016032 | GO:0016032 | viral process | 1/32 | 428/18888 | 0.0023364 | 1.379089 | 0.3267975 | 0.5200473 | 0.5382946 | 0.4375078 | PTX3 | 1 |
| GO:0009314 | GO:0009314 | response to radiation | 1/32 | 431/18888 | 0.0023202 | 1.369490 | 0.3196627 | 0.5225391 | 0.5385811 | 0.4377406 | BRAT1 | 1 |
| GO:0040013 | GO:0040013 | negative regulation of locomotion | 1/32 | 431/18888 | 0.0023202 | 1.369490 | 0.3196627 | 0.5225391 | 0.5385811 | 0.4377406 | ING2 | 1 |
| GO:0030098 | GO:0030098 | lymphocyte differentiation | 1/32 | 432/18888 | 0.0023148 | 1.366319 | 0.3172961 | 0.5233669 | 0.5385811 | 0.4377406 | IFNW1 | 1 |
| GO:0043434 | GO:0043434 | response to peptide hormone | 1/32 | 438/18888 | 0.0022831 | 1.347603 | 0.3032171 | 0.5283046 | 0.5415632 | 0.4401644 | ADM | 1 |
| GO:0060537 | GO:0060537 | muscle tissue development | 1/32 | 438/18888 | 0.0022831 | 1.347603 | 0.3032171 | 0.5283046 | 0.5415632 | 0.4401644 | RBM24 | 1 |
| GO:0009150 | GO:0009150 | purine ribonucleotide metabolic process | 1/32 | 446/18888 | 0.0022422 | 1.323430 | 0.2847581 | 0.5348112 | 0.5471767 | 0.4447269 | ATP5MC2 | 1 |
| GO:0043086 | GO:0043086 | negative regulation of catalytic activity | 1/32 | 449/18888 | 0.0022272 | 1.314588 | 0.2779254 | 0.5372286 | 0.5485931 | 0.4458780 | PTX3 | 1 |
| GO:0006935 | GO:0006935 | chemotaxis | 1/32 | 466/18888 | 0.0021459 | 1.266631 | 0.2400859 | 0.5506995 | 0.5601943 | 0.4553071 | PPBP | 1 |
| GO:0009259 | GO:0009259 | ribonucleotide metabolic process | 1/32 | 466/18888 | 0.0021459 | 1.266631 | 0.2400859 | 0.5506995 | 0.5601943 | 0.4553071 | ATP5MC2 | 1 |
| GO:0042330 | GO:0042330 | taxis | 1/32 | 468/18888 | 0.0021368 | 1.261218 | 0.2357289 | 0.5522591 | 0.5607067 | 0.4557235 | PPBP | 1 |
| GO:0043269 | GO:0043269 | regulation of monoatomic ion transport | 1/32 | 470/18888 | 0.0021277 | 1.255851 | 0.2313911 | 0.5538135 | 0.5612117 | 0.4561340 | KCNJ13 | 1 |
| GO:0019693 | GO:0019693 | ribose phosphate metabolic process | 1/32 | 480/18888 | 0.0020833 | 1.229688 | 0.2099841 | 0.5615072 | 0.5679244 | 0.4615899 | ATP5MC2 | 1 |
| GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 1/32 | 482/18888 | 0.0020747 | 1.224585 | 0.2057578 | 0.5630304 | 0.5683824 | 0.4619621 | RGS1 | 1 |
| GO:1903131 | GO:1903131 | mononuclear cell differentiation | 1/32 | 484/18888 | 0.0020661 | 1.219525 | 0.2015496 | 0.5645485 | 0.5688335 | 0.4623288 | IFNW1 | 1 |
| GO:0034762 | GO:0034762 | regulation of transmembrane transport | 1/32 | 489/18888 | 0.0020450 | 1.207055 | 0.1911064 | 0.5683215 | 0.5712238 | 0.4642715 | KCNJ13 | 1 |
| GO:0031667 | GO:0031667 | response to nutrient levels | 1/32 | 490/18888 | 0.0020408 | 1.204592 | 0.1890309 | 0.5690723 | 0.5712238 | 0.4642715 | ADM | 1 |
| GO:0016049 | GO:0016049 | cell growth | 1/32 | 496/18888 | 0.0020161 | 1.190020 | 0.1766679 | 0.5735505 | 0.5746327 | 0.4670421 | BRAT1 | 1 |
| GO:0001667 | GO:0001667 | ameboidal-type cell migration | 1/32 | 498/18888 | 0.0020080 | 1.185241 | 0.1725808 | 0.5750332 | 0.5750332 | 0.4673677 | AGO2 | 1 |
# Visualización del análisis funcional
barplot(go_results_miR_655_3p_predicted, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
Combined
# Gene Ontology (GO) para todos los genes combinados
gene_symbols_miR_655_3p_combined <- combined_targets_miR_655_3p$target_symbol %>% unique()
go_results_miR_655_3p_combined <- enrichGO(
gene = gene_symbols_miR_655_3p_combined,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
qvalueCutoff = 0.05, # Relacionada con el control de la tasa de falsos descubrimientos (FDR).
pvalueCutoff = 0.05
)
go_results_miR_655_3p_combined@result |>
kable(format = "html") |>
kable_styling("striped")| ID | Description | GeneRatio | BgRatio | RichFactor | FoldEnrichment | zScore | pvalue | p.adjust | qvalue | geneID | Count | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO:0010464 | GO:0010464 | regulation of mesenchymal cell proliferation | 3/37 | 33/18888 | 0.0909091 | 46.407862 | 11.5661791 | 0.0000363 | 0.0307078 | 0.0240808 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0010463 | GO:0010463 | mesenchymal cell proliferation | 3/37 | 45/18888 | 0.0666667 | 34.032432 | 9.8284932 | 0.0000928 | 0.0392914 | 0.0308120 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0060213 | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/37 | 13/18888 | 0.1538462 | 78.536383 | 12.3893604 | 0.0002873 | 0.0475315 | 0.0372738 | TOB1/AGO2 | 2 |
| GO:0090092 | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5/37 | 317/18888 | 0.0157729 | 8.051837 | 5.6095681 | 0.0003619 | 0.0475315 | 0.0372738 | TGFBR2/ZEB1/MAGI2/ING2/TOB1 | 5 |
| GO:0060211 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/37 | 15/18888 | 0.1333333 | 68.064865 | 11.5115915 | 0.0003858 | 0.0475315 | 0.0372738 | TOB1/AGO2 | 2 |
| GO:1900153 | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/37 | 15/18888 | 0.1333333 | 68.064865 | 11.5115915 | 0.0003858 | 0.0475315 | 0.0372738 | TOB1/AGO2 | 2 |
| GO:0000377 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5/37 | 337/18888 | 0.0148368 | 7.573983 | 5.3947963 | 0.0004787 | 0.0475315 | 0.0372738 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0000398 | GO:0000398 | mRNA splicing, via spliceosome | 5/37 | 337/18888 | 0.0148368 | 7.573983 | 5.3947963 | 0.0004787 | 0.0475315 | 0.0372738 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0000375 | GO:0000375 | RNA splicing, via transesterification reactions | 5/37 | 341/18888 | 0.0146628 | 7.485139 | 5.3539561 | 0.0005051 | 0.0475315 | 0.0372738 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0042474 | GO:0042474 | middle ear morphogenesis | 2/37 | 21/18888 | 0.0952381 | 48.617761 | 9.6725803 | 0.0007659 | 0.0551280 | 0.0432309 | PRRX1/RPL38 | 2 |
| GO:0048704 | GO:0048704 | embryonic skeletal system morphogenesis | 3/37 | 94/18888 | 0.0319149 | 16.292122 | 6.5847186 | 0.0008204 | 0.0551280 | 0.0432309 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0060395 | GO:0060395 | SMAD protein signal transduction | 3/37 | 95/18888 | 0.0315789 | 16.120626 | 6.5455881 | 0.0008461 | 0.0551280 | 0.0432309 | TGFBR2/MAGI2/TOB1 | 3 |
| GO:0141091 | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 5/37 | 388/18888 | 0.0128866 | 6.578434 | 4.9187807 | 0.0009045 | 0.0551280 | 0.0432309 | TGFBR2/ZEB1/MAGI2/ING2/TOB1 | 5 |
| GO:0043583 | GO:0043583 | ear development | 4/37 | 223/18888 | 0.0179372 | 9.156708 | 5.4283585 | 0.0009202 | 0.0551280 | 0.0432309 | ZEB1/ADAM10/PRRX1/RPL38 | 4 |
| GO:1903312 | GO:1903312 | negative regulation of mRNA metabolic process | 3/37 | 100/18888 | 0.0300000 | 15.314595 | 6.3584891 | 0.0009818 | 0.0551280 | 0.0432309 | RBM24/SRSF7/TOB1 | 3 |
| GO:1903311 | GO:1903311 | regulation of mRNA metabolic process | 5/37 | 404/18888 | 0.0123762 | 6.317902 | 4.7868321 | 0.0010834 | 0.0551280 | 0.0432309 | RBM24/SRSF7/KHDRBS2/TOB1/AGO2 | 5 |
| GO:0002053 | GO:0002053 | positive regulation of mesenchymal cell proliferation | 2/37 | 26/18888 | 0.0769231 | 39.268191 | 8.6505933 | 0.0011781 | 0.0551280 | 0.0432309 | TGFBR2/PRRX1 | 2 |
| GO:1900151 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/37 | 26/18888 | 0.0769231 | 39.268191 | 8.6505933 | 0.0011781 | 0.0551280 | 0.0432309 | TOB1/AGO2 | 2 |
| GO:0007178 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 5/37 | 417/18888 | 0.0119904 | 6.120941 | 4.6847644 | 0.0012471 | 0.0551280 | 0.0432309 | TGFBR2/ZEB1/MAGI2/ING2/TOB1 | 5 |
| GO:0048024 | GO:0048024 | regulation of mRNA splicing, via spliceosome | 3/37 | 112/18888 | 0.0267857 | 13.673745 | 5.9597439 | 0.0013617 | 0.0551280 | 0.0432309 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:1903019 | GO:1903019 | negative regulation of glycoprotein metabolic process | 2/37 | 28/18888 | 0.0714286 | 36.463321 | 8.3196053 | 0.0013668 | 0.0551280 | 0.0432309 | PTX3/AGO2 | 2 |
| GO:0006417 | GO:0006417 | regulation of translation | 5/37 | 451/18888 | 0.0110865 | 5.659495 | 4.4370793 | 0.0017621 | 0.0646410 | 0.0506909 | RPL38/RBM24/EIF1B/TOB1/AGO2 | 5 |
| GO:0000289 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2/37 | 32/18888 | 0.0625000 | 31.905405 | 7.7517508 | 0.0017847 | 0.0646410 | 0.0506909 | TOB1/AGO2 | 2 |
| GO:0048568 | GO:0048568 | embryonic organ development | 5/37 | 455/18888 | 0.0109890 | 5.609742 | 4.4096023 | 0.0018316 | 0.0646410 | 0.0506909 | TGFBR2/ZEB1/PRRX1/ADM/RPL38 | 5 |
| GO:0042471 | GO:0042471 | ear morphogenesis | 3/37 | 127/18888 | 0.0236220 | 12.058736 | 5.5398054 | 0.0019520 | 0.0650279 | 0.0509944 | ZEB1/PRRX1/RPL38 | 3 |
| GO:0048706 | GO:0048706 | embryonic skeletal system development | 3/37 | 128/18888 | 0.0234375 | 11.964527 | 5.5143411 | 0.0019961 | 0.0650279 | 0.0509944 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0050684 | GO:0050684 | regulation of mRNA processing | 3/37 | 134/18888 | 0.0223881 | 11.428802 | 5.3672895 | 0.0022742 | 0.0713440 | 0.0559474 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:0008380 | GO:0008380 | RNA splicing | 5/37 | 484/18888 | 0.0103306 | 5.273621 | 4.2196624 | 0.0023976 | 0.0725274 | 0.0568754 | RBM24/SNRNP40/SRSF5/SRSF7/KHDRBS2 | 5 |
| GO:0048562 | GO:0048562 | embryonic organ morphogenesis | 4/37 | 297/18888 | 0.0134680 | 6.875239 | 4.5213438 | 0.0026295 | 0.0767994 | 0.0602255 | TGFBR2/ZEB1/PRRX1/RPL38 | 4 |
| GO:0022613 | GO:0022613 | ribonucleoprotein complex biogenesis | 5/37 | 499/18888 | 0.0100200 | 5.115095 | 4.1273020 | 0.0027360 | 0.0772463 | 0.0605759 | RPL38/SRSF5/NOA1/RRP9/AGO2 | 5 |
| GO:0035307 | GO:0035307 | positive regulation of protein dephosphorylation | 2/37 | 44/18888 | 0.0454545 | 23.203931 | 6.5325812 | 0.0033539 | 0.0916373 | 0.0718612 | MAGI2/CAMTA1 | 2 |
| GO:0048701 | GO:0048701 | embryonic cranial skeleton morphogenesis | 2/37 | 45/18888 | 0.0444444 | 22.688288 | 6.4531486 | 0.0035056 | 0.0927884 | 0.0727639 | TGFBR2/PRRX1 | 2 |
| GO:0032924 | GO:0032924 | activin receptor signaling pathway | 2/37 | 50/18888 | 0.0400000 | 20.419459 | 6.0914390 | 0.0043111 | 0.1073977 | 0.0842204 | TGFBR2/MAGI2 | 2 |
| GO:0090102 | GO:0090102 | cochlea development | 2/37 | 50/18888 | 0.0400000 | 20.419459 | 6.0914390 | 0.0043111 | 0.1073977 | 0.0842204 | ZEB1/ADAM10 | 2 |
| GO:0003197 | GO:0003197 | endocardial cushion development | 2/37 | 52/18888 | 0.0384615 | 19.634096 | 5.9611604 | 0.0046551 | 0.1126538 | 0.0883422 | TGFBR2/RBM24 | 2 |
| GO:0035306 | GO:0035306 | positive regulation of dephosphorylation | 2/37 | 54/18888 | 0.0370370 | 18.906907 | 5.8379629 | 0.0050114 | 0.1179071 | 0.0924618 | MAGI2/CAMTA1 | 2 |
| GO:0000381 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 2/37 | 55/18888 | 0.0363636 | 18.563145 | 5.7788182 | 0.0051941 | 0.1186087 | 0.0930119 | RBM24/KHDRBS2 | 2 |
| GO:1901342 | GO:1901342 | regulation of vasculature development | 4/37 | 362/18888 | 0.0110497 | 5.640735 | 3.9497113 | 0.0053213 | 0.1186087 | 0.0930119 | TGFBR2/ADAM10/ADM/AGO2 | 4 |
| GO:0043484 | GO:0043484 | regulation of RNA splicing | 3/37 | 186/18888 | 0.0161290 | 8.233653 | 4.3922320 | 0.0057087 | 0.1222469 | 0.0958650 | RBM24/SRSF7/KHDRBS2 | 3 |
| GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 3/37 | 187/18888 | 0.0160428 | 8.189623 | 4.3773336 | 0.0057941 | 0.1222469 | 0.0958650 | TGFBR2/ADM/AGO2 | 3 |
| GO:1904018 | GO:1904018 | positive regulation of vasculature development | 3/37 | 190/18888 | 0.0157895 | 8.060313 | 4.3332957 | 0.0060546 | 0.1222469 | 0.0958650 | TGFBR2/ADM/AGO2 | 3 |
| GO:0031102 | GO:0031102 | neuron projection regeneration | 2/37 | 61/18888 | 0.0327869 | 16.737262 | 5.4540446 | 0.0063538 | 0.1222469 | 0.0958650 | PRRX1/ADM | 2 |
| GO:1903018 | GO:1903018 | regulation of glycoprotein metabolic process | 2/37 | 61/18888 | 0.0327869 | 16.737262 | 5.4540446 | 0.0063538 | 0.1222469 | 0.0958650 | PTX3/AGO2 | 2 |
| GO:0042255 | GO:0042255 | ribosome assembly | 2/37 | 62/18888 | 0.0322581 | 16.467306 | 5.4043896 | 0.0065576 | 0.1222469 | 0.0958650 | RPL38/NOA1 | 2 |
| GO:0048839 | GO:0048839 | inner ear development | 3/37 | 196/18888 | 0.0153061 | 7.813569 | 4.2480532 | 0.0065966 | 0.1222469 | 0.0958650 | ZEB1/ADAM10/PRRX1 | 3 |
| GO:0061157 | GO:0061157 | mRNA destabilization | 3/37 | 198/18888 | 0.0151515 | 7.734644 | 4.2204400 | 0.0067835 | 0.1222469 | 0.0958650 | RBM24/TOB1/AGO2 | 3 |
| GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3/37 | 198/18888 | 0.0151515 | 7.734644 | 4.2204400 | 0.0067835 | 0.1222469 | 0.0958650 | MAGI2/ING2/TOB1 | 3 |
| GO:0050779 | GO:0050779 | RNA destabilization | 3/37 | 202/18888 | 0.0148515 | 7.581482 | 4.1663562 | 0.0071667 | 0.1255717 | 0.0984723 | RBM24/TOB1/AGO2 | 3 |
| GO:0061014 | GO:0061014 | positive regulation of mRNA catabolic process | 3/37 | 203/18888 | 0.0147783 | 7.544135 | 4.1530666 | 0.0072645 | 0.1255717 | 0.0984723 | RBM24/TOB1/AGO2 | 3 |
| GO:0017148 | GO:0017148 | negative regulation of translation | 3/37 | 206/18888 | 0.0145631 | 7.434269 | 4.1137350 | 0.0075626 | 0.1265578 | 0.0992456 | RBM24/TOB1/AGO2 | 3 |
| GO:0000288 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/37 | 67/18888 | 0.0298507 | 15.238403 | 5.1724045 | 0.0076204 | 0.1265578 | 0.0992456 | TOB1/AGO2 | 2 |
| GO:0051216 | GO:0051216 | cartilage development | 3/37 | 209/18888 | 0.0143541 | 7.327557 | 4.0751872 | 0.0078679 | 0.1281555 | 0.1004985 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:1904888 | GO:1904888 | cranial skeletal system development | 2/37 | 72/18888 | 0.0277778 | 14.180180 | 4.9640837 | 0.0087556 | 0.1399239 | 0.1097272 | TGFBR2/PRRX1 | 2 |
| GO:0000380 | GO:0000380 | alternative mRNA splicing, via spliceosome | 2/37 | 73/18888 | 0.0273973 | 13.985931 | 4.9249017 | 0.0089912 | 0.1410283 | 0.1105932 | RBM24/KHDRBS2 | 2 |
| GO:0060390 | GO:0060390 | regulation of SMAD protein signal transduction | 2/37 | 75/18888 | 0.0266667 | 13.612973 | 4.8487995 | 0.0094709 | 0.1458512 | 0.1143753 | TGFBR2/TOB1 | 2 |
| GO:1902373 | GO:1902373 | negative regulation of mRNA catabolic process | 2/37 | 76/18888 | 0.0263158 | 13.433855 | 4.8118298 | 0.0097149 | 0.1464348 | 0.1148330 | RBM24/TOB1 | 2 |
| GO:0048705 | GO:0048705 | skeletal system morphogenesis | 3/37 | 229/18888 | 0.0131004 | 6.687596 | 3.8363431 | 0.0100895 | 0.1464348 | 0.1148330 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0051145 | GO:0051145 | smooth muscle cell differentiation | 2/37 | 78/18888 | 0.0256410 | 13.089397 | 4.7399384 | 0.0102114 | 0.1464348 | 0.1148330 | ZEB1/ADM | 2 |
| GO:0035304 | GO:0035304 | regulation of protein dephosphorylation | 2/37 | 79/18888 | 0.0253165 | 12.923709 | 4.7049737 | 0.0104638 | 0.1464348 | 0.1148330 | MAGI2/CAMTA1 | 2 |
| GO:0022618 | GO:0022618 | protein-RNA complex assembly | 3/37 | 234/18888 | 0.0128205 | 6.544698 | 3.7810728 | 0.0106963 | 0.1464348 | 0.1148330 | RPL38/SRSF5/AGO2 | 3 |
| GO:0034249 | GO:0034249 | negative regulation of amide metabolic process | 3/37 | 234/18888 | 0.0128205 | 6.544698 | 3.7810728 | 0.0106963 | 0.1464348 | 0.1148330 | RBM24/TOB1/AGO2 | 3 |
| GO:0007193 | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 2/37 | 80/18888 | 0.0250000 | 12.762162 | 4.6706358 | 0.0107190 | 0.1464348 | 0.1148330 | RGS1/CORT | 2 |
| GO:0048844 | GO:0048844 | artery morphogenesis | 2/37 | 81/18888 | 0.0246914 | 12.604605 | 4.6369056 | 0.0109769 | 0.1475779 | 0.1157294 | TGFBR2/PRRX1 | 2 |
| GO:1903313 | GO:1903313 | positive regulation of mRNA metabolic process | 3/37 | 240/18888 | 0.0125000 | 6.381081 | 3.7168427 | 0.0114521 | 0.1475948 | 0.1157427 | RBM24/TOB1/AGO2 | 3 |
| GO:0001570 | GO:0001570 | vasculogenesis | 2/37 | 83/18888 | 0.0240964 | 12.300879 | 4.5711952 | 0.0115009 | 0.1475948 | 0.1157427 | TGFBR2/ADM | 2 |
| GO:2000736 | GO:2000736 | regulation of stem cell differentiation | 2/37 | 83/18888 | 0.0240964 | 12.300879 | 4.5711952 | 0.0115009 | 0.1475948 | 0.1157427 | TGFBR2/RBM24 | 2 |
| GO:0006446 | GO:0006446 | regulation of translational initiation | 2/37 | 84/18888 | 0.0238095 | 12.154440 | 4.5391805 | 0.0117670 | 0.1485926 | 0.1165251 | EIF1B/AGO2 | 2 |
| GO:0071826 | GO:0071826 | protein-RNA complex organization | 3/37 | 244/18888 | 0.0122951 | 6.276473 | 3.6752278 | 0.0119727 | 0.1485926 | 0.1165251 | RPL38/SRSF5/AGO2 | 3 |
| GO:0007179 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 3/37 | 245/18888 | 0.0122449 | 6.250855 | 3.6649691 | 0.0121049 | 0.1485926 | 0.1165251 | TGFBR2/ZEB1/ING2 | 3 |
| GO:0007188 | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3/37 | 249/18888 | 0.0120482 | 6.150440 | 3.6244977 | 0.0126425 | 0.1529738 | 0.1199608 | ADM/RGS1/CORT | 3 |
| GO:1902369 | GO:1902369 | negative regulation of RNA catabolic process | 2/37 | 88/18888 | 0.0227273 | 11.601966 | 4.4163548 | 0.0128583 | 0.1533940 | 0.1202904 | RBM24/TOB1 | 2 |
| GO:0060021 | GO:0060021 | roof of mouth development | 2/37 | 91/18888 | 0.0219780 | 11.219483 | 4.3293283 | 0.0137048 | 0.1612212 | 0.1264284 | TGFBR2/PRRX1 | 2 |
| GO:0042982 | GO:0042982 | amyloid precursor protein metabolic process | 2/37 | 96/18888 | 0.0208333 | 10.635135 | 4.1929731 | 0.0151679 | 0.1736114 | 0.1361446 | ADAM10/AGO2 | 2 |
| GO:0072091 | GO:0072091 | regulation of stem cell proliferation | 2/37 | 96/18888 | 0.0208333 | 10.635135 | 4.1929731 | 0.0151679 | 0.1736114 | 0.1361446 | TGFBR2/PRRX1 | 2 |
| GO:0043488 | GO:0043488 | regulation of mRNA stability | 3/37 | 273/18888 | 0.0109890 | 5.609742 | 3.3989247 | 0.0161545 | 0.1824387 | 0.1430669 | RBM24/TOB1/AGO2 | 3 |
| GO:0090596 | GO:0090596 | sensory organ morphogenesis | 3/37 | 278/18888 | 0.0107914 | 5.508847 | 3.3552885 | 0.0169487 | 0.1841399 | 0.1444011 | ZEB1/PRRX1/RPL38 | 3 |
| GO:0090100 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2/37 | 105/18888 | 0.0190476 | 9.723552 | 3.9711902 | 0.0179630 | 0.1841399 | 0.1444011 | TGFBR2/ING2 | 2 |
| GO:0043487 | GO:0043487 | regulation of RNA stability | 3/37 | 285/18888 | 0.0105263 | 5.373542 | 3.2959407 | 0.0180970 | 0.1841399 | 0.1444011 | RBM24/TOB1/AGO2 | 3 |
| GO:0035303 | GO:0035303 | regulation of dephosphorylation | 2/37 | 106/18888 | 0.0188679 | 9.631820 | 3.9482039 | 0.0182861 | 0.1841399 | 0.1444011 | MAGI2/CAMTA1 | 2 |
| GO:0042472 | GO:0042472 | inner ear morphogenesis | 2/37 | 106/18888 | 0.0188679 | 9.631820 | 3.9482039 | 0.0182861 | 0.1841399 | 0.1444011 | ZEB1/PRRX1 | 2 |
| GO:0061448 | GO:0061448 | connective tissue development | 3/37 | 288/18888 | 0.0104167 | 5.317568 | 3.2711019 | 0.0186022 | 0.1841399 | 0.1444011 | TGFBR2/ZEB1/PRRX1 | 3 |
| GO:0061013 | GO:0061013 | regulation of mRNA catabolic process | 3/37 | 290/18888 | 0.0103448 | 5.280895 | 3.2547346 | 0.0189433 | 0.1841399 | 0.1444011 | RBM24/TOB1/AGO2 | 3 |
| GO:0048664 | GO:0048664 | neuron fate determination | 1/37 | 10/18888 | 0.1000000 | 51.048649 | 7.0134147 | 0.0194220 | 0.1841399 | 0.1444011 | PRRX1 | 1 |
| GO:0061668 | GO:0061668 | mitochondrial ribosome assembly | 1/37 | 10/18888 | 0.1000000 | 51.048649 | 7.0134147 | 0.0194220 | 0.1841399 | 0.1444011 | NOA1 | 1 |
| GO:0070922 | GO:0070922 | RISC complex assembly | 1/37 | 10/18888 | 0.1000000 | 51.048649 | 7.0134147 | 0.0194220 | 0.1841399 | 0.1444011 | AGO2 | 1 |
| GO:2000563 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation | 1/37 | 10/18888 | 0.1000000 | 51.048649 | 7.0134147 | 0.0194220 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0060840 | GO:0060840 | artery development | 2/37 | 113/18888 | 0.0176991 | 9.035159 | 3.7954116 | 0.0206163 | 0.1841399 | 0.1444011 | TGFBR2/PRRX1 | 2 |
| GO:0071560 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 3/37 | 302/18888 | 0.0099338 | 5.071058 | 3.1596060 | 0.0210636 | 0.1841399 | 0.1444011 | TGFBR2/ZEB1/ING2 | 3 |
| GO:0001865 | GO:0001865 | NK T cell differentiation | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0022605 | GO:0022605 | mammalian oogenesis stage | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | PTX3 | 1 |
| GO:0045602 | GO:0045602 | negative regulation of endothelial cell differentiation | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | ZEB1 | 1 |
| GO:0060433 | GO:0060433 | bronchus development | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0060439 | GO:0060439 | trachea morphogenesis | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0072015 | GO:0072015 | podocyte development | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | MAGI2 | 1 |
| GO:0098696 | GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | ADAM10 | 1 |
| GO:1901998 | GO:1901998 | toxin transport | 1/37 | 11/18888 | 0.0909091 | 46.407862 | 6.6738443 | 0.0213438 | 0.1841399 | 0.1444011 | ADAM10 | 1 |
| GO:0071559 | GO:0071559 | response to transforming growth factor beta | 3/37 | 309/18888 | 0.0097087 | 4.956180 | 3.1064131 | 0.0223586 | 0.1841399 | 0.1444011 | TGFBR2/ZEB1/ING2 | 3 |
| GO:0001547 | GO:0001547 | antral ovarian follicle growth | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | PTX3 | 1 |
| GO:0002645 | GO:0002645 | positive regulation of tolerance induction | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0042117 | GO:0042117 | monocyte activation | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | ADAM10 | 1 |
| GO:0045906 | GO:0045906 | negative regulation of vasoconstriction | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | ADM | 1 |
| GO:0062042 | GO:0062042 | regulation of cardiac epithelial to mesenchymal transition | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | TGFBR2 | 1 |
| GO:0072310 | GO:0072310 | glomerular epithelial cell development | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | MAGI2 | 1 |
| GO:0097084 | GO:0097084 | vascular associated smooth muscle cell development | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | ADM | 1 |
| GO:0098528 | GO:0098528 | skeletal muscle fiber differentiation | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | RBM24 | 1 |
| GO:1900152 | GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | TOB1 | 1 |
| GO:2001214 | GO:2001214 | positive regulation of vasculogenesis | 1/37 | 12/18888 | 0.0833333 | 42.540540 | 6.3770957 | 0.0232621 | 0.1841399 | 0.1444011 | ADM | 1 |
| GO:0042254 | GO:0042254 | ribosome biogenesis | 3/37 | 319/18888 | 0.0094044 | 4.800813 | 3.0331423 | 0.0242832 | 0.1876251 | 0.1471341 | RPL38/NOA1/RRP9 | 3 |
| GO:0006413 | GO:0006413 | translational initiation | 2/37 | 124/18888 | 0.0161290 | 8.233653 | 3.5803127 | 0.0245141 | 0.1876251 | 0.1471341 | EIF1B/AGO2 | 2 |
| GO:0002664 | GO:0002664 | regulation of T cell tolerance induction | 1/37 | 13/18888 | 0.0769231 | 39.268191 | 6.1147863 | 0.0251766 | 0.1876251 | 0.1471341 | TGFBR2 | 1 |
| GO:0038180 | GO:0038180 | nerve growth factor signaling pathway | 1/37 | 13/18888 | 0.0769231 | 39.268191 | 6.1147863 | 0.0251766 | 0.1876251 | 0.1471341 | MAGI2 | 1 |
| GO:0060670 | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 1/37 | 13/18888 | 0.0769231 | 39.268191 | 6.1147863 | 0.0251766 | 0.1876251 | 0.1471341 | ADM | 1 |
| GO:0000956 | GO:0000956 | nuclear-transcribed mRNA catabolic process | 2/37 | 126/18888 | 0.0158730 | 8.102960 | 3.5440532 | 0.0252530 | 0.1876251 | 0.1471341 | TOB1/AGO2 | 2 |
| GO:0072089 | GO:0072089 | stem cell proliferation | 2/37 | 126/18888 | 0.0158730 | 8.102960 | 3.5440532 | 0.0252530 | 0.1876251 | 0.1471341 | TGFBR2/PRRX1 | 2 |
| GO:0031623 | GO:0031623 | receptor internalization | 2/37 | 127/18888 | 0.0157480 | 8.039157 | 3.5262223 | 0.0256258 | 0.1887395 | 0.1480080 | MAGI2/ADM | 2 |
| GO:0002031 | GO:0002031 | G protein-coupled receptor internalization | 1/37 | 14/18888 | 0.0714286 | 36.463321 | 5.8806671 | 0.0270875 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0003413 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 1/37 | 14/18888 | 0.0714286 | 36.463321 | 5.8806671 | 0.0270875 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0007127 | GO:0007127 | meiosis I | 2/37 | 131/18888 | 0.0152672 | 7.793687 | 3.4568030 | 0.0271395 | 0.1918694 | 0.1504624 | PTTG1/ING2 | 2 |
| GO:0002517 | GO:0002517 | T cell tolerance induction | 1/37 | 15/18888 | 0.0666667 | 34.032432 | 5.6699714 | 0.0289948 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0003198 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 1/37 | 15/18888 | 0.0666667 | 34.032432 | 5.6699714 | 0.0289948 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0010820 | GO:0010820 | positive regulation of T cell chemotaxis | 1/37 | 15/18888 | 0.0666667 | 34.032432 | 5.6699714 | 0.0289948 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:0032352 | GO:0032352 | positive regulation of hormone metabolic process | 1/37 | 15/18888 | 0.0666667 | 34.032432 | 5.6699714 | 0.0289948 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:1902166 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/37 | 15/18888 | 0.0666667 | 34.032432 | 5.6699714 | 0.0289948 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0061982 | GO:0061982 | meiosis I cell cycle process | 2/37 | 139/18888 | 0.0143885 | 7.345129 | 3.3263962 | 0.0302729 | 0.1918694 | 0.1504624 | PTTG1/ING2 | 2 |
| GO:0006402 | GO:0006402 | mRNA catabolic process | 3/37 | 348/18888 | 0.0086207 | 4.400746 | 2.8367695 | 0.0303602 | 0.1918694 | 0.1504624 | RBM24/TOB1/AGO2 | 3 |
| GO:0003214 | GO:0003214 | cardiac left ventricle morphogenesis | 1/37 | 16/18888 | 0.0625000 | 31.905405 | 5.4789915 | 0.0308984 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0010819 | GO:0010819 | regulation of T cell chemotaxis | 1/37 | 16/18888 | 0.0625000 | 31.905405 | 5.4789915 | 0.0308984 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:0042448 | GO:0042448 | progesterone metabolic process | 1/37 | 16/18888 | 0.0625000 | 31.905405 | 5.4789915 | 0.0308984 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0072520 | GO:0072520 | seminiferous tubule development | 1/37 | 16/18888 | 0.0625000 | 31.905405 | 5.4789915 | 0.0308984 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:2001212 | GO:2001212 | regulation of vasculogenesis | 1/37 | 16/18888 | 0.0625000 | 31.905405 | 5.4789915 | 0.0308984 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0045765 | GO:0045765 | regulation of angiogenesis | 3/37 | 353/18888 | 0.0084986 | 4.338412 | 2.8050858 | 0.0314823 | 0.1918694 | 0.1504624 | TGFBR2/ADM/AGO2 | 3 |
| GO:0008228 | GO:0008228 | opsonization | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | PTX3 | 1 |
| GO:0010831 | GO:0010831 | positive regulation of myotube differentiation | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | RBM24 | 1 |
| GO:0031054 | GO:0031054 | pre-miRNA processing | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0032926 | GO:0032926 | negative regulation of activin receptor signaling pathway | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0044793 | GO:0044793 | negative regulation by host of viral process | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | PTX3 | 1 |
| GO:1901163 | GO:1901163 | regulation of trophoblast cell migration | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:1902165 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/37 | 17/18888 | 0.0588235 | 30.028617 | 5.3047937 | 0.0327984 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0007224 | GO:0007224 | smoothened signaling pathway | 2/37 | 146/18888 | 0.0136986 | 6.992966 | 3.2205155 | 0.0331273 | 0.1918694 | 0.1504624 | TGFBR2/PRRX1 | 2 |
| GO:0006367 | GO:0006367 | transcription initiation at RNA polymerase II promoter | 2/37 | 149/18888 | 0.0134228 | 6.852168 | 3.1772533 | 0.0343819 | 0.1918694 | 0.1504624 | GTF2F2/TAF13 | 2 |
| GO:0043116 | GO:0043116 | negative regulation of vascular permeability | 1/37 | 18/18888 | 0.0555556 | 28.360360 | 5.1450224 | 0.0346948 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0061450 | GO:0061450 | trophoblast cell migration | 1/37 | 18/18888 | 0.0555556 | 28.360360 | 5.1450224 | 0.0346948 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0090287 | GO:0090287 | regulation of cellular response to growth factor stimulus | 3/37 | 373/18888 | 0.0080429 | 4.105789 | 2.6839828 | 0.0361882 | 0.1918694 | 0.1504624 | ZEB1/ING2/TOB1 | 3 |
| GO:0003417 | GO:0003417 | growth plate cartilage development | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0008356 | GO:0008356 | asymmetric cell division | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0032516 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0043011 | GO:0043011 | myeloid dendritic cell differentiation | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0046931 | GO:0046931 | pore complex assembly | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:0060438 | GO:0060438 | trachea development | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0061158 | GO:0061158 | 3'-UTR-mediated mRNA destabilization | 1/37 | 19/18888 | 0.0526316 | 26.867710 | 4.9977611 | 0.0365876 | 0.1918694 | 0.1504624 | RBM24 | 1 |
| GO:0045807 | GO:0045807 | positive regulation of endocytosis | 2/37 | 155/18888 | 0.0129032 | 6.586922 | 3.0942114 | 0.0369463 | 0.1918694 | 0.1504624 | MAGI2/PTX3 | 2 |
| GO:0002029 | GO:0002029 | desensitization of G protein-coupled receptor signaling pathway | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0002643 | GO:0002643 | regulation of tolerance induction | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0006700 | GO:0006700 | C21-steroid hormone biosynthetic process | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0033141 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | IFNW1 | 1 |
| GO:0042985 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0140131 | GO:0140131 | positive regulation of lymphocyte chemotaxis | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:2001014 | GO:2001014 | regulation of skeletal muscle cell differentiation | 1/37 | 20/18888 | 0.0500000 | 25.524324 | 4.8614326 | 0.0384767 | 0.1918694 | 0.1504624 | RBM24 | 1 |
| GO:0002181 | GO:0002181 | cytoplasmic translation | 2/37 | 160/18888 | 0.0125000 | 6.381081 | 3.0283006 | 0.0391382 | 0.1918694 | 0.1504624 | RPL38/RBM24 | 2 |
| GO:0050657 | GO:0050657 | nucleic acid transport | 2/37 | 161/18888 | 0.0124224 | 6.341447 | 3.0154554 | 0.0395825 | 0.1918694 | 0.1504624 | TGFBR2/SRSF7 | 2 |
| GO:0050658 | GO:0050658 | RNA transport | 2/37 | 161/18888 | 0.0124224 | 6.341447 | 3.0154554 | 0.0395825 | 0.1918694 | 0.1504624 | TGFBR2/SRSF7 | 2 |
| GO:0022401 | GO:0022401 | negative adaptation of signaling pathway | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0035809 | GO:0035809 | regulation of urine volume | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0070886 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | CAMTA1 | 1 |
| GO:0106058 | GO:0106058 | positive regulation of calcineurin-mediated signaling | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | CAMTA1 | 1 |
| GO:1902683 | GO:1902683 | regulation of receptor localization to synapse | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:2000738 | GO:2000738 | positive regulation of stem cell differentiation | 1/37 | 21/18888 | 0.0476190 | 24.308880 | 4.7347253 | 0.0403623 | 0.1918694 | 0.1504624 | RBM24 | 1 |
| GO:0030307 | GO:0030307 | positive regulation of cell growth | 2/37 | 163/18888 | 0.0122699 | 6.263638 | 2.9900885 | 0.0404768 | 0.1918694 | 0.1504624 | ADAM10/BRAT1 | 2 |
| GO:0051236 | GO:0051236 | establishment of RNA localization | 2/37 | 164/18888 | 0.0121951 | 6.225445 | 2.9775636 | 0.0409269 | 0.1918694 | 0.1504624 | TGFBR2/SRSF7 | 2 |
| GO:0051147 | GO:0051147 | regulation of muscle cell differentiation | 2/37 | 165/18888 | 0.0121212 | 6.187715 | 2.9651421 | 0.0413789 | 0.1918694 | 0.1504624 | ZEB1/RBM24 | 2 |
| GO:0010566 | GO:0010566 | regulation of ketone biosynthetic process | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0035739 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0045947 | GO:0045947 | negative regulation of translational initiation | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0048025 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | SRSF7 | 1 |
| GO:0060713 | GO:0060713 | labyrinthine layer morphogenesis | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0061318 | GO:0061318 | renal filtration cell differentiation | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0072112 | GO:0072112 | podocyte differentiation | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:1902473 | GO:1902473 | regulation of protein localization to synapse | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:2000561 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation | 1/37 | 22/18888 | 0.0454545 | 23.203931 | 4.6165384 | 0.0422442 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0001701 | GO:0001701 | in utero embryonic development | 3/37 | 401/18888 | 0.0074813 | 3.819101 | 2.5279282 | 0.0433553 | 0.1918694 | 0.1504624 | TGFBR2/ADAM10/ADM | 3 |
| GO:0010893 | GO:0010893 | positive regulation of steroid biosynthetic process | 1/37 | 23/18888 | 0.0434783 | 22.195065 | 4.5059401 | 0.0441225 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0033139 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein | 1/37 | 23/18888 | 0.0434783 | 22.195065 | 4.5059401 | 0.0441225 | 0.1918694 | 0.1504624 | IFNW1 | 1 |
| GO:0046597 | GO:0046597 | negative regulation of viral entry into host cell | 1/37 | 23/18888 | 0.0434783 | 22.195065 | 4.5059401 | 0.0441225 | 0.1918694 | 0.1504624 | PTX3 | 1 |
| GO:0072311 | GO:0072311 | glomerular epithelial cell differentiation | 1/37 | 23/18888 | 0.0434783 | 22.195065 | 4.5059401 | 0.0441225 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:1902254 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1/37 | 23/18888 | 0.0434783 | 22.195065 | 4.5059401 | 0.0441225 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0006401 | GO:0006401 | RNA catabolic process | 3/37 | 404/18888 | 0.0074257 | 3.790741 | 2.5120451 | 0.0441628 | 0.1918694 | 0.1504624 | RBM24/TOB1/AGO2 | 3 |
| GO:0003148 | GO:0003148 | outflow tract septum morphogenesis | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0010839 | GO:0010839 | negative regulation of keratinocyte proliferation | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | ZEB1 | 1 |
| GO:0023058 | GO:0023058 | adaptation of signaling pathway | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0035162 | GO:0035162 | embryonic hemopoiesis | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0042501 | GO:0042501 | serine phosphorylation of STAT protein | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | IFNW1 | 1 |
| GO:0046641 | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0046885 | GO:0046885 | regulation of hormone biosynthetic process | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0050686 | GO:0050686 | negative regulation of mRNA processing | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | SRSF7 | 1 |
| GO:0090103 | GO:0090103 | cochlea morphogenesis | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | ZEB1 | 1 |
| GO:0097150 | GO:0097150 | neuronal stem cell population maintenance | 1/37 | 24/18888 | 0.0416667 | 21.270270 | 4.4021357 | 0.0459973 | 0.1918694 | 0.1504624 | PRRX1 | 1 |
| GO:0017015 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 2/37 | 177/18888 | 0.0112994 | 5.768209 | 2.8236350 | 0.0469488 | 0.1918694 | 0.1504624 | ZEB1/ING2 | 2 |
| GO:0010561 | GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1/37 | 25/18888 | 0.0400000 | 20.419459 | 4.3044425 | 0.0478685 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0099633 | GO:0099633 | protein localization to postsynaptic specialization membrane | 1/37 | 25/18888 | 0.0400000 | 20.419459 | 4.3044425 | 0.0478685 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:0099645 | GO:0099645 | neurotransmitter receptor localization to postsynaptic specialization membrane | 1/37 | 25/18888 | 0.0400000 | 20.419459 | 4.3044425 | 0.0478685 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:1903844 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 2/37 | 180/18888 | 0.0111111 | 5.672072 | 2.7902766 | 0.0483825 | 0.1918694 | 0.1504624 | ZEB1/ING2 | 2 |
| GO:0019827 | GO:0019827 | stem cell population maintenance | 2/37 | 182/18888 | 0.0109890 | 5.609742 | 2.7684518 | 0.0493471 | 0.1918694 | 0.1504624 | PRRX1/ING2 | 2 |
| GO:0002026 | GO:0002026 | regulation of the force of heart contraction | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0002092 | GO:0002092 | positive regulation of receptor internalization | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0003181 | GO:0003181 | atrioventricular valve morphogenesis | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0010460 | GO:0010460 | positive regulation of heart rate | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0032925 | GO:0032925 | regulation of activin receptor signaling pathway | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0048596 | GO:0048596 | embryonic camera-type eye morphogenesis | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | ZEB1 | 1 |
| GO:0062009 | GO:0062009 | secondary palate development | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0070935 | GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | RBM24 | 1 |
| GO:0072010 | GO:0072010 | glomerular epithelium development | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:1901623 | GO:1901623 | regulation of lymphocyte chemotaxis | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:1902455 | GO:1902455 | negative regulation of stem cell population maintenance | 1/37 | 26/18888 | 0.0384615 | 19.634096 | 4.2122708 | 0.0497361 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0007219 | GO:0007219 | Notch signaling pathway | 2/37 | 183/18888 | 0.0109290 | 5.579087 | 2.7576603 | 0.0498321 | 0.1918694 | 0.1504624 | TGFBR2/ADAM10 | 2 |
| GO:0007565 | GO:0007565 | female pregnancy | 2/37 | 183/18888 | 0.0109290 | 5.579087 | 2.7576603 | 0.0498321 | 0.1918694 | 0.1504624 | ADM/AGO2 | 2 |
| GO:0045580 | GO:0045580 | regulation of T cell differentiation | 2/37 | 183/18888 | 0.0109290 | 5.579087 | 2.7576603 | 0.0498321 | 0.1918694 | 0.1504624 | TGFBR2/ZEB1 | 2 |
| GO:0042692 | GO:0042692 | muscle cell differentiation | 3/37 | 428/18888 | 0.0070093 | 3.578176 | 2.3901976 | 0.0508947 | 0.1918694 | 0.1504624 | ZEB1/ADM/RBM24 | 3 |
| GO:0098727 | GO:0098727 | maintenance of cell number | 2/37 | 186/18888 | 0.0107527 | 5.489102 | 2.7257566 | 0.0512975 | 0.1918694 | 0.1504624 | PRRX1/ING2 | 2 |
| GO:0007141 | GO:0007141 | male meiosis I | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | ING2 | 1 |
| GO:0010818 | GO:0010818 | T cell chemotaxis | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | ADAM10 | 1 |
| GO:0033081 | GO:0033081 | regulation of T cell differentiation in thymus | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | ZEB1 | 1 |
| GO:0033119 | GO:0033119 | negative regulation of RNA splicing | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | SRSF7 | 1 |
| GO:0042983 | GO:0042983 | amyloid precursor protein biosynthetic process | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0042984 | GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | AGO2 | 1 |
| GO:0045940 | GO:0045940 | positive regulation of steroid metabolic process | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0060669 | GO:0060669 | embryonic placenta morphogenesis | 1/37 | 27/18888 | 0.0370370 | 18.906907 | 4.1251074 | 0.0516002 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:0030098 | GO:0030098 | lymphocyte differentiation | 3/37 | 432/18888 | 0.0069444 | 3.545045 | 2.3707388 | 0.0520632 | 0.1918694 | 0.1504624 | TGFBR2/ZEB1/IFNW1 | 3 |
| GO:0031331 | GO:0031331 | positive regulation of cellular catabolic process | 3/37 | 432/18888 | 0.0069444 | 3.545045 | 2.3707388 | 0.0520632 | 0.1918694 | 0.1504624 | RBM24/TOB1/AGO2 | 3 |
| GO:0006352 | GO:0006352 | DNA-templated transcription initiation | 2/37 | 189/18888 | 0.0105820 | 5.401973 | 2.6945378 | 0.0527784 | 0.1918694 | 0.1504624 | GTF2F2/TAF13 | 2 |
| GO:0061138 | GO:0061138 | morphogenesis of a branching epithelium | 2/37 | 189/18888 | 0.0105820 | 5.401973 | 2.6945378 | 0.0527784 | 0.1918694 | 0.1504624 | TGFBR2/ADM | 2 |
| GO:0001773 | GO:0001773 | myeloid dendritic cell activation | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0003272 | GO:0003272 | endocardial cushion formation | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0003416 | GO:0003416 | endochondral bone growth | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | TGFBR2 | 1 |
| GO:0010922 | GO:0010922 | positive regulation of phosphatase activity | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | MAGI2 | 1 |
| GO:0120255 | GO:0120255 | olefinic compound biosynthetic process | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | ADM | 1 |
| GO:1903901 | GO:1903901 | negative regulation of viral life cycle | 1/37 | 28/18888 | 0.0357143 | 18.231660 | 4.0425039 | 0.0534607 | 0.1918694 | 0.1504624 | PTX3 | 1 |
| GO:0003171 | GO:0003171 | atrioventricular valve development | 1/37 | 29/18888 | 0.0344828 | 17.602982 | 3.9640665 | 0.0553176 | 0.1960419 | 0.1537345 | TGFBR2 | 1 |
| GO:0003401 | GO:0003401 | axis elongation | 1/37 | 29/18888 | 0.0344828 | 17.602982 | 3.9640665 | 0.0553176 | 0.1960419 | 0.1537345 | MAGI2 | 1 |
| GO:0006910 | GO:0006910 | phagocytosis, recognition | 1/37 | 29/18888 | 0.0344828 | 17.602982 | 3.9640665 | 0.0553176 | 0.1960419 | 0.1537345 | PTX3 | 1 |
| GO:0140013 | GO:0140013 | meiotic nuclear division | 2/37 | 197/18888 | 0.0101523 | 5.182604 | 2.6144404 | 0.0568019 | 0.1984584 | 0.1556294 | PTTG1/ING2 | 2 |
| GO:0002507 | GO:0002507 | tolerance induction | 1/37 | 30/18888 | 0.0333333 | 17.016216 | 3.8894473 | 0.0571710 | 0.1984584 | 0.1556294 | TGFBR2 | 1 |
| GO:0008209 | GO:0008209 | androgen metabolic process | 1/37 | 30/18888 | 0.0333333 | 17.016216 | 3.8894473 | 0.0571710 | 0.1984584 | 0.1556294 | ADM | 1 |
| GO:0070723 | GO:0070723 | response to cholesterol | 1/37 | 30/18888 | 0.0333333 | 17.016216 | 3.8894473 | 0.0571710 | 0.1984584 | 0.1556294 | TGFBR2 | 1 |
| GO:1902230 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1/37 | 30/18888 | 0.0333333 | 17.016216 | 3.8894473 | 0.0571710 | 0.1984584 | 0.1556294 | ING2 | 1 |
| GO:0006403 | GO:0006403 | RNA localization | 2/37 | 200/18888 | 0.0100000 | 5.104865 | 2.5855182 | 0.0583380 | 0.2008628 | 0.1575150 | TGFBR2/SRSF7 | 2 |
| GO:0031099 | GO:0031099 | regeneration | 2/37 | 200/18888 | 0.0100000 | 5.104865 | 2.5855182 | 0.0583380 | 0.2008628 | 0.1575150 | PRRX1/ADM | 2 |
| GO:0098868 | GO:0098868 | bone growth | 1/37 | 31/18888 | 0.0322581 | 16.467306 | 3.8183381 | 0.0590209 | 0.2023914 | 0.1587137 | TGFBR2 | 1 |
| GO:0044703 | GO:0044703 | multi-organism reproductive process | 2/37 | 204/18888 | 0.0098039 | 5.004770 | 2.5478440 | 0.0604086 | 0.2063149 | 0.1617904 | ADM/AGO2 | 2 |
| GO:0001763 | GO:0001763 | morphogenesis of a branching structure | 2/37 | 206/18888 | 0.0097087 | 4.956180 | 2.5293741 | 0.0614534 | 0.2082956 | 0.1633437 | TGFBR2/ADM | 2 |
| GO:0002063 | GO:0002063 | chondrocyte development | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | TGFBR2 | 1 |
| GO:0017145 | GO:0017145 | stem cell division | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | ING2 | 1 |
| GO:0030511 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | ING2 | 1 |
| GO:0060351 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | TGFBR2 | 1 |
| GO:1903846 | GO:1903846 | positive regulation of cellular response to transforming growth factor beta stimulus | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | ING2 | 1 |
| GO:2000765 | GO:2000765 | regulation of cytoplasmic translation | 1/37 | 33/18888 | 0.0303030 | 15.469288 | 3.6855814 | 0.0627100 | 0.2082956 | 0.1633437 | RBM24 | 1 |
| GO:0006470 | GO:0006470 | protein dephosphorylation | 2/37 | 210/18888 | 0.0095238 | 4.861776 | 2.4931402 | 0.0635619 | 0.2089225 | 0.1638353 | MAGI2/CAMTA1 | 2 |
| GO:0002323 | GO:0002323 | natural killer cell activation involved in immune response | 1/37 | 34/18888 | 0.0294118 | 15.014308 | 3.6234689 | 0.0645493 | 0.2089225 | 0.1638353 | IFNW1 | 1 |
| GO:0003382 | GO:0003382 | epithelial cell morphogenesis | 1/37 | 34/18888 | 0.0294118 | 15.014308 | 3.6234689 | 0.0645493 | 0.2089225 | 0.1638353 | RILPL2 | 1 |
| GO:0070570 | GO:0070570 | regulation of neuron projection regeneration | 1/37 | 34/18888 | 0.0294118 | 15.014308 | 3.6234689 | 0.0645493 | 0.2089225 | 0.1638353 | PRRX1 | 1 |
| GO:1901797 | GO:1901797 | negative regulation of signal transduction by p53 class mediator | 1/37 | 34/18888 | 0.0294118 | 15.014308 | 3.6234689 | 0.0645493 | 0.2089225 | 0.1638353 | ING2 | 1 |
| GO:1902253 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1/37 | 34/18888 | 0.0294118 | 15.014308 | 3.6234689 | 0.0645493 | 0.2089225 | 0.1638353 | ING2 | 1 |
| GO:0044706 | GO:0044706 | multi-multicellular organism process | 2/37 | 212/18888 | 0.0094340 | 4.815910 | 2.4753653 | 0.0646254 | 0.2089225 | 0.1638353 | ADM/AGO2 | 2 |
| GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 2/37 | 215/18888 | 0.0093023 | 4.748711 | 2.4491160 | 0.0662320 | 0.2121817 | 0.1663912 | TGFBR2/ZEB1 | 2 |
| GO:0036314 | GO:0036314 | response to sterol | 1/37 | 35/18888 | 0.0285714 | 14.585328 | 3.5639293 | 0.0663851 | 0.2121817 | 0.1663912 | TGFBR2 | 1 |
| GO:0048048 | GO:0048048 | embryonic eye morphogenesis | 1/37 | 35/18888 | 0.0285714 | 14.585328 | 3.5639293 | 0.0663851 | 0.2121817 | 0.1663912 | ZEB1 | 1 |
| GO:0002064 | GO:0002064 | epithelial cell development | 2/37 | 216/18888 | 0.0092593 | 4.726727 | 2.4404739 | 0.0667705 | 0.2126113 | 0.1667281 | MAGI2/RILPL2 | 2 |
| GO:1903046 | GO:1903046 | meiotic cell cycle process | 2/37 | 218/18888 | 0.0091743 | 4.683362 | 2.4233474 | 0.0678520 | 0.2130806 | 0.1670961 | PTTG1/ING2 | 2 |
| GO:0001569 | GO:0001569 | branching involved in blood vessel morphogenesis | 1/37 | 36/18888 | 0.0277778 | 14.180180 | 3.5067842 | 0.0682173 | 0.2130806 | 0.1670961 | TGFBR2 | 1 |
| GO:0016486 | GO:0016486 | peptide hormone processing | 1/37 | 36/18888 | 0.0277778 | 14.180180 | 3.5067842 | 0.0682173 | 0.2130806 | 0.1670961 | ADAM10 | 1 |
| GO:0060317 | GO:0060317 | cardiac epithelial to mesenchymal transition | 1/37 | 36/18888 | 0.0277778 | 14.180180 | 3.5067842 | 0.0682173 | 0.2130806 | 0.1670961 | TGFBR2 | 1 |
| GO:2000406 | GO:2000406 | positive regulation of T cell migration | 1/37 | 36/18888 | 0.0277778 | 14.180180 | 3.5067842 | 0.0682173 | 0.2130806 | 0.1670961 | ADAM10 | 1 |
| GO:1903131 | GO:1903131 | mononuclear cell differentiation | 3/37 | 484/18888 | 0.0061983 | 3.164172 | 2.1368478 | 0.0684273 | 0.2130806 | 0.1670961 | TGFBR2/ZEB1/IFNW1 | 3 |
| GO:0008207 | GO:0008207 | C21-steroid hormone metabolic process | 1/37 | 37/18888 | 0.0270270 | 13.796932 | 3.4518720 | 0.0700461 | 0.2149603 | 0.1685701 | ADM | 1 |
| GO:0031076 | GO:0031076 | embryonic camera-type eye development | 1/37 | 37/18888 | 0.0270270 | 13.796932 | 3.4518720 | 0.0700461 | 0.2149603 | 0.1685701 | ZEB1 | 1 |
| GO:0045880 | GO:0045880 | positive regulation of smoothened signaling pathway | 1/37 | 37/18888 | 0.0270270 | 13.796932 | 3.4518720 | 0.0700461 | 0.2149603 | 0.1685701 | PRRX1 | 1 |
| GO:0060391 | GO:0060391 | positive regulation of SMAD protein signal transduction | 1/37 | 37/18888 | 0.0270270 | 13.796932 | 3.4518720 | 0.0700461 | 0.2149603 | 0.1685701 | TGFBR2 | 1 |
| GO:0031330 | GO:0031330 | negative regulation of cellular catabolic process | 2/37 | 224/18888 | 0.0089286 | 4.557915 | 2.3731893 | 0.0711318 | 0.2166372 | 0.1698851 | RBM24/TOB1 | 2 |
| GO:0003180 | GO:0003180 | aortic valve morphogenesis | 1/37 | 38/18888 | 0.0263158 | 13.433855 | 3.3990462 | 0.0718714 | 0.2166372 | 0.1698851 | TGFBR2 | 1 |
| GO:0035909 | GO:0035909 | aorta morphogenesis | 1/37 | 38/18888 | 0.0263158 | 13.433855 | 3.3990462 | 0.0718714 | 0.2166372 | 0.1698851 | TGFBR2 | 1 |
| GO:0045823 | GO:0045823 | positive regulation of heart contraction | 1/37 | 38/18888 | 0.0263158 | 13.433855 | 3.3990462 | 0.0718714 | 0.2166372 | 0.1698851 | ADM | 1 |
| GO:1902229 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1/37 | 38/18888 | 0.0263158 | 13.433855 | 3.3990462 | 0.0718714 | 0.2166372 | 0.1698851 | ING2 | 1 |
| GO:0016049 | GO:0016049 | cell growth | 3/37 | 496/18888 | 0.0060484 | 3.087620 | 2.0873388 | 0.0725041 | 0.2177695 | 0.1707731 | TGFBR2/ADAM10/BRAT1 | 3 |
| GO:0032350 | GO:0032350 | regulation of hormone metabolic process | 1/37 | 39/18888 | 0.0256410 | 13.089397 | 3.3481734 | 0.0736932 | 0.2190109 | 0.1717466 | ADM | 1 |
| GO:0038179 | GO:0038179 | neurotrophin signaling pathway | 1/37 | 39/18888 | 0.0256410 | 13.089397 | 3.3481734 | 0.0736932 | 0.2190109 | 0.1717466 | MAGI2 | 1 |
| GO:1903524 | GO:1903524 | positive regulation of blood circulation | 1/37 | 39/18888 | 0.0256410 | 13.089397 | 3.3481734 | 0.0736932 | 0.2190109 | 0.1717466 | ADM | 1 |
| GO:0015931 | GO:0015931 | nucleobase-containing compound transport | 2/37 | 231/18888 | 0.0086580 | 4.419796 | 2.3168637 | 0.0750233 | 0.2205456 | 0.1729501 | TGFBR2/SRSF7 | 2 |
| GO:0035886 | GO:0035886 | vascular associated smooth muscle cell differentiation | 1/37 | 40/18888 | 0.0250000 | 12.762162 | 3.2991319 | 0.0755115 | 0.2205456 | 0.1729501 | ADM | 1 |
| GO:0045429 | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1/37 | 40/18888 | 0.0250000 | 12.762162 | 3.2991319 | 0.0755115 | 0.2205456 | 0.1729501 | PTX3 | 1 |
| GO:0070884 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 1/37 | 40/18888 | 0.0250000 | 12.762162 | 3.2991319 | 0.0755115 | 0.2205456 | 0.1729501 | CAMTA1 | 1 |
| GO:0140448 | GO:0140448 | signaling receptor ligand precursor processing | 1/37 | 40/18888 | 0.0250000 | 12.762162 | 3.2991319 | 0.0755115 | 0.2205456 | 0.1729501 | ADAM10 | 1 |
| GO:0008406 | GO:0008406 | gonad development | 2/37 | 233/18888 | 0.0085837 | 4.381858 | 2.3011816 | 0.0761476 | 0.2216393 | 0.1738078 | ING2/PTX3 | 2 |
| GO:0003203 | GO:0003203 | endocardial cushion morphogenesis | 1/37 | 41/18888 | 0.0243902 | 12.450890 | 3.2518103 | 0.0773263 | 0.2227734 | 0.1746971 | TGFBR2 | 1 |
| GO:0106056 | GO:0106056 | regulation of calcineurin-mediated signaling | 1/37 | 41/18888 | 0.0243902 | 12.450890 | 3.2518103 | 0.0773263 | 0.2227734 | 0.1746971 | CAMTA1 | 1 |
| GO:1904407 | GO:1904407 | positive regulation of nitric oxide metabolic process | 1/37 | 41/18888 | 0.0243902 | 12.450890 | 3.2518103 | 0.0773263 | 0.2227734 | 0.1746971 | PTX3 | 1 |
| GO:0030595 | GO:0030595 | leukocyte chemotaxis | 2/37 | 237/18888 | 0.0084388 | 4.307903 | 2.2703406 | 0.0784127 | 0.2251375 | 0.1765510 | ADAM10/PPBP | 2 |
| GO:0045137 | GO:0045137 | development of primary sexual characteristics | 2/37 | 238/18888 | 0.0084034 | 4.289802 | 2.2627367 | 0.0789823 | 0.2255294 | 0.1768583 | ING2/PTX3 | 2 |
| GO:0001709 | GO:0001709 | cell fate determination | 1/37 | 42/18888 | 0.0238095 | 12.154440 | 3.2061068 | 0.0791377 | 0.2255294 | 0.1768583 | PRRX1 | 1 |
| GO:0042445 | GO:0042445 | hormone metabolic process | 2/37 | 240/18888 | 0.0083333 | 4.254054 | 2.2476537 | 0.0801256 | 0.2255294 | 0.1768583 | ADAM10/ADM | 2 |
| GO:0002274 | GO:0002274 | myeloid leukocyte activation | 2/37 | 241/18888 | 0.0082988 | 4.236402 | 2.2401737 | 0.0806992 | 0.2255294 | 0.1768583 | TGFBR2/ADAM10 | 2 |
| GO:0003176 | GO:0003176 | aortic valve development | 1/37 | 43/18888 | 0.0232558 | 11.871779 | 3.1619276 | 0.0809456 | 0.2255294 | 0.1768583 | TGFBR2 | 1 |
| GO:0045663 | GO:0045663 | positive regulation of myoblast differentiation | 1/37 | 43/18888 | 0.0232558 | 11.871779 | 3.1619276 | 0.0809456 | 0.2255294 | 0.1768583 | RBM24 | 1 |
| GO:0046640 | GO:0046640 | regulation of alpha-beta T cell proliferation | 1/37 | 43/18888 | 0.0232558 | 11.871779 | 3.1619276 | 0.0809456 | 0.2255294 | 0.1768583 | TGFBR2 | 1 |
| GO:0060412 | GO:0060412 | ventricular septum morphogenesis | 1/37 | 43/18888 | 0.0232558 | 11.871779 | 3.1619276 | 0.0809456 | 0.2255294 | 0.1768583 | TGFBR2 | 1 |
| GO:2000403 | GO:2000403 | positive regulation of lymphocyte migration | 1/37 | 43/18888 | 0.0232558 | 11.871779 | 3.1619276 | 0.0809456 | 0.2255294 | 0.1768583 | ADAM10 | 1 |
| GO:0060560 | GO:0060560 | developmental growth involved in morphogenesis | 2/37 | 243/18888 | 0.0082305 | 4.201535 | 2.2253347 | 0.0818503 | 0.2268262 | 0.1778753 | TGFBR2/MAGI2 | 2 |
| GO:0042771 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1/37 | 44/18888 | 0.0227273 | 11.601966 | 3.1191865 | 0.0827501 | 0.2268262 | 0.1778753 | ING2 | 1 |
| GO:0060443 | GO:0060443 | mammary gland morphogenesis | 1/37 | 44/18888 | 0.0227273 | 11.601966 | 3.1191865 | 0.0827501 | 0.2268262 | 0.1778753 | TGFBR2 | 1 |
| GO:0120178 | GO:0120178 | steroid hormone biosynthetic process | 1/37 | 44/18888 | 0.0227273 | 11.601966 | 3.1191865 | 0.0827501 | 0.2268262 | 0.1778753 | ADM | 1 |
| GO:1903539 | GO:1903539 | protein localization to postsynaptic membrane | 1/37 | 44/18888 | 0.0227273 | 11.601966 | 3.1191865 | 0.0827501 | 0.2268262 | 0.1778753 | ADAM10 | 1 |
| GO:0033173 | GO:0033173 | calcineurin-NFAT signaling cascade | 1/37 | 45/18888 | 0.0222222 | 11.344144 | 3.0778039 | 0.0845511 | 0.2286106 | 0.1792746 | CAMTA1 | 1 |
| GO:0035196 | GO:0035196 | miRNA processing | 1/37 | 45/18888 | 0.0222222 | 11.344144 | 3.0778039 | 0.0845511 | 0.2286106 | 0.1792746 | AGO2 | 1 |
| GO:0062237 | GO:0062237 | protein localization to postsynapse | 1/37 | 45/18888 | 0.0222222 | 11.344144 | 3.0778039 | 0.0845511 | 0.2286106 | 0.1792746 | ADAM10 | 1 |
| GO:0097028 | GO:0097028 | dendritic cell differentiation | 1/37 | 45/18888 | 0.0222222 | 11.344144 | 3.0778039 | 0.0845511 | 0.2286106 | 0.1792746 | TGFBR2 | 1 |
| GO:0048863 | GO:0048863 | stem cell differentiation | 2/37 | 248/18888 | 0.0080645 | 4.116827 | 2.1889239 | 0.0847506 | 0.2286106 | 0.1792746 | TGFBR2/RBM24 | 2 |
| GO:0042789 | GO:0042789 | mRNA transcription by RNA polymerase II | 1/37 | 46/18888 | 0.0217391 | 11.097532 | 3.0377066 | 0.0863486 | 0.2292705 | 0.1797921 | TAF13 | 1 |
| GO:0045601 | GO:0045601 | regulation of endothelial cell differentiation | 1/37 | 46/18888 | 0.0217391 | 11.097532 | 3.0377066 | 0.0863486 | 0.2292705 | 0.1797921 | ZEB1 | 1 |
| GO:0046633 | GO:0046633 | alpha-beta T cell proliferation | 1/37 | 46/18888 | 0.0217391 | 11.097532 | 3.0377066 | 0.0863486 | 0.2292705 | 0.1797921 | TGFBR2 | 1 |
| GO:1990573 | GO:1990573 | potassium ion import across plasma membrane | 1/37 | 46/18888 | 0.0217391 | 11.097532 | 3.0377066 | 0.0863486 | 0.2292705 | 0.1797921 | KCNJ13 | 1 |
| GO:2000516 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 1/37 | 46/18888 | 0.0217391 | 11.097532 | 3.0377066 | 0.0863486 | 0.2292705 | 0.1797921 | TGFBR2 | 1 |
| GO:0006509 | GO:0006509 | membrane protein ectodomain proteolysis | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | ADAM10 | 1 |
| GO:0010830 | GO:0010830 | regulation of myotube differentiation | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | RBM24 | 1 |
| GO:0010837 | GO:0010837 | regulation of keratinocyte proliferation | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | ZEB1 | 1 |
| GO:0043666 | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:0060711 | GO:0060711 | labyrinthine layer development | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | ADM | 1 |
| GO:1905314 | GO:1905314 | semi-lunar valve development | 1/37 | 47/18888 | 0.0212766 | 10.861415 | 2.9988264 | 0.0881428 | 0.2295607 | 0.1800196 | TGFBR2 | 1 |
| GO:0035850 | GO:0035850 | epithelial cell differentiation involved in kidney development | 1/37 | 48/18888 | 0.0208333 | 10.635135 | 2.9611004 | 0.0899335 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:0072583 | GO:0072583 | clathrin-dependent endocytosis | 1/37 | 48/18888 | 0.0208333 | 10.635135 | 2.9611004 | 0.0899335 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:0097720 | GO:0097720 | calcineurin-mediated signaling | 1/37 | 48/18888 | 0.0208333 | 10.635135 | 2.9611004 | 0.0899335 | 0.2295607 | 0.1800196 | CAMTA1 | 1 |
| GO:1902459 | GO:1902459 | positive regulation of stem cell population maintenance | 1/37 | 48/18888 | 0.0208333 | 10.635135 | 2.9611004 | 0.0899335 | 0.2295607 | 0.1800196 | ING2 | 1 |
| GO:1990090 | GO:1990090 | cellular response to nerve growth factor stimulus | 1/37 | 48/18888 | 0.0208333 | 10.635135 | 2.9611004 | 0.0899335 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:0006959 | GO:0006959 | humoral immune response | 2/37 | 258/18888 | 0.0077519 | 3.957260 | 2.1188881 | 0.0906449 | 0.2295607 | 0.1800196 | IFNW1/PPBP | 2 |
| GO:0045927 | GO:0045927 | positive regulation of growth | 2/37 | 258/18888 | 0.0077519 | 3.957260 | 2.1188881 | 0.0906449 | 0.2295607 | 0.1800196 | ADAM10/BRAT1 | 2 |
| GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 2/37 | 259/18888 | 0.0077220 | 3.941981 | 2.1120786 | 0.0912410 | 0.2295607 | 0.1800196 | MAGI2/ADM | 2 |
| GO:0006376 | GO:0006376 | mRNA splice site recognition | 1/37 | 49/18888 | 0.0204082 | 10.418092 | 2.9244701 | 0.0917208 | 0.2295607 | 0.1800196 | SRSF5 | 1 |
| GO:0042181 | GO:0042181 | ketone biosynthetic process | 1/37 | 49/18888 | 0.0204082 | 10.418092 | 2.9244701 | 0.0917208 | 0.2295607 | 0.1800196 | ADM | 1 |
| GO:0044788 | GO:0044788 | modulation by host of viral process | 1/37 | 49/18888 | 0.0204082 | 10.418092 | 2.9244701 | 0.0917208 | 0.2295607 | 0.1800196 | PTX3 | 1 |
| GO:0046596 | GO:0046596 | regulation of viral entry into host cell | 1/37 | 49/18888 | 0.0204082 | 10.418092 | 2.9244701 | 0.0917208 | 0.2295607 | 0.1800196 | PTX3 | 1 |
| GO:0051150 | GO:0051150 | regulation of smooth muscle cell differentiation | 1/37 | 49/18888 | 0.0204082 | 10.418092 | 2.9244701 | 0.0917208 | 0.2295607 | 0.1800196 | ZEB1 | 1 |
| GO:0009299 | GO:0009299 | mRNA transcription | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | TAF13 | 1 |
| GO:0022602 | GO:0022602 | ovulation cycle process | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | PTX3 | 1 |
| GO:0043114 | GO:0043114 | regulation of vascular permeability | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | ADM | 1 |
| GO:0043330 | GO:0043330 | response to exogenous dsRNA | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | IFNW1 | 1 |
| GO:0060071 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:1990089 | GO:1990089 | response to nerve growth factor | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | MAGI2 | 1 |
| GO:2000404 | GO:2000404 | regulation of T cell migration | 1/37 | 50/18888 | 0.0200000 | 10.209730 | 2.8888810 | 0.0935046 | 0.2295607 | 0.1800196 | ADAM10 | 1 |
| GO:0050885 | GO:0050885 | neuromuscular process controlling balance | 1/37 | 51/18888 | 0.0196078 | 10.009539 | 2.8542824 | 0.0952851 | 0.2332557 | 0.1829172 | CAMTA1 | 1 |
| GO:0051155 | GO:0051155 | positive regulation of striated muscle cell differentiation | 1/37 | 52/18888 | 0.0192308 | 9.817048 | 2.8206272 | 0.0970622 | 0.2362404 | 0.1852578 | RBM24 | 1 |
| GO:0051646 | GO:0051646 | mitochondrion localization | 1/37 | 52/18888 | 0.0192308 | 9.817048 | 2.8206272 | 0.0970622 | 0.2362404 | 0.1852578 | BRAT1 | 1 |
| GO:0048260 | GO:0048260 | positive regulation of receptor-mediated endocytosis | 1/37 | 53/18888 | 0.0188679 | 9.631820 | 2.7878710 | 0.0988358 | 0.2391827 | 0.1875651 | MAGI2 | 1 |
| GO:0050850 | GO:0050850 | positive regulation of calcium-mediated signaling | 1/37 | 53/18888 | 0.0188679 | 9.631820 | 2.7878710 | 0.0988358 | 0.2391827 | 0.1875651 | CAMTA1 | 1 |
| GO:0046638 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1/37 | 54/18888 | 0.0185185 | 9.453454 | 2.7559727 | 0.1006061 | 0.2427731 | 0.1903807 | TGFBR2 | 1 |
| GO:0007140 | GO:0007140 | male meiotic nuclear division | 1/37 | 55/18888 | 0.0181818 | 9.281572 | 2.7248936 | 0.1023730 | 0.2435672 | 0.1910034 | ING2 | 1 |
| GO:0010559 | GO:0010559 | regulation of glycoprotein biosynthetic process | 1/37 | 55/18888 | 0.0181818 | 9.281572 | 2.7248936 | 0.1023730 | 0.2435672 | 0.1910034 | AGO2 | 1 |
| GO:0030857 | GO:0030857 | negative regulation of epithelial cell differentiation | 1/37 | 55/18888 | 0.0181818 | 9.281572 | 2.7248936 | 0.1023730 | 0.2435672 | 0.1910034 | ZEB1 | 1 |
| GO:0060425 | GO:0060425 | lung morphogenesis | 1/37 | 55/18888 | 0.0181818 | 9.281572 | 2.7248936 | 0.1023730 | 0.2435672 | 0.1910034 | TGFBR2 | 1 |
| GO:2000772 | GO:2000772 | regulation of cellular senescence | 1/37 | 55/18888 | 0.0181818 | 9.281572 | 2.7248936 | 0.1023730 | 0.2435672 | 0.1910034 | ING2 | 1 |
| GO:0052372 | GO:0052372 | modulation by symbiont of entry into host | 1/37 | 56/18888 | 0.0178571 | 9.115830 | 2.6945974 | 0.1041365 | 0.2463788 | 0.1932082 | PTX3 | 1 |
| GO:2000648 | GO:2000648 | positive regulation of stem cell proliferation | 1/37 | 56/18888 | 0.0178571 | 9.115830 | 2.6945974 | 0.1041365 | 0.2463788 | 0.1932082 | PRRX1 | 1 |
| GO:0001541 | GO:0001541 | ovarian follicle development | 1/37 | 57/18888 | 0.0175439 | 8.955903 | 2.6650502 | 0.1058966 | 0.2491512 | 0.1953824 | PTX3 | 1 |
| GO:0034332 | GO:0034332 | adherens junction organization | 1/37 | 57/18888 | 0.0175439 | 8.955903 | 2.6650502 | 0.1058966 | 0.2491512 | 0.1953824 | ADAM10 | 1 |
| GO:0043331 | GO:0043331 | response to dsRNA | 1/37 | 58/18888 | 0.0172414 | 8.801491 | 2.6362198 | 0.1076534 | 0.2511913 | 0.1969822 | IFNW1 | 1 |
| GO:0061005 | GO:0061005 | cell differentiation involved in kidney development | 1/37 | 58/18888 | 0.0172414 | 8.801491 | 2.6362198 | 0.1076534 | 0.2511913 | 0.1969822 | MAGI2 | 1 |
| GO:0072132 | GO:0072132 | mesenchyme morphogenesis | 1/37 | 58/18888 | 0.0172414 | 8.801491 | 2.6362198 | 0.1076534 | 0.2511913 | 0.1969822 | TGFBR2 | 1 |
| GO:0007548 | GO:0007548 | sex differentiation | 2/37 | 288/18888 | 0.0069444 | 3.545045 | 1.9281926 | 0.1090176 | 0.2518141 | 0.1974705 | ING2/PTX3 | 2 |
| GO:0007566 | GO:0007566 | embryo implantation | 1/37 | 59/18888 | 0.0169492 | 8.652313 | 2.6080762 | 0.1094068 | 0.2518141 | 0.1974705 | AGO2 | 1 |
| GO:0010718 | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1/37 | 59/18888 | 0.0169492 | 8.652313 | 2.6080762 | 0.1094068 | 0.2518141 | 0.1974705 | TGFBR2 | 1 |
| GO:0010921 | GO:0010921 | regulation of phosphatase activity | 1/37 | 59/18888 | 0.0169492 | 8.652313 | 2.6080762 | 0.1094068 | 0.2518141 | 0.1974705 | MAGI2 | 1 |
| GO:0043616 | GO:0043616 | keratinocyte proliferation | 1/37 | 59/18888 | 0.0169492 | 8.652313 | 2.6080762 | 0.1094068 | 0.2518141 | 0.1974705 | ZEB1 | 1 |
| GO:0030100 | GO:0030100 | regulation of endocytosis | 2/37 | 291/18888 | 0.0068729 | 3.508498 | 1.9105306 | 0.1109072 | 0.2530911 | 0.1984720 | MAGI2/PTX3 | 2 |
| GO:0051321 | GO:0051321 | meiotic cell cycle | 2/37 | 291/18888 | 0.0068729 | 3.508498 | 1.9105306 | 0.1109072 | 0.2530911 | 0.1984720 | PTTG1/ING2 | 2 |
| GO:0043113 | GO:0043113 | receptor clustering | 1/37 | 60/18888 | 0.0166667 | 8.508108 | 2.5805911 | 0.1111569 | 0.2530911 | 0.1984720 | MAGI2 | 1 |
| GO:0060350 | GO:0060350 | endochondral bone morphogenesis | 1/37 | 60/18888 | 0.0166667 | 8.508108 | 2.5805911 | 0.1111569 | 0.2530911 | 0.1984720 | TGFBR2 | 1 |
| GO:0003179 | GO:0003179 | heart valve morphogenesis | 1/37 | 61/18888 | 0.0163934 | 8.368631 | 2.5537379 | 0.1129036 | 0.2556935 | 0.2005127 | TGFBR2 | 1 |
| GO:0045744 | GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 1/37 | 61/18888 | 0.0163934 | 8.368631 | 2.5537379 | 0.1129036 | 0.2556935 | 0.2005127 | ADM | 1 |
| GO:0002090 | GO:0002090 | regulation of receptor internalization | 1/37 | 62/18888 | 0.0161290 | 8.233653 | 2.5274912 | 0.1146470 | 0.2568942 | 0.2014543 | MAGI2 | 1 |
| GO:0033619 | GO:0033619 | membrane protein proteolysis | 1/37 | 62/18888 | 0.0161290 | 8.233653 | 2.5274912 | 0.1146470 | 0.2568942 | 0.2014543 | ADAM10 | 1 |
| GO:0060261 | GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 1/37 | 62/18888 | 0.0161290 | 8.233653 | 2.5274912 | 0.1146470 | 0.2568942 | 0.2014543 | TAF13 | 1 |
| GO:0097120 | GO:0097120 | receptor localization to synapse | 1/37 | 62/18888 | 0.0161290 | 8.233653 | 2.5274912 | 0.1146470 | 0.2568942 | 0.2014543 | ADAM10 | 1 |
| GO:0045428 | GO:0045428 | regulation of nitric oxide biosynthetic process | 1/37 | 63/18888 | 0.0158730 | 8.102960 | 2.5018272 | 0.1163870 | 0.2594205 | 0.2034355 | PTX3 | 1 |
| GO:0061951 | GO:0061951 | establishment of protein localization to plasma membrane | 1/37 | 63/18888 | 0.0158730 | 8.102960 | 2.5018272 | 0.1163870 | 0.2594205 | 0.2034355 | RILPL2 | 1 |
| GO:0022617 | GO:0022617 | extracellular matrix disassembly | 1/37 | 64/18888 | 0.0156250 | 7.976351 | 2.4767235 | 0.1181237 | 0.2619131 | 0.2053901 | ADAM10 | 1 |
| GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 1/37 | 64/18888 | 0.0156250 | 7.976351 | 2.4767235 | 0.1181237 | 0.2619131 | 0.2053901 | ADAM10 | 1 |
| GO:0035904 | GO:0035904 | aorta development | 1/37 | 65/18888 | 0.0153846 | 7.853638 | 2.4521588 | 0.1198571 | 0.2631270 | 0.2063421 | TGFBR2 | 1 |
| GO:0043903 | GO:0043903 | regulation of biological process involved in symbiotic interaction | 1/37 | 65/18888 | 0.0153846 | 7.853638 | 2.4521588 | 0.1198571 | 0.2631270 | 0.2063421 | PTX3 | 1 |
| GO:0080164 | GO:0080164 | regulation of nitric oxide metabolic process | 1/37 | 65/18888 | 0.0153846 | 7.853638 | 2.4521588 | 0.1198571 | 0.2631270 | 0.2063421 | PTX3 | 1 |
| GO:0048608 | GO:0048608 | reproductive structure development | 2/37 | 307/18888 | 0.0065147 | 3.325645 | 1.8200914 | 0.1211310 | 0.2631270 | 0.2063421 | ING2/PTX3 | 2 |
| GO:0001947 | GO:0001947 | heart looping | 1/37 | 66/18888 | 0.0151515 | 7.734644 | 2.4281128 | 0.1215872 | 0.2631270 | 0.2063421 | TGFBR2 | 1 |
| GO:0031100 | GO:0031100 | animal organ regeneration | 1/37 | 66/18888 | 0.0151515 | 7.734644 | 2.4281128 | 0.1215872 | 0.2631270 | 0.2063421 | ADM | 1 |
| GO:0042446 | GO:0042446 | hormone biosynthetic process | 1/37 | 66/18888 | 0.0151515 | 7.734644 | 2.4281128 | 0.1215872 | 0.2631270 | 0.2063421 | ADM | 1 |
| GO:0048255 | GO:0048255 | mRNA stabilization | 1/37 | 66/18888 | 0.0151515 | 7.734644 | 2.4281128 | 0.1215872 | 0.2631270 | 0.2063421 | RBM24 | 1 |
| GO:0051898 | GO:0051898 | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/37 | 66/18888 | 0.0151515 | 7.734644 | 2.4281128 | 0.1215872 | 0.2631270 | 0.2063421 | MAGI2 | 1 |
| GO:0046651 | GO:0046651 | lymphocyte proliferation | 2/37 | 308/18888 | 0.0064935 | 3.314847 | 1.8146380 | 0.1217778 | 0.2631270 | 0.2063421 | TGFBR2/IFNW1 | 2 |
| GO:0016311 | GO:0016311 | dephosphorylation | 2/37 | 309/18888 | 0.0064725 | 3.304120 | 1.8092070 | 0.1224255 | 0.2634496 | 0.2065950 | MAGI2/CAMTA1 | 2 |
| GO:0030217 | GO:0030217 | T cell differentiation | 2/37 | 310/18888 | 0.0064516 | 3.293461 | 1.8037981 | 0.1230740 | 0.2634496 | 0.2065950 | TGFBR2/ZEB1 | 2 |
| GO:0009620 | GO:0009620 | response to fungus | 1/37 | 67/18888 | 0.0149254 | 7.619201 | 2.4045665 | 0.1233140 | 0.2634496 | 0.2065950 | PTX3 | 1 |
| GO:0045143 | GO:0045143 | homologous chromosome segregation | 1/37 | 67/18888 | 0.0149254 | 7.619201 | 2.4045665 | 0.1233140 | 0.2634496 | 0.2065950 | PTTG1 | 1 |
| GO:0061458 | GO:0061458 | reproductive system development | 2/37 | 311/18888 | 0.0064309 | 3.282871 | 1.7984112 | 0.1237235 | 0.2634496 | 0.2065950 | ING2/PTX3 | 2 |
| GO:0042987 | GO:0042987 | amyloid precursor protein catabolic process | 1/37 | 68/18888 | 0.0147059 | 7.507154 | 2.3815017 | 0.1250375 | 0.2634496 | 0.2065950 | ADAM10 | 1 |
| GO:0045668 | GO:0045668 | negative regulation of osteoblast differentiation | 1/37 | 68/18888 | 0.0147059 | 7.507154 | 2.3815017 | 0.1250375 | 0.2634496 | 0.2065950 | TOB1 | 1 |
| GO:0051123 | GO:0051123 | RNA polymerase II preinitiation complex assembly | 1/37 | 68/18888 | 0.0147059 | 7.507154 | 2.3815017 | 0.1250375 | 0.2634496 | 0.2065950 | TAF13 | 1 |
| GO:0070918 | GO:0070918 | regulatory ncRNA processing | 1/37 | 68/18888 | 0.0147059 | 7.507154 | 2.3815017 | 0.1250375 | 0.2634496 | 0.2065950 | AGO2 | 1 |
| GO:2000144 | GO:2000144 | positive regulation of DNA-templated transcription initiation | 1/37 | 68/18888 | 0.0147059 | 7.507154 | 2.3815017 | 0.1250375 | 0.2634496 | 0.2065950 | TAF13 | 1 |
| GO:0032943 | GO:0032943 | mononuclear cell proliferation | 2/37 | 315/18888 | 0.0063492 | 3.241184 | 1.7770798 | 0.1263298 | 0.2650956 | 0.2078858 | TGFBR2/IFNW1 | 2 |
| GO:0019229 | GO:0019229 | regulation of vasoconstriction | 1/37 | 69/18888 | 0.0144928 | 7.398355 | 2.3589012 | 0.1267576 | 0.2650956 | 0.2078858 | ADM | 1 |
| GO:0048645 | GO:0048645 | animal organ formation | 1/37 | 69/18888 | 0.0144928 | 7.398355 | 2.3589012 | 0.1267576 | 0.2650956 | 0.2078858 | TGFBR2 | 1 |
| GO:2000379 | GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1/37 | 70/18888 | 0.0142857 | 7.292664 | 2.3367486 | 0.1284745 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 1/37 | 70/18888 | 0.0142857 | 7.292664 | 2.3367486 | 0.1284745 | 0.2665277 | 0.2090089 | ADAM10 | 1 |
| GO:0003208 | GO:0003208 | cardiac ventricle morphogenesis | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0019933 | GO:0019933 | cAMP-mediated signaling | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | ADM | 1 |
| GO:0032835 | GO:0032835 | glomerulus development | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | MAGI2 | 1 |
| GO:0035567 | GO:0035567 | non-canonical Wnt signaling pathway | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | MAGI2 | 1 |
| GO:0061371 | GO:0061371 | determination of heart left/right asymmetry | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0071677 | GO:0071677 | positive regulation of mononuclear cell migration | 1/37 | 71/18888 | 0.0140845 | 7.189951 | 2.3150284 | 0.1301881 | 0.2665277 | 0.2090089 | ADAM10 | 1 |
| GO:0060326 | GO:0060326 | cell chemotaxis | 2/37 | 322/18888 | 0.0062112 | 3.170723 | 1.7405577 | 0.1309233 | 0.2665277 | 0.2090089 | ADAM10/PPBP | 2 |
| GO:0003143 | GO:0003143 | embryonic heart tube morphogenesis | 1/37 | 72/18888 | 0.0138889 | 7.090090 | 2.2937256 | 0.1318984 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0030514 | GO:0030514 | negative regulation of BMP signaling pathway | 1/37 | 72/18888 | 0.0138889 | 7.090090 | 2.2937256 | 0.1318984 | 0.2665277 | 0.2090089 | TOB1 | 1 |
| GO:0042698 | GO:0042698 | ovulation cycle | 1/37 | 72/18888 | 0.0138889 | 7.090090 | 2.2937256 | 0.1318984 | 0.2665277 | 0.2090089 | PTX3 | 1 |
| GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 1/37 | 72/18888 | 0.0138889 | 7.090090 | 2.2937256 | 0.1318984 | 0.2665277 | 0.2090089 | PTX3 | 1 |
| GO:0060411 | GO:0060411 | cardiac septum morphogenesis | 1/37 | 72/18888 | 0.0138889 | 7.090090 | 2.2937256 | 0.1318984 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0003170 | GO:0003170 | heart valve development | 1/37 | 73/18888 | 0.0136986 | 6.992966 | 2.2728264 | 0.1336055 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0045661 | GO:0045661 | regulation of myoblast differentiation | 1/37 | 73/18888 | 0.0136986 | 6.992966 | 2.2728264 | 0.1336055 | 0.2665277 | 0.2090089 | RBM24 | 1 |
| GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 1/37 | 73/18888 | 0.0136986 | 6.992966 | 2.2728264 | 0.1336055 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:2000036 | GO:2000036 | regulation of stem cell population maintenance | 1/37 | 73/18888 | 0.0136986 | 6.992966 | 2.2728264 | 0.1336055 | 0.2665277 | 0.2090089 | ING2 | 1 |
| GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 2/37 | 328/18888 | 0.0060976 | 3.112722 | 1.7100371 | 0.1348920 | 0.2665277 | 0.2090089 | TGFBR2/ZEB1 | 2 |
| GO:0003281 | GO:0003281 | ventricular septum development | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0014823 | GO:0014823 | response to activity | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | ZEB1 | 1 |
| GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | TGFBR2 | 1 |
| GO:0048663 | GO:0048663 | neuron fate commitment | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | PRRX1 | 1 |
| GO:0060260 | GO:0060260 | regulation of transcription initiation by RNA polymerase II | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | TAF13 | 1 |
| GO:0072678 | GO:0072678 | T cell migration | 1/37 | 74/18888 | 0.0135135 | 6.898466 | 2.2523171 | 0.1353092 | 0.2665277 | 0.2090089 | ADAM10 | 1 |
| GO:0043489 | GO:0043489 | RNA stabilization | 1/37 | 75/18888 | 0.0133333 | 6.806487 | 2.2321850 | 0.1370098 | 0.2692512 | 0.2111446 | RBM24 | 1 |
| GO:0030198 | GO:0030198 | extracellular matrix organization | 2/37 | 332/18888 | 0.0060241 | 3.075220 | 1.6900755 | 0.1375534 | 0.2696938 | 0.2114917 | ADAM10/PTX3 | 2 |
| GO:0043062 | GO:0043062 | extracellular structure organization | 2/37 | 333/18888 | 0.0060060 | 3.065985 | 1.6851320 | 0.1382206 | 0.2703762 | 0.2120268 | ADAM10/PTX3 | 2 |
| GO:0015986 | GO:0015986 | proton motive force-driven ATP synthesis | 1/37 | 76/18888 | 0.0131579 | 6.716927 | 2.2124178 | 0.1387070 | 0.2704337 | 0.2120719 | ATP5MC2 | 1 |
| GO:0045229 | GO:0045229 | external encapsulating structure organization | 2/37 | 334/18888 | 0.0059880 | 3.056805 | 1.6802070 | 0.1388886 | 0.2704337 | 0.2120719 | ADAM10/PTX3 | 2 |
| GO:0060562 | GO:0060562 | epithelial tube morphogenesis | 2/37 | 335/18888 | 0.0059701 | 3.047680 | 1.6753004 | 0.1395574 | 0.2708877 | 0.2124279 | TGFBR2/ADM | 2 |
| GO:0060485 | GO:0060485 | mesenchyme development | 2/37 | 336/18888 | 0.0059524 | 3.038610 | 1.6704119 | 0.1402268 | 0.2708877 | 0.2124279 | TGFBR2/RBM24 | 2 |
| GO:0006809 | GO:0006809 | nitric oxide biosynthetic process | 1/37 | 77/18888 | 0.0129870 | 6.629695 | 2.1930040 | 0.1404010 | 0.2708877 | 0.2124279 | PTX3 | 1 |
| GO:0035914 | GO:0035914 | skeletal muscle cell differentiation | 1/37 | 77/18888 | 0.0129870 | 6.629695 | 2.1930040 | 0.1404010 | 0.2708877 | 0.2124279 | RBM24 | 1 |
| GO:0035418 | GO:0035418 | protein localization to synapse | 1/37 | 78/18888 | 0.0128205 | 6.544698 | 2.1739322 | 0.1420918 | 0.2729065 | 0.2140111 | ADAM10 | 1 |
| GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1/37 | 78/18888 | 0.0128205 | 6.544698 | 2.1739322 | 0.1420918 | 0.2729065 | 0.2140111 | TGFBR2 | 1 |
| GO:0043010 | GO:0043010 | camera-type eye development | 2/37 | 346/18888 | 0.0057803 | 2.950789 | 1.6225019 | 0.1469609 | 0.2807018 | 0.2201241 | TGFBR2/ZEB1 | 2 |
| GO:0003151 | GO:0003151 | outflow tract morphogenesis | 1/37 | 81/18888 | 0.0123457 | 6.302302 | 2.1186655 | 0.1471447 | 0.2807018 | 0.2201241 | TGFBR2 | 1 |
| GO:0050810 | GO:0050810 | regulation of steroid biosynthetic process | 1/37 | 81/18888 | 0.0123457 | 6.302302 | 2.1186655 | 0.1471447 | 0.2807018 | 0.2201241 | ADM | 1 |
| GO:0032496 | GO:0032496 | response to lipopolysaccharide | 2/37 | 348/18888 | 0.0057471 | 2.933830 | 1.6131260 | 0.1483160 | 0.2807411 | 0.2201549 | ADM/PPBP | 2 |
| GO:0032147 | GO:0032147 | activation of protein kinase activity | 1/37 | 82/18888 | 0.0121951 | 6.225445 | 2.1008601 | 0.1488226 | 0.2807411 | 0.2201549 | TGFBR2 | 1 |
| GO:0061844 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 1/37 | 82/18888 | 0.0121951 | 6.225445 | 2.1008601 | 0.1488226 | 0.2807411 | 0.2201549 | PPBP | 1 |
| GO:0070897 | GO:0070897 | transcription preinitiation complex assembly | 1/37 | 82/18888 | 0.0121951 | 6.225445 | 2.1008601 | 0.1488226 | 0.2807411 | 0.2201549 | TAF13 | 1 |
| GO:2000142 | GO:2000142 | regulation of DNA-templated transcription initiation | 1/37 | 82/18888 | 0.0121951 | 6.225445 | 2.1008601 | 0.1488226 | 0.2807411 | 0.2201549 | TAF13 | 1 |
| GO:0060337 | GO:0060337 | type I interferon-mediated signaling pathway | 1/37 | 83/18888 | 0.0120482 | 6.150440 | 2.0833481 | 0.1504973 | 0.2826412 | 0.2216449 | IFNW1 | 1 |
| GO:0072332 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1/37 | 83/18888 | 0.0120482 | 6.150440 | 2.0833481 | 0.1504973 | 0.2826412 | 0.2216449 | ING2 | 1 |
| GO:0070661 | GO:0070661 | leukocyte proliferation | 2/37 | 352/18888 | 0.0056818 | 2.900491 | 1.5945729 | 0.1510343 | 0.2830223 | 0.2219438 | TGFBR2/IFNW1 | 2 |
| GO:0009895 | GO:0009895 | negative regulation of catabolic process | 2/37 | 353/18888 | 0.0056657 | 2.892275 | 1.5899754 | 0.1517155 | 0.2832679 | 0.2221364 | RBM24/TOB1 | 2 |
| GO:0046209 | GO:0046209 | nitric oxide metabolic process | 1/37 | 84/18888 | 0.0119048 | 6.077220 | 2.0661206 | 0.1521687 | 0.2832679 | 0.2221364 | PTX3 | 1 |
| GO:0071357 | GO:0071357 | cellular response to type I interferon | 1/37 | 84/18888 | 0.0119048 | 6.077220 | 2.0661206 | 0.1521687 | 0.2832679 | 0.2221364 | IFNW1 | 1 |
| GO:1990778 | GO:1990778 | protein localization to cell periphery | 2/37 | 356/18888 | 0.0056180 | 2.867902 | 1.5762787 | 0.1537630 | 0.2838778 | 0.2226147 | ADAM10/RILPL2 | 2 |
| GO:0008589 | GO:0008589 | regulation of smoothened signaling pathway | 1/37 | 85/18888 | 0.0117647 | 6.005723 | 2.0491695 | 0.1538370 | 0.2838778 | 0.2226147 | PRRX1 | 1 |
| GO:0051149 | GO:0051149 | positive regulation of muscle cell differentiation | 1/37 | 85/18888 | 0.0117647 | 6.005723 | 2.0491695 | 0.1538370 | 0.2838778 | 0.2226147 | RBM24 | 1 |
| GO:2001057 | GO:2001057 | reactive nitrogen species metabolic process | 1/37 | 85/18888 | 0.0117647 | 6.005723 | 2.0491695 | 0.1538370 | 0.2838778 | 0.2226147 | PTX3 | 1 |
| GO:0035050 | GO:0035050 | embryonic heart tube development | 1/37 | 86/18888 | 0.0116279 | 5.935889 | 2.0324870 | 0.1555020 | 0.2850870 | 0.2235629 | TGFBR2 | 1 |
| GO:0051851 | GO:0051851 | modulation by host of symbiont process | 1/37 | 86/18888 | 0.0116279 | 5.935889 | 2.0324870 | 0.1555020 | 0.2850870 | 0.2235629 | PTX3 | 1 |
| GO:0071230 | GO:0071230 | cellular response to amino acid stimulus | 1/37 | 86/18888 | 0.0116279 | 5.935889 | 2.0324870 | 0.1555020 | 0.2850870 | 0.2235629 | ZEB1 | 1 |
| GO:0009791 | GO:0009791 | post-embryonic development | 1/37 | 87/18888 | 0.0114943 | 5.867661 | 2.0160654 | 0.1571639 | 0.2862749 | 0.2244944 | AGO2 | 1 |
| GO:0033077 | GO:0033077 | T cell differentiation in thymus | 1/37 | 87/18888 | 0.0114943 | 5.867661 | 2.0160654 | 0.1571639 | 0.2862749 | 0.2244944 | ZEB1 | 1 |
| GO:0098586 | GO:0098586 | cellular response to virus | 1/37 | 87/18888 | 0.0114943 | 5.867661 | 2.0160654 | 0.1571639 | 0.2862749 | 0.2244944 | IFNW1 | 1 |
| GO:0001892 | GO:0001892 | embryonic placenta development | 1/37 | 88/18888 | 0.0113636 | 5.800983 | 1.9998974 | 0.1588226 | 0.2874417 | 0.2254095 | ADM | 1 |
| GO:0046889 | GO:0046889 | positive regulation of lipid biosynthetic process | 1/37 | 88/18888 | 0.0113636 | 5.800983 | 1.9998974 | 0.1588226 | 0.2874417 | 0.2254095 | ADM | 1 |
| GO:0099072 | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 1/37 | 88/18888 | 0.0113636 | 5.800983 | 1.9998974 | 0.1588226 | 0.2874417 | 0.2254095 | ADAM10 | 1 |
| GO:0001843 | GO:0001843 | neural tube closure | 1/37 | 89/18888 | 0.0112360 | 5.735803 | 1.9839761 | 0.1604781 | 0.2885880 | 0.2263083 | ADM | 1 |
| GO:0042310 | GO:0042310 | vasoconstriction | 1/37 | 89/18888 | 0.0112360 | 5.735803 | 1.9839761 | 0.1604781 | 0.2885880 | 0.2263083 | ADM | 1 |
| GO:2000243 | GO:2000243 | positive regulation of reproductive process | 1/37 | 89/18888 | 0.0112360 | 5.735803 | 1.9839761 | 0.1604781 | 0.2885880 | 0.2263083 | AGO2 | 1 |
| GO:0002088 | GO:0002088 | lens development in camera-type eye | 1/37 | 90/18888 | 0.0111111 | 5.672072 | 1.9682947 | 0.1621304 | 0.2897141 | 0.2271914 | TGFBR2 | 1 |
| GO:0034340 | GO:0034340 | response to type I interferon | 1/37 | 90/18888 | 0.0111111 | 5.672072 | 1.9682947 | 0.1621304 | 0.2897141 | 0.2271914 | IFNW1 | 1 |
| GO:0060606 | GO:0060606 | tube closure | 1/37 | 90/18888 | 0.0111111 | 5.672072 | 1.9682947 | 0.1621304 | 0.2897141 | 0.2271914 | ADM | 1 |
| GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 2/37 | 369/18888 | 0.0054201 | 2.766864 | 1.5185280 | 0.1626993 | 0.2901185 | 0.2275086 | ADM/PPBP | 2 |
| GO:0007281 | GO:0007281 | germ cell development | 2/37 | 371/18888 | 0.0053908 | 2.751949 | 1.5098652 | 0.1640829 | 0.2919710 | 0.2289613 | ING2/PTX3 | 2 |
| GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | ADAM10 | 1 |
| GO:0033138 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | IFNW1 | 1 |
| GO:0042475 | GO:0042475 | odontogenesis of dentin-containing tooth | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | ADM | 1 |
| GO:0045132 | GO:0045132 | meiotic chromosome segregation | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | PTTG1 | 1 |
| GO:0048525 | GO:0048525 | negative regulation of viral process | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | PTX3 | 1 |
| GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 1/37 | 93/18888 | 0.0107527 | 5.489102 | 1.9226266 | 0.1670685 | 0.2935830 | 0.2302254 | PPBP | 1 |
| GO:0045666 | GO:0045666 | positive regulation of neuron differentiation | 1/37 | 94/18888 | 0.0106383 | 5.430707 | 1.9078426 | 0.1687082 | 0.2946306 | 0.2310469 | ZEB1 | 1 |
| GO:0050848 | GO:0050848 | regulation of calcium-mediated signaling | 1/37 | 94/18888 | 0.0106383 | 5.430707 | 1.9078426 | 0.1687082 | 0.2946306 | 0.2310469 | CAMTA1 | 1 |
| GO:0051781 | GO:0051781 | positive regulation of cell division | 1/37 | 94/18888 | 0.0106383 | 5.430707 | 1.9078426 | 0.1687082 | 0.2946306 | 0.2310469 | PPBP | 1 |
| GO:0014020 | GO:0014020 | primary neural tube formation | 1/37 | 95/18888 | 0.0105263 | 5.373542 | 1.8932685 | 0.1703448 | 0.2962670 | 0.2323302 | ADM | 1 |
| GO:0071229 | GO:0071229 | cellular response to acid chemical | 1/37 | 95/18888 | 0.0105263 | 5.373542 | 1.8932685 | 0.1703448 | 0.2962670 | 0.2323302 | ZEB1 | 1 |
| GO:0030336 | GO:0030336 | negative regulation of cell migration | 2/37 | 381/18888 | 0.0052493 | 2.679719 | 1.4673925 | 0.1710337 | 0.2966712 | 0.2326471 | MAGI2/ING2 | 2 |
| GO:0050863 | GO:0050863 | regulation of T cell activation | 2/37 | 382/18888 | 0.0052356 | 2.672704 | 1.4632202 | 0.1717316 | 0.2966712 | 0.2326471 | TGFBR2/ZEB1 | 2 |
| GO:0000245 | GO:0000245 | spliceosomal complex assembly | 1/37 | 96/18888 | 0.0104167 | 5.317568 | 1.8788989 | 0.1719782 | 0.2966712 | 0.2326471 | SRSF5 | 1 |
| GO:0003073 | GO:0003073 | regulation of systemic arterial blood pressure | 1/37 | 96/18888 | 0.0104167 | 5.317568 | 1.8788989 | 0.1719782 | 0.2966712 | 0.2326471 | ADM | 1 |
| GO:0051153 | GO:0051153 | regulation of striated muscle cell differentiation | 1/37 | 97/18888 | 0.0103093 | 5.262747 | 1.8647287 | 0.1736085 | 0.2988748 | 0.2343752 | RBM24 | 1 |
| GO:0009100 | GO:0009100 | glycoprotein metabolic process | 2/37 | 386/18888 | 0.0051813 | 2.645008 | 1.4466631 | 0.1745286 | 0.2998493 | 0.2351394 | PTX3/AGO2 | 2 |
| GO:0030101 | GO:0030101 | natural killer cell activation | 1/37 | 98/18888 | 0.0102041 | 5.209046 | 1.8507530 | 0.1752357 | 0.3004547 | 0.2356142 | IFNW1 | 1 |
| GO:0035278 | GO:0035278 | miRNA-mediated gene silencing by inhibition of translation | 1/37 | 99/18888 | 0.0101010 | 5.156429 | 1.8369668 | 0.1768598 | 0.3020166 | 0.2368390 | AGO2 | 1 |
| GO:0060349 | GO:0060349 | bone morphogenesis | 1/37 | 99/18888 | 0.0101010 | 5.156429 | 1.8369668 | 0.1768598 | 0.3020166 | 0.2368390 | TGFBR2 | 1 |
| GO:0008593 | GO:0008593 | regulation of Notch signaling pathway | 1/37 | 100/18888 | 0.0100000 | 5.104865 | 1.8233655 | 0.1784807 | 0.3023464 | 0.2370976 | ADAM10 | 1 |
| GO:0019935 | GO:0019935 | cyclic-nucleotide-mediated signaling | 1/37 | 100/18888 | 0.0100000 | 5.104865 | 1.8233655 | 0.1784807 | 0.3023464 | 0.2370976 | ADM | 1 |
| GO:0035279 | GO:0035279 | miRNA-mediated gene silencing by mRNA destabilization | 1/37 | 100/18888 | 0.0100000 | 5.104865 | 1.8233655 | 0.1784807 | 0.3023464 | 0.2370976 | AGO2 | 1 |
| GO:0050764 | GO:0050764 | regulation of phagocytosis | 1/37 | 100/18888 | 0.0100000 | 5.104865 | 1.8233655 | 0.1784807 | 0.3023464 | 0.2370976 | PTX3 | 1 |
| GO:0001654 | GO:0001654 | eye development | 2/37 | 393/18888 | 0.0050891 | 2.597896 | 1.4181843 | 0.1794419 | 0.3023796 | 0.2371236 | TGFBR2/ZEB1 | 2 |
| GO:0006754 | GO:0006754 | ATP biosynthetic process | 1/37 | 101/18888 | 0.0099010 | 5.054322 | 1.8099448 | 0.1800986 | 0.3023796 | 0.2371236 | ATP5MC2 | 1 |
| GO:1990868 | GO:1990868 | response to chemokine | 1/37 | 101/18888 | 0.0099010 | 5.054322 | 1.8099448 | 0.1800986 | 0.3023796 | 0.2371236 | PPBP | 1 |
| GO:1990869 | GO:1990869 | cellular response to chemokine | 1/37 | 101/18888 | 0.0099010 | 5.054322 | 1.8099448 | 0.1800986 | 0.3023796 | 0.2371236 | PPBP | 1 |
| GO:0050900 | GO:0050900 | leukocyte migration | 2/37 | 396/18888 | 0.0050505 | 2.578215 | 1.4061669 | 0.1815546 | 0.3023796 | 0.2371236 | ADAM10/PPBP | 2 |
| GO:2000146 | GO:2000146 | negative regulation of cell motility | 2/37 | 396/18888 | 0.0050505 | 2.578215 | 1.4061669 | 0.1815546 | 0.3023796 | 0.2371236 | MAGI2/ING2 | 2 |
| GO:0001841 | GO:0001841 | neural tube formation | 1/37 | 102/18888 | 0.0098039 | 5.004770 | 1.7967002 | 0.1817133 | 0.3023796 | 0.2371236 | ADM | 1 |
| GO:0008585 | GO:0008585 | female gonad development | 1/37 | 102/18888 | 0.0098039 | 5.004770 | 1.7967002 | 0.1817133 | 0.3023796 | 0.2371236 | PTX3 | 1 |
| GO:0008630 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1/37 | 102/18888 | 0.0098039 | 5.004770 | 1.7967002 | 0.1817133 | 0.3023796 | 0.2371236 | ING2 | 1 |
| GO:0150063 | GO:0150063 | visual system development | 2/37 | 397/18888 | 0.0050378 | 2.571720 | 1.4021855 | 0.1822598 | 0.3026941 | 0.2373703 | TGFBR2/ZEB1 | 2 |
| GO:0042274 | GO:0042274 | ribosomal small subunit biogenesis | 1/37 | 103/18888 | 0.0097087 | 4.956180 | 1.7836275 | 0.1833250 | 0.3029763 | 0.2375915 | RRP9 | 1 |
| GO:0099175 | GO:0099175 | regulation of postsynapse organization | 1/37 | 103/18888 | 0.0097087 | 4.956180 | 1.7836275 | 0.1833250 | 0.3029763 | 0.2375915 | ADAM10 | 1 |
| GO:0002027 | GO:0002027 | regulation of heart rate | 1/37 | 104/18888 | 0.0096154 | 4.908524 | 1.7707227 | 0.1849336 | 0.3029763 | 0.2375915 | ADM | 1 |
| GO:0019218 | GO:0019218 | regulation of steroid metabolic process | 1/37 | 104/18888 | 0.0096154 | 4.908524 | 1.7707227 | 0.1849336 | 0.3029763 | 0.2375915 | ADM | 1 |
| GO:0042100 | GO:0042100 | B cell proliferation | 1/37 | 104/18888 | 0.0096154 | 4.908524 | 1.7707227 | 0.1849336 | 0.3029763 | 0.2375915 | IFNW1 | 1 |
| GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 1/37 | 104/18888 | 0.0096154 | 4.908524 | 1.7707227 | 0.1849336 | 0.3029763 | 0.2375915 | TGFBR2 | 1 |
| GO:1990830 | GO:1990830 | cellular response to leukemia inhibitory factor | 1/37 | 104/18888 | 0.0096154 | 4.908524 | 1.7707227 | 0.1849336 | 0.3029763 | 0.2375915 | SRSF7 | 1 |
| GO:0048880 | GO:0048880 | sensory system development | 2/37 | 403/18888 | 0.0049628 | 2.533432 | 1.3785496 | 0.1864997 | 0.3049522 | 0.2391411 | TGFBR2/ZEB1 | 2 |
| GO:0046425 | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 1/37 | 106/18888 | 0.0094340 | 4.815910 | 1.7454014 | 0.1881415 | 0.3058653 | 0.2398571 | IFNW1 | 1 |
| GO:0046545 | GO:0046545 | development of primary female sexual characteristics | 1/37 | 106/18888 | 0.0094340 | 4.815910 | 1.7454014 | 0.1881415 | 0.3058653 | 0.2398571 | PTX3 | 1 |
| GO:1990823 | GO:1990823 | response to leukemia inhibitory factor | 1/37 | 106/18888 | 0.0094340 | 4.815910 | 1.7454014 | 0.1881415 | 0.3058653 | 0.2398571 | SRSF7 | 1 |
| GO:0030593 | GO:0030593 | neutrophil chemotaxis | 1/37 | 107/18888 | 0.0093458 | 4.770902 | 1.7329774 | 0.1897408 | 0.3075190 | 0.2411539 | PPBP | 1 |
| GO:0003279 | GO:0003279 | cardiac septum development | 1/37 | 108/18888 | 0.0092593 | 4.726727 | 1.7207065 | 0.1913371 | 0.3075190 | 0.2411539 | TGFBR2 | 1 |
| GO:0010586 | GO:0010586 | miRNA metabolic process | 1/37 | 108/18888 | 0.0092593 | 4.726727 | 1.7207065 | 0.1913371 | 0.3075190 | 0.2411539 | AGO2 | 1 |
| GO:0140888 | GO:0140888 | interferon-mediated signaling pathway | 1/37 | 108/18888 | 0.0092593 | 4.726727 | 1.7207065 | 0.1913371 | 0.3075190 | 0.2411539 | IFNW1 | 1 |
| GO:1901796 | GO:1901796 | regulation of signal transduction by p53 class mediator | 1/37 | 108/18888 | 0.0092593 | 4.726727 | 1.7207065 | 0.1913371 | 0.3075190 | 0.2411539 | ING2 | 1 |
| GO:1902414 | GO:1902414 | protein localization to cell junction | 1/37 | 108/18888 | 0.0092593 | 4.726727 | 1.7207065 | 0.1913371 | 0.3075190 | 0.2411539 | ADAM10 | 1 |
| GO:0140694 | GO:0140694 | non-membrane-bounded organelle assembly | 2/37 | 413/18888 | 0.0048426 | 2.472090 | 1.3400845 | 0.1935992 | 0.3105654 | 0.2435429 | RPL38/NOA1 | 2 |
| GO:0048477 | GO:0048477 | oogenesis | 1/37 | 110/18888 | 0.0090909 | 4.640786 | 1.6966100 | 0.1945204 | 0.3114533 | 0.2442392 | PTX3 | 1 |
| GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 1/37 | 111/18888 | 0.0090090 | 4.598977 | 1.6847779 | 0.1961076 | 0.3122239 | 0.2448434 | ADAM10 | 1 |
| GO:0045445 | GO:0045445 | myoblast differentiation | 1/37 | 111/18888 | 0.0090090 | 4.598977 | 1.6847779 | 0.1961076 | 0.3122239 | 0.2448434 | RBM24 | 1 |
| GO:0090398 | GO:0090398 | cellular senescence | 1/37 | 111/18888 | 0.0090090 | 4.598977 | 1.6847779 | 0.1961076 | 0.3122239 | 0.2448434 | ING2 | 1 |
| GO:0001558 | GO:0001558 | regulation of cell growth | 2/37 | 418/18888 | 0.0047847 | 2.442519 | 1.3212695 | 0.1971633 | 0.3133159 | 0.2456998 | ADAM10/BRAT1 | 2 |
| GO:0009206 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1/37 | 112/18888 | 0.0089286 | 4.557915 | 1.6730858 | 0.1976916 | 0.3135670 | 0.2458967 | ATP5MC2 | 1 |
| GO:0009145 | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1/37 | 113/18888 | 0.0088496 | 4.517580 | 1.6615305 | 0.1992726 | 0.3154840 | 0.2474000 | ATP5MC2 | 1 |
| GO:2001243 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 1/37 | 114/18888 | 0.0087719 | 4.477952 | 1.6501093 | 0.2008506 | 0.3173890 | 0.2488939 | ING2 | 1 |
| GO:1903706 | GO:1903706 | regulation of hemopoiesis | 2/37 | 424/18888 | 0.0047170 | 2.407955 | 1.2990444 | 0.2014520 | 0.3177464 | 0.2491742 | TGFBR2/ZEB1 | 2 |
| GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 1/37 | 115/18888 | 0.0086957 | 4.439013 | 1.6388192 | 0.2024256 | 0.3180974 | 0.2494494 | TGFBR2 | 1 |
| GO:0048259 | GO:0048259 | regulation of receptor-mediated endocytosis | 1/37 | 115/18888 | 0.0086957 | 4.439013 | 1.6388192 | 0.2024256 | 0.3180974 | 0.2494494 | MAGI2 | 1 |
| GO:0002062 | GO:0002062 | chondrocyte differentiation | 1/37 | 116/18888 | 0.0086207 | 4.400746 | 1.6276575 | 0.2039976 | 0.3193825 | 0.2504572 | TGFBR2 | 1 |
| GO:0006368 | GO:0006368 | transcription elongation by RNA polymerase II | 1/37 | 116/18888 | 0.0086207 | 4.400746 | 1.6276575 | 0.2039976 | 0.3193825 | 0.2504572 | GTF2F2 | 1 |
| GO:0040013 | GO:0040013 | negative regulation of locomotion | 2/37 | 431/18888 | 0.0046404 | 2.368847 | 1.2735854 | 0.2064704 | 0.3225022 | 0.2529036 | MAGI2/ING2 | 2 |
| GO:0009201 | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1/37 | 118/18888 | 0.0084746 | 4.326157 | 1.6057086 | 0.2071324 | 0.3225022 | 0.2529036 | ATP5MC2 | 1 |
| GO:1904659 | GO:1904659 | glucose transmembrane transport | 1/37 | 118/18888 | 0.0084746 | 4.326157 | 1.6057086 | 0.2071324 | 0.3225022 | 0.2529036 | PPBP | 1 |
| GO:0034470 | GO:0034470 | ncRNA processing | 2/37 | 433/18888 | 0.0046189 | 2.357905 | 1.2664019 | 0.2079071 | 0.3231143 | 0.2533836 | RRP9/AGO2 | 2 |
| GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 1/37 | 119/18888 | 0.0084034 | 4.289802 | 1.5949163 | 0.2086954 | 0.3231535 | 0.2534144 | TGFBR2 | 1 |
| GO:0051702 | GO:0051702 | biological process involved in interaction with symbiont | 1/37 | 119/18888 | 0.0084034 | 4.289802 | 1.5949163 | 0.2086954 | 0.3231535 | 0.2534144 | PTX3 | 1 |
| GO:0010717 | GO:0010717 | regulation of epithelial to mesenchymal transition | 1/37 | 120/18888 | 0.0083333 | 4.254054 | 1.5842421 | 0.2102553 | 0.3239054 | 0.2540040 | TGFBR2 | 1 |
| GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 1/37 | 120/18888 | 0.0083333 | 4.254054 | 1.5842421 | 0.2102553 | 0.3239054 | 0.2540040 | TGFBR2 | 1 |
| GO:0008645 | GO:0008645 | hexose transmembrane transport | 1/37 | 121/18888 | 0.0082645 | 4.218897 | 1.5736837 | 0.2118122 | 0.3239054 | 0.2540040 | PPBP | 1 |
| GO:0030510 | GO:0030510 | regulation of BMP signaling pathway | 1/37 | 121/18888 | 0.0082645 | 4.218897 | 1.5736837 | 0.2118122 | 0.3239054 | 0.2540040 | TOB1 | 1 |
| GO:0046660 | GO:0046660 | female sex differentiation | 1/37 | 121/18888 | 0.0082645 | 4.218897 | 1.5736837 | 0.2118122 | 0.3239054 | 0.2540040 | PTX3 | 1 |
| GO:0072009 | GO:0072009 | nephron epithelium development | 1/37 | 121/18888 | 0.0082645 | 4.218897 | 1.5736837 | 0.2118122 | 0.3239054 | 0.2540040 | MAGI2 | 1 |
| GO:0030326 | GO:0030326 | embryonic limb morphogenesis | 1/37 | 122/18888 | 0.0081967 | 4.184316 | 1.5632387 | 0.2133662 | 0.3239054 | 0.2540040 | PRRX1 | 1 |
| GO:0035113 | GO:0035113 | embryonic appendage morphogenesis | 1/37 | 122/18888 | 0.0081967 | 4.184316 | 1.5632387 | 0.2133662 | 0.3239054 | 0.2540040 | PRRX1 | 1 |
| GO:1904892 | GO:1904892 | regulation of receptor signaling pathway via STAT | 1/37 | 122/18888 | 0.0081967 | 4.184316 | 1.5632387 | 0.2133662 | 0.3239054 | 0.2540040 | IFNW1 | 1 |
| GO:0001838 | GO:0001838 | embryonic epithelial tube formation | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | ADM | 1 |
| GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | ADAM10 | 1 |
| GO:0015749 | GO:0015749 | monosaccharide transmembrane transport | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | PPBP | 1 |
| GO:0045446 | GO:0045446 | endothelial cell differentiation | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | ZEB1 | 1 |
| GO:0045834 | GO:0045834 | positive regulation of lipid metabolic process | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | ADM | 1 |
| GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 1/37 | 123/18888 | 0.0081301 | 4.150297 | 1.5529050 | 0.2149171 | 0.3239054 | 0.2540040 | ADAM10 | 1 |
| GO:0002286 | GO:0002286 | T cell activation involved in immune response | 1/37 | 124/18888 | 0.0080645 | 4.116827 | 1.5426802 | 0.2164651 | 0.3245248 | 0.2544897 | IFNW1 | 1 |
| GO:0043200 | GO:0043200 | response to amino acid | 1/37 | 124/18888 | 0.0080645 | 4.116827 | 1.5426802 | 0.2164651 | 0.3245248 | 0.2544897 | ZEB1 | 1 |
| GO:0000280 | GO:0000280 | nuclear division | 2/37 | 446/18888 | 0.0044843 | 2.289177 | 1.2206500 | 0.2172730 | 0.3245248 | 0.2544897 | PTTG1/ING2 | 2 |
| GO:0001503 | GO:0001503 | ossification | 2/37 | 446/18888 | 0.0044843 | 2.289177 | 1.2206500 | 0.2172730 | 0.3245248 | 0.2544897 | RPL38/TOB1 | 2 |
| GO:0022612 | GO:0022612 | gland morphogenesis | 1/37 | 125/18888 | 0.0080000 | 4.083892 | 1.5325624 | 0.2180102 | 0.3245248 | 0.2544897 | TGFBR2 | 1 |
| GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 1/37 | 125/18888 | 0.0080000 | 4.083892 | 1.5325624 | 0.2180102 | 0.3245248 | 0.2544897 | TGFBR2 | 1 |
| GO:0072676 | GO:0072676 | lymphocyte migration | 1/37 | 125/18888 | 0.0080000 | 4.083892 | 1.5325624 | 0.2180102 | 0.3245248 | 0.2544897 | ADAM10 | 1 |
| GO:0009142 | GO:0009142 | nucleoside triphosphate biosynthetic process | 1/37 | 126/18888 | 0.0079365 | 4.051480 | 1.5225494 | 0.2195522 | 0.3245388 | 0.2545007 | ATP5MC2 | 1 |
| GO:0033135 | GO:0033135 | regulation of peptidyl-serine phosphorylation | 1/37 | 126/18888 | 0.0079365 | 4.051480 | 1.5225494 | 0.2195522 | 0.3245388 | 0.2545007 | IFNW1 | 1 |
| GO:0098659 | GO:0098659 | inorganic cation import across plasma membrane | 1/37 | 126/18888 | 0.0079365 | 4.051480 | 1.5225494 | 0.2195522 | 0.3245388 | 0.2545007 | KCNJ13 | 1 |
| GO:0099587 | GO:0099587 | inorganic ion import across plasma membrane | 1/37 | 126/18888 | 0.0079365 | 4.051480 | 1.5225494 | 0.2195522 | 0.3245388 | 0.2545007 | KCNJ13 | 1 |
| GO:0003014 | GO:0003014 | renal system process | 1/37 | 127/18888 | 0.0078740 | 4.019579 | 1.5126393 | 0.2210913 | 0.3245482 | 0.2545081 | ADM | 1 |
| GO:0003206 | GO:0003206 | cardiac chamber morphogenesis | 1/37 | 127/18888 | 0.0078740 | 4.019579 | 1.5126393 | 0.2210913 | 0.3245482 | 0.2545081 | TGFBR2 | 1 |
| GO:0003231 | GO:0003231 | cardiac ventricle development | 1/37 | 127/18888 | 0.0078740 | 4.019579 | 1.5126393 | 0.2210913 | 0.3245482 | 0.2545081 | TGFBR2 | 1 |
| GO:0030512 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1/37 | 127/18888 | 0.0078740 | 4.019579 | 1.5126393 | 0.2210913 | 0.3245482 | 0.2545081 | ING2 | 1 |
| GO:0071621 | GO:0071621 | granulocyte chemotaxis | 1/37 | 128/18888 | 0.0078125 | 3.988176 | 1.5028300 | 0.2226275 | 0.3262378 | 0.2558330 | PPBP | 1 |
| GO:1990266 | GO:1990266 | neutrophil migration | 1/37 | 129/18888 | 0.0077519 | 3.957260 | 1.4931197 | 0.2241606 | 0.3279172 | 0.2571500 | PPBP | 1 |
| GO:0051028 | GO:0051028 | mRNA transport | 1/37 | 131/18888 | 0.0076336 | 3.896843 | 1.4739886 | 0.2272182 | 0.3315198 | 0.2599752 | SRSF7 | 1 |
| GO:0010975 | GO:0010975 | regulation of neuron projection development | 2/37 | 460/18888 | 0.0043478 | 2.219507 | 1.1731109 | 0.2274062 | 0.3315198 | 0.2599752 | PRRX1/MAGI2 | 2 |
| GO:0019730 | GO:0019730 | antimicrobial humoral response | 1/37 | 132/18888 | 0.0075758 | 3.867322 | 1.4645643 | 0.2287426 | 0.3326660 | 0.2608740 | PPBP | 1 |
| GO:0014902 | GO:0014902 | myotube differentiation | 1/37 | 133/18888 | 0.0075188 | 3.838244 | 1.4552319 | 0.2302641 | 0.3326660 | 0.2608740 | RBM24 | 1 |
| GO:0042476 | GO:0042476 | odontogenesis | 1/37 | 133/18888 | 0.0075188 | 3.838244 | 1.4552319 | 0.2302641 | 0.3326660 | 0.2608740 | ADM | 1 |
| GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 1/37 | 133/18888 | 0.0075188 | 3.838244 | 1.4552319 | 0.2302641 | 0.3326660 | 0.2608740 | TGFBR2 | 1 |
| GO:0048593 | GO:0048593 | camera-type eye morphogenesis | 1/37 | 133/18888 | 0.0075188 | 3.838244 | 1.4552319 | 0.2302641 | 0.3326660 | 0.2608740 | ZEB1 | 1 |
| GO:0006935 | GO:0006935 | chemotaxis | 2/37 | 466/18888 | 0.0042918 | 2.190929 | 1.1532558 | 0.2317615 | 0.3326660 | 0.2608740 | ADAM10/PPBP | 2 |
| GO:0045727 | GO:0045727 | positive regulation of translation | 1/37 | 134/18888 | 0.0074627 | 3.809601 | 1.4459897 | 0.2317826 | 0.3326660 | 0.2608740 | AGO2 | 1 |
| GO:0051384 | GO:0051384 | response to glucocorticoid | 1/37 | 134/18888 | 0.0074627 | 3.809601 | 1.4459897 | 0.2317826 | 0.3326660 | 0.2608740 | ADM | 1 |
| GO:0042330 | GO:0042330 | taxis | 2/37 | 468/18888 | 0.0042735 | 2.181566 | 1.1467040 | 0.2332148 | 0.3326660 | 0.2608740 | ADAM10/PPBP | 2 |
| GO:0006354 | GO:0006354 | DNA-templated transcription elongation | 1/37 | 135/18888 | 0.0074074 | 3.781381 | 1.4368360 | 0.2332982 | 0.3326660 | 0.2608740 | GTF2F2 | 1 |
| GO:0030879 | GO:0030879 | mammary gland development | 1/37 | 135/18888 | 0.0074074 | 3.781381 | 1.4368360 | 0.2332982 | 0.3326660 | 0.2608740 | TGFBR2 | 1 |
| GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 1/37 | 135/18888 | 0.0074074 | 3.781381 | 1.4368360 | 0.2332982 | 0.3326660 | 0.2608740 | ING2 | 1 |
| GO:0072175 | GO:0072175 | epithelial tube formation | 1/37 | 135/18888 | 0.0074074 | 3.781381 | 1.4368360 | 0.2332982 | 0.3326660 | 0.2608740 | ADM | 1 |
| GO:0007368 | GO:0007368 | determination of left/right symmetry | 1/37 | 137/18888 | 0.0072993 | 3.726179 | 1.4187881 | 0.2363208 | 0.3347219 | 0.2624862 | TGFBR2 | 1 |
| GO:0034219 | GO:0034219 | carbohydrate transmembrane transport | 1/37 | 137/18888 | 0.0072993 | 3.726179 | 1.4187881 | 0.2363208 | 0.3347219 | 0.2624862 | PPBP | 1 |
| GO:0090288 | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1/37 | 137/18888 | 0.0072993 | 3.726179 | 1.4187881 | 0.2363208 | 0.3347219 | 0.2624862 | TOB1 | 1 |
| GO:1904375 | GO:1904375 | regulation of protein localization to cell periphery | 1/37 | 137/18888 | 0.0072993 | 3.726179 | 1.4187881 | 0.2363208 | 0.3347219 | 0.2624862 | ADAM10 | 1 |
| GO:0007389 | GO:0007389 | pattern specification process | 2/37 | 474/18888 | 0.0042194 | 2.153951 | 1.1272436 | 0.2375785 | 0.3357334 | 0.2632794 | TGFBR2/ZEB1 | 2 |
| GO:0010212 | GO:0010212 | response to ionizing radiation | 1/37 | 138/18888 | 0.0072464 | 3.699177 | 1.4098909 | 0.2378277 | 0.3357334 | 0.2632794 | BRAT1 | 1 |
| GO:0001101 | GO:0001101 | response to acid chemical | 1/37 | 139/18888 | 0.0071942 | 3.672565 | 1.4010761 | 0.2393317 | 0.3372944 | 0.2645036 | ZEB1 | 1 |
| GO:0007498 | GO:0007498 | mesoderm development | 1/37 | 140/18888 | 0.0071429 | 3.646332 | 1.3923424 | 0.2408328 | 0.3388462 | 0.2657204 | RPL38 | 1 |
| GO:0030317 | GO:0030317 | flagellated sperm motility | 1/37 | 141/18888 | 0.0070922 | 3.620471 | 1.3836883 | 0.2423311 | 0.3395182 | 0.2662474 | ING2 | 1 |
| GO:0097722 | GO:0097722 | sperm motility | 1/37 | 141/18888 | 0.0070922 | 3.620471 | 1.3836883 | 0.2423311 | 0.3395182 | 0.2662474 | ING2 | 1 |
| GO:0022412 | GO:0022412 | cellular process involved in reproduction in multicellular organism | 2/37 | 482/18888 | 0.0041494 | 2.118201 | 1.1017395 | 0.2434053 | 0.3395182 | 0.2662474 | ING2/PTX3 | 2 |
| GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 2/37 | 482/18888 | 0.0041494 | 2.118201 | 1.1017395 | 0.2434053 | 0.3395182 | 0.2662474 | MAGI2/RGS1 | 2 |
| GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 1/37 | 142/18888 | 0.0070423 | 3.594975 | 1.3751125 | 0.2438265 | 0.3395182 | 0.2662474 | ADAM10 | 1 |
| GO:0062013 | GO:0062013 | positive regulation of small molecule metabolic process | 1/37 | 142/18888 | 0.0070423 | 3.594975 | 1.3751125 | 0.2438265 | 0.3395182 | 0.2662474 | ADM | 1 |
| GO:0003158 | GO:0003158 | endothelium development | 1/37 | 143/18888 | 0.0069930 | 3.569836 | 1.3666138 | 0.2453190 | 0.3395182 | 0.2662474 | ZEB1 | 1 |
| GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 1/37 | 143/18888 | 0.0069930 | 3.569836 | 1.3666138 | 0.2453190 | 0.3395182 | 0.2662474 | TGFBR2 | 1 |
| GO:0060972 | GO:0060972 | left/right pattern formation | 1/37 | 143/18888 | 0.0069930 | 3.569836 | 1.3666138 | 0.2453190 | 0.3395182 | 0.2662474 | TGFBR2 | 1 |
| GO:1903900 | GO:1903900 | regulation of viral life cycle | 1/37 | 143/18888 | 0.0069930 | 3.569836 | 1.3666138 | 0.2453190 | 0.3395182 | 0.2662474 | PTX3 | 1 |
| GO:0010565 | GO:0010565 | regulation of cellular ketone metabolic process | 1/37 | 144/18888 | 0.0069444 | 3.545045 | 1.3581907 | 0.2468086 | 0.3410226 | 0.2674272 | ADM | 1 |
| GO:0031667 | GO:0031667 | response to nutrient levels | 2/37 | 490/18888 | 0.0040816 | 2.083618 | 1.0767236 | 0.2492402 | 0.3437563 | 0.2695709 | ZEB1/ADM | 2 |
| GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 1/37 | 146/18888 | 0.0068493 | 3.496483 | 1.3415665 | 0.2497793 | 0.3437563 | 0.2695709 | TGFBR2 | 1 |
| GO:0009799 | GO:0009799 | specification of symmetry | 1/37 | 147/18888 | 0.0068027 | 3.472697 | 1.3333629 | 0.2512603 | 0.3437563 | 0.2695709 | TGFBR2 | 1 |
| GO:0009855 | GO:0009855 | determination of bilateral symmetry | 1/37 | 147/18888 | 0.0068027 | 3.472697 | 1.3333629 | 0.2512603 | 0.3437563 | 0.2695709 | TGFBR2 | 1 |
| GO:1904019 | GO:1904019 | epithelial cell apoptotic process | 1/37 | 147/18888 | 0.0068027 | 3.472697 | 1.3333629 | 0.2512603 | 0.3437563 | 0.2695709 | TGFBR2 | 1 |
| GO:0048285 | GO:0048285 | organelle fission | 2/37 | 493/18888 | 0.0040568 | 2.070939 | 1.0674646 | 0.2514301 | 0.3437563 | 0.2695709 | PTTG1/ING2 | 2 |
| GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 1/37 | 149/18888 | 0.0067114 | 3.426084 | 1.3171671 | 0.2542140 | 0.3437563 | 0.2695709 | ADAM10 | 1 |
| GO:0008277 | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 1/37 | 149/18888 | 0.0067114 | 3.426084 | 1.3171671 | 0.2542140 | 0.3437563 | 0.2695709 | ADM | 1 |
| GO:0008584 | GO:0008584 | male gonad development | 1/37 | 149/18888 | 0.0067114 | 3.426084 | 1.3171671 | 0.2542140 | 0.3437563 | 0.2695709 | ING2 | 1 |
| GO:0035148 | GO:0035148 | tube formation | 1/37 | 149/18888 | 0.0067114 | 3.426084 | 1.3171671 | 0.2542140 | 0.3437563 | 0.2695709 | ADM | 1 |
| GO:2000377 | GO:2000377 | regulation of reactive oxygen species metabolic process | 1/37 | 149/18888 | 0.0067114 | 3.426084 | 1.3171671 | 0.2542140 | 0.3437563 | 0.2695709 | TGFBR2 | 1 |
| GO:0001667 | GO:0001667 | ameboidal-type cell migration | 2/37 | 498/18888 | 0.0040161 | 2.050146 | 1.0521771 | 0.2550816 | 0.3437563 | 0.2695709 | TGFBR2/AGO2 | 2 |
| GO:0001890 | GO:0001890 | placenta development | 1/37 | 150/18888 | 0.0066667 | 3.403243 | 1.3091726 | 0.2556865 | 0.3437563 | 0.2695709 | ADM | 1 |
| GO:0016331 | GO:0016331 | morphogenesis of embryonic epithelium | 1/37 | 150/18888 | 0.0066667 | 3.403243 | 1.3091726 | 0.2556865 | 0.3437563 | 0.2695709 | ADM | 1 |
| GO:0035107 | GO:0035107 | appendage morphogenesis | 1/37 | 150/18888 | 0.0066667 | 3.403243 | 1.3091726 | 0.2556865 | 0.3437563 | 0.2695709 | PRRX1 | 1 |
| GO:0035108 | GO:0035108 | limb morphogenesis | 1/37 | 150/18888 | 0.0066667 | 3.403243 | 1.3091726 | 0.2556865 | 0.3437563 | 0.2695709 | PRRX1 | 1 |
| GO:0046546 | GO:0046546 | development of primary male sexual characteristics | 1/37 | 150/18888 | 0.0066667 | 3.403243 | 1.3091726 | 0.2556865 | 0.3437563 | 0.2695709 | ING2 | 1 |
| GO:0035296 | GO:0035296 | regulation of tube diameter | 1/37 | 152/18888 | 0.0065789 | 3.358464 | 1.2933847 | 0.2586231 | 0.3460565 | 0.2713747 | ADM | 1 |
| GO:0072073 | GO:0072073 | kidney epithelium development | 1/37 | 152/18888 | 0.0065789 | 3.358464 | 1.2933847 | 0.2586231 | 0.3460565 | 0.2713747 | MAGI2 | 1 |
| GO:0097746 | GO:0097746 | blood vessel diameter maintenance | 1/37 | 152/18888 | 0.0065789 | 3.358464 | 1.2933847 | 0.2586231 | 0.3460565 | 0.2713747 | ADM | 1 |
| GO:0035150 | GO:0035150 | regulation of tube size | 1/37 | 153/18888 | 0.0065359 | 3.336513 | 1.2855892 | 0.2600872 | 0.3474666 | 0.2724805 | ADM | 1 |
| GO:0097530 | GO:0097530 | granulocyte migration | 1/37 | 154/18888 | 0.0064935 | 3.314847 | 1.2778580 | 0.2615485 | 0.3488686 | 0.2735799 | PPBP | 1 |
| GO:0008037 | GO:0008037 | cell recognition | 1/37 | 155/18888 | 0.0064516 | 3.293461 | 1.2701901 | 0.2630069 | 0.3497125 | 0.2742417 | PTX3 | 1 |
| GO:0030183 | GO:0030183 | B cell differentiation | 1/37 | 155/18888 | 0.0064516 | 3.293461 | 1.2701901 | 0.2630069 | 0.3497125 | 0.2742417 | IFNW1 | 1 |
| GO:0031960 | GO:0031960 | response to corticosteroid | 1/37 | 156/18888 | 0.0064103 | 3.272349 | 1.2625845 | 0.2644626 | 0.3499997 | 0.2744669 | ADM | 1 |
| GO:0045667 | GO:0045667 | regulation of osteoblast differentiation | 1/37 | 156/18888 | 0.0064103 | 3.272349 | 1.2625845 | 0.2644626 | 0.3499997 | 0.2744669 | TOB1 | 1 |
| GO:0046718 | GO:0046718 | symbiont entry into host cell | 1/37 | 156/18888 | 0.0064103 | 3.272349 | 1.2625845 | 0.2644626 | 0.3499997 | 0.2744669 | PTX3 | 1 |
| GO:0048754 | GO:0048754 | branching morphogenesis of an epithelial tube | 1/37 | 157/18888 | 0.0063694 | 3.251506 | 1.2550403 | 0.2659154 | 0.3513734 | 0.2755442 | TGFBR2 | 1 |
| GO:0007189 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1/37 | 158/18888 | 0.0063291 | 3.230927 | 1.2475564 | 0.2673655 | 0.3516437 | 0.2757562 | ADM | 1 |
| GO:0021915 | GO:0021915 | neural tube development | 1/37 | 158/18888 | 0.0063291 | 3.230927 | 1.2475564 | 0.2673655 | 0.3516437 | 0.2757562 | ADM | 1 |
| GO:0072006 | GO:0072006 | nephron development | 1/37 | 158/18888 | 0.0063291 | 3.230927 | 1.2475564 | 0.2673655 | 0.3516437 | 0.2757562 | MAGI2 | 1 |
| GO:0008643 | GO:0008643 | carbohydrate transport | 1/37 | 159/18888 | 0.0062893 | 3.210607 | 1.2401320 | 0.2688128 | 0.3529991 | 0.2768190 | PPBP | 1 |
| GO:0007605 | GO:0007605 | sensory perception of sound | 1/37 | 161/18888 | 0.0062112 | 3.170723 | 1.2254582 | 0.2716990 | 0.3551374 | 0.2784959 | RPL38 | 1 |
| GO:0010976 | GO:0010976 | positive regulation of neuron projection development | 1/37 | 161/18888 | 0.0062112 | 3.170723 | 1.2254582 | 0.2716990 | 0.3551374 | 0.2784959 | MAGI2 | 1 |
| GO:1902600 | GO:1902600 | proton transmembrane transport | 1/37 | 161/18888 | 0.0062112 | 3.170723 | 1.2254582 | 0.2716990 | 0.3551374 | 0.2784959 | ATP5MC2 | 1 |
| GO:0048592 | GO:0048592 | eye morphogenesis | 1/37 | 162/18888 | 0.0061728 | 3.151151 | 1.2182070 | 0.2731379 | 0.3559197 | 0.2791094 | ZEB1 | 1 |
| GO:0120254 | GO:0120254 | olefinic compound metabolic process | 1/37 | 162/18888 | 0.0061728 | 3.151151 | 1.2182070 | 0.2731379 | 0.3559197 | 0.2791094 | ADM | 1 |
| GO:0007292 | GO:0007292 | female gamete generation | 1/37 | 163/18888 | 0.0061350 | 3.131819 | 1.2110118 | 0.2745741 | 0.3561474 | 0.2792879 | PTX3 | 1 |
| GO:0034250 | GO:0034250 | positive regulation of amide metabolic process | 1/37 | 163/18888 | 0.0061350 | 3.131819 | 1.2110118 | 0.2745741 | 0.3561474 | 0.2792879 | AGO2 | 1 |
| GO:0044409 | GO:0044409 | symbiont entry into host | 1/37 | 163/18888 | 0.0061350 | 3.131819 | 1.2110118 | 0.2745741 | 0.3561474 | 0.2792879 | PTX3 | 1 |
| GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 1/37 | 164/18888 | 0.0060976 | 3.112722 | 1.2038717 | 0.2760075 | 0.3574593 | 0.2803167 | TGFBR2 | 1 |
| GO:0050905 | GO:0050905 | neuromuscular process | 1/37 | 165/18888 | 0.0060606 | 3.093857 | 1.1967861 | 0.2774382 | 0.3582167 | 0.2809106 | CAMTA1 | 1 |
| GO:0060294 | GO:0060294 | cilium movement involved in cell motility | 1/37 | 165/18888 | 0.0060606 | 3.093857 | 1.1967861 | 0.2774382 | 0.3582167 | 0.2809106 | ING2 | 1 |
| GO:0003205 | GO:0003205 | cardiac chamber development | 1/37 | 168/18888 | 0.0059524 | 3.038610 | 1.1758476 | 0.2817137 | 0.3620812 | 0.2839411 | TGFBR2 | 1 |
| GO:0030509 | GO:0030509 | BMP signaling pathway | 1/37 | 168/18888 | 0.0059524 | 3.038610 | 1.1758476 | 0.2817137 | 0.3620812 | 0.2839411 | TOB1 | 1 |
| GO:0050792 | GO:0050792 | regulation of viral process | 1/37 | 168/18888 | 0.0059524 | 3.038610 | 1.1758476 | 0.2817137 | 0.3620812 | 0.2839411 | PTX3 | 1 |
| GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 1/37 | 169/18888 | 0.0059172 | 3.020630 | 1.1689717 | 0.2831334 | 0.3633545 | 0.2849396 | ADM | 1 |
| GO:0001539 | GO:0001539 | cilium or flagellum-dependent cell motility | 1/37 | 170/18888 | 0.0058824 | 3.002862 | 1.1621464 | 0.2845503 | 0.3635206 | 0.2850699 | ING2 | 1 |
| GO:0007519 | GO:0007519 | skeletal muscle tissue development | 1/37 | 170/18888 | 0.0058824 | 3.002862 | 1.1621464 | 0.2845503 | 0.3635206 | 0.2850699 | RBM24 | 1 |
| GO:0060285 | GO:0060285 | cilium-dependent cell motility | 1/37 | 170/18888 | 0.0058824 | 3.002862 | 1.1621464 | 0.2845503 | 0.3635206 | 0.2850699 | ING2 | 1 |
| GO:0030856 | GO:0030856 | regulation of epithelial cell differentiation | 1/37 | 171/18888 | 0.0058480 | 2.985301 | 1.1553710 | 0.2859646 | 0.3647771 | 0.2860552 | ZEB1 | 1 |
| GO:0046661 | GO:0046661 | male sex differentiation | 1/37 | 173/18888 | 0.0057803 | 2.950789 | 1.1419671 | 0.2887849 | 0.3672685 | 0.2880089 | ING2 | 1 |
| GO:0050680 | GO:0050680 | negative regulation of epithelial cell proliferation | 1/37 | 173/18888 | 0.0057803 | 2.950789 | 1.1419671 | 0.2887849 | 0.3672685 | 0.2880089 | ZEB1 | 1 |
| GO:0007259 | GO:0007259 | receptor signaling pathway via JAK-STAT | 1/37 | 174/18888 | 0.0057471 | 2.933830 | 1.1353371 | 0.2901910 | 0.3685034 | 0.2889774 | IFNW1 | 1 |
| GO:0010634 | GO:0010634 | positive regulation of epithelial cell migration | 1/37 | 177/18888 | 0.0056497 | 2.884104 | 1.1157278 | 0.2943930 | 0.3727218 | 0.2922854 | TGFBR2 | 1 |
| GO:0072331 | GO:0072331 | signal transduction by p53 class mediator | 1/37 | 177/18888 | 0.0056497 | 2.884104 | 1.1157278 | 0.2943930 | 0.3727218 | 0.2922854 | ING2 | 1 |
| GO:0035265 | GO:0035265 | organ growth | 1/37 | 180/18888 | 0.0055556 | 2.836036 | 1.0965260 | 0.2985709 | 0.3757645 | 0.2946715 | TGFBR2 | 1 |
| GO:0071772 | GO:0071772 | response to BMP | 1/37 | 180/18888 | 0.0055556 | 2.836036 | 1.0965260 | 0.2985709 | 0.3757645 | 0.2946715 | TOB1 | 1 |
| GO:0071773 | GO:0071773 | cellular response to BMP stimulus | 1/37 | 180/18888 | 0.0055556 | 2.836036 | 1.0965260 | 0.2985709 | 0.3757645 | 0.2946715 | TOB1 | 1 |
| GO:1905475 | GO:1905475 | regulation of protein localization to membrane | 1/37 | 180/18888 | 0.0055556 | 2.836036 | 1.0965260 | 0.2985709 | 0.3757645 | 0.2946715 | ADAM10 | 1 |
| GO:0042129 | GO:0042129 | regulation of T cell proliferation | 1/37 | 181/18888 | 0.0055249 | 2.820367 | 1.0902131 | 0.2999581 | 0.3763919 | 0.2951635 | TGFBR2 | 1 |
| GO:0046631 | GO:0046631 | alpha-beta T cell activation | 1/37 | 181/18888 | 0.0055249 | 2.820367 | 1.0902131 | 0.2999581 | 0.3763919 | 0.2951635 | TGFBR2 | 1 |
| GO:0060538 | GO:0060538 | skeletal muscle organ development | 1/37 | 182/18888 | 0.0054945 | 2.804871 | 1.0839431 | 0.3013427 | 0.3775700 | 0.2960873 | RBM24 | 1 |
| GO:0006694 | GO:0006694 | steroid biosynthetic process | 1/37 | 185/18888 | 0.0054054 | 2.759386 | 1.0653851 | 0.3054805 | 0.3816254 | 0.2992675 | ADM | 1 |
| GO:0050954 | GO:0050954 | sensory perception of mechanical stimulus | 1/37 | 185/18888 | 0.0054054 | 2.759386 | 1.0653851 | 0.3054805 | 0.3816254 | 0.2992675 | RPL38 | 1 |
| GO:0048736 | GO:0048736 | appendage development | 1/37 | 186/18888 | 0.0053763 | 2.744551 | 1.0592812 | 0.3068545 | 0.3816531 | 0.2992893 | PRRX1 | 1 |
| GO:0051302 | GO:0051302 | regulation of cell division | 1/37 | 186/18888 | 0.0053763 | 2.744551 | 1.0592812 | 0.3068545 | 0.3816531 | 0.2992893 | PPBP | 1 |
| GO:0060173 | GO:0060173 | limb development | 1/37 | 186/18888 | 0.0053763 | 2.744551 | 1.0592812 | 0.3068545 | 0.3816531 | 0.2992893 | PRRX1 | 1 |
| GO:0001837 | GO:0001837 | epithelial to mesenchymal transition | 1/37 | 187/18888 | 0.0053476 | 2.729874 | 1.0532175 | 0.3082258 | 0.3816773 | 0.2993082 | TGFBR2 | 1 |
| GO:0008217 | GO:0008217 | regulation of blood pressure | 1/37 | 187/18888 | 0.0053476 | 2.729874 | 1.0532175 | 0.3082258 | 0.3816773 | 0.2993082 | ADM | 1 |
| GO:0046890 | GO:0046890 | regulation of lipid biosynthetic process | 1/37 | 187/18888 | 0.0053476 | 2.729874 | 1.0532175 | 0.3082258 | 0.3816773 | 0.2993082 | ADM | 1 |
| GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 1/37 | 190/18888 | 0.0052632 | 2.686771 | 1.0352625 | 0.3123239 | 0.3850631 | 0.3019634 | TGFBR2 | 1 |
| GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 1/37 | 190/18888 | 0.0052632 | 2.686771 | 1.0352625 | 0.3123239 | 0.3850631 | 0.3019634 | TGFBR2 | 1 |
| GO:2001242 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 1/37 | 190/18888 | 0.0052632 | 2.686771 | 1.0352625 | 0.3123239 | 0.3850631 | 0.3019634 | ING2 | 1 |
| GO:0031503 | GO:0031503 | protein-containing complex localization | 1/37 | 191/18888 | 0.0052356 | 2.672704 | 1.0293546 | 0.3136847 | 0.3856182 | 0.3023987 | ADAM10 | 1 |
| GO:0097696 | GO:0097696 | receptor signaling pathway via STAT | 1/37 | 191/18888 | 0.0052356 | 2.672704 | 1.0293546 | 0.3136847 | 0.3856182 | 0.3023987 | IFNW1 | 1 |
| GO:0006006 | GO:0006006 | glucose metabolic process | 1/37 | 192/18888 | 0.0052083 | 2.658784 | 1.0234843 | 0.3150429 | 0.3867266 | 0.3032678 | BRAT1 | 1 |
| GO:0030324 | GO:0030324 | lung development | 1/37 | 193/18888 | 0.0051813 | 2.645008 | 1.0176513 | 0.3163985 | 0.3878285 | 0.3041320 | TGFBR2 | 1 |
| GO:0051260 | GO:0051260 | protein homooligomerization | 1/37 | 195/18888 | 0.0051282 | 2.617879 | 1.0060953 | 0.3191017 | 0.3905768 | 0.3062872 | KCTD1 | 1 |
| GO:0045664 | GO:0045664 | regulation of neuron differentiation | 1/37 | 196/18888 | 0.0051020 | 2.604523 | 1.0003713 | 0.3204495 | 0.3910961 | 0.3066944 | ZEB1 | 1 |
| GO:0099173 | GO:0099173 | postsynapse organization | 1/37 | 196/18888 | 0.0051020 | 2.604523 | 1.0003713 | 0.3204495 | 0.3910961 | 0.3066944 | ADAM10 | 1 |
| GO:0002520 | GO:0002520 | immune system development | 1/37 | 197/18888 | 0.0050761 | 2.591302 | 0.9946828 | 0.3217946 | 0.3916092 | 0.3070968 | TGFBR2 | 1 |
| GO:0030323 | GO:0030323 | respiratory tube development | 1/37 | 197/18888 | 0.0050761 | 2.591302 | 0.9946828 | 0.3217946 | 0.3916092 | 0.3070968 | TGFBR2 | 1 |
| GO:0007369 | GO:0007369 | gastrulation | 1/37 | 200/18888 | 0.0050000 | 2.552432 | 0.9778257 | 0.3258145 | 0.3959324 | 0.3104870 | TGFBR2 | 1 |
| GO:0051701 | GO:0051701 | biological process involved in interaction with host | 1/37 | 202/18888 | 0.0049505 | 2.527161 | 0.9667573 | 0.3284815 | 0.3986015 | 0.3125801 | PTX3 | 1 |
| GO:0098739 | GO:0098739 | import across plasma membrane | 1/37 | 203/18888 | 0.0049261 | 2.514712 | 0.9612727 | 0.3298112 | 0.3996425 | 0.3133964 | KCNJ13 | 1 |
| GO:0051346 | GO:0051346 | negative regulation of hydrolase activity | 1/37 | 204/18888 | 0.0049020 | 2.502385 | 0.9558208 | 0.3311383 | 0.4001058 | 0.3137597 | PTX3 | 1 |
| GO:0055001 | GO:0055001 | muscle cell development | 1/37 | 204/18888 | 0.0049020 | 2.502385 | 0.9558208 | 0.3311383 | 0.4001058 | 0.3137597 | ADM | 1 |
| GO:0071674 | GO:0071674 | mononuclear cell migration | 1/37 | 206/18888 | 0.0048544 | 2.478090 | 0.9450132 | 0.3337849 | 0.4027290 | 0.3158168 | ADAM10 | 1 |
| GO:0008016 | GO:0008016 | regulation of heart contraction | 1/37 | 208/18888 | 0.0048077 | 2.454262 | 0.9343316 | 0.3364212 | 0.4047568 | 0.3174070 | ADM | 1 |
| GO:0043123 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 1/37 | 208/18888 | 0.0048077 | 2.454262 | 0.9343316 | 0.3364212 | 0.4047568 | 0.3174070 | C18orf32 | 1 |
| GO:0003341 | GO:0003341 | cilium movement | 1/37 | 209/18888 | 0.0047847 | 2.442519 | 0.9290371 | 0.3377356 | 0.4057618 | 0.3181951 | ING2 | 1 |
| GO:0009152 | GO:0009152 | purine ribonucleotide biosynthetic process | 1/37 | 211/18888 | 0.0047393 | 2.419367 | 0.9185390 | 0.3403567 | 0.4083317 | 0.3202104 | ATP5MC2 | 1 |
| GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 1/37 | 212/18888 | 0.0047170 | 2.407955 | 0.9133347 | 0.3416635 | 0.4087415 | 0.3205318 | IFNW1 | 1 |
| GO:0042594 | GO:0042594 | response to starvation | 1/37 | 212/18888 | 0.0047170 | 2.407955 | 0.9133347 | 0.3416635 | 0.4087415 | 0.3205318 | ADM | 1 |
| GO:0042098 | GO:0042098 | T cell proliferation | 1/37 | 213/18888 | 0.0046948 | 2.396650 | 0.9081598 | 0.3429678 | 0.4091461 | 0.3208490 | TGFBR2 | 1 |
| GO:0045216 | GO:0045216 | cell-cell junction organization | 1/37 | 213/18888 | 0.0046948 | 2.396650 | 0.9081598 | 0.3429678 | 0.4091461 | 0.3208490 | ADAM10 | 1 |
| GO:0007286 | GO:0007286 | spermatid development | 1/37 | 214/18888 | 0.0046729 | 2.385451 | 0.9030140 | 0.3442695 | 0.4095454 | 0.3211622 | ING2 | 1 |
| GO:2000241 | GO:2000241 | regulation of reproductive process | 1/37 | 214/18888 | 0.0046729 | 2.385451 | 0.9030140 | 0.3442695 | 0.4095454 | 0.3211622 | AGO2 | 1 |
| GO:0060348 | GO:0060348 | bone development | 1/37 | 215/18888 | 0.0046512 | 2.374356 | 0.8978970 | 0.3455688 | 0.4105144 | 0.3219220 | TGFBR2 | 1 |
| GO:0071805 | GO:0071805 | potassium ion transmembrane transport | 1/37 | 217/18888 | 0.0046083 | 2.352472 | 0.8877478 | 0.3481598 | 0.4130130 | 0.3238815 | KCNJ13 | 1 |
| GO:0040029 | GO:0040029 | epigenetic regulation of gene expression | 1/37 | 220/18888 | 0.0045455 | 2.320393 | 0.8727319 | 0.3520275 | 0.4158540 | 0.3261093 | ING2 | 1 |
| GO:0046034 | GO:0046034 | ATP metabolic process | 1/37 | 220/18888 | 0.0045455 | 2.320393 | 0.8727319 | 0.3520275 | 0.4158540 | 0.3261093 | ATP5MC2 | 1 |
| GO:0060541 | GO:0060541 | respiratory system development | 1/37 | 220/18888 | 0.0045455 | 2.320393 | 0.8727319 | 0.3520275 | 0.4158540 | 0.3261093 | TGFBR2 | 1 |
| GO:0048515 | GO:0048515 | spermatid differentiation | 1/37 | 222/18888 | 0.0045045 | 2.299489 | 0.8628564 | 0.3545936 | 0.4183019 | 0.3280290 | ING2 | 1 |
| GO:0006364 | GO:0006364 | rRNA processing | 1/37 | 224/18888 | 0.0044643 | 2.278958 | 0.8530862 | 0.3571498 | 0.4207314 | 0.3299341 | RRP9 | 1 |
| GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 1/37 | 225/18888 | 0.0044444 | 2.268829 | 0.8482400 | 0.3584242 | 0.4216462 | 0.3306516 | PPBP | 1 |
| GO:0009260 | GO:0009260 | ribonucleotide biosynthetic process | 1/37 | 226/18888 | 0.0044248 | 2.258790 | 0.8434192 | 0.3596961 | 0.4225557 | 0.3313647 | ATP5MC2 | 1 |
| GO:0042180 | GO:0042180 | cellular ketone metabolic process | 1/37 | 227/18888 | 0.0044053 | 2.248839 | 0.8386237 | 0.3609656 | 0.4234597 | 0.3320736 | ADM | 1 |
| GO:0050920 | GO:0050920 | regulation of chemotaxis | 1/37 | 229/18888 | 0.0043668 | 2.229199 | 0.8291074 | 0.3634973 | 0.4258398 | 0.3339401 | ADAM10 | 1 |
| GO:0002685 | GO:0002685 | regulation of leukocyte migration | 1/37 | 230/18888 | 0.0043478 | 2.219507 | 0.8243861 | 0.3647594 | 0.4261396 | 0.3341752 | ADAM10 | 1 |
| GO:0043547 | GO:0043547 | positive regulation of GTPase activity | 1/37 | 230/18888 | 0.0043478 | 2.219507 | 0.8243861 | 0.3647594 | 0.4261396 | 0.3341752 | RGS1 | 1 |
| GO:0019318 | GO:0019318 | hexose metabolic process | 1/37 | 232/18888 | 0.0043103 | 2.200373 | 0.8150158 | 0.3672764 | 0.4278998 | 0.3355555 | BRAT1 | 1 |
| GO:0019722 | GO:0019722 | calcium-mediated signaling | 1/37 | 232/18888 | 0.0043103 | 2.200373 | 0.8150158 | 0.3672764 | 0.4278998 | 0.3355555 | CAMTA1 | 1 |
| GO:0046390 | GO:0046390 | ribose phosphate biosynthetic process | 1/37 | 233/18888 | 0.0042918 | 2.190929 | 0.8103664 | 0.3685313 | 0.4287720 | 0.3362395 | ATP5MC2 | 1 |
| GO:0006909 | GO:0006909 | phagocytosis | 1/37 | 237/18888 | 0.0042194 | 2.153951 | 0.7920011 | 0.3735266 | 0.4330555 | 0.3395986 | PTX3 | 1 |
| GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 1/37 | 237/18888 | 0.0042194 | 2.153951 | 0.7920011 | 0.3735266 | 0.4330555 | 0.3395986 | TGFBR2 | 1 |
| GO:0048588 | GO:0048588 | developmental cell growth | 1/37 | 238/18888 | 0.0042017 | 2.144901 | 0.7874668 | 0.3747694 | 0.4330555 | 0.3395986 | TGFBR2 | 1 |
| GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 1/37 | 238/18888 | 0.0042017 | 2.144901 | 0.7874668 | 0.3747694 | 0.4330555 | 0.3395986 | PPBP | 1 |
| GO:0072593 | GO:0072593 | reactive oxygen species metabolic process | 1/37 | 238/18888 | 0.0042017 | 2.144901 | 0.7874668 | 0.3747694 | 0.4330555 | 0.3395986 | TGFBR2 | 1 |
| GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 1/37 | 239/18888 | 0.0041841 | 2.135927 | 0.7829547 | 0.3760098 | 0.4333065 | 0.3397955 | TGFBR2 | 1 |
| GO:0097529 | GO:0097529 | myeloid leukocyte migration | 1/37 | 239/18888 | 0.0041841 | 2.135927 | 0.7829547 | 0.3760098 | 0.4333065 | 0.3397955 | PPBP | 1 |
| GO:0065004 | GO:0065004 | protein-DNA complex assembly | 1/37 | 240/18888 | 0.0041667 | 2.127027 | 0.7784648 | 0.3772478 | 0.4341425 | 0.3404510 | TAF13 | 1 |
| GO:0006813 | GO:0006813 | potassium ion transport | 1/37 | 241/18888 | 0.0041494 | 2.118201 | 0.7739968 | 0.3784834 | 0.4343841 | 0.3406405 | KCNJ13 | 1 |
| GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 1/37 | 241/18888 | 0.0041494 | 2.118201 | 0.7739968 | 0.3784834 | 0.4343841 | 0.3406405 | TGFBR2 | 1 |
| GO:0050807 | GO:0050807 | regulation of synapse organization | 1/37 | 243/18888 | 0.0041152 | 2.100767 | 0.7651255 | 0.3809475 | 0.4366205 | 0.3423943 | ADAM10 | 1 |
| GO:0009205 | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1/37 | 244/18888 | 0.0040984 | 2.092158 | 0.7607218 | 0.3821760 | 0.4368463 | 0.3425713 | ATP5MC2 | 1 |
| GO:2001234 | GO:2001234 | negative regulation of apoptotic signaling pathway | 1/37 | 244/18888 | 0.0040984 | 2.092158 | 0.7607218 | 0.3821760 | 0.4368463 | 0.3425713 | ING2 | 1 |
| GO:0016485 | GO:0016485 | protein processing | 1/37 | 245/18888 | 0.0040816 | 2.083618 | 0.7563392 | 0.3834021 | 0.4376571 | 0.3432072 | ADAM10 | 1 |
| GO:0050803 | GO:0050803 | regulation of synapse structure or activity | 1/37 | 249/18888 | 0.0040161 | 2.050146 | 0.7390153 | 0.3882829 | 0.4420371 | 0.3466419 | ADAM10 | 1 |
| GO:0060047 | GO:0060047 | heart contraction | 1/37 | 249/18888 | 0.0040161 | 2.050146 | 0.7390153 | 0.3882829 | 0.4420371 | 0.3466419 | ADM | 1 |
| GO:0009144 | GO:0009144 | purine nucleoside triphosphate metabolic process | 1/37 | 250/18888 | 0.0040000 | 2.041946 | 0.7347349 | 0.3894972 | 0.4428243 | 0.3472592 | ATP5MC2 | 1 |
| GO:0009199 | GO:0009199 | ribonucleoside triphosphate metabolic process | 1/37 | 251/18888 | 0.0039841 | 2.033811 | 0.7304745 | 0.3907092 | 0.4436068 | 0.3478728 | ATP5MC2 | 1 |
| GO:0005996 | GO:0005996 | monosaccharide metabolic process | 1/37 | 252/18888 | 0.0039683 | 2.025740 | 0.7262337 | 0.3919188 | 0.4443845 | 0.3484827 | BRAT1 | 1 |
| GO:0050870 | GO:0050870 | positive regulation of T cell activation | 1/37 | 253/18888 | 0.0039526 | 2.017733 | 0.7220124 | 0.3931261 | 0.4445631 | 0.3486228 | TGFBR2 | 1 |
| GO:0051896 | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/37 | 253/18888 | 0.0039526 | 2.017733 | 0.7220124 | 0.3931261 | 0.4445631 | 0.3486228 | MAGI2 | 1 |
| GO:0006164 | GO:0006164 | purine nucleotide biosynthetic process | 1/37 | 256/18888 | 0.0039063 | 1.994088 | 0.7094637 | 0.3967340 | 0.4480449 | 0.3513532 | ATP5MC2 | 1 |
| GO:0001649 | GO:0001649 | osteoblast differentiation | 1/37 | 257/18888 | 0.0038911 | 1.986329 | 0.7053186 | 0.3979319 | 0.4482026 | 0.3514768 | TOB1 | 1 |
| GO:0045860 | GO:0045860 | positive regulation of protein kinase activity | 1/37 | 257/18888 | 0.0038911 | 1.986329 | 0.7053186 | 0.3979319 | 0.4482026 | 0.3514768 | TGFBR2 | 1 |
| GO:0051259 | GO:0051259 | protein complex oligomerization | 1/37 | 258/18888 | 0.0038760 | 1.978630 | 0.7011921 | 0.3991276 | 0.4489523 | 0.3520648 | KCTD1 | 1 |
| GO:0097305 | GO:0097305 | response to alcohol | 1/37 | 259/18888 | 0.0038610 | 1.970990 | 0.6970841 | 0.4003210 | 0.4496974 | 0.3526491 | TGFBR2 | 1 |
| GO:0003015 | GO:0003015 | heart process | 1/37 | 260/18888 | 0.0038462 | 1.963410 | 0.6929943 | 0.4015120 | 0.4504380 | 0.3532298 | ADM | 1 |
| GO:1903522 | GO:1903522 | regulation of blood circulation | 1/37 | 262/18888 | 0.0038168 | 1.948422 | 0.6848690 | 0.4038872 | 0.4525033 | 0.3548494 | ADM | 1 |
| GO:0034612 | GO:0034612 | response to tumor necrosis factor | 1/37 | 263/18888 | 0.0038023 | 1.941013 | 0.6808331 | 0.4050714 | 0.4532305 | 0.3554197 | ADAM10 | 1 |
| GO:0072522 | GO:0072522 | purine-containing compound biosynthetic process | 1/37 | 264/18888 | 0.0037879 | 1.933661 | 0.6768148 | 0.4062533 | 0.4539532 | 0.3559864 | ATP5MC2 | 1 |
| GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 1/37 | 265/18888 | 0.0037736 | 1.926364 | 0.6728139 | 0.4074329 | 0.4546714 | 0.3565497 | PPBP | 1 |
| GO:0009141 | GO:0009141 | nucleoside triphosphate metabolic process | 1/37 | 266/18888 | 0.0037594 | 1.919122 | 0.6688304 | 0.4086102 | 0.4547869 | 0.3566402 | ATP5MC2 | 1 |
| GO:0016072 | GO:0016072 | rRNA metabolic process | 1/37 | 266/18888 | 0.0037594 | 1.919122 | 0.6688304 | 0.4086102 | 0.4547869 | 0.3566402 | RRP9 | 1 |
| GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 1/37 | 267/18888 | 0.0037453 | 1.911934 | 0.6648641 | 0.4097852 | 0.4554961 | 0.3571964 | TGFBR2 | 1 |
| GO:0003007 | GO:0003007 | heart morphogenesis | 1/37 | 269/18888 | 0.0037175 | 1.897719 | 0.6569823 | 0.4121284 | 0.4563043 | 0.3578301 | TGFBR2 | 1 |
| GO:0032868 | GO:0032868 | response to insulin | 1/37 | 269/18888 | 0.0037175 | 1.897719 | 0.6569823 | 0.4121284 | 0.4563043 | 0.3578301 | ADM | 1 |
| GO:0048762 | GO:0048762 | mesenchymal cell differentiation | 1/37 | 269/18888 | 0.0037175 | 1.897719 | 0.6569823 | 0.4121284 | 0.4563043 | 0.3578301 | TGFBR2 | 1 |
| GO:0003018 | GO:0003018 | vascular process in circulatory system | 1/37 | 275/18888 | 0.0036364 | 1.856315 | 0.6337334 | 0.4191040 | 0.4634218 | 0.3634116 | ADM | 1 |
| GO:0090150 | GO:0090150 | establishment of protein localization to membrane | 1/37 | 277/18888 | 0.0036101 | 1.842912 | 0.6261122 | 0.4214113 | 0.4647595 | 0.3644607 | RILPL2 | 1 |
| GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 1/37 | 277/18888 | 0.0036101 | 1.842912 | 0.6261122 | 0.4214113 | 0.4647595 | 0.3644607 | TGFBR2 | 1 |
| GO:0042113 | GO:0042113 | B cell activation | 1/37 | 278/18888 | 0.0035971 | 1.836282 | 0.6223251 | 0.4225615 | 0.4654221 | 0.3649803 | IFNW1 | 1 |
| GO:0098742 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 1/37 | 279/18888 | 0.0035842 | 1.829701 | 0.6185534 | 0.4237096 | 0.4660805 | 0.3654966 | TGFBR2 | 1 |
| GO:0018105 | GO:0018105 | peptidyl-serine phosphorylation | 1/37 | 282/18888 | 0.0035461 | 1.810236 | 0.6073298 | 0.4271404 | 0.4692451 | 0.3679782 | IFNW1 | 1 |
| GO:0043122 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 1/37 | 286/18888 | 0.0034965 | 1.784918 | 0.5925739 | 0.4316840 | 0.4736222 | 0.3714107 | C18orf32 | 1 |
| GO:0045165 | GO:0045165 | cell fate commitment | 1/37 | 289/18888 | 0.0034602 | 1.766389 | 0.5816593 | 0.4350686 | 0.4767181 | 0.3738385 | PRRX1 | 1 |
| GO:0009165 | GO:0009165 | nucleotide biosynthetic process | 1/37 | 293/18888 | 0.0034130 | 1.742275 | 0.5673036 | 0.4395510 | 0.4803867 | 0.3767153 | ATP5MC2 | 1 |
| GO:0072659 | GO:0072659 | protein localization to plasma membrane | 1/37 | 293/18888 | 0.0034130 | 1.742275 | 0.5673036 | 0.4395510 | 0.4803867 | 0.3767153 | RILPL2 | 1 |
| GO:0018209 | GO:0018209 | peptidyl-serine modification | 1/37 | 294/18888 | 0.0034014 | 1.736349 | 0.5637491 | 0.4406662 | 0.4809848 | 0.3771844 | IFNW1 | 1 |
| GO:1901293 | GO:1901293 | nucleoside phosphate biosynthetic process | 1/37 | 295/18888 | 0.0033898 | 1.730463 | 0.5602082 | 0.4417792 | 0.4815791 | 0.3776504 | ATP5MC2 | 1 |
| GO:0048511 | GO:0048511 | rhythmic process | 1/37 | 297/18888 | 0.0033670 | 1.718810 | 0.5531666 | 0.4439987 | 0.4833387 | 0.3790303 | PTX3 | 1 |
| GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 1/37 | 298/18888 | 0.0033557 | 1.713042 | 0.5496657 | 0.4451053 | 0.4833387 | 0.3790303 | TGFBR2 | 1 |
| GO:0043087 | GO:0043087 | regulation of GTPase activity | 1/37 | 298/18888 | 0.0033557 | 1.713042 | 0.5496657 | 0.4451053 | 0.4833387 | 0.3790303 | RGS1 | 1 |
| GO:0043491 | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1/37 | 299/18888 | 0.0033445 | 1.707313 | 0.5461780 | 0.4462097 | 0.4839176 | 0.3794842 | MAGI2 | 1 |
| GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 1/37 | 301/18888 | 0.0033223 | 1.695968 | 0.5392415 | 0.4484121 | 0.4856842 | 0.3808696 | IFNW1 | 1 |
| GO:0033674 | GO:0033674 | positive regulation of kinase activity | 1/37 | 303/18888 | 0.0033003 | 1.684774 | 0.5323563 | 0.4506060 | 0.4874372 | 0.3822443 | TGFBR2 | 1 |
| GO:0002263 | GO:0002263 | cell activation involved in immune response | 1/37 | 305/18888 | 0.0032787 | 1.673726 | 0.5255216 | 0.4527914 | 0.4891765 | 0.3836082 | IFNW1 | 1 |
| GO:0051607 | GO:0051607 | defense response to virus | 1/37 | 307/18888 | 0.0032573 | 1.662822 | 0.5187367 | 0.4549684 | 0.4909022 | 0.3849615 | IFNW1 | 1 |
| GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 1/37 | 310/18888 | 0.0032258 | 1.646731 | 0.5086510 | 0.4582180 | 0.4936860 | 0.3871446 | ADAM10 | 1 |
| GO:0007249 | GO:0007249 | canonical NF-kappaB signal transduction | 1/37 | 311/18888 | 0.0032154 | 1.641436 | 0.5053132 | 0.4592970 | 0.4936860 | 0.3871446 | C18orf32 | 1 |
| GO:0044403 | GO:0044403 | biological process involved in symbiotic interaction | 1/37 | 311/18888 | 0.0032154 | 1.641436 | 0.5053132 | 0.4592970 | 0.4936860 | 0.3871446 | PTX3 | 1 |
| GO:0001666 | GO:0001666 | response to hypoxia | 1/37 | 313/18888 | 0.0031949 | 1.630947 | 0.4986731 | 0.4614488 | 0.4947432 | 0.3879736 | ADM | 1 |
| GO:0051146 | GO:0051146 | striated muscle cell differentiation | 1/37 | 313/18888 | 0.0031949 | 1.630947 | 0.4986731 | 0.4614488 | 0.4947432 | 0.3879736 | RBM24 | 1 |
| GO:0098813 | GO:0098813 | nuclear chromosome segregation | 1/37 | 317/18888 | 0.0031546 | 1.610367 | 0.4855327 | 0.4657273 | 0.4986992 | 0.3910759 | PTTG1 | 1 |
| GO:0001822 | GO:0001822 | kidney development | 1/37 | 319/18888 | 0.0031348 | 1.600271 | 0.4790311 | 0.4678542 | 0.4990838 | 0.3913774 | MAGI2 | 1 |
| GO:0019058 | GO:0019058 | viral life cycle | 1/37 | 319/18888 | 0.0031348 | 1.600271 | 0.4790311 | 0.4678542 | 0.4990838 | 0.3913774 | PTX3 | 1 |
| GO:0097193 | GO:0097193 | intrinsic apoptotic signaling pathway | 1/37 | 319/18888 | 0.0031348 | 1.600271 | 0.4790311 | 0.4678542 | 0.4990838 | 0.3913774 | ING2 | 1 |
| GO:0009101 | GO:0009101 | glycoprotein biosynthetic process | 1/37 | 324/18888 | 0.0030864 | 1.575576 | 0.4629715 | 0.4731354 | 0.5040826 | 0.3952975 | AGO2 | 1 |
| GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 1/37 | 325/18888 | 0.0030769 | 1.570728 | 0.4597923 | 0.4741855 | 0.5045667 | 0.3956771 | TGFBR2 | 1 |
| GO:0019216 | GO:0019216 | regulation of lipid metabolic process | 1/37 | 326/18888 | 0.0030675 | 1.565910 | 0.4566238 | 0.4752335 | 0.5050474 | 0.3960541 | ADM | 1 |
| GO:0036293 | GO:0036293 | response to decreased oxygen levels | 1/37 | 327/18888 | 0.0030581 | 1.561121 | 0.4534659 | 0.4762795 | 0.5055248 | 0.3964284 | ADM | 1 |
| GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 1/37 | 328/18888 | 0.0030488 | 1.556361 | 0.4503187 | 0.4773235 | 0.5058372 | 0.3966734 | TGFBR2 | 1 |
| GO:0008202 | GO:0008202 | steroid metabolic process | 1/37 | 329/18888 | 0.0030395 | 1.551631 | 0.4471819 | 0.4783655 | 0.5058372 | 0.3966734 | ADM | 1 |
| GO:0072001 | GO:0072001 | renal system development | 1/37 | 329/18888 | 0.0030395 | 1.551631 | 0.4471819 | 0.4783655 | 0.5058372 | 0.3966734 | MAGI2 | 1 |
| GO:0042742 | GO:0042742 | defense response to bacterium | 1/37 | 330/18888 | 0.0030303 | 1.546929 | 0.4440555 | 0.4794055 | 0.5063048 | 0.3970401 | PPBP | 1 |
| GO:0062012 | GO:0062012 | regulation of small molecule metabolic process | 1/37 | 331/18888 | 0.0030211 | 1.542255 | 0.4409395 | 0.4804434 | 0.5067691 | 0.3974042 | ADM | 1 |
| GO:0048545 | GO:0048545 | response to steroid hormone | 1/37 | 338/18888 | 0.0029586 | 1.510315 | 0.4194111 | 0.4876528 | 0.5137337 | 0.4028658 | ADM | 1 |
| GO:0034765 | GO:0034765 | regulation of monoatomic ion transmembrane transport | 1/37 | 349/18888 | 0.0028653 | 1.462712 | 0.3865409 | 0.4987856 | 0.5248092 | 0.4115511 | KCNJ13 | 1 |
| GO:0070482 | GO:0070482 | response to oxygen levels | 1/37 | 354/18888 | 0.0028249 | 1.442052 | 0.3719682 | 0.5037678 | 0.5293937 | 0.4151462 | ADM | 1 |
| GO:0007517 | GO:0007517 | muscle organ development | 1/37 | 359/18888 | 0.0027855 | 1.421968 | 0.3576151 | 0.5087018 | 0.5339163 | 0.4186928 | RBM24 | 1 |
| GO:0031346 | GO:0031346 | positive regulation of cell projection organization | 1/37 | 360/18888 | 0.0027778 | 1.418018 | 0.3547702 | 0.5096828 | 0.5342839 | 0.4189811 | MAGI2 | 1 |
| GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 1/37 | 362/18888 | 0.0027624 | 1.410184 | 0.3491057 | 0.5116392 | 0.5356717 | 0.4200694 | TGFBR2 | 1 |
| GO:0050878 | GO:0050878 | regulation of body fluid levels | 1/37 | 370/18888 | 0.0027027 | 1.379693 | 0.3267772 | 0.5193892 | 0.5431144 | 0.4259059 | ADM | 1 |
| GO:0010631 | GO:0010631 | epithelial cell migration | 1/37 | 375/18888 | 0.0026667 | 1.361297 | 0.3130813 | 0.5241720 | 0.5474398 | 0.4292978 | TGFBR2 | 1 |
| GO:0051347 | GO:0051347 | positive regulation of transferase activity | 1/37 | 376/18888 | 0.0026596 | 1.357677 | 0.3103653 | 0.5251230 | 0.5477576 | 0.4295471 | TGFBR2 | 1 |
| GO:0090132 | GO:0090132 | epithelium migration | 1/37 | 378/18888 | 0.0026455 | 1.350493 | 0.3049563 | 0.5270194 | 0.5490596 | 0.4305681 | TGFBR2 | 1 |
| GO:0050867 | GO:0050867 | positive regulation of cell activation | 1/37 | 380/18888 | 0.0026316 | 1.343385 | 0.2995775 | 0.5289085 | 0.5503507 | 0.4315806 | TGFBR2 | 1 |
| GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 1/37 | 382/18888 | 0.0026178 | 1.336352 | 0.2942284 | 0.5307902 | 0.5516310 | 0.4325846 | TGFBR2 | 1 |
| GO:0090130 | GO:0090130 | tissue migration | 1/37 | 383/18888 | 0.0026110 | 1.332863 | 0.2915650 | 0.5317283 | 0.5519288 | 0.4328181 | TGFBR2 | 1 |
| GO:0060271 | GO:0060271 | cilium assembly | 1/37 | 385/18888 | 0.0025974 | 1.325939 | 0.2862600 | 0.5335991 | 0.5531927 | 0.4338092 | RILPL2 | 1 |
| GO:2001233 | GO:2001233 | regulation of apoptotic signaling pathway | 1/37 | 396/18888 | 0.0025253 | 1.289107 | 0.2575905 | 0.5437590 | 0.5630365 | 0.4415286 | ING2 | 1 |
| GO:0050678 | GO:0050678 | regulation of epithelial cell proliferation | 1/37 | 407/18888 | 0.0024570 | 1.254267 | 0.2297412 | 0.5537034 | 0.5726335 | 0.4490545 | ZEB1 | 1 |
| GO:0030900 | GO:0030900 | forebrain development | 1/37 | 408/18888 | 0.0024510 | 1.251192 | 0.2272483 | 0.5545969 | 0.5728581 | 0.4492306 | ZEB1 | 1 |
| GO:0009615 | GO:0009615 | response to virus | 1/37 | 409/18888 | 0.0024450 | 1.248133 | 0.2247618 | 0.5554887 | 0.5730803 | 0.4494049 | IFNW1 | 1 |
| GO:0044782 | GO:0044782 | cilium organization | 1/37 | 412/18888 | 0.0024272 | 1.239045 | 0.2173398 | 0.5581536 | 0.5751291 | 0.4510116 | RILPL2 | 1 |
| GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 1/37 | 419/18888 | 0.0023866 | 1.218345 | 0.2002366 | 0.5643114 | 0.5807676 | 0.4554333 | TGFBR2 | 1 |
| GO:0007059 | GO:0007059 | chromosome segregation | 1/37 | 423/18888 | 0.0023641 | 1.206824 | 0.1905949 | 0.5677926 | 0.5836411 | 0.4576866 | PTTG1 | 1 |
| GO:0007018 | GO:0007018 | microtubule-based movement | 1/37 | 426/18888 | 0.0023474 | 1.198325 | 0.1834249 | 0.5703857 | 0.5855959 | 0.4592196 | ING2 | 1 |
| GO:0016032 | GO:0016032 | viral process | 1/37 | 428/18888 | 0.0023364 | 1.192725 | 0.1786735 | 0.5721060 | 0.5866510 | 0.4600470 | PTX3 | 1 |
| GO:0003002 | GO:0003002 | regionalization | 1/37 | 429/18888 | 0.0023310 | 1.189945 | 0.1763064 | 0.5729636 | 0.5868200 | 0.4601795 | TGFBR2 | 1 |
| GO:0009314 | GO:0009314 | response to radiation | 1/37 | 431/18888 | 0.0023202 | 1.184423 | 0.1715889 | 0.5746739 | 0.5878608 | 0.4609957 | BRAT1 | 1 |
| GO:0043434 | GO:0043434 | response to peptide hormone | 1/37 | 438/18888 | 0.0022831 | 1.165494 | 0.1552519 | 0.5806075 | 0.5924995 | 0.4646333 | ADM | 1 |
| GO:0060537 | GO:0060537 | muscle tissue development | 1/37 | 438/18888 | 0.0022831 | 1.165494 | 0.1552519 | 0.5806075 | 0.5924995 | 0.4646333 | RBM24 | 1 |
| GO:0030099 | GO:0030099 | myeloid cell differentiation | 1/37 | 439/18888 | 0.0022779 | 1.162839 | 0.1529398 | 0.5814486 | 0.5926437 | 0.4647464 | TGFBR2 | 1 |
| GO:0009410 | GO:0009410 | response to xenobiotic stimulus | 1/37 | 444/18888 | 0.0022523 | 1.149744 | 0.1414586 | 0.5856293 | 0.5961875 | 0.4675254 | TGFBR2 | 1 |
| GO:0009150 | GO:0009150 | purine ribonucleotide metabolic process | 1/37 | 446/18888 | 0.0022422 | 1.144589 | 0.1369028 | 0.5872902 | 0.5971606 | 0.4682885 | ATP5MC2 | 1 |
| GO:0043086 | GO:0043086 | negative regulation of catalytic activity | 1/37 | 449/18888 | 0.0022272 | 1.136941 | 0.1301077 | 0.5897694 | 0.5982451 | 0.4691390 | PTX3 | 1 |
| GO:0048732 | GO:0048732 | gland development | 1/37 | 449/18888 | 0.0022272 | 1.136941 | 0.1301077 | 0.5897694 | 0.5982451 | 0.4691390 | TGFBR2 | 1 |
| GO:0010720 | GO:0010720 | positive regulation of cell development | 1/37 | 454/18888 | 0.0022026 | 1.124420 | 0.1188836 | 0.5938692 | 0.6016833 | 0.4718352 | TGFBR2 | 1 |
| GO:0009259 | GO:0009259 | ribonucleotide metabolic process | 1/37 | 466/18888 | 0.0021459 | 1.095465 | 0.0924447 | 0.6035469 | 0.6100289 | 0.4783797 | ATP5MC2 | 1 |
| GO:0016055 | GO:0016055 | Wnt signaling pathway | 1/37 | 466/18888 | 0.0021459 | 1.095465 | 0.0924447 | 0.6035469 | 0.6100289 | 0.4783797 | MAGI2 | 1 |
| GO:0198738 | GO:0198738 | cell-cell signaling by wnt | 1/37 | 468/18888 | 0.0021368 | 1.090783 | 0.0881045 | 0.6051378 | 0.6109079 | 0.4790690 | MAGI2 | 1 |
| GO:0043269 | GO:0043269 | regulation of monoatomic ion transport | 1/37 | 470/18888 | 0.0021277 | 1.086142 | 0.0837828 | 0.6067226 | 0.6110512 | 0.4791814 | KCNJ13 | 1 |
| GO:0045859 | GO:0045859 | regulation of protein kinase activity | 1/37 | 470/18888 | 0.0021277 | 1.086142 | 0.0837828 | 0.6067226 | 0.6110512 | 0.4791814 | TGFBR2 | 1 |
| GO:0019693 | GO:0019693 | ribose phosphate metabolic process | 1/37 | 480/18888 | 0.0020833 | 1.063514 | 0.0624451 | 0.6145540 | 0.6182034 | 0.4847901 | ATP5MC2 | 1 |
| GO:0050673 | GO:0050673 | epithelial cell proliferation | 1/37 | 482/18888 | 0.0020747 | 1.059101 | 0.0582305 | 0.6161020 | 0.6190254 | 0.4854347 | ZEB1 | 1 |
| GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 1/37 | 485/18888 | 0.0020619 | 1.052550 | 0.0519410 | 0.6184126 | 0.6206108 | 0.4866779 | TGFBR2 | 1 |
| GO:0034762 | GO:0034762 | regulation of transmembrane transport | 1/37 | 489/18888 | 0.0020450 | 1.043940 | 0.0436143 | 0.6214724 | 0.6229433 | 0.4885071 | KCNJ13 | 1 |
| GO:0050808 | GO:0050808 | synapse organization | 1/37 | 493/18888 | 0.0020284 | 1.035470 | 0.0353545 | 0.6245083 | 0.6252465 | 0.4903132 | ADAM10 | 1 |
| GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 1/37 | 496/18888 | 0.0020161 | 1.029207 | 0.0292027 | 0.6267697 | 0.6267697 | 0.4915077 | TGFBR2 | 1 |
# Visualización del análisis funcional
barplot(go_results_miR_655_3p_combined, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
6: Exportar resultados
write.csv(filter_val_hsa_miR_655_3p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/updated/validated_targets.csv", row.names = FALSE)
write.csv(filter_pre_hsa_miR_655_3p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/updated/predicted_targets.csv", row.names = FALSE)
write.csv(combined_targets_miR_655_3p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/updated/combined_targets.csv", row.names = FALSE)
write.csv(summary_targets_miR_655_3p, "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/updated/summary_targets.csv", row.names = FALSE)Both hsa-miR-655-3p & hsa-miR-520d-5p
1. Validated
list_miRNAs <- c("hsa-miR-655-3p","hsa-miR-520d-5p")
validated_targets_both <- lapply(list_miRNAs, function(miRNA){
get_multimir(org = "hsa",
mirna = list_miRNAs,
table = "validated",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE
)@data # Extract the data
}) %>%
bind_rows() %>% # Relate
distinct() # Combine and eliminate duplicatesSearching mirecords ...
Searching mirtarbase ...
Searching tarbase ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.Searching mirecords ...
Searching mirtarbase ...
Searching tarbase ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.2. Predicted
predicted_targets_both <- lapply(list_miRNAs, function(miRNA){
get_multimir(org = "hsa",
mirna = list_miRNAs,
table = "predicted",
predicted.cutoff = 10,
predicted.cutoff.type = "p",
predicted.site = "conserved",
add.link = TRUE,
use.tibble = TRUE,
summary = TRUE
)@data
}) %>%
bind_rows() %>%
distinct() # Combine and eliminate duplicatesSearching diana_microt ...
Searching elmmo ...
Searching microcosm ...
Searching miranda ...
Searching mirdb ...
Searching pictar ...
Searching pita ...
Searching targetscan ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.Searching diana_microt ...
Searching elmmo ...
Searching microcosm ...
Searching miranda ...
Searching mirdb ...
Searching pictar ...
Searching pita ...
Searching targetscan ...Some of the links to external databases may be broken due to outdated identifiers in these databases. Please refer to Supplementary Table 2 in the multiMiR paper for details of the issue.3. Filter and combined
combined_targets <- validated_targets_both %>%
mutate(type = "validated") %>%
bind_rows(
predicted_targets_both %>% mutate(type = "predicted") # Agregar etiquetas de origen
) %>%
distinct()4. Resumir targets por miRNA
summary_targets <- combined_targets %>%
group_by(mature_mirna_id, type) %>%
summarise(
num_targets = n(),
top_targets = paste0(unique(target_symbol)[1:10], collapse = ", ")
)`summarise()` has grouped output by 'mature_mirna_id'. You can override using
the `.groups` argument.5: Análisis funcional
# Gene Ontology (GO) para todos los genes combinados
gene_symbols <- combined_targets$target_symbol %>% unique()
go_results <- enrichGO(
gene = gene_symbols,
OrgDb = org.Hs.eg.db,
keyType = "SYMBOL",
ont = "BP", # Biological Processes
pAdjustMethod = "BH",
pvalueCutoff = 0.05
)
# Visualización del análisis funcional
barplot(go_results, showCategory = 10, title = "Top 10 Procesos Biológicos Enriquecidos")
Search in PubMed with entrez
hsa-miR-520d-5p
Validated
genes_hsa_miR_520d_5p_validated_mirtarbase <- unique(filter_val_hsa_miR_520d_5p$target_symbol)
# Archivo para guardar los resultados
output_file <- "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/rentrez_search/metabolism_obesity_updated.txt"
# Abrir un archivo para escribir
file_conn <- file(output_file, open = "w")
# Bucle para consultar cada gen
for (gene in genes_hsa_miR_520d_5p_validated_mirtarbase) {
query <- paste0(gene, " AND metabolism", " AND adipose")
# Buscar en PubMed
search_results <- entrez_search(db = "pubmed", term = query, retmax = 10)
# Si hay resultados, recuperar los abstracts
if (length(search_results$ids) > 0) {
abstracts <- entrez_fetch(db = "pubmed", id = search_results$ids, rettype = "abstract")
writeLines(paste("###---------->", gene, "<----------###", sep = " "), file_conn)
writeLines(abstracts, file_conn)
writeLines("\n", file_conn)
}
}
# Cerrar el archivo
close(file_conn)
cat("Resultados guardados en:", output_file, "\n")Resultados guardados en: /home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/rentrez_search/metabolism_obesity_updated.txt Predicted
genes_hsa_miR_520d_5p_predicted <- unique(filter_pre_hsa_miR_520d_5p$target_symbol)
# Archivo para guardar los resultados
output_file <- "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/rentrez_search/predicted_metabolism_updated.txt"
# Abrir un archivo para escribir
file_conn <- file(output_file, open = "w")
# Bucle para consultar cada gen
for (gene in genes_hsa_miR_520d_5p_predicted) {
query <- paste0(gene, " AND metabolism", " AND diabetes", " AND adipose")
# Buscar en PubMed
search_results <- entrez_search(db = "pubmed", term = query, retmax = 10)
# Si hay resultados, recuperar los abstracts
if (length(search_results$ids) > 0) {
abstracts <- entrez_fetch(db = "pubmed", id = search_results$ids, rettype = "abstract")
writeLines(paste("###---------->", gene, "<----------###", sep = " "), file_conn)
writeLines(abstracts, file_conn)
writeLines("\n", file_conn)
}
}
# Cerrar el archivo
close(file_conn)
cat("Resultados guardados en:", output_file, "\n")Resultados guardados en: /home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_520d_5p/rentrez_search/predicted_metabolism_updated.txt hsa-miR-655-3p
Validated
genes_hsa_miR_655_3p_validated_mirtarbase <- unique(filter_val_hsa_miR_655_3p$target_symbol)
# Archivo para guardar los resultados
output_file <- "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/rentrez_search/mirtarbase_metabolism_updated.txt"
# Abrir un archivo para escribir
file_conn <- file(output_file, open = "w")
# Bucle para consultar cada gen
for (gene in genes_hsa_miR_655_3p_validated_mirtarbase) {
query <- paste0(gene, " AND metabolism", " AND adipose")
# Buscar en PubMed
search_results <- entrez_search(db = "pubmed", term = query, retmax = 10)
# Si hay resultados, recuperar los abstracts
if (length(search_results$ids) > 0) {
abstracts <- entrez_fetch(db = "pubmed", id = search_results$ids, rettype = "abstract")
writeLines(paste("###---------->", gene, "<----------###", sep = " "), file_conn)
writeLines(abstracts, file_conn)
writeLines("\n", file_conn)
}
}
# Cerrar el archivo
close(file_conn)
cat("Resultados guardados en:", output_file, "\n")Resultados guardados en: /home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/rentrez_search/mirtarbase_metabolism_updated.txt Predicted
genes_hsa_miR_655_3p_predicted <- unique(filter_pre_hsa_miR_655_3p$target_symbol)
# Archivo para guardar los resultados
output_file <- "/home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/rentrez_search/predicted_metabolism_updated.txt"
# Abrir un archivo para escribir
file_conn <- file(output_file, open = "w")
# Bucle para consultar cada gen
for (gene in genes_hsa_miR_655_3p_predicted) {
query <- paste0(gene, " AND metabolism", " AND diabetes", " AND adipose")
# Buscar en PubMed
search_results <- entrez_search(db = "pubmed", term = query, retmax = 10)
# Si hay resultados, recuperar los abstracts
if (length(search_results$ids) > 0) {
abstracts <- entrez_fetch(db = "pubmed", id = search_results$ids, rettype = "abstract")
writeLines(paste("###---------->", gene, "<----------###", sep = " "), file_conn)
writeLines(abstracts, file_conn)
writeLines("\n", file_conn)
}
}
# Cerrar el archivo
close(file_conn)
cat("Resultados guardados en:", output_file, "\n")Resultados guardados en: /home/joshoacr13/Documentos/TFM/mirna_analysis/miRNA_targets/hsa_miR_655_3p/rentrez_search/predicted_metabolism_updated.txt